428
Appendix L Human Health Risk Assessment Contents To be completed

Appendix L HHRA Combined

Embed Size (px)

DESCRIPTION

Human Health Risk Assessment for Gowanus Superfund Site

Citation preview

Page 1: Appendix L HHRA Combined

Appendix L Human Health Risk Assessment

Contents

To be completed

azelman
Text Box
Human Health Risk Assessment (HHRA)
Page 2: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 3: Appendix L HHRA Combined

I

Contents

Contents.......................................................................................................................................... i

1 Introduction ..................................................................................................................... 1-1 1.1 Introduction ............................................................................................................ 1-1

1.2 Site Background ..................................................................................................... 1-1

2 Conceptual Site Model .................................................................................................. 2-1

3 Scope of Human Health Risk Assessment................................................................. 3-1

4 Hazard Assessment/Identification of COPCs ........................................................... 4-1 4.1 Data Summary ........................................................................................................ 4-1

4.1.1 Surface Sediment ........................................................................................ 4-1

4.1.2 Surface Water .............................................................................................. 4-2

4.1.3 Ambient Air ................................................................................................. 4-2

4.1.4 Fish Tissue ................................................................................................... 4-2

4.2 Data Evaluation ...................................................................................................... 4-3

4.3 Selection of COPCs ................................................................................................ 4-4

4.4 Constituents of Potential Concern ....................................................................... 4-5

5 Exposure Assessment ..................................................................................................... 5-1 5.1 Characterization of Exposure Setting .................................................................. 5-1

5.1.1 Physical Setting ........................................................................................... 5-1

5.1.2 Potentially Exposed Populations.............................................................. 5-1

5.2 Identification of Exposure Pathways .................................................................. 5-2

5.2.1 Contaminant Sources ................................................................................. 5-2

5.2.2 Release and Transport Mechanisms ........................................................ 5-2

5.2.3 Exposure Points and Exposure Routes .................................................... 5-3

5.2.4 Summary of Potential Exposure Pathways ............................................ 5-3

5.3 Quantification of Exposure ................................................................................... 5-3

5.3.1 Exposure Concentrations .......................................................................... 5-3

5.3.2 Estimation of Chemical Intakes ................................................................ 5-5

6 Toxicity Assessment ....................................................................................................... 6-1 6.1 Toxicity Information for Noncarcinogenic Effects ............................................ 6-2

6.2 Toxicity Information for Carcinogenic Effects ................................................... 6-2

6.3 Approach for Potential Mutagenic Effects ......................................................... 6-3

7 Risk Characterization ..................................................................................................... 7-1 7.1 Methods for Estimating Risks .............................................................................. 7-1

7.1.1 Noncarcinogenic Hazard Estimation ....................................................... 7-1

7.1.2 Carcinogenic Risk Estimation ................................................................... 7-1

7.1.3 Lead .............................................................................................................. 7-2

7.2 Risk Assessment Results ....................................................................................... 7-3

7.2.1 Recreational Adults .................................................................................... 7-4

7.2.2 Recreational Adolescents ........................................................................... 7-4

7.2.3 Recreational Children ................................................................................ 7-4

7.2.4 Recreational Receptors – Lifetime Carcinogenic Risks ......................... 7-5

7.2.5 Industrial Workers ..................................................................................... 7-6

Page 4: Appendix L HHRA Combined

7.2.6 Adult Residents ........................................................................................... 7-6

7.2.7 Child Residents ........................................................................................... 7-7

7.2.8 Child/Adult (Lifetime) Residents ............................................................ 7-7

7.2.9 Adult Anglers .............................................................................................. 7-8

7.2.10 Adolescent Anglers ..................................................................................... 7-9

7.2.11 Children of Anglers .................................................................................... 7-9

7.2.12 Anglers – Lifetime Carcinogenic Risks .................................................. 7-10

8 Uncertainty Assessment ................................................................................................. 8-1 8.1 Uncertainty in Data Evaluation and COPC Identification ............................... 8-1

8.2 Uncertainty Associated with Exposure Assessment ......................................... 8-2

8.3 Uncertainty Associated with Toxicity Assessment ........................................... 8-4

9 Human Health Risk Summary ..................................................................................... 9-1

10 References ....................................................................................................................... 10-1

Attachment

USEPA RAGS Part D and Supporting Tables

Tables

4-1 Summary of Data Quantitatively Used in HHRA 4-2 Chemicals of Potential Concern 5-1 WHO Dioxin-like PCB TEFs 5-2 Preparation/Cooking Loss Factor (PCF) for Fish 7-1 Summary of RME Cancer Risks and Hazard Indexes 7-2 Summary of CTE Cancer Risks and Hazard Indexes 7-3 PCBs, Mercury, and Arsenic in Canal and Reference Fish and Crab Tissue Samples 7-4 Summary of Total RME Cancer Risks for Recreational User and Angler 7-5 Summary of Total CTE Cancer Risks for Recreational User and Angler

Figures

2-1 Conceptual Exposure Model for Human Health Risk Assessment

Page 5: Appendix L HHRA Combined

1-1

SECTION 1

Introduction

1.1 Introduction

This baseline human health risk assessment (HHRA) for the Gowanus Canal Superfund Site is Appendix L to the remedial investigation (RI) report. The baseline HHRA was conducted to assess the nature, magnitude, and probability of potential harm to public health posed by environmental media containing hazardous substances released to the Gowanus Canal by past activities along the canal—specifically, the potential human health risks associated with direct contact with sediment and surface water in the canal, with ingestion of fish and crabs caught in the canal, with direct contact of sediment and surface water that overtops the canal during significant rainfall events, and with inhalation of emissions from the canal into the ambient air near the canal. The data evaluated in the HHRA are presented in Appendix I to the RI report and discussed in Section 4 of the RI report.

1.2 Site Background

The Gowanus Canal is located in Brooklyn, New York, a borough of New York City. The canal is connected to the Gowanus Bay in the Upper New York Bay and borders the neighborhoods of Red Hook, Cobble Hill, Carroll Gardens, and Park Slope. The waterfront adjacent to the canal is primarily commercial and industrial and currently consists of concrete plants, warehouses, and parking lots. There are five bridge crossings over the canal, at Union Street, Carroll Street, Third Street, Ninth Street, and Hamilton Avenue (Figure 1-1 of the RI). The Gowanus Expressway and the New York Subway also cross over the canal.

The Gowanus Canal, completed in the 1860s, was built to allow water access for industrial needs by bulkheading and dredging a tidal creek and wetland that was previously fished for oysters. The canal quickly became one of the nation’s busiest industrial waterways and was home to heavy industry such as gas works, coal yards, manufacturers of cement, manufacturers of soap, tanneries, paint and ink factories, machine shops, chemical plants, and oil refineries. It was also used as a repository of untreated industrial wastes, raw sewage, and surface water runoff for many decades. Although much of the industrial activity along the canal has stopped, high contaminant levels remain in the sediments. Despite ongoing pollution problems, some local residents use the Gowanus Canal for recreational purposes such as canoeing and swimming/diving, while others catch and eat fish and crabs.

The City built a “flushing tunnel” in 1911 to replace stagnant canal water with fresh, oxygen-rich water to improve water quality. The tunnel was in operation until the 1960s, when a mechanical failure caused it to shut down and the canal water became stagnant and thus polluted once again. The flushing tunnel was rehabilitated and reactivated in 1999 by the City’s Department of Environmental Protection (NYCDEP) to pump water from Buttermilk Channel to the Gowanus Canal using the 1911 technology. The flushing tunnel

Page 6: Appendix L HHRA Combined

was shut down by NYCDEP on July 19, 2010, for an extended period of facility improvements to modernize the technology and improve operations. In early 2010, an aeration pipe was installed within the canal to circulate superoxygenated water while the flushing tunnel is shut down. The aeration pipe began operation in early July 2010, and repairs were started on the flushing tunnel. The completion date is anticipated to be September 2014.

The canal is part of the New York-New Jersey Estuary, which the U.S. Environmental Protection Agency (USEPA) has designated an Estuary of National Significance under the Clean Water Act Section 320 and USEPA’s National Estuary Program.

Page 7: Appendix L HHRA Combined

2-1

SECTION 2

Conceptual Site Model

The conceptual site model (CSM) for human receptors presents an overview of site conditions, potential contaminant migration pathways, and potential exposure pathways to potential receptors. Figure 2-1 presents the preliminary CSM developed for the Gowanus Canal. Table 1 in the Attachment summarizes the potential exposure pathways and scenarios that were evaluated as part of the risk assessment.

There have been many sources of contamination to the canal, as discussed in Section 1. Although much of the industrial activity along the canal has stopped, high contaminant levels remain in the sediments.

The watershed drainage area of the Gowanus Canal is 1,758 acres, and the canal waterfront, or riparian area (defined as all blocks wholly or partially within ¼ mile of the canal), is occupied by commercial and industrial properties. The waterfront properties include concrete plants, warehouses, and parking lots. The riparian areas are classified as 18 percent residential, 6 percent park, and 76 percent mixed use. The entire watershed is 53 percent residential, 2 percent park, and 45 percent mixed use (NYCDEP, 2008).

Combined sewers (i.e., sewers that receive both sewage and stormwater flows) serve 92 percent of the Gowanus Canal watershed, while storm sewers serve 2 percent (NYCDEP, 2008). Direct runoff drains 6 percent of the watershed. Three stormwater outfalls also discharge to the canal. During significant rainfall events, the Gowanus Canal receives untreated discharges of combined sewage that exceed the capacity of the Red Hook and Owls Head wastewater pollution control plants (WPCPs); during such events, the canal has overflowed onto neighboring properties and streets. The area surrounding the canal is within a 100-year flood zone, indicating that there is a 1 percent annual chance of flooding in this area (FEMA, 2007).

Currently, the New York State Department of Health (NYSDOH) has fish-consumption advisories for the Upper Bay of the New York Harbor (north of the Verrazano Narrows Bridge), including the Gowanus Canal (NYSDOH, 2010). There are no warning signs concerning the fish-consumption advisories posted along the canal; however, New York City has posted caution signs at locations of combined sewer outfall (CSO) discharges that state during wet weather the CSOs may discharge harmful bacteria to the canal and people should not swim, boat, or fish during these periods. A fishing license is not required to fish in the Gowanus Canal. The main contaminants of concern identified in the NYSDOH health advisories for the waters of the Upper Bay of New York Harbor are polychlorinated biphenyls (PCBs) and dioxin in fish, and cadmium, dioxin, and PCBs in crab and lobster. The NYSDOH advisories include the following advice:

• For women under 50 years and children under 15 years: Do not eat any fish from these waters, eat no more than a few meals per year of crab meat from these waters, and avoid eating the crab tomalley (hepatopancras) and cooking liquid.

Page 8: Appendix L HHRA Combined

• For all others: Do not eat gizzard shad, white perch, or crab and lobster tomalley (hepatopancreas) and cooking liquid; eat only one meal per month of Atlantic needlefish, bluefish, rainbow smelt, and striped bass; eat no more than four meals per month of all other fish species and blue crab meat.

Potential current and future receptors at the Gowanus Canal may include recreational users, anglers, local residents, and nearby industrial workers. The recreational receptors may contact surface water and sediment through incidental ingestion and dermal absorption and inhale ambient air (volatile and particulate emissions from the surface water and sediment) at canal level while boating, fishing, and crabbing in the canal and potentially, although less common and less likely, while swimming/diving in the canal.

Swimming/diving in the canal, although it does occur (Gowanus Dredgers Canoe Club, 2010; New York Times, 2007; The Gowanus Lounge, 2007), is rare due to the general conditions of the canal, which are largely associated with CSO discharges to the canal. The anglers may also ingest fish or crabs caught in the canal, and share the fish and crabs with family members, including young children and adolescents. Residents and industrial workers may inhale ambient air (associated with volatile and particulate emissions from the canal) at street level. Also, it has been noted that during significant rainfall events the canal may overflow (about two to three times per year), and these residents and industrial workers may contact surface water and sediment (that has overtopped the canal) through incidental ingestion and dermal contact. If any of the sediment that has overtopped the canal is not washed away with rain, it is usually swept up by the local residents or workers and does not accumulate.

Future use of the area surrounding the canal is most likely to remain the same as current use (industrial and residential), with the potential for construction of new housing, which would result in additional residential populations living close to the canal.

Page 9: Appendix L HHRA Combined

3-1

SECTION 3

Scope of Human Health Risk Assessment

The primary objective of the baseline HHRA is to assess the potential current and future health risks from the contamination associated with the Gowanus Canal, in the absence of any remedial action. The risk assessment evaluates potential carcinogenic risks and noncarcinogenic hazards for a reasonable maximum exposure (RME) scenario consistent with the National Contingency Plan (NCP) (USEPA, 1994a) and Risk Assessment Guidance for Superfund (RAGS) guidance documents (USEPA, 1989, 1991, 2001a, 2004, 2009). The RME is the highest exposure that is reasonably expected to occur at a site (USEPA, 1989). The risk assessment comprises the following components:

• Hazard Assessment/Identification of Chemicals of Potential Concern—Identification of the contaminants found in the canal media and selection of the chemicals of potential concern (COPCs). COPCs represent that subset of the chemicals found at the canal that is expected to contribute the most to the risk estimates for the canal.

• Exposure Assessment—Identification of the potential pathways of human exposure and estimation of the magnitude, frequency, and duration of these exposures.

• Toxicity Assessment—Assessment of the potential adverse effects of the COPCs and compilation of the noncarcinogenic and carcinogenic toxicity values used for developing numerical risk estimates.

• Risk Characterization—Integration of the results of the hazard, exposure, and toxicity assessments to develop numerical estimates of health risks and characterize the potential health risks associated with potential exposure to site-related contamination.

• Uncertainty Assessment—Identification and discussion of sources of uncertainty in the risk assessment.

Page 10: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 11: Appendix L HHRA Combined

4-1

SECTION 4

Hazard Assessment/Identification of COPCs

The identification of COPCs includes data collection, data evaluation, and data screening to identify those chemicals which would contribute the most to the total risk estimates associated with the site.

The data collection and evaluation involve gathering and reviewing the available site information and compiling a set of data for the purpose of conducting the baseline HHRA. Once the data collection and evaluation are completed, the established data set is further screened to focus the risk assessment efforts on the contaminants that need to be evaluated quantitatively in the risk assessment (data screening).

4.1 Data Summary

The purpose of this investigation is to evaluate the potential human health risks associated with contamination in surface sediment and surface water in the Gowanus Canal, in fish and crab caught in the canal, and in air from emissions from the canal media. Surface water and sediment samples collected from the canal, fish and crab tissue samples collected from the canal, and air samples collected at canal level and street level adjacent to the canal were evaluated in the baseline HHRA. Samples for all media have also been collected from reference areas. All of the data are included in Appendix I to the RI report. The samples evaluated in the baseline HHRA and the laboratory analysis performed for these samples are identified in Table 4-1. All data used in the risk assessment were validated in accordance with USEPA Region 2 Data Validation SOPs (USEPA Region 2, 1992, 2001b).

4.1.1 Surface Sediment

Surface sediment sampling activities were conducted within the Gowanus Canal and New York Harbor between June 17 and July 1, 2010. Surface sediment samples were collected over the length of the canal from 0 to 6 inches below the top of soft sediment. Some of the surface sediment samples were collected at locations where sediments are exposed at low-tide. Figures 2-3a through 2-3c in the RI report identify the locations where the surface sediment samples were collected. A total of 27 surface sediment samples were collected from the canal. Twelve of the samples were collected from “exposed” locations. All sediment samples were analyzed for Target Compound List (TCL) organics and Target Analyte List (TAL) metals (including mercury and cyanide), and these data were evaluated in the HHRA. Additionally, 19 sediment samples were analyzed for PCB congeners. These 19 locations were selected to provide data for areas with the greatest potential for human exposure (e.g., the canoe launch), to provide data in areas where high PCB concentrations were previously measured in sediment, and to provide spatial coverage throughout the canal. The PCB concentrations and risks were calculated based on total PCBs derived from congener data. Aroclor data were not used in the risk calculations. Ten surface sediment samples were also collected from the Gowanus Bay and Upper New York Bay, outside the mouth of the canal, to provide information for offsite conditions. Figure 2-4 of the RI identifies the reference surface sediment locations.

Page 12: Appendix L HHRA Combined

Two data groupings of surface sediment were evaluated in the HHRA. All of the surface sediment data were included in the data set to evaluate overflow sediment. Only the surface sediment samples collected from “exposed” locations were included in the data set used to evaluate contact with sediment during recreational use of the canal.

4.1.2 Surface Water

Surface water samples were collected from the length of Gowanus Canal during two sampling events representing dry-weather (June 19, 2010; 27 samples) and wet-weather (July 13, 2010; 26 samples) conditions. Figures 2-5a through 2-5c in the RI identify the locations where the surface water samples were collected. Ten offsite surface water samples were collected from the New York Harbor and Buttermilk Channel. Figure 2-6 identifies the offsite surface water sample locations. The surface water samples were collected from approximately 6 inches below the water surface. Surface water samples from all locations were analyzed for TCL organics and TAL metals (total and dissolved including mercury and cyanide). The total metals data were evaluated to estimate risks associated with metals in the HHRA, as the receptors would come in direct contact with total (rather than dissolved) concentrations in surface water.

4.1.3 Ambient Air

Air-sampling activities were conducted along the Gowanus Canal and at background locations during two sampling events. Air samples were collected between July 7 and 9, 2010, prior to the start of the canal oxygenation system. A second round of air sampling was conducted July 28 and 29, 2010, following the start-up of the oxygenation system. Air samples were collected at 10 locations along the length of the canal with two samples collected at each location, one at canal level and one at street level. Air samples were also collected at three background locations, with one sample at street level at each location. Figure 2-9 in the RI shows the locations of the air samples. Air samples along the canal were analyzed for VOCs and PAHs. Location 506 at the street level was also analyzed for PCBs during the first sampling event.

4.1.4 Fish Tissue

Fish and crab samples were collected in the Gowanus Canal and reference locations in Gowanus Bay and Upper New York Bay from June 21 through July 9, 2010. Fish and shellfish were collected in six reaches of the canal and in three reference areas (Figures 2-7 and 2-8 of the RI). Species targeted for sampling and evaluation in the HHRA included blue crab, striped bass, and white perch. Additional species caught and evaluated in the HHRA included American eel. These species were targeted on the basis of previous catch records for the canal, since they are typically consumed by humans, and because they represent different levels within the food web and have potentially different exposure within the ecosystem. These species were selected as the target fish/crab species for the canal in consultation with USEPA.

Both top-level predator (striped bass) and middle-level predator (white perch) fish tissue samples were collected and evaluated in the HHRA. The top-level predators represent species reflecting high-end bioaccumulation due to their position in the food web and are occasionally harvested and consumed by anglers. However, these fish tend to have a relatively large home range, and thus lower site fidelity, and a greater chance of

Page 13: Appendix L HHRA Combined

accumulating contaminants from offsite sources. The midlevel predator represents species most frequently harvested and consumed by anglers and likely retains greater site fidelity. However, the midlevel predator may not reflect maximum bioaccumulation due to its position in the food web. Additionally, because eel were caught during the sampling, and eel are consumed by humans, the eel were evaluated in the HHRA and represent bottom feeders.

Section 2.5 of the RI details the fish sampling, tissue preparation and grouping, and the preparation of fish samples for laboratory analysis. Twelve composite samples of blue crab, six composite samples of eel, five composite samples of striped bass, and two composite samples of white perch were included for quantitative evaluation in the HHRA.

Edible tissue (filet only) samples were analyzed to assess potential human health risks associated with ingestion of striped bass, white perch, and eel. For blue crab, edible portion samples and hepatopancreas samples were analyzed separately and combined to estimate human health risks. The hepatopancreas is a main component of a crab’s digestive system. It functions as both the liver and pancreas for the crab, and is involved in producing digestive enzymes and is responsible for filtering impurities from the crab’s blood. Some chemicals, such as PCBs and mercury, accumulate in the hepatopancreas. May and Burger (1996) reported that most crabbers in the Newark Bay Complex eat only cleaned crabs, and discard the hepatopancreas, with fewer than 3 percent of those surveyed eating the whole crab. The New Jersey Department of Environmental Protection (NJDEP) (2002) reported that 15 percent of the population surveyed in the Newark Bay Complex ate the hepatopancreas. It is possible that an individual may be exposed to the hepatopancreas during cooking unless actions are taken to remove the hepatopancreas from the crab prior to cooking. Based on the NJDEP report (NJDEP, 2002) and the potential for the hepatopancreas to be released during cooking, an individual may be exposed to both crab edible tissue and hepatopancreas. Therefore, the risk evaluation considered exposures to both the edible tissue and the hepatopancreas as the RME scenario. Risks from ingestion of the edible tissue only are discussed in the Uncertainty Assessment.

4.2 Data Evaluation

All of the data included in the risk assessment were evaluated to assess their reliability for use in the quantitative risk assessment. The following criteria were used to assess data usability:

• Estimated values flagged with a J or NJ qualifier were treated as unqualified detected concentrations.

• Data qualified with an R (rejected) were not used in the risk assessment.

• Data qualified with a B (blank contamination) were used in the risk assessment as if the constituents were not detected.

• For duplicate samples, the maximum concentration between the two samples was used as the sample concentration.

Page 14: Appendix L HHRA Combined

• Only the detected congeners were used to calculate the total PCB concentrations for each sample. Undetected congeners and congeners qualified with a B were not included in the calculations (see Section 5.3.1).

• Nondetected values (for all analytes except PCBs) were included in the risk assessment and exposure concentration calculation at the detection limit using ProUCL (USEPA, 2010a).

4.3 Selection of COPCs

The identification of COPCs is shown in Tables 2.1 through 2.13 in the Attachment. The methodology used to select the COPCs for quantitative evaluation in the baseline HHRA is outlined below:

• Sediment data were compared to the USEPA Regional Screening Levels (RSLs) for residential exposure to soil (USEPA, 2010b). RSLs that are based on the chemical’s noncarcinogenic effects (noted with an ‘’”N” next to the screening toxicity value on the COPC screening table) were divided by 10 to account for potential exposure to multiple constituents. RSLs that are based on carcinogenic effects (noted with a “C”‘’ next to the screening toxicity value on the COPC screening table) were used without adjustment because the target carcinogenic risk used in the RSL calculations is based on a 1 × 10–6 risk level. Constituents whose maximum detected concentration is below the screening level were not retained as COPCs. As discussed in Section 4.1.1, sediment samples were analyzed for both Aroclors and PCB congeners. Only the PCB congener data were evaluated in the risk assessment so that the risks associated with PCBs would not be double-counted in the HHRA. In accordance with EPA guidance (USEPA, 1996) for PCB congener analysis, the “dioxin-like” PCB toxicity equivalent (TEQ) concentration, the “non-dioxin-like” total PCB concentration, and the total PCB concentration were calculated for each sample using the methods discussed in Section 5.3.1. The dioxin-like PCB TEQ concentration was screened against the 2,3,7,8-TCDD RSL (which was re-calculated from the value on the RSL table using the 2,3,7,8-TCDD oral cancer slope factor from USEPA, 1995), the non-dioxin-like PCB concentration was screened against the Aroclor-1260 RSL, and the total PCB concentration was screened against the Aroclor-1254 RSL.

• Surface water data were compared to the USEPA tap water RSLs (USEPA, 2010b). RSLs that are based on the chemical’s noncarcinogenic effects were divided by 10 to account for potential exposure to multiple constituents. RSLs that are based on carcinogenic effects were used without adjustment because the target carcinogenic risk used in the RSL calculations is based on a 1 ×10–6 risk level. Constituents whose maximum detected concentration is below the screening value were not retained as COPCs.

• Fish tissue and crab sample data were compared to the USEPA Region 3 fish ingestion RSLs (USEPA Region 3, 2010c). RSLs that are based on noncarcinogenic effects were divided by 10 to account for exposure to multiple constituents. RSLs that are based on carcinogenic effects were used without adjustment. Constituents whose maximum detected concentrations are below the screening level were not retained as COPCs. In accordance with USEPA guidance (USEPA, 1996) for PCB congener analysis, the “dioxin-like” PCB TEQ concentration, the “non-dioxin-like” total PCB concentration,

Page 15: Appendix L HHRA Combined

and the total PCB concentration were calculated for each sample using the methods discussed in Section 5.3.1. The dioxin-like PCB TEQ concentration was screened against the 2,3,7,8-TCDD RSL (which was re-calculated from the value on the RSL table using the 2,3,7,8-TCDD oral cancer slope factor from USEPA, 1995), the non-dioxin-like PCB concentration was screened against the Aroclor-1260 RSL, and the total PCB concentration was screened against the Aroclor-1254 RSL.

• Air data were compared to the USEPA resident air RSLs (USEPA, 2010b). RSLs that are based on noncarcinogenic effects were divided by 10 to account for exposure to multiple constituents. RSLs that are based on carcinogenic effects were used without adjustment. Constituents whose maximum detected concentrations are below the screening level were not retained as COPCs.

• Essential human nutrients (calcium, magnesium, potassium, and sodium) that are toxic at concentrations significantly higher than those found in canal media, and whose concentrations in canal media are only slightly higher than the concentrations at which they occur naturally, were not retained as COPCs.

• Lead concentrations less than 0.015 mg/L in surface water (the Safe Drinking Water Act action level for lead in potable water) and less than 400 mg/kg in sediment (USEPA, 1994b) are considered adequately protective of human health under residential land-use conditions. Lead was retained as a COPC when exceeding these values. Lead was not detected in fish tissue.

• Constituents that were detected in less than 5 percent of the samples were not retained as COPCs (USEPA, 1989).

• Detected constituents classified as USEPA Class A carcinogens (known human carcinogens) were retained as COPCs for evaluation regardless of the comparison of the concentration to the screening level (USEPA, 1989).

• For constituents detected in canal samples that do not have established USEPA RSLs, the RSL values for surrogate constituents were selected based on guidance from the Superfund Technical Support Center and used in the COPC screening process.

4.4 Constituents of Potential Concern

Table 4-2 lists the chemicals that were identified as COPCs for site media:

• Surface sediment (exposed and near-shore)—11 PAHs [acenaphthene, benzo(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, benzo(k)fluoranthene, chrysene, dibenz(a,h)anthracene, fluoranthene, indeno(1,2,3-cd)pyrene, naphthalene, and pyrene], one additional SVOC [bis(2-ethylhexyl)phthalate], PCBs, and 10 metals (aluminum, arsenic, cadmium, chromium, cobalt, copper, iron, lead, manganese, and vanadium).

• Surface sediment (overflow scenario)—the chemicals indicated above (exposed and near-shore) plus one additional PAH (fluorene).

• Surface water (dry event)—one VOC (benzene), four PAHs [benzo(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene , and indeno(1,2,3-cd)pyrene], one additional

Page 16: Appendix L HHRA Combined

SVOC [bis(2-ethylhexyl)phthalate], and four metals (arsenic, chromium, copper, and selenium).

• Surface water (wet event and overflow)—the chemicals indicated above (dry event) plus four additional VOCs (1,4-dichlorobenzene, chloroform, ethylbenzene, and tetrachloroethene), two additional PAHs [dibenz(a,h)anthracene and naphthalene] , two additional metals (cobalt and lead), and one less metal (copper).

• Ambient air (street level)—benzene, chloroform, ethylbenzene and naphthalene.

• Ambient air (canal level)—the chemicals indicated above (street level) plus xylene.

• Fish tissue (striped bass)—two pesticides (p,p’-DDE and p,p’-DDT), PCBs, and three metals (arsenic, mercury, and selenium).

• Fish tissue (white perch)—PCBs and two metals (mercury and selenium)

• Fish tissue (eel)—six pesticides (alpha-chlordane, gamma-chlordane, dieldrin, p,p’-DDD, p,p’-DDE, and p,p’-DDT), PCBs, and six metals (arsenic, chromium, copper, cyanide. mercury, and selenium).

• Blue crab—five PAHs (benzo(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, dibenz(a,h)anthracene, and indeno(1,2,3-cd)pyrene), PCBs, and three metals (arsenic, copper, and mercury).

Page 17: Appendix L HHRA Combined

5-1

SECTION 5

Exposure Assessment

Exposure assessment is the estimation of the likelihood, magnitude, frequency, duration, and routes of potential exposure to a chemical. Exposure refers to the potential contact of an individual (or receptor) with a chemical. Exposure can occur when contaminants migrate from a source to an exposure point, or when a receptor comes into direct contact with contaminated media.

The components of exposure assessment include the following:

•••• Characterization of exposure setting

•••• Identification of exposure pathways, and evaluation of whether they are complete

•••• Quantification of exposure

5.1 Characterization of Exposure Setting

Characterization of exposure setting consists of two parts: (1) characterization of the site with respect to its physical characteristics and (2) characterization of the site with respect to human populations at or near the site.

5.1.1 Physical Setting

The physical setting is described in the Section 2, the CSM. The Gowanus Canal is a 1.8-mile-long canal located in the New York City borough of Brooklyn, Kings County, New York. The canal borders several residential neighborhoods including Red Hook, Cobble Hill, Carroll Gardens, and Park Slope. The waterfront properties abutting the canal are primarily commercial and industrial.

The Gowanus Canal is a tidally influenced dead-end channel that opens to Gowanus Bay and Upper New York Bay. The canal experiences a semidiurnal tidal cycle (i.e., two high tides and two low tides each tidal day). The entire canal is classified as a saline tributary to Upper New York Bay, and the reach between the head of the canal and 22nd Street is classified as a “minor river, tidal tributary,” according to Title 6 of the New York Code of Rules and Regulations, Chapter X, Part 890. The only freshwater inflows to the canal are wet-weather CSO and stormwater discharges. Because of its narrow width, limited freshwater input, and enclosed upper end, the canal has low current speeds and limited tidal exchange with Gowanus Bay, though these are enhanced by additional circulation from the flushing tunnel when it is operating (NYCDEP, 2008).

5.1.2 Potentially Exposed Populations

As discussed above, the area around the Gowanus Canal consists of industrial, commercial, and residential properties. The Gowanus Canal itself may be used for recreational activities such as boating, swimming/diving, fishing, and crabbing (Gowanus Dredgers Canoe Club, 2010; New York Times, 2007; The Gowanus Lounge, 2007). Despite current fish advisories for the Upper New York Bay, which includes the Gowanus Canal, there have been observations of fishing/crabbing along the canal (The Gowanus Lounge, 2007). Although

Page 18: Appendix L HHRA Combined

most properties abutting the canal are commercial and industrial, there are residential neighborhoods within a few blocks of the canal. Therefore, potential current receptors for the surface water, sediment, air, and/or fish and crabs include recreationalists, anglers (and their families), local residents, and industrial workers. Table 1 in the Attachment identifies the potential receptors.

Future use of the canal and use of the surrounding area will likely remain the same as current use. Additionally, there have been discussions concerning construction of residential housing complexes adjacent to the canal. Therefore, the future potentially exposed populations are assumed to be the same as the current potentially exposed populations.

5.2 Identification of Exposure Pathways

An exposure pathway may be described as the physical course that a COPC takes from the point of release to a receptor. To be complete, an exposure pathway must have all of the following components present:

• A source

• A mechanism of a chemical release and transport

• An environmental transport medium

• An exposure point (receptor location)

• An exposure route (inhalation, dermal absorption, ingestion)

• A receptor or exposed population

In the absence of any one of these components, an exposure pathway is considered incomplete and, by definition, there is no risk or hazard. In some cases, a receptor may contact a source directly, eliminating the release and transport pathway.

The potential exposure pathways for Gowanus Canal are identified in the preliminary CSM (Figure 2-1) and Table 1 in the Attachment.

5.2.1 Contaminant Sources

The potential contaminant sources are identified in the preliminary CSM, in Section 2, and include past use of the areas abutting the canal by gas works, coal yards, manufacturers of cement, manufacturers of soap, tanneries, paint and ink factories, machine shops, chemical plants, and oil refineries. The canal was also used as a repository of untreated industrial wastes, raw sewage, and surface water runoff for many decades.

5.2.2 Release and Transport Mechanisms

The primary contaminant release and transport mechanism at the Gowanus Canal site appears to be the discharge from past industrial activities into the canal surface water, accumulation in the sediment, and bioaccumulation into fish and crabs. The transport pathway from emissions from surface water and sediment to ambient air will be evaluated in the risk assessment using the ambient air data collected along the canal. Additionally, the canal has been known to overflow during heavy precipitation events, resulting in transport of surface water and sediment out of the canal onto properties and streets adjacent to the canal. The surface water and sediment remains on the properties and streets adjacent to the canal only for short periods of time during the overflow and flooding events.

Page 19: Appendix L HHRA Combined

5.2.3 Exposure Points and Exposure Routes

Potential exposure points include the surface water and sediment within the canal, surface water and sediment temporarily deposited on properties adjacent to the canal when the canal overflows its banks during heavy precipitation events, ambient air at canal level and street level adjacent to the canal, and fish and crab caught in the canal. Table 1 in the Attachment lists all of the potential exposure pathways that were considered for evaluation in the risk assessment.

5.2.4 Summary of Potential Exposure Pathways

In summary, the potential pathways that were evaluated under the current/future land use scenario include the following:

•••• Adult, adolescent (12–18 years old), and child (1–6 years old) recreational: incidental ingestion and dermal contact with canal surface water (during both wet- and dry-sampling events); incidental ingestion and dermal contact with exposed and near-shore sediment in the canal; inhalation of ambient air at canal level (both before and during aeration system operation).

•••• Adult and adolescent (12–18 years old) angler and child (1–6 years old) of angler: ingestion of fish (striped bass, white perch, and eel) and crab caught in the canal.

•••• Adult and child (1–6 years) residents: inhalation of ambient air at street level (both before and during aeration system operation); incidental ingestion and dermal contact with canal overflow surface water (using surface water collected during wet events); incidental ingestion and dermal contact with sediment deposited adjacent to the canal (using surface sediment data) during canal overflow events.

•••• Adult industrial worker: inhalation of ambient air at street level (both before and during aeration system operation); incidental ingestion and dermal contact with canal overflow surface water (using surface water collected during wet events); incidental ingestion and dermal contact with sediment deposited adjacent to the canal (using surface sediment data) during canal overflow events.

5.3 Quantification of Exposure

Quantification of exposure involves estimating the exposure point concentration (EPC) and chemical intake.

5.3.1 Exposure Concentrations

The EPC is the estimated concentration at the point of contact. EPCs may be measured directly (i.e., surface water concentration) or calculated using fate and transport models. No fate and transport modeling was conducted for the Gowanus Canal risk assessment since data were collected at potential exposure points.

The EPCs for each COPC were calculated as the 95 percent upper confidence limit (UCL) of the mean concentration. The maximum detected concentration was used in place of the UCL as the EPC when the calculated UCL was greater than the maximum detected value or less than eight samples were available for the data grouping.

Page 20: Appendix L HHRA Combined

ProUCL, Version 4.00.05 (USEPA, 2010a), was used to calculate the UCLs and determine the data distribution. The data distribution identified was used to compute the most appropriate UCL for that specific data set. The recommendations in the ProUCL output file and outlined in the ProUCL model documentation were used to select the appropriate UCL.

In accordance with USEPA guidance (USEPA, 1996), EPCs were calculated separately for each medium (sediment and fish tissue) and data groupings for which PCB congeners were analyzed for (1) “dioxin-like” PCB TEQ concentrations, (2) “non-dioxin-like” total PCB concentrations, and (3) total PCB concentrations. These three concentrations were calculated for each sample using the methods discussed below. The concentrations were calculated using only the detected PCB congeners in each sample. Nondetected congeners and B-flagged congeners were not included in the individual sample sums. The calculations are included in Tables 2.8 Supplement A, 2.11 Supplement A, and 2.12 Supplement A in the Attachment for fish and crab, and for sediment, respectively. Detection limits are not shown on these tables for all of the dioxin congeners. The reporting limits are unreliable because during data validation the reporting limits were not provided correctly if the sample was reanalyzed or diluted. Appendix H presents the data quality evaluation. The uncertainties associated with the EPC calculation approach for PCBs are discussed in Section 8.

TEQ concentrations for “dioxin-like” PCBs were calculated for each sample in accordance with the World Health Organization (WHO) toxicity equivalency factor (TEF) approach (USEPA, 2010d). The purpose of using the WHO TEF approach is to adjust the relative carcinogenic potency of specific dioxin-like PCB congeners relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD), the most potent dioxin congener. TEFs are published by WHO for mammals (including humans), fish, and wildlife. PCB TEQs were calculated using the mammal TEFs. Using the measured concentration values for each congener and the TEF for that congener, the TEQ for a mixture of PCB congeners in a specific sample is calculated as follows:

TEQ = Σ (TEFi × Ci)

where:

TEFi = Toxicity equivalency factor for congener i Ci = Concentration of congener i

Risks from the calculated dioxin-like PCB TEQ are therefore based on the toxicity factors for 2,3,7,8-TCDD. The TEFs used to calculate the dioxin-like PCB TEQ concentrations are provided in Table 5-1. Although there are also noncancer toxicity factors for 2,3,7,8-TCDD, there is greater uncertainty associated with evaluating the noncancer risk for the dioxin-like PCB TEQ concentrations using these values. Therefore, the evaluation of noncancer hazards associated with the dioxin-like PCB TEQ concentrations is presented in the uncertainty evaluation (Section 8).

The non-dioxin-like PCB concentrations (the sum of all detected non-dioxin-like PCB congeners) were also calculated and evaluated for carcinogenic risks using carcinogenic toxicity factors for total PCBs. The total PCB concentrations (the sum of all detected PCB congeners, not adjusted using TEFs) were also calculated for each sample and were used to evaluate noncarcinogenic effects.

Page 21: Appendix L HHRA Combined

Most arsenic present in fish and crab tissue is present in the organic form of arsenic (organoarsenical compounds), which is relatively nontoxic to humans and is excreted rapidly and unchanged in urine (U.S. Food and Drug Administration [FDA], 1993; ATSDR, 2007). Some regulatory agencies (for example, FDA) regulate arsenic in fish based on a default but conservative assumption that 10 percent of the total arsenic in fish tissue is potentially in the toxic (carcinogenic) form. Therefore, for this HHRA, it was assumed that 10 percent of the measured total arsenic in fish and crab tissue was in the inorganic form of arsenic. To account for this adjustment, the EPCs for arsenic used in the intake calculations are 10 percent of the total measured arsenic concentrations. The total measured arsenic concentrations are shown in Tables 3.8 through 3.11 in the Attachment, while 10 percent of the total measured values are shown in the Tables 7.8.RME through 7.10.RME and 7.7.CTE through 7.9.CTE in the Attachment.

5.3.2 Estimation of Chemical Intakes

The quantification of exposure is based on an estimate of the chronic daily intake (CDI), the average amount of the chemical contaminant entering the receptor’s body per day. Chemical intake estimates for the ingestion and dermal exposure pathways are generally expressed as follows:

CDI = C × CR × EF × ED BW × AT Where:

CDI = chronic daily intake (mg/kg-day) C = chemical concentration (mg/L, mg/kg) CR = contact rate (L/day, mg/day) EF = exposure frequency (days/year) ED = exposure duration (years) BW = body weight (kg) AT = averaging time (days)

For the dermal pathway, the contact rate usually incorporates the skin surface area in contact with the exposure medium (water or sediment), and an absorption factor. The intake equation for the dermal exposure pathway is shown in the Attachment, Tables 4.1 (RME and CTE) and 4.5 (RME and CTE) for sediment and Tables 4.2 (RME and CTE) and 4.6 (RME and CTE) for surface water.

Chemical exposure estimates for the inhalation pathway are generally expressed as follows:

EC = Ca × ET × EF × ED × CF AT Where:

EC = exposure concentration (mg/m3) Ca = chemical concentration in air (mg/m3) ET = exposure time (hours/day) EF = exposure frequency (days/year) ED = exposure duration (years) CF = conversion factor (day/24 hours) AT = averaging time (days)

Page 22: Appendix L HHRA Combined

The intake and exposure equations require exposure parameters that are specific to each exposure pathway. Many of the exposure parameters have default values, which were used for this assessment. These assumptions, based on estimates of body weights, media intake levels, and exposure frequencies and duration, are provided in USEPA guidance. Other assumptions (e.g., for the recreational scenarios) require consideration of location-specific information and were determined using professional judgment. Tables 4.1.RME through 4.6.RME in the Attachment present the exposure parameters that were used for the exposure scenarios that were evaluated in the risk assessment. RME scenario exposure parameters were compiled for all scenarios; central tendency exposure (CTE) parameters were compiled only for scenarios where the RME risk for an environmental medium is greater than ’USEPA’s noncarcinogenic hazard or carcinogenic risk target levels (target organ-specific hazard index (HI) >1.0, and excess lifetime cancer risk (ELCR) >1 × 10-4). The exposure parameters selected for each receptor are discussed below.

For the fish consumption evaluation, the fish ingestion rate for each of the species of fish evaluated was adjusted to a percentage of the total fish ingestion rate assumed, as reported in literature for the State of New York. The percentage of ingestion of each fish type was obtained from the 1991 New York State Angler Report (Connelly et al., 1992). It was assumed that eel represent bottom feeders with 44 percent of the total fish consumption, striped bass represent the intermediate level with 47 percent consumption, and white perch represent the remaining 9 percent. A 100 percent crab ingestion rate was assumed for blue crab. Burger (2002) found that individuals typically consumed either fish or crabs, and that those who did consume both fish and crabs had lower consumptions of each. Therefore, the total noncarcinogenic hazards and carcinogenic risks were not combined for consumption of both fish and crabs.

For the fish and crab ingestion scenarios, an additional exposure parameter was used in the CDI calculation (USEPA, 2000) for the CTE scenario. During cooking and fish preparation, concentrations of some lipophilic contaminants decrease. Therefore, if appropriate for the COPC, a preparation/cooking loss factor (PCF) was applied to the equation for the CTE assessment.

Appendix C of USEPA’s Guidance for Assessment Chemical Contaminant Data for Use in Fish Advisories, Volume 2: Risk Assessment and Consumption Limits (USEPA, 2000) summarizes many of the studies that have evaluated loss of PCBs and pesticides from fish during food preparation and cooking. A review of the available literature found the results range considerably, both between various cooking methods and within the same method. Cooking losses, expressed as percent loss based on total PCB mass before and after cooking, as high as 74 percent were reported in one study (Skea et al., 1979). Other studies reported net gains of PCBs (Moya et al., 1998; Armbruster et al., 1987). PCB losses from cooking may be a function of the cooking method (baking, frying, broiling, etc.), cooking duration, temperature during cooking, preparation techniques (i.e., trimmed vs. untrimmed, with or without skin), lipid content of the fish, the fish species, magnitude of the PCB contamination in the raw fish, the extent to which lipids separated during cooking are consumed, reporting method, and/or the experimental study design. Personal preferences for various preparation and cooking methods and other related habits (such as consuming pan drippings) may result in consumption of PCBs "lost" from the fish upon cooking.

Page 23: Appendix L HHRA Combined

A review of literature found that PCB cooking losses may range from 0 to 74 percent. Despite the wide range of cooking loss estimates, most PCB losses were between 10 and 40 percent. A value of 20 percent (midpoint of 0 – 40 percent) was selected as the CTE estimate for cooking loss. For the RME, a cooking loss factor was not used to include the possibility that pan drippings are consumed along with the fish. Table 5-2 identifies the PCFs used for the CTE evaluation.

Recreational Adult, Adolescent, and Child

The recreational adult, adolescent (ages 12–18), and child (ages 1–6) are individuals who may use the canal for boating, fishing, crabbing, or—although unlikely—swimming/diving and be exposed to the surface water, sediment, and air at canal level. It is assumed that the RME recreational user would engage in recreational activities in the canal for 1 day per week for one-half of the year, from May through October (26 days/year). For estimating the exposure to the surface water and sediment during recreational activities, swimming was assumed. It was assumed that the RME recreational user would be exposed to surface water and sediment for 2.6 hours during each exposure, the national average time spent swimming per swimming event (USEPA, 1989). It was assumed that the RME ingestion rate of sediment during swimming would be 50 percent of the resident ingestion rate of soil (50 mg/day for adults and adolescents and 100 mg/day for children [USEPA, 1991]). The RME ingestion rate of surface water was assumed to equal 0.05 L/day, the surface water ingestion rate for swimming activities (USEPA, 1989). For dermal exposure to sediment, it was assumed that the head, hands, forearms, lower legs, and feet could come into contact with the sediment (i.e., skin surface areas of 6,925 cm2 [adult], 10,470 cm2 [adolescent; includes full arms and legs since information was not available for this age group for forearms and lower legs alone], and 2,800 cm2 [child] [USEPA, 2004]). A sediment-to-skin adherence factor of 0.3 cm2, the average adherence factor for reed gatherers (USEPA, 2004), was selected for the adult, and a sediment-to-skin adherence factor of 0.2 cm2, the average adherence factor for children in wet soil (USEPA, 2004), was selected for the adolescent and child. For surface water, it was assumed the full body (18,000 cm2 [adult], 15,758 cm2 [adolescent], and 6,600 cm2 [child] [USEPA, 2004]) would be exposed. The default exposure durations of 24 years (adult), 6 years (adolescent ages 12–18), and 6 years (child ages 1–6) and default body weights of 70 kg (adult), 57 kg (mean body weight of girls and boys ages 12–18), and 15 kg (child ages 1–6) were used for exposure to all media.

For the CTE scenarios, the exposure frequency was assumed to be one-half of the RME exposure frequency (or 1 day every other week for one-half of the year). It was assumed that the CTE recreational user would be exposed to the surface water and sediment for one-half of the RME exposure time, or 1.3 hours during each exposure. It was also assumed that the ingestion rates of sediment and surface water would be half the RME values, or 25 mg/day for adults and adolescents and 50 mg/day for children for sediment, and 0.025 L/day for all recreational receptors for surface water. The CTE skin surface areas for exposure to surface water and sediment, and the sediment-to-skin adherence factors were assumed to be the same as the RME values. The total CTE exposure duration for the recreational receptor was assumed to be 9 years (USEPA, 1997), the 50th percentile value for living at one residence, therefore, for each of the receptors (adult, adolescent, and child) the exposure duration was assumed to be 3years. The default body weights of 70 kg (adult), 57 kg (mean body weight

Page 24: Appendix L HHRA Combined

of girls and boys from 12–18), and 15 kg (child ages 1–6) were used to evaluate CTE exposure to all media.

Adult Angler

It was assumed the adult angler would ingest the fish or crabs they catch in the canal. There is not a lot of published literature concerning ingestion rates of self-caught crabs. Burger (2002) reported results of an angler study for fish and crabs in the Newark Bay Complex, and has estimated a yearly consumption rate for self-caught crab by multiplying the number of crab meals eaten per month by the number of crabs eaten at each meal by the number of months per year crabs are caught. Burger assumed the average size of one crab is 70 g. In the Burger (2002) study, it was noted that most of the people interviewed mainly fished or mainly crabbed, and that more than 30 percent of the people who fished and crabbed in the Newark Bay Complex did not eat their catch. People reported crabbing for only 3 months of the year, which is why data from only the 3-month period were used to calculate the annual ingestion rate. This may underestimate the risks and hazards associated with crab ingestion if crabs are actually caught in the canal and eaten for longer than 3 months a year. The yearly consumption rate of self-caught crab estimated from Burger (2002) is 5,760 grams (g), or 16 g/day. A 95% UCL of the yearly consumption value was estimated on the basis of this to be 23 g/day, and an average yearly consumption value was estimated to be 16 g/day. The 95% UCL value was used for the RME scenario for crab ingestion, and the average value was used for the CTE scenario.

Burger (2002) also presented a yearly consumption rate of self-caught fish (based on the Newark Bay Complex study) of 8,210 g, or 22 g/day. This is similar to the value of 26 g/day, the 95th percentile recreational freshwater angler’s fish ingestion rate, in the Exposure Factors Handbook (USEPA, 1997) and is also similar to the 1991 New York State Angler Survey derived rate of 31.9 g/day (Connelly et al., 1992). The fish ingestion rate of 26 g/day (USEPA, 1997) was used for an RME adult. The mean recreational freshwater angler’s fish ingestion rate of 8 g/day (USEPA, 1997) was used for the CTE adult angler.

Adolescent Angler

It was assumed that the adolescent angler, ages 12–18 years, would fish or crab in the canal and ingest the fish and crabs caught in the canal. In addition to eating the fish or crab caught by an adult family member, several studies have found that children begin fishing at approximately 10 years of age (Connelly et al., 1992). There is not a lot of published literature concerning ingestion rates of self-caught crabs by adults, and even less for children. Therefore, the fish ingestion rate for the adolescent was estimated assuming that the intake for an adolescent is about two-thirds of that of an adult. This approach yields ingestion rates generally consistent with the limited information provided in USEPA’s Exposure Factors Handbook (USEPA, 1997). For adolescents ages 10-19 years, the 95th percentile intake is 26.8 g/day (USEPA, 1997), which is comparable with the 17 g/day used in the HHRA for adolescents ages 12-18 years. The RME ingestion rate of crabs by adolescents was assumed to be 15 g/day (two-thirds the adult rate).. Similarly, the CTE ingestion rate of fish by adolescents was assumed to be 5.3 g/day, and the CTE ingestion rate of crabs by adolescents was assumed to be 10.7 g/day.

Page 25: Appendix L HHRA Combined

Child of Angler

It was assumed that the child (ages 1–6 years) of an angler would ingest the fish and crabs caught by a parent/relative in the canal. There is not a lot of published literature concerning ingestion rates of self-caught crabs by adults, and even less for children. However, based on information presented in USEPA’s Exposure Factors Handbook (USEPA, 1997) for fish ingestion rates for children, children ingest about one-third the amount of fish that adults ingest. This approach yields ingestion rates generally consistent with the limited information provided in USEPA Exposure Factors Handbook (USEPA, 1997). According to Table 10-1 of the Exposure Factors Handbook (USEPA, 1997), the 95th percentile intake for children ages 0-9 years is 16.5 g/day, compared to the RME value used in the HHRA of 9 g/day for children ages 1-6 years. The RME ingestion rate of crabs by children was assumed to be 8 g/day. Similarly, the CTE ingestion rate of fish by children was assumed to be 2.7 g/day and the CTE ingestion rate of crabs by children was assumed to be 5.3 g/day.

Industrial Adult

The industrial adult is an individual who works near the canal and may be exposed to ambient air (collected at street-level stations) 250 days/year, 8 hours/day. This industrial adult may also be exposed to canal overflow surface water and sediment. It was conservatively assumed that the canal overflows three times per year and remains in overflow conditions 3 days during each overflow event, for a total of 9 days per year of exposure to the overflowed surface water and surface sediment. It is assumed that the adult industrial worker could be exposed to the overflow water and sediment 8 hours/day during these 9 days. It was assumed that the ingestion rate of the canal overflow sediment would be equal to the adult industrial worker ingestion rate of soil, or 100 mg/day (USEPA, 2002). The ingestion rate of surface water was conservatively assumed to equal 0.05 L/day, the ingestion rate of surface water for swimming activities (USEPA, 1989). For dermal exposure to sediment, it was assumed that the head, hands, and forearms could come into contact with the sediment, for a surface area of 3,300 cm2 (USEPA, 2004). For dermal exposure to surface water, it was assumed the head, hands, forearms, and lower legs could come into contact with the surface water, for a surface area of 5,700 cm2 (USEPA, 2004). A sediment-to-skin adherence factor of 0.2 cm2, the soil adherence factor for industrial workers (Exhibit 3-5 in USEPA, 2004), was selected. The default exposure duration of 25 years for an adult industrial worker and default body weight of 70 kg were used for exposure to media.

Residential Adult and Child

The residential adult and child are individuals who live near the canal and may be exposed to ambient air (collected at street-level stations) 350 days/year, 24 hours/day (RME scenario). This resident may also be exposed to canal overflow surface water and sediment. It was conservatively assumed that the canal overflows three times per year and remains in overflow conditions 3 days during each overflow event, for a total of 9 days per year of exposure to the overflowed surface water and surface sediment. It was assumed the RME ingestion rate of the canal overflow sediment would be equal to the resident ingestion rates of soil (100 mg/day [adult] and 200 mg/day [child] [USEPA, 2002]). The RME ingestion rate of surface water was assumed to equal 0.05 L/day, the surface water ingestion rate for exposure scenarios involving swimming activities (USEPA, 1989), and the RME exposure time for exposure to the surface water was assumed to equal 2.6 hours during each exposure, the national average time spent swimming per swimming event (USEPA, 1989).

Page 26: Appendix L HHRA Combined

For dermal exposure to sediment and the surface water, it was assumed that the head, hands, forearms, and lower legs could come into contact with the sediment, for a surface area of 5,700 cm2 (adult) and 2,800 cm2 (child, including feet) (USEPA, 2004). A sediment-to-skin adherence factor of 0.2 cm2, the average adherence factor for children in wet soil (USEPA, 2004), was selected. Default exposure durations of 24 years (adult) and 6 years (child) and default body weights of 70 kg (adult) and 15 kg (child) were used for exposure to all media.

For the CTE scenario, it was assumed the residential receptors would be exposed to ambient air 234 days/year (USEPA, 1993). It was assumed that the CTE resident would be exposed to the surface water for one-half of the RME exposure time, or 1.3 hours during each exposure. It was also assumed that the ingestion rates of sediment and surface water would be one-half the RME value, or 50 mg/day for adults 100 mg/day for children for sediment, and 0.025 L/day for both adults and children for surface water. The CTE skin surface areas for exposure to surface water and sediment and the sediment-to-skin adherence factors were assumed to be the same as the RME values. The CTE exposure duration for the residential receptor was assumed to be 9 years (USEPA, 1997), the 50th percentile value for living at one residence; therefore, the CTE exposure duration for the adult was assumed to be 3 years and the CTE exposure duration for the child was assumed to be 6 years, for a total residential exposure duration of 9 years. The default body weights of 70 kg (adult), and 15 kg (child ages 1–6) were used to evaluate CTE exposure to all media.

Page 27: Appendix L HHRA Combined

6-1

SECTION 6

Toxicity Assessment

Toxicity assessment defines the relationship between the magnitude of exposure and possible severity of adverse effects, and it weighs the quality of available toxicological evidence. Toxicity assessment generally consists of two steps: hazard identification and dose-response assessment. Hazard identification is the process of determining the potential adverse effects from exposure to the chemical and the type of health effect involved. Dose-response assessment is the process of quantitatively evaluating the toxicity information and characterizing the relationship between the dose of the constituent administered or received and the incidence of adverse health effects in the exposed population. Toxicity criteria (e.g., reference doses [RfDs], inhalation reference concentrations [RfCs], cancer slope factors [CSFs], and inhalation unit risk factors [IURs]) are derived from the dose-response relationship.

USEPA recommends that a tiered approach be used to obtain the toxicity values (RfDs, RfCs, CSFs, and IURs) that are used to estimate noncarcinogenic and carcinogenic risks (USEPA, 2003a). The hierarchy of toxicity value sources is the following:

1. Integrated Risk Information System (IRIS) (USEPA, 2010e)

2. Provisional Peer-Reviewed Toxicity Values (PPRTV)

3. Other USEPA and non-USEPA sources, including the National Center for Environmental Assessment (NCEA), Agency for Toxic Substances and Disease Registry (ATSDR), Health Effects Assessment Summary Tables (HEAST), California EPA (Cal EPA), and USEPA’s Office of Water

The use in an HHRA of toxicity values from sources other than IRIS increases the uncertainty of the quantitative risk estimates. Some of the COPCs elicit both systemic (noncarcinogenic) toxic effects and cancer (carcinogenic) effects. Because of this, these constituents are evaluated as both noncarcinogens and carcinogens. The health risks for carcinogenic and noncarcinogenic effects were estimated separately based on different toxicity values.

Chromium is a COPC for sediment, surface water, and fish tissue (eel). It was assumed that all of the chromium detected in these media is hexavalent chromium, or Cr(VI), both for determining if chromium was a COPC (comparing the total chromium concentrations to the Cr(VI) RSLs) and for calculating the risks associated with exposure to chromium in these media. Cr(VI) is unstable in the body (in biological tissues) and is ultimately reduced to trivalent chromium, or Cr(III), by a variety of reducing agents, including ascorbate and glutathione (ATSDR, 2008; USEPA, 2010e). Cr(VI) exerts toxicity through direct contact mechanisms rather than bioaccumulation to a critical concentration in tissue. Therefore, all of the chromium detected in fish tissue samples is most likely Cr(III). However, the Cr(VI) toxicity values were used to evaluate the risks associated with chromium in fish tissue and all media. An RfD and RfC for Cr(VI) are available in IRIS; however, IRIS does not include a

Page 28: Appendix L HHRA Combined

CSF or IUR for CR(VI). The CSF for CR(VI) used in the HHRA is the same one included on the RSL Table (USEPA, 2010b) from NJDEP.

6.1 Toxicity Information for Noncarcinogenic Effects

Noncarcinogenic health effects include a variety of toxic effects on body systems, ranging from toxicity to the kidneys to central nervous system disorders. The toxicity of a chemical is assessed through a review of toxic effects noted in short-term (acute) animal studies, long-term (chronic) animal studies, and epidemiological investigations.

USEPA (1989) defines the chronic RfD as a dose that is likely to be without appreciable risk of deleterious effects during a lifetime of exposure. Chronic RfDs are specifically developed to be protective for long-term exposure to a chemical or compound (for example, 7 years to a lifetime), and consider uncertainty in the toxicological database and sensitive receptors. Chronic RfDs were used to evaluate noncarcinogenic risks to all receptors evaluated in the risk assessment.

In the development of RfDs, all available studies examining the toxicity of a chemical following exposure are considered on the basis of scientific merit. The lowest dose level at which an observed toxic effect occurs is identified as the lowest observed adverse effect level (LOAEL), and the dose at which no effect is observed is identified as the no observed adverse effect level (NOAEL). Several uncertainty factors (UFs) may be applied to account for uncertainties such as limited data, extrapolation of data from animal studies to human exposures, or the use of subchronic studies to develop chronic criteria. These UFs range from 10 to 10,000, and are based on professional judgment. Consequently, there are varying degrees of uncertainty in the toxicity criteria, which range from 1 to 3,000 for the COPCs identified for this site.

USEPA-derived oral RfDs and inhalation RfCs, and associated UF and modifying factor (MF) values, available for the COPCs are presented in Tables 5.1 and 5.2 in the Attachment. The RfD for Aroclor 1254 was used to estimate the noncarcinogenic effects associated with exposure to total PCBs.

Per USEPA guidance, oral RfDs were adjusted from administered dose (oral) to absorbed dose (dermal) to evaluate dermal toxicity. When appropriate, the RfDs were adjusted using oral absorption factors (USEPA, 2004). This adjustment is shown in Table 5.1 in the Attachment.

6.2 Toxicity Information for Carcinogenic Effects

Potential carcinogenic effects are quantified as CSFs or IURs that convert estimated exposures directly to incremental lifetime carcinogenic risks.

CSFs and IURs may be derived from the results of chronic animal bioassays, human epidemiological studies, or both. Animal bioassays are usually conducted at dose levels that are much higher than are likely to be encountered in the environment. This design detects possible adverse effects in the relatively small test populations used in the studies. The actual risks from exposure to a potential carcinogen are not likely to exceed the estimated risks and are probably much lower or even zero. USEPA-derived CSFs and IURs are presented in the Attachment, Tables 6.1 and 6.2. The CSF for 2,3,7,8-TCDD (dioxin) was

Page 29: Appendix L HHRA Combined

used to estimate the carcinogenic risks associated with the dioxin-like PCBs and the CSF for total PCBs was used to estimate the carcinogenic risks associated with the non-dioxin-like PCBs.As was done for oral RfDs, oral CSFs were adjusted from administered dose (oral) to absorbed dose (dermal) to evaluate dermal toxicity. When appropriate, the CSFs were adjusted using oral absorption factors (USEPA, 2004). This adjustment is shown in Table 6.1 in the Attachment. The IRIS toxicity profile for PCBs (USEPA, 2010e) presents a tiered approach for evaluating carcinogenic risks associated with exposure to PCBs. IRIS recommends that the first tier upper-bound CSF of 2.0 (mg/kg-day)-1 be used to evaluate upper-bound risks estimates for exposures to PCBs through ingestion of fish and sediment, and dermal contact with sediment, and that the central-estimate of 1.0 (mg/kg/day)-1 be used to evaluate cancer risks for the CTE estimate.

6.3 Approach for Potential Mutagenic Effects

For COPCs that act via a mutagenic mode of action (MMOA), cancer risks were estimated using age-dependent adjustment factors (ADAFs), as is consistent with cancer guidelines and supplemental guidance (USEPA, 2005a, b). Consistent with the Superfund guidance on MMOA (http://www.epa.gov/oswer/riskassessment/sghandbook/chemicals.htm), the carcinogenic PAHs are considered to act via a MMOA. Additionally, chromium is also categorized as a chemical with a MMOA (McCarrol, et al., 2010). The calculation of cancer risk using ADAFs is presented in Tables 7s of the Attachment. As chemical-specific data are not available for the carcinogenic PAHs or chromium, default ADAFs, as included in the USEPA Region 3 memorandum Derivation of RBCs for Carcinogens That Act via a Mutagenic Mode of Action and Incorporate Default ADAFs (USEPA, 2006), were used for the MMOA evaluation. The default ADAFs used to adjust the CSFs are 10 for 0-2 year olds, 3 for 2-6 year olds, 3 used for 6-12 year olds, and 1 for 16-30 year olds. The CSF was multiplied by the appropriate ADAF to derive the age-specific CSF for a receptor to calculate the total carcinogenic risk. Additionally, the exposure factors for children 0–2 years old and 2–6 years old were assumed to be the same as the parameters for a child 0–6 years old, with the exception of the exposure duration, which was instead 2 years and 4 years, respectively. The exposure factors for the adult residential receptor were used for residents 6–16 years old and 16–30 years old, with the exception of the exposure durations, which were 10 years and 14 years, respectively. For the adolescent receptors, the exposure factors for the adolescents 12-16 years old and 16-18 years old were assumed to be the same as the parameters for an adolescent 12-18 years old, with the exception of the exposure duration, which was 4 years and 2 years, respectively.

Page 30: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 31: Appendix L HHRA Combined

7-1

SECTION 7

Risk Characterization

Risk characterization combines the results of the previous elements of the risk assessment to evaluate the potential health risks associated with exposure to the COPCs. The risk characterization is then used as an integral component in risk management decision-making.

7.1 Methods for Estimating Risks

Potential human health risks are discussed independently for carcinogenic and noncarcinogenic effects because of the different toxicological endpoints, relevant exposure duration, and methods used to characterize risk. The methodology used to estimate noncarcinogenic hazards and carcinogenic risks are described below.

7.1.1 Noncarcinogenic Hazard Estimation

Noncarcinogenic health risks are estimated by comparing the calculated exposures to RfDs (or RfCs). The calculated intake divided by the RfD (or exposure concentration divided by the RfC) is equal to the hazard quotient (HQ):

HQ = Intake / RfD or Exposure Concentration / RfC

The intake and RfD (or exposure concentration and RfC) represent the same exposure route (i.e., oral intakes are divided by oral RfDs, inhalation exposure concentrations are divided by inhalation RfCs). An HQ that exceeds 1.0 (i.e., intake exceeds the RfD) indicates that there is a potential for adverse health effects associated with exposure to that constituent.

To assess the potential for noncarcinogenic health effects posed by exposure to multiple constituents, an HI approach is used (USEPA, 1986). This approach assumes that noncarcinogenic hazards associated with exposure to more than one constituent are additive (HI = sum of the HQs). Synergistic or antagonistic interactions between constituents are not considered. The HI may exceed 1.0 even if all of the individual HQs are less than 1. HIs may be added across exposure routes to estimate the total noncarcinogenic health effects to a receptor posed by exposure through multiple routes. If the HI is greater than 1, separate HIs are estimated for each target organ to assess whether the HI for a specific target organ is greater than 1. A target-organ-specific HI greater than 1 indicates that there is some potential for adverse noncarcinogenic health effects associated with exposure to the COPCs, possibly warranting remedial action. If the HI for each target organ does not exceed 1, noncarcinogenic hazards are not expected.

7.1.2 Carcinogenic Risk Estimation

The potential for carcinogenic effects due to exposure to site-related constituents is evaluated by estimating the ELCR, which is the incremental increase in the probability of developing cancer during one’s lifetime in addition to the probability of getting cancer associated with exposure to all non-site-related sources of carcinogens.

Page 32: Appendix L HHRA Combined

Carcinogenic risk is calculated by multiplying the intake by the CSF (or exposure concentration by the IUR).

ELCR = Intake × CSF or Exposure Concentration × IUR

The combined risk from exposure to multiple constituents was evaluated by adding the risks from individual constituents. Risks were also added across the exposure routes if an individual would be exposed through multiple routes.

As required under the NCP (USEPA, 1994a) "[f]or known or suspected carcinogens, acceptable exposure levels are generally concentration levels that represent an excess upper

bound lifetime cancer risk to an individual of between 10-4 to 10-6 using information on the relationship between dose and response." When a cumulative carcinogenic risk to a receptor under the assumed RME exposure conditions exceeds 1 in 10 thousand (i.e., 10-4 ELCR), the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) generally requires remedial action to reduce risks at the site.

7.1.3 Lead

Lead concentrations less than 0.015 mg/L in surface water (the Safe Drinking Water Act action level for lead in potable water) and less than 400 mg/kg in sediment (USEPA, 1994b) are considered adequately protective of human health under residential land-use conditions. Lead concentrations less than 800 mg/kg in sediment are considered adequately protective of human health under industrial land-use conditions. Lead was retained as a COPC when exceeding the residential values. Lead was identified as a COPC for exposed and near-shore surface sediment, surface sediment for the overflow scenario, and surface water during the wet event. Lead does not have available published toxicity factors, and therefore potential risks associated with lead are evaluated differently than the other COPCs. The toxicity of lead is evaluated by USEPA based on blood-lead uptake using a physiologically based pharmacokinetic model called the Integrated Exposure Uptake Biokinetic (IEUBK) model.

The IEUBK model is used to evaluate lead exposure to children. An interim approach to assessing risks associated with adult exposures to lead was developed by USEPA’s Technical Review Workgroup for Lead (USEPA, 2003b) and updated in 2005. This methodology is a variation of the IEUBK model. The adult lead methodology (ALM) is used to evaluate risks associated with nonresidential adult exposures to lead in soil (or sediment for this assessment). The model focuses on estimating fetal blood concentrations in women exposed to lead in soil (USEPA, 2003b). It was used in this risk evaluation to be protective of potentially sensitive receptors within the industrial worker population and recreational population that may be exposed to overflow sediment. Because the lead model is a probabilistic model, several of the USEPA default parameters are based on central tendency (i.e., average) values (USEPA, 2003b). Therefore, the arithmetic means for sediment concentration served as the input value for the soil (sediment) concentrations.

The exposure parameters used in the ALM for ingestion and exposure frequency are the same as those that were used to evaluate direct contact with overflow sediment by the industrial worker and direct contact with exposed and near-shore sediment by the recreational adult. The sediment ingestion rate of 100 mg/day and exposure frequency of 9 days/year was assumed for the adult industrial worker. For the recreational adult, a

Page 33: Appendix L HHRA Combined

sediment ingestion rate of 50 mg/day and an exposure frequency of 26 days/year were used.

The ALM uses different sets of geometric standard deviations (GSDs) and baseline blood lead levels based on different studies. The GSD is a measure of the inter-individual variability in blood lead concentrations in a population whose members are exposed to the same nonresidential environmental lead levels. The baseline blood lead concentration is intended to represent the best estimate of a reasonable central value of blood lead concentrations in women of child-bearing age that are not exposed to lead-contaminated nonresidential soil (sediment) or dust at the site (USEPA, 2003b, c). In this analysis, geometric means were used.

ALM spreadsheets provided by USEPA (version date June 21, 2009) were used to calculate blood lead concentrations for the industrial worker. The model results are expressed as the predicted geometric mean blood lead level for adults (that is, women of child-bearing age) and the corresponding 95th percentile fetal blood lead concentrations and the percent of the population potentially experiencing concentrations above 10 micrograms per deciliter (µg/dL), below which adverse manifestations are not expected.

The potential risks associated with residential/recreational exposures to lead are addressed using the IEUBK Lead Model for Windows, Version 1.1, Build 11 (USEPA, 1994c, 2010f). The IEUBK model was designed to provide predictions of the probability of elevated blood lead levels for children. This model addresses three components of environmental risk assessments: the multimedia nature of exposures to lead, lead pharmacokinetics, and significant variability in exposure and risk, through estimation of probability distributions of blood lead levels for children exposed to similar environmental concentrations. Although use of the IEUBK model to evaluate exposure to lead in the sediment and surface water for recreational and residential receptors is extremely conservative, there is currently no better method available. The arithmetic mean of the lead concentration in sediment and surface water was used with the default input parameters to represent site-specific exposures to lead.

7.2 Risk Assessment Results

The results of the risk characterization are presented below by receptor group. The risk estimates are calculated in the Attachment, Tables 7.1.RME through 7.10.RME and 7.1.CTE through 7.9.CTE, and summarized in the Attachment, Tables 9.1.RME through 9.10.RME and 9.1.CTE through 9.9.CTE. A summary of the RME results is shown in Table 7-1, and a summary of the CTE results is shown in Table7-2. CTE risks were calculated when the total RME HI to a receptor group exceeded 1.0 and/or the total RME ELCR exceeded 1 × 10-4. The risk estimates for each receptor group are summarized below and compared to USEPA’s target HI of 1 and target ELCR range of 1 × 10-6 to 1 × 10-4. Noncarcinogenic hazards less than 1 are below USEPA’s noncarcinogenic goal of protection of an HI of 1. Carcinogenic risks between or below 1 × 10-6 to 1 × 10-4 are within USEPA’s acceptable carcinogenic risk levels.

Noncarcinogenic hazards and carcinogenic risks are calculated for each of the receptors. However, carcinogenic risks are combined for the adult, adolescent, and child to estimate the carcinogenic risks to the recreational user, angler, and resident.

Page 34: Appendix L HHRA Combined

7.2.1 Recreational Adults

Tables 9.1.RME and 9.1.CTE in the Attachment summarize the HIs (and ELCRs, which are discussed in Section 7.2.4) for recreational adult exposure to Gowanus Canal exposed and near-shore surface sediment, Gowanus Canal surface water, and air at canal level. The higher of the risks and hazards estimated for the two surface water scenarios and the two ambient air scenarios were included in the total estimated risks and hazards for the receptor group.

• Total HI (RME) = 0.2, below USEPA’s target.

• Total HI (CTE) = 0.08, below USEPA’s target.

• Lead was identified as a COPC for sediment and surface water (wet-weather event only). Exposure to lead in sediment was evaluated using the adult lead model. The model results are presented in Table 11.1 (Attachment). The mean sediment lead concentration of 660 mg/kg results in geometric mean blood levels ranging from 1.1 to 1.6 microgram per deciliter (µg/dL) for women of child-bearing age. The corresponding 95th percentile fetal blood lead levels range from 2.6 to 4.9 µg/dL. The probabilities that the fetal blood lead levels exceed 10 µg/dL range from 0.005 to 0.5 percent. These values are less than the blood lead goal as described in the 1994 OSWER Directive (USEPA, 1994b) of no more than 5 percent of children (fetuses of exposed women) exceeding 10 µg/dL blood lead.

7.2.2 Recreational Adolescents

Table 9.2.RME in the Attachment summarizes the HIs (and ELCRs, which are discussed in Section 7.2.4) for recreational adolescent exposure to Gowanus Canal exposed and near-shore surface sediment, Gowanus Canal surface water, and air at canal level. The higher of the risks and hazards estimated for the two surface water scenarios and the two ambient air scenarios were included in the total estimated risks and hazards for the receptor group.

• Total HI (RME) = 0.2, below USEPA’s target.

• Total HI (CTE) = 0.1, below USEPA’s target.

• Lead was identified as a COPC for sediment and surface water (wet-weather event only). Exposure to lead in sediment was evaluated using the adult lead model, as discussed for the recreational adults. The probabilities that the fetal blood lead levels exceed 10 µg/DL range from 0.005 to 0.5 percent, which is less than the blood lead goal as described in the 1994 OSWER Directive (USEPA, 1994b) of no more than 5 percent of children (fetuses of exposed women) exceeding 10 µg/dL blood lead.

7.2.3 Recreational Children

Tables 9.3.RME and 9.3.CTE in the Attachment summarize the HIs (and ELCRs, which are discussed in Section 7.2.4) for recreational child exposure to Gowanus Canal exposed and near-shore surface sediment, Gowanus Canal surface water, and air at canal level. The higher of the risks and hazards estimated for the two surface water scenarios and the two ambient air scenarios were included in the total estimated risks and hazards for the receptor group.

Page 35: Appendix L HHRA Combined

• Total HI (RME) = 0.5, below USEPA’s target.

• Total HI (CTE) = 0.2, below USEPA’s target.

• Lead was identified as a COPC for sediment and surface water (wet-weather event only). Site-specific lead exposures were evaluated for recreational children using the IEUBK model. This calculation was based on the site-specific arithmetic mean concentration of lead detected in the sediment (660 mg/kg) and surface water (13 mg/L). The results of the model, along with the probability distribution plot are presented in Table 11.2 in the Attachment. The predicted geometric mean blood lead

level for a young child was 7.1 µg/dL, with 23 percent of the population potentially

experiencing concentrations exceeding 10 µg/dL, below which adverse manifestations are not expected. These results indicate that if a child was exposed to the sediment and surface water at levels consistent with residential exposure to soil and potable use of surface water, the percent of the exposed population with a blood lead level exceeding

10 µg/dL would be above the 5 percent level that USEPA considers being protective of human health. However, it is unlikely that a child recreational receptor would be exposed to the sediment and surface water at the levels estimated in the IEUBK model, and it is more likely there would be no adverse effects associated with exposure to the lead.

7.2.4 Recreational Receptors – Lifetime Carcinogenic Risks

Carcinogenic risks were estimated for the combined lifetime (young child/ adolescent/adult) recreational receptor, following USEPA risk assessment methodology. The total carcinogenic risk to a recreational receptor was calculated by adding the risks calculated for the young child, adolescent, and adult. The RME carcinogenic risks are summarized in Table 7-4, the CTE carcinogenic risks are summarized in Table 7-5, and the risks are discussed below. The higher of the risks estimated for the two surface water scenarios and the two ambient air scenarios were included in the total estimated risks.

• Total ELCR (RME) = 1 × 10-3, above USEPA’s target risk range. The risk is associated primarily with exposure to surface water (7 × 10-4) and sediment (7 × 10-4), and the risk drivers are carcinogenic PAHs. The carcinogenic PAHs were highest in the surface water samples collected at sampling locations 319 and 325 during the dry-weather sampling event and locations 309 and 319 during the wet-weather sampling event. The carcinogenic PAHs were highest (10 times higher than the next highest detection) in sediment sample 314, at the head of the 6th Street basin (see Figure 2-3a in the RI), and were therefore associated primarily with this location. The concentrations of the PAHs in the canal surface water during both dry- and wet-weather events and in the sediment were statistically significantly greater than in the reference area (see Sections 4.3.2 and 4.4.5 of the RI)

• Exposed and Near Shore Sediment ELCR (RME) = 7 × 10-4, above USEPA’s target risk range

• Surface water, dry weather event ELCR (RME) = 6 × 10-4, above USEPA’s target risk range

Page 36: Appendix L HHRA Combined

• Surface water, wet weather event ELCR (RME) = 5 × 10-4, above USEPA’s target risk range

• Air at canal level, prior to aeration system operation ELCR (RME) = 4 × 10-7, below USEPA’s target risk range

• Air at canal level, after to aeration system operation started ELCR (RME) = 4 × 10-7, below USEPA’s target risk range

• Total ELCR (CTE) = 3 × 10-4, above USEPA’s target risk range

• Exposed and Near Shore Sediment ELCR (CTE) = 1 × 10-4, above USEPA’s target risk range

• Surface water, dry weather event ELCR (CTE) = 1 × 10-4, above USEPA’s target risk range

• Surface water, wet weather event ELCR (CTE) = 9 × 10-5, within USEPA’s target risk range

7.2.5 Industrial Workers

Table 9.4.RME in the Attachment summarizes the HIs and ELCRs for industrial worker exposures to ambient air at street level and surface water and sediment associated with canal overflow. The higher of the risks and hazards estimated for the two ambient air scenarios were included in the total estimated risks and hazards for the receptor group.

• Total HI (RME) = 0.8, below USEPA’s target HI.

• Total ELCR (RME) = 8 × 10-5, within USEPA’s target risk range.

• Lead was identified as a COPC for sediment and surface water. Exposure to lead in sediment was evaluated using the adult lead model. The model results are presented in Table 11.3 of the Attachment. The mean sediment lead concentration of 533 mg/kg results in geometric mean blood levels ranging from 1.1 to 1.6 ug/dL for women of child-bearing age. The corresponding 95th percentile fetal blood lead levels range from

2.5 to 4.8 µg/dL. The probabilities that the fetal blood lead levels exceed 10 µg/DL range from 0.003 to 0.4 percent. These values are less than the blood lead goal as described in the 1994 OSWER Directive (USEPA, 1994b) of no more than 5 percent of children (fetuses of exposed women) exceeding 10 µg/dL blood lead.

7.2.6 Adult Residents

Tables 9.5.RME and 9.4.CTE, in the Attachment summarize the HIs for adult resident exposures to ambient air at street level and surface water and sediment associated with canal overflow. The higher of the hazards estimated for the two ambient air scenarios were included in the total estimated risks and hazards for the receptor group.

• Total HI (RME) = 1 (calculated HI value is 1.1), equals USEPA’s target of HI of 1. The HI is associated with inhalation of ambient air. The HIs for all target organs are below USEPA’s target, and therefore, the hazard is within USEPA acceptable levels.

• Surface water and sediment HIs (RME) are below 0.1, below USEPA’s target.

Page 37: Appendix L HHRA Combined

• Total HI (CTE) = 0.7, below USEPA’s target.

• Lead was identified as a COPC for sediment and surface water. Exposure to lead in sediment was evaluated using the adult lead model. The model results are presented in Table 11.3 in the Attachment. The mean sediment lead concentration of 533 mg/kg

results in geometric mean blood levels ranging from 1.1 to 1.6 µg/dL for women of child-bearing age. The corresponding 95th percentile fetal blood lead levels range from

2.5 to 4.8 ug/dL. The probabilities that the fetal blood lead levels exceed 10 µg/DL range from 0.003 to 0.4 percent. These values are less than the blood lead goal as described in the 1994 OSWER Directive (USEPA, 1994b) of no more than 5 percent of children (fetuses of exposed women) exceeding 10 µg/dL blood lead.

7.2.7 Child Residents

Tables 9.6.RME and 9.5.CTE in the Attachment summarize the HIs for child resident exposures to ambient air at street level and surface water and sediment associated with canal overflow. The higher of the hazards estimated for the two ambient air scenarios were included in the total estimated risks and hazards for the receptor group.

• Total HI (RME) = 1 (calculated HI value is 1.3), equals USEPA’s target HI of 1. The HI is associated with inhalation of ambient air. The HIs for all target organs are below USEPA’s target.

• Surface water and sediment HIs (RME) are below 0.3, below USEPA’s target.

• Total HI (CTE) = 0.8, below USEPA’s target.

• Lead was identified as a COPC for overflow sediment and surface water. Site-specific lead exposures were evaluated for recreational children using the IEUBK model. This calculation was based on the site-specific arithmetic mean concentration of lead detected in the sediment (533 mg/kg) and surface water (13 mg/L). The results of the model, along with the probability distribution plot are presented in Table 11.2 in the Attachment. The predicted geometric mean blood lead level for a young child was 6.1

µg/dL, with 14.9 percent of the population potentially experiencing concentrations

exceeding 10 µg/dL, below which adverse manifestations are not expected. These results indicate that if a child was exposed to the sediment and surface water at levels consistent with residential exposure to soil and potable use of surface water, the percent

of the exposed population with a blood lead level exceeding 10 µg/dL would be above the 5 percent level that USEPA considers to be protective of human health. However, it is unlikely that a child recreational receptor would be exposed to the sediment and surface water at the levels estimated in the IEUBK model, and it is more likely there would be no adverse effects associated with exposure to the lead.

7.2.8 Child/Adult (Lifetime) Residents

Carcinogenic risks were estimated for the combined lifetime (child/adult) resident, following USEPA risk assessment methodology. Tables 9.7.RME and 9.6.CTE in the Attachment summarize the ELCRs for lifetime resident exposures to ambient air at street level and surface water and sediment associated with canal overflow. The higher of the risks

Page 38: Appendix L HHRA Combined

estimated for the two ambient air scenarios were included in the total estimated risks and hazards for the receptor group.

• Total ELCR (RME) = 3 × 10-4, above USEPA’s target risk range. The ELCR is associated primarily with exposure to overflow sediment (2 × 10-4), with smaller contributions from exposure to overflow surface water (6 × 10-5) and ambient air after the aeration system started operating (4 × 10-5). The sediment risk drivers are carcinogenic PAHs, with highest concentrations in samples 314, at the head of the 6th Street basin, and 315, at the mouth of the 7th Street turning basin (see Figure 2-3a in the RI). PAH concentrations were variable in the reference area sediment, but concentrations observed in the canal were generally higher than those in the reference area (see discussion in Section 4.3.2 of the RI). Additionally, the statistical comparison of the PAH data from the canal and the reference area surface sediment indicated concentrations in the canal were statistically significantly greater than the reference area.

• Total ELCR (CTE) = 8 × 10-5, within USEPA’s target risk range.

7.2.9 Adult Anglers

Tables 9.8.RME and 9.7.CTE in the Attachment summarize the HIs (and ELCRs, which are discussed in Section 7.2.12) for angler adults who ingest fish and crab caught from the canal. Striped bass are representative of upper level predator fish, white perch are representative of middle level predator fish, and eel are representative of bottom feeders.

• Total Fish HI (RME) = 17, above USEPA’s target HI. The HIs for ingestion of striped bass and eel exceed USEPA’s target HI. The hazard is associated with PCBs, with smaller contributions (below 1) from mercury. About 70 percent of the total HI is contributed by assumed consumption of American eel. The average concentration of total PCBs in the eel from the canal is about two times higher than the average concentration of total PCBs in the reference samples (see Table 7-3 for average concentrations in canal and reference fish tissue samples). The average concentration of mercury in the eel from the canal samples is slightly lower than the average concentration in the eel from the reference samples.

• Total Crab HI (RME) = 3, above USEPA’s target HI. The hazard is associated with PCBs, with smaller contributions (below 1) from arsenic and mercury. The average concentration of PCBs in blue crab from the canal is almost twice the average concentration of PCBs in blue crab from the reference samples (Table 7-3); however, the average concentrations of arsenic and mercury in blue crab from the reference samples are slightly higher than the average concentrations in the canal samples.

• White perch HI (RME) is below USEPA’s target.

• Total Fish HI (CTE) = 2, above USEPA’s target HI. The hazard is primarily associated with PCBs in fish (mainly eel).

• Total Crab HI (CTE) = 2, above USEPA’s target HI. The hazard is primarily associated with PCBs.

Page 39: Appendix L HHRA Combined

7.2.10 Adolescent Anglers

Tables 9.9.RME and 9.8.CTE in the Attachment summarize the HIs (and ELCRs, which are discussed in Section 7.2.12) for adolescent anglers who ingest fish and crab caught from the canal. Striped bass are representative of upper level predator fish, white perch are representative of middle level predator fish, and eel are representative of bottom feeders.

• Total Fish HI (RME) = 13, above USEPA’s target HI. The hazard is associated with PCBs, with smaller contributions (below 1) from mercury (in striped bass and eel). The HIs for ingestion of striped bass and eel exceed USEPA’s target HI. About 74 percent of the total HI is contributed by assumed consumption of American eel. The average concentration of total PCBs in the eel from the canal is about two times higher than the average concentration of total PCBs in the reference samples (see Table 7-3 for average concentrations in canal and reference fish and crab tissue samples). The average concentration of mercury in the eel from the canal samples is slightly lower than the average concentration in the eel from the reference samples.

• Total Crab HI (RME) = 3, above USEPA’s target HI. The hazard is associated with PCBs, with smaller contributions (below 1) from arsenic and mercury. The average concentration of PCBs in blue crab from the canal is almost twice the average concentration of PCBs in blue crab from the reference samples. The average concentrations of arsenic and mercury in the blue crab from the reference samples are slightly higher than the average concentrations in the canal samples.

• White perch HI (RME) is below USEPA’s target.

• Total Fish HI (CTE) = 1 (calculated HI value is 1.3), equals USEPA’s target HI.

Total Crab HI (CTE) = 0.6, below USEPA’s target HI.

7.2.11 Children of Anglers

Tables 9.10.RME and 9.9.CTE in the Attachment summarize the HIs (and ELCRs, which are discussed in Section 7.2.12)for children of anglers who ingest fish and crab caught from the canal. Striped bass are representative of upper level predator fish, white perch are representative of middle level predator fish, and eel are representative of bottom feeders.

• Total Fish HI (RME) = 27, above USEPA’s target HI. The hazard is associated with PCBs, with smaller contributions (below 1) from mercury (in striped bass and eel). About 70 percent of the total HI is contributed by assumed consumption of American eel. The average concentration of total PCBs in the eel from the canal is about two times higher than the average concentration of total PCBs in the reference samples (see Table 7-3 for average concentrations in canal and reference fish and crab tissue samples). The average concentration of mercury in the eel from the canal samples is slightly lower than the average concentration in the eel from the reference samples.

• Total Crab HI (RME) = 5, above USEPA’s target HI. The hazard is associated with PCBs, with smaller contributions (below 1) from arsenic and mercury. The average concentration of PCBs in blue crab from the canal is almost twice the average concentration of PCBs in blue crab from the reference samples. The average

Page 40: Appendix L HHRA Combined

concentrations of arsenic and mercury in the blue crab from the reference samples are slightly higher than the average concentrations in the canal samples.

• Total Fish HI (CTE) = 3, above USEPA’s target HI, primarily associated with PCBs in eel.

• Total Crab HI (CTE) = 4, above USEPA’s target HI, primarily associated with PCBs.

7.2.12 Anglers – Lifetime Carcinogenic Risks

Carcinogenic risks were estimated for the combined lifetime (child/adolescent/adult) angler, following USEPA risk assessment methodology. The total carcinogenic risk to a angler was calculated by adding the risks calculated for the young child, adolescent, and adult. The RME carcinogenic risks are summarized in Table 7-4 and the CTE carcinogenic risks are summarized in Table 7-5, and are presented below. Striped bass are representative of upper level predator fish, white perch are representative of middle level predator fish, and eel are representative of bottom feeders.

• Total Fish ELCR (RME) = 7 × 10-4, above USEPA’s target risk range. The risk from ingestion of eel (bottom feeders) and striped bass (top level predators) exceed USEPA’s target risk range. The risk is associated primarily with ingestion of eel (74 percent). The risk drivers are PCBs. The dioxin-like PCBs and nondioxin-like PCBs contributed to the risk at similar risk levels. The average concentration of non-dioxin-like PCBs and dioxin-like PCB TEQs in the eel from the canal is almost two times higher than the average concentrations in the reference samples (see Table 7-3 for average concentrations in canal and reference fish and crab tissue samples).

• Total white perch (middle level predators) ELCR (RME) is within the target risk range .

• Total Crab ELCR (RME) = 3 × 10-4, above USEPA’s target risk range. The risk drivers are PCBs. The average concentration of non-dioxin-like PCBs and dioxin-like PCB TEQs in blue crab from the canal (see Table 7-3 for average concentrations in canal and reference fish and crab tissue samples) is almost twice the average concentration of PCBs in blue crab from the reference samples.

• Total Fish ELCR (CTE) = 2 × 10-5, within USEPA’s target risk range.

• Total Crab ELCR (CTE) = 6 × 10-5, within USEPA’s target risk range.

Page 41: Appendix L HHRA Combined

8-1

SECTION 8

Uncertainty Assessment

The risk measures used in HHRAs are not fully probabilistic estimates of risk, but are conditional estimates given that a set of assumptions about exposure and toxicity are realized. Thus, it is important to specify the assumptions and uncertainties inherent in the risk assessment to place the risk estimates in proper perspective (USEPA, 1989).

8.1 Uncertainty in Data Evaluation and COPC Identification

The sampling conducted along the canal for use in the HHRA focused on areas where contact with the canal is most likely to occur (shallow and exposed sediment and surface water and air samples collected from similar locations) to estimate the most realistic exposure and risk to potential receptors. Additional surface water and surface sediment samples were collected from locations where historic operations and discharges to the canal have most likely occurred. Only the surface sediment samples from the exposed and shallow areas were used to evaluate the recreational exposure risks, as this is the sediment that these receptors are most likely to contact. All of the surface water samples were included in the recreational scenario evaluations since the receptors could be exposed to the water throughout the canal while boating. All of the surface water and surface sediment samples were used to evaluate risks to the residential and industrial worker receptors associated with exposure to canal overflow water and sediment. Therefore, the available data were evaluated in the HHRA in data groupings for each receptor group to estimate the reasonable maximum exposures and risks.

The uncertainty associated with the data analysis is minimal, and all of the data were validated prior to being used in the HHRA. A data quality evaluation was performed on all analytical data evaluated in the HHRA, as discussed in Section 4.1 of the RI.

A few constituents (mainly pesticides) were not detected in any of the fish or crab tissue samples but had detection limits above the human health risk-based screening level. This may result in slightly underestimating the risk associated with ingestion of fish and crab. However, it should be noted that risks above acceptable levels were identified for the fish and/or crab tissue and risks were primarily associated with the PCBs detected in the fish and crab tissue. The pesticides detected in the fish and crab tissue did not contribute significantly to the risk.

A comparison of data collected from the canal to data collected from the reference locations was not used to identify the COPCs for the canal media. This may result in including COPCs related to background conditions in the risk estimates.

All of the canal data were screened against residential screening levels to select the COPCs. The use of residential screening levels is conservative, as not all the scenarios evaluated in the HHRA are residential (i.e., the industrial worker scenario). This may result in including COPCs with small contributions to overall risk estimates.

Page 42: Appendix L HHRA Combined

8.2 Uncertainty Associated with Exposure Assessment

The exposure factors used for quantifying exposure were conservative and reflect upper-bound assumptions. The reliability of the values chosen for the exposure factors also contributes substantially to the uncertainty of the resulting risk estimates. Because most of the exposure factors are upper-bound assumptions, the resulting risks are likely overestimates.

The most conservative recreational scenario (swimming) was used to evaluate potential exposure and risks for recreational adults, adolescents, and children. Based on the current conditions of the canal, it is likely that this is an overestimate of actual exposure to recreational receptors. Although possible, it is highly unlikely that a recreational receptor would swim in the canal for 26 days per year for 2.6 hours per day. Although the RME scenario indicated a slight risk above USEPA target levels, the CTE scenario (using more realistic but conservative assumptions of an exposure frequency of 13 days per year and an exposure time of 1.3 hours per day) indicated a risk within USEPA acceptable risk levels.

For the purposes of this risk assessment, the angler population is defined as those individuals who consume self-caught fish from the Gowanus Canal at least once per year, in the absence of a fishing ban or fish consumption advisories. Sources of uncertainty in the PCB concentrations in fish used in the assessment include the fact that concentrations were averaged over location, and weighted by species. The weighting of species intake in order to derive an average EPC in fish is a source of uncertainty because there are limited site- specific data available to estimate the species ingestion preferences (e.g., weighting factors).

Cancer risks and noncancer health hazards were not specifically quantified for subsistence anglers, or other subpopulations of anglers who may be highly exposed. Although there are no known distinct subpopulations that may be highly exposed, there is some degree of uncertainty as to whether these subpopulations have been adequately addressed in this risk assessment.

As described in Section 5.3.2, reported cooking losses vary considerably among the numerous studies reviewed. However, little information is available to quantify personal preferences among anglers for various preparation and cooking methods and other related habits (such as consumption of pan drippings). The assumption that there is no loss of PCBs during cooking or preparation, used in the RME cancer risk and noncarcinogenic hazard calculations, is conservative and could overestimate cancer risks and noncarcinogenic hazards.

The sediment/skin adherence factor represents the amount of sediment that adheres to skin and is available for dermal exposure. Because this value is likely to vary based on one’s activity, the values used for this parameter, which are estimates from single activities, are somewhat uncertain. For dermal contact with canal sediments, published adherence factors for adults gathering reeds and for children playing in wet soils were used as a surrogate for recreational children and adults and children. Although it is somewhat uncertain whether these scenarios are representative of contact with canal sediments, they appear to be a reasonable use of available data.

Commercial PCB mixtures tested in laboratory animals were not subject to prior selective retention of persistent congeners through the food chain, so there is a potential that

Page 43: Appendix L HHRA Combined

carcinogenic risks and noncarcinogenic hazards have been underestimated. However, since the CSFs are based on animal exposures to a group of PCB mixtures (i.e., Aroclor 1260, 1254, 1242, and 1016) that contain overlapping groups of congeners spanning the range of congeners most often found in environmental mixtures, this source of potential uncertainty is unlikely to have a significant impact.

The fact that any previous exposures (either background, or past consumption of contaminated fish) may still be reflected in an individual's body burden today is an additional source of uncertainty, and may result in an underestimate of noncarcinogenic health hazards.

The risk assessment assumed that people would consume both the combined muscle (edible portion) and hepatopancreas from blue crab. This may result in an overestimation of risk, as many crabbers do not consume the hepatopancreas, and some chemicals, such as PCBs and mercury, accumulate in the hepatopancreas. However, the hepatopancreas is small compared to the edible portion of the fish, and therefore, although concentrations may be higher in the hepatopancreas, it contributes a small amount of the total amount of crab consumed by the receptor. Therefore, it would not significantly change the total amount of contaminants consumed.

Dioxin-like PCB TEQ concentrations, non-dioxin-like PCB concentrations, and total PCB concentrations were calculated for each sample using detected PCB congeners only. In general, if the nondetected dioxin congeners were included in the sample concentration calculations, the non-dioxin-like PCB concentrations and the total PCB concentrations would be similar to those used in the risk assessment and the resulting risks would not differ significantly. The dioxin-like PCB TEQ concentrations would not always be similar, since if the most toxic congener (3,3’,4,4’,5-Pentachlorobiphenyl [126]) was not detected in a sample, inclusion of this congener at the detection limit times the TEF would contribute significantly to the dioxin-like PCB TEQ, even if it was not detected. Therefore, this may result in an underestimation of actual risk if this congener was present in the sample at a concentration below the reporting limit. However, when this congener was detected in a sample, it was generally J flagged as detected below the reporting limit, so it is unlikely that it would be present in the samples at concentrations similar to reporting limits, and it would likely be present at much lower concentrations and not contribute significantly to the dioxin-like PCB TEQ concentration for the sample. Additionally, congeners that were B qualified, indicating they were detected in a laboratory or field blank at a concentration similar to that in the sample, were not included in the concentration calculation. There were a number of samples with B-qualified congeners, which may result in an underestimation of risk if these congeners are present in the samples at a concentration below the blank contamination level. However, the B-qualified concentrations were generally below the reporting limits.

There are inherent limitations and uncertainties associated with estimating health risks on the basis of fish and crab consumption that should be considered when interpreting the results of this HHRA. Factors contributing to these uncertainties include the following:

• Game fish and blue crab ranges are not limited to the canal, but reflect cumulative uptake from all areas they traverse. Blue crab and some of the game fish species kept by anglers have relatively large home ranges, and those caught within the canal are likely, at least in part, to have inhabited areas outside the canal and therefore to have been

Page 44: Appendix L HHRA Combined

potentially exposed to contaminants not related to the canal. However, differences between canal and reference concentrations of PCBs in fish and crab tissue and sediment were identified, with canal media having higher concentrations.

Assumptions regarding fishing/crabbing frequency and fish/crab consumption rates are variable and affect the estimates of exposure and associated risk.

8.3 Uncertainty Associated with Toxicity Assessment

Uncertainty associated with the noncarcinogenic toxicity factors is included in Table 5.1 in the Attachment. The USEPA applies several UFs to extrapolate doses from animal studies to humans. The UFs for the COPCs range from 1 to 3,000. Therefore, there is a high degree of uncertainty in the noncarcinogenic toxicity criteria based on the available scientific data. The noncarcinogenic toxicity factors used in the HHRA are expected to be overestimates of actual toxicity.

CSFs and IURs developed by USEPA represent upper-bound estimates. Carcinogenic risks generated in this assessment should be regarded as an upper-bound estimate on the potential carcinogenic risks. The true ELCR is likely to be less than the predicted value (USEPA, 1989).

Use of provisional or withdrawn toxicity factors increases the uncertainty of the quantitative hazard and risk estimates. Provisional toxicity values (from Cal EPA, PPRTV, ATSDR, and NCEA) were used in the HHRA. The provisional values were used to provide a quantitative estimate rather than a merely qualitative risk discussion; however, USEPA has not fully promulgated these toxicity values.

The TEFs used to adjust the concentrations of the dioxin-like PCB congeners to TEQ of dioxin for the sediment and fish/crab also results in uncertainty in the risk assessment. In particular, although the TEF scheme and TEQ methodology is intended primarily for estimating exposure and risk through ingestion (primarily dietary intakes; USEPA, 2010c), it was also used to estimate exposure and risk through dermal contact. Additionally, not using the dioxin-like PCB congener TEQ to evaluate noncarcinogenic risks may underestimate the noncarcinogenic hazard associated with exposure to the PCBs. However, there is a lot of uncertainty with use of this process, and even more uncertainty with use of it for noncarcinogenic hazards since the TEFs are based on the relationship of the PCB congeners to the carcinogenic risks associated with dioxin. Although, there is a large degree of uncertainty associated with use of this method for noncarcinogenic-hazard evaluation, noncarcinogenic hazards were estimated as part of the uncertainty evaluation.

Noncarcinogenic hazards were calculated for the dioxin-like PCB TEQ concentrations for sediment and fish/crab using the RfD for 2,3,7,8-TCDD from the 1998 dioxin ATSDR toxicity profile. It should be noted that use of this RfD in itself presents a source of uncertainty, as the ATSDR toxicity profiles are a Tier 3 source of toxicity information. Noncarcinogenic hazards were calculated for the non-dioxin-like PCB concentrations using the RfD for Aroclor 1254. The sum of the noncarcinogenic hazards associated with the dioxin-like PCB TEQ concentrations and the non-dioxin-like PCB concentrations for all receptors for sediment and fish/crab are below 1 and in most cases are less than the noncarcinogenic hazards associated with the total PCB concentration, which were estimated using the total PCB concentrations and the RfD for Aroclor 1254. Therefore, evaluation of

Page 45: Appendix L HHRA Combined

the noncarcinogenic hazards for the dioxin-like PCB TEQ concentrations does not change the conclusions of the HHRA.

Page 46: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 47: Appendix L HHRA Combined

9-1

SECTION 9

Human Health Risk Summary

The risk assessment was conducted to evaluate the potential human health risks associated with direct contact with sediment and surface water in the Gowanus Canal, with ingestion of fish and crabs from the canal, with direct contact of sediment and surface water that overtops the canal during significant rainfall events, and with inhalation of emissions from the canal into the ambient air near the canal.

Table 5 and Tables 9.1.RME through 9.10.RME in the Attachment summarize the RME ELCRs and HIs. Table 6 and Tables 9.1.CTE through 9.9CTE in the Attachment summarize the CTE ELCRs and HIs. Estimated HIs and ELCRs associated with exposure to canal-related media indicate the potential for unacceptable risks based on exposure to some media by some receptor groups. Risk estimates are summarized below:

Recreational receptors (adult, adolescent, and child) Exposures are to surface water and surface sediment (from exposed and near-shore

locations) in the canal and to ambient air at canal level while swimming in the canal for 26 days per year for 2.6 hours each day (very conservative assumptions given the nature of the canal and current CSO discharges).

HIs and ELCRs (RME) for inhalation of canal level air are within USEPA acceptable levels.

Total HI (RME) (all media combined) for all recreational receptors is within acceptable risk levels.

Total ELCR (RME) for recreational receptor (1 × 10-3) exceeds USEPA’s target risk range, primarily because of carcinogenic PAHs in surface water and sediment above background levels (see Sections 4.3.2 and 4.4.5 of the RI).

Total HI (CTE) for all recreational receptors are below USEPA’s target level.

Total ELCR (CTE) for recreational receptor (3 × 10-4) exceeds USEPA’s target levels and ranges; the CTE scenario may be more representative of likely exposure (although still conservative, at an assumed swimming frequency of 13 days per year for 1.3 hours per day). The risk is primarily associated with exposure to the young child (67 percent of the risk).

Exposure to lead in sediment by adult and adolescent recreational receptors was demonstrated not to be a concern using the adult lead model. The IEUBK model indicated potential adverse effects for children exposed to lead in sediment and surface water; however, the model is based on residential exposure to these media, including using the surface water as a potable water supply. Therefore, it is unlikely, based on a more-realistic recreational exposure, that there would be any adverse effects based on exposure to recreational children.

Industrial workers and residential receptors (adult and child)

Page 48: Appendix L HHRA Combined

9-2

Exposures are to ambient air at street level and surface water and sediment associated with canal overflow.

Total HI and ELCR (RME) for industrial workers are below or within USEPA’s target levels.

Total HIs (RME) for residential adults (Total HI equals 1, calculated value is 1.1) and for children (Total HI equals 1, calculated value is 1.3) do not exceed USEPA’s target level of 1. Inhalation of ambient air at street level contributes over 75 percent of the hazard. No target organ HIs exceed USEPA’s target levels.

HIs (RME) for exposure to surface water and sediment are within USEPA acceptable levels.

ELCRs (RME) for inhalation of street level air are within USEPA acceptable levels.

ELCR (RME) for lifetime (child/adult) resident (3 × 10-4) exceeds USEPA’s acceptable level primarily associated with carcinogenic PAHs in sediment (with a smaller contribution from surface water below 1 × 10-4) that were above background levels (see Sections 4.3.2 and 4.4.5 of the RI).

Exposure to lead in sediment by industrial workers was demonstrated not to be a concern using the adult lead model. The IEUBK model indicated potential adverse effects for children exposed to lead in sediment and surface water; however, the model is based on residential exposure to these media, including using the surface water as a potable water supply. Therefore, it is unlikely, on the basis of a more realistic exposure, that there would be any adverse effects based on recreational children’s exposure to lead.

Anglers (adult, adolescent, and child) Exposure is from ingestion of fish (striped bass [representative of top level

predators], white perch [representative of middle level predators], and eel [representative of bottom feeders]) and crab caught in the Gowanus Canal. Assuming that fishing/crabbing and ingestion of fish/crab from the Gowanus Canal occur at typical recreational angler fish consumption rates is very conservative given the nature of the canal and current CSO discharges to the canal.

Total Fish HIs (RME) (all fish types) for adults (17), adolescents (13), and children (27) exceed acceptable risk levels, primarily because of PCBs. The ingestion of striped bass and eel contributed higher HIs than ingestion of white perch (which for the child only did contribute to HI above 1). Additionally, mercury contributed to the HIs, at HIs above 0.1 but below 1.

Total Crab HIs (RME) for adults (37), adolescents (3), and children (5) exceed acceptable risk levels, primarily because of PCBs. Additionally, mercury and arsenic contributed to the HIs, at HIs above 0.1 but below 1.0.

Average PCB concentrations in canal samples are about twice the average PCB concentrations in reference samples; however, concentrations of PCBs in reference samples would also result in HIs and ELCRs above acceptable risk levels.

Page 49: Appendix L HHRA Combined

9-3

Total Fish ELCR (RME) for angler (7 × 10-4) exceeds USEPA’s target risk range, primarily because of PCBs.

Total Crab ELCR (RME) for angler (3 × 10-4) exceeds USEPA’s target risk range, primarily because of PCBs.

Total Fish HIs (CTE) for adults (2.0), adolescents (1.7), and children (3.2) exceed USEPA’s target level; these are associated with PCBs in fish and crab.

Total Crab HIs (CTE) for adults (2) and children (3) exceed USEPA’s target level; these are associated with PCBs. Total HI (CTE) for adolescents (Total HI equals 1, calculated as 1.3) does not exceed USEPA’s target level.

Total Fish ELCR (CTE) for angler receptor is within USEPA’s target range; the CTE scenario may be more representative of consumption of fish for the Gowanus Canal (although still conservative).

Total Crab ELCR (CTE) for angler receptor is within USEPA’s target range; the CTE scenario may be more representative of consumption of crab for the Gowanus Canal (although still conservative).

A primary contributor to fish consumption risk is PCBs in tissues of fish caught from the canal. This conclusion is supported by NYDOH’s decision to issue fish consumption advisories for the Upper Bay of the New York Harbor (north of the Verrazano Narrows Bridge), including the Gowanus Canal (NYSDOH, 2010) in part on the basis of PCB concentrations present in fish. Reference area average PCB fish concentrations are about one half the average concentrations identified in canal fish. However, these would also result in risks above acceptable risk levels.

Page 50: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 51: Appendix L HHRA Combined

10-1

SECTION 10

References

Ambruster, G., K.G. Gerow, W.H. Gutenmann, C.B. Littman, and D.J. Lisk. 1987. The effectsof several methods of fish preparation on residues of polychlorinated biphenyls and sensory characteristics in striped bass. Journal of Food Safety 8:235-243.

ATSDR (Agency for Toxic Substances and Disease Registry). 2007. Toxicological Profile for Arsenic. U.S. Department of Health and Human Services. August.

ATSDR (Agency for Toxic Substances and Disease Registry). 2008. Toxicological Profile for Chromium. U.S. Department of Health and Human Services. September.

Burger, J. 2002. Consumption Patterns and Why People Fish. Environmental Research Section A 90, 125–135.

Connelly, Nancy A., Barbara A. Knuth, and Carole A. Bisogni. 1992. Effects of the Health Advisory and Advisory Changes on Fishing Habits and Fish Consumption in New York Sport Fisheries. Report for New York Sea Grant Institute Project No. R/FHD-2=PD. September.

FEMA (Federal Emergency Management Agency). 2007. Flood Insurance Rate Map 360490211F. September 5.

Gowanus Dredgers Canoe Club. 2010. Welcome to the Gowanus Dredgers Canoe Club. Available at http://www.waterfrontmuseum.org/dredgers/home.html.

Gowanus Lounge. November 6, 2007. Yummy Blue Plate Special: Gowanus Canal Blue Fish. Available at http://gowanuslounge.blogspot.com/2007/11/yummy-blue-plate-special-gowanus-canal.html.

May, H., and J. Burger. 1996. Fishing in a Polluted Estuary: Fishing Behavior, Fish Consumption, and Potential Risk. Risk Analysis. Vol. 16, no. 4. pp. 459–471.

McCarroll N., N. Keshava, J, Chen, G. Akerman, A. Kligerman, and E. Rinde. 2010. An evaluation of the mode of action framework for mutagenic carcinogens case study II: Chromium (VI), Environmental and Molecular Mutagenesis Volume 51, Issue 2, pages 89–111, March.

Moya, J., K.G. Garrahan, T.M. Poston, G.S. Durell. 1998. Effects of cooking on levels of PCBs in the fillets of winter flounder. Bull. Environ. Contamin. Toxicol. 60:845-851.

New York Times. 2007. Divers Who Jump in to Take the Mystery out of City Waterways. Available at http://www.nytimes.com/2007/11/27/nyregion/27divers.html?_r=1. November 27.

NJDEP (New Jersey Department of Environmental Protection). 2002. Estimate of Cancer Risk to Consumers of Crabs Caught in the Area of the Diamond Alkali Site and Other Areas of the Newark Bay Complex from 2,3,7,8-TCDD and 2,3,7,8-TCDD Equivalents. Prepared by

Page 52: Appendix L HHRA Combined

the Division of Science, Research and Technology (April 25). Available at http://www.state.nj.us/ dep/ dsr/craboutreach/crabsra.pdf.

NYCDEP (New York City Department of Environmental Protection). 2008. Gowanus Canal Waterbody/Watershed Facility Plan Report. New York City Department of Environmental Protection, Bureau of Engineering Design and Construction. City-wide Long Term CSO Control Planning Project. August.

NYSDOH (New York State Department of Health). 2010. Chemicals in Sportfish and Game, 2010–2011 Health Advisories. Available at http://www.health.state.ny.us/environmental/ outdoors/fish/docs/fish.pdf .

Skea, J.C., H.A. Simonin, E.J. Harris, S. Jackling, and J.J. Spagnoli. 1979. Reducing levels of mirex, arochlor 1254, and DDE by trimming and cooking Lake Ontario brown trout (Salmo trutta L.) and smallmouth bass (Micropterus dolomieui lacepede). J Great Lakes Res. 5(2):153-159.

USEPA. 1986. Guidelines for Health Risk Assessment of Chemical Mixtures. Federal Register, Vol. 51 34041. September.

USEPA. 1989. Risk Assessment Guidance for Superfund, Volume 1, Human Health Evaluation Manual, Part A, Interim Final. Office of Solid Waste and Emergency Response. EPA/540/1-89/002.

USEPA. 1991. Risk Assessment Guidance for Superfund. Vol. 1: Human Health Evaluation Manual-Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

USEPA Region 2. 1992. Evaluation of Metals Data for the Contract Laboratory Program (SOP HW-2, Revision 11). January.

USEPA. 1993. Superfund’s Standard Default Exposure Factors for the Central Tendency and Reasonable Maximum Exposure. Washington, DC.

USEPA. 1994a. National Oil and Hazardous Substances Contingency Plan. September 15.

USEPA. 1994b. Revised Interim Soil Lead Guidance for CERCLA Sites and RCRA Corrective Action Facilities. OSWER Directive 9355.4-12. July 14.

USEPA. 1994c. Guidance Manual for the IEUBK Model for Lead in Children. PB93-963510, OSWER 9285.7-15-1. February.

USEPA. 1995. Health Assessment Document for Polychlorinated Dibenzo-p-Dioxins. Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office. Cincinnati, OH. EPA 600/8-84-014F.

USEPA. 1996. PCBs: Cancer Dose-Response Assessment and Application to Environmental Mixtures. EPA/600/P-96/001F. September.

USEPA. 1997. Exposure Factors Handbook. EPA/ 600/P-95/Fa, -Fb, and -Fc.

USEPA. 2000. Guidance for Assessing Chemical Contaminant Data for Use in Fish Advisories. Volume 2: Risk Assessment and Fish Consumption Limits - Third Edition. Appendix C. Dose Modifications Due to Food Preparation and Cooking. EPA 823-B-00-008. November.

Page 53: Appendix L HHRA Combined

USEPA. 2001a. Risk Assessment Guidance for Superfund, Volume 1, Human Health Evaluation Manual Part D, Standardized Planning, Reporting, and Review of Superfund Risk Assessments. Office of Solid Waste and Emergency Response. OSWER 9285.7-47. December.

USEPA Region 2. 2001b. Data Validation SOP for Statement of Work OLM04.2 (SOP HW-6, Revision 12). March.

USEPA. 2002. Supplemental Guidance for Developing Soil Screening Levels for Superfund Sites. OSWER 9355.4-24. December.

USEPA. 2003a. Human Health Toxicity Values in Superfund Risk Assessments. OSWER Directive 9285.7-53. December.

USEPA. 2003b. Recommendations of the Technical Review Workgroup for Lead for an Approach to Assessing Risks Associated with Adult Exposure to Lead in Soil. Office of Solid Waste and Emergency Response. OSWER 9285.7-54. January.

USEPA. 2004. Risk Assessment Guidance for Superfund, Volume 1, Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Interim. OSWER 9285.7-02EP. July.

USEPA. 2005a. Guidelines for Carcinogenic Risk Assessment. EPA/630/P-03/001F. March.

USEPA. 2005b. Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. EPA/630/R-03/003F. March.

USEPA. 2006. Derivation of RBCs for Carcinogens that Act Via a Mutagenic Mode of Action and Incorporate Default ADAFs. Region 3. October.

USEPA. 2009. Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part F, Supplemental Guidance for Inhalation Risk Assessment). Final. EPA-540-R-070-002. OSWER 9285.7-82. Office of Superfund Remediation and Technology Innovation. January.

USEPA. 2010a. ProUCL, Version 4.00.05. Prepared by Lockheed Martin Environmental Services. May.

USEPA. 2010b. EPA Regional Screening Level Summary Table. May

USEPA Region 3. 2010c. Regional Screening Level Fish Ingestion Table November 2010. Available at http://www.epa.gov/reg3hwmd/risk/human/index.htm. December.

USEPA. 2010d. Recommended Toxicity Equivalence Factors (TEFs) for Human Health Risk Assessments of 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Dioxin-Like Compounds. Risk Assessment Forum, Washington, DC. EPA/100/R-10/005.

USEPA. 2010e. Integrated Risk Information System database.

USEPA. 2010f. IEUBKWin32 Lead Model for Windows, Version 1.1, Build 11. http://www.epa.gov/superfund/lead/products.htm#guid

U.S. Food and Drug Administration (U.S. FDA). 1993. Guidance Documents for Trace Elements in Seafood. Center for Food Safety and Applied Nutrition. January.

Page 54: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 55: Appendix L HHRA Combined

Date of Sample

Medium Sampling Location Sample Parameters

Surface sediment 6/23/2010 301 GC-SD301-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/17/2010 302 GC-SD302-0.0-0.52 VOCs, SVOCs, Pest, PCBs, Metals

6/17/2010 303 GC-SD303-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/17/2010 304 GC-SD304-0.0-0.5 VOCs, SVOCs, Pest, PCBs, Metals

6/17/2010 305 GC-SD305-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/17/2010 306 GC-SD306-0.0-0.5 VOCs, SVOCs, Pest, PCBs, Metals

6/17/2010 307A GC-SD307A-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/18/2010 307B GC-SD307B-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/23/2010 308A D-062310-0111,2 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/23/2010 308A GC-SD308A-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/24/2010 308B GC-SD308B-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/18/2010 309 GC-SD309-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/24/2010 310 GC-SD310-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/23/2010 311 GC-SD311-0.0-0.5 VOCs, SVOCs, Pest, PCBs, Metals

6/23/2010 312 GC-SD312-0.0-0.5 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/18/2010 313 GC-SD313-0.0-0.5 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/18/2010 314 GC-SD314-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/18/2010 314 D-06182010-011,2 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/18/2010 314 D-06242010-011,2 VOCs

6/18/2010 315 D-06182010-021 SVOCs, Pest, PCBs, PCB congeners, Metals

6/18/2010 315 GC-SD315-0.0-0.5 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/21/2010 316 GC-SD316-0.0-0.52 VOCs, SVOCs, Pest, PCBs, Metals

6/22/2010 317 GC-SD317-0.0-0.5 VOCs, SVOCs, Pest, PCBs, Metals

6/22/2010 318 GC-SD318-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/22/2010 319 GC-SD319-0.0-0.52 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/22/2010 320 GC-SD320-0.0-0.5 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/21/2010 321 GC-SD321-0.0-0.5 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/22/2010 322 GC-SD322-0.0-0.5 VOCs, SVOCs, Pest, PCBs, Metals

6/22/2010 323 GC-SD323-0.0-0.5 VOCs, SVOCs, Pest, PCBs, Metals

6/21/2010 324 GC-SD324-0.0-0.5 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/21/2010 324 D-06212010-011 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

6/21/2010 325 GC-SD325-0.0-0.5 VOCs, SVOCs, Pest, PCBs, PCB congeners, Metals

Surface water— 6/19/2010 301 GC-SW301-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

dry-weather event 6/19/2010 302 GC-SW302-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 303 GC-SW303-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 304 GC-SW304-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 305 GC-SW305-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 306 GC-SW306-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 307A GC-SW307A-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 307B GC-SW307B-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 308A GC-SW308A-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 308B GC-SW308B-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 309 GC-SW309-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 310 GC-SW310-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 311 GC-SW311-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 312 GC-SW312-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 312 D-06192010-021

VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 313 GC-SW313-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 314 GC-SW314-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 315 GC-SW315-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

TABLE 4-1

Summary of Data Quantitatively Used in HHRA

Gowanus Canal Remedial Investigation, Brooklyn, New York

1 of 22

Page 56: Appendix L HHRA Combined

Date of Sample

Medium Sampling Location Sample Parameters

TABLE 4-1

Summary of Data Quantitatively Used in HHRA

Gowanus Canal Remedial Investigation, Brooklyn, New York

Surface water— 6/19/2010 316 GC-SW316-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

dry-weather event 6/19/2010 316 D-06192010-031 VOCs, SVOCs, Pest, PCBs, Metals

(continued) 6/19/2010 317 GC-SW317-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 318 GC-SW318-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 318 D-06192010-041 VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 319 GC-SW319-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 320 GC-SW320-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 321 GC-SW321-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 322 GC-SW322-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 323 GC-SW323-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 324 GC-SW324-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

6/19/2010 325 GC-SW325-0.5-DW VOCs, SVOCs, Pest, PCBs, Metals

Surface water— 7/13/2010 301 GC-SW301-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

wet-weather event 7/13/2010 302 GC-SW302-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 303 GC-SW303-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 303 D-07132010-011 VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 304 GC-SW304-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 305 GC-SW305-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 306 GC-SW306-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 307A GC-SW307A-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 307B GC-SW307B-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 308A GC-SW308A-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 308B GC-SW308B-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 309 GC-SW309-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 310 GC-SW310-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 310 D-07132010-021 VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 311 GC-SW311-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 312 GC-SW312-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 313 GC-SW313-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 314 GC-SW314-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 315 GC-SW315-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 316 GC-SW316-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 317 GC-SW317-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 318 GC-SW318-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 319 GC-SW319-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 319 D-07132010-031 VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 320 GC-SW320-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 321 GC-SW321-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 322 GC-SW322-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 323 GC-SW323-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 324 GC-SW324-0.5-WW VOCs, SVOCs, Pest, PCBs, Metals

7/13/2010 324 D-07132010-04 VOCs, SVOCs, Pest, PCBs, Metals

2 of 22

Page 57: Appendix L HHRA Combined

Date of Sample

Medium Sampling Location Sample Parameters

TABLE 4-1

Summary of Data Quantitatively Used in HHRA

Gowanus Canal Remedial Investigation, Brooklyn, New York

Ambient air—canal level 7/8/2010 501 GC-AS501-C-1 VOCs, SVOCs

Event 1 (prior to start 7/8/2010 502 GC-AS502-C-1 VOCs, SVOCs

of aeration system) 7/8/2010 503 GC-AS503-C-1 VOCs, SVOCs

7/8/2010 504 GC-AS504-C-13 VOCs, SVOCs

7/8/2010 505 D-07082010-02-PAH1 VOCs, SVOCs

7/8/2010 505 D-07082010-01-VOC1 VOCs, SVOCs

7/8/2010 505 GC-AS505-C-1 VOCs, SVOCs

7/8/2010 506 D-07082010-02-VOC1 VOCs, SVOCs

7/8/2010 506 GC-AS506-C-1 VOCs, SVOCs

7/8/2010 507 GC-AS507-C-13 VOCs, SVOCs

7/8/2010 508 GC-AS508-C-1 VOCs, SVOCs

7/8/2010 509 GC-AS509-C-1 VOCs, SVOCs

7/8/2010 510 GC-AS510-C-1 VOCs, SVOCs

Ambient air—canal level 7/29/2010 501 GC-AS501-C-2 VOCs, SVOCs

Event 2 (after start 7/29/2010 502 GC-AS502-C-2 VOCs, SVOCs

of aeration system) 7/29/2010 503 GC-AS503-C-2 VOCs, SVOCs

7/29/2010 504 GC-AS504-C-2 VOCs, SVOCs

7/29/2010 505 GC-AS505-C-2 VOCs, SVOCs

7/29/2010 505 D-07292010-01 VOCs, SVOCs

7/29/2010 506 D-07292010-02-VOC1 VOCs

7/29/2010 506 GC-AS506-C-2 VOCs, SVOCs

7/29/2010 507 GC-AS507-C-2 VOCs, SVOCs

7/29/2010 508 GC-AS508-C-2 VOCs, SVOCs

7/29/2010 509 GC-AS509-C-2 VOCs, SVOCs

7/29/2010 510 GC-AS510-C-2 VOCs, SVOCs

Ambient air—street level 7/9/2010 501 GC-AS501-S-1 VOCs, SVOCs

Event 1 (prior to start 7/8/2010 502 GC-AS502-S-1 VOCs, SVOCs

of aeration system) 7/8/2010 503 GC-AS503-S-1 VOCs, SVOCs

7/8/2010 504 D-07082010-01-PAH1 SVOCs

7/8/2010 504 GC-AS504-S-1 VOCs, SVOCs

7/8/2010 505 GC-AS505-S-1 VOCs, SVOCs

7/8/2010 506 D-07082010-031 PCBs

7/8/2010 506 GC-AS506-S-1 VOCs, SVOCs, PCBs

7/8/2010 507 GC-AS507-S-1 VOCs, SVOCs

7/8/2010 508 GC-AS508-S-1 VOCs, SVOCs

7/8/2010 509 GC-AS509-S-1 VOCs, SVOCs

7/8/2010 510 GC-AS510-S-1 VOCs, SVOCs

Ambient air—street level 7/29/2010 501 GC-AS501-S-2 VOCs, SVOCs

Event 2 (after start 7/29/2010 502 GC-AS502-S-2 VOCs, SVOCs

of aeration system) 7/29/2010 503 GC-AS503-S-2 VOCs, SVOCs

7/29/2010 504 D-07292010-02-PAH1 SVOCs

7/29/2010 504 GC-AS504-S-2 VOCs, SVOCs

7/29/2010 505 GC-AS505-S-2 VOCs, SVOCs

7/29/2010 506 GC-AS506-S-2 VOCs, SVOCs

7/29/2010 507 GC-AS507-S-2 VOCs, SVOCs

7/29/2010 508 GC-AS508-S-2 VOCs, SVOCs

7/29/2010 509 GC-AS509-S-2 VOCs, SVOCs

7/29/2010 510 GC-AS510-S-2 VOCs, SVOCs

3 of 22

Page 58: Appendix L HHRA Combined

Date of Sample

Medium Sampling Location Sample Parameters

TABLE 4-1

Summary of Data Quantitatively Used in HHRA

Gowanus Canal Remedial Investigation, Brooklyn, New York

Fish tissue— 10/18/2010 401 GC-TI401-SB-FI-1 Pest, Metals, PCB congeners

striped bass filet 10/18/2010 401 GC-TI401-SB-FI-2 Pest, Metals, PCB congeners

(representative of top- 10/21/2010 403 GC-TI403-SB-FI-1 Pest, Metals, PCB congeners

level predator fish) 10/22/2010 406 GC-TI406-SB-FI-1 Pest, Metals, PCB congeners

10/22/2010 406 GC-TI406-SB-FI-2 Pest, Metals, PCB congeners

Fish tissue— 10/18/2010 401 GC-TI401-WP-FI-1 Pest, Metals, PCB congeners

white perch filet 10/19/2010 401 GC-TI401-WP-FI-2 Pest, Metals, PCB congeners

(representative of middle-

level predator fish)

Fish tissue— 10/19/2010 402 GC-TI402-XAE-FI-1 Pest, Metals, PCB congeners

eel filet 10/19/2010 402 GC-TI402-XAE-FI-2 Pest, Metals, PCB congeners

(representative of 10/20/2010 403 GC-TI403-XAE-FI-1 Pest, Metals, PCB congeners

bottom feeder fish) 10/21/2010 403 GC-TI403-XAE-FI-2 Pest, Metals, PCB congeners

10/21/2010 403 GC-TI403-XAE-FI-3 Pest, Metals, PCB congeners

10/22/2010 406 GC-TI406-XAE-FI-1 Pest, Metals, PCB congeners

Crab 8/16/2010 401 GC-TI401-BC-ED-14 SVOCs, Pest, Metals, PCB congeners

8/16/2010 401 GC-TI401-BC-ED-24 SVOCs, Pest, Metals, PCB congeners

8/17/2010 402 GC-TI402-BC-ED-14 SVOCs, Pest, Metals, PCB congeners

8/17/2010 402 GC-TI402-BC-ED-24 SVOCs, Pest, Metals, PCB congeners

8/17/2010 403 GC-TI403-BC-ED-14 SVOCs, Pest, Metals, PCB congeners

8/17/2010 403 GC-TI403-BC-ED-24 SVOCs, Pest, Metals, PCB congeners

8/18/2010 404 GC-TI404-BC-ED-14 SVOCs, Pest, Metals, PCB congeners

8/18/2010 404 GC-TI404-BC-ED-24 SVOCs, Pest, Metals, PCB congeners

8/19/2010 405 GC-TI405-BC-ED-14 SVOCs, Pest, Metals, PCB congeners

8/19/2010 405 GC-TI405-BC-ED-24 SVOCs, Pest, Metals, PCB congeners

8/19/2010 406 GC-TI406-BC-ED-14 SVOCs, Pest, Metals, PCB congeners

8/20/2010 406 GC-TI406-BC-ED-24 SVOCs, Pest, Metals, PCB congeners

8/24/2010 401-402 GC-TI401-402-BC-HP-15 SVOCs, Pest, Metals, PCB congeners

8/25/2010 403-406 GC-TI403-404-405-406-BC-HP-25 SVOCs, Pest, Metals, PCB congeners

1. Duplicate sample.

2. Sediment sample used in recreational scenario for exposure to exposed and near shore surface sediment. All sediment samples used for overflow scenario.

3. Sample not used, volume not available to calculate µg/m3.

4. Edible tissue sample.

5. Hepatopancreas sample.

4 of 22

Page 59: Appendix L HHRA Combined

Surface Sediment (Exposed and Near-

Shore Sediment in Gowanus Canal) Surface Sediment Surface Water (Gowanus Canal) Ambient Air Fish

Canal overflow scenario Dry-weather event Canal level, pre-aeration system Striped bass

Acenaphthene Acenaphthene Benzene Benzene p,p'-DDE

Benzo(a)anthracene Benzo(a)anthracene Benzo(a)anthracene Chloroform p,p'-DDT

Benzo(a)pyrene Benzo(a)pyrene Benzo(a)pyrene Ethylbenzene Dioxin-like PCB TEQ

Benzo(b)fluoranthene Benzo(b)fluoranthene Benzo(b)fluoranthene Xylene, total Nondioxin-like PCB

Benzo(k)fluoranthene Benzo(k)fluoranthene Bis(2-ethylhexyl) phthalate Naphthalene Total PCB

Bis(2-ethylhexyl) phthalate Bis(2-ethylhexyl) phthalate Indeno(1,2,3-c,d)pyrene Arsenic

Chrysene Chrysene Arsenic Canal level, during aeration Mercury

Dibenz(a,h)anthracene Dibenz(a,h)anthracene Chromium system operation Selenium

Fluoranthene Fluoranthene Copper Benzene White perch

Indeno(1,2,3-c,d)pyrene Fluorene Selenium Chloroform Dioxin-like PCB TEQ

Naphthalene Indeno(1,2,3-c,d)pyrene Ethylbenzene Nondioxin-like PCB

Pyrene Naphthalene Wet-weather event Xylene, total Total PCB

Dioxin-Like PCB TEQ Pyrene (and surface water overflow) Naphthalene Mercury

Nondioxin-Like PCB Dioxin-Like PCB TEQ 1,4-Dichlorobenzene Selenium

Total PCB Nondioxin-Like PCB Benzene Street level, pre-aeration system Eel

Aluminum Total PCB Chloroform Benzene alpha-Chlordane

Arsenic Aluminum Ethylbenzene Chloroform Dieldrin

Cadmium Arsenic Tetrachloroethylene(PCE) Ethylbenzene gamma-Chlordane

Chromium Cadmium Benzo(a)anthracene Naphthalene p,p'-DDD

Cobalt Chromium Benzo(a)pyrene p,p'-DDE

Copper Cobalt Benzo(b)fluoranthene Street level, during aeration p,p'-DDT

Iron Copper Dibenz(a,h)anthracene system operation Dioxin-like PCB TEQ

Lead Iron Indeno(1,2,3-c,d)pyrene Benzene Nondioxin-like

Manganese Lead Naphthalene Chloroform Total PCB

Vanadium Manganese Arsenic Ethylbenzene Arsenic

Vanadium Chromium Naphthalene Chromium

Cobalt Copper

Lead Cyanide, total

Selenium Mercury

Selenium

Blue crab

Benzo(a)anthracene

Benzo(a)pyrene

Benzo(b)fluoranthene

Dibenz(a,h)anthracene

Indeno(1,2,3-cd)pyrene

Dioxin-like PCB TEQ

Nondioxin-like

Total PCB

Arsenic

Copper

Mercury

TABLE 4-2

Chemicals of Potential Concern

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 60: Appendix L HHRA Combined

PCB Congener WHO TEFa,b

3,3',4,4'-Tetrachlorobiphenyl (77) 0.0001

3,4,4',5-Tetrachlorobiphenyl (81) 0.0003

2,3,3',4,4'-Pentachlorobiphenyl (105) 0.00003

2,3,4,4',5-Pentachlorobiphenyl (114) 0.00003

2,3',4,4',5-Pentachlorobiphenyl (118) 0.00003

2,3',4,4',5'-Pentachlorobiphenyl (123) 0.00003

3,3',4,4',5-Pentachlorobiphenyl (126) 0.1

Congeners (156/157) 0.00003

2,3',4,4',5,5'-Hexachlorobiphenyl (167) 0.00003

3,3',4,4',5,5'-Hexachlorobiphenyl (169) 0.03

2,3,3',4,4',5,5'-Heptachlorobiphenyl (189) 0.00003

b USEPA. 2010c. Recommended Toxicity Equivalence Factors (TEFs) for Human Health Risk Assessments of

2,3,7,8-Tetrachlorodibenzo-p-dioxin and Dioxin-Like Compounds. Risk Assessment Forum, Washington, DC.

EPA/100/R-10/005.

a Van den Berg et al., 2006. The 2005 World Health Organization Re-evaluation of Human and Mammalian

Toxic Equivalency Factors for Dioxins and Dioxin-like Compounds. ToxSci Advance Acces. July 7.

TABLE 5-1

WHO Dioxin-like PCB TEFs

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 61: Appendix L HHRA Combined

COPC PCFa

Chlordane 33

Dieldrin 30

p,p'-DDD 30

p,p'-DDE 35

p,p'-DDT 30

PCBs 20

a USEPA. 2000. Guidance for Assessing Chemical Contaminant

Data for Use in Fish Advisories. Volume 2: Risk Assessment and

Fish Consumption Limits - Third Edition. Appendix C. Dose

Modifications Due to Food Preparation and Cooking. November.

EPA 823-B-00-008.

TABLE 5-2

Preparation/Cooking Loss Factor (PCF) for Fish

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 62: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5 and <10-4

Chemicals with Cancer Risks

>10-6 and <10-5Hazard

Index

Chemicals

with HI>1

Ingestion 2E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene 0.03

Dermal

Contact 1E-04

Benzo(a)pyrene,

Chromium

Benzo(a)anthracene, Benzo(b)fluoranthene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene, Nondioxin-like PCBs 0.13

Total 1E-04

Benzo(a)pyrene, Chromium

Benzo(a)anthracene,

Benzo(b)fluoranthene, Dibenz(a,h)anthracene, Indeno(1,2,3-c,d)pyrene, Non-

dioxin-like PCBs, Arsenic 0.2

Ingestion 2E-06 Arsenic 0.01

Dermal

Contact 2E-04 Benzo(a)pyrene Chromium

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene 0.03

Total 2E-04 Benzo(a)pyrene Chromium

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Arsenic 0.04

Ingestion 2E-06 Arsenic 0.01

Dermal

Contact 1E-04

PCE, Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Chromium 0.02

Total 1E-04

PCE, Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene, Arsenic,

Chromium 0.03

Inhalation 2E-07 0.006

Total 2E-07 0.006

Ingestion 3E-07 0.007

Total 3E-07 0.007

All media 3E-04 0.2

TABLE 7-1

Summary of RME Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Surface sediment—exposed and near-shore sediment in

Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Recreational Adult

Surface water—Gowanus Canal, wet-weather event

Ambient air at canal level, after aeration system started

Ambient air at canal level, pre-aeration system operation

8 of 22

Page 63: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5 and <10-4

Chemicals with Cancer Risks

>10-6 and <10-5Hazard

Index

Chemicals

with HI>1

TABLE 7-1

Summary of RME Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational

Ingestion 1E-05

Benzo(a)anthracene,

Benzo(a)pyrene 0.03

Dermal

Contact 8E-05 Benzo(a)pyrene

Benzo(a)anthracene, Benzo(b)fluoranthene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene, Chromium 0.2

Total 1E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene, Dibenz(a,h)anthracene, Indeno(1,2,3-c,d)pyrene,

Chromium 0.2

Ingestion 9E-07 0.01

Dermal

Contact 1E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 0.03

Total 1E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 0.05

Ingestion 8E-07 0.01

Dermal

Contact 8E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene

PCE, Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 0.02

Total 8E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene

PCE, Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 0.04

Inhalation 6E-08 0.006

Total 6E-08 0.006

Ingestion 7E-08 0.007

Total 7E-08 0.007

All media 2E-04 0.2

Recreational

Adolescent

Ambient air at canal level, pre-aeration system operation

Ambient air at canal level, after aeration system started

Surface

sediment—exposed and near-shore sediment in Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Surface water—Gowanus Canal, wet-weather event

9 of 22

Page 64: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5 and <10-4

Chemicals with Cancer Risks

>10-6 and <10-5Hazard

Index

Chemicals

with HI>1

TABLE 7-1

Summary of RME Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational

Ingestion 2E-04 Benzo(a)pyrene

Benzo(a)anthracene, Benzo(b)fluoranthene

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene, Arsenic, Chromium 0.3

Dermal Contact 2E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene, Chromium

Dibenz(a,h)anthracene, Indeno(1,2,3-c,d)pyrene 0.2

Total 4E-04 Benzo(a)pyrene

Benzo(a)anthracene, Benzo(b)fluoranthene, Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium Benzo(k)fluoranthene, Arsenic 0.4

Ingestion 6E-06

Benzo(a)pyrene, Arsenic,

Chromium 0.05

Dermal

Contact 4E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Indeno(1,2,3-c,d)pyrene 0.05

Total 4E-04 Benzo(a)pyrene

Benzo(b)fluoranthene,

Chromium

Benzo(a)anthracene,

Indeno(1,2,3-c,d)pyrene,

Arsenic 0.1

Ingestion 4E-06 Arsenic, Chromium 0.05

Dermal

Contact 3E-04 Benzo(a)pyrene

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium

PCE, Benzo(a)anthracene,

Benzo(b)fluoranthene 0.04

Total 3E-04 Benzo(a)pyrene

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium

PCE, Benzo(b)fluoranthene,

Arsenic 0.09

Inhalation 6E-08 0.01

Total 6E-08 0.01

Ingestion 7E-08 0.01

Total 7E-08 0.01

All media 8E-04 0.5

Recreational

Child

Surface sediment—exposed and near-shore sediment in

Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Surface water—Gowanus Canal, wet-weather event

Ambient air at canal level, pre-aeration system operationAmbient air at canal level, after aeration system started

10 of 22

Page 65: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5 and <10-4

Chemicals with Cancer Risks

>10-6 and <10-5Hazard

Index

Chemicals

with HI>1

TABLE 7-1

Summary of RME Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational Inhalation 2E-05 Naphthalene Benzene, Chloroform 0.3

Total 2E-05 Naphthalene Benzene, Chloroform 0.3

Inhalation 3E-05 Naphthalene Benzene, Chloroform 0.7

Total 3E-05 Naphthalene Benzene, Chloroform 0.7

Ingestion 1E-05

Benzo(a)pyrene,

Benzo(a)anthracene 0.02

Dermal Contact 1E-05 Benzo(a)pyrene, Chromium 0.02

Total 2E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Chromium 0.04

Ingestion 5E-07 0.01

Dermal

Contact 3E-05

PCE, Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium 0.006

Total 3E-05

PCE, Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium 0.02

All media 8E-05 0.8

Inhalation NA 0.5

Total NA 0.5

Inhalation NA 1.0

Total NA 1.0

Ingestion NA 0.02Dermal

Contact NA 0.03

Total NA 0.06

Ingestion NA 0.004Dermal

Contact NA 0.002

Total NA 0.006

All media NA 1.1

Industrial

Worker AdultAmbient air at street

level, pre-aeration system operation

Ambient air at street level, after aeration system started

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Canal Overflow—surface water

Resident

AdultAmbient air at street

level, pre-aeration

system operation

Ambient air at street level, after aeration system started

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Canal Overflow—surface water

11 of 22

Page 66: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5 and <10-4

Chemicals with Cancer Risks

>10-6 and <10-5Hazard

Index

Chemicals

with HI>1

TABLE 7-1

Summary of RME Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational Inhalation NA 0.5

Total NA 0.5

Inhalation NA 1.0

Total NA 1.0

Ingestion NA 0.2Dermal

Contact NA 0.07

Total NA 0.3

Ingestion NA 0.02Dermal

Contact NA 0.005

Total NA 0.02

All media NA 1.3

Inhalation 2E-05 Naphthalene Benzene, Chloroform NA

Total 2E-05 Naphthalene Benzene, Chloroform NA

Inhalation 4E-05 Naphthalene Benzene, Chloroform NA

Total 4E-05 Naphthalene Benzene, Chloroform NA

Ingestion 1E-04

Benzo(a)anthracene,

Benzo(a)pyrene,

Benzo(b)fluoranthene

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene NA

Dermal

Contact 7E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium NA

Total 2E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene

Indeno(1,2,3-c,d)pyrene,

Arsenic, Chromium NA

Ingestion 2E-06 NA

Dermal

Contact 6E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene

PCE, Benzo(b)fluoranthene, Indeno(1,2,3-c,d)pyrene,

Chromium NA

Total 6E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene

PCE, Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium NA

All media 3E-04 NA

Resident

ChildAmbient air at street

level, pre-aeration system operation

Ambient air at street level, after aeration system started

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Canal Overflow—surface water

Resident

Child/AdultAmbient air at street

level, pre-aeration

system operation

Ambient air at street level, after aeration system started

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Canal Overflow—surface water

12 of 22

Page 67: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5 and <10-4

Chemicals with Cancer Risks

>10-6 and <10-5Hazard

Index

Chemicals

with HI>1

TABLE 7-1

Summary of RME Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational Ingestion 1E-04

Dioxin-Like PCB,

Nondioxin-Like PCB Arsenic 4.2 Total PCB

Total 1E-04

Dioxin-Like PCB, Nondioxin-Like PCB Arsenic 4.2 Total PCB

Ingestion 2E-05

Dioxin-Like PCB, Nondioxin-

Like PCB 0.8

Total 2E-05

Dioxin-Like PCB, Nondioxin-Like PCB 0.8

Ingestion 3E-04

Nondioxin-Like PCB, Dioxin-Like PCB Dieldrin, Chromium Arsenic 12 Total PCB

Total 3E-04

Nondioxin-Like PCB,

Dioxin-Like PCB Dieldrin, Chromium Arsenic 12 Total PCB

Ingestion 2E-04

Dioxin-Like PCB,

Nondioxin-Like PCB, Arsenic

Benzo(a)pyrene, Dibenz(a,h)anthracene 3.4 Total PCB

Total 2E-04

Dioxin-Like PCB,

Nondioxin-Like PCB,

Arsenic

Benzo(a)pyrene,

Dibenz(a,h)anthracene 3.4 Total PCB

Fish Total Risk 4E-04 17

Crab Total Risk 2E-04 3.4

Ingestion 2E-05

Dioxin-Like PCB, Nondioxin-

like, Arsenic 3.4 Total PCB

Total 2E-05

Dioxin-Like PCB, Nondioxin-

Like PCB, Arsenic 3.4 Total PCB

Ingestion 4E-06

Dioxin-Like PCB, Nondioxin-

Like PCB 0.7

Total 4E-06

Dioxin-Like PCB, Nondioxin-

Like PCB 0.7

Ingestion 7E-05

Dioxin-Like PCB,

Nondioxin-Like PCB Dieldrin, Chromium 9.4 Total PCB

Total 7E-05

Dioxin-Like PCB,

Nondioxin-Like PCB Dieldrin, Chromium 9.4 Total PCB

Ingestion 4E-05 Dioxin-Like PCB

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Nondioxin-Like PCB, Arsenic 2.7 Total PCB

Total 4E-05 Dioxin-Like PCB

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Nondioxin-Like PCB, Arsenic 2.7 Total PCB

Fish Total Risk 9E-05 13

Crab Total Risk 4E-05 2.7

Angler

AdolescentStriped Bass in

Gowanus Canal (top-

level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

Angler AdultStriped Bass in

Gowanus Canal (top-

level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

13 of 22

Page 68: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5 and <10-4

Chemicals with Cancer Risks

>10-6 and <10-5Hazard

Index

Chemicals

with HI>1

TABLE 7-1

Summary of RME Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational

Ingestion 4E-05

Dioxin-Like PCB,

Nondioxin-Like PCB Arsenic 6.8 Total PCB

Total 4E-05

Dioxin-Like PCB,

Nondioxin-Like PCB Arsenic 6.8 Total PCB

Ingestion 8E-06

Dioxin-Like PCB, Nondioxin-Like PCB 1.4 Total PCB

Total 8E-06

Dioxin-Like PCB, Nondioxin-

Like PCB 1.4 Total PCB

Ingestion 2E-04

Dioxin-Like PCB,

Nondioxin-Like PCB,

Chromium Dieldrin, Arsenic 19 Total PCB

Total 2E-04

Nondioxin-Like PCB,

Chromium Dieldrin, Arsenic 19 Total PCB

Ingestion 9E-05

Dioxin-Like PCB, Nondioxin-Like PCB,

Benzo(a)pyreneDibenz(a,h)anthracene, Arsenic 5.5 Total PCB

Total 9E-05

Dioxin-Like PCB,

Nondioxin-Like PCB,

Benzo(a)pyrene

Dibenz(a,h)anthracene,

Arsenic 5.5 Total PCB

Fish Total Risk 2E-04 27

Crab Total Risk 9E-05 5.5

NA—Not applicable, pathway incomplete.

Receptor Total risks and hazards for recreational receptors includes sum of exposed and near-shore sediment, maximum of dry event and wet event surface water,

and maximum of air prior to aeration system operation and after aeration system started.

Receptor Total risks and hazards for residential and industrial receptors includes maximum between air prior to and after aeration system operation,

and surface water, and sediment.

Angler ChildStriped Bass in

Gowanus Canal (top-level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

14 of 22

Page 69: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5

and <10-4

Chemicals with Cancer

Risks >10-6

and <10-5

Hazard

Index

Chemicals

with HI>1

Ingestion 6E-07 7E-03

Dermal

Contact 7E-06 Benzo(a)pyrene 7E-02

Total 8E-06 Benzo(a)pyrene 7E-02

Ingestion 3E-08 1E-03Dermal

Contact 8E-06 Benzo(a)pyrene 7E-03

Total 8E-06 Benzo(a)pyrene 9E-03

Ingestion 3E-08 1E-03

Dermal

Contact 5E-06 Benzo(a)pyrene 6E-03

Total 5E-06 Benzo(a)pyrene 7E-03

All media 2E-05 8E-02

Ingestion 2E-06 Benzo(a)pyrene 9E-03

Dermal

Contact 3E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Chromium 8E-02

Total 3E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene,

Chromium 9E-02

Ingestion 6E-08 2E-03

Dermal

Contact 3E-05 Benzo(a)pyrene

Benzo(b)fluoranthene,

Chromium 8E-03

Total 3E-05 Benzo(a)pyrene

Benzo(b)fluoranthene,

Chromium 1E-02

Ingestion 5E-08 2E-03

Dermal

Contact 2E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene 6E-03

Total 2E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene 8E-03

All media 5E-05 1E-01

TABLE 7-2

Summary of CTE Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational

AdultSurface

sediment—exposed and

near-shore sediment in

Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Surface water—Gowanus Canal, wet-weather event

Recreational

Adolescent

Surface

sediment—exposed and

near shore sediment in

Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Surface water—Gowanus Canal, wet-weather event

15 of 22

Page 70: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5

and <10-4

Chemicals with Cancer

Risks >10-6

and <10-5

Hazard

Index

Chemicals

with HI>1

TABLE 7-2

Summary of CTE Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational

Ingestion 4E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium 6E-02

Dermal

Contact 7E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium 8E-02

Total 1E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene,

Chromium 1E-01

Ingestion 5E-07 7E-03

Dermal

Contact 1E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 1E-02

Total 1E-04 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 2E-02

Ingestion 3E-07 6E-03

Dermal

Contact 7E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 1E-02

Total 7E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Indeno(1,2,3-c,d)pyrene,

Chromium 2E-02

All media 2E-04 2E-01

Recreational

Child

Surface

sediment—exposed and

near-shore sediment in

Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Surface water—Gowanus Canal, wet-weather event

16 of 22

Page 71: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5

and <10-4

Chemicals with Cancer

Risks >10-6

and <10-5

Hazard

Index

Chemicals

with HI>1

TABLE 7-2

Summary of CTE Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational Inhalation NA 3E-01

Total NA 3E-01

Inhalation NA 7E-01

Total NA 7E-01

Ingestion NA 6E-03Dermal

Contact NA 2E-02

Total NA 2E-02

Ingestion NA 5E-04Dermal

Contact NA 6E-04

Total NA 1E-03

All media NA 7E-01

Inhalation NA 3E-01

Total NA 3E-01

Inhalation NA 7E-01

Total NA 7E-01

Ingestion NA 6E-02Dermal

Contact NA 4E-02

Total NA 9E-02

Ingestion NA 2E-03Dermal

Contact NA 1E-03

Total NA 4E-03

All media NA 8E-01

Resident

AdultAmbient air at street

level, pre-aeration

system operation

Ambient air at street level, after aeration system started

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Canal overflow—surface water

Resident

ChildAmbient air at street

level, pre-aeration

system operation

Ambient air at street level, after aeration system started

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Canal overflow—surface water

17 of 22

Page 72: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5

and <10-4

Chemicals with Cancer

Risks >10-6

and <10-5

Hazard

Index

Chemicals

with HI>1

TABLE 7-2

Summary of CTE Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational Inhalation 5E-06 Naphthalene NA

Total 5E-06 Naphthalene NA

Inhalation 1E-05 Naphthalene NA

Total 1E-05 Naphthalene NA

Ingestion 3E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene NA

Dermal

Contact 2E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene NA

Total 5E-05 Benzo(a)pyrene

Benzo(a)anthracene,

Benzo(b)fluoranthene,

Dibenz(a,h)anthracene

Indeno(1,2,3-c,d)pyrene NA

Ingestion 2E-07 NA

Dermal

Contact 1E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene NA

Total 1E-05

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Indeno(1,2,3-c,d)pyrene NA

All media 8E-05 NA

Resident

Child/AdultAmbient air at street

level, pre-aeration

system operation

Ambient air at street level, after aeration system started

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Canal overflow—surface water

18 of 22

Page 73: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5

and <10-4

Chemicals with Cancer

Risks >10-6

and <10-5

Hazard

Index

Chemicals

with HI>1

TABLE 7-2

Summary of CTE Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational Ingestion 1E-06 0.5

Total 1E-06 0.5

Ingestion 1E-07 0.1

Total 1E-07 0.1

Ingestion 3E-06 Dioxin-Like PCB 1.2 Total PCB

Total 3E-06 Dioxin-Like PCB 1.2 Total PCB

Ingestion 1E-05

Dioxin-Like PCB,

Nondioxin-Like PCB,

Arsenic 2.3 Total PCB

Total 1E-05

Dioxin-Like PCB,

Nondioxin-Like PCB,

Arsenic 2.3 Total PCB

Fish Total Risk 4E-06 1.7

Crab Total Risk 1E-05 2.3

Ingestion 8E-07 0.4

Total 8E-07 0.4

Ingestion 9E-08 0.04

Total 9E-08 0.04

Ingestion 3E-06 Dioxin-Like PCB 0.9

Total 3E-06 Dioxin-Like PCB 0.9

Ingestion 1E-05

Benzo(a)pyrene, Dioxin-

Like PCB, Nondioxin-Like

PCB, Arsenic 0.6

Total 1E-05

Benzo(a)pyrene, Dioxin-

Like PCB, Nondioxin-Like

PCB, Arsenic 0.6

Fish Total Risk 4E-06 1.3

Crab Total Risk 1E-05 0.6

Angler

AdolescentStriped Bass in

Gowanus Canal (top-

level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

Angler AdultStriped Bass in

Gowanus Canal (top-

level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

19 of 22

Page 74: Appendix L HHRA Combined

Receptor Media

Exposure

Route

Cancer

Risk

Chemicals with

Cancer Risks >10-4

Chemicals with Cancer

Risks >10-5

and <10-4

Chemicals with Cancer

Risks >10-6

and <10-5

Hazard

Index

Chemicals

with HI>1

TABLE 7-2

Summary of CTE Cancer Risks and Hazard Indexes

Gowanus Canal Remedial Investigation, Brooklyn, New York

Recreational

Ingestion 2E-06 0.7

Total 2E-06 0.7

Ingestion 2E-07 0.08

Total 2E-07 0.08

Ingestion 7E-06

Dioxin-Like PCB,

Nondioxin-Like PCB,

Chromium 1.9 Total PCB

Total 7E-06

Dioxin-Like PCB,

Nondioxin-Like PCB,

Chromium 1.9 Total PCB

Ingestion 3E-05 Dioxin-Like PCB

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Nondioxin-Like PCB,

Arsenic 3.6

Total 3E-05 Dioxin-Like PCB

Benzo(a)pyrene,

Dibenz(a,h)anthracene,

Nondioxin-Like PCB,

Arsenic 3.6

Fish Total Risk 9E-06 2.7

Crab Total Risk 3E-05 3.6

NA—Not applicable, pathway incomplete.

Receptor Total risks and hazards for recreational receptors includes sum of exposed and near-shore sediment, maximum of dry event and wet event surface water,

and maximum of air prior to aeration system operation and after aeration system started.

Receptor Total risks and hazards for residential and industrial receptors includes maximum between air prior to and after aeration system operation,

and surface water, and sediment.

Angler ChildStriped Bass in

Gowanus Canal (top-

level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

20 of 22

Page 75: Appendix L HHRA Combined

TABLE 7-4

Summary of Total RME Cancer Risks for Recreational User and Angler

Gowanus Canal Remedial Investigation, Brooklyn, New York

Media Exposure Pathway

Recreational adult

Cancer Risk

Recreational

Adolescent Cancer

Risk

Recreational Child

Cancer Risk

Total Recreational

Cancer Risk

Ingestion 2E-05 1E-05 2E-04 3E-04

Dermal 1E-04 8E-05 2E-04 4E-04

Total1E-04 1E-04 4E-04 7E-04

Ingestion 2E-06 9E-07 6E-06 9E-06

Dermal 2E-04 1E-04 4E-04 7E-04

Total 2E-04 1E-04 4E-04 7E-04

Ingestion 2E-06 8E-07 4E-06 7E-06

Dermal 1E-04 8E-05 3E-04 4E-04

Total1E-04 8E-05 3E-04 5E-04

Inhalation 2E-07 6E-08 6E-08 4E-07

Total2E-07 6E-08 6E-08 4E-07

Inhalation 3E-07 7E-08 7E-08 4E-07

Total3E-07 7E-08 7E-08 4E-07

All media1 3E-04 2E-04 8E-04 1E-03

Angler adult Cancer

Risk

Angler Adolescent

Cancer Risk

Angler Child Cancer

Risk

Total Angler Cancer

Risk

Ingestion 1E-04 2E-05 4E-05 2E-04

Total 1E-04 2E-05 4E-05 2E-04

Ingestion 2E-05 4E-06 8E-06 3E-05

Total 2E-05 4E-06 8E-06 3E-05

Ingestion 3E-04 7E-05 2E-04 5E-04

Total 3E-04 7E-05 2E-04 5E-04

Ingestion 2E-04 4E-05 9E-05 3E-04

Total 2E-04 4E-05 9E-05 3E-04

Fish Total Risk 4E-04 9E-05 2E-04 7E-04

Crab Total Risk 2E-04 4E-05 9E-05 3E-04

Ambient air at canal level, after aeration system started

Receptor

Surface

sediment—exposed and

near-shore sediment in

Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Surface water—Gowanus Canal, wet-weather event

Ambient air at canal level, pre-aeration system operation

1Total risk includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air

prior to areation system operation and after aeration system started

Striped Bass in

Gowanus Canal (top-

level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

21 of 22

Page 76: Appendix L HHRA Combined

TABLE 7-5

Summary of Total CTE Cancer Risks for Recreational User and Angler

Gowanus Canal Remedial Investigation, Brooklyn, New York

Media Exposure Pathway

Recreational adult

Cancer Risk

Recreational

Adolescent Cancer

Risk

Recreational Child

Cancer Risk

Total Recreational

Cancer Risk

Ingestion 6E-07 2E-06 4E-05 5E-05

Dermal 7E-06 3E-05 7E-05 1E-04

Total8E-06 3E-05 1E-04 1E-04

Ingestion 3E-08 6E-08 5E-07 6E-07

Dermal 8E-06 3E-05 1E-04 1E-04

Total 8E-06 3E-05 1E-04 1E-04

Ingestion 3E-08 5E-08 3E-07 4E-07

Dermal 5E-06 2E-05 7E-05 9E-05

Total5E-06 2E-05 7E-05 9E-05

All media1 2E-05 5E-05 2E-04 3E-04

Angler adult Cancer

Risk

Angler Adolescent

Cancer Risk

Angler Child Cancer

Risk

Total Angler Cancer

Risk

Ingestion 1E-06 8E-07 2E-06 3E-06

Total 1E-06 8E-07 2E-06 3E-06

Ingestion 1E-07 9E-08 2E-07 4E-07

Total 1E-07 9E-08 2E-07 4E-07

Ingestion 3E-06 3E-06 7E-06 1E-05

Total 3E-06 3E-06 7E-06 1E-05

Ingestion 1E-05 1E-05 3E-05 6E-05

Total 1E-05 1E-05 3E-05 6E-05

Fish Total Risk 4E-06 4E-06 9E-06 2E-05

Crab Total Risk 1E-05 1E-05 3E-05 6E-05

Receptor

Surface

sediment—exposed and

near-shore sediment in

Gowanus Canal

Surface water—Gowanus Canal, dry-weather event

Surface water—Gowanus Canal, wet-weather event

1Total risk includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air

prior to areation system operation and after aeration system started

Striped Bass in

Gowanus Canal (top-

level predator fish)

White Perch in Gowanus Canal (middle-level predator fish)

Eel in Gowanus Canal (bottom feeder fish)

Blue Crab in Gowanus Canal

22 of 22

Page 77: Appendix L HHRA Combined

FIGURE 2-1

Conceptual Exposure Model for Human Health Risk

Assessment

Gowanus Canal Remedial Investigation

Brooklyn, New York

Page 78: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 79: Appendix L HHRA Combined

Attachment USEPA RAGS Part D and Supporting Tables

Page 80: Appendix L HHRA Combined

Page Intentionally Left Blank

Page 81: Appendix L HHRA Combined

TABLE 1

SELECTION OF EXPOSURE PATHWAYS

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Medium Exposure Exposure Receptor Receptor Exposure Type of Rationale for Selection or Exclusion

Timeframe Medium Point Population Age Route Analysis of Exposure Pathway

Current/Future Sediment Surface Sediment Recreational Adult Ingestion Quant

Dermal Quant

Adolescent Ingestion Quant

Dermal Quant

Child Ingestion Quant

Dermal Quant

Surface Water Surface Water Gowanus Canal Recreational Adult Ingestion Quant

Dermal Quant

Adolescent Ingestion Quant

Dermal Quant

Child Ingestion Quant

Dermal Quant

Air AirAmbient air at canal level Recreational Adult Inhalation Quant

Adolescent Inhalation Quant

Child Inhalation Quant

Ambient air at street level Industrial Worker Adult Inhalation Quant

Workers at the businesses surrounding the canal may inhale

ambient air from particulate and volatile emissions from

exposed sediment and volatile emissions from surface water

during the workday.

Resident Adult Inhalation Quant

Child Inhalation Quant

Child/Adult Inhalation Quant

Fish and Crab Tissue Angler Adult Ingestion Quant

Adolescent Ingestion Quant

Child Ingestion Quant

Angler Adult Ingestion Quant

Adolescent Ingestion Quant

Child Ingestion Quant

Eel in Gowanus Canal Angler Adult Ingestion Quant

Adolescent Ingestion Quant

Child Ingestion Quant

Exposed and near shore

sediment in Gowanus

Canal

People have been observed boating and fishing/crabbing in the

canal. These receptors may be exposed to surface sediment at

boat launch locations, bridge crossing locations, and at

locations with exposed sediment, or sediment covered by

shallow water.

People have been observed boating and fishing/crabbing in the

canal. These receptors may be exposed to surface water

throughout the canal during these activities.

People have been observed boating and fishing in the canal.

These receptors may inhale ambient air from particulate and

volatile emissions from exposed sediment and volatile

emissions from surface water throughout the canal during these

activities.

Striped Bass in Gowanus

Canal

People have been observed fishing in the canal. These

receptors may eat the fish they catch from the canal. Striped

bass are representative of top-level predator fish.

White Perch in Gowanus

Canal

People have been observed fishing in the canal. These

receptors may eat the fish they catch from the canal. White

perch are representative of middle-level predator fish.

People live within a few blocks of the canal, and may inhale

ambient air from particulate and volatile emissions from

exposed sediment and volatile emissions from surface water at

their residences and the surrounding areas.

Surface

Water/Sediment

People have been observed fishing in the canal. These

receptors may eat the fish they catch from the canal. American

eel are representative of bottom feeders.

Page 1 of 2

Page 82: Appendix L HHRA Combined

TABLE 1

SELECTION OF EXPOSURE PATHWAYS

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Medium Exposure Exposure Receptor Receptor Exposure Type of Rationale for Selection or Exclusion

Timeframe Medium Point Population Age Route Analysis of Exposure Pathway

Curren/tFuture Fish and Crab Tissue Angler Adult Ingestion Quant

Adolescent Ingestion Quant

Child Ingestion Quant

Sediment Industrial Worker Adult Ingestion Quant

Dermal Quant

Residential Adult Ingestion Quant

Dermal Quant

Child Ingestion Quant

Dermal Quant

Child/Adult Ingestion Quant

Dermal Quant

Air Industrial Worker Adult Inhalation None

Residential Adult Inhalation None

Child Inhalation None

Child/Adult Inhalation None

Surface WaterIndustrial Worker Adult Ingestion Quant

Dermal Quant

Residential Adult Ingestion Quant

Dermal Quant

Child Ingestion Quant

Dermal Quant

Child/Adult Ingestion Quant

Dermal Quant

Air Industrial Worker Adult Inhalation None

Residential Adult Inhalation None

Child Inhalation None

Child/Adult Inhalation None

Quant: will be quantitatively evaluated.

Qual: will be qualitatively evaluated.

None: Not considered to be a significant exposure pathway, and therefore not evaluated.

Crab in Gowanus Canal People have been observed crabbing in the canal. These

receptors may eat the crab they catch from the canal.

Volatile emissions from

overflow surface water in

areas adjacent to

Gowanus Canal

Emissions from surface water associated with canal overflow is

not expected to be a significant exposure pathway.

Particulate and volatile

emissions from sediment

deposited in areas

adjacent to Gowanus

Canal associated with

canal overflow

Emissions from deposited sediment associated with canal

overflow is not expected to be a significant exposure pathway.

Overflow Surface

Water

Canal Overflow - Surface

Water (surface water data

from wet event)

Workers at businesses surrounding the canal may be exposed

to canal surface water when the canal overflows.

People live within a few blocks of the canal. These receptors

may be exposed to surface water outside of the canal when the

canal overflows.

Overflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow

Workers at businesses surrounding the canal may be exposed

to sediment that gets deposited near the canal when the canal

overflows, prior to being washed away with rain.

People live within a few blocks of the canal. These receptors

may be exposed to surface sediment that gets deposited

outside of the canal when the canal overflows prior to being

wahsed away with rain.

Surface

Water/Sediment

Page 2 of 2

Page 83: Appendix L HHRA Combined

TABLE H-2.1

Exposed Sediment in Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Surface Sediment

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Exposed and near shore sediment in Gowanus Canal

1,2-dichloroethane ug/kg8.50 J3.90 307B 3.90 - 23.05 / 14107-06-2 8.50 430 --- --- NO Below Screening Level--- C

1,4-dichlorobenzene ug/kg240 J7.60 301 5.00 - 2402 / 14106-46-7 240 2400 --- --- NO Below Screening Level--- C

Acetone ug/kg90.0 21.0 314 9.90 - 90.07 / 1467-64-1 90.0 6100000 --- --- NO Below Screening Level--- N

Benzene ug/kg46.0 J46.0 314 5.00 - 46.01 / 1471-43-2 46.0 1100 --- --- NO Below Screening Level--- C

Carbon disulfide ug/kg89.0 4.70 314 4.70 - 89.04 / 1475-15-0 89.0 82000 --- --- NO Below Screening Level--- N

Chlorobenzene ug/kg53.0 53.0 301 5.00 - 53.01 / 14108-90-7 53.0 29000 --- --- NO Below Screening Level--- N

Ethylbenzene ug/kg1100 J6.60 314 5.00 - 11003 / 14100-41-4 1100 5400 --- --- NO Below Screening Level--- C

Isopropylbenzene (cumene) ug/kg640 J4.60 314 4.60 - 6403 / 1498-82-8 640 210000 --- --- NO Below Screening Level--- N

m, p xylenes ug/kg120 J5.40 314 5.00 - 1202 / 14179601-23-1 120 340000 --- --- NO Below Screening Level--- N

Methylcyclohexane ug/kg170 J27.0 314 5.00 - 1702 / 14108-87-2 170 --- --- --- NO No toxicity information---

Methylene chloride ug/kg4.70 J4.70 307A 4.70 - 23.01 / 1475-09-2 4.70 11000 --- --- NO Below Screening Level--- C

o-xylene (1,2-dimethylbenzene) ug/kg290 J19.0 314 5.00 - 2902 / 1495-47-6 290 380000 --- --- NO Below Screening Level--- N

Tetrachloroethylene(PCE) ug/kg11.0 J5.80 302 5.00 - 23.02 / 14127-18-4 11.0 550 --- --- NO Below Screening Level--- C

Toluene ug/kg36.0 J36.0 314 5.00 - 36.01 / 14108-88-3 36.0 500000 --- --- NO Below Screening Level--- N

Trichloroethylene (TCE) ug/kg4.20 J4.20 301 4.20 - 23.01 / 1479-01-6 4.20 2800 --- --- NO Below Screening Level--- C

Trichlorofluoromethane ug/kg8.90 J4.60 302 4.60 - 23.03 / 1475-69-4 8.90 79000 --- --- NO Below Screening Level--- N

2-methylnaphthalene ug/kg15000 270 314 120 - 150008 / 1491-57-6 15000 31000 --- --- NO Below Screening Level--- N

Acenaphthene ug/kg460000 J160 314 160 - 46000010 / 1483-32-9 460000 340000 --- --- YES Above Screening Level--- N

Acenaphthylene ug/kg150000 J270 314 230 - 1500008 / 14208-96-8 150000 340000 --- --- NO Below Screening Level--- N

Anthracene ug/kg350000 J330 314 250 - 35000011 / 14120-12-7 350000 1700000 --- --- NO Below Screening Level--- N

Benzo(a)anthracene ug/kg320000 J1100 314 1100 - 32000014 / 1456-55-3 320000 150 --- --- YES Above Screening Level--- C

Benzo(a)pyrene ug/kg200000 J1200 314 250 - 20000013 / 1450-32-8 200000 15 --- --- YES Above Screening Level--- C

Benzo(b)fluoranthene ug/kg210000 J1000 314 250 - 21000013 / 14205-99-2 210000 150 --- --- YES Above Screening Level--- C

Benzo(g,h,i)perylene ug/kg74000 J610 314 260 - 7400013 / 14191-24-2 74000 170000 --- --- NO Below Screening Level--- N

Benzo(k)fluoranthene ug/kg120000 J820 314 250 - 12000013 / 14207-08-9 120000 1500 --- --- YES Above Screening Level--- C

Biphenyl (diphenyl) ug/kg650 J650 319 650 - 2300001 / 1492-52-4 650 210000 --- --- NO Below Screening Level--- N

Bis(2-ethylhexyl) phthalate ug/kg57000 J2600 314 2600 - 16000012 / 14117-81-7 57000 35000 --- --- YES Above Screening Level--- C

Carbazole ug/kg1400 J1400 308A 1400 - 2300001 / 1486-74-8 1400 --- --- --- NO No toxicity information---

Chrysene ug/kg320000 J790 314 790 - 32000014 / 14218-01-9 320000 15000 --- --- YES Above Screening Level--- C

Dibenz(a,h)anthracene ug/kg14000 200 314 200 - 1400012 / 1453-70-3 14000 15 --- --- YES Above Screening Level--- C

PAGE 1 of 3\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 1/25/2011 3:55:45 PM

Page 84: Appendix L HHRA Combined

TABLE H-2.1

Exposed Sediment in Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Surface Sediment

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Exposed and near shore sediment in Gowanus Canal

Dibenzofuran ug/kg1100 J1100 319 1100 - 2300001 / 14132-64-9 1100 7800 --- --- NO Below Screening Level--- N

Di-n-butyl phthalate ug/kg550 J510 318 510 - 2300002 / 1484-74-2 550 610000 --- --- NO Below Screening Level--- N

Di-n-octylphthalate ug/kg9300 J9300 307A 6200 - 2300001 / 14117-84-0 9300 35000 --- --- NO Below Screening Level--- N

Fluoranthene ug/kg630000 J1200 314 1200 - 63000014 / 14206-44-0 630000 230000 --- --- YES Above Screening Level--- N

Fluorene ug/kg130000 J130 314 130 - 1300007 / 1486-73-7 130000 230000 --- --- NO Below Screening Level--- N

Indeno(1,2,3-c,d)pyrene ug/kg120000 J1000 314 1000 - 12000014 / 14193-39-5 120000 150 --- --- YES Above Screening Level--- C

Naphthalene ug/kg9100 J120 319 120 - 91008 / 1491-20-3 9100 3600 --- --- YES Above Screening Level--- C

Phenanthrene ug/kg470000 J510 314 510 - 47000013 / 1485-01-8 470000 1700000 --- --- NO Below Screening Level--- N

Pyrene ug/kg670000 J1400 314 1400 - 67000014 / 14129-00-0 670000 170000 --- --- YES Above Screening Level--- N

Alpha-chlordane ug/kg14.0 J6.70 308A 4.20 - 5302 / 145103-71-9 14.0 1600 --- --- NO Below Screening Level--- C

Beta endosulfan ug/kg13.0 J13.0 308A 8.20 - 10001 / 1433213-65-9 13.0 37000 --- --- NO Below Screening Level--- N

Endosulfan sulfate ug/kg21.0 J21.0 308A 8.20 - 10001 / 141031-07-8 21.0 37000 --- --- NO Below Screening Level--- N

Gamma-chlordane ug/kg29.0 J5.90 308A 4.20 - 5303 / 145103-74-2 29.0 1600 --- --- NO Below Screening Level--- C

Methoxychlor ug/kg33.0 J33.0 308A 33.0 - 53001 / 1472-43-5 33.0 31000 --- --- NO Below Screening Level--- N

P,P'-DDD ug/kg21.0 NJ7.90 302 7.90 - 21.04 / 472-54-8 21.0 2000 --- --- NO Below Screening Level--- C

P,P'-DDE ug/kg16.0 NJ16.0 308A 8.20 - 10001 / 1472-55-9 16.0 1400 --- --- NO Below Screening Level--- C

Aroclor 1016 ug/kg290 220 318 41.0 - 2902 / 1412674-11-2 290 390 --- --- NO Below Screening Level--- N

Aroclor 1248 ug/kg2200 J2200 316 41.0 - 22001 / 1412672-29-6 2200 220 --- --- YES Above Screening Level--- C

Aroclor 1254 ug/kg590 J590 308A 48.0 - 5901 / 1411097-69-1 590 110 --- --- YES Above Screening Level--- N

Aroclor 1260 ug/kg3400 J440 314 41.0 - 34003 / 1411096-82-5 3400 220 --- --- YES Above Screening Level--- C

PCB Dioxin ng/kg111 0.241 314 0.241 - 11112 / 12PCBDioxin 111 3.7 --- --- YES Above Screening Level--- C

PCB Nondioxin ng/kg14700000 92500 314 92500 - 1470000012 / 12PCBNonDioxin 14700000 220000 --- --- YES Above Screening Level--- C

Total PCB Congeners ng/kg15100000 99500 314 99500 - 1510000012 / 12PCBTotalCongen 15100000 110000 --- --- YES Above Screening Level--- N

Aluminum mg/kg18900 J4870 310 4870 - 1890014 / 147429-90-5 18900 7700 --- --- YES Above Screening Level--- N

Arsenic mg/kg44.7 3.40 308A 3.40 - 44.714 / 147440-38-2 44.7 0.39 --- --- YES Above Screening Level--- C

Barium mg/kg397 J86.5 316 86.5 - 39714 / 147440-39-3 397 1500 --- --- NO Below Screening Level--- N

Beryllium mg/kg0.46 J0.26 309 0.26 - 1.408 / 147440-41-7 0.46 16 --- --- NO Below Screening Level--- N

Cadmium mg/kg20.2 J1.50 308A 1.50 - 20.214 / 147440-43-9 20.2 7 --- --- YES Above Screening Level--- N

Calcium mg/kg10900 J5360 314 5360 - 1090014 / 147440-70-2 10900 --- --- --- NO Essential Nutrient---

Chromium mg/kg139 J22.7 314 22.7 - 13914 / 147440-47-3 139 0.29 --- --- YES Above Screening Level--- C

PAGE 2 of 3\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 1/25/2011 3:55:45 PM

Page 85: Appendix L HHRA Combined

TABLE H-2.1

Exposed Sediment in Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Surface Sediment

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Exposed and near shore sediment in Gowanus Canal

Cobalt mg/kg14.8 J10.0 318 7.30 - 15.36 / 147440-48-4 14.8 2.3 --- --- YES Above Screening Level--- N

Copper mg/kg790 85.8 308A 85.8 - 79014 / 147440-50-8 790 310 --- --- YES Above Screening Level--- N

Cyanide, Total mg/kg18.0 J0.54 302 0.54 - 18.04 / 1457-12-5 18.0 160 --- --- NO Below Screening Level--- N

Iron mg/kg87000 12400 308A 12400 - 8700014 / 147439-89-6 87000 5500 --- --- YES Above Screening Level--- N

Lead mg/kg4220 184 308A 184 - 422014 / 147439-92-1 4220 400 --- --- YES Above Screening Level--- N

Magnesium mg/kg11400 J4210 318 4210 - 1140014 / 147439-95-4 11400 --- --- --- NO Essential Nutrient---

Manganese mg/kg480 89.1 308A 89.1 - 48014 / 147439-96-5 480 180 --- --- YES Above Screening Level--- N

Mercury mg/kg1.80 J0.61 318 0.61 - 1.8014 / 147439-97-6 1.80 2.3 --- --- NO Below Screening Level--- N

Nickel mg/kg84.5 J18.1 314 18.1 - 84.514 / 147440-02-0 84.5 150 --- --- NO Below Screening Level--- N

Potassium mg/kg4410 J730 310 730 - 441014 / 147440-09-7 4410 --- --- --- NO Essential Nutrient---

Selenium mg/kg4.90 J0.74 310 0.74 - 10.76 / 147782-49-2 4.90 39 --- --- NO Below Screening Level--- N

Silver mg/kg6.80 J1.90 310 1.20 - 6.8012 / 147440-22-4 6.80 39 --- --- NO Below Screening Level--- N

Sodium mg/kg15300 J2610 305 2610 - 1530014 / 147440-23-5 15300 --- --- --- NO Essential Nutrient---

Vanadium mg/kg61.2 J19.4 316 19.4 - 61.214 / 147440-62-2 61.2 39 --- --- YES Above Screening Level--- N

Zinc mg/kg1520 240 308A 240 - 15207 / 77440-66-6 1520 2300 --- --- NO Below Screening Level--- N

PAGE 3 of 3\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 1/25/2011 3:55:45 PM

Page 86: Appendix L HHRA Combined

TABLE H-2.2

Surface Water in Canal - Dry Weather - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Surface Water

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Gowanus Canal

1,4-dichlorobenzene ug/l0.11 J0.11 320 0.11 - 0.501 / 27106-46-7 0.11 0.43 190 NRWQC NO Below Screening Level--- C

Acetone ug/l6.70 1.10 317 1.10 - 6.7026 / 2767-64-1 6.70 2200 --- --- NO Below Screening Level--- N

Benzene ug/l11.0 0.50 304 0.50 - 11.018 / 2771-43-2 11.0 0.41 10 NYSDEC YES Above Screening Level--- C

Ethylbenzene ug/l1.30 0.19 320 0.19 - 1.3016 / 27100-41-4 1.30 1.5 2100 NRWQC NO Below Screening Level--- C

m, p xylenes ug/l1.30 0.16 320 0.16 - 1.3017 / 27179601-23-1 1.30 120 --- --- NO Below Screening Level--- N

Methylene chloride ug/l1.00 0.76 310 0.50 - 1.003 / 2775-09-2 1.00 4.8 200 NYSDEC NO Below Screening Level--- C

o-xylene (1,2-dimethylbenzene) ug/l0.53 0.24 320 0.24 - 0.535 / 2795-47-6 0.53 120 --- --- NO Below Screening Level--- N

Tert-butyl methyl ether ug/l0.18 J0.18 304 0.18 - 0.501 / 271634-04-4 0.18 12 --- --- NO Below Screening Level--- C

Toluene ug/l0.95 0.17 308B 0.17 - 0.9516 / 27108-88-3 0.95 230 6000 NYSDEC NO Below Screening Level--- N

2-methylnaphthalene ug/l0.017 J0.017 315 0.017 - 0.101 / 2791-57-6 0.017 15 --- --- NO Below Screening Level--- N

Acenaphthene ug/l0.94 0.26 319 0.10 - 0.9421 / 2783-32-9 0.94 220 990 NRWQC NO Below Screening Level--- N

Anthracene ug/l5.20 J1.20 325 0.10 - 5.203 / 27120-12-7 5.20 1100 40000 NRWQC NO Below Screening Level--- N

Benzo(a)anthracene ug/l0.83 0.12 325 0.10 - 0.837 / 2756-55-3 0.83 0.029 0.018 NRWQC YES Above Screening Level--- C

Benzo(a)pyrene ug/l0.66 0.19 319 0.10 - 0.663 / 2750-32-8 0.66 0.0029 0.018 NRWQC YES Above Screening Level--- C

Benzo(b)fluoranthene ug/l0.88 0.11 319 0.10 - 0.8821 / 27205-99-2 0.88 0.029 0.018 NRWQC YES Above Screening Level--- C

Benzo(g,h,i)perylene ug/l0.15 0.099 302, 307A 0.099 - 0.155 / 27191-24-2 0.15 110 --- --- NO Below Screening Level--- N

Benzo(k)fluoranthene ug/l0.29 0.10 319, 325 0.10 - 0.2911 / 27207-08-9 0.29 0.29 0.018 NRWQC NO Below Screening Level--- C

Bis(2-ethylhexyl) phthalate ug/l5.60 0.71 321 0.71 - 5.6013 / 27117-81-7 5.60 4.8 2.2 NRWQC YES Above Screening Level--- C

Caprolactam ug/l1.00 J1.00 312 1.00 - 5.001 / 27105-60-2 1.00 1800 --- --- NO Below Screening Level--- N

Carbazole ug/l2.10 J1.10 325 1.10 - 5.002 / 2786-74-8 2.10 --- --- --- NO No toxicity information---

Chrysene ug/l1.10 J0.11 325 0.10 - 1.1015 / 27218-01-9 1.10 2.9 0.018 NRWQC NO Below Screening Level--- C

Dimethyl phthalate ug/l3.40 J1.50 324 1.50 - 5.008 / 27131-11-3 3.40 365 1100000 NRWQC NO Below Screening Level--- N

Di-n-butyl phthalate ug/l1.40 J1.00 301 1.00 - 5.003 / 2784-74-2 1.40 370 4500 NRWQC NO Below Screening Level--- N

Fluoranthene ug/l2.30 J0.095 325 0.095 - 2.3023 / 27206-44-0 2.30 150 140 NRWQC NO Below Screening Level--- N

Fluorene ug/l0.19 0.11 325 0.10 - 0.1915 / 2786-73-7 0.19 150 5300 NRWQC NO Below Screening Level--- N

Indeno(1,2,3-c,d)pyrene ug/l0.22 0.097 319 0.097 - 0.2210 / 27193-39-5 0.22 0.029 0.018 NRWQC YES Above Screening Level--- C

Phenanthrene ug/l0.58 0.10 325 0.10 - 0.5811 / 2785-01-8 0.58 1100 --- --- NO Below Screening Level--- N

Phenol ug/l1.30 J1.30 314 1.30 - 5.001 / 27108-95-2 1.30 1100 860000 NRWQC NO Below Screening Level--- N

Pyrene ug/l1.50 J0.15 325 0.10 - 1.506 / 27129-00-0 1.50 110 4000 NRWQC NO Below Screening Level--- N

Arsenic ug/l23.4 18.8 309 9.10 - 23.416 / 257440-38-2 23.4 0.045 0.14 NRWQC YES Above Screening Level--- C

PAGE 1 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 12/10/2010 1:09:47 PM

Page 87: Appendix L HHRA Combined

TABLE H-2.2

Surface Water in Canal - Dry Weather - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Surface Water

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Gowanus Canal

Barium ug/l22.3 J18.4 310 10.0 - 1005 / 277440-39-3 22.3 730 --- --- NO Below Screening Level--- N

Calcium ug/l315000 J279000 312 254000 - 31500012 / 277440-70-2 315000 --- --- --- NO Essential Nutrient---

Chromium ug/l99.7 4.00 323 2.00 - 99.716 / 277440-47-3 99.7 0.043 --- --- YES Above Screening Level--- C

Copper ug/l232 123 308B 25.0 - 37511 / 277440-50-8 232 150 --- --- YES Above Screening Level--- N

Lead ug/l4.90 J1.90 323 1.90 - 10.05 / 277439-92-1 4.90 15 --- --- NO Below Screening Level--- N

Magnesium ug/l998000 809000 312 809000 - 99800027 / 277439-95-4 998000 --- --- --- NO Essential Nutrient---

Manganese ug/l72.9 45.0 310 45.0 - 72.927 / 277439-96-5 72.9 88 100 NRWQC NO Below Screening Level--- N

Mercury ug/l0.06 J0.047 324 0.047 - 0.2014 / 277439-97-6 0.06 1.1 0.0007 NYSDEC NO Below Screening Level--- N

Nickel ug/l52.3 J2.00 323 2.00 - 52.315 / 277440-02-0 52.3 73 4600 NRWQC NO Below Screening Level--- N

Potassium ug/l328000 J299000 312 268000 - 32800012 / 277440-09-7 328000 --- --- --- NO Essential Nutrient---

Selenium ug/l50.9 34.3 322 18.7 - 50.916 / 267782-49-2 50.9 18 4200 NRWQC YES Above Screening Level--- N

Sodium ug/l6620000 J5550000 307B 5550000 - 662000027 / 277440-23-5 6620000 --- --- --- NO Essential Nutrient---

Thallium ug/l2.10 J2.10 318 2.10 - 10.01 / 277440-28-0 2.10 --- 0.47 NRWQC NO No toxicity information---

Zinc ug/l25.7 J11.0 321 11.0 - 25.712 / 237440-66-6 25.7 1100 26000 NRWQC NO Below Screening Level--- N

PAGE 2 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 12/10/2010 1:09:47 PM

Page 88: Appendix L HHRA Combined

TABLE H-2.3

Surface Water in Canal - Wet Weather - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Surface Water

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Gowanus Canal

1,2,4-trichlorobenzene ug/l0.12 J0.12 305 0.12 - 0.501 / 26120-82-1 0.12 0.41 70 NRWQC NO Below Screening Level--- N

1,3-dichlorobenzene ug/l0.13 J0.13 303, 305 0.13 - 0.502 / 26541-73-1 0.13 37 960 NRWQC NO Below Screening Level--- N

1,4-dichlorobenzene ug/l0.87 0.12 306 0.12 - 0.8714 / 26106-46-7 0.87 0.43 190 NRWQC YES Above Screening Level--- C

Acetone ug/l12.0 12.0 307B 5.00 - 15.01 / 2667-64-1 12.0 2200 --- --- NO Below Screening Level--- N

Benzene ug/l2.90 0.36 316 0.36 - 2.9016 / 2671-43-2 2.90 0.41 10 NYSDEC YES Above Screening Level--- C

Carbon disulfide ug/l0.17 J0.14 308B, 313 0.14 - 0.505 / 2675-15-0 0.17 100 --- --- NO Below Screening Level--- N

Chlorobenzene ug/l0.33 J0.12 306 0.12 - 0.5017 / 26108-90-7 0.33 9.1 400 NYSDEC NO Below Screening Level--- N

Chloroform ug/l0.69 0.50 321 0.50 - 0.6914 / 2667-66-3 0.69 0.19 470 NRWQC YES Above Screening Level--- C

cis-1,2-dichloroethylene ug/l0.51 0.21 319 0.21 - 0.5117 / 26156-59-2 0.51 37 --- --- NO Below Screening Level--- N

Ethylbenzene ug/l2.60 0.18 316 0.18 - 2.6021 / 26100-41-4 2.60 1.5 2100 NRWQC YES Above Screening Level--- C

Isopropylbenzene (cumene) ug/l0.20 J0.096 316 0.096 - 0.504 / 2698-82-8 0.20 68 --- --- NO Below Screening Level--- N

m, p xylenes ug/l2.60 0.18 316 0.18 - 2.6022 / 26179601-23-1 2.60 120 --- --- NO Below Screening Level--- N

Methyl acetate ug/l0.44 J0.44 317 0.44 - 0.501 / 2679-20-9 0.44 3700 --- --- NO Below Screening Level--- N

Methylene chloride ug/l3.40 0.99 321 0.50 - 3.409 / 2675-09-2 3.40 4.8 200 NYSDEC NO Below Screening Level--- C

o-xylene (1,2-dimethylbenzene) ug/l5.10 0.13 316 0.13 - 5.1020 / 2695-47-6 5.10 120 --- --- NO Below Screening Level--- N

Tetrachloroethylene(PCE) ug/l40.0 J0.70 319 0.50 - 40.024 / 26127-18-4 40.0 0.11 3.3 NRWQC YES Above Screening Level--- C

Toluene ug/l16.0 0.85 316 0.50 - 16.024 / 26108-88-3 16.0 230 6000 NYSDEC NO Below Screening Level--- N

trans-1,3-dichloropropene ug/l0.16 J0.16 306 0.16 - 0.501 / 2610061-02-6 0.16 0.43 --- --- NO Below Screening Level--- C

Trichloroethylene (TCE) ug/l0.12 J0.10 320 0.10 - 0.502 / 2679-01-6 0.12 2 30 NRWQC NO Below Screening Level--- C

2-methylnaphthalene ug/l3.00 0.17 316 0.10 - 3.003 / 2691-57-6 3.00 15 --- --- NO Below Screening Level--- N

Acenaphthene ug/l0.40 0.095 313 0.095 - 1.0020 / 2683-32-9 0.40 220 990 NRWQC NO Below Screening Level--- N

Anthracene ug/l0.095 J0.095 302 0.095 - 1.001 / 26120-12-7 0.095 1100 40000 NRWQC NO Below Screening Level--- N

Benzo(a)anthracene ug/l0.15 0.074 302 0.074 - 1.004 / 2656-55-3 0.15 0.029 0.018 NRWQC YES Above Screening Level--- C

Benzo(a)pyrene ug/l0.30 0.14 309 0.10 - 1.006 / 2650-32-8 0.30 0.0029 0.018 NRWQC YES Above Screening Level--- C

Benzo(b)fluoranthene ug/l0.33 0.12 319 0.10 - 1.0016 / 26205-99-2 0.33 0.029 0.018 NRWQC YES Above Screening Level--- C

Benzo(g,h,i)perylene ug/l1.50 J0.13 308A 0.10 - 1.5023 / 26191-24-2 1.50 110 --- --- NO Below Screening Level--- N

Benzo(k)fluoranthene ug/l0.12 J0.037 319 0.037 - 1.007 / 26207-08-9 0.12 0.29 0.018 NRWQC NO Below Screening Level--- C

Benzyl butyl phthalate ug/l1.10 J0.73 307A 0.73 - 50.03 / 2685-68-7 1.10 35 1900 NRWQC NO Below Screening Level--- C

Caprolactam ug/l1.50 J0.33 320 0.33 - 50.011 / 26105-60-2 1.50 1800 --- --- NO Below Screening Level--- N

Chrysene ug/l0.11 0.057 302 0.057 - 1.003 / 26218-01-9 0.11 2.9 0.018 NRWQC NO Below Screening Level--- C

PAGE 1 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/30/2010 4:38:10 PM

Page 89: Appendix L HHRA Combined

TABLE H-2.3

Surface Water in Canal - Wet Weather - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Surface Water

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Gowanus Canal

Dibenz(a,h)anthracene ug/l0.11 0.071 303 0.071 - 1.004 / 2653-70-3 0.11 0.0029 0.018 NRWQC YES Above Screening Level--- C

Di-n-butyl phthalate ug/l0.62 J0.28 320 0.28 - 50.012 / 2684-74-2 0.62 370 4500 NRWQC NO Below Screening Level--- N

Di-n-octylphthalate ug/l0.28 J0.23 318 0.23 - 50.03 / 26117-84-0 0.28 4.8 --- --- NO Below Screening Level--- N

Fluoranthene ug/l0.32 0.089 313 0.089 - 1.0022 / 26206-44-0 0.32 150 140 NRWQC NO Below Screening Level--- N

Fluorene ug/l0.32 J0.079 313 0.079 - 1.003 / 2686-73-7 0.32 150 5300 NRWQC NO Below Screening Level--- N

Indeno(1,2,3-c,d)pyrene ug/l1.10 0.16 316 0.10 - 1.1023 / 26193-39-5 1.10 0.029 0.018 NRWQC YES Above Screening Level--- C

Naphthalene ug/l1.40 0.13 316 0.10 - 1.405 / 2691-20-3 1.40 0.14 --- --- YES Above Screening Level--- C

Pentachlorophenol ug/l0.13 J0.13 311 0.13 - 2.001 / 2687-86-5 0.13 0.56 3 NRWQC NO Below Screening Level--- C

Phenanthrene ug/l1.40 0.13 316 0.10 - 1.4014 / 2685-01-8 1.40 1100 --- --- NO Below Screening Level--- N

Pyrene ug/l0.34 0.10 313 0.10 - 1.0022 / 26129-00-0 0.34 110 4000 NRWQC NO Below Screening Level--- N

Arsenic ug/l26.2 6.90 302 6.90 - 26.226 / 267440-38-2 26.2 0.045 0.14 NRWQC YES Above Screening Level--- C

Barium ug/l42.8 J18.4 307A 18.4 - 42.826 / 267440-39-3 42.8 730 --- --- NO Below Screening Level--- N

Calcium ug/l296000 97200 324 97200 - 29600024 / 247440-70-2 296000 --- --- --- NO Essential Nutrient---

Chromium ug/l29.3 J3.90 308B 3.90 - 29.326 / 267440-47-3 29.3 0.043 --- --- YES Above Screening Level--- C

Cobalt ug/l3.90 J3.90 307A 3.90 - 10.01 / 267440-48-4 3.90 1.1 --- --- YES Above Screening Level--- N

Iron ug/l1040 J651 317 651 - 15003 / 267439-89-6 1040 2600 --- --- NO Below Screening Level--- N

Lead ug/l26.8 2.90 317 2.90 - 26.826 / 267439-92-1 26.8 15 --- --- YES Above Screening Level--- N

Magnesium ug/l972000 276000 303 276000 - 97200025 / 257439-95-4 972000 --- --- --- NO Essential Nutrient---

Manganese ug/l65.6 48.4 307A 48.4 - 65.626 / 267439-96-5 65.6 88 100 NRWQC NO Below Screening Level--- N

Mercury ug/l0.089 J0.065 302 0.065 - 0.2019 / 267439-97-6 0.089 1.1 0.0007 NYSDEC NO Below Screening Level--- N

Nickel ug/l29.8 J2.10 308B 2.10 - 29.825 / 257440-02-0 29.8 73 4600 NRWQC NO Below Screening Level--- N

Potassium ug/l290000 88700 324 88700 - 29000024 / 247440-09-7 290000 --- --- --- NO Essential Nutrient---

Selenium ug/l64.6 J13.9 301 13.9 - 64.626 / 267782-49-2 64.6 18 4200 NRWQC YES Above Screening Level--- N

Sodium ug/l7090000 J2340000 301 2340000 - 709000025 / 257440-23-5 7090000 --- --- --- NO Essential Nutrient---

Zinc ug/l75.7 J17.7 318 17.7 - 75.724 / 267440-66-6 75.7 1100 26000 NRWQC NO Below Screening Level--- N

PAGE 2 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/30/2010 4:38:11 PM

Page 90: Appendix L HHRA Combined

TABLE H-2.4

Ambient Air at Canal Level, Round 1 - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Ambient air at Canal level

Acetone ug/m360.0 22.0 506 22.0 - 60.010 / 1067-64-1 60.0 3200 --- --- NO Below Screening Level--- N

Benzene ug/m31.10 0.69 501 0.69 - 1.1010 / 1071-43-2 1.10 0.31 --- --- YES Above Screening Level--- C

Bromoform ug/m30.12 0.12 505 0.10 - 0.521 / 1075-25-2 0.12 2.2 --- --- NO Below Screening Level--- C

Carbon disulfide ug/m32.70 2.70 508 1.60 - 2.701 / 1075-15-0 2.70 73 --- --- NO Below Screening Level--- N

Chloroform ug/m30.28 0.16 501 0.16 - 0.287 / 1067-66-3 0.28 0.11 --- --- YES Above Screening Level--- C

Chloromethane ug/m33.10 1.70 504 1.70 - 3.1010 / 1074-87-3 3.10 9.4 --- --- NO Below Screening Level--- N

Ethylbenzene ug/m35.10 0.48 508 0.48 - 5.1010 / 10100-41-4 5.10 0.97 --- --- YES Above Screening Level--- C

Methyl ethyl ketone (2-butanone)

ug/m34.30 1.70 504 1.70 - 4.3010 / 1078-93-3 4.30 520 --- --- NO Below Screening Level--- N

Methylene chloride ug/m34.50 J1.80 501 1.70 - 4.506 / 1075-09-2 4.50 5.2 --- --- NO Below Screening Level--- C

Toluene ug/m38.50 2.70 507 2.70 - 8.5010 / 10108-88-3 8.50 520 --- --- NO Below Screening Level--- N

Trichloroethylene (TCE) ug/m30.90 0.069 507 0.069 - 0.907 / 1079-01-6 0.90 1.2 --- --- NO Below Screening Level--- C

Xylene, total ug/m316.0 1.80 508 1.80 - 16.010 / 101330-20-7 16.0 10 --- --- YES Above Screening Level--- N

Acenaphthene ug/m35.70 0.057 502 0.057 - 5.7010 / 1083-32-9 5.70 --- --- --- NO No toxicity information---

Acenaphthylene ug/m30.049 J0.0014 502 0.0014 - 0.04910 / 10208-96-8 0.049 --- --- --- NO No toxicity information---

Anthracene ug/m30.37 0.0042 502 0.0042 - 0.3710 / 10120-12-7 0.37 --- --- --- NO No toxicity information---

Benzo(a)anthracene ug/m30.0023 J0.002 501 0.002 - 0.0942 / 1056-55-3 0.0023 0.0087 --- --- NO Below Screening Level--- C

Benzo(b)fluoranthene ug/m30.0025 J0.0025 501 0.0025 - 0.0941 / 10205-99-2 0.0025 0.0087 --- --- NO Below Screening Level--- C

Chrysene ug/m30.0088 J0.0088 502 0.0088 - 0.0941 / 10218-01-9 0.0088 0.087 --- --- NO Below Screening Level--- C

Fluoranthene ug/m31.00 0.019 502 0.019 - 1.0010 / 10206-44-0 1.00 --- --- --- NO No toxicity information---

Fluorene ug/m34.70 0.034 502 0.034 - 4.7010 / 1086-73-7 4.70 --- --- --- NO No toxicity information---

Naphthalene ug/m33.40 0.19 503 0.19 - 3.4010 / 1091-20-3 3.40 0.072 --- --- YES Above Screening Level--- C

Phenanthrene ug/m36.50 0.084 502 0.084 - 6.5010 / 1085-01-8 6.50 --- --- --- NO No toxicity information---

Pyrene ug/m30.55 0.014 502 0.014 - 0.5510 / 10129-00-0 0.55 --- --- --- NO No toxicity information---

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/29/2010 3:57:25 PM

Page 91: Appendix L HHRA Combined

TABLE H-2.5

Ambient Air at Canal Level, Round 2 - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Ambient air at Canal level

Acetone ug/m3300 24.0 509 24.0 - 30010 / 1067-64-1 300 3200 --- --- NO Below Screening Level--- N

Benzene ug/m33.80 0.64 510 0.64 - 3.8010 / 1071-43-2 3.80 0.31 --- --- YES Above Screening Level--- C

Carbon disulfide ug/m33.30 3.30 503 1.60 - 7.801 / 1075-15-0 3.30 73 --- --- NO Below Screening Level--- N

Chloroform ug/m30.24 0.16 503 0.098 - 0.248 / 1067-66-3 0.24 0.11 --- --- YES Above Screening Level--- C

Chloromethane ug/m32.20 1.60 506, 510 1.60 - 5.208 / 1074-87-3 2.20 9.4 --- --- NO Below Screening Level--- N

Ethylbenzene ug/m34.40 0.41 510 0.41 - 4.4010 / 10100-41-4 4.40 0.97 --- --- YES Above Screening Level--- C

Methyl ethyl ketone (2-butanone)

ug/m318.0 2.70 509 2.70 - 18.010 / 1078-93-3 18.0 520 --- --- NO Below Screening Level--- N

Methylene chloride ug/m32.00 J1.90 506 1.70 - 8.702 / 1075-09-2 2.00 5.2 --- --- NO Below Screening Level--- C

Toluene ug/m325.0 5.00 510 3.80 - 25.09 / 10108-88-3 25.0 520 --- --- NO Below Screening Level--- N

Trichloroethylene (TCE) ug/m30.20 0.096 505 0.096 - 0.278 / 1079-01-6 0.20 1.2 --- --- NO Below Screening Level--- C

Xylene, total ug/m328.0 2.90 510 2.90 - 28.09 / 101330-20-7 28.0 10 --- --- YES Above Screening Level--- N

Acenaphthene ug/m33.30 J0.084 502 0.084 - 3.308 / 883-32-9 3.30 --- --- --- NO No toxicity information---

Acenaphthylene ug/m30.04 J0.0043 502 0.0043 - 0.048 / 8208-96-8 0.04 --- --- --- NO No toxicity information---

Anthracene ug/m30.15 J0.0054 502 0.0054 - 0.158 / 8120-12-7 0.15 --- --- --- NO No toxicity information---

Benzo(a)anthracene ug/m30.0033 J0.0024 509 0.0024 - 0.0713 / 856-55-3 0.0033 0.0087 --- --- NO Below Screening Level--- C

Chrysene ug/m30.0043 J0.0043 505 0.0043 - 0.0711 / 8218-01-9 0.0043 0.087 --- --- NO Below Screening Level--- C

Fluoranthene ug/m30.45 J0.021 502 0.021 - 0.458 / 8206-44-0 0.45 --- --- --- NO No toxicity information---

Fluorene ug/m32.30 J0.056 502 0.056 - 2.308 / 886-73-7 2.30 --- --- --- NO No toxicity information---

Naphthalene ug/m32.60 J0.47 503 0.47 - 2.608 / 891-20-3 2.60 0.072 --- --- YES Above Screening Level--- C

Phenanthrene ug/m33.00 J0.098 502 0.098 - 3.008 / 885-01-8 3.00 --- --- --- NO No toxicity information---

Pyrene ug/m30.23 J0.014 502 0.014 - 0.238 / 8129-00-0 0.23 --- --- --- NO No toxicity information---

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/29/2010 3:58:04 PM

Page 92: Appendix L HHRA Combined

TABLE H-2.6

Ambient Air at Street Level, Round 1 - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Ambient air at Street Level

Acetone ug/m353.0 25.0 510 25.0 - 53.010 / 1067-64-1 53.0 3200 --- --- NO Below Screening Level--- N

Benzene ug/m32.30 0.61 501 0.61 - 2.3010 / 1071-43-2 2.30 0.31 --- --- YES Above Screening Level--- C

Bromoform ug/m30.37 0.37 503 0.10 - 0.521 / 1075-25-2 0.37 2.2 --- --- NO Below Screening Level--- C

Carbon disulfide ug/m33.80 2.60 504 1.60 - 3.802 / 1075-15-0 3.80 73 --- --- NO Below Screening Level--- N

Chloroform ug/m30.39 0.17 501 0.17 - 0.396 / 1067-66-3 0.39 0.11 --- --- YES Above Screening Level--- C

Chloromethane ug/m33.00 1.80 502 1.80 - 3.0010 / 1074-87-3 3.00 9.4 --- --- NO Below Screening Level--- N

Ethylbenzene ug/m31.70 0.56 501 0.56 - 1.7010 / 10100-41-4 1.70 0.97 --- --- YES Above Screening Level--- C

Methyl ethyl ketone (2-butanone)

ug/m311.0 1.90 510 1.90 - 11.010 / 1078-93-3 11.0 520 --- --- NO Below Screening Level--- N

Methylene chloride ug/m35.10 J1.70 501 1.70 - 5.105 / 1075-09-2 5.10 5.2 --- --- NO Below Screening Level--- C

Toluene ug/m36.20 3.00 501 3.00 - 6.2010 / 10108-88-3 6.20 520 --- --- NO Below Screening Level--- N

Trichloroethylene (TCE) ug/m30.74 0.06 507 0.054 - 0.745 / 1079-01-6 0.74 1.2 --- --- NO Below Screening Level--- C

Xylene, total ug/m36.80 2.00 501 2.00 - 6.8010 / 101330-20-7 6.80 10 --- --- NO Below Screening Level--- N

Acenaphthene ug/m30.61 0.037 505 0.037 - 0.6110 / 1083-32-9 0.61 --- --- --- NO No toxicity information---

Acenaphthylene ug/m30.018 J0.0016 507 0.0016 - 0.01810 / 10208-96-8 0.018 --- --- --- NO No toxicity information---

Anthracene ug/m30.043 J0.0029 507 0.0029 - 0.04310 / 10120-12-7 0.043 --- --- --- NO No toxicity information---

Fluoranthene ug/m30.094 0.012 505 0.012 - 0.09410 / 10206-44-0 0.094 --- --- --- NO No toxicity information---

Fluorene ug/m30.31 0.03 505 0.03 - 0.3110 / 1086-73-7 0.31 --- --- --- NO No toxicity information---

Naphthalene ug/m31.30 0.10 503, 505 0.10 - 1.3010 / 1091-20-3 1.30 0.072 --- --- YES Above Screening Level--- C

Phenanthrene ug/m30.55 0.059 509 0.059 - 0.5510 / 1085-01-8 0.55 --- --- --- NO No toxicity information---

Pyrene ug/m30.06 J0.0088 505 0.0088 - 0.0610 / 10129-00-0 0.06 --- --- --- NO No toxicity information---

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/29/2010 3:58:54 PM

Page 93: Appendix L HHRA Combined

TABLE H-2.7

Ambient Air at Street Level, Round 1 - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Ambient air at Street Level

Acetone ug/m3460 23.0 507 23.0 - 46010 / 1067-64-1 460 3200 --- --- NO Below Screening Level--- N

Benzene ug/m31.40 0.67 510 0.67 - 1.4010 / 1071-43-2 1.40 0.31 --- --- YES Above Screening Level--- C

Chloroform ug/m30.45 0.16 505 0.16 - 0.459 / 1067-66-3 0.45 0.11 --- --- YES Above Screening Level--- C

Chloromethane ug/m32.50 1.40 502 1.40 - 5.208 / 1074-87-3 2.50 9.4 --- --- NO Below Screening Level--- N

Ethylbenzene ug/m31.80 0.56 510 0.56 - 1.8010 / 10100-41-4 1.80 0.97 --- --- YES Above Screening Level--- C

Methyl ethyl ketone (2-butanone)

ug/m330.0 2.30 507 2.30 - 30.010 / 1078-93-3 30.0 520 --- --- NO Below Screening Level--- N

Methylene chloride ug/m32.00 J2.00 506 1.70 - 8.701 / 1075-09-2 2.00 5.2 --- --- NO Below Screening Level--- C

Toluene ug/m37.50 5.00 504, 505 3.70 - 7.506 / 10108-88-3 7.50 520 --- --- NO Below Screening Level--- N

Trichloroethylene (TCE) ug/m30.60 0.06 502 0.06 - 0.608 / 1079-01-6 0.60 1.2 --- --- NO Below Screening Level--- C

Xylene, total ug/m37.60 2.40 510 2.40 - 7.6010 / 101330-20-7 7.60 10 --- --- NO Below Screening Level--- N

Acenaphthene ug/m31.30 0.079 507 0.079 - 1.3010 / 1083-32-9 1.30 --- --- --- NO No toxicity information---

Acenaphthylene ug/m30.14 0.0019 507 0.0019 - 0.1410 / 10208-96-8 0.14 --- --- --- NO No toxicity information---

Anthracene ug/m30.11 0.004 507 0.004 - 0.1110 / 10120-12-7 0.11 --- --- --- NO No toxicity information---

Fluoranthene ug/m30.20 0.018 509 0.018 - 0.2010 / 10206-44-0 0.20 --- --- --- NO No toxicity information---

Fluorene ug/m30.63 0.057 507 0.057 - 0.6310 / 1086-73-7 0.63 --- --- --- NO No toxicity information---

Naphthalene ug/m34.40 0.26 507 0.26 - 4.4010 / 1091-20-3 4.40 0.072 --- --- YES Above Screening Level--- C

Phenanthrene ug/m30.87 0.099 509 0.099 - 0.8710 / 1085-01-8 0.87 --- --- --- NO No toxicity information---

Pyrene ug/m30.11 0.0093 509 0.0093 - 0.1110 / 10129-00-0 0.11 --- --- --- NO No toxicity information---

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/29/2010 3:59:37 PM

Page 94: Appendix L HHRA Combined

TABLE H-2.8

Striped Bass Filet from Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Striped Bass in Gowanus Canal

Alpha-chlordane ug/kg8.20 J5.10 GC-TI406-SB 1.70 - 8.202 / 45103-71-9 8.20 9 --- --- NO Below Screening Level--- C

Gamma-chlordane ug/kg3.50 J3.50 GC-TI403-SB 1.70 - 3.501 / 55103-74-2 3.50 9 --- --- NO Below Screening Level--- C

P,P'-DDD ug/kg5.60 J4.80 GC-TI406-SB 3.30 - 5.603 / 472-54-8 5.60 13 --- --- NO Below Screening Level--- C

P,P'-DDE ug/kg12.0 NJ4.80 GC-TI406-SB 4.80 - 12.05 / 572-55-9 12.0 9.3 --- --- YES Above Screening Level--- C

P,P'-DDT ug/kg9.60 NJ9.60 GC-TI403-SB 3.30 - 9.601 / 550-29-3 9.60 9.3 --- --- YES Above Screening Level--- C

PCB Dioxin ng/kg4.31 2.83 GC-TI406-SB 2.83 - 4.315 / 5PCBDioxin 4.31 0.020 --- --- YES Above Screening Level--- C

PCB Nondioxin ng/kg409000 244000 GC-TI403-SB 244000 - 4090005 / 5PCBNonDioxin 409000 1600 --- --- YES Above Screening Level--- C

Total PCB Congeners ng/kg435000 263000 GC-TI403-SB 263000 - 4350005 / 5PCBTotalCongen 435000 1600 --- --- YES Above Screening Level--- C

Arsenic mg/kg0.68 J0.45 GC-TI403-SB 0.45 - 0.983 / 57440-38-2 0.68 0.0021 --- --- YES Above Screening Level--- C

Calcium mg/kg541 J197 GC-TI403-SB 197 - 5415 / 57440-70-2 541 --- --- --- NO Essential Nutrient---

Magnesium mg/kg343 J190 GC-TI401-SB 190 - 3435 / 57439-95-4 343 --- --- --- NO Essential Nutrient---

Mercury mg/kg0.20 0.15 GC-TI406-SB 0.15 - 0.484 / 57439-97-6 0.20 0.022 --- --- YES Above Screening Level--- N

Potassium mg/kg3970 2070 GC-TI406-SB 2070 - 39705 / 57440-09-7 3970 --- --- --- NO Essential Nutrient---

Selenium mg/kg1.20 J1.20 GC-TI403-SB, GC-TI406-SB

1.20 - 3.502 / 57782-49-2 1.20 0.68 --- --- YES Above Screening Level--- N

Sodium mg/kg1060 468 GC-TI403-SB 468 - 10605 / 57440-23-5 1060 --- --- --- NO Essential Nutrient---

Zinc mg/kg16.4 3.90 GC-TI403-SB 3.90 - 16.45 / 57440-66-6 16.4 41 --- --- NO Below Screening Level--- N

Cyanide, Total mg/kg0.63 J0.28 GC-TI401-SB 0.28 - 2.503 / 557-12-5 0.63 2.7 --- --- NO Below Screening Level--- N

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA1 1/25/2011 3:34:51 PM

Page 95: Appendix L HHRA Combined

TABLE H-2.9

White Perch Filet from Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

White Perch in Gowanus Canal

Gamma-chlordane ug/kg5.00 J5.00 GC-TI401-WP 1.70 - 5.001 / 25103-74-2 5.00 9 --- --- NO Below Screening Level--- C

P,P'-DDE ug/kg7.00 NJ6.00 GC-TI401-WP 6.00 - 7.002 / 272-55-9 7.00 9.3 --- --- NO Below Screening Level--- C

PCB Dioxin ng/kg5.08 4.46 GC-TI401-WP 4.46 - 5.082 / 2PCBDioxin 5.08 0.020 --- --- YES Above Screening Level--- C

PCB Nondioxin ng/kg437000 302000 GC-TI401-WP 302000 - 4370002 / 2PCBNonDioxin 437000 1600 --- --- YES Above Screening Level--- C

Total PCB Congeners ng/kg462000 324000 GC-TI401-WP 324000 - 4620002 / 2PCBTotalCongen 462000 1600 --- --- YES Above Screening Level--- C

Calcium mg/kg4220 J318 GC-TI401-WP 318 - 42202 / 27440-70-2 4220 --- --- --- NO Essential Nutrient---

Copper mg/kg1.30 J0.90 GC-TI401-WP 0.90 - 1.302 / 27440-50-8 1.30 5.4 --- --- NO Below Screening Level--- N

Magnesium mg/kg362 J245 GC-TI401-WP 245 - 3622 / 27439-95-4 362 --- --- --- NO Essential Nutrient---

Manganese mg/kg5.20 5.20 GC-TI401-WP 1.50 - 5.201 / 27439-96-5 5.20 19 --- --- NO Below Screening Level--- N

Mercury mg/kg0.19 0.16 GC-TI401-WP 0.16 - 0.192 / 27439-97-6 0.19 0.022 --- --- YES Above Screening Level--- N

Potassium mg/kg2590 2550 GC-TI401-WP 2550 - 25902 / 27440-09-7 2590 --- --- --- NO Essential Nutrient---

Selenium mg/kg1.40 J1.40 GC-TI401-WP 1.40 - 3.401 / 27782-49-2 1.40 0.68 --- --- YES Above Screening Level--- N

Sodium mg/kg823 628 GC-TI401-WP 628 - 8232 / 27440-23-5 823 --- --- --- NO Essential Nutrient---

Zinc mg/kg9.50 5.10 GC-TI401-WP 5.10 - 9.502 / 27440-66-6 9.50 41 --- --- NO Below Screening Level--- N

Cyanide, Total mg/kg0.91 J0.22 GC-TI401-WP 0.22 - 0.912 / 257-12-5 0.91 2.7 --- --- NO Below Screening Level--- N

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA1 1/25/2011 3:35:19 PM

Page 96: Appendix L HHRA Combined

TABLE H-2.10

Atlantic Eel Filet from Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Eel in Gowanus Canal

Alpha-chlordane ug/kg22.0 J10.0 GC-TI402-XAE 1.70 - 22.03 / 45103-71-9 22.0 9 --- --- YES Above Screening Level--- C

Dieldrin ug/kg17.0 J5.00 GC-TI402-XAE 3.30 - 17.05 / 660-57-1 17.0 0.2 --- --- YES Above Screening Level--- C

Gamma-chlordane ug/kg13.0 J9.90 GC-TI403-XAE 1.70 - 13.02 / 35103-74-2 13.0 9 --- --- YES Above Screening Level--- C

Methoxychlor ug/kg39.0 J34.0 GC-TI403-XAE 17.0 - 39.02 / 672-43-5 39.0 680 --- --- NO Below Screening Level--- N

P,P'-DDD ug/kg38.0 NJ13.0 GC-TI403-XAE 13.0 - 38.04 / 472-54-8 38.0 13 --- --- YES Above Screening Level--- C

P,P'-DDE ug/kg25.0 J16.0 GC-TI403-XAE 3.30 - 25.04 / 572-55-9 25.0 9.3 --- --- YES Above Screening Level--- C

P,P'-DDT ug/kg47.0 J30.0 GC-TI406-XAE 3.30 - 47.02 / 450-29-3 47.0 9.3 --- --- YES Above Screening Level--- C

PCB Dioxin ng/kg14.1 4.73 GC-TI406-XAE 4.73 - 14.16 / 6PCBDioxin 14.1 0.020 --- --- YES Above Screening Level--- C

PCB Nondioxin ng/kg1220000 480000 GC-TI406-XAE 480000 - 12200006 / 6PCBNonDioxin 1220000 1600 --- --- YES Above Screening Level--- C

Total PCB Congeners ng/kg1350000 519000 GC-TI406-XAE 519000 - 13500006 / 6PCBTotalCongen 1350000 1600 --- --- YES Above Screening Level--- C

Arsenic mg/kg0.50 J0.50 GC-TI402-XAE 0.50 - 0.981 / 67440-38-2 0.50 0.0021 --- --- YES Above Screening Level--- C

Calcium mg/kg295 J198 GC-TI402-XAE 198 - 4853 / 67440-70-2 295 --- --- --- NO Essential Nutrient---

Chromium mg/kg0.67 J0.53 GC-TI402-XAE 0.53 - 0.972 / 67440-47-3 0.67 0.0063 --- --- YES Above Screening Level--- C

Copper mg/kg7.40 0.86 GC-TI402-XAE 0.86 - 7.403 / 67440-50-8 7.40 5.4 --- --- YES Above Screening Level--- N

Iron mg/kg12.7 12.7 GC-TI402-XAE 9.70 - 12.71 / 67439-89-6 12.7 95 --- --- NO Essential Nutrient--- N

Magnesium mg/kg278 J169 GC-TI403-XAE 169 - 4854 / 67439-95-4 278 --- --- --- NO Essential Nutrient---

Mercury mg/kg0.26 0.056 GC-TI406-XAE 0.056 - 0.266 / 67439-97-6 0.26 0.022 --- --- YES Above Screening Level--- N

Potassium mg/kg3570 1960 GC-TI403-XAE 1960 - 35706 / 67440-09-7 3570 --- --- --- NO Essential Nutrient---

Selenium mg/kg1.40 J1.20 GC-TI403-XAE 1.20 - 3.402 / 67782-49-2 1.40 0.68 --- --- YES Above Screening Level--- N

Sodium mg/kg944 524 GC-TI403-XAE 524 - 9446 / 67440-23-5 944 --- --- --- NO Essential Nutrient---

Zinc mg/kg29.7 11.5 GC-TI403-XAE 11.5 - 29.76 / 67440-66-6 29.7 41 --- --- NO Below Screening Level--- N

Cyanide, Total mg/kg3.10 0.30 GC-TI403-XAE 0.30 - 3.106 / 657-12-5 3.10 2.7 --- --- YES Above Screening Level--- N

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA1 1/25/2011 3:33:57 PM

Page 97: Appendix L HHRA Combined

TABLE H-2.11

Blue Crab Edible Tissue and Hepatopancreas from Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Crab in Gowanus Canal

Acenaphthene ug/kg73.0 23.8 GC-TI401-BC 23.8 - 73.012 / 1283-32-9 73.0 8100 --- --- NO Below Screening Level--- N

Acenaphthylene ug/kg14.3 6.07 GC-TI401-BC 3.64 - 14.36 / 12208-96-8 14.3 8100 --- --- NO Below Screening Level--- N

Anthracene ug/kg12.4 3.85 GC-TI401-BC 3.85 - 12.412 / 12120-12-7 12.4 41000 --- --- NO Below Screening Level--- N

Benzo(a)anthracene ug/kg15.7 4.75 GC-TI402-BC 2.87 - 15.75 / 1256-55-3 15.7 4.3 --- --- YES Above Screening Level--- C

Benzo(a)pyrene ug/kg17.5 5.45 GC-TI402-BC 4.53 - 17.511 / 1250-32-8 17.5 0.43 --- --- YES Above Screening Level--- C

Benzo(b)fluoranthene ug/kg9.61 4.82 GC-TI402-BC 2.74 - 9.619 / 12205-99-2 9.61 4.3 --- --- YES Above Screening Level--- C

Benzo(g,h,i)perylene ug/kg28.2 13.6 GC-TI401-BC 13.6 - 28.212 / 12191-24-2 28.2 4100 --- --- NO Below Screening Level--- N

Benzo(k)fluoranthene ug/kg8.76 3.65 GC-TI402-BC 2.44 - 8.768 / 12207-08-9 8.76 43 --- --- NO Below Screening Level--- C

Chrysene ug/kg13.6 5.03 GC-TI402-BC 2.91 - 13.68 / 12218-01-9 13.6 430 --- --- NO Below Screening Level--- C

Dibenz(a,h)anthracene ug/kg5.13 2.59 GC-TI402-BC 2.59 - 5.1312 / 1253-70-3 5.13 0.43 --- --- YES Above Screening Level--- C

Fluoranthene ug/kg21.9 8.44 GC-TI402-BC 8.44 - 21.912 / 12206-44-0 21.9 5400 --- --- NO Below Screening Level--- N

Fluorene ug/kg26.8 6.43 GC-TI404-BC 6.43 - 26.812 / 1286-73-7 26.8 5400 --- --- NO Below Screening Level--- N

Indeno(1,2,3-c,d)pyrene ug/kg12.3 7.46 GC-TI402-BC 7.46 - 12.312 / 12193-39-5 12.3 4.3 --- --- YES Above Screening Level--- C

Phenanthrene ug/kg44.1 12.2 GC-TI401-BC 12.2 - 44.112 / 1285-01-8 44.1 41000 --- --- NO Below Screening Level--- N

Pyrene ug/kg28.6 9.88 GC-TI401-BC 9.88 - 28.612 / 12129-00-0 28.6 4100 --- --- NO Below Screening Level--- N

P,P'-DDE ug/kg2.79 2.05 GC-TI402-BC 2.05 - 2.7912 / 1272-55-9 2.79 9.3 --- --- NO Below Screening Level--- C

PCB Dioxin ng/kg5.54 3.91 GC-TI405-BC 3.91 - 5.5412 / 12PCBDioxin 5.54 0.020 --- --- YES Above Screening Level--- C

PCB Nondioxin ng/kg167000 115000 GC-TI405-BC 115000 - 16700012 / 12PCBNonDioxin 167000 1600 --- --- YES Above Screening Level--- C

Total PCB Congeners ng/kg194000 133000 GC-TI405-BC 133000 - 19400012 / 12PCBTotalCongen 194000 1600 --- --- YES Above Screening Level--- C

Arsenic mg/kg1.47 0.902 GC-TI401-BC 0.902 - 1.4712 / 127440-38-2 1.47 0.0021 --- --- YES Above Screening Level--- C

Calcium mg/kg1740 1050 GC-TI406-BC 1050 - 174012 / 127440-70-2 1740 --- --- --- NO Essential Nutrient---

Copper mg/kg11.7 8.19 GC-TI406-BC 8.19 - 11.712 / 127440-50-8 11.7 5.4 --- --- YES Above Screening Level--- N

Iron mg/kg13.3 8.43 GC-TI406-BC 7.96 - 13.36 / 127439-89-6 13.3 95 --- --- NO Essential Nutrient--- N

Magnesium mg/kg395 318 GC-TI406-BC 318 - 39512 / 127439-95-4 395 --- --- --- NO Essential Nutrient---

Manganese mg/kg3.24 2.20 GC-TI405-BC 2.20 - 3.2412 / 127439-96-5 3.24 19 --- --- NO Below Screening Level--- N

Mercury mg/kg0.142 0.0792 GC-TI402-BC 0.0792 - 0.14212 / 127439-97-6 0.142 0.022 --- --- YES Above Screening Level--- N

Potassium mg/kg2390 1910 GC-TI406-BC 1910 - 239012 / 127440-09-7 2390 --- --- --- NO Essential Nutrient---

Silver mg/kg0.463 0.421 GC-TI401-BC 0.421 - 0.4972 / 127440-22-4 0.463 0.68 --- --- NO Below Screening Level--- N

Sodium mg/kg3490 2630 GC-TI401-BC, GC-TI402-BC

2630 - 349012 / 127440-23-5 3490 --- --- --- NO Essential Nutrient---

Zinc mg/kg24.0 18.9 GC-TI406-BC 18.9 - 24.012 / 127440-66-6 24.0 41 --- --- NO Below Screening Level--- N

PAGE 1 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA1 1/25/2011 3:36:40 PM

Page 98: Appendix L HHRA Combined

TABLE H-2.11

Blue Crab Edible Tissue and Hepatopancreas from Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Crab in Gowanus Canal

Cyanide, Total mg/kg0.847 0.527 GC-TI401-BC 0.527 - 1.2510 / 1257-12-5 0.847 2.7 --- --- NO Below Screening Level--- N

PAGE 2 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA1 1/25/2011 3:36:40 PM

Page 99: Appendix L HHRA Combined

TABLE H-2.12

All Surface Sediment in Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Overflow Surface Sediment

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

1,2-dichloroethane ug/kg45.0 J3.90 323 3.90 - 45.06 / 27107-06-2 45.0 430 --- --- NO Below Screening Level--- C

1,4-dichlorobenzene ug/kg240 J7.60 301 5.00 - 2403 / 26106-46-7 240 2400 --- --- NO Below Screening Level--- C

Acetone ug/kg90.0 21.0 314 9.90 - 90.011 / 2767-64-1 90.0 6100000 --- --- NO Below Screening Level--- N

Benzene ug/kg110 J6.80 304 5.00 - 1104 / 2771-43-2 110 1100 --- --- NO Below Screening Level--- C

Carbon disulfide ug/kg89.0 4.70 314 4.70 - 89.09 / 2775-15-0 89.0 82000 --- --- NO Below Screening Level--- N

Chlorobenzene ug/kg53.0 53.0 301 5.00 - 53.01 / 27108-90-7 53.0 29000 --- --- NO Below Screening Level--- N

Cyclohexane ug/kg14.0 J8.00 304 5.00 - 23.03 / 27110-82-7 14.0 120000 --- --- NO Below Screening Level--- N

Ethylbenzene ug/kg3600 J5.30 315 5.00 - 36008 / 27100-41-4 3600 5400 --- --- NO Below Screening Level--- C

Isopropylbenzene (cumene) ug/kg760 J4.60 315 4.60 - 7607 / 2798-82-8 760 210000 --- --- NO Below Screening Level--- N

m, p xylenes ug/kg810 J5.40 315 5.00 - 8105 / 27179601-23-1 810 340000 --- --- NO Below Screening Level--- N

Methylcyclohexane ug/kg170 J15.0 314 5.00 - 1703 / 27108-87-2 170 --- --- --- NO No toxicity information---

Methylene chloride ug/kg7.70 J2.20 306 2.20 - 23.06 / 2775-09-2 7.70 11000 --- --- NO Below Screening Level--- C

o-xylene (1,2-dimethylbenzene) ug/kg1200 J19.0 315 5.00 - 12005 / 2795-47-6 1200 380000 --- --- NO Below Screening Level--- N

Tert-butyl methyl ether ug/kg34.0 J34.0 304 5.00 - 34.01 / 271634-04-4 34.0 43000 --- --- NO Below Screening Level--- C

Tetrachloroethylene(PCE) ug/kg11.0 J5.80 302 5.00 - 23.02 / 27127-18-4 11.0 550 --- --- NO Below Screening Level--- C

Toluene ug/kg36.0 J5.80 314 5.00 - 36.04 / 27108-88-3 36.0 500000 --- --- NO Below Screening Level--- N

Trichloroethylene (TCE) ug/kg4.20 J4.20 301 4.20 - 23.01 / 2779-01-6 4.20 2800 --- --- NO Below Screening Level--- C

Trichlorofluoromethane ug/kg8.90 J4.60 302 4.60 - 23.03 / 2775-69-4 8.90 79000 --- --- NO Below Screening Level--- N

2-methylnaphthalene ug/kg870000 J190 315 120 - 87000016 / 2791-57-6 870000 31000 --- --- YES Above Screening Level--- N

Acenaphthene ug/kg580000 J160 315 160 - 58000021 / 2783-32-9 580000 340000 --- --- YES Above Screening Level--- N

Acenaphthylene ug/kg150000 J270 314 160 - 15000014 / 27208-96-8 150000 340000 --- --- NO Below Screening Level--- N

Anthracene ug/kg610000 J330 315 250 - 61000024 / 27120-12-7 610000 1700000 --- --- NO Below Screening Level--- N

Benzo(a)anthracene ug/kg490000 J1100 315 1100 - 49000027 / 2756-55-3 490000 150 --- --- YES Above Screening Level--- C

Benzo(a)pyrene ug/kg200000 J1200 314 250 - 20000026 / 2750-32-8 200000 15 --- --- YES Above Screening Level--- C

Benzo(b)fluoranthene ug/kg210000 J1000 314 250 - 21000026 / 27205-99-2 210000 150 --- --- YES Above Screening Level--- C

Benzo(g,h,i)perylene ug/kg74000 J610 314 260 - 7400026 / 27191-24-2 74000 170000 --- --- NO Below Screening Level--- N

Benzo(k)fluoranthene ug/kg120000 J820 314 250 - 12000026 / 27207-08-9 120000 1500 --- --- YES Above Screening Level--- C

Biphenyl (diphenyl) ug/kg71000 J650 315 650 - 2300002 / 2792-52-4 71000 210000 --- --- NO Below Screening Level--- N

Bis(2-ethylhexyl) phthalate ug/kg57000 J2600 314 2600 - 16000021 / 27117-81-7 57000 35000 --- --- YES Above Screening Level--- C

Carbazole ug/kg1400 J1400 308A 1400 - 2300001 / 2786-74-8 1400 --- --- --- NO No toxicity information---

PAGE 1 of 3\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 1/25/2011 3:54:46 PM

Page 100: Appendix L HHRA Combined

TABLE H-2.12

All Surface Sediment in Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Overflow Surface Sediment

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Chrysene ug/kg490000 J730 315 730 - 49000027 / 27218-01-9 490000 15000 --- --- YES Above Screening Level--- C

Dibenz(a,h)anthracene ug/kg14000 200 314 200 - 1400023 / 2753-70-3 14000 15 --- --- YES Above Screening Level--- C

Dibenzofuran ug/kg1100 J1100 319 1100 - 2300001 / 27132-64-9 1100 7800 --- --- NO Below Screening Level--- N

Di-n-butyl phthalate ug/kg550 J510 318 510 - 2300002 / 2784-74-2 550 610000 --- --- NO Below Screening Level--- N

Di-n-octylphthalate ug/kg9300 J9300 307A 6200 - 2300001 / 27117-84-0 9300 35000 --- --- NO Below Screening Level--- N

Fluoranthene ug/kg630000 J1200 314 1200 - 63000027 / 27206-44-0 630000 230000 --- --- YES Above Screening Level--- N

Fluorene ug/kg540000 J130 315 130 - 54000017 / 2786-73-7 540000 230000 --- --- YES Above Screening Level--- N

Indeno(1,2,3-c,d)pyrene ug/kg120000 J1000 314 1000 - 12000027 / 27193-39-5 120000 150 --- --- YES Above Screening Level--- C

Naphthalene ug/kg1600000 J120 315 120 - 160000019 / 2791-20-3 1600000 3600 --- --- YES Above Screening Level--- C

Phenanthrene ug/kg1100000 J510 315 510 - 110000026 / 2785-01-8 1100000 1700000 --- --- NO Below Screening Level--- N

Pyrene ug/kg670000 J1400 314 230 - 67000026 / 27129-00-0 670000 170000 --- --- YES Above Screening Level--- N

Alpha-chlordane ug/kg14.0 J6.70 308A 2.70 - 5302 / 275103-71-9 14.0 1600 --- --- NO Below Screening Level--- C

Beta endosulfan ug/kg13.0 J13.0 308A 5.30 - 10001 / 2733213-65-9 13.0 37000 --- --- NO Below Screening Level--- N

Endosulfan sulfate ug/kg21.0 J21.0 308A 5.30 - 10001 / 271031-07-8 21.0 37000 --- --- NO Below Screening Level--- N

Gamma-chlordane ug/kg29.0 J5.90 308A 2.70 - 5303 / 275103-74-2 29.0 1600 --- --- NO Below Screening Level--- C

Methoxychlor ug/kg33.0 J33.0 308A 27.0 - 53001 / 2772-43-5 33.0 31000 --- --- NO Below Screening Level--- N

P,P'-DDD ug/kg1100 NJ7.90 315 7.90 - 11005 / 572-54-8 1100 2000 --- --- NO Below Screening Level--- C

P,P'-DDE ug/kg16.0 NJ16.0 308A 5.30 - 10001 / 2672-55-9 16.0 1400 --- --- NO Below Screening Level--- C

Aroclor 1016 ug/kg290 140 318 41.0 - 2904 / 2712674-11-2 290 390 --- --- NO Below Screening Level--- N

Aroclor 1248 ug/kg2200 J230 316 41.0 - 22002 / 2712672-29-6 2200 220 --- --- YES Above Screening Level--- C

Aroclor 1254 ug/kg590 J590 308A 48.0 - 5901 / 2711097-69-1 590 110 --- --- YES Above Screening Level--- N

Aroclor 1260 ug/kg3400 J150 314 41.0 - 34007 / 2711096-82-5 3400 220 --- --- YES Above Screening Level--- C

PCB Dioxin ng/kg111 0.241 314 0.241 - 11119 / 19PCBDioxin 111 3.7 --- --- YES Above Screening Level--- C

PCB Nondioxin ng/kg14700000 92500 314 92500 - 1470000019 / 19PCBNonDioxin 14700000 220000 --- --- YES Above Screening Level--- C

Total PCB Congeners ng/kg15100000 99500 314 99500 - 1510000019 / 19PCBTotalCongen 15100000 110000 --- --- YES Above Screening Level--- N

Aluminum mg/kg18900 J4870 310 4870 - 1890027 / 277429-90-5 18900 7700 --- --- YES Above Screening Level--- N

Arsenic mg/kg44.7 3.40 308A 3.40 - 44.727 / 277440-38-2 44.7 0.39 --- --- YES Above Screening Level--- C

Barium mg/kg631 J83.1 317 83.1 - 63127 / 277440-39-3 631 1500 --- --- NO Below Screening Level--- N

Beryllium mg/kg0.46 J0.11 309 0.11 - 1.6012 / 277440-41-7 0.46 16 --- --- NO Below Screening Level--- N

Cadmium mg/kg20.2 J1.50 308A 1.50 - 20.227 / 277440-43-9 20.2 7 --- --- YES Above Screening Level--- N

PAGE 2 of 3\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 1/25/2011 3:54:46 PM

Page 101: Appendix L HHRA Combined

TABLE H-2.12

All Surface Sediment in Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Overflow Surface Sediment

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Calcium mg/kg11300 J4890 313 4890 - 1130027 / 277440-70-2 11300 --- --- --- NO Essential Nutrient---

Chromium mg/kg139 J22.7 314 22.7 - 13927 / 277440-47-3 139 0.29 --- --- YES Above Screening Level--- C

Cobalt mg/kg14.8 J6.50 318 6.50 - 17.114 / 277440-48-4 14.8 2.3 --- --- YES Above Screening Level--- N

Copper mg/kg790 85.8 308A 85.8 - 79027 / 277440-50-8 790 310 --- --- YES Above Screening Level--- N

Cyanide, Total mg/kg18.0 J0.54 302 0.54 - 18.014 / 2757-12-5 18.0 160 --- --- NO Below Screening Level--- N

Iron mg/kg87000 12400 308A 12400 - 8700027 / 277439-89-6 87000 5500 --- --- YES Above Screening Level--- N

Lead mg/kg4220 146 308A 146 - 422027 / 277439-92-1 4220 400 --- --- YES Above Screening Level--- N

Magnesium mg/kg11400 J4210 318 4210 - 1140027 / 277439-95-4 11400 --- --- --- NO Essential Nutrient---

Manganese mg/kg480 89.1 308A 89.1 - 48027 / 277439-96-5 480 180 --- --- YES Above Screening Level--- N

Mercury mg/kg2.30 J0.59 313 0.59 - 2.3027 / 277439-97-6 2.30 2.3 --- --- NO Below Screening Level--- N

Nickel mg/kg84.5 J18.1 314 18.1 - 84.527 / 277440-02-0 84.5 150 --- --- NO Below Screening Level--- N

Potassium mg/kg4410 J730 310 730 - 441027 / 277440-09-7 4410 --- --- --- NO Essential Nutrient---

Selenium mg/kg4.90 J0.74 310 0.74 - 12.015 / 277782-49-2 4.90 39 --- --- NO Below Screening Level--- N

Silver mg/kg6.80 J1.80 310 1.20 - 6.8022 / 277440-22-4 6.80 39 --- --- NO Below Screening Level--- N

Sodium mg/kg18700 J2610 322 2610 - 1870027 / 277440-23-5 18700 --- --- --- NO Essential Nutrient---

Vanadium mg/kg61.2 J19.4 316 19.4 - 61.227 / 277440-62-2 61.2 39 --- --- YES Above Screening Level--- N

Zinc mg/kg1520 240 308A 240 - 152017 / 177440-66-6 1520 2300 --- --- NO Below Screening Level--- N

PAGE 3 of 3\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 1/25/2011 3:54:46 PM

Page 102: Appendix L HHRA Combined

TABLE H-2.13

Surface Water in Canal, Wet Weather - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Overflow Surface Water

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Canal Overflow – Surface Water

1,2,4-trichlorobenzene ug/l0.12 J0.12 305 0.12 - 0.501 / 26120-82-1 0.12 0.41 70 NRWQC NO Below Screening Level--- N

1,3-dichlorobenzene ug/l0.13 J0.13 303, 305 0.13 - 0.502 / 26541-73-1 0.13 37 960 NRWQC NO Below Screening Level--- N

1,4-dichlorobenzene ug/l0.87 0.12 306 0.12 - 0.8714 / 26106-46-7 0.87 0.43 190 NRWQC YES Above Screening Level--- C

Acetone ug/l12.0 12.0 307B 5.00 - 15.01 / 2667-64-1 12.0 2200 --- --- NO Below Screening Level--- N

Benzene ug/l2.90 0.36 316 0.36 - 2.9016 / 2671-43-2 2.90 0.41 10 NYSDEC YES Above Screening Level--- C

Carbon disulfide ug/l0.17 J0.14 308B, 313 0.14 - 0.505 / 2675-15-0 0.17 100 --- --- NO Below Screening Level--- N

Chlorobenzene ug/l0.33 J0.12 306 0.12 - 0.5017 / 26108-90-7 0.33 9.1 400 NYSDEC NO Below Screening Level--- N

Chloroform ug/l0.69 0.50 321 0.50 - 0.6914 / 2667-66-3 0.69 0.19 470 NRWQC YES Above Screening Level--- C

cis-1,2-dichloroethylene ug/l0.51 0.21 319 0.21 - 0.5117 / 26156-59-2 0.51 37 --- --- NO Below Screening Level--- N

Ethylbenzene ug/l2.60 0.18 316 0.18 - 2.6021 / 26100-41-4 2.60 1.5 2100 NRWQC YES Above Screening Level--- C

Isopropylbenzene (cumene) ug/l0.20 J0.096 316 0.096 - 0.504 / 2698-82-8 0.20 68 --- --- NO Below Screening Level--- N

m, p xylenes ug/l2.60 0.18 316 0.18 - 2.6022 / 26179601-23-1 2.60 120 --- --- NO Below Screening Level--- N

Methyl acetate ug/l0.44 J0.44 317 0.44 - 0.501 / 2679-20-9 0.44 3700 --- --- NO Below Screening Level--- N

Methylene chloride ug/l3.40 0.99 321 0.50 - 3.409 / 2675-09-2 3.40 4.8 200 NYSDEC NO Below Screening Level--- C

o-xylene (1,2-dimethylbenzene) ug/l5.10 0.13 316 0.13 - 5.1020 / 2695-47-6 5.10 120 --- --- NO Below Screening Level--- N

Tetrachloroethylene(PCE) ug/l40.0 J0.70 319 0.50 - 40.024 / 26127-18-4 40.0 0.11 3.3 NRWQC YES Above Screening Level--- C

Toluene ug/l16.0 0.85 316 0.50 - 16.024 / 26108-88-3 16.0 230 6000 NYSDEC NO Below Screening Level--- N

trans-1,3-dichloropropene ug/l0.16 J0.16 306 0.16 - 0.501 / 2610061-02-6 0.16 0.43 --- --- NO Below Screening Level--- C

Trichloroethylene (TCE) ug/l0.12 J0.10 320 0.10 - 0.502 / 2679-01-6 0.12 2 30 NRWQC NO Below Screening Level--- C

2-methylnaphthalene ug/l3.00 0.17 316 0.10 - 3.003 / 2691-57-6 3.00 15 --- --- NO Below Screening Level--- N

Acenaphthene ug/l0.40 0.095 313 0.095 - 1.0020 / 2683-32-9 0.40 220 990 NRWQC NO Below Screening Level--- N

Anthracene ug/l0.095 J0.095 302 0.095 - 1.001 / 26120-12-7 0.095 1100 40000 NRWQC NO Below Screening Level--- N

Benzo(a)anthracene ug/l0.15 0.074 302 0.074 - 1.004 / 2656-55-3 0.15 0.029 0.018 NRWQC YES Above Screening Level--- C

Benzo(a)pyrene ug/l0.30 0.14 309 0.10 - 1.006 / 2650-32-8 0.30 0.0029 0.018 NRWQC YES Above Screening Level--- C

Benzo(b)fluoranthene ug/l0.33 0.12 319 0.10 - 1.0016 / 26205-99-2 0.33 0.029 0.018 NRWQC YES Above Screening Level--- C

Benzo(g,h,i)perylene ug/l1.50 J0.13 308A 0.10 - 1.5023 / 26191-24-2 1.50 110 --- --- NO Below Screening Level--- N

Benzo(k)fluoranthene ug/l0.12 J0.037 319 0.037 - 1.007 / 26207-08-9 0.12 0.29 0.018 NRWQC NO Below Screening Level--- C

Benzyl butyl phthalate ug/l1.10 J0.73 307A 0.73 - 50.03 / 2685-68-7 1.10 35 1900 NRWQC NO Below Screening Level--- C

Caprolactam ug/l1.50 J0.33 320 0.33 - 50.011 / 26105-60-2 1.50 1800 --- --- NO Below Screening Level--- N

Chrysene ug/l0.11 0.057 302 0.057 - 1.003 / 26218-01-9 0.11 2.9 0.018 NRWQC NO Below Screening Level--- C

PAGE 1 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/30/2010 4:35:33 PM

Page 103: Appendix L HHRA Combined

TABLE H-2.13

Surface Water in Canal, Wet Weather - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Overflow Surface Water

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Canal Overflow – Surface Water

Dibenz(a,h)anthracene ug/l0.11 0.071 303 0.071 - 1.004 / 2653-70-3 0.11 0.0029 0.018 NRWQC YES Above Screening Level--- C

Di-n-butyl phthalate ug/l0.62 J0.28 320 0.28 - 50.012 / 2684-74-2 0.62 370 4500 NRWQC NO Below Screening Level--- N

Di-n-octylphthalate ug/l0.28 J0.23 318 0.23 - 50.03 / 26117-84-0 0.28 4.8 --- --- NO Below Screening Level--- N

Fluoranthene ug/l0.32 0.089 313 0.089 - 1.0022 / 26206-44-0 0.32 150 140 NRWQC NO Below Screening Level--- N

Fluorene ug/l0.32 J0.079 313 0.079 - 1.003 / 2686-73-7 0.32 150 5300 NRWQC NO Below Screening Level--- N

Indeno(1,2,3-c,d)pyrene ug/l1.10 0.16 316 0.10 - 1.1023 / 26193-39-5 1.10 0.029 0.018 NRWQC YES Above Screening Level--- C

Naphthalene ug/l1.40 0.13 316 0.10 - 1.405 / 2691-20-3 1.40 0.14 --- --- YES Above Screening Level--- C

Pentachlorophenol ug/l0.13 J0.13 311 0.13 - 2.001 / 2687-86-5 0.13 0.56 3 NRWQC NO Below Screening Level--- C

Phenanthrene ug/l1.40 0.13 316 0.10 - 1.4014 / 2685-01-8 1.40 1100 --- --- NO Below Screening Level--- N

Pyrene ug/l0.34 0.10 313 0.10 - 1.0022 / 26129-00-0 0.34 110 4000 NRWQC NO Below Screening Level--- N

Arsenic ug/l26.2 6.90 302 6.90 - 26.226 / 267440-38-2 26.2 0.045 0.14 NRWQC YES Above Screening Level--- C

Barium ug/l42.8 J18.4 307A 18.4 - 42.826 / 267440-39-3 42.8 730 --- --- NO Below Screening Level--- N

Calcium ug/l296000 97200 324 97200 - 29600024 / 247440-70-2 296000 --- --- --- NO Essential Nutrient---

Chromium ug/l29.3 J3.90 308B 3.90 - 29.326 / 267440-47-3 29.3 0.043 --- --- YES Above Screening Level--- C

Cobalt ug/l3.90 J3.90 307A 3.90 - 10.01 / 267440-48-4 3.90 1.1 --- --- YES Above Screening Level--- N

Iron ug/l1040 J651 317 651 - 15003 / 267439-89-6 1040 2600 --- --- NO Below Screening Level--- N

Lead ug/l26.8 2.90 317 2.90 - 26.826 / 267439-92-1 26.8 15 --- --- YES Above Screening Level--- N

Magnesium ug/l972000 276000 303 276000 - 97200025 / 257439-95-4 972000 --- --- --- NO Essential Nutrient---

Manganese ug/l65.6 48.4 307A 48.4 - 65.626 / 267439-96-5 65.6 88 100 NRWQC NO Below Screening Level--- N

Mercury ug/l0.089 J0.065 302 0.065 - 0.2019 / 267439-97-6 0.089 1.1 0.0007 NYSDEC NO Below Screening Level--- N

Nickel ug/l29.8 J2.10 308B 2.10 - 29.825 / 257440-02-0 29.8 73 4600 NRWQC NO Below Screening Level--- N

Potassium ug/l290000 88700 324 88700 - 29000024 / 247440-09-7 290000 --- --- --- NO Essential Nutrient---

Selenium ug/l64.6 J13.9 301 13.9 - 64.626 / 267782-49-2 64.6 18 4200 NRWQC YES Above Screening Level--- N

Sodium ug/l7090000 J2340000 301 2340000 - 709000025 / 257440-23-5 7090000 --- --- --- NO Essential Nutrient---

Zinc ug/l75.7 J17.7 318 17.7 - 75.724 / 267440-66-6 75.7 1100 26000 NRWQC NO Below Screening Level--- N

PAGE 2 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA1 11/30/2010 4:35:33 PM

Page 104: Appendix L HHRA Combined

TABLE H-2.14

Blue Crab Edible Tissue from Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Crab in Gowanus Canal

Acenaphthene ug/kg79.4 J9.91 GC-TI401-BC 9.91 - 79.412 / 1283-32-9 79.4 8100 --- --- NO Below Screening Level--- N

Acenaphthylene ug/kg16.4 2.70 GC-TI401-BC 2.70 - 16.46 / 12208-96-8 16.4 8100 --- --- NO Below Screening Level--- N

Anthracene ug/kg12.7 J8.59 GC-TI401-BC 3.22 - 12.72 / 12120-12-7 12.7 41000 --- --- NO Below Screening Level--- N

Benzo(a)anthracene ug/kg21.0 2.86 GC-TI402-BC 2.86 - 21.05 / 1256-55-3 21.0 4.3 --- --- YES Above Screening Level--- C

Benzo(a)pyrene ug/kg22.8 3.61 GC-TI402-BC 3.31 - 22.811 / 1250-32-8 22.8 0.43 --- --- YES Above Screening Level--- C

Benzo(b)fluoranthene ug/kg11.4 3.58 GC-TI402-BC 3.23 - 11.49 / 12205-99-2 11.4 4.3 --- --- YES Above Screening Level--- C

Benzo(g,h,i)perylene ug/kg32.1 8.46 GC-TI401-BC 8.46 - 32.112 / 12191-24-2 32.1 4100 --- --- NO Below Screening Level--- N

Benzo(k)fluoranthene ug/kg10.9 2.61 GC-TI402-BC 2.61 - 10.98 / 12207-08-9 10.9 43 --- --- NO Below Screening Level--- C

Chrysene ug/kg17.5 3.28 GC-TI402-BC 3.23 - 17.58 / 12218-01-9 17.5 430 --- --- NO Below Screening Level--- C

Dibenz(a,h)anthracene ug/kg5.78 3.07 GC-TI402-BC 3.07 - 5.789 / 1253-70-3 5.78 0.43 --- --- YES Above Screening Level--- C

Fluoranthene ug/kg19.3 3.55 GC-TI402-BC 3.23 - 19.311 / 12206-44-0 19.3 5400 --- --- NO Below Screening Level--- N

Fluorene ug/kg28.6 4.97 GC-TI404-BC 3.26 - 28.610 / 1286-73-7 28.6 5400 --- --- NO Below Screening Level--- N

Indeno(1,2,3-c,d)pyrene ug/kg13.7 5.89 GC-TI402-BC 5.89 - 13.712 / 12193-39-5 13.7 4.3 --- --- YES Above Screening Level--- C

Phenanthrene ug/kg43.5 3.26 GC-TI401-BC 3.26 - 43.512 / 1285-01-8 43.5 41000 --- --- NO Below Screening Level--- N

Pyrene ug/kg26.5 J3.55 GC-TI401-BC 3.55 - 26.512 / 12129-00-0 26.5 4100 --- --- NO Below Screening Level--- N

P,P'-DDE ug/kg2.28 J1.14 GC-TI402-BC 1.14 - 3.374 / 1272-55-9 2.28 9.3 --- --- NO Below Screening Level--- C

PCB Dioxin ng/kg4.52 1.92 GC-TI405-BC 1.92 - 4.5212 / 12PCBDioxin 4.52 0.020 --- --- YES Above Screening Level--- C

PCB Nondioxin ng/kg149000 64200 GC-TI405-BC 64200 - 14900012 / 12PCBNonDioxin 149000 1600 --- --- YES Above Screening Level--- C

Total PCB Congeners ng/kg171000 73000 GC-TI405-BC 73000 - 17100012 / 12PCBTotalCongen 171000 1600 --- --- YES Above Screening Level--- C

Arsenic mg/kg1.80 0.89 GC-TI401-BC, GC-TI404-BC

0.89 - 1.8012 / 127440-38-2 1.80 0.0021 --- --- YES Above Screening Level--- C

Calcium mg/kg1970 850 GC-TI405-BC 850 - 197012 / 127440-70-2 1970 --- --- --- NO Essential Nutrient---

Copper mg/kg14.1 9.10 GC-TI401-BC 9.10 - 14.112 / 127440-50-8 14.1 5.4 --- --- YES Above Screening Level--- N

Iron mg/kg13.3 5.60 GC-TI406-BC 5.60 - 13.36 / 127439-89-6 13.3 95 --- --- NO Essential Nutrient--- N

Magnesium mg/kg453 J342 GC-TI401-BC 342 - 45312 / 127439-95-4 453 --- --- --- NO Essential Nutrient---

Manganese mg/kg1.70 0.66 GC-TI402-BC, GC-TI406-BC

0.66 - 1.707 / 127439-96-5 1.70 19 --- --- NO Below Screening Level--- N

Mercury mg/kg0.20 0.10 GC-TI402-BC 0.10 - 0.2012 / 127439-97-6 0.20 0.022 --- --- YES Above Screening Level--- N

Potassium mg/kg2870 2360 GC-TI403-BC 2360 - 287012 / 127440-09-7 2870 --- --- --- NO Essential Nutrient---

Silver mg/kg0.44 J0.40 GC-TI401-BC 0.40 - 0.992 / 127440-22-4 0.44 0.68 --- --- NO Below Screening Level--- N

Sodium mg/kg4100 2660 GC-TI402-BC 2660 - 410012 / 127440-23-5 4100 --- --- --- NO Essential Nutrient---

Zinc mg/kg26.8 19.8 GC-TI401-BC 19.8 - 26.812 / 127440-66-6 26.8 41 --- --- NO Below Screening Level--- N

PAGE 1 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA1 1/25/2011 3:36:05 PM

Page 105: Appendix L HHRA Combined

TABLE H-2.14

Blue Crab Edible Tissue from Canal - Selection of Chemical of Potential Concern

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical

Maximum Detected

Value Units

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Minimum Detected

Value

Location of Maximum

Concentration

Range of Detection

LimitsDetection Frequency

Cas Number

Conc. Used For Screening

Back-ground Value

Screening Toxicity

Value

Potential ARAR/TBC

Value

Potential ARAR/TBC

Source

COPC Flag

Rationale for Contaminant Delection or Selection

Crab in Gowanus Canal

Cyanide, Total mg/kg0.59 J0.28 GC-TI401-BC 0.28 - 2.5010 / 1257-12-5 0.59 2.7 --- --- NO Below Screening Level--- N

PAGE 2 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA1 1/25/2011 3:36:05 PM

Page 106: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

PCB 77 Dioxin 0.0001 33 0.0033 532 0.0532 391 0.0391 440 0.044 631 0.0631 20.9 R 0.00209 28.4 0.00284 312 0.0312

PCB 81 Dioxin 0.0003 8.72 R 0.002616 26.5 R 0.00795 24.6 R 0.00738 26.6 0.00798 33 R 0.0099 5 U 0 7.74 U 0 2.33 U 0

PCB 105 Dioxin 0.00003 10,300 0.309 4,410 0.1323 3,940 0.1182 4,200 0.126 4,780 0.1434 20,200 0.606 9,860 0.2958 5,460 0.1638

PCB 114 Dioxin 0.00003 616 0.01848 325 0.00975 312 0.00936 327 0.00981 352 0.01056 762 0.02286 488 0.01464 394 0.01182

PCB 118 Dioxin 0.00003 33,500 1.005 13,500 0.405 12,300 0.369 14,200 0.426 16,100 0.483 34,100 1.023 24,400 0.732 15,500 0.465

PCB 123 Dioxin 0.00003 619 0.01857 260 0.0078 231 0.00693 265 0.00795 322 0.00966 811 0.02433 410 0.0123 256 0.00768

PCB 126 Dioxin 0.1 56.5 5.65 24.6 2.46 24.3 2.43 37.6 3.76 42.9 4.29 42.8 4.28 35.4 3.54 26.6 2.66

PCB 156/157 Dioxin 0.00003 4,130 0.1239 1,340 0.0402 1,170 0.0351 1,680 0.0504 1,730 0.0519 3,710 0.1113 2,840 0.0852 2,480 0.0744

PCB 167 Dioxin 0.00003 2,180 0.0654 578 0.01734 497 0.01491 760 0.0228 756 0.02268 1,970 0.0591 1,510 0.0453 1,120 0.0336

PCB 169 Dioxin 0.03 19.9 U 0 11.8 U 0 12.8 U 0 12.2 U 0 11.3 U 0 51.3 U 0 21.6 U 0 22.9 U 0

PCB 189 Dioxin 0.00003 297 0.00891 71.5 0.002145 61.8 0.001854 119 0.00357 116 0.00348 305 0.00915 187 0.00561 164 0.00492

PCB Dioxin 7.2 3.13 3.02 4.46 5.08 6.14 4.73 3.45

PCB 1 NonDioxin 4.12 32.2 16.9 8.14 17.6 9.41 4.79 21.9

PCB 2 NonDioxin 2.29 U 2.27 U 2.27 U 2.03 U 3.93 U 2.28 U 2.32 U 2.31 U

PCB 3 NonDioxin 2.29 U 5.44 3.22 2.65 4.19 3.32 2.32 U 4.38

PCB 4 NonDioxin 78.3 913 443 325 465 90.3 65.8 418

PCB 5 NonDioxin 2.29 U 5.67 4.56 2.39 5.9 2.28 U 2.32 U 4.94

PCB 6 NonDioxin 4.93 154 98.7 71.3 104 10.5 5.33 91.3

PCB 7 NonDioxin 2.29 U 22.4 11.7 10.1 15.7 2.28 U 2.32 U 12

PCB 8 NonDioxin 17.5 459 306 210 323 34.9 17.1 306

PCB 9 NonDioxin 2.29 U 37.2 20.8 15.2 24.5 3.46 2.32 U 19.4

PCB 10 NonDioxin 8.25 113 43.5 39 50.7 8.38 7.78 40.7

PCB 11 NonDioxin 44.1 146 69.6 70.3 106 35.9 47.3 104

PCB 12/13 NonDioxin 7.35 36.1 20.4 20.5 30.3 8.88 8.56 23.5

PCB 14 NonDioxin 2.29 U 2.27 U 2.27 U 2.03 U 3.93 U 2.28 U 2.32 U 2.31 U

PCB 15 NonDioxin 94.6 248 132 101 161 80.4 105 171

PCB 16 NonDioxin 32.3 651 507 399 652 28.2 21.3 429

PCB 17 NonDioxin 85.6 2,530 1,410 1,460 2,230 71.8 69.8 1,260

PCB 18/30 NonDioxin 245 3,690 2,080 1,850 2,830 222 197 1,830

PCB 19 NonDioxin 91.8 929 423 404 570 82.7 77.6 433

PCB 20/28 NonDioxin 10,300 11,000 6,970 6,220 8,260 5,100 9,010 6,310

PCB 21/33 NonDioxin 4.58 U 699 727 602 987 69.6 26.9 639

PCB 22 NonDioxin 152 1,850 1,280 1,140 1,560 209 287 1,160

PCB 23 NonDioxin 2.29 U 7.65 4.44 4.52 8.33 2.28 U 2.32 U 5.24

PCB 24 NonDioxin 6.03 41.9 27.4 24 36 5.1 4.91 23.9

PCB 25 NonDioxin 64.5 1,000 597 640 943 65.6 74.9 570

PCB 26/29 NonDioxin 1,590 2,320 1,320 1,430 2,270 747 1,520 1,370

PCB 27 NonDioxin 45 657 356 417 637 36.5 30 365

PCB 31 NonDioxin 4,220 7,030 4,510 4,490 6,210 2,150 5,010 4,550

PCB 32 NonDioxin 186 1,790 1,100 1,090 1,890 190 250 1,130

PCB 34 NonDioxin 11.6 89.6 46.9 57.3 106 14.9 20.8 67.6

PCB 35 NonDioxin 2.29 U 2.27 U 2.27 U 2.03 U 3.93 U 2.28 U 2.32 U 2.31 U

PCB 36 NonDioxin 2.29 U 2.92 R 2.27 U 2.03 U 3.93 U 2.28 U 2.32 U 2.31 U

GC-TI327-XAE

GC-TI403-SB-FI-1GC-TI402-XAE-FI-1 GC-TI402-XAE-FI-2GC-TI401-WP-FI-1 GC-TI401-WP-FI-2GC-TI401-SB-FI-1 GC-TI401-SB-FI-2GC-TI327-XAE-FI-1

American Eel

GC-TI403-SBGC-TI402-XAE GC-TI402-XAEGC-TI401-WP GC-TI401-WPGC-TI401-SB GC-TI401-SB

American Eel American Eel Striped Bass

Fillet FilletFillet

White Perch White PerchStriped Bass Striped Bass

FilletFillet FilletFillet Fillet

Page 107: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

GC-TI327-XAE

GC-TI403-SB-FI-1GC-TI402-XAE-FI-1 GC-TI402-XAE-FI-2GC-TI401-WP-FI-1 GC-TI401-WP-FI-2GC-TI401-SB-FI-1 GC-TI401-SB-FI-2GC-TI327-XAE-FI-1

American Eel

GC-TI403-SBGC-TI402-XAE GC-TI402-XAEGC-TI401-WP GC-TI401-WPGC-TI401-SB GC-TI401-SB

American Eel American Eel Striped Bass

Fillet FilletFillet

White Perch White PerchStriped Bass Striped Bass

FilletFillet FilletFillet Fillet

PCB 37 NonDioxin 42.1 788 376 334 409 2.28 U 66.3 R 467

PCB 38 NonDioxin 26.3 15.8 10.6 2.03 U 3.93 U 74.7 33 22.6

PCB 39 NonDioxin 2.29 U 63 41.3 47.5 3.93 U 2.28 U 2.32 U 50.7

PCB 40/41/71 NonDioxin 916 4,960 3,620 4,790 9,780 820 981 5,580

PCB 42 NonDioxin 1,490 3,070 2,100 2,570 4,400 1,490 2,380 2,560

PCB 43 NonDioxin 63.3 542 347 394 664 2.28 U 30.1 460

PCB 44/47/65 NonDioxin 16,900 15,500 9,500 10,800 22,300 27,100 19,000 15,300

PCB 45/51 NonDioxin 333 1,890 1,160 1,360 2,770 330 332 1,460

PCB 46 NonDioxin 37.7 345 235 305 624 27.1 23 258

PCB 48 NonDioxin 38.1 1,630 1,190 1,310 2,100 39.6 41.1 1,110

PCB 49/69 NonDioxin 3,340 12,900 7,590 9,020 20,800 3,760 6,380 13,100

PCB 50/53 NonDioxin 278 1,940 1,050 1,300 2,870 370 181 1,520

PCB 52 NonDioxin 23,600 17,100 11,200 11,800 24,100 57,900 30,100 17,100

PCB 54 NonDioxin 8.87 55 39 32.6 55.3 6.86 8.68 34.4

PCB 55 NonDioxin 2.29 U 2.47 U 3.15 U 99.7 143 5.54 U 18.6 2.54 U

PCB 56 NonDioxin 53.7 2,870 2,210 2,530 4,320 74.1 82.6 2,040

PCB 57 NonDioxin 76.4 102 62 86.7 166 27.6 62.3 145

PCB 58 NonDioxin 83.9 579 379 59.9 110 136 96.4 88.6

PCB 59/62/75 NonDioxin 2,160 1,430 923 1,090 1,940 4,950 2,290 1,470

PCB 60 NonDioxin 2,650 1,890 1,650 1,500 1,950 7,030 2,600 1,530

PCB 61/70/74/76 NonDioxin 11,000 14,400 12,600 13,000 19,000 12,500 9,290 11,100

PCB 63 NonDioxin 857 888 597 685 1,100 1,360 1,010 1,030

PCB 64 NonDioxin 7,240 5,070 3,340 3,890 6,720 34,900 9,850 4,860

PCB 66 NonDioxin 13,100 10,900 9,070 9,060 12,000 23,900 12,400 8,090

PCB 67 NonDioxin 59.1 320 215 281 403 52.4 102 278

PCB 68 NonDioxin 238 289 165 229 406 182 261 397

PCB 72 NonDioxin 449 380 223 321 641 336 442 599

PCB 73 NonDioxin 65.2 111 2.27 U 85.2 210 2.28 U 46.1 131

PCB 78 NonDioxin 19.1 2.45 U 3.12 U 2.03 U 3.93 U 35.5 8.07 U 29.4

PCB 79 NonDioxin 65.4 195 154 177 249 145 142 214

PCB 80 NonDioxin 2.29 U 170 138 2.03 U 3.93 U 5.28 U 7.13 U 2.42 U

PCB 82 NonDioxin 447 792 783 892 1,340 771 615 959

PCB 83/99 NonDioxin 24,000 14,900 10,500 13,200 20,400 24,400 17,300 18,600

PCB 84 NonDioxin 1,950 2,440 1,470 2,260 4,460 4,090 3,240 2,760

PCB 85/116/117 NonDioxin 4,730 3,510 2,830 2,970 4,390 8,510 5,800 4,430

PCB 86/87/97/109/119/125 NonDioxin 4,710 8,320 6,880 7,720 11,700 8,800 -- 8,920

PCB 86/87/97/108/119/125 NonDioxin -- -- -- -- -- -- 8,130 --

PCB 88/91 NonDioxin 1,500 3,380 1,990 2,620 5,350 4,070 3,190 4,520

PCB 89 NonDioxin 2.29 U 60.8 55.1 89.5 163 4.94 4.84 63.7

PCB 90/101/113 NonDioxin 15,900 19,100 14,100 16,500 24,800 25,100 21,000 21,600

PCB 92 NonDioxin 4,530 3,630 2,760 3,410 5,740 7,350 6,400 5,800

PCB 93/95/98/100/102 NonDioxin 6,790 11,900 7,000 9,730 18,800 14,500 11,900 12,600

PCB 94 NonDioxin 22.8 121 62 136 341 40.5 38.3 124

Page 108: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

GC-TI327-XAE

GC-TI403-SB-FI-1GC-TI402-XAE-FI-1 GC-TI402-XAE-FI-2GC-TI401-WP-FI-1 GC-TI401-WP-FI-2GC-TI401-SB-FI-1 GC-TI401-SB-FI-2GC-TI327-XAE-FI-1

American Eel

GC-TI403-SBGC-TI402-XAE GC-TI402-XAEGC-TI401-WP GC-TI401-WPGC-TI401-SB GC-TI401-SB

American Eel American Eel Striped Bass

Fillet FilletFillet

White Perch White PerchStriped Bass Striped Bass

FilletFillet FilletFillet Fillet

PCB 96 NonDioxin 12.9 88.2 56.9 70.5 169 21.8 11.8 101

PCB 103 NonDioxin 9.34 458 252 326 597 59.9 24.9 540

PCB 104 NonDioxin 2.29 U 19.3 13.1 15.2 27.8 2.28 U 2.32 U 16.6

PCB 106 NonDioxin 2.29 U 2.27 U 4.36 U 2.03 U 3.93 U 2.28 U 14.8 U 2.31 U

PCB 107 NonDioxin 985 1,300 1,070 1,380 1,600 527 -- 1,590

PCB 107/124 NonDioxin -- -- -- -- -- -- 170 --

PCB 108/124 NonDioxin 150 304 342 402 515 104 -- 319

PCB 109 NonDioxin -- -- -- -- -- -- 678 --

PCB 110/115 NonDioxin 14,600 13,300 10,500 12,500 20,700 40,700 25,400 17,100

PCB 111 NonDioxin 77.2 35.5 R 21 32.8 57.2 59.6 67.4 73.3

PCB 112 NonDioxin 2.29 U 2.27 U 2.27 U 3.96 U 3.93 U 2.28 U 2.32 U 3.08 U

PCB 120 NonDioxin 342 149 90.4 143 205 202 219 260

PCB 121 NonDioxin 35.2 19.6 11 16.6 31 31.1 30 34.3

PCB 122 NonDioxin 58.1 66.5 84.3 109 159 99.6 58.4 94.7

PCB 127 NonDioxin 2.29 U 30.4 21.3 2.03 U 3.93 U 42.5 53.4 48.4

PCB 128/166 NonDioxin 5,820 2,870 2,060 2,360 2,990 9,020 6,600 4,910

PCB 129/138/160/163 NonDioxin 43,700 21,400 14,800 20,600 22,800 68,300 48,500 33,600

PCB 130 NonDioxin 1,540 1,030 752 933 1,260 2,970 2,250 1,900

PCB 131 NonDioxin 40.9 136 101 133 163 129 119 154

PCB 132 NonDioxin 1,870 3,350 2,440 3,380 4,790 5,950 5,010 4,460

PCB 133 NonDioxin 1,130 445 293 501 721 1,120 972 987

PCB 134/143 NonDioxin 516 1,620 956 1,460 944 1,680 1,300 897

PCB 135/151/154 NonDioxin 4,120 6,460 4,500 6,450 8,390 9,170 6,620 8,340

PCB 136 NonDioxin 613 1,620 899 1,320 2,130 2,450 1,750 1,870

PCB 137 NonDioxin 1,490 790 653 819 949 1,680 1,190 1,440

PCB 139/140 NonDioxin 605 382 276 366 477 923 766 610

PCB 141 NonDioxin 2,080 1,670 1,810 2,150 2,470 6,200 4,070 2,800

PCB 142 NonDioxin 2.63 U 2.27 U 2.27 U 2.03 U 5.82 2.28 U 3.45 U 2.31 U

PCB 144 NonDioxin 228 744 553 700 695 529 419 719

PCB 145 NonDioxin 2.29 U 3.6 2.83 3.27 R 5.17 2.28 U 2.32 U 4.69

PCB 146 NonDioxin 10,100 4,410 3,170 5,080 5,860 10,600 9,790 9,030

PCB 147/149 NonDioxin 10,400 15,500 10,200 13,400 17,300 38,900 27,800 19,600

PCB 148 NonDioxin 191 115 62.6 100 155 192 167 207

PCB 150 NonDioxin 2.29 U 105 53.9 77.2 120 25.9 11.2 109

PCB 152 NonDioxin 2.29 U 21.8 13.4 18.8 33.7 6.89 3.1 23.6

PCB 153/168 NonDioxin 71,300 25,000 17,500 25,100 26,400 73,700 52,900 41,100

PCB 155 NonDioxin 114 50.2 48.5 84.7 90.5 76 102 60.5

PCB 158 NonDioxin 3,430 1,710 1,320 1,690 1,540 6,440 4,870 2,380

PCB 159 NonDioxin 54.1 61.7 55.6 78.5 104 191 124 114

PCB 161 NonDioxin 2.29 U 2.27 U 2.27 U 2.03 U 3.93 U 2.28 U 2.47 U 2.31 U

PCB 162 NonDioxin 125 54.5 47.2 R 98.7 R 122 R 89.3 67.7 99.2

PCB 164 NonDioxin 687 582 578 818 1,160 2,040 1,530 1,120

PCB 165 NonDioxin 83.7 36.3 19.3 32.3 58 58.1 69.5 83.9

Page 109: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

GC-TI327-XAE

GC-TI403-SB-FI-1GC-TI402-XAE-FI-1 GC-TI402-XAE-FI-2GC-TI401-WP-FI-1 GC-TI401-WP-FI-2GC-TI401-SB-FI-1 GC-TI401-SB-FI-2GC-TI327-XAE-FI-1

American Eel

GC-TI403-SBGC-TI402-XAE GC-TI402-XAEGC-TI401-WP GC-TI401-WPGC-TI401-SB GC-TI401-SB

American Eel American Eel Striped Bass

Fillet FilletFillet

White Perch White PerchStriped Bass Striped Bass

FilletFillet FilletFillet Fillet

PCB 170 NonDioxin 5,240 2,200 1,770 2,820 2,800 9,430 5,380 3,900

PCB 171/173 NonDioxin 2,110 1,100 725 1,110 1,040 3,990 2,890 1,560

PCB 172 NonDioxin 962 388 334 567 647 1,630 958 806

PCB 174 NonDioxin 994 1,120 1,010 1,380 1,850 3,590 2,390 1,870

PCB 175 NonDioxin 395 193 137 216 194 612 429 287

PCB 176 NonDioxin 78.3 365 212 282 324 371 273 341

PCB 177 NonDioxin 2,420 1,900 1,220 1,330 1,840 7,220 5,160 2,720

PCB 178 NonDioxin 2,850 1,110 730 1,310 1,370 3,280 2,490 1,920

PCB 179 NonDioxin 910 1,240 801 1,190 1,430 1,930 1,490 1,260

PCB 180/193 NonDioxin 19,000 7,480 5,860 8,940 8,500 26,200 16,800 12,600

PCB 181 NonDioxin 64.9 39.1 27.4 41 54.4 108 90.1 66.5

PCB 182 NonDioxin 61.3 41 27.3 42.4 58.8 74.9 68.4 78.2

PCB 183/185 NonDioxin 7,510 3,590 2,320 3,790 3,210 11,900 8,470 4,990

PCB 184 NonDioxin 55.4 22.8 11.7 29.2 29.7 41.1 50.3 28.6

PCB 186 NonDioxin 2.29 U 2.27 U 2.27 U 2.03 U 3.93 U 2.28 U 2.32 U 2.31 U

PCB 187 NonDioxin 16,900 8,580 5,570 8,360 9,080 22,900 17,500 12,200

PCB 188 NonDioxin 89.1 51.2 26 43 53.3 66.6 79.8 65.6

PCB 190 NonDioxin 1,310 650 463 691 657 2,590 1,900 1,010

PCB 191 NonDioxin 298 129 100 150 125 527 342 193

PCB 192 NonDioxin 2.29 U 2.27 U 2.27 U 5.43 4.01 2.28 U 2.32 U 2.31 U

PCB 194 NonDioxin 2,770 742 825 1,360 1,360 2,820 1,890 1,960

PCB 195 NonDioxin 733 382 308 471 461 1,590 1,050 640

PCB 196 NonDioxin 1,490 628 495 789 767 2,200 1,590 1,080

PCB 197/200 NonDioxin 341 155 105 155 174 337 334 246

PCB 198/199 NonDioxin 3,570 1,290 1,080 1,720 1,960 3,880 3,200 2,720

PCB 201 NonDioxin 713 270 188 309 300 579 519 460

PCB 202 NonDioxin 2,470 700 511 922 960 1,220 1,390 1,420

PCB 203 NonDioxin 2,840 1,230 887 1,460 1,530 3,560 3,280 2,200

PCB 204 NonDioxin 5.93 2.6 R 2.27 U 5.18 6.73 4.58 5.59 4.9

PCB 205 NonDioxin 111 51.4 38.6 66.2 66.6 190 133 95.3

PCB 206 NonDioxin 1,800 611 521 816 1,200 1,400 1,610 1,300

PCB 207 NonDioxin 219 96.1 75.8 125 165 207 236 186

PCB 208 NonDioxin 847 272 234 287 431 473 576 598

PCB 209 NonDioxin 869 286 264 448 606 496 759 585

PCB Nondioxin 424,000 348,000 244,000 302,000 437,000 684,000 480,000 409,000

Total PCB Congeners 475,000 369,000 263,000 324,000 462,000 746,000 519,000 435,000

Page 110: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

PCB 36 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

32.9 0.00329 33.6 0.00336 31.1 0.00311 301 J 0.0301 287 0.0287 50.8 0.00508

2.29 U 0 5.25 U 0 2.26 U 0 28.2 R 0.00846 17.1 R 0.00513 8.95 R 0.002685

22,200 0.666 14,100 0.423 17,300 0.519 4,990 J 0.1497 4,670 0.1401 33,400 1.002

1,190 0.0357 827 0.02481 1,030 0.0309 412 J 0.01236 375 0.01125 1,970 0.0591

35,800 1.074 34,600 1.038 32,500 0.975 15,700 J 0.471 14,600 0.438 73,800 2.214

1,110 0.0333 816 0.02448 901 0.02703 315 J 0.00945 248 0.00744 1,840 0.0552

88.7 8.87 51.7 5.17 72.7 7.27 35.4 J 3.54 21.1 2.11 101 10.1

8,430 0.2529 5,090 0.1527 6,770 0.2031 2,050 J 0.0615 2,050 0.0615 13,800 0.414

3,620 0.1086 2,130 0.0639 2,850 0.0855 914 J 0.02742 937 0.02811 7,080 0.2124

76 U 0 21.3 U 0 55.6 U 0 19.5 U 0 20.6 U 0 70.7 U 0

485 0.01455 346 0.01038 388 0.01164 136 J 0.00408 136 0.00408 1,200 0.036

11.1 6.91 9.13 4.31 2.83 14.1

12.8 9.06 9.54 6.63 J 4.84 3.03

2.29 U 2.3 U 2.26 U 2.29 U 2.32 U 2.28 U

2.44 R 2.46 2.26 U 2.46 J 2.32 U 2.28 U

159 88 92.2 340 J 196 129

2.29 U 2.3 U 2.26 U 4.23 R 2.69 R 2.28 U

10.8 6.55 7.8 60.4 J 56.7 5.28

2.29 U 2.3 U 2.26 U 8.59 J 6.48 2.28 U

34.1 18.6 23.7 281 J 194 34.1

3.25 2.3 U 2.93 14.4 J 11.5 2.57

45.7 U 6.72 9.35 34.8 J 18.3 10.7

61.6 40.1 38.8 39.1 J 24 47.4

12.3 8.71 8.6 15.4 J 10.3 R 12.2

2.29 U 2.3 U 2.26 U 2.29 U 2.32 U 2.28 U

123 79.7 102 104 J 66 160

59.6 24.5 33.9 U 576 J 306 63.2

174 87.9 82.9 1,360 J 816 139

606 392 344 2,110 J 1,410 449

218 131 116 349 J 200 167

8,510 5,270 5,810 6,550 J 4,410 10,200

91.4 U 18.6 67.8 U 693 J 407 46.1

795 407 323 1,230 J 880 359

45.7 U 2.3 U 33.9 U 3.98 J 3.34 2.28 U

45.7 U 8.28 33.9 U 29.8 J 19.9 11.6

213 101 119 477 J 374 72.3

1,190 660 882 1,130 J 833 1,280

107 58.1 61.2 356 J 218 61.3

3,030 1,630 2,250 3,670 J 2,300 3,780

543 270 306 1,140 J 722 301

45.7 U 21.7 33.9 U 39.8 J 36.5 10.4

45.7 U 2.3 U 33.9 U 2.29 U 2.32 U 2.28 U

45.7 U 2.3 U 33.9 U 2.29 U 2.32 U 2.28 U

GC-TI406-XAE-FI-1GC-TI406-SB-FI-1 GC-TI406-SB-FI-2GC-TI403-XAE-FI-1 GC-TI403-XAE-FI-2 GC-TI403-XAE-FI-3

GC-TI406-XAEGC-TI406-SB GC-TI406-SBGC-TI403-XAE GC-TI403-XAE GC-TI403-XAE

American EelAmerican EelAmerican Eel American Eel Striped Bass Striped Bass

FilletFillet FilletFillet Fillet Fillet

Page 111: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 86/87/97/108/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

PCB 94 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

GC-TI406-XAE-FI-1GC-TI406-SB-FI-1 GC-TI406-SB-FI-2GC-TI403-XAE-FI-1 GC-TI403-XAE-FI-2 GC-TI403-XAE-FI-3

GC-TI406-XAEGC-TI406-SB GC-TI406-SBGC-TI403-XAE GC-TI403-XAE GC-TI403-XAE

American EelAmerican EelAmerican Eel American Eel Striped Bass Striped Bass

FilletFillet FilletFillet Fillet Fillet

230 134 223 306 J 273 288

64.8 24.6 59.2 12.4 J 16.8 61.2

45.7 U 3.38 33.9 U 44.3 J 40.6 2.28 U

2,060 1,310 1,410 3,790 J 4,430 1,810

3,490 2,770 1,970 1,820 J 1,780 2,840

156 67.5 200 333 J 344 38.3

26,700 24,700 21,900 10,100 J 10,300 38,700

535 649 589 1,080 J 937 438

89.9 50 48.5 214 J 146 63.4

142 94.6 67.9 1,120 J 1,010 61.7

7,200 6,900 5,250 7,500 J 9,010 4,360

1,200 768 688 1,000 J 900 394

43,900 36,300 38,500 11,200 J 11,200 39,800

15 11.6 8.48 27.4 J 16.7 13.9

2.29 U 12.8 R 2.26 U 2.29 U 2.32 U 32.7

246 160 99.9 1,620 J 1,700 81.4

83.4 47.6 63.4 75.3 J 122 57.5

161 92.6 137 40 J 70.2 156

3,500 2,640 2,950 967 J 1,010 4,340

4,370 2,620 3,540 2,090 J 1,370 6,520

7,680 5,740 7,300 11,300 J 9,860 22,100

1,660 942 1,400 668 J 824 1,440

13,600 12,300 12,000 3,220 J 3,150 20,200

12,600 10,000 11,300 9,570 J 7,960 27,700

137 88.9 104 199 J 229 102

398 239 331 195 J 310 284

440 289 447 277 J 485 522

2.29 U 59.6 171 2.29 U 2.32 U 26.7

50.2 5.54 U 50.5 12.9 J 19.8 48.4

379 175 203 133 J 187 129

2.29 U 4.9 U 2.26 U 2.29 U 2.32 U 6.81 U

1,220 860 806 620 J 794 1,280

33,200 31,700 31,800 16,100 J 17,500 58,500

5,620 3,610 4,600 1,320 J 1,660 3,130

10,400 8,440 8,910 3,360 J 3,840 13,300

14,200 -- 9,180 7,030 J 8,290 --

-- 9,860 -- -- -- 9,190

5,400 4,310 4,230 2,040 J 3,360 3,580

10.7 8.92 10.2 R 48.9 J 55.1 7.9

43,900 30,200 35,600 14,500 J 19,800 30,600

7,850 7,200 8,060 3,370 J 4,990 7,430

26,300 16,700 20,800 7,430 J 9,140 10,700

98.3 104 134 47.8 J 55.3 31

Page 112: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 107/124 NonDioxin

PCB 108/124 NonDioxin

PCB 109 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

GC-TI406-XAE-FI-1GC-TI406-SB-FI-1 GC-TI406-SB-FI-2GC-TI403-XAE-FI-1 GC-TI403-XAE-FI-2 GC-TI403-XAE-FI-3

GC-TI406-XAEGC-TI406-SB GC-TI406-SBGC-TI403-XAE GC-TI403-XAE GC-TI403-XAE

American EelAmerican EelAmerican Eel American Eel Striped Bass Striped Bass

FilletFillet FilletFillet Fillet Fillet

46.1 36.5 29.7 49.5 J 74.8 21.3

108 80.2 40.3 366 J 540 20

3.06 2.3 U 2.26 U 10.8 J 16.7 2.28 U

2.74 U 19.4 U 2.26 U 2.29 U 2.32 U 42.8 U

1,350 -- 1,010 1,290 J 1,720 --

-- 118 -- -- -- 178

248 -- 181 338 J 348 --

-- 771 -- -- -- 1,190

43,700 33,100 38,600 9,630 J 14,100 36,100

88 85.8 85.5 34.8 J 61.9 181

2.29 U 2.3 U 2.26 U 2.29 U 2.32 U 2.28 U

348 292 326 175 J 249 736

52.4 43.6 49.6 19.1 J 30 96.6

150 111 116 71 J 77.5 129

154 51.6 2.26 U 36.1 J 54.5 189

14,100 9,390 12,600 3,250 J 4,210 18,000

111,000 77,600 92,700 24,600 J 29,800 141,000

4,730 3,630 3,940 874 J 1,360 5,280

344 172 226 82.5 J 129 96.3

8,440 5,310 7,920 2,210 J 3,380 3,930

1,720 1,430 1,470 485 J 789 2,870

2,670 1,810 2,240 401 J 604 1,700

22,000 9,250 23,300 7,030 J 8,770 10,100

4,660 2,580 3,730 1,050 J 1,560 1,570

4,150 2,350 3,340 1,110 J 1,330 5,220

1,530 1,060 1,260 443 J 587 1,790

7,890 4,360 6,850 2,290 J 2,780 9,490

2.29 U 3.59 U 2.26 U 2.29 U 2.32 U 4.92 U

1,170 667 789 653 J 770 346

2.29 U 2.3 U 2.26 U 2.29 U 3.1 2.28 U

17,100 14,100 14,400 5,260 J 8,360 29,700

70,000 41,400 59,100 12,300 J 16,300 34,300

327 249 305 127 J 208 508

41.1 29.6 19.8 97.9 J 154 8.04

7 8.81 11.1 12.9 J 24.3 2.64

116,000 89,100 105,000 36,200 J 37,000 219,000

126 397 123 64.7 J 80.9 413

9,310 6,600 8,260 2,030 J 2,010 11,800

224 42.9 209 69.4 J 100 196

2.29 U 2.57 U 2.26 U 2.29 U 2.32 U 3.58 U

213 92.3 140 79.9 J 104 305

2,370 1,360 1,950 650 J 1,060 2,930

83.3 76.2 74.4 36.9 J 70.4 189

Page 113: Appendix L HHRA Combined

TABLE 2.8 Supplement a

PCB Congener Concentrations (ng/kg) in Large Fish Species– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

GC-TI406-XAE-FI-1GC-TI406-SB-FI-1 GC-TI406-SB-FI-2GC-TI403-XAE-FI-1 GC-TI403-XAE-FI-2 GC-TI403-XAE-FI-3

GC-TI406-XAEGC-TI406-SB GC-TI406-SBGC-TI403-XAE GC-TI403-XAE GC-TI403-XAE

American EelAmerican EelAmerican Eel American Eel Striped Bass Striped Bass

FilletFillet FilletFillet Fillet Fillet

14,800 8,330 12,000 4,060 J 4,130 27,200

6,550 3,850 5,360 1,420 J 1,550 8,160

2,400 1,590 1,900 669 J 882 5,190

4,150 1,700 3,700 1,170 J 1,700 4,490

919 626 757 242 J 291 1,450

850 470 585 261 J 317 225

9,830 7,250 8,750 1,570 J 2,010 11,900

4,360 3,970 3,500 1,310 J 1,710 8,320

3,130 2,370 3,010 1,120 J 1,270 2,480

39,600 24,800 33,200 12,300 J 12,200 99,800

193 98.5 155 54.2 J 68.8 324

126 77.1 107 48.9 J 82.1 204

18,000 11,800 15,200 4,740 J 4,850 28,200

77.2 90.2 66.1 20.6 J 27.4 129

2.29 U 2.3 U 2.26 U 2.29 U 2.32 U 2.28 U

35,900 25,900 29,500 8,870 J 11,400 67,800

117 113 110 71.8 J 84.2 397

4,470 2,810 3,810 984 J 949 6,320

866 561 734 210 J 195 1,560

2.29 U 3.08 2.26 U 2.29 U 2.32 U 2.28 U

4,270 3,840 3,980 1,570 J 1,590 12,100

2,690 1,700 2,180 602 J 648 3,640

3,630 2,840 2.26 U 978 J 1,090 8,040

635 538 525 167 J 244 975

5,910 5,550 5,110 1,720 J 2,560 17,000

937 1,130 730 329 J 436 2,390

1,460 2,820 1,460 862 J 1,250 6,790

6,250 5,000 5,300 1,660 J 2,100 13,600

7.84 8.75 6.27 2.9 J 5.42 19.3

345 242 278 76 J 81.2 539

2,420 2,730 2,180 845 J 1,040 6,190

338 394 318 127 J 167 844

754 987 688 344 J 504 2,870

764 1,280 637 396 J 470 2,950

918,000 665,000 782,000 308,000 345,000 1,220,000

991,000 723,000 844,000 332,000 369,000 1,350,000

Page 114: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

PCB 77 Dioxin 0.0001 1,010 0.101 335 0.0335 514 0.0514 598 0.0598 702 0.0702 464 0.0464 629 0.0629 681

PCB 81 Dioxin 0.0003 45.8 0.01374 19.6 0.00588 26.6 0.00798 29.8 0.00894 33.9 0.01017 27.5 0.00825 32.6 0.00978 34.8

PCB 105 Dioxin 0.00003 6,150 0.1845 2,600 0.078 3,200 0.096 3,980 0.1194 4,320 0.1296 2,370 0.0711 3,780 0.1134 3,870

PCB 114 Dioxin 0.00003 466 0.01398 194 0.00582 215 0.00645 300 0.009 310 0.0093 179 0.00537 260 0.0078 293

PCB 118 Dioxin 0.00003 20,300 0.609 8,380 0.2514 9,730 0.2919 13,000 0.39 13,700 0.411 6,980 0.2094 10,700 0.321 12,300

PCB 123 Dioxin 0.00003 410 0.0123 181 0.00543 213 0.00639 270 0.0081 288 0.00864 175 0.00525 237 0.00711 268

PCB 126 Dioxin 0.1 60 6 19.6 1.96 27.6 2.76 35.3 3.53 39.9 3.99 24.7 2.47 31.5 3.15 38.7

PCB 156/157 Dioxin 0.00003 2,750 0.0825 1,140 0.0342 1,200 0.036 1,770 0.0531 1,790 0.0537 917 0.02751 1,290 0.0387 1,650

PCB 167 Dioxin 0.00003 1,330 0.0399 523 0.01569 604 0.01812 837 0.02511 880 0.0264 434 0.01302 600 0.018 790

PCB 169 Dioxin 0.03 12.1 U 0 6.03 U 0 6.63 U 0 0 U 0 0 U 0 5.18 U 0 5.37 U 0 0 U

PCB 189 Dioxin 0.00003 219 0.00657 76.9 0.002307 91.4 0.002742 132 0.00396 140 0.0042 68 0.00204 90.8 0.002724 128

PCB Dioxin 7.06 2.39 3.28 4.21 4.71 2.86 3.73 4.53

PCB 1 NonDioxin 11.9 5.94 4.33 8.26 7.2 2.31 U 3.4 4.73 U

PCB 2 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 3 NonDioxin 14 5.89 4.02 9.04 7.81 2.31 U 2.29 U 5.57 U

PCB 4 NonDioxin 40.9 21.3 16.8 28.9 25.9 6 16.4 19.9

PCB 5 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 6 NonDioxin 17.7 9.29 7.6 12.6 11.4 3.37 5.8 9.07

PCB 7 NonDioxin 7.32 3.61 2.32 U 5.05 2.78 U 2.31 U 2.29 U 2.91 U

PCB 8 NonDioxin 78.6 35.6 30.1 52.3 48.5 11.7 19 38.3

PCB 9 NonDioxin 5.6 2.5 2.32 U 3.71 2.13 U 2.31 U 2.29 U 2.23 U

PCB 10 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 11 NonDioxin 87.6 38.6 57.7 57.7 69.1 21 47.8 47.5

PCB 12/13 NonDioxin 15 7.34 10.9 10.5 12.6 7.67 8.23 10.7

PCB 14 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 15 NonDioxin 670 275 437 429 525 443 677 533

PCB 16 NonDioxin 21.3 8.5 6.34 13.5 12 2.6 7.33 10

PCB 17 NonDioxin 40.8 20.5 21 28.4 28.5 10.2 20.3 22.4

PCB 18/30 NonDioxin 62.6 24.2 24.1 46.6 46 10.7 31.7 39

PCB 19 NonDioxin 8.38 4.32 3.34 5.9 5.25 2.31 U 5.35 3.33 U

PCB 20/28 NonDioxin 8,320 4,010 5,410 5,690 6,510 4,910 7,380 6,270

PCB 21/33 NonDioxin 63.3 26.8 29.7 43.8 45.2 27.3 29.1 44.5

PCB 22 NonDioxin 59.8 24.1 36.1 38 45.1 18.5 23 34.9

PCB 23 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 24 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 25 NonDioxin 35.2 13.2 14.9 21.8 22.6 8.8 12.7 19.3

PCB 26/29 NonDioxin 50.7 18.4 19.3 40 40.1 9.35 22.3 35.1

PCB 27 NonDioxin 9.19 3.99 5.88 9.67 10.7 2.4 5.41 8.84

PCB 31 NonDioxin 231 81.5 72.3 140 133 37.9 68.7 115

PCB 32 NonDioxin 40.7 19.7 30.4 35.8 42.1 19.6 22.7 36.1

PCB 34 NonDioxin 4.59 U 2.28 U 3.63 2.7 U 4.89 2.31 U 2.29 U 2.76 U

PCB 35 NonDioxin 4.59 U 2.28 U 2.32 U 0 R 0 R 2.31 U 2.29 U 0 R

GC-TI401-402-BC-HP-1 GC-TI401-BC-ED-1 GC-TI401-BC-ED-2 GC-TI401-BC-WB-1 GC-TI401-BC-WB-2 GC-TI402-BC-ED-1 GC-TI402-BC-ED-2 GC-TI402-BC-WB-1

GC-TI401-402-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI402-BC GC-TI402-BC GC-TI402-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabHepatopancreas Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body

Page 115: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI401-402-BC-HP-1 GC-TI401-BC-ED-1 GC-TI401-BC-ED-2 GC-TI401-BC-WB-1 GC-TI401-BC-WB-2 GC-TI402-BC-ED-1 GC-TI402-BC-ED-2 GC-TI402-BC-WB-1

GC-TI401-402-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI402-BC GC-TI402-BC GC-TI402-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabHepatopancreas Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body

PCB 36 NonDioxin 4.59 U 2.28 U 5.46 0 U 3.39 2.31 U 2.29 U 0 U

PCB 37 NonDioxin 1,560 585 827 964 1,110 945 1,240 1,190

PCB 38 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 39 NonDioxin 7.61 4.29 5.59 5.58 6.36 2.42 5.24 4.48

PCB 40/41/71 NonDioxin 217 50 139 223 275 92.6 63.7 253

PCB 42 NonDioxin 58.2 27.2 26.3 39.3 38.4 13.8 24.7 31.5

PCB 43 NonDioxin 9.78 2.66 5.93 11 12.9 5.38 8.34 12.9

PCB 44/47/65 NonDioxin 7,790 4,740 5,270 5,930 6,230 3,490 6,260 5,200

PCB 45/51 NonDioxin 10.3 5.14 5.78 7.15 7.5 4.62 U 10.8 4.09

PCB 46 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 48 NonDioxin 21.7 6.81 8.88 17 18 5.59 12.5 16.4

PCB 49/69 NonDioxin 220 80.1 46.3 135 112 18.6 47.7 98.7

PCB 50/53 NonDioxin 11 4.55 U 4.63 U 8.01 7.82 4.62 U 8.26 8.19

PCB 52 NonDioxin 144 48.3 42.3 133 127 19.8 65.8 118

PCB 54 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 55 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 56 NonDioxin 113 30.7 42.3 66.2 72.6 20.2 28.1 60.7

PCB 57 NonDioxin 5.63 2.28 U 2.32 U 6.46 6.3 2.31 U 2.29 U 6.6

PCB 58 NonDioxin 7.99 3.07 3.83 6.12 6.51 2.31 U 2.29 U 4.33

PCB 59/62/75 NonDioxin 470 335 332 388 384 213 412 315

PCB 60 NonDioxin 4.59 U 1,050 1,480 1,030 1,290 1,540 2,020 1,320

PCB 61/70/74/76 NonDioxin 7,530 3,280 4,370 4,930 5,570 3,450 5,260 5,070

PCB 63 NonDioxin 117 53.3 49.5 78.1 75.1 23.3 44.4 60.5

PCB 64 NonDioxin 108 54 39.6 75 65.6 23.7 46.4 57.2

PCB 66 NonDioxin 11,000 4,710 6,780 7,160 8,380 5,510 8,500 7,690

PCB 67 NonDioxin 4.59 U 6.81 6.6 12.6 12.3 2.57 6.58 10.1

PCB 68 NonDioxin 66 34.9 37.5 47 48.3 16.3 30.7 36.1

PCB 72 NonDioxin 31 13.7 15.3 21.7 22.5 5.71 10.3 17.1

PCB 73 NonDioxin 7.06 3.86 9.75 7.77 11.3 2.47 2.77 7.01

PCB 78 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 79 NonDioxin 22.6 17.3 20.4 19.4 21.2 12.8 21.5 16.7

PCB 80 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 82 NonDioxin 14.6 6.99 6.1 9.95 9.33 4.2 8.63 8.33

PCB 83/99 NonDioxin 16,300 8,900 9,700 11,800 12,200 6,650 10,500 10,500

PCB 84 NonDioxin 16.1 8.99 12.1 11.9 13.8 11.5 18.1 13.5

PCB 85/116/117 NonDioxin 2,450 1,370 1,530 1,790 1,880 1,140 1,800 1,660

PCB 86/87/97/109/119/125 NonDioxin 1,230 678 722 893 915 488 798 783

PCB 88/91 NonDioxin 63.1 32.3 30.8 44.3 43.1 17.5 39.3 35.6

PCB 89 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 90/101/113 NonDioxin 907 353 257 568 504 102 240 422

PCB 92 NonDioxin 132 40.1 30.7 116 108 11.7 31.5 100

PCB 93/95/98/100/102 NonDioxin 744 353 440 505 555 328 592 493

Page 116: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI401-402-BC-HP-1 GC-TI401-BC-ED-1 GC-TI401-BC-ED-2 GC-TI401-BC-WB-1 GC-TI401-BC-WB-2 GC-TI402-BC-ED-1 GC-TI402-BC-ED-2 GC-TI402-BC-WB-1

GC-TI401-402-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI402-BC GC-TI402-BC GC-TI402-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabHepatopancreas Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body

PCB 94 NonDioxin 8.16 4.28 14.3 9.34 15.4 5.08 6.2 9.94

PCB 96 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 103 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 104 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 106 NonDioxin 5.16 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 107 NonDioxin 633 275 330 414 445 187 300 364

PCB 108/124 NonDioxin 31.2 6.89 8.39 17.4 18 4.62 U 6.13 13.4

PCB 110/115 NonDioxin 813 355 304 533 497 222 364 457

PCB 111 NonDioxin 45.3 21.6 16.7 30.8 27.6 11.3 21 24.8

PCB 112 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 120 NonDioxin 175 101 101 130 129 65.4 102 109

PCB 121 NonDioxin 20.2 11.2 11.1 14.7 14.6 6.49 12.4 11.9

PCB 122 NonDioxin 5.99 U 2.28 U 2.32 U 3.28 U 3.2 U 2.31 U 2.29 U 3.35 U

PCB 127 NonDioxin 27.7 2.28 U 2.32 U 10.8 R 10.5 R 2.31 U 2.29 U 11 R

PCB 128/166 NonDioxin 2,450 1,290 1,430 1,740 1,820 1,040 1,560 1,600

PCB 129/138/160/163 NonDioxin 22,200 10,100 11,100 14,800 15,300 7,530 12,200 13,400

PCB 130 NonDioxin 313 123 110 197 187 44.2 84.3 151

PCB 131 NonDioxin 4.59 U 2.72 4.23 1.66 2.62 2.49 3.61 1.5

PCB 132 NonDioxin 28.9 9.2 4.3 16.9 13.6 2.68 8.6 13.1

PCB 133 NonDioxin 553 312 246 406 363 168 316 321

PCB 134/143 NonDioxin 9.19 U 4.55 U 4.63 U 0 U 0 U 4.62 U 4.57 U 0 U

PCB 135/151/154 NonDioxin 1,640 737 891 1,090 1,180 686 945 1,070

PCB 136 NonDioxin 7.54 4.52 4.36 5.69 5.57 3.43 9.86 5.06

PCB 137 NonDioxin 1,150 579 515 801 756 414 612 707

PCB 139/140 NonDioxin 449 238 251 320 326 189 281 292

PCB 141 NonDioxin 86.3 42.6 17 59.6 43.3 11.9 21.7 41.5

PCB 142 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 144 NonDioxin 32 12.3 10.9 20 18.9 7.08 12.8 17

PCB 145 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 146 NonDioxin 4,690 2,330 2,360 3,250 3,240 1,430 2,230 2,730

PCB 147/149 NonDioxin 1,040 413 350 657 612 163 351 512

PCB 148 NonDioxin 117 71.1 73.1 89 89.8 52.8 80.2 78.3

PCB 150 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 152 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 153/168 NonDioxin 40,900 18,300 21,100 27,100 28,600 14,200 19,500 24,800

PCB 155 NonDioxin 48.7 26.5 39.4 35.1 42.9 26.3 57.7 35.2

PCB 158 NonDioxin 2,720 1,100 1,240 1,730 1,800 986 1,400 1,680

PCB 159 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 161 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 162 NonDioxin 84.2 34.3 38 53.7 55.5 26.5 38.8 49.4

PCB 164 NonDioxin 4.59 U 25.6 11 29.5 20.4 3.27 6.22 16.2

PCB 165 NonDioxin 30.3 19.3 14.1 23.6 20.2 8.71 17.3 17.3

Page 117: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI401-402-BC-HP-1 GC-TI401-BC-ED-1 GC-TI401-BC-ED-2 GC-TI401-BC-WB-1 GC-TI401-BC-WB-2 GC-TI402-BC-ED-1 GC-TI402-BC-ED-2 GC-TI402-BC-WB-1

GC-TI401-402-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI401-BC GC-TI402-BC GC-TI402-BC GC-TI402-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabHepatopancreas Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body

PCB 170 NonDioxin 4,130 1,170 1,310 2,320 2,380 1,200 1,630 2,360

PCB 171/173 NonDioxin 1,480 581 730 931 1,010 583 803 940

PCB 172 NonDioxin 807 267 222 477 444 199 314 441

PCB 174 NonDioxin 55.3 22.7 9.65 35.4 27 5.93 14.2 25.6

PCB 175 NonDioxin 209 88.1 98.5 135 140 70.3 108 125

PCB 176 NonDioxin 12 5.43 4.72 7.99 7.48 3.09 6.36 6.63

PCB 177 NonDioxin 1,260 282 270 662 646 117 209 571

PCB 178 NonDioxin 1,330 709 654 951 911 467 783 810

PCB 179 NonDioxin 17.8 6.83 2.81 11.1 8.5 2.31 U 4.11 7.08

PCB 180/193 NonDioxin 14,900 5,340 6,390 9,060 9,620 4,680 6,640 8,740

PCB 181 NonDioxin 54.2 28 26.4 38.2 37 21.6 33.2 34.6

PCB 182 NonDioxin 37.8 28.3 22 32 28 15.4 26.4 24.3

PCB 183/185 NonDioxin 5,200 2,100 2,590 3,310 3,580 1,810 2,580 3,160

PCB 184 NonDioxin 16.1 12.6 14.6 14 15.2 8.92 16.2 11.8

PCB 186 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 187 NonDioxin 9,810 4,410 5,150 6,510 6,920 2,820 4,440 5,600

PCB 188 NonDioxin 60.4 34.1 44 44.3 50.2 32.5 45.9 43.6

PCB 190 NonDioxin 1,190 376 435 693 722 345 492 681

PCB 191 NonDioxin 261 87.3 105 155 164 85.7 122 155

PCB 192 NonDioxin 4.59 U 2.28 U 2.32 U 0 U 0 U 2.31 U 2.29 U 0 U

PCB 194 NonDioxin 1,760 629 647 1,070 1,070 520 686 1,010

PCB 195 NonDioxin 571 157 160 318 316 167 228 328

PCB 196 NonDioxin 1,170 477 467 747 734 368 567 687

PCB 197/200 NonDioxin 144 73.4 79.3 101 104 47.9 82 86.1

PCB 198/199 NonDioxin 2,210 842 680 1,370 1,260 634 862 1,260

PCB 201 NonDioxin 312 143 167 209 222 104 150 187

PCB 202 NonDioxin 728 486 446 580 553 314 418 479

PCB 203 NonDioxin 1,390 546 520 874 850 426 615 809

PCB 204 NonDioxin 4.59 U 2.48 2.32 U 1.52 0 U 2.31 U 2.72 0 U

PCB 205 NonDioxin 38.7 11.6 11.7 22.1 21.9 13 18.4 23.2

PCB 206 NonDioxin 472 260 238 342 327 303 314 370

PCB 207 NonDioxin 90.8 66.8 52.4 76.1 67 45.5 71.1 63.5

PCB 208 NonDioxin 248 227 150 235 187 183 208 209

PCB 209 NonDioxin 222 215 184 218 198 185 225 200

PCB Nondioxin 192,000 87,800 101,000 129,000 136,000 73,000 110,000 121,000

Total PCB Congeners 224,000 101,000 117,000 150,000 158,000 84,600 127,000 141,000

Page 118: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

0.0681 777 0.0777 378 0.0378 544 0.0544 701 0.0701 722 0.0722 816 0.0816 432 R 0.0432 360 R

0.01044 37.7 0.01131 21.5 0.00645 26.7 0.00801 38.7 0.01161 34 0.0102 41.3 0.01239 23.8 0.00714 20.4

0.1161 4,700 0.141 2,240 0.0672 3,330 0.0999 4,120 0.1236 4,400 0.132 4,880 0.1464 2,540 0.0762 1,920

0.00879 340 0.0102 153 0.00459 223 0.00669 279 0.00837 316 0.00948 349 0.01047 176 0.00528 137

0.369 14,400 0.432 6,410 0.1923 10,100 0.303 12,000 0.36 14,000 0.42 15,100 0.453 7,390 0.2217 5,450

0.00804 304 0.00912 139 0.00417 231 0.00693 263 0.00789 299 0.00897 318 0.00954 151 0.00453 132

3.87 42.6 4.26 22 2.2 30 3 37.8 3.78 41.4 4.14 46.1 4.61 20.8 2.08 16.5

0.0495 1,860 0.0558 928 0.02784 1,350 0.0405 1,650 0.0495 1,880 0.0564 2,060 0.0618 931 0.02793 702

0.0237 884 0.02652 471 0.01413 660 0.0198 745 0.02235 915 0.02745 963 0.02889 457 0.01371 346

0 0 U 0 6 U 0 6.84 U 0 8.24 U 0 0 U 0 0 U 0 4.46 U 0 3.69 U

0.00384 141 0.00423 71.1 0.002133 101 0.00303 109 0.00327 146 0.00438 150 0.0045 65.5 0.001965 56.3

5.03 2.56 3.54 4.44 4.88 5.42 2.44 1.92

6.71 4.62 U 3.05 2.3 U 6.42 4.43 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

5.45 U 4.62 U 2.32 U 2.3 U 5.33 U 5.21 U 2.3 U 2.31 U

25.9 12.8 12.7 12.2 23.4 22.9 15.4 17.3

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

10.4 11.3 5.07 6.59 9.88 10.7 14.4 13.8

2.85 U 4.62 U 2.32 U 2.3 U 2.79 U 2.73 U 2.3 U 2.31 U

42.2 34.2 17.9 20.4 41 42.1 40.2 33.4

2.18 U 4.62 U 2.32 U 2.3 U 2.13 U 2.09 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

63.3 63.1 60.2 50.1 70.6 64.1 60.5 36.5

11 15.4 11.3 19.2 12.9 17.8 24.1 24

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

674 312 597 928 625 832 506 439

12.8 12 4.63 5.68 11 11.5 7.44 7.68

28.3 29.9 16.1 24.1 25.5 30.3 48.4 41.8

51.2 81.9 17 33 41.7 51.2 65.9 44.4

6.53 4.62 U 3.36 3.24 5.27 5.15 3.99 6.46

7,750 3,390 5,930 7,400 6,840 7,740 4,580 4,430

45.2 70.6 31.4 36.6 R 46.3 26.3 R 51.6 44.9

37.3 51.8 26.1 40.8 38.9 47.9 83.2 56.1

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

21.5 27.1 10.1 20.2 19.7 25.8 39.7 31.3

42.4 74 13.3 27.3 36.4 44.7 62.1 39.9

10.5 18.6 4.08 6.7 9.61 11.1 16 11.1

132 170 51.1 117 120 159 216 125

37.6 61.1 19.8 32 35.5 42.8 79.1 56.3

2.7 U 6.94 2.94 2.96 4.46 4.44 6.48 4.06

0 R 4.93 R 2.32 U 2.7 0 R 1.69 R 5.06 2.82

GC-TI402-BC-WB-1 GC-TI402-BC-WB-2

GC-TI402-BC GC-TI402-BC GC-TI403-THRU-406-BC GC-TI403-BC GC-TI403-BC

GC-TI404-BC-ED-2GC-TI403-404-405-406-BC-HP-2GC-TI403-BC-ED-1 GC-TI403-BC-ED-2 GC-TI403-BC-WB-1 GC-TI403-BC-WB-2 GC-TI404-BC-ED-1

GC-TI403-BC GC-TI403-BC GC-TI404-BC GC-TI404-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible TissueWhole Body Whole Body Hepatopan Edible Tissue Edible Tissue

Page 119: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI402-BC-WB-1 GC-TI402-BC-WB-2

GC-TI402-BC GC-TI402-BC GC-TI403-THRU-406-BC GC-TI403-BC GC-TI403-BC

GC-TI404-BC-ED-2GC-TI403-404-405-406-BC-HP-2GC-TI403-BC-ED-1 GC-TI403-BC-ED-2 GC-TI403-BC-WB-1 GC-TI403-BC-WB-2 GC-TI404-BC-ED-1

GC-TI403-BC GC-TI403-BC GC-TI404-BC GC-TI404-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible TissueWhole Body Whole Body Hepatopan Edible Tissue Edible Tissue

0 U 4.62 U 3.7 3.38 2.29 2.12 4.64 2.31 U

1,360 673 986 1,390 1,200 1,450 834 776

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

6.16 4.71 4.38 4.71 5.61 5.79 7.01 3.38

232 496 80.8 112 239 255 287 153

37.7 32.3 20.3 35.6 34.7 44 70.1 42.3

14.5 24.2 4.58 7.05 12.1 13.4 17.8 12.4

6,860 2,540 5,250 6,180 6,220 6,780 3,270 3,040

10.6 9.38 4.86 8.9 6.93 9.42 22.2 12.6

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.81 3.14

20.4 32.9 6.33 14.8 16.5 21.5 34.7 20.4

115 132 26 67.6 99.9 124 182 66.7

13.1 20.6 4.63 U 8.49 7.85 13 20.7 11.1

144 266 28.9 78.5 119 148 220 78.1

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

64.6 122 22.9 41.2 60.6 71.3 123 64.5

6.46 16.6 2.32 U 2.3 U 6.32 6.18 4.81 2.47

4.24 10.9 2.32 U 2.3 U 4.15 4.06 5.32 2.31 U

435 173 332 363 385 403 201 193

1,620 987 1,560 1,990 1,340 1,620 1,110 1,020

6,140 2,960 4,160 5,200 5,440 6,070 3,130 2,760

72.6 44.3 40.5 51.1 69.6 75.6 72.6 36.7

70.4 89.6 25 60.5 56.6 78.2 134 65.7

9,470 4,160 6,740 8,050 8,360 9,150 5,180 4,420

12.4 21.6 2.32 U 10.1 8.23 U 14.4 15.6 8.19

44.4 28.1 31.5 35.2 44.6 46.7 38.4 17.8

19.6 34.3 9.84 14.5 19.2 21.9 25.3 9.19

7.1 13.9 4.37 2.65 8 6.84 12.2 3.52

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

21.9 15 17.6 21.5 19.5 21.9 18.4 12.1

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

11 13.4 7.91 11 10.5 12.3 11.1 7.76

12,800 5,510 10,600 11,200 12,800 13,100 6,660 5,670

17.5 16.5 8.33 13.2 11.4 14.4 29 25.5

2,050 868 1,550 1,880 1,890 2,090 1,180 920

966 545 734 796 923 958 554 468

48.6 36 18 42.9 35.2 50.4 105 37.6

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

499 498 152 276 440 511 553 191

111 235 8.9 32.8 95 108 98 35.8

651 407 538 610 616 660 481 369

Page 120: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI402-BC-WB-1 GC-TI402-BC-WB-2

GC-TI402-BC GC-TI402-BC GC-TI403-THRU-406-BC GC-TI403-BC GC-TI403-BC

GC-TI404-BC-ED-2GC-TI403-404-405-406-BC-HP-2GC-TI403-BC-ED-1 GC-TI403-BC-ED-2 GC-TI403-BC-WB-1 GC-TI403-BC-WB-2 GC-TI404-BC-ED-1

GC-TI403-BC GC-TI403-BC GC-TI404-BC GC-TI404-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible TissueWhole Body Whole Body Hepatopan Edible Tissue Edible Tissue

10.5 17.3 9.39 8.55 12.4 11.8 19.8 6.7

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.65 0 U 1.66 10.1 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

430 386 276 342 412 450 336 176

16.9 33.8 4.63 U 8.57 12.9 18 20.5 6.55

539 554 258 374 469 537 506 264

30.5 37.9 19.6 20.5 29.4 29.7 13.6 11

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

130 87 110 116 135 138 75.2 60.1

15.4 9.09 10.3 11.5 14.1 14.7 7.11 6.27

3.28 U 8.43 2.32 U 2.3 U 3.21 U 3.14 U 2.3 U 2.31 U

10.8 R 12.2 R 2.32 U 2.3 U 10.6 R 10.3 R 2.3 U 2.31 U

1,910 821 1,540 1,900 1,890 2,100 1,090 873

16,100 7,520 11,800 13,600 15,800 16,800 8,670 6,960

173 105 78.8 91.3 168 174 129 60.8

2.21 4.62 U 2.98 4.6 1.84 2.89 5.81 2.69

16.5 21.6 3.1 9.88 12.9 17 14.2 7.05

408 420 328 364 414 434 214 177

0 U 9.23 U 4.63 U 4.59 U 0 U 0 U 7.77 4.62 U

1,220 639 1,180 1,250 1,360 1,400 732 700

8.96 5.5 3.04 6.41 4.75 6.83 13.5 8.79

821 359 617 773 820 913 408 345

346 135 299 338 356 379 184 165

46.8 68.9 2.32 U 29.2 32.9 50.5 50 15.8

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

20.3 19.4 7.56 14.3 16.9 20.9 25.1 9.32

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

3,190 1,680 2,180 2,680 3,140 3,430 1,780 1,320

619 386 196 379 518 625 765 283

94.5 45.8 90.8 95.6 101 104 54.2 53.5

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

27,800 11,600 24,900 26,300 31,000 31,700 15,000 12,100

54.2 19.4 42.1 44.5 44.6 46.1 25.4 23.3

1,910 822 1,450 1,830 1,930 2,160 920 795

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

56.5 59.9 35.1 42.9 53.8 58.3 31.2 22.7

17.7 35.7 5.65 9.59 17.1 19.3 26.6 9.69

22.4 24.5 17.6 18 22.4 22.6 13.1 9.52

Page 121: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI402-BC-WB-1 GC-TI402-BC-WB-2

GC-TI402-BC GC-TI402-BC GC-TI403-THRU-406-BC GC-TI403-BC GC-TI403-BC

GC-TI404-BC-ED-2GC-TI403-404-405-406-BC-HP-2GC-TI403-BC-ED-1 GC-TI403-BC-ED-2 GC-TI403-BC-WB-1 GC-TI403-BC-WB-2 GC-TI404-BC-ED-1

GC-TI403-BC GC-TI403-BC GC-TI404-BC GC-TI404-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible TissueWhole Body Whole Body Hepatopan Edible Tissue Edible Tissue

2,600 924 1,690 1,810 2,620 2,670 1,060 984

1,070 366 838 954 1,080 1,150 538 463

506 312 280 363 481 528 210 201

30.2 26.1 6.01 9.9 24.8 26.8 31.7 11.4

147 64.9 102 141 143 166 80.4 73.1

8.55 4.62 U 2.32 U 4.55 4.57 U 7.32 12.4 4.61

618 167 189 229 597 613 340 165

996 735 807 923 1,010 1,070 600 487

9.43 5.99 2.32 U 5.8 6.78 10.3 10.7 4.69

9,850 3,990 7,230 7,930 10,200 10,500 4,650 4,050

41.4 14.2 34 38.1 41.7 44.1 19.1 19.9

30.8 11.8 23.8 28.6 29.1 32 15.1 14.3

3,600 1,280 2,800 3,300 3,710 4,010 1,800 1,540

16.2 6.37 12.1 14.2 13.6 14.9 10.1 7.08

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

6,530 2,860 4,060 5,500 6,250 7,100 3,720 2,840

51.5 22 50.2 45.9 54.1 51.3 32.9 29.4

763 288 522 595 776 817 315 285

176 85.9 136 159 184 197 78.3 74.3

0 U 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

1,100 391 794 759 1,160 1,130 439 408

361 105 224 232 356 358 136 136

802 264 551 648 787 842 307 319

106 34.4 59.7 77.4 91.8 102 53.4 41.5

1,390 609 689 919 1,270 1,400 594 508

213 83 132 154 201 213 129 87.6

539 283 441 456 550 557 426 250

916 275 500 708 839 962 371 340

1.66 4.62 U 2.32 U 2.3 U 0 U 0 U 2.3 U 2.31 U

26.3 10.9 14.4 13.4 23.7 22.8 11.1 9.51

375 134 247 265 333 342 213 156

78.8 24 54.6 57 68.4 69.6 42.4 32.5

224 97.2 179 162 205 194 158 107

224 80.5 187 144 200 173 158 105

142,000 65,000 108,000 125,000 141,000 150,000 78,300 64,200

166,000 75,800 125,000 145,000 163,000 175,000 90,100 73,000

Page 122: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

0.036 387 R 0.0387 399 R 0.0399 890 R 0.089 779 R 0.0779 420 R 0.042 410 R 0.041 752 R 0.0752 451

0.00612 32.2 0.00966 30.4 0.00912 50.1 0.01503 40.9 0.01227 48.3 0.01449 42.9 0.01287 36.7 0.01101 22.7

0.0576 3,920 0.1176 3,590 0.1077 4,690 0.1407 3,840 0.1152 5,300 0.159 4,780 0.1434 3,950 0.1185 2,240

0.00411 287 0.00861 267 0.00801 326 0.00978 266 0.00798 384 0.01152 347 0.01041 267 0.00801 157

0.1635 12,300 0.369 11,300 0.339 14,300 0.429 12,200 0.366 16,800 0.504 15,500 0.465 12,400 0.372 6,760

0.00396 250 0.0075 242 0.00726 314 0.00942 253 0.00759 354 0.01062 317 0.00951 271 0.00813 140

1.65 35.8 3.58 33.7 3.37 38.4 3.84 38.6 3.86 47.4 4.74 47.3 4.73 37.9 3.79 22.6

0.02106 1,630 0.0489 1,510 0.0453 1,660 0.0498 1,450 0.0435 2,110 0.0633 1,980 0.0594 1,490 0.0447 777

0.01038 792 0.02376 735 0.02205 839 0.02517 706 0.02118 1,040 0.0312 959 0.02877 720 0.0216 381

0 0 U 0 0 U 0 6.96 U 0 6.67 U 0 0 U 0 0 U 0 6.2 U 0 3.78 U

0.001689 124 0.00372 121 0.00363 134 0.00402 106 0.00318 169 0.00507 152 0.00456 104 0.00312 56.5

4.17 3.91 4.52 4.44 5.54 5.46 4.38 2.63

4.56 U 4.7 U 2.37 2.32 U 6.33 4.83 U 2.2 U 2.27 U

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

5.37 U 5.53 U 2.32 U 2.32 U 5.82 U 5.68 U 2.2 U 2.27 U

25.2 26.6 19.2 9.98 28.2 22.5 12.1 9.56

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

15.7 15.3 13 5.12 15 10.2 3.59 3.16

2.81 U 2.89 U 2.32 U 2.32 U 3.04 U 2.97 U 2.2 U 2.27 U

54.9 51.3 63.5 19.2 69.8 43.3 18.5 17.4

2.15 U 2.21 U 2.32 U 2.32 U 2.33 U 2.27 U 2.2 U 2.27 U

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

70.9 56.7 68.7 58.7 76.6 70.4 56.7 44.6

20.8 20.6 23.8 16.6 20.3 16.1 15.1 14.3

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

569 530 869 671 786 671 634 561

12.8 13.1 13.9 3.14 17 10.5 6.31 5.52

45.5 41.4 45.9 20.4 43.8 28.7 22.2 20.1

72 59.2 60.3 20.3 69.3 45.3 29.2 35

5.67 7.22 5.28 2.42 R 6.57 3.4 R 3.69 2.27 U

6,010 5,970 9,420 7,810 8,960 8,020 6,820 5,180

58.9 55.1 99.6 39.2 87.5 51.9 44.5 21.9

74.2 57.6 83.3 32 73.5 43.3 44 59.5

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

38 32.8 23.7 16 28.5 23.8 18.7 26.3

66.7 53.4 34.4 23.6 50.9 44 26.3 38.4

17 14.1 9.22 5.63 13.1 10.9 6.78 6.66

222 167 163 83.7 191 143 99.7 177

72.2 58.2 52.9 31.7 56.3 43.6 35.2 32.2

6.66 5.2 5.4 4.99 6.04 5.78 3.74 2.48

3.12 R 1.71 R 4.41 3.24 2.58 R 1.93 R 3.02 R 3.09

GC-TI405-BC-WB-2 GC-TI406-BC-ED-1 GC-TI406-BC-ED-2GC-TI404-BC-ED-2 GC-TI404-BC-WB-1 GC-TI404-BC-WB-2 GC-TI405-BC-ED-1 GC-TI405-BC-ED-2 GC-TI405-BC-WB-1

GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI406-BC GC-TI406-BCGC-TI404-BC GC-TI404-BC GC-TI404-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabEdible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue

Page 123: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI405-BC-WB-2 GC-TI406-BC-ED-1 GC-TI406-BC-ED-2GC-TI404-BC-ED-2 GC-TI404-BC-WB-1 GC-TI404-BC-WB-2 GC-TI405-BC-ED-1 GC-TI405-BC-ED-2 GC-TI405-BC-WB-1

GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI406-BC GC-TI406-BCGC-TI404-BC GC-TI404-BC GC-TI404-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabEdible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue

2.86 0 U 9.09 6.54 5.31 3.89 5.37 3.69

1,110 1,090 1,690 1,440 1,640 1,490 1,300 877

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

7.24 5.05 7.42 7.22 7.5 7.38 6.39 5.38

367 289 133 185 284 311 194 123

65.5 48.6 35.7 30.9 45.1 42 35.5 37.2

20.3 17.1 5.92 7.76 13.5 14.4 9.9 4.88 R

5,000 4,920 6,380 5,210 6,970 6,260 5,310 3,450

17.6 11.7 9.89 6.91 10.1 8.28 8.96 5.22 R

1.73 1.9 2.82 2.32 U 1.65 0 U 2.2 U 2.27 U

34 25.3 21 10.3 25.9 19.5 14.4 11.5

197 127 58.3 42.5 126 114 67.1 101

20.7 14.9 8.64 5.06 13.6 11.4 7.61 7.61

238 152 64.2 55.6 148 141 88 115

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.78 U

123 87.2 57.7 36.4 84.4 71.1 54.1 62.7

9.33 8.06 2.32 U 3.05 6.9 8.55 3.52 2.46 U

7.46 4.31 11.3 2.85 11.1 6.11 4.84 4.02 R

304 303 420 355 441 402 373 248

1,060 1,010 2,810 2,090 2,050 1,640 1,850 1,300

4,820 4,650 6,660 5,770 7,020 6,480 5,030 3,590

89.6 68.4 55.3 79.9 80.9 94.9 67.6 59.5

124 82.4 55.1 44.6 77.1 70.3 65 99.2

7,410 7,020 11,600 9,980 11,400 10,400 8,970 5,370

17.9 13.5 6.67 7.9 12.9 13.5 10.1 2.27 U

49 36.9 45.3 49.3 53.9 56.1 44.2 29.9

28.8 19.1 13.9 23.1 22.4 27.6 21.2 15.7

12.9 7.62 20.6 7.88 17.8 10.3 8.96 6.36

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.62 U

20 16.3 26.3 22.7 24.8 22.7 24.8 12.1

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.41 U

12.4 10.5 10.9 8.38 12.4 10.9 9.96 5.5

10,400 9,870 14,400 10,900 15,200 13,100 11,100 6,070

24.2 21.9 15.4 22 15.9 19.8 22.8 10.1

1,670 1,520 2,300 1,810 2,360 2,070 1,890 1,020

813 769 978 829 1,080 992 862 498

88.9 47.7 22.2 52.2 39.2 56.6 56.3 58.6

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

689 474 219 325 505 561 348 404

151 115 14.5 40.5 106 119 58.4 61.8

582 517 658 618 694 669 636 330

Page 124: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI405-BC-WB-2 GC-TI406-BC-ED-1 GC-TI406-BC-ED-2GC-TI404-BC-ED-2 GC-TI404-BC-WB-1 GC-TI404-BC-WB-2 GC-TI405-BC-ED-1 GC-TI405-BC-ED-2 GC-TI405-BC-WB-1

GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI406-BC GC-TI406-BCGC-TI404-BC GC-TI404-BC GC-TI404-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabEdible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue

18.8 10.9 14.5 18.5 15.7 18 15.4 8.03

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

6.23 0 U 2.32 U 2.32 U 0 U 0 U 2.37 5.02

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

450 357 471 438 538 517 412 266

25.6 17.3 6.9 12.9 18.1 21.4 13.2 13

624 481 390 391 566 562 411 338

25.8 24.6 21.1 20 31.2 30.3 23.1 13.9

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

113 106 131 114 149 139 125 70.6

12.1 11.8 11.8 12.2 15.3 15.4 15.5 8.15

3.23 U 3.33 U 2.32 U 2.32 U 3.5 U 3.42 U 2.2 U 2.37 U

10.6 R 11 R 2.32 U 2.32 U 11.5 R 11.2 R 2.2 U 8.36

1,610 1,500 2,070 1,460 2,230 1,860 1,820 929

13,900 13,000 16,800 11,600 19,000 15,900 12,700 7,190

200 161 108 146 193 214 113 81.9

3.58 1.63 4.53 6.84 2.65 4.07 6.43 3.55

19.8 15.7 4.94 6.27 14.9 15.4 10.2 8.02

344 326 393 339 459 426 361 192

4.79 0 U 4.64 U 4.63 U 0 U 0 U 4.39 U 4.54 U

1,080 1,070 1,510 1,140 1,560 1,340 1,110 688

11.2 8.3 4.25 7.86 5.62 7.73 8.35 3.14

693 663 732 582 906 812 613 348

286 277 393 278 416 347 298 176

63.9 43.7 24.3 27.6 50.1 51.4 35.4 34.9

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

27.7 18.3 10.6 19 19.5 24.3 16.5 14.6

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

2,900 2,650 3,030 2,560 3,720 3,420 2,720 1,400

870 582 269 563 589 756 445 440

78.3 78.6 102 88.9 108 100 90 48.4

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

24,900 23,500 31,800 24,200 35,600 31,000 24,000 11,600

34.3 33.3 49.1 44.2 48.9 46 48.3 23.1

1,610 1,560 1,920 1,390 2,250 1,930 1,450 795

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

51.5 47 49.9 41.5 64.2 58.8 42.8 25.6

30.1 20 7.5 19.4 19.2 26 15.3 2.27 U

19.7 17.7 19.2 19.7 23.8 24 20.8 11.8

Page 125: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI405-BC-WB-2 GC-TI406-BC-ED-1 GC-TI406-BC-ED-2GC-TI404-BC-ED-2 GC-TI404-BC-WB-1 GC-TI404-BC-WB-2 GC-TI405-BC-ED-1 GC-TI405-BC-ED-2 GC-TI405-BC-WB-1

GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI405-BC GC-TI406-BC GC-TI406-BCGC-TI404-BC GC-TI404-BC GC-TI404-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabEdible Tissue Whole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole Body Edible Tissue Edible Tissue

2,240 2,230 2,000 1,260 2,890 2,420 1,470 728

899 865 1,150 741 1,290 1,040 842 428

439 441 371 303 552 507 265 145

40.7 28.8 9.87 15.3 28.8 31.5 15.3 22.8

130 127 156 127 178 160 134 73

12.2 7.53 3.02 8.02 6.75 9.63 5.66 4.62

693 598 273 354 683 721 255 183

880 820 1,180 979 1,240 1,120 966 506

13.4 9.87 2.32 U 4.03 7.4 9.61 6.08 6.18

8,580 8,340 8,760 6,380 11,300 9,840 6,800 3,380

32.6 33.5 40.2 28 46 38.6 27.2 14.8

23.8 23.6 22.5 19.8 28.9 27.1 22.8 11.5

3,100 2,990 3,940 2,780 4,460 3,760 3,020 1,540

12.4 10.6 16.5 14.4 16.3 15.1 16.9 9.58

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

6,060 5,600 5,510 4,590 7,300 6,710 4,620 3,060

43.4 41.7 59.3 50.2 59.8 54.3 50.1 27

650 643 602 443 846 746 463 241

148 148 166 122 205 178 121 62.6

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

946 942 793 630 1,190 1,090 716 343

303 308 226 145 369 318 178 94.3

638 655 557 429 812 730 508 264

88.1 82 87.5 65.5 111 97.3 78.8 51.8

1,210 1,180 737 705 1,350 1,320 747 441

199 176 200 176 247 231 197 121

542 439 582 552 643 623 626 349

762 755 525 491 885 856 598 328

0 U 0 U 2.32 U 2.32 U 0 U 0 U 2.2 U 2.27 U

21.7 21 15.5 13 25.1 23.4 13.3 8.51

312 281 209 200 318 310 290 159

61 55.5 40.1 38.3 61.2 59.6 56.6 30.4

193 163 120 123 173 174 168 97.4

183 151 145 121 177 162 169 104

123,000 115,000 149,000 116,000 167,000 148,000 117,000 67,800

142,000 133,000 171,000 135,000 194,000 172,000 136,000 78,800

Page 126: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

0.0451 217 R 0.0217 659 0.0659 640 0.064 517 0.0517 567 0.0567 472 0.0472 359 0.0359 271

0.00681 38.7 0.01161 31.3 0.00939 28.7 0.00861 24.9 0.00747 27.7 0.00831 24.9 0.00747 24.9 0.00747 15.1

0.0672 4,420 0.1326 3,700 0.111 4,280 0.1284 3,360 0.1008 3,960 0.1188 3,270 0.0981 3,060 0.0918 2,140

0.00471 310 0.0093 272 0.00816 276 0.00828 234 0.00702 266 0.00798 235 0.00705 239 0.00717 150

0.2028 14,100 0.423 11,800 0.354 13,800 0.414 10,900 0.327 12,800 0.384 10,700 0.321 10,100 0.303 6,950

0.0042 301 0.00903 241 0.00723 261 0.00783 242 0.00726 253 0.00759 239 0.00717 232 0.00696 141

2.26 42.6 4.26 36.5 3.65 38.4 3.84 33.3 3.33 36.7 3.67 32.9 3.29 31.8 3.18 16.8

0.02331 1,760 0.0528 1,510 0.0453 1,450 0.0435 1,310 0.0393 1,480 0.0444 1,390 0.0417 1,580 0.0474 964

0.01143 851 0.02553 735 0.02205 738 0.02214 643 0.01929 761 0.02283 696 0.02088 827 0.02481 459

0 0 U 0 0 U 0 6.45 U 0 6.38 U 0 0 U 0 0 U 0 6.39 U 0 6.44 U

0.001695 129 0.00387 117 0.00351 87.4 0.002622 84.4 0.002532 94.3 0.002829 92.9 0.002787 114 0.00342 64.9

4.93 4.28 4.54 3.89 4.32 3.84 3.71 2.04

2.55 U 4.44 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

3 U 5.22 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

18.3 21.2 12 9.98 11.5 9.96 9.91 5.76

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

6.62 8.58 5.69 3.04 6.22 4.39 7.72 2.33

1.57 U 2.73 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

31.4 40.2 22.7 7.53 21.5 10.5 17.9 12.1

1.2 U 2.09 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

63.3 60.6 91.6 40 89.3 52.3 82.8 48.5

15.2 14.7 22.8 6.93 19.4 7.69 9.57 6.39

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

642 602 539 366 461 329 239 232

9.53 11.4 6.97 4.7 7.66 6.12 9.65 3.35

26.2 27.8 48.6 22.4 43.8 24.6 29.9 21.3

40.5 52.5 75.6 34.5 75.9 46.7 76.9 15.9

4.7 3.12 U 3.47 4.09 2.57 2.91 4.47 U 2.48

7,140 6,350 6,530 4,910 5,710 4,460 3,360 3,220

50.1 40.1 36.5 18.6 40.3 27.9 51 21.2

47.4 59.6 100 22.2 85.3 28.3 43.3 35.2

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

22.2 29.6 48.6 15.5 46.1 22.2 38.9 22.7

36.5 51.7 77.8 30.7 83.4 50.4 99.3 25.2

9.32 11.1 18.5 7.35 19.9 12.1 23.8 3.61

128 197 295 93.8 266 120 185 127

40.8 43 74 24.8 69.3 33.7 55.7 30.3

4.43 4.14 6.18 2.28 U 6.78 2.44 8.48 2.29 U

0 R 1.94 R 6.86 2.72 6.41 3.41 5.13 2.85

GC-TI-INNER-BC-ED-2 GC-TI-INNER-BC-WB-1 GC-TI-INNER-BC-WB-2GC-TI-INNER-MIDDLE-OUTER-BC-HP-1GC-TIMIDDLE-BC-ED-1GC-TI406-BC-ED-2 GC-TI406-BC-WB-1 GC-TI406-BC-WB-2 GC-TI-INNER-BC-ED-1

GC-TI406-BC GC-TI406-BC GC-TI406-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-IN-MID-OUT-BC GC-TIMIDDLE-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole BodyEdible Tissue Hepat Edible Tissue

Page 127: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI-INNER-BC-ED-2 GC-TI-INNER-BC-WB-1 GC-TI-INNER-BC-WB-2GC-TI-INNER-MIDDLE-OUTER-BC-HP-1GC-TIMIDDLE-BC-ED-1GC-TI406-BC-ED-2 GC-TI406-BC-WB-1 GC-TI406-BC-WB-2 GC-TI-INNER-BC-ED-1

GC-TI406-BC GC-TI406-BC GC-TI406-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-IN-MID-OUT-BC GC-TIMIDDLE-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole BodyEdible Tissue Hepat Edible Tissue

4.22 2.31 6.87 2.79 5.09 1.99 4.47 U 4.26

1,360 1,130 822 749 728 666 460 367

0 U 0 U 4.74 2.28 U 3.51 0 U 4.47 U 2.29 U

6.65 6.21 9.37 5.91 8.67 6.13 6.67 5.68

259 262 390 141 444 272 598 135

40.4 45 119 42.5 101 44.8 50.5 60.9

13 9.02 R 20.7 13.1 23.2 18.1 30.4 2.29 U

5,840 5,070 5,630 5,570 5,110 5,010 3,620 4,050

9.25 3.84 R 21.7 13.3 19.7 13.5 13.9 9.1

0 U 0 U 4.31 2.36 3.19 1.68 4.47 U 2.29 U

18.4 19.5 41 23.1 41.2 28.5 41.9 16.7

99.9 145 285 75 260 107 187 134

10.4 12.5 29.9 13.1 29.7 17.8 29.3 8.21

126 171 341 114 336 174 323 86.3

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

0 U 0 U 5.89 U 2.28 U 0 U 0 U 4.47 U 2.29 U

68.7 84.8 199 49.1 186 78.1 150 94.7

6.33 6.19 7.45 2.28 U 11 6.07 21.1 2.29 U

6.14 4.06 R 5.16 U 2.28 U 0 R 0 R 7.87 R 2.29 U

394 331 413 363 374 334 262 279

1,660 1,180 1,720 1,200 1,490 1,100 850 711

5,570 5,060 5,250 4,270 4,900 4,170 3,910 2,720

78.2 80.9 93.5 47.5 85.6 52 63.1 62.6

74.2 102 220 70.8 193 83.2 114 102

9,410 7,470 8,620 6,520 7,750 6,160 5,260 3,840

12.6 8.05 U 4.55 U 2.28 U 0 U 0 U 4.47 U 2.29 U

48.9 43.4 53.1 33 51.9 37.5 48.5 40

24 22.6 42.2 16.8 45.1 27.3 53.3 14.7

10 9.17 8.54 2.28 U 9.2 3.19 11.1 2.62

0 U 0 U 5.54 U 2.28 U 0 U 0 U 4.47 U 2.29 U

24.3 16 29.3 21.1 27.9 21.9 24 19.6

0 U 0 U 5.11 U 2.28 U 0 U 0 U 4.47 U 2.29 U

11 8.89 18.6 10.1 18.7 12.6 18.9 14.2

12,200 9,880 10,900 10,600 10,000 9,710 7,500 7,300

21.4 12.5 29 32.6 28.1 30.6 25.6 19.6

2,010 1,550 1,870 1,670 1,690 1,530 1,190 1,230

941 771 934 871 894 845 780 679

57.8 60.3 136 56.8 117 58.5 62.7 64.7

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

468 592 891 352 816 424 603 457

96.3 126 169 62.9 201 129 292 55.6

659 484 545 545 523 521 460 319

Page 128: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI-INNER-BC-ED-2 GC-TI-INNER-BC-WB-1 GC-TI-INNER-BC-WB-2GC-TI-INNER-MIDDLE-OUTER-BC-HP-1GC-TIMIDDLE-BC-ED-1GC-TI406-BC-ED-2 GC-TI406-BC-WB-1 GC-TI406-BC-WB-2 GC-TI-INNER-BC-ED-1

GC-TI406-BC GC-TI406-BC GC-TI406-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-IN-MID-OUT-BC GC-TIMIDDLE-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole BodyEdible Tissue Hepat Edible Tissue

15.8 11.5 21.1 8.4 21.3 12.3 22 4.98

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

1.86 3.15 10.4 3.77 8.99 4.12 4.98 4.88

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

0 U 0 U 4.46 U 3.7 U 0 U 0 U 4.47 U 3.24 U

459 403 460 326 519 430 686 336

17.6 20.8 33.4 11.5 36 20.6 43.3 23.3

497 515 837 388 800 476 693 479

27.9 25.6 22.5 25.7 43.9 48.5 105 14.4

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

136 110 128 128 146 148 196 96.6

16.5 12.6 12.5 13.4 13 13.7 14.3 9.95

1.81 U 3.14 U 10.7 4.29 U 10.5 2.88 10 7.21

5.94 R 15.6 R 15.5 20.3 15.6 19 15.7 14.6

1,960 1,500 1,650 1,690 1,610 1,640 1,500 1,470

14,700 12,800 11,300 10,400 11,300 10,700 11,400 9,180

156 168 172 78.2 169 102 162 128

5.05 2.23 8.12 3.46 6.01 2.46 4.47 U 3.55 R

14.2 15.8 36.9 11.6 36.6 18.5 35.6 35.8

402 327 348 345 543 562 1,100 182

0 U 0 U 11.4 4.56 U 8.44 0 U 8.93 U 7.98

1,220 1,040 852 938 823 882 742 719

8.18 4.78 10.2 12.7 9.32 11 6.79 10.3

728 647 516 582 519 566 527 429

330 278 270 279 247 251 180 213

46.3 54.1 29.6 22.6 37.6 33.5 60.5 31.1

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

19.8 21.1 32.2 15.9 31 19.2 27.5 15

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

3,140 2,630 2,730 2,280 2,960 2,660 3,600 2,220

573 664 950 402 853 451 574 550

95.8 74 69.2 80.6 68.2 76.3 65.5 57.3

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

27,600 22,500 21,600 20,700 20,800 20,000 18,400 14,600

48.4 32.6 58.5 44.8 50.6 39.9 27.9 30.8

1,720 1,510 1,280 1,200 1,250 1,190 1,150 758

0 U 0 U 2.29 U 2.28 U 2.2 2.44 8.5 2.29 U

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

51.7 47.5 48.3 40.3 66.9 63.2 120 34.4

19.7 13.3 U 21.3 2.28 U 24.7 9.87 34.3 30.3

22.8 18.7 22.2 23.8 34.9 37.4 71.2 13.2

Page 129: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TI-INNER-BC-ED-2 GC-TI-INNER-BC-WB-1 GC-TI-INNER-BC-WB-2GC-TI-INNER-MIDDLE-OUTER-BC-HP-1GC-TIMIDDLE-BC-ED-1GC-TI406-BC-ED-2 GC-TI406-BC-WB-1 GC-TI406-BC-WB-2 GC-TI-INNER-BC-ED-1

GC-TI406-BC GC-TI406-BC GC-TI406-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-INNER-BC GC-TI-IN-MID-OUT-BC GC-TIMIDDLE-BC

Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabWhole Body Whole Body Edible Tissue Edible Tissue Whole Body Whole BodyEdible Tissue Hepat Edible Tissue

2,040 2,000 679 1,090 757 1,060 979 888

979 820 622 687 571 612 426 521

381 392 160 195 245 279 486 166

23.9 34.9 14.7 10.3 17.1 14.3 24.1 32.4

150 124 112 102 110 103 106 73.4

7.02 7.37 14.7 7.58 12.4 7.09 5.89 13.1

471 585 366 152 330 173 226 326

1,040 813 923 824 1,100 1,050 1,610 458

8.59 10.5 23.3 8.67 19.9 9.14 10.3 23.8

8,540 7,680 5,230 5,740 5,350 5,720 5,680 4,380

33 29.5 19.3 24.5 17.9 21.5 14 17.6

26 21.3 18.4 26.1 18.3 23.8 18 23.4

3,490 2,900 2,540 2,500 2,370 2,320 1,880 2,080

16.7 12 21.6 17.3 19 15.6 11.5 14.9

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

5,730 5,580 4,670 4,660 4,980 5,010 5,860 4,880

52.3 39.5 39.1 42.6 35.9 38 26.7 32.1

619 595 290 341 300 338 330 246

151 137 76.9 87.8 86.3 95 113 61.1

0 U 0 U 2.29 U 2.28 U 0 U 0 U 4.47 U 2.29 U

940 871 423 560 463 565 577 548

262 272 72.3 134 72.7 117 73.9 109

650 602 353 482 345 437 324 366

92.8 86.2 90.7 94.8 81.2 83.1 54 76.9

1,060 1,100 570 733 720 853 1,150 809

222 192 212 198 193 181 138 181

648 490 745 632 699 614 568 448

768 724 293 472 302 430 326 505

0 U 0 U 2.29 U 2.42 0 U 1.72 4.47 U 2.29 U

18.7 19.8 4.61 9.39 5.87 9.42 9.48 10.8

329 276 149 268 160 246 192 322

63.9 52.9 42.4 71.9 39.8 60.5 32.3 58.3

185 154 157 260 166 240 192 194

180 148 159 271 151 230 130 219

133,000 115,000 111,000 100,000 106,000 98,400 94,600 76,500

155,000 134,000 132,000 117,000 127,000 116,000 111,000 87,700

Page 130: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

0.0271 203 0.0203 263 0.0263 296 0.0296 246 0.0246 291 0.0291 157 0.0157 150 0.015 198

0.00453 10.5 0.00315 13.7 0.00411 17.9 0.00537 14.5 0.00435 16.9 0.00507 8.21 0.002463 6.53 R 0.001959 10.1

0.0642 1,500 0.045 2,010 0.0603 2,400 0.072 1,930 0.0579 2,310 0.0693 1,250 0.0375 1,200 0.036 1,600

0.0045 99.5 0.002985 138 0.00414 175 0.00525 138 0.00414 167 0.00501 79.6 0.002388 77.9 0.002337 114

0.2085 4,700 0.141 6,070 0.1821 7,840 0.2352 6,200 0.186 7,230 0.2169 4,060 0.1218 3,690 0.1107 5,250

0.00423 91.5 0.002745 139 0.00417 167 0.00501 131 0.00393 166 0.00498 82.7 0.002481 74.7 0.002241 101

1.68 12.4 1.24 17.3 1.73 21 2.1 17.8 1.78 21.5 2.15 9.2 0.92 9.16 0.916 12.4 R

0.02892 600 0.018 872 0.02616 1,140 0.0342 872 0.02616 1,080 0.0324 550 0.0165 582 0.01746 715

0.01377 303 0.00909 423 0.01269 562 0.01686 449 0.01347 539 0.01617 259 0.00777 275 0.00825 347

0 4.41 U 0 5.65 U 0 0 U 0 0 U 0 0 U 0 3.38 U 0 4.54 U 0 5.61 U

0.001947 39.8 0.001194 56.6 0.001698 78.7 0.002361 60.4 0.001812 73.2 0.002196 39.1 0.001173 43.3 0.001299 46.5

1.48 2.05 2.51 2.1 2.53 1.13 1.11 0.268

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

4.94 8.34 6.93 6.32 8.79 5.09 7.99 8.12

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

2.28 U 3.48 3.84 2.15 4.7 2.29 U 2.76 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

10.5 17.2 13.7 12.6 17.4 13.4 17.6 14

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

42 66.8 58.1 53.3 71.4 51.7 58.7 57.4

5.59 8.25 7.28 6.7 8.63 6.9 8.04 7.29

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

210 232 234 218 234 173 179 209

3.04 5.88 5.12 4.88 6.97 3.29 4.73 4.42

14.6 28.2 23.7 18.9 28.7 24.2 29.2 26.2

13.9 22.8 33 31.4 38.4 15.4 21.9 21.4

2.28 U 2.61 1.78 0 U 1.86 2.29 U 3.08 3.79

2,880 3,260 3,260 3,010 3,290 2,540 2,330 3,050

14.7 24.1 29.6 24.8 31.9 20.9 24.9 25.9

33.1 43.6 37.5 35.9 43.5 52.3 57.4 47.3

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

42 25.6 27.3 41.1 29.4 29.7 32.3 27.4

21.3 31.6 46 43 51.1 26.3 34.8 31.1

3.61 5.85 9.28 9.22 11 3.85 5.03 5.21

153 146 143 162 157 170 210 169

22.4 37.5 37.4 31.7 42.7 29.5 41.4 37.4

2.28 U 2.99 2.38 2.36 4.57 2.29 U 2.25 U 2.29 U

2.28 U 3.42 3.49 1.43 3.91 2.9 3.44 3.17

GC-TIMIDDLE-BC-ED-3GC-TIMIDDLE-BC-WB-1GC-TIMIDDLE-BC-WB-2GC-TIMIDDLE-BC-WB-3GC-TI-OUTER-BC-ED-1GC-TI-OUTER-BC-ED-2GC-TIMIDDLE-BC-ED-1GC-TIMIDDLE-BC-ED-2 GC-TI-OUTER-BC-ED-3

GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TI-OUTER-BC GC-TI-OUTER-BC GC-TI-OUTER-BCGC-TIMIDDLE-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue CrabWhole Body Edible Tissue Edible Tissue Edible TissueEdible Tissue Edible Tissue Edible Tissue Whole Body Whole Body

Page 131: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TIMIDDLE-BC-ED-3GC-TIMIDDLE-BC-WB-1GC-TIMIDDLE-BC-WB-2GC-TIMIDDLE-BC-WB-3GC-TI-OUTER-BC-ED-1GC-TI-OUTER-BC-ED-2GC-TIMIDDLE-BC-ED-1GC-TIMIDDLE-BC-ED-2 GC-TI-OUTER-BC-ED-3

GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TI-OUTER-BC GC-TI-OUTER-BC GC-TI-OUTER-BCGC-TIMIDDLE-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue CrabWhole Body Edible Tissue Edible Tissue Edible TissueEdible Tissue Edible Tissue Edible Tissue Whole Body Whole Body

3.79 4.62 3.06 2.74 3.29 5.34 5.44 6.19

285 349 393 334 381 213 209 259

2.29 2.3 U 0 U 1.65 0 U 2.29 U 2.25 U 2.29 U

5.04 6.19 5.96 5.49 6.33 5.56 5.8 4.93

121 167 265 254 291 126 162 141

45.3 60.5 58 46.7 57.6 76.3 93.2 76.9

4.27 5.78 8.54 11.5 12.9 4.16 R 5.02 5.12

2,730 3,610 3,930 2,980 3,610 2,760 2,600 4,380

6.73 10.7 10.4 8.72 11.6 11.9 13.9 12.8

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.84 2.38

11.3 18.7 23.8 19.8 25.4 17.2 23.1 19.6

105 135 149 128 150 172 239 186

6.52 9.56 14.1 12.9 15.3 8.88 12.7 11.3

67.1 100 153 138 164 84.8 141 116

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.47 U 2.87 U

60 93 110 85 109 116 141 114

2.32 2.75 5.93 7.54 8.04 2.29 U 2.88 2.63 U

2.94 5.51 R 0 R 2.12 R 0 R 5.35 6.29 R 5.27

189 256 274 209 258 197 180 287

500 719 750 597 757 478 434 519

1,830 2,530 3,050 2,410 2,930 1,730 1,650 2,250

60.6 76.7 62.7 61.3 72.8 66.3 69.5 59.6

99 101 105 103 105 126 162 126

2,980 3,500 4,240 3,610 4,010 2,560 2,340 3,500

17.9 18.3 0 U 12.9 13 17.9 18.9 R 19.5

44.7 45.3 42.4 45.8 46.2 36 35.6 36.7

16.4 19.1 25.5 26.7 29 12 15.6 13.4

3.04 4.84 5 5.28 6.65 3 2.91 2.65

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.37 U 2.76 U

13.9 18 20.8 16.7 19.7 14.9 16.8 19.2

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.44 U

8.83 13.8 15.5 11.6 15.3 15.7 21.6 19.1

5,050 6,120 7,360 5,730 6,520 4,720 4,730 6,390

12.1 18.9 21.3 15.9 20.8 19.2 26.2 22.1

804 1,160 1,220 911 1,170 795 796 1,060

463 638 707 551 679 512 556 668

53.3 64 64.1 55.9 63.6 65.8 88.2 66.2

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

402 548 498 458 564 488 677 516

49.6 62.8 122 117 129 47 76.8 56.8

224 293 359 290 341 242 252 305

Page 132: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TIMIDDLE-BC-ED-3GC-TIMIDDLE-BC-WB-1GC-TIMIDDLE-BC-WB-2GC-TIMIDDLE-BC-WB-3GC-TI-OUTER-BC-ED-1GC-TI-OUTER-BC-ED-2GC-TIMIDDLE-BC-ED-1GC-TIMIDDLE-BC-ED-2 GC-TI-OUTER-BC-ED-3

GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TI-OUTER-BC GC-TI-OUTER-BC GC-TI-OUTER-BCGC-TIMIDDLE-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue CrabWhole Body Edible Tissue Edible Tissue Edible TissueEdible Tissue Edible Tissue Edible Tissue Whole Body Whole Body

6.96 8.32 9.76 11.1 12.3 4.63 4.78 4.1

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

3.77 4.57 4.91 4.11 4.69 5.78 8.13 5.96

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

2.42 U 2.97 U 0 U 0 U 0 U 2.29 U 2.25 U 2.82 U

266 326 434 383 430 255 269 327

14.6 20.1 28.9 22.6 26.8 17.8 25.7 19

338 442 539 437 514 469 612 503

10.5 14.4 39.9 36.8 40.5 8.03 7.79 15.6

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

64.6 86 125 101 118 62.6 62 85.3

6.58 9.12 11.2 8.73 10.6 6.92 6.58 9.4

2.69 U 8.32 7.99 2.78 8.8 7.95 10.7 9.11

8.73 13.7 14.9 10.7 14.3 8.54 9.34 15

909 1,360 1,480 1,070 1,400 983 999 1,210

6,550 8,480 9,800 7,900 9,320 6,990 6,990 8,120

111 171 138 125 168 133 147 130

3.87 4.55 0 R 2.79 3.24 4.6 4.96 4.58

21.3 29.7 35.7 25.3 31.4 48.1 70.5 50

135 195 440 403 456 89.6 91.6 205

4.55 U 7.85 5.74 0 U 5.59 8.62 13.9 9.73

444 629 725 527 662 545 548 594

6.26 J 9.26 9.31 6.41 8.55 10.9 15.5 11.6

256 369 457 331 415 269 266 349

124 184 204 140 183 143 132 181

18.6 34.1 39.4 30.2 41.7 20.8 37.7 29.6

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

12.2 15.5 18.5 16.5 19 14.4 17.3 13.9

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

1,610 2,130 2,610 2,160 2,550 1,570 1,610 2,090

457 594 557 490 588 582 707 554

36.1 51.8 59.6 44.3 55.8 38.6 36.6 57.2

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.34 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

9,580 12,600 15,700 12,000 14,300 8,670 8,590 11,200

20.2 28 30 22.3 28 20.1 20.5 30.5

483 699 868 668 829 471 424 567

2.28 U 2.3 U 2.39 2.36 2.45 2.29 U 3.01 2.29 U

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

22.6 33.4 58.5 49.7 58.4 24.9 24 31.5

18.9 R 25.4 R 31.4 9.53 R 9.89 R 27.4 40.1 31.1

9.91 13 29.5 26.9 29.8 6.4 6.87 15.7

Page 133: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc

GC-TIMIDDLE-BC-ED-3GC-TIMIDDLE-BC-WB-1GC-TIMIDDLE-BC-WB-2GC-TIMIDDLE-BC-WB-3GC-TI-OUTER-BC-ED-1GC-TI-OUTER-BC-ED-2GC-TIMIDDLE-BC-ED-1GC-TIMIDDLE-BC-ED-2 GC-TI-OUTER-BC-ED-3

GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TIMIDDLE-BC GC-TI-OUTER-BC GC-TI-OUTER-BC GC-TI-OUTER-BCGC-TIMIDDLE-BC

Blue CrabBlue Crab Blue Crab Blue Crab Blue Crab Blue Crab Blue CrabBlue Crab Blue CrabWhole Body Edible Tissue Edible Tissue Edible TissueEdible Tissue Edible Tissue Edible Tissue Whole Body Whole Body

559 796 914 676 849 535 610 672

320 476 494 349 462 345 320 395

108 146 256 213 244 92.4 110 156

20.8 30.4 30.1 21.7 28.6 24.5 40.3 32.4

55 74.1 82.6 69.2 83.3 47.1 48.5 62.7

8 10.8 11.1 7.41 9.38 13.5 15.3 11.6

249 440 298 243 378 320 367 346

343 469 782 695 798 203 229 450

13.3 18.6 20 12.5 16.2 24.3 37.7 26.5

2,880 4,360 4,750 3,660 4,740 2,810 3,090 3,390

10.8 14.6 16.6 11.7 14.4 11.5 12 15.2

13.7 19.3 21.9 14.9 18.9 15.4 17.5 22

1,300 1,930 2,020 1,460 1,920 1,370 1,330 1,450

10.6 13.5 13.9 10.9 12.9 10.6 10.3 13.7

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

3,510 4,740 5,160 4,160 5,060 3,750 3,740 4,190

20.3 27.1 30.6 22.1 27 21.1 21.7 32.8

154 217 270 203 250 158 166 188

39.2 59 75.7 59.7 74.6 39.3 39.7 44.3

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

313 423 556 386 467 308 392 380

64.6 86.1 99.1 67.2 82.6 66.9 78 84.7

210 296 354 242 304 216 243 281

54.1 67.7 70.5 54.1 63.7 55.1 54.2 67.2

471 655 905 660 798 462 587 656

122 172 169 126 162 128 131 150

335 458 482 400 490 265 305 443

287 412 455 298 387 333 375 355

2.28 U 2.3 U 0 U 0 U 0 U 2.29 U 2.25 U 2.29 U

6.42 8.82 10.4 7.27 9.01 6.9 7.79 7.39

176 240 285 180 226 184 226 263

31.5 40.8 51 31.7 38.3 31.6 37.3 57.1

106 147 193 130 160 96.2 115 202

129 161 194 129 152 118 136 203

53,200 70,300 81,600 64,600 77,300 52,500 53,600 66,200

60,800 80,300 94,300 74,700 89,200 59,000 59,700 74,500

Page 134: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

TEQ

0.0198

0.00303

0.048

0.00342

0.1575

0.00303

1.24

0.02145

0.01041

0

0.001395

GC-TI-OUTER-BC-ED-3

GC-TI-OUTER-BC

Blue CrabEdible Tissue

Page 135: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

TEQ

GC-TI-OUTER-BC-ED-3

GC-TI-OUTER-BC

Blue CrabEdible Tissue

Page 136: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

TEQ

GC-TI-OUTER-BC-ED-3

GC-TI-OUTER-BC

Blue CrabEdible Tissue

Page 137: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

TEQ

GC-TI-OUTER-BC-ED-3

GC-TI-OUTER-BC

Blue CrabEdible Tissue

Page 138: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

Conc TEQ Conc TEQ Conc TEQ

216 0.0216 180 0.018 243 0.0243

13.1 0.00393 3.56 R 0.001068 14.3 0.00429

1,780 0.0534 1,470 0.0441 2,010 0.0603

126 0.00378 101 0.00303 149 0.00447

5,820 0.1746 4,610 0.1383 6,620 0.1986

126 0.00378 97.2 0.002916 138 0.00414

15.8 1.58 12.4 1.24 8.98 R 0.898

851 0.02553 725 0.02175 959 0.02877

425 0.01275 354 0.01062 483 0.01449

0 U 0 0 U 0 0 U 0

61 0.00183 53.4 0.001602 65.6 0.001968

1.88 1.48 0.341

0 U 0 U 0 U

0 U 0 U 0 U

0 U 0 U 0 U

6.5 8.26 8.63

0 U 0 U 0 U

2.25 3.47 2.18

0 U 0 U 0 U

14.7 17.6 15.1

0 U 0 U 0 U

0 U 0 U 0 U

60.8 62.1 64.6

7.68 8.26 7.93

0 U 0 U 0 U

192 188 217

5.15 5.43 5.9

25.9 29.3 27.2

33.4 29.8 37.1

0 U 2.64 2.72

2,780 2,480 3,140

29.7 28.6 33

49.7 55.4 46.2

0 U 0 U 0 U

0 U 0 U 0 U

32.4 33.2 30.6

47.6 44 50.4

9.67 7.71 10.5

174 206 174

37.1 43.4 42.6

2.48 1.21 2.39

3.55 3.68 3.72

GC-TI-OUTER-BC-WB-3GC-TI-OUTER-BC-WB-1GC-TI-OUTER-BC-WB-2

GC-TI-OUTER-BCGC-TI-OUTER-BC GC-TI-OUTER-BC

Blue Crab Blue Crab Blue CrabWhole BodyWhole Body Whole Body

Page 139: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

Conc TEQ Conc TEQ Conc TEQ

GC-TI-OUTER-BC-WB-3GC-TI-OUTER-BC-WB-1GC-TI-OUTER-BC-WB-2

GC-TI-OUTER-BCGC-TI-OUTER-BC GC-TI-OUTER-BC

Blue Crab Blue Crab Blue CrabWhole BodyWhole Body Whole Body

3.78 4.66 4.44

285 245 316

0 U 0 U 0 U

5.88 5.92 5.42

264 224 270

68.8 87.1 69.4

8.88 R 8.65 12.3

3,010 2,750 4,170

12.5 13.9 13.1

0 U 2.43 1.71

24.4 25.8 25.9

176 232 186

14.8 15.1 16.4

154 167 174

0 U 0 U 0 U

0 U 0 U 0 U

126 142 124

6.16 5.48 5.96

3.79 R 0 R 3.78 R

216 192 280

587 493 612

2,370 1,970 2,720

65.4 68.6 60.6

122 155 123

3,350 2,760 4,000

12.7 0 R 14

39.6 37.4 40

24.1 21 24.7

5.36 4.08 5.04

0 U 0 U 0 U

17.6 17.8 20.6

0 U 0 U 0 U

16.6 21.2 19

5,530 5,130 6,700

21.1 26.1 23.1

910 852 1,100

590 588 700

64.9 84.6 65.2

0 U 0 U 0 U

522 666 541

119 108 123

306 282 349

Page 140: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

Conc TEQ Conc TEQ Conc TEQ

GC-TI-OUTER-BC-WB-3GC-TI-OUTER-BC-WB-1GC-TI-OUTER-BC-WB-2

GC-TI-OUTER-BCGC-TI-OUTER-BC GC-TI-OUTER-BC

Blue Crab Blue Crab Blue CrabWhole BodyWhole Body Whole Body

9.7 7.24 9.16

0 U 0 U 0 U

5.55 7.68 5.68

0 U 0 U 0 U

0 U 0 U 0 U

381 329 428

25.2 28.2 25.9

534 624 557

36.3 21.7 40.8

0 U 0 U 0 U

102 81.1 117

9.07 7.68 10.8

8.55 10.6 9.36

10.6 10.2 15.2

1,130 1,070 1,290

8,280 7,620 9,050

141 149 139

3.26 4.25 3.29

44.5 65.5 45.9

385 236 458

6.1 11.9 6.98

603 576 636

9.7 14.3 10.2

344 303 399

154 139 181

32.4 41 38.3

0 U 0 U 0 U

18.2 18.8 17.7

0 U 0 U 0 U

2,160 1,890 2,520

580 688 560

46.5 40.7 59.5

0 U 2.01 0 U

0 U 0 U 0 U

11,500 9,990 13,200

22.4 21.6 29.8

669 528 732

2.48 3.79 2.4

0 U 0 U 0 U

52.7 37.7 56.5

29.4 39.3 32

25.3 16.1 31.4

Page 141: Appendix L HHRA Combined

TABLE 2.11 Supplement a

PCB Congener Concentrations (ng/kg) in Blue Crab– Wet Weight, and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

Conc TEQ Conc TEQ Conc TEQ

GC-TI-OUTER-BC-WB-3GC-TI-OUTER-BC-WB-1GC-TI-OUTER-BC-WB-2

GC-TI-OUTER-BCGC-TI-OUTER-BC GC-TI-OUTER-BC

Blue Crab Blue Crab Blue CrabWhole BodyWhole Body Whole Body

665 663 759

369 335 404

207 164 249

24.4 38 30.1

64.3 56.7 74.9

11.3 14 9.99

293 347 312

614 426 778

20.2 33.8 21.9

3,650 3,460 4,040

12.2 12.3 14.9

16.2 17.6 20.9

1,520 1,410 1,570

10.9 10.5 13.1

0 U 0 U 0 U

4,370 4,040 4,660

22.7 22.4 31.1

208 189 228

60.8 50.2 63.7

0 U 0 U 0 U

387 418 436

68.9 77.4 81.6

248 255 293

54.8 54.2 63.5

663 667 796

131 132 147

353 343 478

331 368 347

0 U 0 U 0 U

7.65 8.03 7.98

186 221 243

31.8 36.6 50.1

124 126 199

122 135 182

64,800 59,400 74,200

74,200 67,000 84,800

Page 142: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

PCB 77 Dioxin 0.0001 464 0.0464 4,190 0.419 3,550 0.355 3,010 0.301 3,810 0.381 1,550 0.155 1,750 0.175

PCB 81 Dioxin 0.0003 0 U 0 93 0.0279 83.7 0.02511 81.3 0.02439 85.3 0.02559 49.8 R 0 50 R 0

PCB 105 Dioxin 0.00003 1,560 0.0468 6,680 0.2004 6,430 0.1929 7,050 0.2115 6,120 0.1836 35,200 1.056 34,100 1.023

PCB 114 Dioxin 0.00003 83.3 0.002499 409 0.01227 369 0.01107 392 0.01176 347 0.01041 1,580 0.0474 1,500 0.045

PCB 118 Dioxin 0.00003 3,990 0.1197 18,000 0.54 17,000 0.51 18,500 0.555 16,500 0.495 106,000 3.18 106,000 3.18

PCB 123 Dioxin 0.00003 67.6 0.002028 317 0.00951 288 0.00864 343 0.01029 304 0.00912 1,930 0.0579 1,810 0.0543

PCB 126 Dioxin 0.1 0 U 0 94.4 9.44 100 10 111 11.1 101 10.1 123 R 0 85.3 R 0

PCB 156/157 Dioxin 0.00003 564 0.01692 2,190 0.0657 2,290 0.0687 2,700 0.081 2,190 0.0657 15,900 0.477 15,100 0.453

PCB 167 Dioxin 0.00003 193 0.00579 749 0.02247 806 0.02418 1,010 0.0303 823 0.02469 6,550 0.1965 6,500 0.195

PCB 169 Dioxin 0.03 0 U 0 0 U 0 0 U 0 0 U 0 0 U 0 0 U 0 0 U 0

PCB 189 Dioxin 0.00003 44.2 0.001326 171 0.00513 192 0.00576 339 0.01017 225 0.00675 1,160 0.0348 1,110 0.0333

PCB Dioxin 0.241463 10.74238 11.20136 12.33541 11.30186 5.2046 5.1586

PCB 1 NonDioxin 285 4,860 J 4,530 J 3,840 J 3,300 161 184

PCB 2 NonDioxin 41.4 783 787 550 585 75.4 94

PCB 3 NonDioxin 153 2,350 J 2,310 2,140 1,920 330 402

PCB 4 NonDioxin 895 15,000 J 9,390 J 7,400 J 6,710 311 U 384 U

PCB 5 NonDioxin 0 U 140 78.5 79.8 44.2 0 U 0 U

PCB 6 NonDioxin 343 5,690 3,900 3,400 3,420 217 252

PCB 7 NonDioxin 37.7 522 281 269 218 0 U 38.4

PCB 8 NonDioxin 930 15,700 10,900 9,360 9,110 764 936

PCB 9 NonDioxin 34.6 716 402 374 320 39.7 46.5

PCB 10 NonDioxin 49.4 673 527 399 402 0 U 0 U

PCB 11 NonDioxin 433 3,890 3,940 3,150 3,360 414 U 446 U

PCB 12/13 NonDioxin 438 6,080 5,240 4,430 4,850 345 419

PCB 14 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 15 NonDioxin 2,490 29,900 26,700 22,800 27,800 2,490 2,900

PCB 16 NonDioxin 368 5,220 3,120 2,790 2,570 583 640

PCB 17 NonDioxin 1,010 13,700 8,540 7,190 7,370 1,080 1,160

PCB 18/30 NonDioxin 931 14,700 9,710 8,500 8,090 1,430 1,610

PCB 19 NonDioxin 344 4,150 J 2,040 1,660 1,340 623 671

PCB 20/28 NonDioxin 5,190 61,900 45,700 39,800 44,700 11,100 12,900

PCB 21/33 NonDioxin 769 11,300 6,650 6,090 5,560 1,570 1,870

PCB 22 NonDioxin 840 12,300 7,930 7,200 7,000 1,630 1,870

PCB 23 NonDioxin 0 U 45.7 22.7 18.7 0 U 0 U 0 U

PCB 24 NonDioxin 0 U 217 128 117 104 0 U 0 U

PCB 25 NonDioxin 748 7,110 6,310 5,200 5,560 2,920 2,970

PCB 26/29 NonDioxin 1,040 12,400 10,900 8,850 9,720 2,310 2,470

PCB 27 NonDioxin 261 2,600 1,910 1,590 1,700 895 930

6/23/20106/18/20106/17/20106/17/20106/17/20106/23/2010 6/23/2010

308A301 303 305 307A 307B 308A

GC-SD301-0.0-0.5 GC-SD303-0.0-0.5 GC-SD305-0.0-0.5 GC-SD307A-0.0-0.5 D-062310-01 (dup)GC-SD307B-0.0-0.5 GC-SD308A-0.0-0.5

Page 29

Page 143: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/23/20106/18/20106/17/20106/17/20106/17/20106/23/2010 6/23/2010

308A301 303 305 307A 307B 308A

GC-SD301-0.0-0.5 GC-SD303-0.0-0.5 GC-SD305-0.0-0.5 GC-SD307A-0.0-0.5 D-062310-01 (dup)GC-SD307B-0.0-0.5 GC-SD308A-0.0-0.5

PCB 31 NonDioxin 3,450 44,400 35,200 29,900 31,600 4,640 5,420

PCB 32 NonDioxin 664 8,560 5,510 4,950 5,010 3,730 4,320

PCB 34 NonDioxin 31.7 437 312 245 278 0 U 0 U

PCB 35 NonDioxin 115 1,310 1,070 891 1,000 110 136

PCB 36 NonDioxin 0 U 80 92 65 74.9 0 U 0 U

PCB 37 NonDioxin 1,520 15,800 13,600 12,000 14,800 2,200 2,550

PCB 38 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 39 NonDioxin 27.8 333 256 221 240 57.7 R 76.4

PCB 40/41/71 NonDioxin 1,260 14,500 10,200 8,570 8,810 30,400 31,800

PCB 42 NonDioxin 601 6,960 5,090 4,180 4,280 14,200 15,000

PCB 43 NonDioxin 96.7 1,190 710 558 602 579 695

PCB 44/47/65 NonDioxin 2,670 25,700 18,800 18,800 16,600 68,800 76,000

PCB 45/51 NonDioxin 351 3,890 2,460 3,550 2,100 9,860 10,300

PCB 46 NonDioxin 88.8 1,090 702 617 555 4,570 4,360

PCB 48 NonDioxin 311 5,000 2,760 2,300 2,250 1,300 1,550

PCB 49/69 NonDioxin 1,960 20,400 15,900 14,100 14,400 57,300 64,600

PCB 50/53 NonDioxin 296 3,090 2,090 2,190 1,730 15,500 16,500

PCB 52 NonDioxin 2,630 22,900 17,200 15,200 14,700 109,000 129,000

PCB 54 NonDioxin 25.2 137 80.8 205 65.5 271 309

PCB 55 NonDioxin 35.2 480 335 297 291 0 U 0 U

PCB 56 NonDioxin 1,190 12,300 8,390 7,600 8,190 8,110 8,730

PCB 57 NonDioxin 26.5 299 226 180 194 95.3 97.3

PCB 58 NonDioxin 0 U 150 112 94.1 93.8 145 241

PCB 59/62/75 NonDioxin 219 2,540 1,800 1,500 1,540 2,560 2,960

PCB 60 NonDioxin 542 4,730 3,400 3,200 3,480 2,100 2,380

PCB 61/70/74/76 NonDioxin 4,770 45,800 32,300 27,600 30,900 64,700 71,500

PCB 63 NonDioxin 158 1,610 1,160 942 1,080 813 827

PCB 64 NonDioxin 913 9,990 7,120 6,040 6,180 12,700 14,000

PCB 66 NonDioxin 2,810 28,100 20,000 17,100 19,500 44,000 48,200

PCB 67 NonDioxin 93.9 1,240 833 699 750 577 624

PCB 68 NonDioxin 43.7 445 383 341 358 889 999

PCB 72 NonDioxin 51.6 587 497 379 427 715 771

PCB 73 NonDioxin 0 U 104 81.2 104 75.3 0 U 0 U

PCB 78 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 79 NonDioxin 41.5 235 185 177 202 1,800 1,720

PCB 80 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 82 NonDioxin 370 1,980 1,830 1,930 1,550 15,700 14,400

PCB 83/99 NonDioxin 2,020 12,400 10,400 12,100 10,200 95,000 115,000

PCB 84 NonDioxin 706 4,020 3,340 3,350 2,610 58,300 54,500

Page 30

Page 144: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/23/20106/18/20106/17/20106/17/20106/17/20106/23/2010 6/23/2010

308A301 303 305 307A 307B 308A

GC-SD301-0.0-0.5 GC-SD303-0.0-0.5 GC-SD305-0.0-0.5 GC-SD307A-0.0-0.5 D-062310-01 (dup)GC-SD307B-0.0-0.5 GC-SD308A-0.0-0.5

PCB 85/116/117 NonDioxin 596 3,170 3,100 3,160 2,670 26,000 24,400

PCB 86/87/97/109/119/125 NonDioxin 2,190 11,000 10,700 11,500 9,250 102,000 111,000

PCB 88/91 NonDioxin 474 3,300 2,810 3,260 2,440 37,100 38,400

PCB 89 NonDioxin 27.8 239 152 157 129 1,170 1,140

PCB 90/101/113 NonDioxin 3,310 18,900 16,200 19,700 16,100 155,000 163,000

PCB 92 NonDioxin 582 3,460 2,850 3,310 2,680 35,200 36,000

PCB 93/95/98/100/102 NonDioxin 2,270 12,700 11,100 12,800 8,740 178,000 177,000

PCB 94 NonDioxin 27.5 207 154 283 133 1,690 1,640

PCB 96 NonDioxin 19.5 146 107 160 92.5 1,540 1,430

PCB 103 NonDioxin 35.9 292 268 459 248 1,840 1,870

PCB 104 NonDioxin 0 U 21.9 0 U 78.1 0 U 64.6 67.6

PCB 106 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 107 NonDioxin 277 1,360 1,280 1,280 1,160 8,080 7,840

PCB 108/124 NonDioxin 137 579 550 614 538 4,710 4,640

PCB 110/115 NonDioxin 3,860 18,600 19,200 20,500 17,200 223,000 228,000

PCB 111 NonDioxin 0 U 20.1 21.6 22 19.9 0 U 0 U

PCB 112 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 120 NonDioxin 0 U 99 104 95.6 103 150 143

PCB 121 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 122 NonDioxin 44.6 222 208 218 187 1,380 1,460

PCB 127 NonDioxin 0 U 20 24.9 33.1 0 U 236 224

PCB 128/166 NonDioxin 775 2,870 3,060 3,760 2,950 35,700 32,400

PCB 129/138/160/163 NonDioxin 4,760 18,100 19,800 26,000 19,900 199,000 236,000

PCB 130 NonDioxin 284 1,110 1,180 1,420 1,220 12,700 11,800

PCB 131 NonDioxin 57.9 204 215 258 223 2,960 2,650

PCB 132 NonDioxin 1,540 5,170 5,420 7,540 6,100 87,500 82,300

PCB 133 NonDioxin 67 332 340 430 398 2,530 2,430

PCB 134/143 NonDioxin 217 843 872 1,140 912 13,400 12,000

PCB 135/151/154 NonDioxin 1,110 5,060 5,970 8,660 6,660 65,100 62,400

PCB 136 NonDioxin 388 1,800 1,660 2,680 1,870 29,800 27,400

PCB 137 NonDioxin 245 867 786 953 833 12,000 12,000

PCB 139/140 NonDioxin 74.1 311 319 389 328 3,820 3,660

PCB 141 NonDioxin 781 2,610 2,970 4,680 3,180 34,300 32,500

PCB 142 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 144 NonDioxin 159 654 803 1,140 913 8,930 8,220

PCB 145 NonDioxin 0 U 0 U 0 U 0 U 0 U 93.5 93.2

PCB 146 NonDioxin 651 2,780 2,930 3,860 3,380 26,500 26,600

PCB 147/149 NonDioxin 3,470 12,800 15,100 22,300 16,900 190,000 183,000

PCB 148 NonDioxin 0 U 60.3 66 97.5 71.8 242 247

Page 31

Page 145: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/23/20106/18/20106/17/20106/17/20106/17/20106/23/2010 6/23/2010

308A301 303 305 307A 307B 308A

GC-SD301-0.0-0.5 GC-SD303-0.0-0.5 GC-SD305-0.0-0.5 GC-SD307A-0.0-0.5 D-062310-01 (dup)GC-SD307B-0.0-0.5 GC-SD308A-0.0-0.5

PCB 150 NonDioxin 0 U 70.5 71.4 159 99.1 518 497

PCB 152 NonDioxin 0 U 26.6 21.4 65.7 31.1 320 331

PCB 153/168 NonDioxin 3,790 16,000 17,700 24,300 19,000 155,000 159,000

PCB 155 NonDioxin 0 U 19.6 21 30.8 20.7 0 U 0 U

PCB 158 NonDioxin 441 1,660 1,760 2,490 1,690 20,700 19,500

PCB 159 NonDioxin 36.1 121 142 280 166 1,400 1,370

PCB 161 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 162 NonDioxin 0 U 62.2 69.5 76.8 71.3 488 R 408

PCB 164 NonDioxin 274 1,050 1,160 1,680 1,260 14,300 13,100

PCB 165 NonDioxin 0 U 19.3 0 U 22.2 20.8 0 U 0 U

PCB 170 NonDioxin 902 3,380 4,210 6,940 5,160 28,600 25,900

PCB 171/173 NonDioxin 308 1,200 1,520 2,320 1,880 10,200 8,880

PCB 172 NonDioxin 176 679 820 1,320 992 4,990 4,810

PCB 174 NonDioxin 941 3,210 4,090 7,340 5,420 34,300 30,100

PCB 175 NonDioxin 46.6 179 235 370 320 1,350 1,270

PCB 176 NonDioxin 123 500 624 953 846 4,540 4,070

PCB 177 NonDioxin 627 2,390 2,960 4,350 3,800 15,900 15,000

PCB 178 NonDioxin 219 987 1,220 1,790 1,560 6,390 5,850

PCB 179 NonDioxin 386 1,670 2,070 3,020 2,590 14,100 13,100

PCB 180/193 NonDioxin 2,170 8,240 10,300 17,500 13,300 66,200 R 62,900

PCB 181 NonDioxin 0 U 40.6 43 64.7 61.1 403 376

PCB 182 NonDioxin 0 U 38.1 40.4 0 U 46.8 163 175

PCB 183/185 NonDioxin 755 2,860 3,670 5,560 4,700 24,400 22,100

PCB 184 NonDioxin 0 U 0 U 19.1 0 U 30.1 0 U 0 U

PCB 186 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 187 NonDioxin 1,400 5,920 7,510 10,700 9,800 42,300 40,500

PCB 188 NonDioxin 0 U 26.1 32.8 51.6 32.1 103 95.2

PCB 190 NonDioxin 194 803 989 1,600 1,160 5,150 4,990

PCB 191 NonDioxin 42.1 155 192 330 255 1,220 1,120

PCB 192 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

PCB 194 NonDioxin 551 2,140 2,560 4,240 2,510 12,400 12,700

PCB 195 NonDioxin 214 771 835 1,670 908 4,710 4,830

PCB 196 NonDioxin 313 1,140 1,490 2,530 1,970 7,560 7,390

PCB 197/200 NonDioxin 97.9 403 448 779 659 2,920 2,720

PCB 198/199 NonDioxin 650 3,100 3,920 5,970 5,080 18,800 19,000

PCB 201 NonDioxin 89.4 384 499 671 720 2,530 2,450

PCB 202 NonDioxin 187 852 1,070 1,230 1,090 3,990 3,840

PCB 203 NonDioxin 467 1,810 2,250 3,740 3,290 11,800 12,800

PCB 204 NonDioxin 0 U 0 U 0 U 0 U 0 U 0 U 0 U

Page 32

Page 146: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/23/20106/18/20106/17/20106/17/20106/17/20106/23/2010 6/23/2010

308A301 303 305 307A 307B 308A

GC-SD301-0.0-0.5 GC-SD303-0.0-0.5 GC-SD305-0.0-0.5 GC-SD307A-0.0-0.5 D-062310-01 (dup)GC-SD307B-0.0-0.5 GC-SD308A-0.0-0.5

PCB 205 NonDioxin 30.1 110 135 228 153 673 687

PCB 206 NonDioxin 397 2,120 2,360 3,190 2,600 11,300 11,700

PCB 207 NonDioxin 51 252 299 389 309 1,430 1,520

PCB 208 NonDioxin 153 857 1,090 1,200 1,160 3,430 3,510

PCB 209 NonDioxin 303 1,780 2,290 2,000 2,450 8,290 8,230

PCB Nondioxin 92,484 731,667 607,428 633,461 587,210 2,637,144 2,792,703

Total PCB Congeners 99,450 764,560 638,537 666,997 617,715 2,807,014 2,960,573

Page 33

Page 147: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

2,120 0.212 4,200 0.42 5,960 0.596 3,220 0.322 9,260 0.926 16,200 1.62 14,800 1.48

50.7 0.01521 94.9 0.02847 156 0.0468 92.1 0.02763 0 U 0 757 0.2271 756 0.2268

5,020 0.1506 8,060 0.2418 15,800 0.474 8,430 0.2529 41,700 1.251 72,200 2.166 65,200 1.956

249 0.00747 454 0.01362 939 0.02817 492 0.01476 2,890 0.0867 4,940 0.1482 4,460 0.1338

14,200 0.426 22,100 0.663 42,300 1.269 23,300 0.699 125,000 3.75 206,000 R 0 119,000 3.57

252 0.00756 408 0.01224 720 0.0216 342 0.01026 2,740 0.0822 3,400 0.102 3,100 0.093

60.8 6.08 115 11.5 151 15.1 69.2 6.92 0 U 0 971 97.1 965 96.5

2,200 0.066 3,170 0.0951 8,220 0.2466 4,380 0.1314 37,500 1.125 61,000 1.83 61,000 1.83

867 0.02601 1,190 0.0357 3,500 0.105 2,070 0.0621 18,800 0.564 24,200 0.726 26,100 0.783

0 U 0 0 U 0 0 U 0 0 U 0 0 U 0 0 U 0 0 U 0

248 0.00744 306 0.00918 1,300 0.039 704 0.02112 8,180 0.2454 14,400 0.432 14,100 0.423

6.99829 13.01911 17.92617 8.46117 8.0303 104.3513 106.9956

1,280 2,440 1,480 1,030 9,480 7,540 J 7,950 J

168 286 278 184 1,560 668 790

668 1,360 1,010 649 5,680 5,770 5,880 J

3,690 6,410 6,800 4,250 63,300 53,200 J 55,700 J

0 U 88.6 147 81.5 2,200 2,050 1,760

1,630 3,320 4,920 2,370 42,700 24,800 25,700

97.1 264 371 202 4,840 4,380 4,400

4,380 9,240 12,600 6,760 104,000 111,000 116,000

151 379 533 303 7,500 7,050 6,930

262 529 375 267 2,350 1,620 1,430

1,930 2,830 3,670 2,350 5,280 9,980 10,100

2,050 3,760 5,700 2,510 14,700 10,600 11,400

0 U 0 U 0 U 0 U 0 U 38.8 45.9

12,900 23,800 22,700 13,200 58,200 65,200 68,000

1,370 3,420 8,900 4,240 55,200 75,500 63,300

3,640 7,460 17,000 8,650 69,500 86,400 82,000

4,290 9,890 23,300 11,000 135,000 175,000 158,000

740 1,920 2,900 1,390 24,000 21,500 21,500 J

20,700 41,600 76,200 35,400 208,000 295,000 R 258,000

2,750 6,950 16,600 7,880 92,400 143,000 119,000

3,550 7,960 19,200 8,540 70,000 101,000 94,300

0 U 0 U 42.7 0 U 0 U 379 368

52.2 148 271 159 1,900 2,100 2,090

2,770 5,190 10,400 3,890 24,600 25,400 25,500

4,690 9,360 14,100 7,120 45,700 55,700 54,500

959 1,720 3,450 1,690 11,500 13,100 12,100

6/18/20106/24/2010 6/18/20106/18/2010 6/18/20106/23/20106/24/2010

308B 309 314310 312 313 314

GC-SD308B-0.0-0.5 GC-SD309-0.0-0.5 GC-SD310-0.0-0.5 GC-SD312-0.0-0.5 D-06182010-01 (dup)GC-SD313-0.0-0.5 GC-SD314-0.0-0.5

Page 34

Page 148: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/24/2010 6/18/20106/18/2010 6/18/20106/23/20106/24/2010

308B 309 314310 312 313 314

GC-SD308B-0.0-0.5 GC-SD309-0.0-0.5 GC-SD310-0.0-0.5 GC-SD312-0.0-0.5 D-06182010-01 (dup)GC-SD313-0.0-0.5 GC-SD314-0.0-0.5

15,100 30,100 59,600 27,000 176,000 263,000 R 221,000

2,560 4,710 R 10,600 4,910 36,300 58,700 54,000

127 254 374 182 1,010 1,200 1,230

537 951 1,460 788 2,660 4,120 4,020

0 U 57.8 0 U 0 U 0 U 275 179

7,270 14,500 18,800 10,200 50,000 72,700 67,900

0 U 0 U 0 U 0 U 0 U 147 194

128 226 457 214 934 1,260 1,330

5,960 10,500 24,300 10,400 70,200 103,000 96,900

2,890 5,220 11,800 5,350 35,300 52,100 50,400

386 683 1,780 758 5,940 9,470 8,860

11,100 19,300 48,300 20,300 138,000 193,000 R 128,000

1,460 2,810 8,270 3,710 33,100 37,700 33,600

444 845 2,220 942 10,700 12,100 10,300

1,290 2,830 8,710 3,530 28,200 47,900 44,900

9,710 15,000 39,400 16,900 92,700 128,000 87,800

1,530 2,350 6,650 2,880 23,600 30,200 27,100

11,100 17,900 50,200 21,000 143,000 226,000 R 155,000

0 U 72.8 186 108 1,070 619 625

165 279 811 221 1,870 3,550 3,330

4,910 9,460 19,500 9,870 42,400 71,700 69,600

103 209 290 134 661 1,130 1,150

66.5 107 133 75 0 U 457 624

997 1,940 3,950 1,760 12,700 18,100 17,500

2,060 4,080 9,700 4,860 24,800 45,400 45,300

18,800 32,900 82,900 36,200 170,000 299,000 R 214,000

637 1,130 2,290 1,100 4,800 7,760 7,700

3,960 7,320 20,600 8,710 50,500 80,200 76,800

12,800 21,400 43,200 21,000 90,100 151,000 R 110,000

421 836 2,210 811 4,390 6,420 6,610

244 354 530 293 662 654 787

273 441 621 321 908 1,120 1,240

0 U 0 U 0 U 0 U 0 U 370 436

0 U 0 U 0 U 0 U 0 U 0 U 0 U

185 255 630 270 964 1,560 1,980

0 U 0 U 0 U 0 U 0 U 0 U 0 U

1,390 2,000 4,700 2,600 11,100 20,000 17,200

9,820 13,100 41,900 29,600 188,000 149,000 R 152,000

3,350 4,110 9,510 5,270 29,800 44,700 39,400

Page 35

Page 149: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/24/2010 6/18/20106/18/2010 6/18/20106/23/20106/24/2010

308B 309 314310 312 313 314

GC-SD308B-0.0-0.5 GC-SD309-0.0-0.5 GC-SD310-0.0-0.5 GC-SD312-0.0-0.5 D-06182010-01 (dup)GC-SD313-0.0-0.5 GC-SD314-0.0-0.5

2,450 3,450 7,860 4,120 17,900 31,700 28,700

8,760 12,000 34,100 17,700 89,700 144,000 R 91,900

2,840 3,350 11,700 8,110 59,400 53,700 56,000

110 177 455 250 1,520 2,320 2,100

14,500 19,900 76,300 41,400 273,000 365,000 R 321,000

2,780 3,400 9,050 4,960 31,400 50,600 54,100

12,200 14,200 46,500 25,400 210,000 300,000 R 217,000

130 179 459 271 1,190 R 1,140 1,080

100 136 395 232 1,770 1,770 1,540

252 372 1,480 1,310 11,600 8,630 9,610

0 U 0 U 63.5 40.7 0 U 59.4 64.2

0 U 0 U 0 U 0 U 0 U 0 U 0 U

1,110 1,380 3,310 1,910 5,880 11,600 10,900

459 649 1,760 927 3,940 7,540 7,140

18,100 21,900 66,000 32,800 164,000 262,000 R 177,000

0 U 0 U 0 U 0 U 0 U 38.4 33.7

0 U 0 U 0 U 0 U 0 U 0 U 0 U

56.4 121 234 214 1,200 829 1,010

0 U 0 U 0 U 0 U 0 U 0 U 0 U

170 214 573 289 1,340 2,260 2,010

0 U 0 U 0 U 0 U 0 U 244 410

3,370 3,930 10,500 5,940 39,100 64,200 63,400

23,500 25,000 128,000 60,700 441,000 681,000 R 605,000

1,290 1,450 4,940 2,430 13,400 23,800 25,000

259 256 920 513 3,890 6,120 6,330

7,040 7,450 34,400 16,000 119,000 211,000 153,000

366 408 1,430 814 5,590 9,280 9,500

1,110 1,160 4,650 2,470 21,500 32,300 35,100

6,860 8,010 45,600 26,300 230,000 391,000 R 298,000

2,280 2,600 14,100 8,010 66,500 81,800 120,000

992 876 2,580 1,680 9,010 13,500 15,900

369 373 1,400 913 7,150 9,100 11,000

3,670 3,980 26,900 11,600 109,000 204,000 155,000

0 U 0 U 0 U 0 U 0 U 0 U 0 U

947 1,060 5,820 2,820 25,500 57,600 60,900

0 U 0 U 0 U 0 U 0 U 56.8 56.7

3,250 3,600 19,000 10,300 72,800 115,000 129,000

19,000 19,900 132,000 69,800 551,000 742,000 R 681,000

50.1 69.1 321 355 2,470 2,220 2,510

Page 36

Page 150: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/24/2010 6/18/20106/18/2010 6/18/20106/23/20106/24/2010

308B 309 314310 312 313 314

GC-SD308B-0.0-0.5 GC-SD309-0.0-0.5 GC-SD310-0.0-0.5 GC-SD312-0.0-0.5 D-06182010-01 (dup)GC-SD313-0.0-0.5 GC-SD314-0.0-0.5

76.2 131 964 1,060 7,960 5,860 8,690

0 U 0 U 132 82.6 0 U 177 224

20,500 23,400 148,000 82,000 631,000 857,000 R 841,000

0 U 0 U 89.5 104 868 516 519

2,090 2,330 9,740 5,160 43,000 73,200 77,700

174 270 1,820 682 6,940 11,100 10,100

0 U 0 U 0 U 0 U 0 U 0 U 0 U

75.4 72.8 167 103 654 1,040 1,180

1,470 1,690 7,720 4,010 38,400 59,400 62,100

0 U 0 U 0 U 0 U 0 U 39 53.2

5,200 7,710 32,000 16,000 188,000 295,000 R 189,000

1,800 2,470 10,900 5,330 56,800 102,000 61,400

1,000 1,340 5,740 3,020 32,600 57,900 58,800

5,110 6,710 40,500 17,900 183,000 300,000 R 202,000

265 377 1,490 789 8,260 15,600 16,500

735 979 5,100 2,450 23,600 45,600 47,700

3,490 4,810 17,800 8,870 99,800 180,000 R 107,000

1,330 1,870 7,710 4,570 42,900 70,100 74,100

2,380 3,220 17,600 9,220 87,700 147,000 R 89,500

12,600 16,700 93,400 43,100 446,000 657,000 R 492,000

55 65.9 237 162 1,520 2,390 2,680

42.4 0 U 98.9 0 U 0 U 783 857

4,460 5,850 28,800 14,500 147,000 269,000 R 169,000

0 U 0 U 40.9 0 U 0 U 115 139

0 U 0 U 0 U 0 U 0 U 0 U 0 U

8,460 11,800 60,500 34,500 266,000 415,000 R 284,000

0 U 54.7 240 309 2,510 1,860 1,930

1,130 1,610 6,120 3,450 40,900 71,200 69,200

234 328 1,530 797 8,780 15,400 14,900

0 U 0 U 0 U 0 U 0 U 0 U 0 U

3,240 3,800 16,700 10,700 93,600 147,000 R 101,000

1,220 1,410 6,510 3,760 35,200 46,900 R 58,200

1,650 2,170 8,970 5,320 45,600 78,700 67,300

542 751 3,280 1,800 13,900 25,000 25,100

4,230 5,190 20,100 12,800 79,200 131,000 130,000

548 754 2,810 1,700 10,100 18,400 18,100

1,140 1,540 4,020 3,120 17,000 23,600 23,400

2,740 3,460 12,700 8,820 57,800 102,000 91,400

0 U 0 U 0 U 0 U 0 U 38.9 34.1

Page 37

Page 151: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/24/2010 6/18/20106/18/2010 6/18/20106/23/20106/24/2010

308B 309 314310 312 313 314

GC-SD308B-0.0-0.5 GC-SD309-0.0-0.5 GC-SD310-0.0-0.5 GC-SD312-0.0-0.5 D-06182010-01 (dup)GC-SD313-0.0-0.5 GC-SD314-0.0-0.5

152 218 857 561 5,530 8,670 8,350

2,970 3,220 8,040 6,810 20,600 30,800 30,200

385 357 1,090 835 2,760 4,980 4,910

1,090 1,220 2,900 2,050 4,620 6,110 6,360

2,570 2,630 4,560 2,440 4,910 4,830 4,880

440,015 655,904 2,073,307 1,055,846 7,886,531 3,836,404 9,769,540

465,283 696,002 2,152,353 1,098,945 8,132,601 4,034,472 10,079,021

Page 38

Page 152: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

13,900 1.39 11,700 1.17 13,300 1.33 5,370 0.537 4,770 0.477 3,940 0.394 5,450 0.545

691 0.2073 532 0.1596 572 0.1716 218 0.0654 205 0.0615 112 0.0336 146 0.0438

51,400 1.542 47,500 1.425 36,700 1.101 17,700 0.531 13,800 0.414 9,170 0.2751 11,000 0.33

3,610 0.1083 3,220 0.0966 2,360 0.0708 1,160 0.0348 976 0.02928 572 0.01716 611 0.01833

104,000 3.12 95,600 2.868 84,000 2.52 50,800 1.524 31,000 0.93 25,200 0.756 28,000 0.84

2,620 0.0786 2,530 0.0759 1,480 0.0444 758 0.02274 709 0.02127 439 0.01317 505 0.01515

539 53.9 442 44.2 261 26.1 113 11.3 110 11 81.6 8.16 148 14.8

33,600 1.008 36,500 1.095 14,400 0.432 9,290 0.2787 4,770 0.1431 3,610 0.1083 3,710 0.1113

13,900 0.417 16,000 0.48 5,480 0.1644 3,960 0.1188 1,890 0.0567 1,430 0.0429 1,420 0.0426

0 U 0 0 U 0 0 U 0 0 U 0 0 U 0 0 U 0 0 U 0

7,270 0.2181 7,490 0.2247 2,050 0.0615 1,570 0.0471 661 0.01983 454 0.01362 416 0.01248

61.9893 51.7948 31.9957 14.45954 13.15268 9.81385 16.75866

10,800 J 10,600 J 1,880 1,860 798 1,320 4,560 J

2,250 2,210 299 196 111 193 713

8,240 J 7,670 1,450 1,130 619 729 2,410

74,700 J 68,100 J 16,500 12,500 7,640 4,900 10,200 J

2,400 2,030 764 400 348 74.2 77.9

32,800 30,400 11,600 6,060 4,500 2,380 4,700

5,760 5,210 1,690 914 776 196 326

140,000 124,000 41,800 26,900 20,700 8,010 13,200

8,820 8,220 2,580 1,350 1,140 304 488

1,810 1,550 645 454 327 311 592

7,570 7,010 5,430 2,130 1,270 2,150 4,350

12,600 12,000 8,890 3,440 2,550 2,770 6,020

43.9 40.5 12.1 6.07 0 U 0 U 0 U

69,200 67,000 41,900 20,800 14,200 15,900 35,800

78,100 63,700 36,400 22,300 19,400 4,930 5,510

94,600 85,400 44,800 27,200 24,200 9,630 12,600

193,000 151,000 80,600 49,700 37,600 13,700 16,300

27,300 J 24,300 J 8,460 5,860 4,040 1,820 2,520

338,000 264,000 222,000 102,000 68,700 52,800 69,300

165,000 128,000 90,500 44,300 36,600 10,900 11,400

104,000 83,000 73,700 32,900 26,800 10,300 12,100

416 346 291 73.6 78.6 19.9 30.3

2,260 1,910 849 422 573 127 206

26,700 22,900 15,900 8,490 6,030 4,890 8,000

58,700 49,100 33,400 16,700 13,300 9,320 14,600

13,900 12,700 6,170 3,670 3,340 1,880 2,810

6/22/20106/22/20106/22/20106/18/2010 6/18/2010 6/21/20106/21/2010

315 318315 320319

D-06182010-02 (dup)

321 324

GC-SD320-0.0-0.5 GC-SD321-0.0-0.5 GC-SD324-0.0-0.5GC-SD315-0.0-0.5 GC-SD318-0.0-0.5 GC-SD319-0.0-0.5

Page 39

Page 153: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/22/20106/22/20106/22/20106/18/2010 6/18/2010 6/21/20106/21/2010

315 318315 320319

D-06182010-02 (dup)

321 324

GC-SD320-0.0-0.5 GC-SD321-0.0-0.5 GC-SD324-0.0-0.5GC-SD315-0.0-0.5 GC-SD318-0.0-0.5 GC-SD319-0.0-0.5

294,000 227,000 209,000 84,700 62,500 40,300 48,400

61,600 51,800 31,700 19,700 14,300 6,530 8,690

1,270 1,060 1,110 304 270 208 389

4,100 3,330 5,700 1,130 891 878 1,320

36.4 R 31.1 0 U 0 U 0 U 0 U 89

69,500 60,000 51,200 21,200 17,500 12,500 21,000

180 109 127 45.2 42.3 21.9 26.4

1,350 1,160 1,630 518 525 294 372

97,200 87,800 74,400 31,700 34,300 19,600 18,500

51,100 44,400 36,800 20,900 16,200 9,360 9,020

9,310 8,100 5,990 2,640 2,460 1,140 1,410

175,000 146,000 125,000 58,100 53,700 28,500 33,900

35,300 33,700 24,600 14,500 12,700 5,000 5,330

11,600 10,000 7,770 4,040 3,990 1,360 1,490

47,000 40,700 33,100 16,200 14,300 6,000 5,650

126,000 105,000 94,400 39,400 40,000 22,100 26,300

30,100 26,500 17,300 11,500 9,470 4,130 4,350

208,000 172,000 128,000 61,200 53,700 28,900 34,600

699 748 347 244 190 100 139

3,380 2,720 2,080 990 718 438 499

69,000 59,200 70,100 26,400 25,900 17,300 15,000

1,130 867 1,000 R 334 264 230 322

441 406 331 112 94.1 104 144

17,800 16,200 12,000 6,070 5,220 2,720 3,270

45,600 38,200 43,200 17,100 14,600 7,320 7,110

277,000 218,000 266,000 101,000 89,400 57,000 55,500

7,060 6,420 7,370 2,780 2,650 1,760 1,810

77,300 71,200 63,600 24,400 27,700 15,000 13,400

138,000 109,000 139,000 55,100 53,200 34,000 34,600

6,120 5,830 5,790 1,950 2,610 1,090 1,250

633 584 862 343 248 301 447

1,050 1,070 1,290 468 323 414 634

366 328 0 U 0 U 0 U 0 U 107

0 U 0 U 0 U 0 U 0 U 0 U 0 U

1,250 1,420 1,210 675 483 403 316

0 U 0 U 0 U 0 U 0 U 0 U 0 U

14,700 11,100 11,200 5,400 5,340 3,040 2,860

134,000 156,000 87,700 59,300 35,400 23,500 20,200

33,300 28,600 22,000 12,700 10,700 6,190 5,990

Page 40

Page 154: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/22/20106/22/20106/22/20106/18/2010 6/18/2010 6/21/20106/21/2010

315 318315 320319

D-06182010-02 (dup)

321 324

GC-SD320-0.0-0.5 GC-SD321-0.0-0.5 GC-SD324-0.0-0.5GC-SD315-0.0-0.5 GC-SD318-0.0-0.5 GC-SD319-0.0-0.5

24,300 20,600 16,200 8,780 7,220 4,610 4,830

85,100 78,900 65,400 37,800 28,300 18,200 16,800

44,900 58,000 24,800 16,700 11,500 7,250 5,700

1,920 1,510 1,270 646 760 334 361

229,000 232,000 139,000 87,500 44,700 33,000 29,200

33,500 31,900 18,200 11,200 6,620 4,730 5,300

169,000 178,000 86,700 65,700 40,100 22,300 21,000

964 897 650 422 411 218 255

1,600 1,760 747 541 534 229 262

7,190 11,200 2,040 2,160 1,450 648 682

77.5 233 52.2 54.5 32.5 31.8 36.2

0 U 0 U 0 U 0 U 0 U 0 U 0 U

7,700 5,960 5,930 2,840 2,190 1,630 1,880

5,200 4,420 3,350 1,550 1,230 754 913

141,000 139,000 113,000 70,800 40,400 33,900 29,000

32 34.9 17.7 R 14.5 0 U 17.5 29.5

0 U 0 U 0 U 0 U 0 U 0 U 0 U

759 1,150 262 260 137 144 171

0 U 88.8 0 U 0 U 0 U 8.53 0 U

1,670 1,330 1,220 482 493 275 326

216 280 0 U 0 U 0 U 0 U 32.5

36,200 35,200 17,800 11,000 6,130 4,720 4,620

413,000 417,000 164,000 143,000 68,300 45,300 35,600

13,800 13,600 6,890 3,970 2,470 1,670 1,860

3,570 3,980 1,530 R 890 558 314 391

109,000 111,000 41,200 36,100 19,500 12,900 10,500

5,260 5,960 1,870 R 1,180 713 493 595

19,600 20,800 6,680 R 5,040 3,000 1,620 1,700

224,000 249,000 57,500 63,500 27,800 17,300 15,500

62,800 71,000 14,400 R 16,600 8,950 4,780 4,270

8,970 10,700 5,100 2,730 1,800 1,230 1,270

6,450 7,850 2,160 R 1,450 892 484 620

104,000 114,000 33,100 32,000 13,300 8,020 6,430

0 U 0 U 0 U 0 U 0 U 0 U 0 U

29,100 26,900 6,910 6,040 3,150 1,690 1,760

47.3 39.1 27 R 12.3 0 U 7.15 0 U

68,500 85,800 22,000 21,700 9,880 7,090 6,290

491,000 554,000 153,000 157,000 74,600 41,700 33,500

1,870 2,820 434 R 402 242 145 163

Page 41

Page 155: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/22/20106/22/20106/22/20106/18/2010 6/18/2010 6/21/20106/21/2010

315 318315 320319

D-06182010-02 (dup)

321 324

GC-SD320-0.0-0.5 GC-SD321-0.0-0.5 GC-SD324-0.0-0.5GC-SD315-0.0-0.5 GC-SD318-0.0-0.5 GC-SD319-0.0-0.5

5,810 10,300 1,070 1,400 771 339 390

217 266 73.1 90.3 75.1 42.3 50.2

599,000 690,000 188,000 187,000 81,000 50,900 39,100

459 766 112 141 66.9 51.5 55.3

39,400 43,300 15,900 11,900 5,530 3,680 3,120

5,450 5,820 2,300 2,110 860 560 355

0 U 0 U 0 U 0 U 0 U 0 U 0 U

602 610 269 R 139 73.4 84.3 98.7

33,300 35,000 11,700 8,680 4,300 2,660 2,400

31 65.3 25.3 0 U 0 U 0 U 25.4

116,000 129,000 55,500 44,400 17,700 15,800 9,650

51,600 49,100 15,900 17,800 5,760 4,410 3,620

29,500 27,800 9,760 9,770 2,910 2,460 1,900

109,000 133,000 58,900 45,300 21,000 16,200 10,800

8,180 8,120 2,390 2,000 766 520 599

24,100 23,200 6,910 6,510 2,600 1,630 1,630

92,000 80,800 26,700 22,000 9,470 8,740 6,820

39,400 39,200 11,700 11,500 4,190 3,080 2,780

84,600 66,000 24,100 23,100 9,490 6,210 5,750

299,000 340,000 153,000 122,000 45,200 30,700 25,500

1,520 1,650 412 430 145 115 107

458 385 129 91.1 51.5 51.6 74.1

101,000 115,000 44,200 35,200 14,800 11,400 9,260

101 105 40.9 24.7 0 U 17.5 30.6

0 U 0 U 0 U 0 U 0 U 0 U 0 U

178,000 222,000 89,900 75,500 30,900 20,900 18,600

1,490 2,230 329 398 165 111 107

37,900 39,100 12,300 13,300 3,570 2,900 2,120

8,110 7,870 2,430 2,450 771 582 522

0 U 0 U 0 U 0 U 0 U 0 U 0 U

75,900 78,300 31,800 21,500 8,510 6,860 4,880

28,600 33,500 13,800 9,260 3,350 2,440 1,530

39,400 41,900 17,400 11,700 4,410 3,270 3,150

13,400 13,300 5,620 3,150 1,350 991 1,050

73,100 77,000 40,800 22,500 9,460 7,730 8,210

9,920 10,300 4,630 2,160 1,220 813 1,140

12,700 14,500 7,940 3,850 1,870 1,650 1,760

56,700 57,300 25,600 15,600 6,030 4,870 5,190

29.1 26.6 10.3 4.98 0 U 0 U 0 U

Page 42

Page 156: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/22/20106/22/20106/22/20106/18/2010 6/18/2010 6/21/20106/21/2010

315 318315 320319

D-06182010-02 (dup)

321 324

GC-SD320-0.0-0.5 GC-SD321-0.0-0.5 GC-SD324-0.0-0.5GC-SD315-0.0-0.5 GC-SD318-0.0-0.5 GC-SD319-0.0-0.5

4,520 5,120 1,480 1,000 441 300 309

19,400 20,800 15,300 6,390 3,370 3,300 3,560

1,690 2,890 2,210 742 441 372 433

2,840 4,650 5,070 1,810 987 1,220 1,550

5,520 4,720 5,100 2,910 1,510 2,430 3,080

8,091,652 7,910,886 4,227,280 2,650,774 1,640,005 1,015,419 1,046,401

8,323,182 8,132,400 4,387,883 2,741,713 1,698,896 1,060,428 1,097,807

Page 43

Page 157: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 77 Dioxin 0.0001

PCB 81 Dioxin 0.0003

PCB 105 Dioxin 0.00003

PCB 114 Dioxin 0.00003

PCB 118 Dioxin 0.00003

PCB 123 Dioxin 0.00003

PCB 126 Dioxin 0.1

PCB 156/157 Dioxin 0.00003

PCB 167 Dioxin 0.00003

PCB 169 Dioxin 0.03

PCB 189 Dioxin 0.00003

PCB Dioxin

PCB 1 NonDioxin

PCB 2 NonDioxin

PCB 3 NonDioxin

PCB 4 NonDioxin

PCB 5 NonDioxin

PCB 6 NonDioxin

PCB 7 NonDioxin

PCB 8 NonDioxin

PCB 9 NonDioxin

PCB 10 NonDioxin

PCB 11 NonDioxin

PCB 12/13 NonDioxin

PCB 14 NonDioxin

PCB 15 NonDioxin

PCB 16 NonDioxin

PCB 17 NonDioxin

PCB 18/30 NonDioxin

PCB 19 NonDioxin

PCB 20/28 NonDioxin

PCB 21/33 NonDioxin

PCB 22 NonDioxin

PCB 23 NonDioxin

PCB 24 NonDioxin

PCB 25 NonDioxin

PCB 26/29 NonDioxin

PCB 27 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

3,080 0.308 2,790 0.279 9,340 0.934 3,750 0.375 3,050 0.305

74.2 0.02226 70 0.021 150 0.045 74.3 0.02229 74.4 0.02232

5,780 0.1734 6,470 0.1941 12,200 0.366 3,520 0.1056 3,780 0.1134

352 0.01056 416 0.01248 623 0.01869 188 0.00564 208 0.00624

15,200 0.456 20,700 0.621 38,300 1.149 9,900 0.297 10,300 0.309

276 0.00828 392 0.01176 512 0.01536 190 0.0057 192 0.00576

50 5 46 4.6 182 18.2 69.3 6.93 68.2 6.82

1,900 0.057 2,230 0.0669 4,050 0.1215 1,050 0.0315 1,080 0.0324

700 0.021 927 0.02781 1,350 0.0405 361 0.01083 408 0.01224

0 U 0 0 U 0 0 U 0 0 U 0 0 U 0

180 0.0054 184 0.00552 421 0.01263 89.7 0.002691 98.8 0.002964

6.0619 5.83957 20.90268 7.786251 7.629324

1,140 1,040 6,650 J 4,620 J 4,520 J

200 166 2,510 839 761

623 540 4,870 J 2,380 J 2,180 J

4,130 3,620 21,100 J 8,380 J 8,370 J

50 36.5 200 32.9 38.1

1,920 1,690 7,210 3,570 3,560

158 137 718 188 197

6,250 5,550 22,400 9,390 9,490

226 202 894 296 318

273 235 660 441 447

2,150 1,680 22,100 3,900 3,320

2,400 2,100 15,900 5,290 5,080

5.08 0 U 28.8 0 U 0 U

12,800 11,800 62,000 26,200 27,200

3,490 2,830 11,300 1,840 2,080

6,960 6,610 25,600 6,290 6,470

10,200 9,260 32,000 6,690 6,990

1,500 1,260 5,940 J 1,760 J 1,530

36,500 36,800 113,000 41,800 41,800

7,480 6,390 19,700 4,730 4,680

7,880 6,320 24,400 6,040 6,270

15.2 10.4 43.3 0 U 0 U

104 78.3 436 74.1 86.5

4,380 4,230 14,900 5,500 5,340

8,210 7,790 25,800 10,000 9,800

1,450 1,280 5,160 1,560 1,620

6/18/20106/18/20106/17/20106/21/20106/21/2010

324 330 333

D-06212010-01 (dup)

325 326

GC-SD325-0.0-0.5 GC-SD326-0.0-0.5 GC-SD330-0.0-0.5 GC-SD333-0.0-0.5

Page 44

Page 158: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 31 NonDioxin

PCB 32 NonDioxin

PCB 34 NonDioxin

PCB 35 NonDioxin

PCB 36 NonDioxin

PCB 37 NonDioxin

PCB 38 NonDioxin

PCB 39 NonDioxin

PCB 40/41/71 NonDioxin

PCB 42 NonDioxin

PCB 43 NonDioxin

PCB 44/47/65 NonDioxin

PCB 45/51 NonDioxin

PCB 46 NonDioxin

PCB 48 NonDioxin

PCB 49/69 NonDioxin

PCB 50/53 NonDioxin

PCB 52 NonDioxin

PCB 54 NonDioxin

PCB 55 NonDioxin

PCB 56 NonDioxin

PCB 57 NonDioxin

PCB 58 NonDioxin

PCB 59/62/75 NonDioxin

PCB 60 NonDioxin

PCB 61/70/74/76 NonDioxin

PCB 63 NonDioxin

PCB 64 NonDioxin

PCB 66 NonDioxin

PCB 67 NonDioxin

PCB 68 NonDioxin

PCB 72 NonDioxin

PCB 73 NonDioxin

PCB 78 NonDioxin

PCB 79 NonDioxin

PCB 80 NonDioxin

PCB 82 NonDioxin

PCB 83/99 NonDioxin

PCB 84 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/18/20106/17/20106/21/20106/21/2010

324 330 333

D-06212010-01 (dup)

325 326

GC-SD325-0.0-0.5 GC-SD326-0.0-0.5 GC-SD330-0.0-0.5 GC-SD333-0.0-0.5

26,400 26,300 76,800 29,400 29,000

6,030 5,200 16,800 4,710 4,750

191 154 912 305 273

792 604 3,400 1,230 981

0 U 23 206 92.7 82.2

8,600 8,650 33,100 12,500 13,200

18.4 14.1 60.5 0 U 0 U

230 201 816 258 232

13,000 12,000 35,000 9,270 9,030

6,340 5,910 20,700 4,180 4,230

819 691 2,700 605 572

20,700 18,500 68,000 16,200 15,800

3,560 3,050 9,960 1,820 1,810

1,080 790 2,780 543 544

3,980 3,540 11,600 2,030 1,950

15,600 20,900 52,500 14,200 13,500

3,070 2,880 8,080 1,710 1,640

22,400 20,400 65,400 14,700 14,000

67.2 58.5 191 60.2 J 43.4

217 188 594 244 233

11,100 11,200 28,500 6,900 6,920

171 203 590 235 220

76.3 72.5 508 117 121

2,040 1,730 7,330 1,610 1,600

4,350 4,280 6,660 2,660 2,630

36,800 38,700 86,100 26,300 25,400

1,050 1,010 3,450 1,040 1,000

9,360 9,600 27,300 5,540 5,560

23,300 25,000 60,900 17,900 17,800

810 834 2,170 701 669

256 233 1,120 390 348

327 334 1,830 497 468

0 U 0 U 210 89.5 78.3

0 U 0 U 0 U 0 U 0 U

253 311 668 137 135

0 U 0 U 0 U 0 U 0 U

2,020 1,780 4,450 889 1,000

12,800 19,100 34,400 6,920 7,160

4,230 4,650 11,300 2,090 2,270

Page 45

Page 159: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 85/116/117 NonDioxin

PCB 86/87/97/109/119/125 NonDioxin

PCB 88/91 NonDioxin

PCB 89 NonDioxin

PCB 90/101/113 NonDioxin

PCB 92 NonDioxin

PCB 93/95/98/100/102 NonDioxin

PCB 94 NonDioxin

PCB 96 NonDioxin

PCB 103 NonDioxin

PCB 104 NonDioxin

PCB 106 NonDioxin

PCB 107 NonDioxin

PCB 108/124 NonDioxin

PCB 110/115 NonDioxin

PCB 111 NonDioxin

PCB 112 NonDioxin

PCB 120 NonDioxin

PCB 121 NonDioxin

PCB 122 NonDioxin

PCB 127 NonDioxin

PCB 128/166 NonDioxin

PCB 129/138/160/163 NonDioxin

PCB 130 NonDioxin

PCB 131 NonDioxin

PCB 132 NonDioxin

PCB 133 NonDioxin

PCB 134/143 NonDioxin

PCB 135/151/154 NonDioxin

PCB 136 NonDioxin

PCB 137 NonDioxin

PCB 139/140 NonDioxin

PCB 141 NonDioxin

PCB 142 NonDioxin

PCB 144 NonDioxin

PCB 145 NonDioxin

PCB 146 NonDioxin

PCB 147/149 NonDioxin

PCB 148 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/18/20106/17/20106/21/20106/21/2010

324 330 333

D-06212010-01 (dup)

325 326

GC-SD325-0.0-0.5 GC-SD326-0.0-0.5 GC-SD330-0.0-0.5 GC-SD333-0.0-0.5

3,040 3,150 7,980 1,740 1,880

11,100 13,200 26,300 5,280 5,610

3,800 5,630 8,660 1,890 2,010

221 164 672 97.1 106

18,500 23,900 45,600 8,990 9,570

3,140 4,220 10,200 2,030 2,100

15,600 16,800 36,000 6,630 7,020

146 119 442 126 123

157 130 421 86.4 84.1

379 389 962 187 190

19.2 18 19.6 0 U 0 U

0 U 0 U 0 U 0 U 0 U

1,080 1,270 3,380 854 892

511 606 939 292 304

20,600 25,400 48,000 9,930 10,700

12.8 13 R 82 19.4 0 U

0 U 0 U 0 U 0 U 0 U

87.3 108 445 85.3 83.2

6.97 0 U 20.4 0 U 0 U

200 189 364 103 122

0 U 0 U 0 U 0 U 0 U

2,550 2,580 5,910 1,370 1,540

19,800 27,000 39,800 8,360 9,120

1,070 949 2,830 579 636

185 186 447 81.3 91

6,530 6,130 13,100 2,480 2,760

277 290 904 206 218

1,010 992 2,080 455 489

7,780 9,370 17,100 3,280 3,580

2,340 2,690 5,530 1,020 1,110

699 740 1,400 338 357

276 293 821 158 169

3,530 3,150 5,110 1,060 1,160

0 U 0 U 0 U 0 U 0 U

822 724 1,880 339 381

4.79 4.09 R 19.1 0 U 0 U

3,200 4,820 8,050 1,630 1,760

19,900 24,700 35,300 6,880 7,630

69.5 73.2 160 45.8 46.7

Page 46

Page 160: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 150 NonDioxin

PCB 152 NonDioxin

PCB 153/168 NonDioxin

PCB 155 NonDioxin

PCB 158 NonDioxin

PCB 159 NonDioxin

PCB 161 NonDioxin

PCB 162 NonDioxin

PCB 164 NonDioxin

PCB 165 NonDioxin

PCB 170 NonDioxin

PCB 171/173 NonDioxin

PCB 172 NonDioxin

PCB 174 NonDioxin

PCB 175 NonDioxin

PCB 176 NonDioxin

PCB 177 NonDioxin

PCB 178 NonDioxin

PCB 179 NonDioxin

PCB 180/193 NonDioxin

PCB 181 NonDioxin

PCB 182 NonDioxin

PCB 183/185 NonDioxin

PCB 184 NonDioxin

PCB 186 NonDioxin

PCB 187 NonDioxin

PCB 188 NonDioxin

PCB 190 NonDioxin

PCB 191 NonDioxin

PCB 192 NonDioxin

PCB 194 NonDioxin

PCB 195 NonDioxin

PCB 196 NonDioxin

PCB 197/200 NonDioxin

PCB 198/199 NonDioxin

PCB 201 NonDioxin

PCB 202 NonDioxin

PCB 203 NonDioxin

PCB 204 NonDioxin

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/18/20106/17/20106/21/20106/21/2010

324 330 333

D-06212010-01 (dup)

325 326

GC-SD325-0.0-0.5 GC-SD326-0.0-0.5 GC-SD330-0.0-0.5 GC-SD333-0.0-0.5

153 175 180 49.5 52

20.9 26.9 47.4 0 U 0 U

19,100 23,900 41,000 8,250 9,070

27.2 28.6 96.2 0 U 0 U

1,650 1,840 3,380 661 730

228 189 362 68.5 72

0 U 0 U 0 U 0 U 0 U

53.8 58.2 122 30.9 36.8

1,310 1,330 2,580 514 547

12.2 0 U 33.7 0 U 0 U

5,180 5,550 9,670 1,840 2,170

1,670 1,600 3,710 660 756

872 930 2,010 349 428

5,490 5,200 10,400 1,740 2,050

234 198 592 115 131

697 589 1,800 297 365

3,320 3,840 7,650 1,440 1,740

1,210 1,210 3,270 649 794

2,600 2,470 6,370 1,130 1,350

12,100 14,600 24,100 4,560 5,710

42.6 50.1 88.5 23.1 23.8

30.7 31.7 143 24.3 26

4,130 4,210 9,400 1,660 2,080

9.68 10 42.7 0 U 0 U

0 U 0 U 0 U 0 U 0 U

9,220 12,600 19,700 3,920 4,850

45.2 51.6 52.2 23.5 21

1,010 1,080 2,180 408 479

201 209 457 83.7 92.6

0 U 0 U 0 U 0 U 0 U

2,430 2,520 6,190 1,240 1,760

849 840 1,380 380 515

1,570 1,340 3,970 741 1,070

434 497 1,190 247 298

3,530 3,620 12,800 2,160 2,960

428 397 1,530 332 392

969 987 3,580 665 801

2,300 2,300 6,550 1,300 1,790

0 U 0 U 0 U 0 U 0 U

Page 47

Page 161: Appendix L HHRA Combined

TABLE 2.12 Supplement a

PCB Congener Concentrations (ng/kg) in Surface Sediments and PCB Dioxin, PCB Non-dioxin, and PCB total calculations

Gowanus Canal Remedial Investigation

Brooklyn, New York

Parameter Type TEF

PCB 205 NonDioxin

PCB 206 NonDioxin

PCB 207 NonDioxin

PCB 208 NonDioxin

PCB 209 NonDioxin

PCB Nondioxin

Total PCB Congeners

Conc TEQ Conc TEQ Conc TEQ Conc TEQ Conc TEQ

6/18/20106/18/20106/17/20106/21/20106/21/2010

324 330 333

D-06212010-01 (dup)

325 326

GC-SD325-0.0-0.5 GC-SD326-0.0-0.5 GC-SD330-0.0-0.5 GC-SD333-0.0-0.5

119 126 349 71.5 102

2,270 2,790 7,600 2,020 1,880

228 289 524 290 269

935 997 2,550 802 901

2,170 1,950 8,740 1,840 1,910

600,025 641,357 1,669,923 447,092 457,462

627,617 675,582 1,737,051 466,284 476,721

Page 48

Page 162: Appendix L HHRA Combined

Gowanus Canal Remedial Investigation, Brooklyn, New York

Screening Toxicity Values from USEPA Regional Screening Level (RSL) Table, November 2010. sediment - screening toxicity value is residential RSL

surface water - screening toxicity value is tap water RSLair - screening toxicity value is ambient air RSLfish - screening toxicity value is fish tissue RSL from EPA Region III Website

Footnotes/DefinitionsARAR/TBC = Applicable or Relevant and Appropriate Requirement/ To Be ConsideredC = CarcinogenicCOPC = Chemical of Potential ConcernJ = Estimated ValueN = Noncarcinogenic

N/A = Not available or not applicable

NJ = Qualitative identification questionable due to poor resolution. Presumptively present at approximate quantityNRWQC = U.S. Environmental Protection Agency (USEPA). 2009. National Recommended Water Quality Criteria for Human Health for Consumption of Organism only from EPA's National Recommended Water Quality Criteria, Office of Water, Office of Science and Technology, 2009. NYSDEC = New York State DEC, Chapter X, Division of Water, Part 703: Surface Water and Groundwater Quality Standards and Groundwater Effluent Limitations . Values correspond to classification of canal (SD) and classification of Bay (I) and are the standards for Health - fish consumption and recreation.

Surrogates used for those Chemicals without a Screening Toxicity Value (RSL)1,3-dichlorobenzene - used 1,2-dichlorobenzene as surrogateacenaphthylene - used acenaphthalene as surrogatebenzo(g,h,i)perylene - used pyrene as surrogatechromoium - used hexavalent chromiumdimethyl phthalate - calculated based on PPRTV toxicity value form PPRTV profile dated 9/25/2007PCB dioxin - used 2,3,7,8-TCDD, however, did not use 2,3,7,8-TCDD RSL, but updated the RSL using the cancer slope factor for 2,3,7,8-TCDD from USEPA, 2005, Health Assessment Document for Polychlorinated Dibenzo-p-Dioxins, EPA 600/8-84-014F.PCB non-dioxin - used Total PCBsphenanthrene - used anthracene as surrogate

Notes for Tables 2.1 through 2.12Selection of Chemicals of Potential Concern

Page 163: Appendix L HHRA Combined

TABLE H-3.1

Exposed Sediment in Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Surface Sediment

Exposure Point

Exposed and near shore sediment in Gowanus Canal

Acenaphthene 35700ug/kg 460000366000 99% KM (Chebyshev) UCLug/kg366000

Benzo(a)anthracene 29300ug/kg 320000127000 95% Chebyshev (Mean, Sd) UCLug/kg127000

Benzo(a)pyrene 19700ug/kg 200000107000 97.5% KM (Chebyshev) UCLug/kg107000

Benzo(b)fluoranthene 21000ug/kg 210000113000 97.5% KM (Chebyshev) UCLug/kg113000

Benzo(k)fluoranthene 12500ug/kg 12000064600 97.5% KM (Chebyshev) UCLug/kg64600

Bis(2-ethylhexyl) phthalate 18800ug/kg 5700033400 95% KM (Chebyshev) UCLug/kg33400

Chrysene 29300ug/kg 320000253000 99% Chebyshev (Mean, Sd) UCLug/kg253000

Dibenz(a,h)anthracene 2080ug/kg 140006180 95% KM (Chebyshev) UCLug/kg6180

Fluoranthene 54500ug/kg 630000496000 99% Chebyshev (Mean, Sd) UCLug/kg496000

Indeno(1,2,3-c,d)pyrene 12700ug/kg 12000048900 95% Chebyshev (Mean, Sd) UCLug/kg48900

Naphthalene 2060ug/kg 91003410 95% KM (t) UCLug/kg3410

Pyrene 61100ug/kg 670000529000 99% Chebyshev (Mean, Sd) UCLug/kg529000

Aroclor 1248 195ug/kg 2200--- Max, detected in <3 samplesug/kg2200

Aroclor 1254 81.8ug/kg 590--- Max, detected in <3 samplesug/kg590

Aroclor 1260 338ug/kg 3400863 95% KM (BCA) UCLug/kg863

PCB Dioxin 20.5ng/kg 11140.2 95% Approximate Gamma UCLng/kg40.2

PCB Nondioxin 2520000ng/kg 147000005230000 95% Approximate Gamma UCLng/kg5230000

Total PCB Congeners 2610000ng/kg 151000005390000 95% Approximate Gamma UCLng/kg5390000

Aluminum 13800mg/kg 1890015900 95% Student's-t UCLmg/kg15900

Arsenic 13.1mg/kg 44.718.0 95% Approximate Gamma UCLmg/kg18

Cadmium 6.20mg/kg 20.29.62 95% Approximate Gamma UCLmg/kg9.62

Chromium 78.7mg/kg 13993.5 95% Student's-t UCLmg/kg93.5

Cobalt 8.95mg/kg 14.812.9 95% KM (Percentile Bootstrap) UCLmg/kg12.9

Copper 264mg/kg 790352 95% Approximate Gamma UCLmg/kg352

Iron 31400mg/kg 8700040000 95% Modified-t UCLmg/kg40000

Lead 660mg/kg 42201870 95% Chebyshev (Mean, Sd) UCLmg/kg1870

Manganese 273mg/kg 480314 95% Student's-t UCLmg/kg314

Vanadium 45.0mg/kg 61.250.1 95% Student's-t UCLmg/kg50.1

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 1/11/2011 12:02:50 PM

Page 164: Appendix L HHRA Combined

TABLE H-3.2

Surface Water in Canal, Dry Weather - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum

Detected Value

95 % UCL

StatisticUnits

Arithmetic

Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Surface Water

Exposure Point

Gowanus Canal

Benzene 1.20ug/l 11.02.24 95% KM (BCA)ug/l2.24

Benzo(a)anthracene 0.131ug/l 0.830.266 95% KM (Percentile Bootstrap)ug/l0.266

Benzo(a)pyrene 0.0863ug/l 0.660.66 95% KM (Percentile Bootstrap)ug/l0.66

Benzo(b)fluoranthene 0.216ug/l 0.880.299 95% KM (BCA)ug/l0.299

Bis(2-ethylhexyl) phthalate 2.51ug/l 5.602.45 95% KM (t)ug/l2.45

Indeno(1,2,3-c,d)pyrene 0.0847ug/l 0.220.132 95% KM (% Bootstrap)ug/l0.132

Arsenic 16.0ug/l 23.419.9 95% KM (Percentile Bootstrap)ug/l19.9

Chromium 11.7ug/l 99.718.9 95% KM (% Bootstrap)ug/l18.9

Copper 88.1ug/l 232172 95% KM (Percentile Bootstrap)ug/l172

Selenium 32.0ug/l 50.941.0 95% KM (Percentile Bootstrap)ug/l41

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 12/10/2010 1:11:10 PM

Page 165: Appendix L HHRA Combined

TABLE H-3.3

Surface Water in Canal, Wet Weather - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Surface Water

Exposure Point

Gowanus Canal

1,4-dichlorobenzene 0.431ug/l 0.870.59 95% KM (Percentile Bootstrap)ug/l0.59

Benzene 0.563ug/l 2.900.835 95% KM (BCA)ug/l0.835

Chloroform 0.423ug/l 0.690.559 95% KM (Percentile Bootstrap)ug/l0.559

Ethylbenzene 0.451ug/l 2.600.868 95% KM (Chebyshev)ug/l0.868

Tetrachloroethylene(PCE) 16.5ug/l 40.024.4 95% KM (Chebyshev)ug/l24.4

Benzo(a)anthracene 0.0758ug/l 0.150.104 95% KM (Percentile Bootstrap)ug/l0.104

Benzo(a)pyrene 0.103ug/l 0.300.205 95% KM (Percentile Bootstrap)ug/l0.205

Benzo(b)fluoranthene 0.154ug/l 0.330.189 95% KM (Percentile Bootstrap)ug/l0.189

Dibenz(a,h)anthracene 0.0742ug/l 0.110.101 95% KM (Percentile Bootstrap)ug/l0.101

Indeno(1,2,3-c,d)pyrene 0.309ug/l 1.100.50 95% KM (Chebyshev)ug/l0.5

Naphthalene 0.136ug/l 1.400.364 95% KM (Percentile Bootstrap)ug/l0.364

Arsenic 14.9ug/l 26.216.6 95% Student's-tug/l16.6

Chromium 6.72ug/l 29.38.53 95% Modified-tug/l8.53

Cobalt 4.96ug/l 3.90--- Max, detected in <3 samplesug/l3.9

Lead 13.0ug/l 26.814.9 95% Student's-tug/l14.9

Selenium 29.3ug/l 64.633.6 95% Approximate Gammaug/l33.6

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 11/29/2010 4:25:16 PM

Page 166: Appendix L HHRA Combined

TABLE H-3.4

Ambient Air at Canal Level,Round 1 - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Ambient air at canal level

Benzene 0.841ug/m3 1.100.914 95% Student's-t UCLug/m30.914

Chloroform 0.181ug/m3 0.280.222 95% KM (Percentile Bootstrap) UCLug/m30.222

Ethylbenzene 1.34ug/m3 5.102.25 95% H-UCLug/m32.25

Xylene, total 4.30ug/m3 16.010.1 95% Chebyshev (Mean, Sd) UCLug/m310.1

Naphthalene 1.10ug/m3 3.402.09 95% Approximate Gamma UCLug/m32.09

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 11/29/2010 12:35:38 PM

Page 167: Appendix L HHRA Combined

TABLE H-3.5

Ambient Air at Canal Level, Round 2 - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Ambient air at canal level

Benzene 1.38ug/m3 3.801.94 95% Approximate Gamma UCLug/m31.94

Chloroform 0.174ug/m3 0.240.205 95% KM (Percentile Bootstrap) UCLug/m30.205

Ethylbenzene 1.40ug/m3 4.402.12 95% Approximate Gamma UCLug/m32.12

Xylene, total 6.76ug/m3 28.017.3 95% KM (Chebyshev) UCLug/m317.3

Naphthalene 1.30ug/m3 2.602.19 95% Approximate Gamma UCLug/m32.19

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 11/29/2010 12:36:16 PM

Page 168: Appendix L HHRA Combined

TABLE H-3.6

Ambient Air at Street Level, Round 1 - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Ambient air at Street Level

Benzene 0.948ug/m3 2.301.26 95% Modified-t UCLug/m31.26

Chloroform 0.18ug/m3 0.390.245 95% KM (t) UCLug/m30.245

Ethylbenzene 0.894ug/m3 1.701.09 95% Student's-t UCLug/m31.09

Naphthalene 0.533ug/m3 1.301.39 Max,UCL exceeds max detected concentrationug/m31.3

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 11/29/2010 12:37:05 PM

Page 169: Appendix L HHRA Combined

TABLE H-3.7

Ambient Air at Street Level, Round 2 - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Air

Air

Exposure Point

Ambient air at Street Level

Benzene 0.982ug/m3 1.401.11 95% Student's-t UCLug/m31.11

Chloroform 0.206ug/m3 0.450.331 95% KM (Chebyshev) UCLug/m30.331

Ethylbenzene 0.956ug/m3 1.801.24 95% Approximate Gamma UCLug/m31.24

Naphthalene 1.19ug/m3 4.403.02 95% H-UCLug/m33.02

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 11/29/2010 12:37:43 PM

Page 170: Appendix L HHRA Combined

TABLE H-3.8

Striped Bass Filet from Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Striped Bass in Gowanus Canal

P,P'-DDE 8.46ug/kg 12.0--- Max, detected in <8 samplesug/kg12

P,P'-DDT 3.24ug/kg 9.60--- Max, detected in <8 samplesug/kg9.6

PCB Dioxin 3.35ng/kg 4.31--- Max, detected in <8 samplesng/kg4.31

PCB Nondioxin 331000ng/kg 409000--- Max, detected in <8 samplesng/kg409000

Total PCB Congeners 354000ng/kg 435000--- Max, detected in <8 samplesng/kg435000

Arsenic 0.53mg/kg 0.68--- Max, detected in <8 samplesmg/kg0.68

Mercury 0.194mg/kg 0.20--- Max, detected in <8 samplesmg/kg0.2

Selenium 1.51mg/kg 1.20--- Max, detected in <8 samplesmg/kg1.2

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA3 1/14/2011 10:02:58 AM

Page 171: Appendix L HHRA Combined

TABLE H-3.9

White Perch Filet from Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

White Perch in Gowanus Canal

PCB Dioxin 4.77ng/kg 5.08--- Max, detected in <8 samplesng/kg5.08

PCB Nondioxin 370000ng/kg 437000--- Max, detected in <8 samplesng/kg437000

Total PCB Congeners 393000ng/kg 462000--- Max, detected in <8 samplesng/kg462000

Mercury 0.175mg/kg 0.19--- Max, detected in <8 samplesmg/kg0.19

Selenium 1.55mg/kg 1.40--- Max, detected in <8 samplesmg/kg1.4

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA3 1/14/2011 10:03:30 AM

Page 172: Appendix L HHRA Combined

TABLE H-3.10

Atlantic Eel Filet from Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Eel in Gowanus Canal

Alpha-chlordane 13.5ug/kg 22.0--- Max, detected in <8 samplesug/kg22

Dieldrin 7.59ug/kg 17.0--- Max, detected in <8 samplesug/kg17

Gamma-chlordane 7.92ug/kg 13.0--- Max, detected in <8 samplesug/kg13

P,P'-DDD 27.3ug/kg 38.0--- Max, detected in <8 samplesug/kg38

P,P'-DDE 16.3ug/kg 25.0--- Max, detected in <8 samplesug/kg25

P,P'-DDT 20.1ug/kg 47.0--- Max, detected in <8 samplesug/kg47

PCB Dioxin 8.69ng/kg 14.1--- Max, detected in <8 samplesng/kg14.1

PCB Nondioxin 792000ng/kg 1220000--- Max, detected in <8 samplesng/kg1220000

Total PCB Congeners 862000ng/kg 1350000--- Max, detected in <8 samplesng/kg1350000

Arsenic 0.488mg/kg 0.50--- Max, detected in <8 samplesmg/kg0.5

Chromium 0.523mg/kg 0.67--- Max, detected in <8 samplesmg/kg0.67

Copper 2.12mg/kg 7.40--- Max, detected in <8 samplesmg/kg7.4

Cyanide, Total 1.25mg/kg 3.10--- Max, detected in <8 samplesmg/kg3.1

Mercury 0.098mg/kg 0.26--- Max, detected in <8 samplesmg/kg0.26

Selenium 1.57mg/kg 1.40--- Max, detected in <8 samplesmg/kg1.4

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA3 1/14/2011 10:02:12 AM

Page 173: Appendix L HHRA Combined

TABLE H-3.11

Blue Crab Edible Tissue and Hepatopancreas from Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Crab in Gowanus Canal

Benzo(a)anthracene 4.27ug/kg 15.77.70 95% KM (t) UCLug/kg7.7

Benzo(a)pyrene 7.28ug/kg 17.511.8 95% KM (Chebyshev) UCLug/kg11.8

Benzo(b)fluoranthene 4.82ug/kg 9.616.39 95% KM (BCA) UCLug/kg6.39

Dibenz(a,h)anthracene 3.56ug/kg 5.133.94 95% Student's-t UCLug/kg3.94

Indeno(1,2,3-c,d)pyrene 9.22ug/kg 12.39.91 95% Student's-t UCLug/kg9.91

PCB Dioxin 4.76ng/kg 5.545.04 95% Student's-t UCLng/kg5.04

PCB Nondioxin 135000ng/kg 167000143000 95% Student's-t UCLng/kg143000

Total PCB Congeners 157000ng/kg 194000166000 95% Student's-t UCLng/kg166000

Arsenic 1.21mg/kg 1.471.31 95% Student's-t UCLmg/kg1.31

Copper 9.65mg/kg 11.710.2 95% Student's-t UCLmg/kg10.2

Mercury 0.115mg/kg 0.1420.124 95% Student's-t UCLmg/kg0.124

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA3 1/13/2011 8:44:27 AM

Page 174: Appendix L HHRA Combined

TABLE H-3.12

All Surface Sediment in Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Overflow Surface Sediment

Exposure Point

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

2-methylnaphthalene 33700ug/kg 870000358000 99% KM (Chebyshev)ug/kg358000

Acenaphthene 41200ug/kg 580000309000 99% KM (Chebyshev)ug/kg309000

Benzo(a)anthracene 36500ug/kg 490000128000 95% Chebyshev (Mean, Sd)ug/kg128000

Benzo(a)pyrene 18700ug/kg 20000073200 97.5% KM (Chebyshev)ug/kg73200

Benzo(b)fluoranthene 19400ug/kg 21000079200 97.5% KM (Chebyshev)ug/kg79200

Benzo(k)fluoranthene 10600ug/kg 12000041000 97.5% KM (Chebyshev)ug/kg41000

Bis(2-ethylhexyl) phthalate 15600ug/kg 5700014600 95% KM (BCA)ug/kg14600

Chrysene 35600ug/kg 490000127000 95% Chebyshev (Mean, Sd)ug/kg127000

Dibenz(a,h)anthracene 1780ug/kg 140005460 97.5% KM (Chebyshev)ug/kg5460

Fluoranthene 51200ug/kg 630000180000 95% Chebyshev (Mean, Sd)ug/kg180000

Fluorene 26400ug/kg 540000231000 99% KM (Chebyshev)ug/kg231000

Indeno(1,2,3-c,d)pyrene 10600ug/kg 12000031400 95% Chebyshev (Mean, Sd)ug/kg31400

Naphthalene 61600ug/kg 1600000655000 99% KM (Chebyshev)ug/kg655000

Pyrene 60200ug/kg 670000387000 99% KM (Chebyshev)ug/kg387000

Aroclor 1248 128ug/kg 2200935 97.5% KM (Chebyshev)ug/kg935

Aroclor 1254 61.9ug/kg 590--- Max, detected in <3 samplesug/kg590

Aroclor 1260 318ug/kg 3400657 95% KM (t)ug/kg657

PCB Dioxin 19.5ng/kg 11145.3 95% Chebyshev (Mean, Sd) UCLng/kg45.3

PCB Nondioxin 2710000ng/kg 147000006440000 95% Chebyshev (Mean, Sd) UCLng/kg6440000

Total PCB Congeners 2810000ng/kg 151000006630000 95% Chebyshev (Mean, Sd) UCLng/kg6630000

Aluminum 13200mg/kg 1890014600 95% Student's-tmg/kg14600

Arsenic 12.1mg/kg 44.714.7 95% Modified-tmg/kg14.7

Cadmium 6.30mg/kg 20.29.99 95% Chebyshev (Mean, Sd)mg/kg9.99

Chromium 76.0mg/kg 13984.5 95% Modified-tmg/kg84.5

Cobalt 9.13mg/kg 14.811.0 95% KM (Percentile Bootstrap)mg/kg11

Copper 226mg/kg 790274 95% Modified-tmg/kg274

Iron 29200mg/kg 8700033600 95% Modified-tmg/kg33600

Lead 533mg/kg 42201200 95% Chebyshev (Mean, Sd)mg/kg1200

Manganese 276mg/kg 480306 95% Student's-tmg/kg306

PAGE 1 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 1/11/2011 12:00:36 PM

Page 175: Appendix L HHRA Combined

TABLE H-3.12

All Surface Sediment in Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Sediment

Overflow Surface Sediment

Exposure Point

Sediment deposited in areas adjacent to Gowanus Canal associated with canal overflow

Vanadium 42.6mg/kg 61.245.9 95% Student's-tmg/kg45.9

PAGE 2 of 2\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 1/11/2011 12:00:36 PM

Page 176: Appendix L HHRA Combined

TABLE H-3.13

Surface Water in Canal, Wet Weather - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water

Overflow Surface Water

Exposure Point

Canal Overflow – Surface Water

1,4-dichlorobenzene 0.431ug/l 0.870.59 95% KM (Percentile Bootstrap)ug/l0.59

Benzene 0.563ug/l 2.900.835 95% KM (BCA)ug/l0.835

Chloroform 0.423ug/l 0.690.559 95% KM (Percentile Bootstrap)ug/l0.559

Ethylbenzene 0.451ug/l 2.600.868 95% KM (Chebyshev)ug/l0.868

Tetrachloroethylene(PCE) 16.5ug/l 40.024.4 95% KM (Chebyshev)ug/l24.4

Benzo(a)anthracene 0.0758ug/l 0.150.104 95% KM (Percentile Bootstrap)ug/l0.104

Benzo(a)pyrene 0.103ug/l 0.300.205 95% KM (Percentile Bootstrap)ug/l0.205

Benzo(b)fluoranthene 0.154ug/l 0.330.189 95% KM (Percentile Bootstrap)ug/l0.189

Dibenz(a,h)anthracene 0.0742ug/l 0.110.101 95% KM (Percentile Bootstrap)ug/l0.101

Indeno(1,2,3-c,d)pyrene 0.309ug/l 1.100.50 95% KM (Chebyshev)ug/l0.5

Naphthalene 0.136ug/l 1.400.364 95% KM (Percentile Bootstrap)ug/l0.364

Arsenic 14.9ug/l 26.216.6 95% Student's-tug/l16.6

Chromium 6.72ug/l 29.38.53 95% Modified-tug/l8.53

Cobalt 4.96ug/l 3.90--- Max, detected in <3 samplesug/l3.9

Lead 13.0ug/l 26.814.9 95% Student's-tug/l14.9

Selenium 29.3ug/l 64.633.6 95% Approximate Gammaug/l33.6

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRA.accdb\rptHHRA3 11/29/2010 4:26:00 PM

Page 177: Appendix L HHRA Combined

TABLE H-3.14

Blue Crab Edible Tissue from Canal - Exposure Point Concentration

Gowanus Canal Remedial Investigation

Brooklyn, New York

Chemical of Potential Concern

Maximum Detected

Value95 % UCL

StatisticUnits

Arithmetic Mean Distribution UnitsValue

Exposure Point Concentration

Scenario Timeframe:

Medium:

Exposure Medium:

Current/Future

Surface Water/Sediment

Fish and Crab Tissue

Exposure Point

Crab in Gowanus Canal

Benzo(a)anthracene 4.19ug/kg 21.07.80 95% KM (t) UCLug/kg7.8

Benzo(a)pyrene 6.49ug/kg 22.813.5 95% KM (Chebyshev) UCLug/kg13.5

Benzo(b)fluoranthene 4.36ug/kg 11.46.14 95% KM (BCA) UCLug/kg6.14

Dibenz(a,h)anthracene 3.24ug/kg 5.783.99 95% KM (Percentile Bootstrap) UCLug/kg3.99

Indeno(1,2,3-c,d)pyrene 8.75ug/kg 13.79.87 95% Student's-t UCLug/kg9.87

PCB Dioxin 3.38ng/kg 4.523.86 95% Student's-t UCLng/kg3.86

PCB Nondioxin 99800ng/kg 149000113000 95% Student's-t UCLng/kg113000

Total PCB Congeners 115000ng/kg 171000131000 95% Student's-t UCLng/kg131000

Arsenic 1.38mg/kg 1.801.53 95% Student's-t UCLmg/kg1.53

Copper 11.3mg/kg 14.112.1 95% Student's-t UCLmg/kg12.1

Mercury 0.153mg/kg 0.200.168 95% Student's-t UCLmg/kg0.168

PAGE 1 of 1\\managed.local\critigen\Projects\Gowanis395863\Database\GowanusStatsHHRATissue.accdb\rptHHRA3 1/13/2011 8:44:01 AM

Page 178: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Recreational Adult

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment 50 mg/day EPA, 1991, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 24 years EPA, 1991

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Adolescent

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) IR-Sed Ingestion Rate of Sediment 50 mg/day EPA, 1991, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 6 years (5)

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 57 kg EPA, 1997, (6)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(1-6 years) IR-Sed Ingestion Rate of Sediment 100 mg/day EPA, 1991, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 6 years EPA, 1991

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Dermal Recreational Adult

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME CDI (mg/kg-day) =

SA Skin Surface Area Available for Contact 6,925 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.3 mg/cm2-day EPA, 2004, (8) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 24 years EPA, 1991

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

TABLE 4.1.RME

Page 1 of 30

Page 179: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

TABLE 4.1.RME

Dermal Recreational Adolescent

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME CDI (mg/kg-day) =

(12-18 years) SA Skin Surface Area Available for Contact 10,470 cm2EPA, 2004, (7) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 1997, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 6 years (5)

BW Body Weight 57 kg EPA, 1997, (6)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Dermal Recreational Child

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME CDI (mg/kg-day) =

(1-6 years) SA Skin Surface Area Available for Contact 2,800 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 6 years EPA, 1991

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Notes:

(1) Assumed sediment ingestion rate is equal to 1/2 of the incidental soil ingestion rate.

(2) Professional judgement, conservatively assumed recreational use of the canal would occur 1 day per week for one-half the year.

(3) SA includes head, hands, forearms, lower legs, and feet.

(4) Average adherence factor for children in wet soil.

(5) Professional Judgement assuming adolescents from 12 to 18 years of age.

(6) Body weight is average of the mean values for boys and girls for the ages 12 through 18.

(7) SA includes head, hands, arms, legs, and feet.

(8) Average adherence factor for reed gatherers (from Exhibit 3-3 of EPA, 2004).

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1997: Exposure Factors Handbook. EPA/ 600/P-95/Fa, Fb, and Fc.

EPA, 2000: Supplemental Guidance to RAGS: Region 4 Bulletins, Human Health Risk Assessment Bulletins. www.epa.gov/region4/waste/oftecser/healtbul.htm.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 2 of 30

Page 180: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Recreational Adult Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.05 l/hour EPA,1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 2.6 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 26 days/year (3)

ED Exposure Duration 24 years EPA, 1991

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Adolescent Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) IR-SW Ingestion Rate of Surface Water 0.05 l/hour EPA,1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 2.6 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 26 days/year (3)

ED Exposure Duration 6 years (4)

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 57 kg EPA, 1991, (5)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.05 l/hour EPA,1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 2.6 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 26 days/year (3)

ED Exposure Duration 6 years EPA, 1991

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Dermal Recreational Adult Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) =

τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 2.6 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 18,000 cm2 EPA, 2004 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 26 days/year (3)ED Exposure Duration 24 years EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 70 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

TABLE 4.2.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Page 3 of 30

Page 181: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.2.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Recreational Adolescent Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME CDI (mg/kg-day) =

(12-18 years) DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) =

τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 2.6 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 15,758 cm2 EPA, 1997, (6) 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 26 days/year (3)ED Exposure Duration 6 years (4) tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 57 kg EPA, 1991, (5) FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Child Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) =

τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 2.6 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 6,600 cm2 EPA, 2004 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 26 days/year (3)ED Exposure Duration 6 years EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 15 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Notes:

(1) Ingestion rate of surface water for swimming.

(2) National average time spent swimming per swimming event.

(3) Professional judgement, conservatively assumed recreational use of the canal would occur 1 day per week for one-half the year.

(4) Professional Judgement assuming adolescents from 12 to 18 years of age.

(5) Body weight is average of the mean values for boys and girls for the ages 12 through 18.

(6) Average total body surface area of boys and girls from 12 to 18 years of age.

Page 4 of 30

Page 182: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.2.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1997: Exposure Factors Handbook. EPA/ 600/P-95/Fa, Fb, and Fc.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 5 of 30

Page 183: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: AirExposure Medium: Air

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Inhalation Recreational Adult Ambient air at canal level Cair Chemical Concentration in Air

Tables 3.4.RME

and 3.5.RME mg/m3Tables 3.4.RME and

3.5.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 2.6 hr/day EPA, 1989, (1) CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 24 years EPA, 1991

CF1 Conversion Factor 1 1/24 day/hr - -

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Adolescent Ambient air at canal level Cair Chemical Concentration in Air

Tables 3.4.RME

and 3.5.RME mg/m3Tables 3.4.RME and

3.5.RME Exposure Concentration (EC) (mg/m3) =

(12-18 years) ET Exposure Time 2.6 hr/day EPA, 1989, (1) CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 6 years (3)

CF1 Conversion Factor 1 1/24 day/hr - -

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child Ambient air at canal level Cair Chemical Concentration in Air

Tables 3.4.RME

and 3.5.RME mg/m3Tables 3.4.RME and

3.5.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 2.6 hr/day EPA, 1989, (1) CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 26 days/year (2)

ED Exposure Duration 6 years EPA, 1991

CF1 Conversion Factor 1 1/24 day/hr - -

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Industrial Worker Adult Ambient air at street level Cair Chemical Concentration in Air

Tables 3.6.RME

and 3.7.RME mg/m3Tables 3.6.RME and

3.7.RME Exposure Concentration (EC) (mg/m3) =

EF Exposure Frequency 250 days/year EPA, 1991 CA x EF x ED x 1/AT

ED Exposure Duration 25 years EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 9,125 days EPA, 1989

Resident Adult Ambient air at street level Cair Chemical Concentration in Air

Tables 3.6.RME

and 3.7.RME mg/m3Tables 3.6.RME and

3.7.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 24 hr/day EPA, 1991 CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 350 days/year EPA, 1991

ED Exposure Duration 24 years EPA, 1991

CF1 Conversion Factor 1 1/24 day/hr - -

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Child Ambient air at street level Cair Chemical Concentration in Air

Tables 3.6.RME

and 3.7.RME mg/m3Tables 3.6.RME and

3.7.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 24 hr/day EPA, 1991 CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 350 days/year EPA, 1991

ED Exposure Duration 6 years EPA, 1991

CF1 Conversion Factor 1 1/24 day/hr - -

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

TABLE 4.3.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Page 6 of 30

Page 184: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: AirExposure Medium: Air

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.3.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Inhalation Resident Child/Adult Ambient air at street level Cair Chemical Concentration in Air

Tables 3.6.RME

and 3.7.RME mg/m3Tables 3.6.RME and

3.7.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 24 hr/day EPA, 1991 CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 350 days/year EPA, 1991

ED Exposure Duration 30 years EPA, 1991

CF1 Conversion Factor 1 1/24 day/hr - -

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

Notes:

(1) National average time spent swimming per swimming event.

(2) Professional judgement, conservatively assumed recreational use of the canal would occur 1 day per week for one-half the year.

(3) Professional Judgement assuming adolescents from 12 to 18 years of age.

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

Page 7 of 30

Page 185: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface Water / Sediment

Exposure Medium: Fish and Crab Tissue

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Angler Adult Striped Bass CFish Chemical Concentration in Fish

Tables 3.8.RME,

3.9.RME, and

3.10.RME mg/kg

Tables 3.8.RME,

3.9.RME, and

3.10.RME Chronic Daily Intake (CDI) (mg/kg-day) =

White Perch IR-Fish Ingestion of Fish 26 g/day EPA, 1997, (1) CFish x IR-Fish x FI x EF x ED x CF3 x 1/BW x 1/AT

Eel FI Fraction Ingested - fish specific unitless EPA, 2000

Striped Bass 0.47 unitless Connelly, 1992, (4)

White Perch 0.09 unitless Connelly, 1992, (4)

Eel 0.44 unitless Connelly, 1992, (4)

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 24 years EPA, 1991

CF3 Conversion Factor 3 0.001 kg/g - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Adolescent Striped Bass CFish Chemical Concentration in Fish

Tables 3.8.RME,

3.9.RME, and

3.10.RME mg/kg

Tables 3.8.RME,

3.9.RME, and

3.10.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) White Perch IR-Fish Ingestion of Fish 17 g/day (2) CFish x IR-Fish x FI x EF x ED x CF3 x 1/BW x 1/AT

Eel FI Fraction Ingested - fish specific unitless EPA, 2000

Striped Bass 0.47 unitless Connelly, 1992, (4)

White Perch 0.09 unitless Connelly, 1992, (4)

Eel 0.44 unitless Connelly, 1992, (4)

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 6 years EPA, 1991

CF Conversion Factor 0.001 kg/g - -

BW Body Weight 57 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child Striped Bass CFish Chemical Concentration in Fish

Tables 3.8.RME,

3.9.RME, and

3.10.RME mg/kg

Tables 3.8.RME,

3.9.RME, and

3.10.RME Chronic Daily Intake (CDI) (mg/kg-day) =

White Perch IR-Fish Ingestion of Fish 9 g/day (3) CFish x IR-Fish x FI x EF x ED x CF3 x 1/BW x 1/AT

Eel FI Fraction Ingested - fish specific unitless EPA, 2000

Striped Bass 0.47 unitless Connelly, 1992, (4)

White Perch 0.09 unitless Connelly, 1992, (4)

Eel 0.44 unitless Connelly, 1992, (4)

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 6 years EPA, 1991

CF Conversion Factor 0.001 kg/g - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Table 4.4.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 8 of 30

Page 186: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface Water / Sediment

Exposure Medium: Fish and Crab Tissue

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Table 4.4.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Ingestion Angler Adult Blue Crab CFish Chemical Concentration in Crab Table 3.11.RME mg/kg Table 3.11.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Fish Ingestion of Crab 23 g/day Burger, 2002 CFish x IR-Sed x EF x ED x CF3 x 1/BW x 1/AT

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 24 years EPA, 1991

CF3 Conversion Factor 3 0.001 kg/g - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Adolescent Blue Crab CFish Chemical Concentration in Crab Table 3.11.RME mg/kg Table 3.11.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) IR-Fish Ingestion of Crab 15 g/day (2) CFish x IR-Fish x EF x ED x CF3 x 1/BW x 1/AT

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 6 years EPA, 1991

CF3 Conversion Factor 3 0.001 kg/g - -

BW Body Weight 57 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child Blue Crab CFish Chemical Concentration in Crab Table 3.11.RME mg/kg Table 3.11.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Fish Ingestion of Crab 8 g/day (3) CFish x IR-Fish x EF x ED x CF3 x 1/BW x 1/AT

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 6 years EPA, 1991

CF Conversion Factor 0.001 kg/g - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Notes:

(1) 95th percentile recreational freshwater anglers fish ingestion rate.

(2) Ingestion rate assumed to be 2/3 the adult ingestion rate.

(3) There are no recreational fish ingestion values or crab ingestion values for children. Therefore, ingestion rate assumed to be 1/3 the adult ingestion rate.

(4) Bottom feeders percent consumption (44%) used to for eel, intermediate level percent consumption (47%) used for striped bass, and remaining percent (4%) used for white perch.

Sources:

Connelly, Nancy A., Barbara A. Knuth, and Carole A. Bisogni, 1992. Effects of the Health Advisory and Advisory Changes on Fishing Habits and Fish Consumption in New York Sport Fisheries.

Report for New York Sea Grant Institute Project No. R/FHD-2=PD. September.

Burger, 2002: Consumption Patterns and Why People Fish. Environmental Research Section A 90, 125-135.

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1997: Exposure Factors Handbook. EPA/ 600/P-95/Fa, Fb, and Fc.

Page 9 of 30

Page 187: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Overflow Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Industrial Worker Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment 100 mg/day EPA, 2002, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 9 days/year (2)

ED Exposure Duration 25 years EPA, 1991

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 9,125 days EPA, 1989

Residential Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment 100 mg/day EPA, 2002, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 9 days/year (2)

ED Exposure Duration 24 years EPA, 1991

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 70 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Child

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment 200 mg/day EPA, 2002, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 9 days/year (2)

ED Exposure Duration 6 years EPA, 1991

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 15 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

TABLE 4.5.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 10 of 30

Page 188: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Overflow Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.5.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Ingestion Residential Child/Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment-adjusted 114.3 mg-year/kg-day calculated CSed x IR-Sed x EF x CF x 1/AT

IR-Sedc Ingestion Rate of Sediment, child 200 mg/day EPA, 1991, (1)

IR-Seda Ingestion Rate of Sediment, adult 100 mg/day EPA, 1991, (1)

EF Exposure Frequency 9 days/year (2)

EDc Exposure Duration , child 6 years EPA, 1991 IR-Sed = (EDc x IR-Sedc/ BWc) +

EDa Exposure Duration, adult 24 years EPA, 1991 (EDa x IR-Seda/BWa)

CF Conversion Factor 0.000001 kg/mg - -

BWc Body Weight, child 15 kg EPA, 1991

BWa Body Weight, adult 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

Dermal Industrial Worker Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME CDI (mg/kg-day) =

SA Skin Surface Area Available for Contact 3,300 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (5) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 9 days/year (2)

ED Exposure Duration 25 years EPA, 1991

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 9,125 days EPA, 1989

Residential Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME CDI (mg/kg-day) =

SA Skin Surface Area Available for Contact 5,700 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 9 days/year (2)

ED Exposure Duration 24 years EPA, 1991

BW Body Weight 70 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Page 11 of 30

Page 189: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Overflow Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.5.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Residential Child

areas adjacent to

Gowanus Canal

associated with canal CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME CDI (mg/kg-day) =

SA Skin Surface Area Available for Contact 2,800 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 9 days/year (2)

ED Exposure Duration 6 years EPA, 1991

BW Body Weight 15 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child/Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME CDI (mg/kg-day) =

SAc

Skin Surface Area Available for Contact,

child 2,800 cm2EPA, 2004, (3) CSed x SA x DABS x CF x EF x 1/AT

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4)

EDc Exposure Duration, child 6 years EPA, 1991 SA = ((EDc x SAc/BWc) x SSAF) +

BWc Body Weight, child 15 kg EPA, 1991 ((EDa x SAa/BWa) x SSAF)

SAa

Skin Surface Area Available for Contact,

adult 5,700 cm2EPA, 2004, (3)

EDa Exposure Duration , adult 24 years EPA, 1991

BWa Body Weight ,adult 70 kg EPA, 1991

SA Skin Surface Area adjusted 615 cm2-year/kg-day calculated

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 9 days/year (2)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

Notes:

(1) Assumed sediment ingestion rate is equal to the incidental soil ingestion rate.

(2) Professional judgement, conservatively assumes canal overflows 3 times a year, and remains on surface 3 days per each overflow event.

(3) SA includes head, hands, forearms, lower legs, and feet (for child only) for residents and head, hands, and forearms for industrial worker.

(4) Average adherence factor for children in wet soil.

(5) Adherence factor for adult industrial worker from Exhibit 3-5 of EPA, 2004.

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 2002: Supplemental Guidance for Developing Soil Screening Levels for Superfund Sites. OSWER 9355.4-24.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 12 of 30

Page 190: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Overflow Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Industrial Worker Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.05 l/hour EPA, 1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 8 hr/day (2) 1/BW x 1/AT

EF Exposure Frequency 9 days/year (5)

ED Exposure Duration 25 years EPA, 1991

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Resident Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.05 l/hour EPA, 1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 2.6 hr/day EPA, 1989, (3) 1/BW x 1/AT

EF Exposure Frequency 9 days/year (5)

ED Exposure Duration 24 years EPA, 1991

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 70 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Child

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.05 l/hour EPA, 1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 2.6 hr/day EPA, 1989, (3) 1/BW x 1/AT

EF Exposure Frequency 9 days/year (5)

ED Exposure Duration 6 years EPA, 1991

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 15 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child/Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW-Adj Ingestion Rate of Surface Water, age-adjusted 0.037 l-year/kg-hour calculated CSW x IR-SW-adj x ET x EF x CF1 x 1/AT

IR-SWc Ingestion Rate of Surface Water, child 0.05 l/hour EPA, 1989, (1)

IR-Swa Ingestion Rate of Surface Water, adult 0.05 l/hour EPA, 1989, (1)

ET Exposure Time 2.6 hr/day EPA, 1989, (3) IR-W-Adj (liter-year/kg-hour) =

EF Exposure Frequency 9 days/year (5) (EDc x IR-SWc/BWc) + (EDa x IR-SWa/BWa)

EDc Exposure Duration, chiild 6 years EPA, 1991

EDa Exposure Duration, adult 24 years EPA, 1991

CF1 Conversion Factor 1 0.001 mg/µg - -

BWc Body Weight, child 15 kg EPA, 1991

BWa Body Weight, adult 70 kg EPA, 1991AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

TABLE 4.6.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Page 13 of 30

Page 191: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Overflow Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.6.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Industrial Worker Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) = τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 8 hr/day (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 5,700 cm2EPA, 2004, (4) 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 9 days/year (5)ED Exposure Duration 25 years EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 70 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

AT-N Averaging Time (Non-Cancer) 9,125 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Residential Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) = τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 2.6 hr/day EPA, 1989, (3) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 5,700 cm2EPA, 2004, (4) 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 9 days/year (5)ED Exposure Duration 24 years EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 70 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Page 14 of 30

Page 192: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Overflow Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.6.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Residential Child

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) = τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 2.6 hr/day EPA, 1989, (3) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 2,800 cm2EPA, 2004, (4) 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 9 days/year (5)ED Exposure Duration 6 years EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 15 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Dermal Residential Child/Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME CDI (mg/kg-day) =

DA-Adj Dermally Absorbed Dose, Age-adjusted calculated mg-year/event-kg calculated DA-Adj x EF x 1/AT

DAevent-A Dermally Absorbed Dose per Event, adult calculated mg/cm2-event calculated

DAevent-C Dermally Absorbed Dose per Event, adult calculated mg/cm2-event calculated DA-Adj = (DAevent-A x SAa x EDa x 1/BWa)

FA Fraction absorbed water chemical specific dimensionless EPA, 2004 + (DAevent-C x SAc x EDc x 1/BWc)

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004

τ Lag Time chemical specific hr/event EPA, 2004

t* Time to Reach Steady-state chemical specific hours EPA, 2004 Inorganics: DAevent (mg/cm2-event) = B Epidermis chemical specific dimensionless EPA, 2004 Kp x CW x tevent x CF1 x CF2

tevent Event Time 2.6 hr/day EPA, 1989, (3)

SAc Skin Surface Area Available for Contact, child 2,800 cm2EPA, 2004, (4) Organics :

SAa Skin Surface Area Available for Contact, adult 5,700 cm2EPA, 2004, (4) tevent<t*: DAevent (mg/cm2-event) =

EV Event Frequency 1 events/day EPA, 2004 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EF Exposure Frequency 9 days/year (5) x CF1 x CF2

EDc Exposure Duration, child 6 years EPA, 1991

EDa Exposure Duration, adult 24 years EPA, 1991BWc Body Weight, child 15 kg EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BWa Body Weight, adult 70 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Notes:

(1) Assumed ingestion rate for canal overflow water would be 1/2 of mean water ingestion rate for adults for exposure scenarios involving swimming activities.

(2) Professional judgement, conservatively assumes industrial receptors will contact overflow ponded surface water 8 hours per day.

(3) Professional judgement, conservatively assumes residential receptor will contact overflow surface water for the same exposure time as the national average time spent swimming per swimming event.

(4) SA includes head, hands, forearms, lower legs, and feet (for child only).

(5) Professional judgement, conservatively assumes canal overflows 3 times a year, and remains on surface 3 days per each overflow event.

Page 15 of 30

Page 193: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Overflow Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.6.RME

VALUES USED FOR DAILY INTAKE CALCULATIONS

REASONABLE MAXIMUM EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 16 of 30

Page 194: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Recreational Adult

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment 25 mg/day EPA, 1997, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 13 days/year (2)

ED Exposure Duration 3 years EPA, 1997 (7)

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Adolescent

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) IR-Sed Ingestion Rate of Sediment 25 mg/day EPA, 1997, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 13 days/year (2)

ED Exposure Duration 3 years EPA, 1997 (7)

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 57 kg EPA, 1997, (5)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Child

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(1-6 years) IR-Sed Ingestion Rate of Sediment 50 mg/day EPA, 1997, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 13 days/year (2)

ED Exposure Duration 3 years EPA, 1997 (7)

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Dermal Recreational Adult

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME CDI (mg/kg-day) =

SA Skin Surface Area Available for Contact 6,925 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 13 days/year (2)

ED Exposure Duration 3 years EPA, 1997 (7)

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

TABLE 4.1.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 17 of 30

Page 195: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.1.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Recreational Adolescent

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME CDI (mg/kg-day) =

(12-18 years) SA Skin Surface Area Available for Contact 10,470 cm2EPA, 2004, (6) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 1997, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 13 days/year (2)

ED Exposure Duration 3 years EPA, 1997 (7)

BW Body Weight 57 kg EPA, 1997, (5)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Dermal Recreational Child

Exposed and near

shore sediment in

Gowanus Canal CSed Chemical Concentration in Sediment Table 3.1.RME mg/kg Table 3.1.RME CDI (mg/kg-day) =

(1-6 years) SA Skin Surface Area Available for Contact 2,800 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 13 days/year (2)

ED Exposure Duration 3 years EPA, 1997 (7)

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Notes:

(1) Assumed CTE sediment ingestion rate is equal to 1/2 of the RME sediment ingestion rate, or 1/2 of the CTE incidental soil ingestion rate.

(2) Professional judgement, assuming 1/2 the RME value, or recreational use of the canal 1 day per week for one-quarter of the year.

(3) SA includes head, hands, forearms, lower legs, and feet.

(4) Average adherence factor for children in wet soil.

(5) Body weight is average of the mean values for boys and girls for the ages 12 through 18.

(6) SA includes head, hands, arms, legs, and feet.

(7) Based on 9 years, the 50th percentile of time at a single residence, divided into three years for each receptor age range.

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1997: Exposure Factors Handbook. EPA/ 600/P-95/Fa, Fb, and Fc.

EPA, 2000: Supplemental Guidance to RAGS: Region 4 Bulletins, Human Health Risk Assessment Bulletins. www.epa.gov/region4/waste/oftecser/healtbul.htm.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 18 of 30

Page 196: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Recreational Adult Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.025 l/hour EPA,1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 1.3 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 13 days/year (3)

ED Exposure Duration 3 years EPA, 1997 (4)

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Adolescent Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) IR-SW Ingestion Rate of Surface Water 0.025 l/hour EPA,1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 1.3 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 13 days/year (3)

ED Exposure Duration 3 years EPA, 1997 (4)

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 57 kg EPA, 1991, (5)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Child Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.025 l/hour EPA,1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 1.3 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 13 days/year (3)

ED Exposure Duration 3 years EPA, 1997 (4)

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Dermal Recreational Adult Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) =

τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 1.3 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 18,000 cm2 EPA, 2004 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 13 days/year (3)ED Exposure Duration 3 years EPA, 1997 (4) tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 70 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

TABLE 4.2.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Page 19 of 30

Page 197: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.2.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Recreational Adolescent Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME CDI (mg/kg-day) =

(12-18 years) DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) =

τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 1.3 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 15,758 cm2 EPA, 1997, (6) 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 13 days/year (3)ED Exposure Duration 3 years EPA, 1997 (4) tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 57 kg EPA, 1991, (5) FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Child Gowanus Canal CSW Chemical Concentration in Surface Water

Tables 3.2.RME

and 3.3.RME µg/l

Tables 3.2.RME and

3.3.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) =

τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 1.3 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 6,600 cm2 EPA, 2004 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 13 days/year (3)ED Exposure Duration 3 years EPA, 1997 (4) tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 15 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Notes:

(1) Professional judgement, assuming 1/2 the RME value, or 1/2 the ingestion rate of surface water for swimming.

(2) 1/2 the RME value, equal to 1/2 the national average time spent swimming per swimming event.

(3) Professional judgement, assuming 1/2 the RME value, or recreational use of the canal 1 day per week for one-quarter of the year.

(4) Based on 9 years, the 50th percentile of time at a single residence, divided into three years for each receptor age range.

(5) Body weight is average of the mean values for boys and girls for the ages 12 through 18.

(6) Average total body surface area of boys and girls from 12 to 18 years of age.

Page 20 of 30

Page 198: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.2.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1997: Exposure Factors Handbook. EPA/ 600/P-95/Fa, Fb, and Fc.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 21 of 30

Page 199: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: AirExposure Medium: Air

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Inhalation Resident Adult Ambient air at street level Cair Chemical Concentration in Air

Tables 3.6.RME

and 3.7.RME mg/m3Tables 3.6.RME and

3.7.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 24 hr/day EPA, 1991 CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 234 days/year EPA, 1993

ED Exposure Duration 3 years EPA, 2004

CF1 Conversion Factor 1 1/24 day/hr - -

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Child Ambient air at street level Cair Chemical Concentration in Air

Tables 3.6.RME

and 3.7.RME mg/m3Tables 3.6.RME and

3.7.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 24 hr/day EPA, 1991 CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 234 days/year EPA, 1993

ED Exposure Duration 6 years EPA, 1991

CF1 Conversion Factor 1 1/24 day/hr - -

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child/Adult Ambient air at street level Cair Chemical Concentration in Air

Tables 3.6.RME

and 3.7.RME mg/m3Tables 3.6.RME and

3.7.RME Exposure Concentration (EC) (mg/m3) =

ET Exposure Time 24 hr/day EPA, 1991 CA x ET x EF x ED x CF x 1/AT

EF Exposure Frequency 234 days/year EPA, 1993

ED Exposure Duration 9 years EPA, 2004

CF1 Conversion Factor 1 1/24 day/hr - -

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

Notes:

(1) Professional judgement, assuming 1/2 the RME value, or 1/2 the ingestion rate of surface water for swimming.

(2) Professional judgement, conservatively assumed recreational use of the canal would occur 1 day per week for one-half the year.

(3) Professional Judgement assuming adolescents from 12 to 18 years of age.

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1993: Superfund's Standard Default Exposure Factors for the Central Tendency and Reasonable Maximum Exposure.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

TABLE 4.3.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Page 22 of 30

Page 200: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface Water / Sediment

Exposure Medium: Fish and Crab Tissue

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Angler Adult Striped Bass CFish Chemical Concentration in Fish

Tables 3.8.RME, 3.9.RME, and

3.10.RME mg/kg

Tables 3.8.RME, 3.9.RME, and

3.10.RME Chronic Daily Intake (CDI) (mg/kg-day) =

White Perch IR-Fish Ingestion of Fish 8 g/day EPA, 1997, (1) CFish x IR-Fish x PCF x FI x EF x ED x CF3 x 1/BW x 1/AT

Eel PCF Preparation/cooking loss factor chem specific EPA, 2000

FI Fraction Ingested - fish specific unitless EPA, 2000

Striped Bass 0.47 unitless NYS, 1991, (4)

White Perch 0.09 unitless NYS, 1991, (4)

Eel 0.44 unitless NYS, 1991, (4)

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 3 years EPA, 1997 (6)

CF3 Conversion Factor 3 0.001 kg/g - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Adolescent Striped Bass CFish Chemical Concentration in Fish

Tables 3.8.RME, 3.9.RME, and

3.10.RME mg/kg

Tables 3.8.RME, 3.9.RME, and

3.10.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) White Perch IR-Fish Ingestion of Fish 5.3 g/day (2) CFish x IR-Fish x PCF x FI x EF x ED x CF3 x 1/BW x 1/AT

Eel PCF Preparation/cooking loss factor chem specific EPA, 2000

FI Fraction Ingested - fish specific unitless EPA, 2000

Striped Bass 0.47 unitless NYS, 1991, (4)

White Perch 0.09 unitless NYS, 1991, (4)

Eel 0.44 unitless NYS, 1991, (4)

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 3 years EPA, 1997 (6)

CF Conversion Factor 0.001 kg/g - -

BW Body Weight 57 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Child Striped Bass CFish Chemical Concentration in Fish

Tables 3.8.RME, 3.9.RME, and

3.10.RME mg/kg

Tables 3.8.RME, 3.9.RME, and

3.10.RME Chronic Daily Intake (CDI) (mg/kg-day) =

White Perch IR-Fish Ingestion of Fish 2.7 g/day (3) CFish x IR-Fish x PCF x FI x EF x ED x CF3 x 1/BW x 1/AT

Eel PCF Preparation/cooking loss factor chem specific EPA, 2000

FI Fraction Ingested - fish specific unitless EPA, 2000

Striped Bass 0.47 unitless NYS, 1991, (4)

White Perch 0.09 unitless NYS, 1991, (4)

Eel 0.44 unitless NYS, 1991, (4)

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 3 years EPA, 1997 (6)

CF Conversion Factor 0.001 kg/g - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Table 4.4.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 23 of 30

Page 201: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface Water / Sediment

Exposure Medium: Fish and Crab Tissue

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Table 4.4.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Ingestion Angler Adult Blue Crab CFish Chemical Concentration in Crab Table 3.11.RME mg/kg Table 3.11.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Fish Ingestion of Crab 16 g/day Burger, 2002 CFish x IR-Fish x PCF x EF x ED x CF3 x 1/BW x 1/AT

PCF Preparation/cooking loss factor chem specific EPA, 2000

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 3 years EPA, 1997 (6)

CF3 Conversion Factor 3 0.001 kg/g - -

BW Body Weight 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Adolescent Blue Crab CFish Chemical Concentration in Crab Table 3.11.RME mg/kg Table 3.11.RME Chronic Daily Intake (CDI) (mg/kg-day) =

(12-18 years) IR-Fish Ingestion of Crab 10.7 g/day (2) CFish x IR-Fish x PCF x EF x ED x CF3 x 1/BW x 1/AT

PCF Preparation/cooking loss factor chem specific EPA, 2000

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 3 years EPA, 1997 (6)

CF3 Conversion Factor 3 0.001 kg/g - -

BW Body Weight 57 kg/g EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Child Blue Crab CFish Chemical Concentration in Crab Table 3.11.RME mg/kg Table 3.11.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Fish Ingestion of Crab 5.3 g/day (3) CFish x IR-Fish x PCF x EF x ED x CF3 x 1/BW x 1/AT

PCF Preparation/cooking loss factor chem specific EPA, 2000

EF Exposure Frequency 365 days/year EPA, 1997

ED Exposure Duration 3 years EPA, 1997 (6)

CF Conversion Factor 0.001 kg/g - -

BW Body Weight 15 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Notes:

(1) Mean recreational freshwater anglers fish ingestion rate.

(2) Ingestion rate assumed to be 2/3 the adult ingestion rate.

(3) There are no recreational fish ingestion values or crab ingestion values for children. Therefore, ingestion rate assumed to be 1/3 the adult ingestion rate.

(4) Bottom feeders percent consumption (44%) used to for eel, intermediate level percent consumption (47%) used for striped bass, and remaining percent (4%) used for white perch.

(5) Average yearly crab ingestion rate.

(6) Based on 9 years, the 50th percentile of time at a single residence, divided into three years for each receptor age range.

Sources:

Burger, 2002: Consumption Patterns and Why People Fish. Environmental Research Section A 90, 125-135.

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1997: Exposure Factors Handbook. EPA/ 600/P-95/Fa, Fb, and Fc.

NYS, 1991: New York State Angler reported fish consumpiton preferences.

Page 24 of 30

Page 202: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Overflow Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Residential Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment 50 mg/day EPA, 1997, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 4.5 days/year (2)

ED Exposure Duration 3 years EPA, 1997

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 70 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Child

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment 100 mg/day EPA, 1997, (1) CSed x IR-Sed x EF x ED x CF x 1/BW x 1/AT

EF Exposure Frequency 4.5 days/year (2)

ED Exposure Duration 6 years EPA, 1991

CF Conversion Factor 0.000001 kg/mg - -

BW Body Weight 15 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child/Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-Sed Ingestion Rate of Sediment-adjusted 42.1 mg-year/kg-day calculated CSed x IR-Sed x EF x CF x 1/AT

IR-Sedc Ingestion Rate of Sediment, child 100 mg/day EPA, 1991, (1)

IR-Seda Ingestion Rate of Sediment, adult 50 mg/day EPA, 1991, (1)

EF Exposure Frequency 4.5 days/year (2)

EDc Exposure Duration , child 6 years EPA, 1991 IR-Sed = (EDc x IR-Sedc/ BWc) +

EDa Exposure Duration, adult 3 years EPA, 1997 (EDa x IR-Seda/BWa)

CF Conversion Factor 0.000001 kg/mg - -

BWc Body Weight, child 15 kg EPA, 1991

BWa Body Weight, adult 70 kg EPA, 1991

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

TABLE 4.5.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Page 25 of 30

Page 203: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Overflow Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.5.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Residential Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME CDI (mg/kg-day) =

SA Skin Surface Area Available for Contact 5,700 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 4.5 days/year (2)

ED Exposure Duration 3 years EPA, 1997

BW Body Weight 70 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

Child

areas adjacent to

Gowanus Canal

associated with canal CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME CDI (mg/kg-day) =

SA Skin Surface Area Available for Contact 2,800 cm2EPA, 2004, (3) CSed x SA x SSAF x DABS x CF x EF x

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4) ED x 1/BW x 1/AT

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 4.5 days/year (2)

ED Exposure Duration 6 years EPA, 1991

BW Body Weight 15 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child/Adult

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow CSed Chemical Concentration in Sediment Table 3.12.RME mg/kg Table 3.12.RME CDI (mg/kg-day) =

SAc

Skin Surface Area Available for Contact,

child 2,800 cm2EPA, 2004, (3) CSed x SA x DABS x CF x EF x 1/AT

SSAF Soil to Skin Adherence Factor 0.2 mg/cm2-day EPA, 2004, (4)

EDc Exposure Duration, child 6 years EPA, 1991 SA = ((EDc x SAc/BWc) x SSAF) +

BWc Body Weight, child 15 kg EPA, 1991 ((EDa x SAa/BWa) x SSAF)

SAa

Skin Surface Area Available for Contact,

adult 5,700 cm2EPA, 2004, (3)

EDa Exposure Duration , adult 3 years EPA, 1997

BWa Body Weight ,adult 70 kg EPA, 1991

SA Skin Surface Area adjusted 273 cm2-year/kg-day calculated

DABS Dermal Absorption Factor Solids chem specific -- EPA, 2004

CF Conversion Factor 0.000001 kg/mg - -

EF Exposure Frequency 4.5 days/year (2)

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

Page 26 of 30

Page 204: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: SedimentExposure Medium: Overflow Surface Sediment

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.5.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Notes:

(1) Assumed CTE sediment ingestion rate is equal to the CTE incidental soil ingestion rate.

(2) Professional judgement, assumed equal to 1/2 RME value.

(3) SA includes head, hands, forearms, lower legs, and feet (for child only).

(4) Average adherence factor for children in wet soil.

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 1997: Exposure Factors Handbook. EPA/ 600/P-95/Fa, Fb, and Fc.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 27 of 30

Page 205: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Overflow Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

Ingestion Resident Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.025 l/hour EPA, 1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 1.3 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 4.5 days/year (4)

ED Exposure Duration 3 years EPA, 1997

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 70 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 8,760 days EPA, 1989

Child

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW Ingestion Rate of Surface Water 0.025 l/hour EPA, 1989, (1) CSW x IR-SW x ET x EF x ED x CF1 x

ET Exposure Time 1.3 hr/day EPA, 1989, (2) 1/BW x 1/AT

EF Exposure Frequency 4.5 days/year (4)

ED Exposure Duration 6 years EPA, 1991

CF1 Conversion Factor 1 0.001 mg/µg - -

BW Body Weight 15 kg EPA, 1991

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

Child/Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME Chronic Daily Intake (CDI) (mg/kg-day) =

IR-SW-Adj Ingestion Rate of Surface Water, age-adjusted 0.011 l-year/kg-hour calculated CSW x IR-SW-adj x ET x EF x CF1 x 1/AT

IR-SWc Ingestion Rate of Surface Water, child 0.025 l/hour EPA, 1989, (1)

IR-Swa Ingestion Rate of Surface Water, adult 0.025 l/hour EPA, 1989, (1)

ET Exposure Time 1.3 hr/day EPA, 1989, (2) IR-W-Adj (liter-year/kg-hour) =

EF Exposure Frequency 4.5 days/year (4) (EDc x IR-SWc/BWc) + (EDa x IR-SWa/BWa)

EDc Exposure Duration, chiild 6 years EPA, 1991

EDa Exposure Duration, adult 3 years EPA, 1997

CF1 Conversion Factor 1 0.001 mg/µg - -

BWc Body Weight, child 15 kg EPA, 1991

BWa Body Weight, adult 70 kg EPA, 1991AT-C Averaging Time (Cancer) 25,550 days EPA, 1989

TABLE 4.6.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Page 28 of 30

Page 206: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Overflow Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.6.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Residential Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) = τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 1.3 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 5,700 cm2EPA, 2004, (3) 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 4.5 days/year (4)ED Exposure Duration 3 years EPA, 1997 tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 70 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-N Averaging Time (Non-Cancer) 1,095 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Child

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME CDI (mg/kg-day) =

DAevent Dermally Absorbed Dose per Event calculated mg/cm2-event calculated DAevent x SA x EV x EF x ED x 1/BW x 1/AT

FA Fraction absorbed water chemical specific dimensionless EPA, 2004

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004 Inorganics: DAevent (mg/cm2-event) = τ Lag Time chemical specific hr/event EPA, 2004 Kp x CW x tevent x CF1 x CF2

t* Time to Reach Steady-state chemical specific hours EPA, 2004

B Epidermis chemical specific dimensionless EPA, 2004 Organics :tevent Event Time 1.3 hr/day EPA, 1989, (2) tevent<t*: DAevent (mg/cm2-event) =

SA Skin Surface Area Available for Contact 2,800 cm2EPA, 2004, (3) 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EV Event Frequency 1 events/day EPA, 2004 x CF1 x CF2

EF Exposure Frequency 4.5 days/year (4)ED Exposure Duration 6 years EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BW Body Weight 15 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-N Averaging Time (Non-Cancer) 2,190 days EPA, 1989

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Page 29 of 30

Page 207: Appendix L HHRA Combined

Scenario Timeframe: Current/Future

Medium: Surface WaterExposure Medium: Overflow Surface Water

Exposure Route Receptor Population Receptor Age Exposure Point Parameter Parameter Definition Value Units Rationale/ Intake Equation/

Code Reference Model Name

TABLE 4.6.CTE

VALUES USED FOR DAILY INTAKE CALCULATIONS

CENTRAL TENDENCY EXPOSUREGowanus Canal Remedial Investigation, Brooklyn, New York

Dermal Residential Child/Adult

Canal Overflow - Surface

Water CSW Chemical Concentration in Surface Water Table 3.13.RME µg/l Table 3.13.RME CDI (mg/kg-day) =

DA-Adj Dermally Absorbed Dose, Age-adjusted calculated mg-year/event-kg calculated DA-Adj x EF x 1/AT

DAevent-A Dermally Absorbed Dose per Event, adult calculated mg/cm2-event calculated

DAevent-C Dermally Absorbed Dose per Event, adult calculated mg/cm2-event calculated DA-Adj = (DAevent-A x SAa x EDa x 1/BWa)

FA Fraction absorbed water chemical specific dimensionless EPA, 2004 + (DAevent-C x SAc x EDc x 1/BWc)

Kp Permeability Coefficient chemical specific cm/hr EPA, 2004

τ Lag Time chemical specific hr/event EPA, 2004

t* Time to Reach Steady-state chemical specific hours EPA, 2004 Inorganics: DAevent (mg/cm2-event) = B Epidermis chemical specific dimensionless EPA, 2004 Kp x CW x tevent x CF1 x CF2

tevent Event Time 1.3 hr/day EPA, 1989, (2)

SAc Skin Surface Area Available for Contact, child 2,800 cm2EPA, 2004, (3) Organics :

SAa Skin Surface Area Available for Contact, adult 5,700 cm2EPA, 2004, (3) tevent<t*: DAevent (mg/cm2-event) =

EV Event Frequency 1 events/day EPA, 2004 2 x FA x Kp x CW x (sqrt((6 x τ x tevent)/π))

EF Exposure Frequency 4.5 days/year (4) x CF1 x CF2

EDc Exposure Duration, child 6 years EPA, 1991

EDa Exposure Duration, adult 3 years EPA, 1997BWc Body Weight, child 15 kg EPA, 1991 tevent>t*: DAevent (mg/cm2-event) =

BWa Body Weight, adult 70 kg EPA, 1991 FA x Kp x CW x ( tevent/(1+B) + 2 x τ x

AT-C Averaging Time (Cancer) 25,550 days EPA, 1989 ((1 + 3B + 3B2)/(1+B)2)) x CF1 x CF2

CF1 Conversion Factor 1 0.001 mg/µg - -

CF2 Conversion Factor 2 0.001 l/cm3- -

Notes:

(1) Professional judgement, assuming 1/2 the RME value, or 1/2 the ingestion rate of surface water for swimming.

(2) 1/2 the RME value, equal to 1/2 the national average time spent swimming per swimming event.

(3) SA includes head, hands, forearms, lower legs, and feet (for child only).

(4) Professional judgement, assumed equal to 1/2 RME value.

Sources:

EPA, 1989: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual, Part A. OERR. EPA/540/1-89/002.

EPA, 1991: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual - Supplemental Guidance, Standard Default Exposure Factors. Interim Final. OSWER Directive 9285.6-03.

EPA, 2004: Risk Assessment Guidance for Superfund. Vol.1: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) Final. EPA/540/R/99/005.

Page 30 of 30

Page 208: Appendix L HHRA Combined

TABLE 5.1

NON-CANCER TOXICITY DATA -- ORAL/DERMAL

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Chronic/ Oral RfD Oral RfD Oral to Dermal Adjusted Units Primary Combined Sources of RfD: Dates of RfD:

of Potential Subchronic Value Units Adjustment Dermal Target Uncertainty/Modifying Target Organ (3) Target Organ (4)

Concern Factor (1) RfD (2) Organ Factors (MM/DD/YY)

1,4-Dichlorobenzene Chronic 7.0E-02 mg/kg-day 100% 7.0E-02 mg/kg-day Liver 100 ATSDR 8/2006

Subchronic NA NA

Benzene Chronic 4.0E-03 mg/kg-day 100% 4.0E-03 mg/kg-day Blood, Immune 300/1 IRIS 11/23/2010

Subchronic 1.0E-02 mg/kg-day 100% 1.0E-02 mg/kg-day Blood, Immune 100 PPRTV 9/29/2009

Chloroform Chronic 1.0E-02 mg/kg-day 100% 1.0E-02 mg/kg-day Liver, Body Weight 100/1 IRIS 11/23/2010

Subchronic 1.0E-02 mg/kg-day NA 1.0E-02 mg/kg-day Liver 1000 HEAST 7/1997

Ethylbenzene Chronic 1.0E-01 mg/kg-day 100% 1.0E-01 mg/kg-day Liver, Kidney 1000/1 IRIS 11/29/2010

Subchronic 5.0E-02 mg/kg-day 100% 5.0E-02 mg/kg-day Liver, Kidney 1000 PPRTV 9/10/2009

Tetrachloroethene Chronic 1.0E-02 mg/kg-day 100% 1.0E-02 mg/kg-day Liver 1000/1 IRIS 11/23/2010

Subchronic 1.0E-01 mg/kg-day 100% 1.0E-01 mg/kg-day Liver 100 HEAST 7/1997

Xylene, total Chronic 2.0E-01 mg/kg-day 100% 2.0E-01 mg/kg-day Body Weight, Mortality 1000/1 IRIS 11/29/2010

Subchronic 4.0E-01 mg/kg-day 100% 4.0E-01 mg/kg-day Body Weight 1000 PPRTV 9/30/2009

2-Methylnaphthalene Chronic 4.0E-03 mg/kg-day 100% 4.0E-03 mg/kg-day Lung 1000/1 IRIS 11/23/2010

Subchronic 4.0E-03 mg/kg-day 1.0E+02 4.0E-03 mg/kg-day Lung 1000/1 PPRTV 9/18/2007

Acenaphthene Chronic 6.0E-02 mg/kg-day 100% 6.0E-02 mg/kg-day Liver 3000/1 IRIS 11/23/2010

Subchronic 6.0E-01 mg/kg-day 100% 6.0E-01 mg/kg-day Liver 300 HEAST 7/1997

Benzo(a)anthracene Chronic NA NA

Subchronic NA NA

Benzo(a)pyrene Chronic NA NA

Subchronic NA NA

Benzo(b)fluoranthene Chronic NA NA

Subchronic NA NA

Benzo(k)fluoranthene Chronic NA NA

Subchronic NA NA

bis(2-Ethylhexyl)phthalate Chronic 2.0E-02 mg/kg-day 100% 2.0E-02 mg/kg-day Increased Liver Weight 1000/1 IRIS 11/29/2010

Subchronic NA NA

Chrysene Chronic NA NA

Subchronic NA NA

Dibenz(a,h)anthracene Chronic NA NA

Subchronic NA NA

Fluoranthene Chronic 4.0E-02 mg/kg-day 100% 4.0E-02 mg/kg-day Kidney, Liver, Blood 3000/1 IRIS 11/23/2010

Subchronic 4.0E-01 mg/kg-day 100% 4.0E-01 mg/kg-day Kidney, Liver, Blood 300 HEAST 7/1997

Fluorene Chronic 4.0E-02 mg/kg-day 100% 4.0E-02 mg/kg-day Blood 3000/1 IRIS 11/23/2010

Subchronic 4.0E-01 mg/kg-day 100% 4.0E-01 mg/kg-day Blood 300 HEAST 7/1997

Page 209: Appendix L HHRA Combined

TABLE 5.1

NON-CANCER TOXICITY DATA -- ORAL/DERMAL

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Chronic/ Oral RfD Oral RfD Oral to Dermal Adjusted Units Primary Combined Sources of RfD: Dates of RfD:

of Potential Subchronic Value Units Adjustment Dermal Target Uncertainty/Modifying Target Organ (3) Target Organ (4)

Concern Factor (1) RfD (2) Organ Factors (MM/DD/YY)

Indeno(1,2,3-cd)pyrene Chronic NA NA

Subchronic NA NA

Naphthalene Chronic 2.0E-02 mg/kg-day 100% 2.0E-02 mg/kg-day Decreased Body Weight 3000/1 IRIS 11/23/2010

Subchronic NA NA

Pyrene Chronic 3.0E-02 mg/kg-day 100% 3.0E-02 mg/kg-day Kidney 3000/1 IRIS 11/23/2010

Subchronic 3.0E-01 mg/kg-day 100% 3.0E-01 mg/kg-day Kidney 300 PPRTV 9/5/2007

Chlordane Chronic 5.0E-04 mg/kg-day 100% 5.0E-04 mg/kg-day Liver 300/1 IRIS 1/12/2011

Subchronic 6.0E-05 mg/kg-day 100% 6.0E-05 mg/kg-day Liver 1000 HEAST 7/1997

Dieldrin Chronic 5.0E-05 mg/kg-day 100% 5.0E-05 mg/kg-day Liver 100/1 IRIS 1/12/2011

Subchronic 5.0E-05 mg/kg-day 100% 5.0E-05 mg/kg-day Liver 100 HEAST 7/1997

p,p'-DDD Chronic NA NA

Subchronic NA NA

p,p'-DDE Chronic NA NA

Subchronic NA NA

p,p'-DDT Chronic 5.0E-04 mg/kg-day 100% 5.0E-04 mg/kg-day Liver 100/1 IRIS 1/12/2011

Subchronic 5.0E-04 mg/kg-day 100% 5.0E-04 mg/kg-day Liver 100 HEAST 7/1997

Aroclor 1248 Chronic NA NA

Subchronic NA NA

Aroclor 12545

Chronic 2.0E-05 mg/kg-day 100% 2.0E-05 mg/kg-day

Ocular, Finger and Toe

Nails 300/1 IRIS 11/29/2010

Subchronic NA NA

Aroclor 1260 Chronic NA NA

Subchronic NA NA

2,3,7,8-TCDD Chronic 1.0E-09 mg/kg-day 100% 1.0E-09 mg/kg-day Immune System NA ATSDR 12/1998

Subchronic NA NA

Aluminum Chronic 1.0E+00 mg/kg-day 100% 1.0E+00 mg/kg-day Neurological 100 PPRTV 10/23/2006

Subchronic NA NA

Arsenic Chronic 3.0E-04 mg/kg-day 100% 3.0E-04 mg/kg-day Skin, Vascular 3/1 IRIS 11/23/2010

Subchronic 3.0E-04 mg/kg-day 100% 3.0E-04 mg/kg-day Skin, Vascular 3 HEAST 7/1997

Cadmium (diet) Chronic 1.0E-03 mg/kg-day 3% 2.5E-05 mg/kg-day Proteinuria (Kidney) 10/1 IRIS 11/23/2010

Subchronic NA NA

Cadmium (water) Chronic 5.0E-04 mg/kg-day 5% 2.5E-05 mg/kg-day Proteinuria (Kidney) 10/1 IRIS 11/23/2010

Subchronic NA NA

Chromium (III) Chronic 1.5E+00 mg/kg-day 1.3% 2.0E-02 mg/kg-day Not identified 100/10 IRIS 11/23/2010

Subchronic NA N/A

Page 210: Appendix L HHRA Combined

TABLE 5.1

NON-CANCER TOXICITY DATA -- ORAL/DERMAL

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Chronic/ Oral RfD Oral RfD Oral to Dermal Adjusted Units Primary Combined Sources of RfD: Dates of RfD:

of Potential Subchronic Value Units Adjustment Dermal Target Uncertainty/Modifying Target Organ (3) Target Organ (4)

Concern Factor (1) RfD (2) Organ Factors (MM/DD/YY)

Chromium (VI) Chronic 3.0E-03 mg/kg-day 2.5% 7.5E-05 mg/kg-day Not identified 300/3 IRIS 11/23/2010

Subchronic 2.0E-02 mg/kg-day 2.5% 5.0E-04 mg/kg-day Not identified 100 HEAST 7/1997

Cobalt Chronic 3.0E-04 mg/kg-day 100% 3.0E-04 mg/kg-day Thyroid 3000 PPRTV 8/25/2008

Subchronic 3.0E-04 mg/kg-day 100% 3.0E-04 mg/kg-day Thyroid 300 PPRTV 8/25/2008

Copper Chronic 4.0E-02 mg/kg-day 100% 4.0E-02 mg/kg-day Gastrointestinal N/A HEAST 7/1997

Subchronic NA NA

Cyanide Chronic 2.0E-02 mg/kg-day 100% 2.0E-02 mg/kg-day Weight Loss, Thyroid 100/5 IRIS 1/12/2011

Subchronic 2.0E-02 mg/kg-day 100% 2.0E-02 mg/kg-day

Whole Body, Thyroid,

Nerve 500 HEAST 7/1997

Iron Chronic 7.0E-01 mg/kg-day 100% 7.0E-01 mg/kg/day Gastrointestinal 1 PPRTV 7/29/2005

Subchronic 7.0E-01 mg/kg-day 100% 7.0E-01 mg/kg/day Gastrointestinal 1 PPRTV 7/29/2005

Manganese (diet) Chronic 1.4E-01 mg/kg-day 100% 7.0E-01 mg/kg-day CNS 1/1 IRIS 11/23/2010

Subchronic NA NA

Manganese (water) Chronic 2.4E-02 mg/kg-day 4% 9.6E-04 mg/kg-day CNS 1/1 IRIS 11/23/2010

Subchronic NA NA

Methylmercury Chronic 1.0E-04 mg/kg-day 100% 1.0E-04 mg/kg-day

Developmental

Neurological 10/1 IRIS 1/12/2011

Subchronic 1.0E-04 mg/kg-day 100% 1.0E-04 mg/kg-day

Developmental

Neurological 10 HEAST 7/1997

Selenium Chronic 5.0E-03 mg/kg-day 100% 5.0E-03 mg/kg-day Whole Body 3/1 IRIS 11/23/2010

Subchronic 5.0E-03 mg/kg-day 100% 5.0E-03 mg/kg-day Whole Body 3 HEAST 7/1997

Vanadium Chronic 5.0E-03 mg/kg-day 100% 5.0E-03 mg/kg-day Hair 100/1 RSL 5/25/2010

Subchronic NA NA

NA = Not Applicable or Not Available.

(1) Source: Risk Assessment Guidance for Superfund. Volume 1: Human Health Evaluation Manual, Part E, Supplemental Guidance for Dermal Risk Assessment (Final).

Section 4.2 and Exhibit 4-1. USEPA recommends that the oral RfD should not be adjusted to estimate the absorbed dose for compounds when the absorption efficiency is greater than 50%.

Constituents with oral absorption efficiencies greater than 50%, or without reported oral absorption efficiencies, are shown with an oral absorption efficiency of 100%.

(2) Adjusted Dermal RfD = RfD (oral) x Oral to Dermal Adjustment Factor

(3) ATSDR = Agency for Toxic Substances and Disease Registry

HEAST = Health Effects Summary Tables

IRIS = Integrated Risk Information System

PPRTV = Provisional Peer Reviewed Toxicity Value, Superfund Health Technical Support Center

RSL = Regional Screening Level Table

(4) For ATSDR values, the date of the ATSDR toxicity profile

For HEAST values, date of HEAST document.

For IRIS values, the date IRIS was searched.

For PPRTV values, date of the PPRTV document.

For RSL values, date of RSL Table.

(5) Aroclor-1254 toxicity values also used for total PCBs.

Page 211: Appendix L HHRA Combined

TABLE 5.2

NON-CANCER TOXICITY DATA -- INHALATION

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Chronic/ Value Units Primary Combined Sources of Dates (2)

of Potential Subchronic Inhalation Target Uncertainty/Modifying RfC:RfD: (MM/DD/YY)

Concern RfC Organ Factors Target Organ

(1)

1,4-Dichlorobenzene Chronic 8.0E-01 mg/m3 Liver 100/1 IRIS 11/23/2010

Subchronic 7.1E-01 mg/m3Liver 30 HEAST 7/1997

Benzene Chronic 3.0E-02 mg/m3Blood 300/1 IRIS 11/23/2010

Subchronic 8.0E-02 mg/m3Blood 100 PPRTV 9/29/2009

Chloroform Chronic 9.8E-02 mg/m3Liver 100 ATSDR 9/1997

Subchronic NA

Ethylbenzene Chronic 1.0E+00 mg/m3Developmental 300/1 IRIS 11/29/2010

Subchronic 9.0E+00 mg/m3Ear 100 PPRTV 9/10/2009

Tetrachloroethene Chronic 2.7E-01 mg/m3Neurological 100 ATSDR 9/1997

Subchronic NA

Xylene, total Chronic 1.0E-01 mg/m3Impaired motor coordination 300/1 IRIS 11/29/2010

Subchronic 4.0E-01 mg/m3Neurological 100 PPRTV 9/30/2009

2-Methylnaphthalene Chronic NA

Subchronic NA

Acenaphthene Chronic NA

Subchronic NA

Benzo(a)anthracene Chronic NA

Subchronic NA

Benzo(a)pyrene Chronic NA

Subchronic NA

Benzo(b)fluoranthene Chronic NA

Subchronic NA

Benzo(k)fluoranthene Chronic NA

Subchronic NA

bis(2-Ethylhexyl)phthalate Chronic NA

Subchronic NA

Page 212: Appendix L HHRA Combined

TABLE 5.2

NON-CANCER TOXICITY DATA -- INHALATION

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Chronic/ Value Units Primary Combined Sources of Dates (2)

of Potential Subchronic Inhalation Target Uncertainty/Modifying RfC:RfD: (MM/DD/YY)

Concern RfC Organ Factors Target Organ

(1)

Chrysene Chronic NA

Subchronic NA

Dibenz(a,h)anthracene Chronic NA

Subchronic NA

Fluoranthene Chronic NA

Subchronic NA

Fluorene Chronic NA

Subchronic NA

Indeno(1,2,3-cd)pyrene Chronic NA

Subchronic NA

Naphthalene Chronic 3.0E-03 mg/m3Nasal, Respiratory 3000/1 IRIS 11/23/2010

Subchronic NA

Pyrene Chronic NA

Subchronic NA

Chlordane Chronic 7.0E-04 mg/m3Liver 1000/1 IRIS 1/2011

Subchronic NA

Dieldrin Chronic NA

Subchronic NA

p,p'-DDD Chronic NA

Subchronic NA

p,p'-DDE Chronic NA

Subchronic NA

p,p'-DDT Chronic NA

Subchronic NA

Aroclor 1248 Chronic NA

Subchronic NA

Aroclor 12543Chronic NA

Subchronic NA

Page 213: Appendix L HHRA Combined

TABLE 5.2

NON-CANCER TOXICITY DATA -- INHALATION

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Chronic/ Value Units Primary Combined Sources of Dates (2)

of Potential Subchronic Inhalation Target Uncertainty/Modifying RfC:RfD: (MM/DD/YY)

Concern RfC Organ Factors Target Organ

(1)

Aroclor 12603 Chronic NA

Subchronic NA

2,3,7,8-TCDD3 Chronic 4.0E-08 mg/m3 NA NA CalEPA 11/23/2010

Subchronic NA

Aluminum Chronic 5.0E-03 mg/m3 Neurological 300 PPRTV 10/23/2006

Subchronic NA

Arsenic Chronic 1.5E-05 mg/m3

Developmental,

Cardiovascular, Nervous

System 3/1 CalEPA 11/23/2010

Subchronic NA

Cadmium Chronic 1.0E-05 mg/m3Kidney 3/3 ATSDR 9/2008

Subchronic NA

Chromium (III) Chronic NA

Subchronic NA

Chromium (VI) Chronic 1.0E-04 mg/m3Respiratory System 300/1 IRIS 11/23/2010

Subchronic NA

Cobalt Chronic 6.0E-06 mg/m3Respiratory System 300 PPRTV 8/25/2008

Subchronic 2.0E-05 mg/m3Respiratory System 100 PPRTV 8/25/2008

Copper Chronic NA

Subchronic NA

Cyanide Chronic NA

Subchronic NA

Iron Chronic NA

Subchronic NA

Manganese Chronic 5.0E-05 mg/m3CNS 1000/1 IRIS 11/23/2010

Subchronic

Methylmercury Chronic NA

Subchronic NA

Page 214: Appendix L HHRA Combined

TABLE 5.2

NON-CANCER TOXICITY DATA -- INHALATION

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Chronic/ Value Units Primary Combined Sources of Dates (2)

of Potential Subchronic Inhalation Target Uncertainty/Modifying RfC:RfD: (MM/DD/YY)

Concern RfC Organ Factors Target Organ

(1)

Selenium Chronic 2.0E-02 mg/m3Respiratory System 30/1 CalEPA 11/23/2010

Subchronic NA

Vanadium Chronic NA

Subchronic N/A

NA = Not Applicable or Not Available

(1) ATSDR = Agency for Toxic Substances and Disease Registry

CalEPA = California EPA

HEAST = Health Effects Summary Tables

IRIS = Integrated Risk Information System

PPRTV = Provisional Peer Reviewed Toxicity Value, Superfund Health Technical Support Center

(2) For ATSDR values, the date of the ATSDR toxicity profile.

For CalEPA values, the date CalEPA toxicity database was searched.

For HEAST values, date of HEAST document.

For IRIS values, the date IRIS was searched.

For PPRTV values, date of the PPRTV document.

(3) Aroclor-1254 toxicity values also used for total PCBs.

Page 215: Appendix L HHRA Combined

TABLE 6.1

CANCER TOXICITY DATA -- ORAL/DERMAL

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Oral Cancer Oral to Dermal Adjusted Dermal Units EPA Source (4) Date (5)

of Potential Slope Factor Adjustment Cancer Slope Factor (2) Carcinogen (MM/DD/YY)

Concern Factor (1) Group (3)

1,4-Dichlorobenzene 5.4E-03 100% 5.4E-03 (mg/kg-day) -1 2B CalEPA 11/23/2010

Benzene 5.5E-02 100% 5.5E-02 (mg/kg-day) -1 A IRIS 11/23/2010

Chloroform 3.1E-02 100% 3.1E-02 (mg/kg-day) -1 B2, 2B CalEPA 11/23/2010

Ethylbenzene 1.1E-02 100% 1.1E-02 (mg/kg-day) -1 2A CalEPA 11/29/2010

Tetrachloroethene 5.4E-01 100% 5.4E-01 (mg/kg-day) -1 2A CalEPA 11/23/2010

Xylene, total NA NA D IRIS 11/29/2010

2-Methylnaphthalene NA NA

Acenaphthene NA NA

Benzo(a)anthracene77.3E-01 100% 7.3E-01 (mg/kg-day) -1 B2 NCEA 7/1993

Benzo(a)pyrene77.3E+00 100% 7.3E+00 (mg/kg-day) -1 B2 IRIS 11/23/2010

Benzo(b)fluoranthene77.3E-01 100% 7.3E-01 (mg/kg-day) -1 B2 NCEA 7/1993

Benzo(k)fluoranthene77.3E-02 100% 7.3E-02 (mg/kg-day) -1 B2 NCEA 7/1993Benzo(k)fluoranthene 7.3E-02 100% 7.3E-02 (mg/kg-day) -1 B2 NCEA 7/1993

bis(2-Ethylhexyl)phthalate 1.4E-02 100% 1.4E-02 (mg/kg-day) -1 B2 IRIS 11/29/2010

Chrysene77.3E-03 100% 7.3E-03 (mg/kg-day) -1 B2 NCEA 7/1993

Dibenz(a,h)anthracene77.3E+00 100% 7.3E+00 (mg/kg-day) -1 B2 NCEA 7/1993

Fluoranthene NA NA D IRIS 11/23/2010

Fluorene NA NA D IRIS 11/23/2010

Indeno(1,2,3-cd)pyrene77.3E-01 100% 7.3E-01 (mg/kg-day) -1 B2 NCEA 7/1993

Naphthalene NA NA

Pyrene NA NA D IRIS 11/23/2010

Chlordane 3.5E-01 100% 3.5E-01 (mg/kg-day) -1 B2 IRIS 1/12/2011

Dieldrin 1.6E+01 100% 1.6E+01 (mg/kg-day) -1 B2 IRIS 1/12/2011

p,p'-DDD 2.4E-01 100% 2.4E-01 (mg/kg-day) -1 B2 IRIS 1/12/2011

p,p'-DDE 3.4E-01 100% 3.4E-01 (mg/kg-day) -1 B2 IRIS 1/12/2011

p,p'-DDT 3.4E-01 100% 3.4E-01 (mg/kg-day) -1 B2 IRIS 1/12/2011

Page 216: Appendix L HHRA Combined

TABLE 6.1

CANCER TOXICITY DATA -- ORAL/DERMAL

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Oral Cancer Oral to Dermal Adjusted Dermal Units EPA Source (4) Date (5)

of Potential Slope Factor Adjustment Cancer Slope Factor (2) Carcinogen (MM/DD/YY)

Concern Factor (1) Group (3)

Total PCBs6 - RME value 2.0E+00 100% 2.0E+00 (mg/kg-day) -1 B2 IRIS 11/23/2010

Total PCBs6- CTE value 1.0E+00 100% 1.0E+00 (mg/kg-day) -1 B2 IRIS 11/23/2010

2,3,7,8-TCDD61.6E+05 100% 1.6E+05 (mg/kg-day) -1 B2 EPA-D 1985

Aluminum NA NA

Arsenic 1.5E+00 100% 1.5E+00 (mg/kg-day) -1 A IRIS 11/23/2010

Cadmium NA NA B1 IRIS 11/23/2010

Chromium (III) NA NA D IRIS 11/23/2010

Chromium (VI)75.0E-01 2.5% 2.0E+01 (mg/kg-day) -1 D NJ 11/23/2010

Cobalt NA NA

Copper NA NA D IRIS 11/29/2010

Cyanide NA NA D IRIS 1/12/2011

Iron NA NAIron NA NA

Manganese NA NA D IRIS 11/23/2010

Methylmercury NA NA C IRIS 1/12/2011

Selenium NA NA D IRIS 11/23/2010

Vanadium NA NA

N/A-Not available

(1) Source: Risk Assessment Guidance for Superfund. Volume 1: Human Health Evaluation Manual, Part E, Supplemental Guidance for Dermal Risk Assessment (Final).

Section 4.2 and Exhibit 4-1. USEPA recommends that the oral RfD should not be adjusted to estimate the absorbed dose for compounds when the absorption efficiency is greater than 50%.

Constituents with oral absorption efficiencies greater than 50%, or without reported oral absorption efficiencies, are shown with an oral absorption efficiency of 100%.

(2) Adjusted Dermal CSF = CSF (oral) / Oral to Dermal Adjustment Factor

(3) EPA Carcinogen Group: IARC Carcinogen Group:

A - Human carcinogen 2A: The agent is probably carcinogenic to humans

B1 - Probable human carcinogen - indicates that limited human data are available 2B: The agent is possibly carcinogenic to humans

B2 - Probable human carcinogen - indicates sufficient evidence in animals and

inadequate or no evidence in humans

C - Possible human carcinogen

D - Not classifiable as a human carcinogen

E - Evidence of noncarcinogenicity

Page 217: Appendix L HHRA Combined

TABLE 6.1

CANCER TOXICITY DATA -- ORAL/DERMAL

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Oral Cancer Oral to Dermal Adjusted Dermal Units EPA Source (4) Date (5)

of Potential Slope Factor Adjustment Cancer Slope Factor (2) Carcinogen (MM/DD/YY)

Concern Factor (1) Group (3)

(4) CalEPA = California EPA

EPA-D = EPA, 1985. Health Assessment Document for Polychlorinated Dibenzo-p-Dioxins. U.S. Environmental Protection Agency, Office of Health and Environmental Assessment,

Environmental Criteria and Assessment Office. Cincinnati, OH. EPA 600/8-84-014F.

IRIS = Integrated Risk Information System

NCEA = National Center for Environmental Assessment

NJ = New Jersey DEP

(5) For CalEPA values, the date CalEPA toxicity database was searched.

For IRIS values, the date IRIS was searched.

For NCEA values, the date of the NCEA document.

For New Jersey values, the date New Jersey DEP toxicity database was searched.

(6) 2,3,7,8-TCDD toxicity values will be used for dioxin-like PCBs.

Total PCBs toxicity values used for non-dioxin like PCBs.

(7) Chemical acts via a mutaganic mode of action. Age-dependent adjustment factor (ADAF) of 10 used for 0-2 year old, ADAF of 3 used for 2-6 year old,(7) Chemical acts via a mutaganic mode of action. Age-dependent adjustment factor (ADAF) of 10 used for 0-2 year old, ADAF of 3 used for 2-6 year old,

and ADAF of 3 used for 6-12 year old. Oral cancer slope factor multiplied by appropriate ADAF to derive age-specific oral cancer slope factor for receptor.

Page 218: Appendix L HHRA Combined

TABLE 6.2

CANCER TOXICITY DATA -- INHALATION

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Unit Risk Units Weight of Evidence/ Source (2) Date (3)

of Potential Cancer Guidance (MM/DD/YY)

Concern Description (1)

1,4-Dichlorobenzene 1.1E-05 (ug/m3) -1 2B CalEPA 11/23/2010

Benzene 7.8E-06 (ug/m3) -1 A IRIS 11/23/2010

Chloroform 2.3E-05 (ug/m3) -1 B2 IRIS 11/23/2010

Ethylbenzene 2.5E-06 (ug/m3) -1 B2 CalEPA 11/29/2010

Tetrachloroethene 5.9E-06 (ug/m3) -1 2A CalEPA 11/23/2010

Xylene, total NA D IRIS 11/29/2010

2-Methylnaphthalene NA

Acenaphthene NA

Benzo(a)anthracene5

1.1E-04 (ug/m3) -1 B2, 2A CalEPA 11/23/2010

Benzo(a)pyrene51.1E-03 (ug/m3) -1 B2, 2A CalEPA 11/23/2010

Benzo(b)fluoranthene51.1E-04 (ug/m3) -1 B2, 2A CalEPA 11/23/2010Benzo(b)fluoranthene51.1E-04 (ug/m3) -1 B2, 2A CalEPA 11/23/2010

Benzo(k)fluoranthene51.1E-04 (ug/m3) -1 B2, 2A CalEPA 11/23/2010

bis(2-Ethylhexyl)phthalate 2.4E-06 (ug/m3) -1 B2, 2B CalEPA 11/29/2010

Chrysene5

1.1E-05 (ug/m3) -1 B2, 2A CalEPA 11/23/2010

Dibenz(a,h)anthracene51.2E-03 (ug/m3) -1 B2, 2A CalEPA 11/23/2010

Fluoranthene NA D IRIS 11/23/2010

Fluorene NA D IRIS 11/23/2010

Indeno(1,2,3-cd)pyrene51.1E-04 (ug/m3) -1 B2, 2A CalEPA 11/23/2010

Naphthalene 3.4E-05 (ug/m3) -1 2B CalEPA 11/23/2010

Pyrene NA D IRIS 11/23/2010

Chlordane 1.0E-04 (ug/m3)-1

B2 IRIS 1/12/2011

Dieldrin 4.6E-03 (ug/m3)-1

B2 IRIS 1/12/2011

p,p'-DDD 6.9E-05 (ug/m3)-1

B2 CalEPA 1/12/2011

p,p'-DDE 9.7E-05 (ug/m3) -1 B2 CalEPA 1/12/2011

Page 219: Appendix L HHRA Combined

TABLE 6.2

CANCER TOXICITY DATA -- INHALATION

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Unit Risk Units Weight of Evidence/ Source (2) Date (3)

of Potential Cancer Guidance (MM/DD/YY)

Concern Description (1)

p,p'-DDT 9.7E-05 (ug/m3)-1

B2 IRIS 1/12/2011

Total PCBs45.7E-04 (ug/m3)

-1B2 IRIS 11/23/2010

2,3,7,8-TCDD43.8E+01 (ug/m3)

-1B2 CalEPA 11/18/2009

Aluminum NA

Arsenic 4.3E-03 (ug/m3)-1

A IRIS 11/23/2010

Cadmium 1.8E-03 (ug/m3)-1

B1 IRIS 11/23/2010

Chromium (III) NA D IRIS 11/23/2010

Chromium (VI)58.4E-02 (ug/m3)

-1A IRIS 11/23/2010

Cobalt 9.0E-03 (ug/m3)-1

B1 PPRTV 8/28/2008

Copper NA D IRIS 11/29/2010

Cyanide NA D IRIS 1/12/2011

Iron NA

Manganese NA D IRIS 11/23/2010

Methylmercury NA C IRIS 1/12/2011

Selenium NA D IRIS 11/23/2010

Vanadium NA

(1) EPA Group: IARC Carcinogen Group:

A - Human carcinogen 2A: The agent is probably carcinogenic to humans

B1 - Probable human carcinogen - indicates that limited human data are available 2B: The agent is possibly carcinogenic to humans

B2 - Probable human carcinogen - indicates sufficient evidence in animals and

inadequate or no evidence in humans

C - Possible human carcinogen

D - Not classifiable as a human carcinogen

E - Evidence of noncarcinogenicity

Page 220: Appendix L HHRA Combined

TABLE 6.2

CANCER TOXICITY DATA -- INHALATION

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Unit Risk Units Weight of Evidence/ Source (2) Date (3)

of Potential Cancer Guidance (MM/DD/YY)

Concern Description (1)

(2) CalEPA = California EPA

IRIS = Integrated Risk Information System

PPRTV = Provisional Peer Reviewed Toxicity Value, Superfund Health Technical Support Center

(3) For CalEPA values, the date CalEPA toxicity database was searched.

For IRIS values, the date IRIS was searched.

For PPRTV values, date of the PPRTV document.

(4) 2,3,7,8-TCDD toxicity values will be used for dioxin-like PCBs

Aroclor-1260 toxicity values alsoused for non-dioxin like PCBs

(5) Chemical acts via a mutaganic mode of action. Age-dependent adjustment factor (ADAF) of 10 used for 0-2 year old, ADAF of 3 used for 2-6 year old,

and ADAF of 3 used for 6-12 year old. Oral cancer slope factor multiplied by appropriate ADAF to derive age-specific oral cancer slope factor for receptor.

Page 221: Appendix L HHRA Combined

TABLE 7.1.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Ingestion

Acenaphthene 3.7E+02 mg/kg 6.4E-06 mg/kg-day NA NA 1.9E-05 mg/kg-day 6.0E-02 mg/kg-day 3.1E-04

Benzo(a)anthracene 1.3E+02 mg/kg 2.2E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.6E-06 6.5E-06 mg/kg-day NA NA

Benzo(a)pyrene 1.1E+02 mg/kg 1.9E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.4E-05 5.4E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 1.1E+02 mg/kg 2.0E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.4E-06 5.7E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 6.5E+01 mg/kg 1.1E-06 mg/kg-day 7.3E-02 1/(mg/kg-day) 8.2E-08 3.3E-06 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 5.8E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 8.2E-09 1.7E-06 mg/kg-day 2.0E-02 mg/kg-day 8.5E-05

Chrysene 2.5E+02 mg/kg 4.4E-06 mg/kg-day 7.3E-03 1/(mg/kg-day) 3.2E-08 1.3E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene 6.2E+00 mg/kg 1.1E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 7.9E-07 3.1E-07 mg/kg-day NA NA

Fluoranthene 5.0E+02 mg/kg 8.7E-06 mg/kg-day NA NA 2.5E-05 mg/kg-day 4.0E-02 mg/kg-day 6.3E-04

Indeno(1,2,3-c,d)pyrene 4.9E+01 mg/kg 8.5E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.2E-07 2.5E-06 mg/kg-day NA NA

Naphthalene 3.4E+00 mg/kg 5.9E-08 mg/kg-day NA NA 1.7E-07 mg/kg-day 2.0E-02 mg/kg-day 8.7E-06

Pyrene 5.3E+02 mg/kg 9.2E-06 mg/kg-day NA NA 2.7E-05 mg/kg-day 3.0E-02 mg/kg-day 9.0E-04

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 7.0E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.1E-07 2.0E-12 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 9.1E-08 mg/kg-day 2.0E+00 1/(mg/kg-day) 1.8E-07 2.7E-07 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 9.4E-08 mg/kg-day NA NA 2.7E-07 mg/kg-day 2.0E-05 mg/kg-day 1.4E-02

Aluminum 1.6E+04 mg/kg 2.8E-04 mg/kg-day NA NA 8.1E-04 mg/kg-day 1.0E+00 mg/kg-day 8.1E-04

Arsenic 1.8E+01 mg/kg 3.1E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.7E-07 9.2E-07 mg/kg-day 3.0E-04 mg/kg-day 3.1E-03

Cadmium 9.6E+00 mg/kg 1.7E-07 mg/kg-day NA NA 4.9E-07 mg/kg-day 1.0E-03 mg/kg-day 4.9E-04

Chromium 9.4E+01 mg/kg 1.6E-06 mg/kg-day 5.0E-01 1/(mg/kg-day) 8.2E-07 4.8E-06 mg/kg-day 3.0E-03 mg/kg-day 1.6E-03

Cobalt 1.3E+01 mg/kg 2.3E-07 mg/kg-day NA NA 6.6E-07 mg/kg-day 3.0E-04 mg/kg-day 2.2E-03

Copper 3.5E+02 mg/kg 6.1E-06 mg/kg-day NA NA 1.8E-05 mg/kg-day 4.0E-02 mg/kg-day 4.5E-04

Iron 4.0E+04 mg/kg 7.0E-04 mg/kg-day NA NA 2.0E-03 mg/kg-day 7.0E-01 mg/kg-day 2.9E-03

Lead 1.9E+03 mg/kg 3.3E-05 mg/kg-day NA NA 9.5E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 5.5E-06 mg/kg-day NA NA 1.6E-05 mg/kg-day 1.4E-01 mg/kg-day 1.1E-04

Vanadium 5.0E+01 mg/kg 8.7E-07 mg/kg-day NA NA 2.5E-06 mg/kg-day 5.0E-03 mg/kg-day 5.1E-04

Exp. Route Total 2.0E-05 2.8E-02

Page 222: Appendix L HHRA Combined

TABLE 7.1.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Dermal

Acenaphthene 3.7E+02 mg/kg 3.4E-05 mg/kg-day NA NA 1.0E-04 mg/kg-day 6.0E-02 mg/kg-day 1.7E-03

Benzo(a)anthracene 1.3E+02 mg/kg 1.2E-05 mg/kg-day 7.3E-01 1/(mg/kg-day) 8.7E-06 3.5E-05 mg/kg-day NA NA

Benzo(a)pyrene 1.1E+02 mg/kg 1.0E-05 mg/kg-day 7.3E+00 1/(mg/kg-day) 7.4E-05 2.9E-05 mg/kg-day NA NA

Benzo(b)fluoranthene 1.1E+02 mg/kg 1.1E-05 mg/kg-day 7.3E-01 1/(mg/kg-day) 7.8E-06 3.1E-05 mg/kg-day NA NA

Benzo(k)fluoranthene 6.5E+01 mg/kg 6.1E-06 mg/kg-day 7.3E-02 1/(mg/kg-day) 4.4E-07 1.8E-05 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 2.4E-06 mg/kg-day 1.4E-02 1/(mg/kg-day) 3.4E-08 7.1E-06 mg/kg-day 2.0E-02 mg/kg-day 3.5E-04

Chrysene 2.5E+02 mg/kg 2.4E-05 mg/kg-day 7.3E-03 1/(mg/kg-day) 1.7E-07 7.0E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene 6.2E+00 mg/kg 5.8E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.3E-06 1.7E-06 mg/kg-day NA NA

Fluoranthene 5.0E+02 mg/kg 4.7E-05 mg/kg-day NA NA 1.4E-04 mg/kg-day 4.0E-02 mg/kg-day 3.4E-03

Indeno(1,2,3-c,d)pyrene 4.9E+01 mg/kg 4.6E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.4E-06 1.3E-05 mg/kg-day NA NA

Naphthalene 3.4E+00 mg/kg 3.2E-07 mg/kg-day NA NA 9.4E-07 mg/kg-day 2.0E-02 mg/kg-day 4.7E-05

Pyrene 5.3E+02 mg/kg 5.0E-05 mg/kg-day NA NA 1.5E-04 mg/kg-day 3.0E-02 mg/kg-day 4.8E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 4.1E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 6.4E-07 1.2E-11 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 5.3E-07 mg/kg-day 2.0E+00 1/(mg/kg-day) 1.1E-06 1.5E-06 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 5.5E-07 mg/kg-day NA NA 1.6E-06 mg/kg-day 2.0E-05 mg/kg-day 8.0E-02

Aluminum 1.6E+04 mg/kg 1.2E-04 mg/kg-day NA NA 3.4E-04 mg/kg-day 1.0E+00 mg/kg-day 3.4E-04

Arsenic 1.8E+01 mg/kg 3.9E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 5.9E-07 1.1E-06 mg/kg-day 3.0E-04 mg/kg-day 3.8E-03

Cadmium 9.6E+00 mg/kg 7.0E-09 mg/kg-day NA NA 2.0E-08 mg/kg-day 2.5E-05 mg/kg-day 8.1E-04

Chromium 9.4E+01 mg/kg 6.8E-07 mg/kg-day 2.0E+01 1/(mg/kg-day) 1.4E-05 2.0E-06 mg/kg-day 7.5E-05 mg/kg-day 2.6E-02

Cobalt 1.3E+01 mg/kg 9.4E-08 mg/kg-day NA NA 2.7E-07 mg/kg-day 3.0E-04 mg/kg-day 9.1E-04

Copper 3.5E+02 mg/kg 2.6E-06 mg/kg-day NA NA 7.4E-06 mg/kg-day 4.0E-02 mg/kg-day 1.9E-04

Iron 4.0E+04 mg/kg 2.9E-04 mg/kg-day NA NA 8.5E-04 mg/kg-day 7.0E-01 mg/kg-day 1.2E-03

Lead 1.9E+03 mg/kg 1.4E-05 mg/kg-day NA NA 4.0E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 2.3E-06 mg/kg-day NA NA 6.6E-06 mg/kg-day 9.6E-04 mg/kg-day 6.9E-03

Vanadium 5.0E+01 mg/kg 3.6E-07 mg/kg-day NA NA 1.1E-06 mg/kg-day 5.0E-03 mg/kg-day 2.1E-04

Exp. Route Total 1.1E-04 1.3E-01

Exposure Point Total 1.3E-04 1.6E-01

1.3E-04 1.6E-01

Exposed Surface Sediment Total 1.3E-04 1.6E-01

Exposure Medium Total

Page 223: Appendix L HHRA Combined

TABLE 7.1.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Dry event) Benzene 2.2E+00 ug/L 1.0E-07 mg/kg-day 5.5E-02 1/(mg/kg-day) 5.6E-09 3.0E-07 mg/kg-day 4.0E-03 mg/kg-day 7.4E-05

Benzo(a)anthracene 2.7E-01 ug/L 1.2E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 8.8E-09 3.5E-08 mg/kg-day NA NA

Benzo(a)pyrene 6.6E-01 ug/L 3.0E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.2E-07 8.7E-08 mg/kg-day NA NA

Benzo(b)fluoranthene 3.0E-01 ug/L 1.4E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 9.9E-09 4.0E-08 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 1.1E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.6E-09 3.2E-07 mg/kg-day 2.0E-02 mg/kg-day 1.6E-05

Indeno(1,2,3-c,d)pyrene 1.3E-01 ug/L 6.0E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.4E-09 1.7E-08 mg/kg-day NA NA

Arsenic 2.0E+01 ug/L 9.0E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.4E-06 2.6E-06 mg/kg-day 3.0E-04 mg/kg-day 8.8E-03

Chromium 1.9E+01 ug/L 8.6E-07 mg/kg-day 5.0E-01 1/(mg/kg-day) 4.3E-07 2.5E-06 mg/kg-day 3.0E-03 mg/kg-day 8.3E-04

Copper 1.7E+02 ug/L 7.8E-06 mg/kg-day NA 2.3E-05 mg/kg-day 4.0E-02 mg/kg-day 5.7E-04

Selenium 4.1E+01 ug/L 1.9E-06 mg/kg-day NA 5.4E-06 mg/kg-day 5.0E-03 mg/kg-day 1.1E-03

Exp. Route Total 2.0E-06 1.1E-02

Dermal

Benzene 2.2E+00 ug/L 6.5E-07 mg/kg-day 5.5E-02 1/(mg/kg-day) 3.6E-08 1.9E-06 mg/kg-day 4.0E-03 mg/kg-day 4.7E-04

Benzo(a)anthracene 2.7E-01 ug/L 5.0E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.6E-06 1.5E-05 mg/kg-day NA NA

Benzo(a)pyrene 6.6E-01 ug/L 2.1E-05 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.5E-04 6.2E-05 mg/kg-day NA NA

Benzo(b)fluoranthene 3.0E-01 ug/L 9.7E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 7.1E-06 2.8E-05 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 5.6E-06 mg/kg-day 1.4E-02 1/(mg/kg-day) 7.8E-08 1.6E-05 mg/kg-day 2.0E-02 mg/kg-day 8.2E-04

Indeno(1,2,3-c,d)pyrene 1.3E-01 ug/L 4.3E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.1E-06 1.3E-05 mg/kg-day NA NA

Arsenic 2.0E+01 ug/L 3.2E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.9E-07 9.5E-07 mg/kg-day 3.0E-04 mg/kg-day 3.2E-03

Chromium 1.9E+01 ug/L 6.2E-07 mg/kg-day 2.0E+01 1/(mg/kg-day) 1.2E-05 1.8E-06 mg/kg-day 7.5E-05 mg/kg-day 2.4E-02

Copper 1.7E+02 ug/L 2.8E-06 mg/kg-day NA NA 8.2E-06 mg/kg-day 4.0E-02 mg/kg-day 2.0E-04

Selenium 4.1E+01 ug/L 6.7E-07 mg/kg-day NA NA 2.0E-06 mg/kg-day 5.0E-03 mg/kg-day 3.9E-04

Exp. Route Total 1.8E-04 2.9E-02

Exposure Point Total 1.8E-04 4.0E-02

1.8E-04 4.0E-02

Surface Water Total - Dry Event 1.8E-04 4.0E-02

Exposure Medium Total

Page 224: Appendix L HHRA Combined

TABLE 7.1.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 2.7E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.4E-10 7.8E-08 mg/kg-day 7.0E-02 mg/kg-day 1.1E-06

Benzene 8.4E-01 ug/L 3.8E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 2.1E-09 1.1E-07 mg/kg-day 4.0E-03 mg/kg-day 2.8E-05

Chloroform 5.6E-01 ug/L 2.5E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 7.9E-10 7.4E-08 mg/kg-day 1.0E-02 mg/kg-day 7.4E-06

Ethylbenzene 8.7E-01 ug/L 3.9E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 4.3E-10 1.1E-07 mg/kg-day 1.0E-01 mg/kg-day 1.1E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 1.1E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 6.0E-07 3.2E-06 mg/kg-day 1.0E-02 mg/kg-day 3.2E-04

Benzo(a)anthracene 1.0E-01 ug/L 4.7E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.4E-09 1.4E-08 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 9.3E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.8E-08 2.7E-08 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 8.6E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.3E-09 2.5E-08 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 4.6E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.3E-08 1.3E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 2.3E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.7E-08 6.6E-08 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 1.7E-08 mg/kg-day NA NA 4.8E-08 mg/kg-day 2.0E-02 mg/kg-day 2.4E-06

Arsenic 1.7E+01 ug/L 7.5E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.1E-06 2.2E-06 mg/kg-day 3.0E-04 mg/kg-day 7.3E-03

Chromium 8.5E+00 ug/L 3.9E-07 mg/kg-day 5.0E-01 1/(mg/kg-day) 1.9E-07 1.1E-06 mg/kg-day 3.0E-03 mg/kg-day 3.8E-04

Cobalt 3.9E+00 ug/L 1.8E-07 mg/kg-day NA NA 5.2E-07 mg/kg-day 3.0E-04 mg/kg-day 1.7E-03

Lead 1.5E+01 ug/L 6.8E-07 mg/kg-day NA NA 2.0E-06 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 1.5E-06 mg/kg-day NA NA 4.4E-06 mg/kg-day 5.0E-03 mg/kg-day 8.9E-04

Exp. Route Total 2.1E-06 1.1E-02

Page 225: Appendix L HHRA Combined

TABLE 7.1.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Dermal

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 6.0E-07 mg/kg-day 5.4E-03 1/(mg/kg-day) 3.2E-09 1.8E-06 mg/kg-day 7.0E-02 mg/kg-day 2.5E-05

Benzene 8.4E-01 ug/L 2.4E-07 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.3E-08 7.1E-07 mg/kg-day 4.0E-03 mg/kg-day 1.8E-04

Chloroform 5.6E-01 ug/L 8.5E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 2.6E-09 2.5E-07 mg/kg-day 1.0E-02 mg/kg-day 2.5E-05

Ethylbenzene 8.7E-01 ug/L 8.5E-07 mg/kg-day 1.1E-02 1/(mg/kg-day) 9.3E-09 2.5E-06 mg/kg-day 1.0E-01 mg/kg-day 2.5E-05

Tetrachloroethylene(PCE) 2.4E+01 ug/L 2.2E-05 mg/kg-day 5.4E-01 1/(mg/kg-day) 1.2E-05 6.4E-05 mg/kg-day 1.0E-02 mg/kg-day 6.4E-03

Benzo(a)anthracene 1.0E-01 ug/L 1.9E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.4E-06 5.7E-06 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 6.6E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.8E-05 1.9E-05 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 6.2E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.5E-06 1.8E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 5.0E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.7E-05 1.5E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 1.6E-05 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.2E-05 4.8E-05 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 3.8E-07 mg/kg-day NA NA 1.1E-06 mg/kg-day 2.0E-02 mg/kg-day 5.5E-05

Arsenic 1.7E+01 ug/L 2.7E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.1E-07 7.9E-07 mg/kg-day 3.0E-04 mg/kg-day 2.6E-03

Chromium 8.5E+00 ug/L 2.8E-07 mg/kg-day 2.0E+01 1/(mg/kg-day) 5.6E-06 8.1E-07 mg/kg-day 7.5E-05 mg/kg-day 1.1E-02

Cobalt 3.9E+00 ug/L 2.5E-08 mg/kg-day NA NA 7.4E-08 mg/kg-day 3.0E-04 mg/kg-day 2.5E-04

Lead 1.5E+01 ug/L 2.4E-08 mg/kg-day NA NA 7.1E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 5.5E-07 mg/kg-day NA NA 1.6E-06 mg/kg-day 5.0E-03 mg/kg-day 3.2E-04

Exp. Route Total 1.2E-04 2.1E-02

Exposure Point Total 1.2E-04 3.1E-02

1.2E-04 3.1E-02

Surface Water Total - Wet Event 1.2E-04 3.1E-02

Air AirAmbient air at canal

levelInhalation

(pre-aeration system Benzene 9.1E-04 mg/m3 2.4E-03 ug/m3 7.8E-06 1/(ug/m3) 1.9E-08 7.1E-06 mg/m3 3.0E-02 mg/m32.4E-04

operation) Chloroform 2.2E-04 mg/m3 5.9E-04 ug/m3 2.3E-05 1/(ug/m3) 1.4E-08 1.7E-06 mg/m3 9.8E-02 mg/m31.7E-05

Ethylbenzene 2.3E-03 mg/m3 6.0E-03 ug/m3 2.5E-06 1/(ug/m3) 1.5E-08 1.7E-05 mg/m3 1.0E+00 mg/m31.7E-05

Xylene, total 1.0E-02 mg/m3 2.7E-02 ug/m3 NA NA 7.8E-05 mg/m3 1.0E-01 mg/m37.8E-04

Naphthalene 2.1E-03 mg/m3 5.5E-03 ug/m3 3.4E-05 1/(ug/m3) 1.9E-07 1.6E-05 mg/m3 3.0E-03 mg/m35.4E-03

Exp. Route Total 2.4E-07 6.4E-03

Exposure Point Total 2.4E-07 6.4E-03

2.4E-07 6.4E-03

Ambient air at canal level Total - Pre-aeration system operation 2.4E-07 6.4E-03

Exposure Medium Total

Exposure Medium Total

Page 226: Appendix L HHRA Combined

TABLE 7.1.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at canal

levelInhalation

(after aeration system Benzene 1.9E-03 mg/m3 5.1E-03 ug/m3 7.8E-06 1/(ug/m3) 4.0E-08 1.5E-05 mg/m3 3.0E-02 mg/m35.0E-04

started) Chloroform 2.1E-04 mg/m3 5.4E-04 ug/m3 2.3E-05 1/(ug/m3) 1.2E-08 1.6E-06 mg/m3 9.8E-02 mg/m31.6E-05

Ethylbenzene 2.1E-03 mg/m3 5.6E-03 ug/m3 2.5E-06 1/(ug/m3) 1.4E-08 1.6E-05 mg/m3 1.0E+00 mg/m31.6E-05

Xylene, total 1.7E-02 mg/m3 4.6E-02 ug/m3 NA NA 1.3E-04 mg/m3 1.0E-01 mg/m31.3E-03

Naphthalene 2.2E-03 mg/m3 5.8E-03 ug/m3 3.4E-05 1/(ug/m3) 2.0E-07 1.7E-05 mg/m3 3.0E-03 mg/m35.6E-03

Exp. Route Total 2.6E-07 7.5E-03

Exposure Point Total 2.6E-07 7.5E-03

2.6E-07 7.5E-03

Ambient air at canal level Total - After aeration system turned on 2.6E-07 7.5E-03

Total Total of Receptor Risks Across All Media 3.2E-04 Total of Receptor Hazards Across All Media 2.1E-01

Notes-

NA = Not available / Not applicable.

DAevent for surface water from dry event calculated on Table 7.1.RME Supplement A.

DAevent for surface water from wet event calculated on Table 7.1.RME Supplement B.

Total includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air prior to areation system operation and after aeration system started

Exposure Medium Total

Page 227: Appendix L HHRA Combined

TABLE 7.1.RME Supplement A

Calculation of Daevent Dry Event

Recreational Scenario

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Water Permeability Lag Fraction Duration

of Potential Concentration Coefficient Time Absorbed Water of Event

Concern (CW) (Kp) B (τevent) t* (FA) (tevent) DAevent

(µg/L) (cm/hr) (dimensionless) (hr) (hr) (dimensionless) (hr) (mg/cm2-event) Eq

Benzene 2.2E+00 1.5E-02 5.1E-02 2.9E-01 7.0E-01 1.0E+00 2.6 1.0E-07 3

Benzo(a)anthracene 2.7E-01 4.7E-01 2.8E+00 2.0E+00 8.5E+00 1.0E+00 2.6 7.9E-07 2

Benzo(a)pyrene 6.6E-01 7.0E-01 4.3E+00 2.7E+00 1.2E+01 1.0E+00 2.6 3.4E-06 2

Benzo(b)fluoranthene 3.0E-01 7.0E-01 4.3E+00 2.8E+00 1.2E+01 1.0E+00 2.6 1.6E-06 2

Bis(2-ethylhexyl) phthalate 2.5E+00 2.5E-02 1.9E-01 1.7E+01 4.0E+01 8.0E-01 2.6 8.9E-07 2

Indeno(1,2,3-c,d)pyrene 1.3E-01 1.0E+00 6.7E+00 3.8E+00 1.7E+01 6.0E-01 2.6 6.9E-07 2

Arsenic 2.0E+01 1.0E-03 NA NA NA NA 2.6 5.2E-08 1

Chromium 1.9E+01 2.0E-03 NA NA NA NA 2.6 9.8E-08 1

Copper 1.7E+02 1.0E-03 NA NA NA NA 2.6 4.5E-07 1

Selenium 4.1E+01 1.0E-03 NA NA NA NA 2.6 1.1E-07 1

Inorganics: DAevent (mg/cm2-event) =

Kp x CW x tevent x 0.001 mg/µg x 0.001 l/cm3 (eq 1)

Organics: DAevent (mg/cm2-event) =

If tevent<t*, then DAevent =

2 x FA x Kp x CW x (sqrt((6 x τevent x tevent)/π)) x 0.001 mg/µg x 0.001 l/cm3 (eq 2)

If tevent>t*, then DAevent =

FA x Kp x CW x ( tevent/(1+B) + 2 x τevent x ((1 + 3xB + 3xB2)/(1+B)2) x 0.001 mg/µg x 0.001 l/cm3 (eq 3)

Notes:

NA - Not applicable

Permeability constants and other input parameter values from EPA 2004, Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E,

Supplemental Guidance for Dermal Risk Assessment - Final). EPA/540/R/99/005. The default value of 0.001 was assigned to inorganics not listed in this document.

B - Dimensionless ratio of the permeability coefficient of a compound through the stratum corneum relative to its permeability

coefficient across the viable epidermis (dimensionless).

t* - Time to reach steady-state

Page 228: Appendix L HHRA Combined

TABLE 7.1.RME Supplement B

Calculation of Daevent Wet Event

Recreational Scenario

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Water Permeability Lag Fraction Duration

of Potential Concentration Coefficient Time Absorbed Water of Event

Concern (CW) (Kp) B (τevent) t* (FA) (tevent) DAevent

(µg/L) (cm/hr) (dimensionless) (hr) (hr) (dimensionless) (hr) (mg/cm2-event) Eq

1,4-dichlorobenzene 5.9E-01 4.2E-02 2.0E-01 7.1E-01 1.7E+00 1.0E+00 2.6 9.6E-08 3

Benzene 8.4E-01 1.5E-02 5.1E-02 2.9E-01 7.0E-01 1.0E+00 2.6 3.9E-08 3

Chloroform 5.6E-01 6.8E-03 2.9E-02 5.0E-01 1.2E+00 1.0E+00 2.6 1.4E-08 3

Ethylbenzene 8.7E-01 4.9E-02 2.0E-01 4.2E-01 1.0E+00 1.0E+00 2.6 1.4E-07 3

Tetrachloroethylene(PCE) 2.4E+01 3.3E-02 1.7E-01 9.1E-01 2.2E+00 1.0E+00 2.6 3.5E-06 3

Benzo(a)anthracene 1.0E-01 4.7E-01 2.8E+00 2.0E+00 8.5E+00 1.0E+00 2.6 3.1E-07 2

Benzo(a)pyrene 2.1E-01 7.0E-01 4.3E+00 2.7E+00 1.2E+01 1.0E+00 2.6 1.0E-06 2

Benzo(b)fluoranthene 1.9E-01 7.0E-01 4.3E+00 2.8E+00 1.2E+01 1.0E+00 2.6 9.8E-07 2

Dibenz(a,h)anthracene 1.0E-01 1.5E+00 9.7E+00 3.9E+00 1.8E+01 6.0E-01 2.6 8.0E-07 2

Indeno(1,2,3-c,d)pyrene 5.0E-01 1.0E+00 6.7E+00 3.8E+00 1.7E+01 6.0E-01 2.6 2.6E-06 2

Naphthalene 3.6E-01 4.7E-02 2.0E-01 5.6E-01 1.3E+00 1.0E+00 2.6 6.0E-08 3

Arsenic 1.7E+01 1.0E-03 NA NA NA NA 2.6 4.3E-08 1

Chromium 8.5E+00 2.0E-03 NA NA NA NA 2.6 4.4E-08 1

Cobalt 3.9E+00 4.0E-04 NA NA NA NA 2.6 4.1E-09 1

Lead 1.5E+01 1.0E-04 NA NA NA NA 2.6 3.9E-09 1

Selenium 3.4E+01 1.0E-03 NA NA NA NA 2.6 8.7E-08 1

Inorganics: DAevent (mg/cm2-event) =

Kp x CW x tevent x 0.001 mg/µg x 0.001 l/cm3 (eq 1)

Organics: DAevent (mg/cm2-event) =

If tevent<t*, then DAevent =

2 x FA x Kp x CW x (sqrt((6 x τevent x tevent)/π)) x 0.001 mg/µg x 0.001 l/cm3 (eq 2)

If tevent>t*, then DAevent =

FA x Kp x CW x ( tevent/(1+B) + 2 x τevent x ((1 + 3xB + 3xB2)/(1+B)2) x 0.001 mg/µg x 0.001 l/cm3 (eq 3)

Ethylbenzene

Notes:

NA - Not applicable

Permeability constants and other input parameter values from EPA 2004, Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E,

Supplemental Guidance for Dermal Risk Assessment - Final). EPA/540/R/99/005. The default value of 0.001 was assigned to inorganics not listed in this document.

B - Dimensionless ratio of the permeability coefficient of a compound through the stratum corneum relative to its permeability

coefficient across the viable epidermis (dimensionless).

t* - Time to reach steady-state

Page 229: Appendix L HHRA Combined

TABLE 7.2.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Ingestion

Acenaphthene 3.7E+02 mg/kg 2.0E-06 mg/kg-day NA NA 2.3E-05 mg/kg-day 6.0E-02 mg/kg-day 3.8E-04

Benzo(a)anthracene (12-16)* 1.3E+02 mg/kg 4.5E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 9.9E-07 7.9E-06 mg/kg-day NA NA

Benzo(a)anthracene (16-18)* 1.3E+02 mg/kg 2.3E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.7E-07

Benzo(a)pyrene (12-16)* 1.1E+02 mg/kg 3.8E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 8.4E-06 6.7E-06 mg/kg-day NA NA

Benzo(a)pyrene (16-18)* 1.1E+02 mg/kg 1.9E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.4E-06

Benzo(b)fluoranthene (12-16)* 1.1E+02 mg/kg 4.0E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 8.8E-07 7.1E-06 mg/kg-day NA NA

Benzo(b)fluoranthene (16-18)* 1.1E+02 mg/kg 2.0E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.5E-07

Benzo(k)fluoranthene (12-16)* 6.5E+01 mg/kg 2.3E-07 mg/kg-day 2.2E-01 1/(mg/kg-day) 5.1E-08 4.0E-06 mg/kg-day NA NA

Benzo(k)fluoranthene (16-18)* 6.5E+01 mg/kg 1.2E-07 mg/kg-day 7.3E-02 1/(mg/kg-day) 8.4E-09

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 1.8E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.5E-09 2.1E-06 mg/kg-day 2.0E-02 mg/kg-day 1.0E-04

Chrysene (12-16)* 2.5E+02 mg/kg 9.0E-07 mg/kg-day 2.2E-02 1/(mg/kg-day) 2.0E-08 1.6E-05 mg/kg-day NA NA

Chrysene (16-18)* 2.5E+02 mg/kg 4.5E-07 mg/kg-day 7.3E-03 1/(mg/kg-day) 3.3E-09

Dibenz(a,h)anthracene (12-16)* 6.2E+00 mg/kg 2.2E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.8E-07 3.9E-07 mg/kg-day NA NA

Dibenz(a,h)anthracene (16-18)* 6.2E+00 mg/kg 1.1E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 8.1E-08

Fluoranthene 5.0E+02 mg/kg 2.7E-06 mg/kg-day NA NA 3.1E-05 mg/kg-day 4.0E-02 mg/kg-day 7.7E-04

Indeno(1,2,3-c,d)pyrene (12-16)* 4.9E+01 mg/kg 1.7E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.8E-07 3.1E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (16-18)* 4.9E+01 mg/kg 8.7E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.4E-08

Naphthalene 3.4E+00 mg/kg 1.8E-08 mg/kg-day NA NA 2.1E-07 mg/kg-day 2.0E-02 mg/kg-day 1.1E-05

Pyrene 5.3E+02 mg/kg 2.8E-06 mg/kg-day NA NA 3.3E-05 mg/kg-day 3.0E-02 mg/kg-day 1.1E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 2.2E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 3.4E-08 2.5E-12 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 2.8E-08 mg/kg-day 2.0E+00 1/(mg/kg-day) 5.6E-08 3.3E-07 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 2.9E-08 mg/kg-day NA NA 3.4E-07 mg/kg-day 2.0E-05 mg/kg-day 1.7E-02

Aluminum 1.6E+04 mg/kg 8.5E-05 mg/kg-day NA NA 9.9E-04 mg/kg-day 1.0E+00 mg/kg-day 9.9E-04

Arsenic 1.8E+01 mg/kg 9.6E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.4E-07 1.1E-06 mg/kg-day 3.0E-04 mg/kg-day 3.7E-03

Cadmium 9.6E+00 mg/kg 5.2E-08 mg/kg-day NA NA 6.0E-07 mg/kg-day 1.0E-03 mg/kg-day 6.0E-04

Chromium (12-16)* 9.4E+01 mg/kg 3.3E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 5.0E-07 5.8E-06 mg/kg-day 3.0E-03 mg/kg-day 1.9E-03

Chromium (16-18)* 9.4E+01 mg/kg 1.7E-07 mg/kg-day 5.0E-01 1/(mg/kg-day) 8.3E-08

Cobalt 1.3E+01 mg/kg 6.9E-08 mg/kg-day NA NA 8.1E-07 mg/kg-day 3.0E-04 mg/kg-day 2.7E-03

Copper 3.5E+02 mg/kg 1.9E-06 mg/kg-day NA NA 2.2E-05 mg/kg-day 4.0E-02 mg/kg-day 5.5E-04

Iron 4.0E+04 mg/kg 2.1E-04 mg/kg-day NA NA 2.5E-03 mg/kg-day 7.0E-01 mg/kg-day 3.6E-03

Lead 1.9E+03 mg/kg 1.0E-05 mg/kg-day NA NA 1.2E-04 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 1.7E-06 mg/kg-day NA NA 2.0E-05 mg/kg-day 1.4E-01 mg/kg-day 1.4E-04

Vanadium 5.0E+01 mg/kg 2.7E-07 mg/kg-day NA NA 3.1E-06 mg/kg-day 5.0E-03 mg/kg-day 6.3E-04

Exp. Route Total 1.4E-05 3.4E-02

Page 230: Appendix L HHRA Combined

TABLE 7.2.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Dermal

Acenaphthene 3.7E+02 mg/kg 1.1E-05 mg/kg-day NA NA 1.2E-04 mg/kg-day 6.0E-02 mg/kg-day 2.1E-03

Benzo(a)anthracene (12-16)* 1.3E+02 mg/kg 2.5E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.4E-06 4.3E-05 mg/kg-day NA NA

Benzo(a)anthracene (16-18)* 1.3E+02 mg/kg 1.2E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 9.0E-07

Benzo(a)pyrene (12-16)* 1.1E+02 mg/kg 2.1E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.6E-05 3.6E-05 mg/kg-day NA NA

Benzo(a)pyrene (16-18)* 1.1E+02 mg/kg 1.0E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 7.6E-06

Benzo(b)fluoranthene (12-16)* 1.1E+02 mg/kg 2.2E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 4.8E-06 3.8E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (16-18)* 1.1E+02 mg/kg 1.1E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 8.0E-07

Benzo(k)fluoranthene (12-16)* 6.5E+01 mg/kg 1.3E-06 mg/kg-day 2.2E-01 1/(mg/kg-day) 2.8E-07 2.2E-05 mg/kg-day NA NA

Benzo(k)fluoranthene (16-18)* 6.5E+01 mg/kg 6.3E-07 mg/kg-day 7.3E-02 1/(mg/kg-day) 4.6E-08

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 7.5E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.0E-08 8.7E-06 mg/kg-day 2.0E-02 mg/kg-day 4.4E-04

Chrysene (12-16)* 2.5E+02 mg/kg 4.9E-06 mg/kg-day 2.2E-02 1/(mg/kg-day) 1.1E-07 8.6E-05 mg/kg-day NA NA

Chrysene (16-18)* 2.5E+02 mg/kg 2.5E-06 mg/kg-day 7.3E-03 1/(mg/kg-day) 1.8E-08

Dibenz(a,h)anthracene (12-16)* 6.2E+00 mg/kg 1.2E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.6E-06 2.1E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (16-18)* 6.2E+00 mg/kg 6.0E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.4E-07

Fluoranthene 5.0E+02 mg/kg 1.4E-05 mg/kg-day NA NA 1.7E-04 mg/kg-day 4.0E-02 mg/kg-day 4.2E-03

Indeno(1,2,3-c,d)pyrene (12-16)* 4.9E+01 mg/kg 9.5E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.1E-06 1.7E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (16-18)* 4.9E+01 mg/kg 4.8E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.5E-07

Naphthalene 3.4E+00 mg/kg 9.9E-08 mg/kg-day NA NA 1.2E-06 mg/kg-day 2.0E-02 mg/kg-day 5.8E-05

Pyrene 5.3E+02 mg/kg 1.5E-05 mg/kg-day NA NA 1.8E-04 mg/kg-day 3.0E-02 mg/kg-day 6.0E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 1.3E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.0E-07 1.5E-11 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 1.6E-07 mg/kg-day 2.0E+00 1/(mg/kg-day) 3.3E-07 1.9E-06 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 1.7E-07 mg/kg-day NA NA 2.0E-06 mg/kg-day 2.0E-05 mg/kg-day 9.9E-02

Aluminum 1.6E+04 mg/kg 3.6E-05 mg/kg-day NA NA 4.2E-04 mg/kg-day 1.0E+00 mg/kg-day 4.2E-04

Arsenic 1.8E+01 mg/kg 1.2E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.8E-07 1.4E-06 mg/kg-day 3.0E-04 mg/kg-day 4.7E-03

Cadmium 9.6E+00 mg/kg 2.2E-09 mg/kg-day NA NA 2.5E-08 mg/kg-day 2.5E-05 mg/kg-day 1.0E-03

Chromium (12-16)* 9.4E+01 mg/kg 1.4E-07 mg/kg-day 6.0E+01 1/(mg/kg-day) 8.4E-06 2.4E-06 mg/kg-day 7.5E-05 mg/kg-day 3.3E-02

Chromium (16-18)* 9.4E+01 mg/kg 7.0E-08 mg/kg-day 2.0E+01 1/(mg/kg-day) 1.4E-06

Cobalt 1.3E+01 mg/kg 2.9E-08 mg/kg-day NA NA 3.4E-07 mg/kg-day 3.0E-04 mg/kg-day 1.1E-03

Copper 3.5E+02 mg/kg 7.9E-07 mg/kg-day NA NA 9.2E-06 mg/kg-day 4.0E-02 mg/kg-day 2.3E-04

Iron 4.0E+04 mg/kg 9.0E-05 mg/kg-day NA NA 1.0E-03 mg/kg-day 7.0E-01 mg/kg-day 1.5E-03

Lead 1.9E+03 mg/kg 4.2E-06 mg/kg-day NA NA 4.9E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 7.0E-07 mg/kg-day NA NA 8.2E-06 mg/kg-day 9.6E-04 mg/kg-day 8.6E-03

Vanadium 5.0E+01 mg/kg 1.1E-07 mg/kg-day NA NA 1.3E-06 mg/kg-day 5.0E-03 mg/kg-day 2.6E-04

Exp. Route Total 8.2E-05 1.6E-01

Exposure Point Total 9.5E-05 2.0E-01

9.5E-05 2.0E-01

Exposed Surface Sediment Total 9.5E-05 2.0E-01

Exposure Medium Total

Page 231: Appendix L HHRA Combined

TABLE 7.2.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Dry event) Benzene 2.2E+00 ug/L 3.1E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.7E-09 3.6E-07 mg/kg-day 4.0E-03 mg/kg-day 9.1E-05

Benzo(a)anthracene (12-16)* 2.7E-01 ug/L 2.5E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.4E-09 4.3E-08 mg/kg-day NA NA

Benzo(a)anthracene (16-18)* 2.7E-01 ug/L 1.2E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 9.0E-10

Benzo(a)pyrene (12-16)* 6.6E-01 ug/L 6.1E-09 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.3E-07 1.1E-07 mg/kg-day NA NA

Benzo(a)pyrene (16-18)* 6.6E-01 ug/L 3.1E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.2E-08

Benzo(b)fluoranthene (12-16)* 3.0E-01 ug/L 2.8E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.1E-09 4.9E-08 mg/kg-day NA NA

Benzo(b)fluoranthene (16-18)* 3.0E-01 ug/L 1.4E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.0E-09

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 3.4E-08 mg/kg-day 1.4E-02 1/(mg/kg-day) 4.8E-10 4.0E-07 mg/kg-day 2.0E-02 mg/kg-day 2.0E-05

Indeno(1,2,3-c,d)pyrene (12-16)* 1.3E-01 ug/L 1.2E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.7E-09 2.1E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (16-18)* 1.3E-01 ug/L 6.1E-10 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.5E-10

Arsenic 2.0E+01 ug/L 2.8E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.2E-07 3.2E-06 mg/kg-day 3.0E-04 mg/kg-day 1.1E-02

Chromium (12-16)* 1.9E+01 ug/L 1.8E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.6E-07 3.1E-06 mg/kg-day 3.0E-03 mg/kg-day 1.0E-03

Chromium (16-18)* 1.9E+01 ug/L 8.8E-08 mg/kg-day 5.0E-01 1/(mg/kg-day) 4.4E-08

Copper 1.7E+02 ug/L 2.4E-06 mg/kg-day NA 2.8E-05 mg/kg-day 4.0E-02 mg/kg-day 7.0E-04

Selenium 4.1E+01 ug/L 5.7E-07 mg/kg-day NA 6.7E-06 mg/kg-day 5.0E-03 mg/kg-day 1.3E-03

Exp. Route Total 9.0E-07 1.4E-02

Dermal

Benzene 2.2E+00 ug/L 1.7E-07 mg/kg-day 5.5E-02 1/(mg/kg-day) 9.6E-09 2.0E-06 mg/kg-day 4.0E-03 mg/kg-day 5.1E-04

Benzo(a)anthracene (12-16)* 2.7E-01 ug/L 8.9E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.0E-06 1.6E-05 mg/kg-day NA NA

Benzo(a)anthracene (16-18)* 2.7E-01 ug/L 4.5E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.3E-07

Benzo(a)pyrene (12-16)* 6.6E-01 ug/L 3.8E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 8.3E-05 6.7E-05 mg/kg-day NA NA

Benzo(a)pyrene (16-18)* 6.6E-01 ug/L 1.9E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.4E-05

Benzo(b)fluoranthene (12-16)* 3.0E-01 ug/L 1.7E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.8E-06 3.1E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (16-18)* 3.0E-01 ug/L 8.7E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.4E-07

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 1.5E-06 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.1E-08 1.8E-05 mg/kg-day 2.0E-02 mg/kg-day 8.8E-04

Indeno(1,2,3-c,d)pyrene (12-16)* 1.3E-01 ug/L 7.7E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.7E-06 1.4E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (16-18)* 1.3E-01 ug/L 3.9E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.8E-07

Arsenic 2.0E+01 ug/L 8.7E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.3E-07 1.0E-06 mg/kg-day 3.0E-04 mg/kg-day 3.4E-03

Chromium (12-16)* 1.9E+01 ug/L 1.1E-07 mg/kg-day 6.0E+01 1/(mg/kg-day) 6.6E-06 1.9E-06 mg/kg-day 7.5E-05 mg/kg-day 2.6E-02

Chromium (16-18)* 1.9E+01 ug/L 5.5E-08 mg/kg-day 2.0E+01 1/(mg/kg-day) 1.1E-06

Copper 1.7E+02 ug/L 7.5E-07 mg/kg-day NA NA 8.8E-06 mg/kg-day 4.0E-02 mg/kg-day 2.2E-04

Selenium 4.1E+01 ug/L 1.8E-07 mg/kg-day NA NA 2.1E-06 mg/kg-day 5.0E-03 mg/kg-day 4.2E-04

Exp. Route Total 1.1E-04 3.1E-02

Exposure Point Total 1.1E-04 4.5E-02

1.1E-04 4.5E-02

Surface Water Total - Dry Event 1.1E-04 4.5E-02

Exposure Medium Total

Page 232: Appendix L HHRA Combined

TABLE 7.2.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 8.2E-09 mg/kg-day 5.4E-03 1/(mg/kg-day) 4.4E-11 9.6E-08 mg/kg-day 7.0E-02 mg/kg-day 1.4E-06

Benzene 8.4E-01 ug/L 1.2E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 6.4E-10 1.4E-07 mg/kg-day 4.0E-03 mg/kg-day 3.4E-05

Chloroform 5.6E-01 ug/L 7.8E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 2.4E-10 9.1E-08 mg/kg-day 1.0E-02 mg/kg-day 9.1E-06

Ethylbenzene 8.7E-01 ug/L 1.2E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 1.3E-10 1.4E-07 mg/kg-day 1.0E-01 mg/kg-day 1.4E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 3.4E-07 mg/kg-day 5.4E-01 1/(mg/kg-day) 1.8E-07 4.0E-06 mg/kg-day 1.0E-02 mg/kg-day 4.0E-04

Benzo(a)anthracene (12-16)* 1.0E-01 ug/L 9.7E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.1E-09 1.7E-08 mg/kg-day NA NA

Benzo(a)anthracene (16-18)* 1.0E-01 ug/L 4.8E-10 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.5E-10

Benzo(a)pyrene (12-16)* 2.1E-01 ug/L 1.9E-09 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.2E-08 3.3E-08 mg/kg-day NA NA

Benzo(a)pyrene (16-18)* 2.1E-01 ug/L 9.5E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.9E-09

Benzo(b)fluoranthene (12-16)* 1.9E-01 ug/L 1.8E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.8E-09 3.1E-08 mg/kg-day NA NA

Benzo(b)fluoranthene (16-18)* 1.9E-01 ug/L 8.8E-10 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.4E-10

Dibenz(a,h)anthracene (12-16)* 1.0E-01 ug/L 9.4E-10 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.1E-08 1.6E-08 mg/kg-day NA NA

Dibenz(a,h)anthracene (16-18)* 1.0E-01 ug/L 4.7E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.4E-09

Indeno(1,2,3-c,d)pyrene (12-16)* 5.0E-01 ug/L 4.6E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.0E-08 8.1E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (16-18)* 5.0E-01 ug/L 2.3E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.7E-09

Naphthalene 3.6E-01 ug/L 5.1E-09 mg/kg-day NA NA 5.9E-08 mg/kg-day 2.0E-02 mg/kg-day 3.0E-06

Arsenic 1.7E+01 ug/L 2.3E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 3.5E-07 2.7E-06 mg/kg-day 3.0E-04 mg/kg-day 9.0E-03

Chromium (12-16)* 8.5E+00 ug/L 7.9E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.2E-07 1.4E-06 mg/kg-day 3.0E-03 mg/kg-day 4.6E-04

Chromium (16-18)* 8.5E+00 ug/L 4.0E-08 mg/kg-day 5.0E-01 1/(mg/kg-day) 2.0E-08

Cobalt 3.9E+00 ug/L 5.4E-08 mg/kg-day NA NA 6.3E-07 mg/kg-day 3.0E-04 mg/kg-day 2.1E-03

Lead 1.5E+01 ug/L 2.1E-07 mg/kg-day NA NA 2.4E-06 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 4.7E-07 mg/kg-day NA NA 5.5E-06 mg/kg-day 5.0E-03 mg/kg-day 1.1E-03

Exp. Route Total 7.6E-07 1.3E-02

Page 233: Appendix L HHRA Combined

TABLE 7.2.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Dermal

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 1.6E-07 mg/kg-day 5.4E-03 1/(mg/kg-day) 8.7E-10 1.9E-06 mg/kg-day 7.0E-02 mg/kg-day 2.7E-05

Benzene 8.4E-01 ug/L 6.5E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 3.6E-09 7.6E-07 mg/kg-day 4.0E-03 mg/kg-day 1.9E-04

Chloroform 5.6E-01 ug/L 2.3E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 7.1E-10 2.7E-07 mg/kg-day 1.0E-02 mg/kg-day 2.7E-05

Ethylbenzene 8.7E-01 ug/L 2.3E-07 mg/kg-day 1.1E-02 1/(mg/kg-day) 2.5E-09 2.7E-06 mg/kg-day 1.0E-01 mg/kg-day 2.7E-05

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.9E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 3.2E-06 6.9E-05 mg/kg-day 1.0E-02 mg/kg-day 6.9E-03

Benzo(a)anthracene (12-16)* 1.0E-01 ug/L 3.5E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 7.6E-07 6.1E-06 mg/kg-day NA NA

Benzo(a)anthracene (16-18)* 1.0E-01 ug/L 5.9E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.3E-07

Benzo(a)pyrene (12-16)* 2.1E-01 ug/L 1.2E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.6E-05 2.1E-05 mg/kg-day NA NA

Benzo(a)pyrene (16-18)* 2.1E-01 ug/L 5.5E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.0E-06

Benzo(b)fluoranthene (12-16)* 1.9E-01 ug/L 1.1E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.4E-06 1.9E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (16-18)* 1.9E-01 ug/L 4.5E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.3E-07

Dibenz(a,h)anthracene (12-16)* 1.0E-01 ug/L 9.0E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.0E-05 1.6E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene (16-18)* 1.0E-01 ug/L 1.5E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.1E-05

Indeno(1,2,3-c,d)pyrene (12-16)* 5.0E-01 ug/L 2.9E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.4E-06 5.1E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (16-18)* 5.0E-01 ug/L 3.4E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.5E-08

Naphthalene 3.6E-01 ug/L 1.0E-07 mg/kg-day NA NA 1.2E-06 mg/kg-day 2.0E-02 mg/kg-day 5.9E-05

Arsenic 1.7E+01 ug/L 7.3E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.1E-07 8.5E-07 mg/kg-day 3.0E-04 mg/kg-day 2.8E-03

Chromium (12-16)* 8.5E+00 ug/L 5.0E-08 mg/kg-day 6.0E+01 1/(mg/kg-day) 3.0E-06 8.7E-07 mg/kg-day 7.5E-05 mg/kg-day 1.2E-02

Chromium (16-18)* 8.5E+00 ug/L 2.5E-08 mg/kg-day 2.0E+01 1/(mg/kg-day) 5.0E-07

Cobalt 3.9E+00 ug/L 6.8E-09 mg/kg-day NA NA 8.0E-08 mg/kg-day 3.0E-04 mg/kg-day 2.7E-04

Lead 1.5E+01 ug/L 6.5E-09 mg/kg-day NA NA 7.6E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 1.5E-07 mg/kg-day NA NA 1.7E-06 mg/kg-day 5.0E-03 mg/kg-day 3.4E-04

Exp. Route Total 7.7E-05 2.2E-02

Exposure Point Total 7.8E-05 3.5E-02

7.8E-05 3.5E-02

Surface Water Total - Wet Event 7.8E-05 3.5E-02

Air AirAmbient air at canal

levelInhalation

(pre-aeration system Benzene 9.1E-04 mg/m3 6.0E-04 ug/m3 7.8E-06 1/(ug/m3) 4.7E-09 7.1E-06 mg/m3 3.0E-02 mg/m32.4E-04

operation) Chloroform 2.2E-04 mg/m3 1.5E-04 ug/m3 2.3E-05 1/(ug/m3) 3.4E-09 1.7E-06 mg/m3 9.8E-02 mg/m31.7E-05

Ethylbenzene 2.3E-03 mg/m3 1.5E-03 ug/m3 2.5E-06 1/(ug/m3) 3.7E-09 1.7E-05 mg/m3 1.0E+00 mg/m31.7E-05

Xylene, total 1.0E-02 mg/m3 6.7E-03 ug/m3 NA NA 7.8E-05 mg/m3 1.0E-01 mg/m37.8E-04

Naphthalene 2.1E-03 mg/m3 1.4E-03 ug/m3 3.4E-05 1/(ug/m3) 4.7E-08 1.6E-05 mg/m3 3.0E-03 mg/m35.4E-03

Exp. Route Total 5.9E-08 6.4E-03

Exposure Point Total 5.9E-08 6.4E-03

5.9E-08 6.4E-03

Ambient air at canal level Total - Pre-aeration system operation 5.9E-08 6.4E-03

Exposure Medium Total

Exposure Medium Total

Page 234: Appendix L HHRA Combined

TABLE 7.2.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at canal

levelInhalation

(after aeration system Benzene 1.9E-03 mg/m3 1.3E-03 ug/m3 7.8E-06 1/(ug/m3) 1.0E-08 1.5E-05 mg/m3 3.0E-02 mg/m35.0E-04

started) Chloroform 2.1E-04 mg/m3 1.4E-04 ug/m3 2.3E-05 1/(ug/m3) 3.1E-09 1.6E-06 mg/m3 9.8E-02 mg/m31.6E-05

Ethylbenzene 2.1E-03 mg/m3 1.4E-03 ug/m3 2.5E-06 1/(ug/m3) 3.5E-09 1.6E-05 mg/m3 1.0E+00 mg/m31.6E-05

Xylene, total 1.7E-02 mg/m3 1.1E-02 ug/m3 NA NA 1.3E-04 mg/m3 1.0E-01 mg/m31.3E-03

Naphthalene 2.2E-03 mg/m3 1.4E-03 ug/m3 3.4E-05 1/(ug/m3) 4.9E-08 1.7E-05 mg/m3 3.0E-03 mg/m35.6E-03

Exp. Route Total 6.6E-08 7.5E-03

Exposure Point Total 6.6E-08 7.5E-03

6.6E-08 7.5E-03

Ambient air at canal level Total - After aeration system turned on 6.6E-08 7.5E-03

Total Total of Receptor Risks Across All Media 2.1E-04 Total of Receptor Hazards Across All Media 2.5E-01

Notes-

NA = Not available / Not applicable.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used to adjust CSF for 12-16 year old for exposure duration of 4 years, ADAF of 1 used to adjust CSF for 16-18 year old for exposure duration of 2 years.

Non-cancer calculations shown under 12-16 year old only, as non-cancer calculations are not adjusted for MMOA.

DAevent for surface water from dry event calculated on Table 7.1.RME Supplement A.

DAevent for surface water from wet event calculated on Table 7.1.RME Supplement B.

Total includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air prior to areation system operation and after aeration system started.

Exposure Medium Total

Page 235: Appendix L HHRA Combined

TABLE 7.3.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Ingestion

Acenaphthene 3.7E+02 mg/kg 1.5E-05 mg/kg-day NA NA 1.7E-04 mg/kg-day 6.0E-02 mg/kg-day 2.9E-03

Benzo(a)anthracene (0-2)* 1.3E+02 mg/kg 1.7E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.3E-05 6.0E-05 mg/kg-day NA NA

Benzo(a)anthracene (2-6)* 1.3E+02 mg/kg 3.4E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 7.5E-06

Benzo(a)pyrene (0-2)* 1.1E+02 mg/kg 1.5E-06 mg/kg-day 7.3E+01 1/(mg/kg-day) 1.1E-04 5.1E-05 mg/kg-day NA NA

Benzo(a)pyrene (2-6)* 1.1E+02 mg/kg 2.9E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 6.4E-05

Benzo(b)fluoranthene (0-2)* 1.1E+02 mg/kg 1.5E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.1E-05 5.4E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-6)* 1.1E+02 mg/kg 3.1E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.7E-06

Benzo(k)fluoranthene (0-2)* 6.5E+01 mg/kg 8.8E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.4E-07 3.1E-05 mg/kg-day NA NA

Benzo(k)fluoranthene (2-6)* 6.5E+01 mg/kg 1.8E-06 mg/kg-day 2.2E-01 1/(mg/kg-day) 3.8E-07

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 1.4E-06 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.9E-08 1.6E-05 mg/kg-day 2.0E-02 mg/kg-day 7.9E-04

Chrysene (0-2)* 2.5E+02 mg/kg 3.4E-06 mg/kg-day 7.3E-02 1/(mg/kg-day) 2.5E-07 1.2E-04 mg/kg-day NA NA

Chrysene (2-6)* 2.5E+02 mg/kg 6.9E-06 mg/kg-day 2.2E-02 1/(mg/kg-day) 1.5E-07

Dibenz(a,h)anthracene (0-2)* 6.2E+00 mg/kg 8.4E-08 mg/kg-day 7.3E+01 1/(mg/kg-day) 6.1E-06 2.9E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (2-6)* 6.2E+00 mg/kg 1.7E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 3.7E-06

Fluoranthene 5.0E+02 mg/kg 2.0E-05 mg/kg-day NA NA 2.4E-04 mg/kg-day 4.0E-02 mg/kg-day 5.9E-03

Indeno(1,2,3-c,d)pyrene (0-2)* 4.9E+01 mg/kg 6.6E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.8E-06 2.3E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-6)* 4.9E+01 mg/kg 1.3E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.9E-06

Naphthalene 3.4E+00 mg/kg 1.4E-07 mg/kg-day NA NA 1.6E-06 mg/kg-day 2.0E-02 mg/kg-day 8.1E-05

Pyrene 5.3E+02 mg/kg 2.2E-05 mg/kg-day NA NA 2.5E-04 mg/kg-day 3.0E-02 mg/kg-day 8.4E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 1.6E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.6E-07 1.9E-11 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 2.1E-07 mg/kg-day 2.0E+00 1/(mg/kg-day) 4.3E-07 2.5E-06 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 2.2E-07 mg/kg-day NA NA 2.6E-06 mg/kg-day 2.0E-05 mg/kg-day 1.3E-01

Aluminum 1.6E+04 mg/kg 6.5E-04 mg/kg-day NA NA 7.6E-03 mg/kg-day 1.0E+00 mg/kg-day 7.6E-03

Arsenic 1.8E+01 mg/kg 7.3E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.1E-06 8.5E-06 mg/kg-day 3.0E-04 mg/kg-day 2.8E-02

Cadmium 9.6E+00 mg/kg 3.9E-07 mg/kg-day NA NA 4.6E-06 mg/kg-day 1.0E-03 mg/kg-day 4.6E-03

Chromium (0-2)* 9.4E+01 mg/kg 1.3E-06 mg/kg-day 5.0E+00 1/(mg/kg-day) 6.3E-06 4.4E-05 mg/kg-day 3.0E-03 mg/kg-day 1.5E-02

Chromium (2-6)* 9.4E+01 mg/kg 2.5E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 3.8E-06

Cobalt 1.3E+01 mg/kg 5.3E-07 mg/kg-day NA NA 6.1E-06 mg/kg-day 3.0E-04 mg/kg-day 2.0E-02

Copper 3.5E+02 mg/kg 1.4E-05 mg/kg-day NA NA 1.7E-04 mg/kg-day 4.0E-02 mg/kg-day 4.2E-03

Iron 4.0E+04 mg/kg 1.6E-03 mg/kg-day NA NA 1.9E-02 mg/kg-day 7.0E-01 mg/kg-day 2.7E-02

Lead 1.9E+03 mg/kg 7.6E-05 mg/kg-day NA NA 8.9E-04 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 1.3E-05 mg/kg-day NA NA 1.5E-04 mg/kg-day 1.4E-01 mg/kg-day 1.1E-03

Vanadium 5.0E+01 mg/kg 2.0E-06 mg/kg-day NA NA 2.4E-05 mg/kg-day 5.0E-03 mg/kg-day 4.8E-03

Exp. Route Total 2.4E-04 2.6E-01

Page 236: Appendix L HHRA Combined

TABLE 7.3.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Dermal

Acenaphthene 3.7E+02 mg/kg 1.1E-05 mg/kg-day NA NA 1.3E-04 mg/kg-day 6.0E-02 mg/kg-day 2.1E-03

Benzo(a)anthracene (0-2)* 1.3E+02 mg/kg 1.3E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 9.2E-06 4.4E-05 mg/kg-day NA NA

Benzo(a)anthracene (2-6)* 1.3E+02 mg/kg 2.5E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.5E-06

Benzo(a)pyrene (0-2)* 1.1E+02 mg/kg 1.1E-06 mg/kg-day 7.3E+01 1/(mg/kg-day) 7.7E-05 3.7E-05 mg/kg-day NA NA

Benzo(a)pyrene (2-6)* 1.1E+02 mg/kg 2.1E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.6E-05

Benzo(b)fluoranthene (0-2)* 1.1E+02 mg/kg 1.1E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 8.1E-06 3.9E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-6)* 1.1E+02 mg/kg 2.2E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 4.9E-06

Benzo(k)fluoranthene (0-2)* 6.5E+01 mg/kg 6.4E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.7E-07 2.2E-05 mg/kg-day NA NA

Benzo(k)fluoranthene (2-6)* 6.5E+01 mg/kg 1.3E-06 mg/kg-day 2.2E-01 1/(mg/kg-day) 2.8E-07

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 7.6E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.1E-08 8.9E-06 mg/kg-day 2.0E-02 mg/kg-day 4.4E-04

Chrysene (0-2)* 2.5E+02 mg/kg 2.5E-06 mg/kg-day 7.3E-02 1/(mg/kg-day) 1.8E-07 8.7E-05 mg/kg-day NA NA

Chrysene (2-6)* 2.5E+02 mg/kg 5.0E-06 mg/kg-day 2.2E-02 1/(mg/kg-day) 1.1E-07

Dibenz(a,h)anthracene (0-2)* 6.2E+00 mg/kg 6.1E-08 mg/kg-day 7.3E+01 1/(mg/kg-day) 4.5E-06 2.1E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (2-6)* 6.2E+00 mg/kg 1.2E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.7E-06

Fluoranthene 5.0E+02 mg/kg 1.5E-05 mg/kg-day NA NA 1.7E-04 mg/kg-day 4.0E-02 mg/kg-day 4.3E-03

Indeno(1,2,3-c,d)pyrene (0-2)* 4.9E+01 mg/kg 4.8E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.5E-06 1.7E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-6)* 4.9E+01 mg/kg 9.7E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.1E-06

Naphthalene 3.4E+00 mg/kg 1.0E-07 mg/kg-day NA NA 1.2E-06 mg/kg-day 2.0E-02 mg/kg-day 5.9E-05

Pyrene 5.3E+02 mg/kg 1.6E-05 mg/kg-day NA NA 1.8E-04 mg/kg-day 3.0E-02 mg/kg-day 6.1E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 1.3E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.0E-07 1.5E-11 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 1.7E-07 mg/kg-day 2.0E+00 1/(mg/kg-day) 3.3E-07 1.9E-06 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 1.7E-07 mg/kg-day NA NA 2.0E-06 mg/kg-day 2.0E-05 mg/kg-day 1.0E-01

Aluminum 1.6E+04 mg/kg 3.6E-05 mg/kg-day NA NA 4.2E-04 mg/kg-day 1.0E+00 mg/kg-day 4.2E-04

Arsenic 1.8E+01 mg/kg 1.2E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.8E-07 1.4E-06 mg/kg-day 3.0E-04 mg/kg-day 4.8E-03

Cadmium 9.6E+00 mg/kg 2.2E-09 mg/kg-day NA NA 2.6E-08 mg/kg-day 2.5E-05 mg/kg-day 1.0E-03

Chromium (0-2)* 9.4E+01 mg/kg 7.1E-08 mg/kg-day 2.0E+02 1/(mg/kg-day) 1.4E-05 2.5E-06 mg/kg-day 7.5E-05 mg/kg-day 3.3E-02

Chromium (2-6)* 9.4E+01 mg/kg 1.4E-07 mg/kg-day 6.0E+01 1/(mg/kg-day) 8.5E-06

Cobalt 1.3E+01 mg/kg 2.9E-08 mg/kg-day NA NA 3.4E-07 mg/kg-day 3.0E-04 mg/kg-day 1.1E-03

Copper 3.5E+02 mg/kg 8.0E-07 mg/kg-day NA NA 9.4E-06 mg/kg-day 4.0E-02 mg/kg-day 2.3E-04

Iron 4.0E+04 mg/kg 9.1E-05 mg/kg-day NA NA 1.1E-03 mg/kg-day 7.0E-01 mg/kg-day 1.5E-03

Lead 1.9E+03 mg/kg 4.3E-06 mg/kg-day NA NA 5.0E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 7.2E-07 mg/kg-day NA NA 8.4E-06 mg/kg-day 9.6E-04 mg/kg-day 8.7E-03

Vanadium 5.0E+01 mg/kg 1.1E-07 mg/kg-day NA NA 1.3E-06 mg/kg-day 5.0E-03 mg/kg-day 2.7E-04

Exp. Route Total 1.9E-04 1.6E-01

Exposure Point Total 4.3E-04 4.2E-01

4.3E-04 4.2E-01

Exposed Surface Sediment Total 4.3E-04 4.2E-01

Exposure Medium Total

Page 237: Appendix L HHRA Combined

TABLE 7.3.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Dry event) Benzene 2.2E+00 ug/L 1.2E-07 mg/kg-day 5.5E-02 1/(mg/kg-day) 6.5E-09 1.4E-06 mg/kg-day 4.0E-03 mg/kg-day 3.5E-04

Benzo(a)anthracene (0-2)* 2.7E-01 ug/L 4.7E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.4E-08 1.6E-07 mg/kg-day NA NA

Benzo(a)anthracene (2-6)* 2.7E-01 ug/L 9.4E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.1E-08

Benzo(a)pyrene (0-2)* 6.6E-01 ug/L 1.2E-08 mg/kg-day 7.3E+01 1/(mg/kg-day) 8.5E-07 4.1E-07 mg/kg-day NA NA

Benzo(a)pyrene (2-6)* 6.6E-01 ug/L 2.3E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 5.1E-07

Benzo(b)fluoranthene (0-2)* 3.0E-01 ug/L 5.3E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.8E-08 1.8E-07 mg/kg-day NA NA

Benzo(b)fluoranthene (2-6)* 3.0E-01 ug/L 1.1E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.3E-08

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 1.3E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.8E-09 1.5E-06 mg/kg-day 2.0E-02 mg/kg-day 7.6E-05

Indeno(1,2,3-c,d)pyrene (0-2)* 1.3E-01 ug/L 2.3E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.7E-08 8.1E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-6)* 1.3E-01 ug/L 4.7E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.0E-08

Arsenic 2.0E+01 ug/L 1.1E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.6E-06 1.2E-05 mg/kg-day 3.0E-04 mg/kg-day 4.1E-02

Chromium (0-2)* 1.9E+01 ug/L 3.3E-07 mg/kg-day 5.0E+00 1/(mg/kg-day) 1.7E-06 1.2E-05 mg/kg-day 3.0E-03 mg/kg-day 3.9E-03

Chromium (2-6)* 1.9E+01 ug/L 6.7E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.0E-06

Copper 1.7E+02 ug/L 9.1E-06 mg/kg-day NA 1.1E-04 mg/kg-day 4.0E-02 mg/kg-day 2.7E-03

Selenium 4.1E+01 ug/L 2.2E-06 mg/kg-day NA 2.5E-05 mg/kg-day 5.0E-03 mg/kg-day 5.1E-03

Exp. Route Total 5.8E-06 5.3E-02

Dermal

Benzene 2.2E+00 ug/L 2.8E-07 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.5E-08 3.2E-06 mg/kg-day 4.0E-03 mg/kg-day 8.1E-04

Benzo(a)anthracene (0-2)* 2.7E-01 ug/L 7.1E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 5.2E-06 2.5E-05 mg/kg-day NA NA

Benzo(a)anthracene (2-6)* 2.7E-01 ug/L 1.4E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.1E-06

Benzo(a)pyrene (0-2)* 6.6E-01 ug/L 3.0E-06 mg/kg-day 7.3E+01 1/(mg/kg-day) 2.2E-04 1.1E-04 mg/kg-day NA NA

Benzo(a)pyrene (2-6)* 6.6E-01 ug/L 6.0E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.3E-04

Benzo(b)fluoranthene (0-2)* 3.0E-01 ug/L 1.4E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.0E-05 4.9E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-6)* 3.0E-01 ug/L 2.8E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.1E-06

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 2.4E-06 mg/kg-day 1.4E-02 1/(mg/kg-day) 3.4E-08 2.8E-05 mg/kg-day 2.0E-02 mg/kg-day 1.4E-03

Indeno(1,2,3-c,d)pyrene (0-2)* 1.3E-01 ug/L 6.1E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.5E-06 2.2E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-6)* 1.3E-01 ug/L 1.2E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.7E-06

Arsenic 2.0E+01 ug/L 1.4E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.1E-07 1.6E-06 mg/kg-day 3.0E-04 mg/kg-day 5.4E-03

Chromium (0-2)* 1.9E+01 ug/L 8.8E-08 mg/kg-day 2.0E+02 1/(mg/kg-day) 1.8E-05 3.1E-06 mg/kg-day 7.5E-05 mg/kg-day 4.1E-02

Chromium (2-6)* 1.9E+01 ug/L 1.8E-07 mg/kg-day 6.0E+01 1/(mg/kg-day) 1.1E-05

Copper 1.7E+02 ug/L 1.2E-06 mg/kg-day NA NA 1.4E-05 mg/kg-day 4.0E-02 mg/kg-day 3.5E-04

Selenium 4.1E+01 ug/L 2.9E-07 mg/kg-day NA NA 3.3E-06 mg/kg-day 5.0E-03 mg/kg-day 6.7E-04

Exp. Route Total 4.1E-04 5.0E-02

Exposure Point Total 4.2E-04 1.0E-01

4.2E-04 1.0E-01

Surface Water Total - Dry Event 4.2E-04 1.0E-01

Exposure Medium Total

Page 238: Appendix L HHRA Combined

TABLE 7.3.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 3.1E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.7E-10 3.6E-07 mg/kg-day 7.0E-02 mg/kg-day 5.2E-06

Benzene 8.4E-01 ug/L 4.4E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 2.4E-09 5.2E-07 mg/kg-day 4.0E-03 mg/kg-day 1.3E-04

Chloroform 5.6E-01 ug/L 3.0E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 9.2E-10 3.5E-07 mg/kg-day 1.0E-02 mg/kg-day 3.5E-05

Ethylbenzene 8.7E-01 ug/L 4.6E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 5.1E-10 5.4E-07 mg/kg-day 1.0E-01 mg/kg-day 5.4E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 1.3E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 7.0E-07 1.5E-05 mg/kg-day 1.0E-02 mg/kg-day 1.5E-03

Benzo(a)anthracene (0-2)* 1.0E-01 ug/L 1.8E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.3E-08 6.4E-08 mg/kg-day NA NA

Benzo(a)anthracene (2-6)* 1.0E-01 ug/L 3.7E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 8.0E-09

Benzo(a)pyrene (0-2)* 2.1E-01 ug/L 3.6E-09 mg/kg-day 7.3E+01 1/(mg/kg-day) 2.6E-07 1.3E-07 mg/kg-day NA NA

Benzo(a)pyrene (2-6)* 2.1E-01 ug/L 7.2E-09 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.6E-07

Benzo(b)fluoranthene (0-2)* 1.9E-01 ug/L 3.3E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.4E-08 1.2E-07 mg/kg-day NA NA

Benzo(b)fluoranthene (2-6)* 1.9E-01 ug/L 6.7E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.5E-08

Dibenz(a,h)anthracene (0-2)* 1.0E-01 ug/L 1.8E-09 mg/kg-day 7.3E+01 1/(mg/kg-day) 1.3E-07 6.2E-08 mg/kg-day NA NA

Dibenz(a,h)anthracene (2-6)* 1.0E-01 ug/L 3.6E-09 mg/kg-day 2.2E+01 1/(mg/kg-day) 7.8E-08

Indeno(1,2,3-c,d)pyrene (0-2)* 5.0E-01 ug/L 8.8E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.4E-08 3.1E-07 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-6)* 5.0E-01 ug/L 1.8E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.9E-08

Naphthalene 3.6E-01 ug/L 1.9E-08 mg/kg-day NA NA 2.2E-07 mg/kg-day 2.0E-02 mg/kg-day 1.1E-05

Arsenic 1.7E+01 ug/L 8.8E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.3E-06 1.0E-05 mg/kg-day 3.0E-04 mg/kg-day 3.4E-02

Chromium (0-2)* 8.5E+00 ug/L 1.5E-07 mg/kg-day 5.0E+00 1/(mg/kg-day) 7.5E-07 5.3E-06 mg/kg-day 3.0E-03 mg/kg-day 1.8E-03

Chromium (2-6)* 8.5E+00 ug/L 3.0E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.5E-07

Cobalt 3.9E+00 ug/L 2.1E-07 mg/kg-day NA NA 2.4E-06 mg/kg-day 3.0E-04 mg/kg-day 8.0E-03

Lead 1.5E+01 ug/L 7.9E-07 mg/kg-day NA NA 9.2E-06 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 1.8E-06 mg/kg-day NA NA 2.1E-05 mg/kg-day 5.0E-03 mg/kg-day 4.1E-03

Exp. Route Total 4.0E-06 5.0E-02

Page 239: Appendix L HHRA Combined

TABLE 7.3.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Dermal

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 2.6E-07 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.4E-09 3.0E-06 mg/kg-day 7.0E-02 mg/kg-day 4.3E-05

Benzene 8.4E-01 ug/L 1.0E-07 mg/kg-day 5.5E-02 1/(mg/kg-day) 5.7E-09 1.2E-06 mg/kg-day 4.0E-03 mg/kg-day 3.0E-04

Chloroform 5.6E-01 ug/L 3.6E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 1.1E-09 4.2E-07 mg/kg-day 1.0E-02 mg/kg-day 4.2E-05

Ethylbenzene 8.7E-01 ug/L 3.6E-07 mg/kg-day 1.1E-02 1/(mg/kg-day) 4.0E-09 4.2E-06 mg/kg-day 1.0E-01 mg/kg-day 4.2E-05

Tetrachloroethylene(PCE) 2.4E+01 ug/L 9.4E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 5.1E-06 1.1E-04 mg/kg-day 1.0E-02 mg/kg-day 1.1E-02

Benzo(a)anthracene (0-2)* 1.0E-01 ug/L 2.8E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.0E-06 9.7E-06 mg/kg-day NA NA

Benzo(a)anthracene (2-6)* 1.0E-01 ug/L 5.6E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.2E-06

Benzo(a)pyrene (0-2)* 2.1E-01 ug/L 9.4E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 6.9E-05 3.3E-05 mg/kg-day NA NA

Benzo(a)pyrene (2-6)* 2.1E-01 ug/L 1.9E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.1E-05

Benzo(b)fluoranthene (0-2)* 1.9E-01 ug/L 8.8E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.4E-06 3.1E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-6)* 1.9E-01 ug/L 1.8E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.8E-06

Dibenz(a,h)anthracene (0-2)* 1.0E-01 ug/L 7.1E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 5.2E-05 2.5E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene (2-6)* 1.0E-01 ug/L 1.4E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 3.1E-05

Indeno(1,2,3-c,d)pyrene (0-2)* 5.0E-01 ug/L 2.3E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.7E-05 8.1E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-6)* 5.0E-01 ug/L 4.7E-06 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.0E-05

Naphthalene 3.6E-01 ug/L 1.6E-07 mg/kg-day NA NA 1.9E-06 mg/kg-day 2.0E-02 mg/kg-day 9.4E-05

Arsenic 1.7E+01 ug/L 1.2E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.7E-07 1.4E-06 mg/kg-day 3.0E-04 mg/kg-day 4.5E-03

Chromium (0-2)* 8.5E+00 ug/L 4.0E-08 mg/kg-day 2.0E+02 1/(mg/kg-day) 7.9E-06 1.4E-06 mg/kg-day 7.5E-05 mg/kg-day 1.9E-02

Chromium (2-6)* 8.5E+00 ug/L 7.9E-08 mg/kg-day 6.0E+01 1/(mg/kg-day) 4.8E-06

Cobalt 3.9E+00 ug/L 1.1E-08 mg/kg-day NA NA 1.3E-07 mg/kg-day 3.0E-04 mg/kg-day 4.2E-04

Lead 1.5E+01 ug/L 1.0E-08 mg/kg-day NA NA 1.2E-07 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 2.3E-07 mg/kg-day NA NA 2.7E-06 mg/kg-day 5.0E-03 mg/kg-day 5.5E-04

Exp. Route Total 2.5E-04 3.6E-02

Exposure Point Total 2.6E-04 8.5E-02

2.6E-04 8.5E-02

Surface Water Total - Wet Event 2.6E-04 8.5E-02

Air AirAmbient air at canal

levelInhalation

(pre-aeration system Benzene 9.1E-04 mg/m3 6.0E-04 ug/m3 7.8E-06 1/(ug/m3) 4.7E-09 7.1E-06 mg/m3 3.0E-02 mg/m32.4E-04

operation) Chloroform 2.2E-04 mg/m3 1.5E-04 ug/m3 2.3E-05 1/(ug/m3) 3.4E-09 1.7E-06 mg/m3 9.8E-02 mg/m31.7E-05

Ethylbenzene 2.3E-03 mg/m3 1.5E-03 ug/m3 2.5E-06 1/(ug/m3) 3.7E-09 1.7E-05 mg/m3 1.0E+00 mg/m31.7E-05

Xylene, total 1.0E-02 mg/m3 6.7E-03 ug/m3 NA NA 7.8E-05 mg/m3 1.0E-01 mg/m37.8E-04

Naphthalene 2.1E-03 mg/m3 1.4E-03 ug/m3 3.4E-05 1/(ug/m3) 4.7E-08 1.6E-05 mg/m3 3.0E-03 mg/m35.4E-03

Exp. Route Total 5.9E-08 6.4E-03

Exposure Point Total 5.9E-08 6.4E-03

5.9E-08 6.4E-03

Ambient air at canal level Total - Pre-aeration system operation 5.9E-08 6.4E-03

Exposure Medium Total

Exposure Medium Total

Page 240: Appendix L HHRA Combined

TABLE 7.3.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at canal

levelInhalation

(after aeration system Benzene 1.9E-03 mg/m3 1.3E-03 ug/m3 7.8E-06 1/(ug/m3) 1.0E-08 1.5E-05 mg/m3 3.0E-02 mg/m35.0E-04

started) Chloroform 2.1E-04 mg/m3 1.4E-04 ug/m3 2.3E-05 1/(ug/m3) 3.1E-09 1.6E-06 mg/m3 9.8E-02 mg/m31.6E-05

Ethylbenzene 2.1E-03 mg/m3 1.4E-03 ug/m3 2.5E-06 1/(ug/m3) 3.5E-09 1.6E-05 mg/m3 1.0E+00 mg/m31.6E-05

Xylene, total 1.7E-02 mg/m3 1.1E-02 ug/m3 NA NA 1.3E-04 mg/m3 1.0E-01 mg/m31.3E-03

Naphthalene 2.2E-03 mg/m3 1.4E-03 ug/m3 3.4E-05 1/(ug/m3) 4.9E-08 1.7E-05 mg/m3 3.0E-03 mg/m35.6E-03

Exp. Route Total 6.6E-08 7.5E-03

Exposure Point Total 6.6E-08 7.5E-03

6.6E-08 7.5E-03

Ambient air at canal level Total - After aeration system turned on 6.6E-08 7.5E-03

Total Total of Receptor Risks Across All Media 8.5E-04 Total of Receptor Hazards Across All Media 5.3E-01

Notes-

NA = Not available / Not applicable.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 used to adjust CSF for 2-6 year old for exposure duration of 4 years.

Non-cancer calculations shown under 0-2 year old only, as non-cancer calculations are not adjusted for MMOA.

DAevent for surface water from dry event calculated on Table 7.1.RME Supplement A.

DAevent for surface water from wet event calculated on Table 7.1.RME Supplement B.

Total includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air prior to areation system operation and after aeration system started

Exposure Medium Total

Page 241: Appendix L HHRA Combined

TABLE 7.4.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at street

levelInhalation

(pre-aeration system Benzene 1.3E-03 mg/m3 3.1E-01 ug/m3 7.8E-06 1/(ug/m3) 2.4E-06 8.6E-04 mg/m3 3.0E-02 mg/m32.9E-02

operation) Chloroform 2.5E-04 mg/m3 6.0E-02 ug/m3 2.3E-05 1/(ug/m3) 1.4E-06 1.7E-04 mg/m3 9.8E-02 mg/m31.7E-03

Ethylbenzene 1.1E-03 mg/m3 2.7E-01 ug/m3 2.5E-06 1/(ug/m3) 6.7E-07 7.5E-04 mg/m3 1.0E+00 mg/m37.5E-04

Naphthalene 1.3E-03 mg/m3 3.2E-01 ug/m3 3.4E-05 1/(ug/m3) 1.1E-05 8.9E-04 mg/m3 3.0E-03 mg/m33.0E-01

Exp. Route Total 1.5E-05 3.3E-01

Exposure Point Total 1.5E-05 3.3E-01

1.5E-05 3.3E-01

Ambient air at street level Total - Pre-aeration system operation 1.5E-05 3.3E-01

Air AirAmbient air at street

levelInhalation

(after aeration system Benzene 1.1E-03 mg/m3 2.7E-01 ug/m3 7.8E-06 1/(ug/m3) 2.1E-06 7.6E-04 mg/m3 3.0E-02 mg/m32.5E-02

started) Chloroform 3.3E-04 mg/m3 8.1E-02 ug/m3 2.3E-05 1/(ug/m3) 1.9E-06 2.3E-04 mg/m3 9.8E-02 mg/m32.3E-03

Ethylbenzene 1.2E-03 mg/m3 3.0E-01 ug/m3 2.5E-06 1/(ug/m3) 7.6E-07 8.5E-04 mg/m3 1.0E+00 mg/m38.5E-04

Naphthalene 3.0E-03 mg/m3 7.4E-01 ug/m3 3.4E-05 1/(ug/m3) 2.5E-05 2.1E-03 mg/m3 3.0E-03 mg/m36.9E-01

Exp. Route Total 3.0E-05 7.2E-01

Exposure Point Total 3.0E-05 7.2E-01

3.0E-05 7.2E-01

Ambient air at street level Total - After aeration system turned on 3.0E-05 7.2E-01

Exposure Medium Total

Exposure Medium Total

Page 242: Appendix L HHRA Combined

TABLE 7.4.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Ingestion

2-methylnaphthalene 3.6E+02 mg/kg 4.5E-06 mg/kg-day NA 1/(mg/kg-day) NA 1.3E-05 mg/kg-day 4.0E-03 mg/kg-day 3.2E-03

Acenaphthene 3.1E+02 mg/kg 3.9E-06 mg/kg-day NA NA 1.1E-05 mg/kg-day 6.0E-02 mg/kg-day 1.8E-04

Benzo(a)anthracene 1.3E+02 mg/kg 1.6E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.2E-06 4.5E-06 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 9.2E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.7E-06 2.6E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 1.0E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 7.3E-07 2.8E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 5.2E-07 mg/kg-day 7.3E-02 1/(mg/kg-day) 3.8E-08 1.4E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.8E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.6E-09 5.1E-07 mg/kg-day 2.0E-02 mg/kg-day 2.6E-05

Chrysene 1.3E+02 mg/kg 1.6E-06 mg/kg-day 7.3E-03 1/(mg/kg-day) 1.2E-08 4.5E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 6.9E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 5.0E-07 1.9E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg 2.3E-06 mg/kg-day NA NA 6.3E-06 mg/kg-day 4.0E-02 mg/kg-day 1.6E-04

Fluorene 2.3E+02 mg/kg 2.9E-06 mg/kg-day NA NA 8.1E-06 mg/kg-day 4.0E-02 mg/kg-day 2.0E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 4.0E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.9E-07 1.1E-06 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg 8.2E-06 mg/kg-day NA NA 2.3E-05 mg/kg-day 2.0E-02 mg/kg-day 1.2E-03

Pyrene 3.9E+02 mg/kg 4.9E-06 mg/kg-day NA NA 1.4E-05 mg/kg-day 3.0E-02 mg/kg-day 4.5E-04

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 5.7E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 8.9E-08 1.6E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 8.1E-08 mg/kg-day 2.0E+00 1/(mg/kg-day) 1.6E-07 2.3E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg 8.3E-08 mg/kg-day NA NA 2.3E-07 mg/kg-day 2.0E-05 mg/kg-day 1.2E-02

Aluminum 1.5E+04 mg/kg 1.8E-04 mg/kg-day NA NA 5.1E-04 mg/kg-day 1.0E+00 mg/kg-day 5.1E-04

Arsenic 1.5E+01 mg/kg 1.8E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.8E-07 5.2E-07 mg/kg-day 3.0E-04 mg/kg-day 1.7E-03

Cadmium 1.0E+01 mg/kg 1.3E-07 mg/kg-day NA NA 3.5E-07 mg/kg-day 1.0E-03 mg/kg-day 3.5E-04

Chromium 8.5E+01 mg/kg 1.1E-06 mg/kg-day 5.0E-01 5.3E-07 3.0E-06 mg/kg-day 3.0E-03 mg/kg-day 9.9E-04

Cobalt 1.1E+01 mg/kg 1.4E-07 mg/kg-day NA NA 3.9E-07 mg/kg-day 3.0E-04 mg/kg-day 1.3E-03

Copper 2.7E+02 mg/kg 3.4E-06 mg/kg-day NA NA 9.7E-06 mg/kg-day 4.0E-02 mg/kg-day 2.4E-04

Iron 3.4E+04 mg/kg 4.2E-04 mg/kg-day NA NA 1.2E-03 mg/kg-day 7.0E-01 mg/kg-day 1.7E-03

Lead 1.2E+03 mg/kg 1.5E-05 mg/kg-day NA NA 4.2E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 3.8E-06 mg/kg-day NA NA 1.1E-05 mg/kg-day 1.4E-01 mg/kg-day 7.7E-05

Vanadium 4.6E+01 mg/kg 5.8E-07 mg/kg-day NA NA 1.6E-06 mg/kg-day 5.0E-03 mg/kg-day 3.2E-04

Exp. Route Total 1.1E-05 2.4E-02

Page 243: Appendix L HHRA Combined

TABLE 7.4.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Dermal

2-methylnaphthalene 3.6E+02 mg/kg 3.9E-06 mg/kg-day NA NA 1.1E-05 mg/kg-day 4.0E-03 mg/kg-day 2.7E-03

Acenaphthene 3.1E+02 mg/kg 3.3E-06 mg/kg-day NA NA 9.3E-06 mg/kg-day 6.0E-02 mg/kg-day 1.6E-04

Benzo(a)anthracene 1.3E+02 mg/kg 1.4E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.0E-06 3.9E-06 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.9E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 5.8E-06 2.2E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 8.5E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.2E-07 2.4E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 4.4E-07 mg/kg-day 7.3E-02 1/(mg/kg-day) 3.2E-08 1.2E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.2E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.7E-09 3.4E-07 mg/kg-day 2.0E-02 mg/kg-day 1.7E-05

Chrysene 1.3E+02 mg/kg 1.4E-06 mg/kg-day 7.3E-03 1/(mg/kg-day) 1.0E-08 3.8E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 5.9E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.3E-07 1.7E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg 1.9E-06 mg/kg-day NA NA 5.4E-06 mg/kg-day 4.0E-02 mg/kg-day 1.4E-04

Fluorene 2.3E+02 mg/kg 2.5E-06 mg/kg-day NA NA 7.0E-06 mg/kg-day 4.0E-02 mg/kg-day 1.7E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 3.4E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.5E-07 9.5E-07 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg 7.1E-06 mg/kg-day NA NA 2.0E-05 mg/kg-day 2.0E-02 mg/kg-day 9.9E-04

Pyrene 3.9E+02 mg/kg 4.2E-06 mg/kg-day NA NA 1.2E-05 mg/kg-day 3.0E-02 mg/kg-day 3.9E-04

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 5.3E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 8.2E-08 1.5E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 7.5E-08 mg/kg-day 2.0E+00 1/(mg/kg-day) 1.5E-07 2.1E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg 7.7E-08 mg/kg-day NA NA 2.2E-07 mg/kg-day 2.0E-05 mg/kg-day 1.1E-02

Aluminum 1.5E+04 mg/kg 1.2E-05 mg/kg-day NA NA 3.4E-05 mg/kg-day 1.0E+00 mg/kg-day 3.4E-05

Arsenic 1.5E+01 mg/kg 3.7E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 5.5E-08 1.0E-07 mg/kg-day 3.0E-04 mg/kg-day 3.4E-04

Cadmium 1.0E+01 mg/kg 8.3E-10 mg/kg-day NA NA 2.3E-09 mg/kg-day 2.5E-05 mg/kg-day 9.3E-05

Chromium 8.5E+01 mg/kg 7.0E-08 mg/kg-day 2.0E+01 1/(mg/kg-day) 1.4E-06 2.0E-07 mg/kg-day 7.5E-05 mg/kg-day 2.6E-03

Cobalt 1.1E+01 mg/kg 9.1E-09 mg/kg-day NA NA 2.6E-08 mg/kg-day 3.0E-04 mg/kg-day 8.5E-05

Copper 2.7E+02 mg/kg 2.3E-07 mg/kg-day NA NA 6.4E-07 mg/kg-day 4.0E-02 mg/kg-day 1.6E-05

Iron 3.4E+04 mg/kg 2.8E-05 mg/kg-day NA NA 7.8E-05 mg/kg-day 7.0E-01 mg/kg-day 1.1E-04

Lead 1.2E+03 mg/kg 1.0E-06 mg/kg-day NA NA 2.8E-06 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 2.5E-07 mg/kg-day NA NA 7.1E-07 mg/kg-day 7.0E-01 mg/kg-day 1.0E-06

Vanadium 4.6E+01 mg/kg 3.8E-08 mg/kg-day NA NA 1.1E-07 mg/kg-day 5.0E-03 mg/kg-day 2.1E-05

Exp. Route Total 9.8E-06 1.9E-02

Exposure Point Total 2.0E-05 4.3E-02

2.0E-05 4.3E-02

Overflow Surface Sediment Total 2.0E-05 4.3E-02

Exposure Medium Total

Page 244: Appendix L HHRA Combined

TABLE 7.4.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

WaterCanal Overflow - Surface Water

Ingestion

1,4-dichlorobenzene 5.9E-01 ug/L 3.0E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.6E-10 8.3E-08 mg/kg-day 7.0E-02 mg/kg-day 1.2E-06

Benzene 8.4E-01 ug/L 9.2E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 5.1E-10 1.2E-07 mg/kg-day 4.0E-03 mg/kg-day 2.9E-05

Chloroform 5.6E-01 ug/L 6.2E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 1.9E-10 7.9E-08 mg/kg-day 1.0E-02 mg/kg-day 7.9E-06

Ethylbenzene 8.7E-01 ug/L 9.6E-09 mg/kg-day 1.1E-02 1/(mg/kg-day) 1.1E-10 1.2E-07 mg/kg-day 1.0E-01 mg/kg-day 1.2E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 2.7E-07 mg/kg-day 5.4E-01 1/(mg/kg-day) 1.5E-07 3.4E-06 mg/kg-day 1.0E-02 mg/kg-day 3.4E-04

Benzo(a)anthracene 1.0E-01 ug/L 1.2E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 8.4E-10 1.5E-08 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 2.3E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.7E-08 2.9E-08 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 2.1E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.5E-09 2.7E-08 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 1.1E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 8.2E-09 1.4E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 5.5E-09 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.0E-09 7.0E-08 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 4.0E-09 mg/kg-day NA NA 5.1E-08 mg/kg-day 2.0E-02 mg/kg-day 2.6E-06

Arsenic 1.7E+01 ug/L 1.8E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.8E-07 2.3E-06 mg/kg-day 3.0E-04 mg/kg-day 7.8E-03

Chromium 8.5E+00 ug/L 9.4E-08 mg/kg-day 5.0E-01 1/(mg/kg-day) 4.7E-08 1.2E-06 mg/kg-day 3.0E-03 mg/kg-day 4.0E-04

Cobalt 3.9E+00 ug/L 4.3E-08 mg/kg-day NA NA 5.5E-07 mg/kg-day 3.0E-04 mg/kg-day 1.8E-03

Lead 1.5E+01 ug/L 1.6E-07 mg/kg-day NA NA 2.1E-06 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 3.7E-07 mg/kg-day NA NA 4.7E-06 mg/kg-day 5.0E-03 mg/kg-day 9.5E-04

Exp. Route Total 5.0E-07 1.1E-02

Page 245: Appendix L HHRA Combined

TABLE 7.4.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

WaterCanal Overflow - Surface Water

Dermal

1,4-dichlorobenzene 5.9E-01 ug/L 1.5E-07 mg/kg-day 5.4E-03 1/(mg/kg-day) 8.0E-10 4.2E-07 mg/kg-day 7.0E-02 mg/kg-day 6.0E-06

Benzene 8.4E-01 ug/L 7.4E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 4.1E-09 2.1E-07 mg/kg-day 4.0E-03 mg/kg-day 5.2E-05

Chloroform 5.6E-01 ug/L 2.4E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 7.4E-10 6.7E-08 mg/kg-day 1.0E-02 mg/kg-day 6.7E-06

Ethylbenzene 8.7E-01 ug/L 2.3E-07 mg/kg-day 1.1E-02 1/(mg/kg-day) 2.6E-09 6.6E-07 mg/kg-day 1.0E-01 mg/kg-day 6.6E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.2E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 2.8E-06 1.5E-05 mg/kg-day 1.0E-02 mg/kg-day 1.5E-03

Benzo(a)anthracene 1.0E-01 ug/L 3.9E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.9E-07 1.1E-06 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 1.3E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 9.6E-06 3.7E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 1.2E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 9.0E-07 3.5E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 1.0E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 7.3E-06 2.8E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 3.3E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.4E-06 9.2E-06 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 9.8E-08 mg/kg-day NA NA 2.7E-07 mg/kg-day 2.0E-02 mg/kg-day 1.4E-05

Arsenic 1.7E+01 ug/L 9.5E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.4E-07 2.7E-07 mg/kg-day 3.0E-04 mg/kg-day 8.9E-04

Chromium 8.5E+00 ug/L 9.8E-08 mg/kg-day 2.0E+01 1/(mg/kg-day) 2.0E-06 2.7E-07 mg/kg-day 7.5E-05 mg/kg-day 3.7E-03

Cobalt 3.9E+00 ug/L 8.9E-09 mg/kg-day NA NA 2.5E-08 mg/kg-day 3.0E-04 mg/kg-day 8.4E-05

Lead 1.5E+01 ug/L 8.5E-09 mg/kg-day NA NA 2.4E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 1.9E-07 mg/kg-day NA NA 5.4E-07 mg/kg-day 5.0E-03 mg/kg-day 1.1E-04

Exp. Route Total 2.5E-05 6.3E-03

Exposure Point Total 2.6E-05 1.8E-02

2.6E-05 1.8E-02

Overflow Surface Water Total 2.6E-05 1.8E-02

Total Total of Receptor Risks Across All Media 7.6E-05 Total of Receptor Hazards Across All Media 7.8E-01

Notes-

NA = Not available / Not applicable.

DAevent for surface water calculated on Table 7.4.RME Supplement A.

Total includes maximum between air prior to and after aeration system operation, and surface water, and sediment.

Exposure Medium Total

Page 246: Appendix L HHRA Combined

TABLE 7.4.RME Supplement A

Calculation of DAevent

Industrial Worker Adult

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Water Permeability Lag Fraction Duration

of Potential Concentration Coefficient Time Absorbed Water of Event

Concern (CW) (Kp) B (τevent) t* (FA) (tevent) DAevent

(µg/L) (cm/hr) (dimensionless) (hr) (hr) (dimensionless) (hr) (mg/cm2-event) Eq

1,4-dichlorobenzene 5.9E-01 4.2E-02 2.0E-01 7.1E-01 1.7E+00 1.0E+00 8 2.1E-07 3

Benzene 8.4E-01 1.5E-02 5.1E-02 2.9E-01 7.0E-01 1.0E+00 8 1.0E-07 3

Chloroform 5.6E-01 6.8E-03 2.9E-02 5.0E-01 1.2E+00 1.0E+00 8 3.3E-08 3

Ethylbenzene 8.7E-01 4.9E-02 2.0E-01 4.2E-01 1.0E+00 1.0E+00 8 3.3E-07 3

Tetrachloroethylene(PCE) 2.4E+01 3.3E-02 1.7E-01 9.1E-01 2.2E+00 1.0E+00 8 7.2E-06 3

Benzo(a)anthracene 1.0E-01 4.7E-01 2.8E+00 2.0E+00 8.5E+00 1.0E+00 8 5.4E-07 2

Benzo(a)pyrene 2.1E-01 7.0E-01 4.3E+00 2.7E+00 1.2E+01 1.0E+00 8 1.8E-06 2

Benzo(b)fluoranthene 1.9E-01 7.0E-01 4.3E+00 2.8E+00 1.2E+01 1.0E+00 8 1.7E-06 2

Dibenz(a,h)anthracene 1.0E-01 1.5E+00 9.7E+00 3.9E+00 1.8E+01 6.0E-01 8 1.4E-06 2

Indeno(1,2,3-c,d)pyrene 5.0E-01 1.0E+00 6.7E+00 3.8E+00 1.7E+01 6.0E-01 8 4.6E-06 2

Naphthalene 3.6E-01 4.7E-02 2.0E-01 5.6E-01 1.3E+00 1.0E+00 8 1.4E-07 3

Arsenic 1.7E+01 1.0E-03 NA NA NA NA 8 1.3E-07 1

Chromium 8.5E+00 2.0E-03 NA NA NA NA 8 1.4E-07 1

Cobalt 3.9E+00 4.0E-04 NA NA NA NA 8 1.2E-08 1

Lead 1.5E+01 1.0E-04 NA NA NA NA 8 1.2E-08 1

Selenium 3.4E+01 1.0E-03 NA NA NA NA 8 2.7E-07 1

Inorganics: DAevent (mg/cm2-event) =

Kp x CW x tevent x 0.001 mg/µg x 0.001 l/cm3 (eq 1)

Organics: DAevent (mg/cm2-event) =

If tevent<t*, then DAevent =

2 x FA x Kp x CW x (sqrt((6 x τevent x tevent)/π)) x 0.001 mg/µg x 0.001 l/cm3 (eq 2)

If tevent>t*, then DAevent =

FA x Kp x CW x ( tevent/(1+B) + 2 x τevent x ((1 + 3xB + 3xB2)/(1+B)2) x 0.001 mg/µg x 0.001 l/cm3 (eq 3)

Notes:

NA - Not applicable

Permeability constants and other input parameter values from EPA 2004, Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E,

Supplemental Guidance for Dermal Risk Assessment - Final). EPA/540/R/99/005. The default value of 0.001 was assigned to inorganics not listed in this document.

B - Dimensionless ratio of the permeability coefficient of a compound through the stratum corneum relative to its permeability

coefficient across the viable epidermis (dimensionless).

t* - Time to reach steady-state

Page 247: Appendix L HHRA Combined

TABLE 7.5.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at street

levelInhalation

(pre-aeration system Benzene 1.3E-03 mg/m3 7.8E-06 1/(ug/m3) 1.2E-03 mg/m3 3.0E-02 mg/m34.0E-02

operation) Chloroform 2.5E-04 mg/m3 2.3E-05 1/(ug/m3) 2.3E-04 mg/m3 9.8E-02 mg/m32.4E-03

Ethylbenzene 1.1E-03 mg/m3 2.5E-06 1/(ug/m3) 1.0E-03 mg/m3 1.0E+00 mg/m31.0E-03

Naphthalene 1.3E-03 mg/m3 3.4E-05 1/(ug/m3) 1.2E-03 mg/m3 3.0E-03 mg/m34.2E-01

Exp. Route Total 0.0E+00 4.6E-01

Exposure Point Total 0.0E+00 4.6E-01

0.0E+00 4.6E-01

Ambient air at street level Total - Pre-aeration system operation 0.0E+00 4.6E-01

Air AirAmbient air at street

levelInhalation

(after aeration system Benzene 1.1E-03 mg/m3 7.8E-06 1/(ug/m3) 1.1E-03 mg/m3 3.0E-02 mg/m33.5E-02

started) Chloroform 3.3E-04 mg/m3 2.3E-05 1/(ug/m3) 3.2E-04 mg/m3 9.8E-02 mg/m33.2E-03

Ethylbenzene 1.2E-03 mg/m3 2.5E-06 1/(ug/m3) 1.2E-03 mg/m3 1.0E+00 mg/m31.2E-03

Naphthalene 3.0E-03 mg/m3 3.4E-05 1/(ug/m3) 2.9E-03 mg/m3 3.0E-03 mg/m39.7E-01

Exp. Route Total 0.0E+00 1.0E+00

Exposure Point Total 0.0E+00 1.0E+00

0.0E+00 1.0E+00

Ambient air at street level Total - After aeration system turned on 0.0E+00 1.0E+00

Exposure Medium Total

Exposure Medium Total

Page 248: Appendix L HHRA Combined

TABLE 7.5.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Ingestion

2-methylnaphthalene 3.6E+02 mg/kg NA 1/(mg/kg-day) 1.3E-05 mg/kg-day 4.0E-03 mg/kg-day 3.2E-03

Acenaphthene 3.1E+02 mg/kg NA 1.1E-05 mg/kg-day 6.0E-02 mg/kg-day 1.8E-04

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 4.5E-06 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 2.6E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 2.8E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 1.4E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 5.1E-07 mg/kg-day 2.0E-02 mg/kg-day 2.6E-05

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 4.5E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 1.9E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 6.3E-06 mg/kg-day 4.0E-02 mg/kg-day 1.6E-04

Fluorene 2.3E+02 mg/kg NA 8.1E-06 mg/kg-day 4.0E-02 mg/kg-day 2.0E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 1.1E-06 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 2.3E-05 mg/kg-day 2.0E-02 mg/kg-day 1.2E-03

Pyrene 3.9E+02 mg/kg NA 1.4E-05 mg/kg-day 3.0E-02 mg/kg-day 4.5E-04

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 1.6E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 2.0E+00 1/(mg/kg-day) 2.3E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 2.3E-07 mg/kg-day 2.0E-05 mg/kg-day 1.2E-02

Aluminum 1.5E+04 mg/kg NA 5.1E-04 mg/kg-day 1.0E+00 mg/kg-day 5.1E-04

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 5.2E-07 mg/kg-day 3.0E-04 mg/kg-day 1.7E-03

Cadmium 1.0E+01 mg/kg NA 3.5E-07 mg/kg-day 1.0E-03 mg/kg-day 3.5E-04

Chromium 8.5E+01 mg/kg 5.0E-01 3.0E-06 mg/kg-day 3.0E-03 mg/kg-day 9.9E-04

Cobalt 1.1E+01 mg/kg NA 3.9E-07 mg/kg-day 3.0E-04 mg/kg-day 1.3E-03

Copper 2.7E+02 mg/kg NA 9.7E-06 mg/kg-day 4.0E-02 mg/kg-day 2.4E-04

Iron 3.4E+04 mg/kg NA 1.2E-03 mg/kg-day 7.0E-01 mg/kg-day 1.7E-03

Lead 1.2E+03 mg/kg NA 4.2E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 1.1E-05 mg/kg-day 1.4E-01 mg/kg-day 7.7E-05

Vanadium 4.6E+01 mg/kg NA 1.6E-06 mg/kg-day 5.0E-03 mg/kg-day 3.2E-04

Exp. Route Total 0.0E+00 2.4E-02

Page 249: Appendix L HHRA Combined

TABLE 7.5.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Dermal

2-methylnaphthalene 3.6E+02 mg/kg NA 1.9E-05 mg/kg-day 4.0E-03 mg/kg-day 4.7E-03

Acenaphthene 3.1E+02 mg/kg NA 1.6E-05 mg/kg-day 6.0E-02 mg/kg-day 2.7E-04

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 6.7E-06 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 3.8E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 4.1E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 2.1E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 5.8E-07 mg/kg-day 2.0E-02 mg/kg-day 2.9E-05

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 6.6E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 2.9E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 9.4E-06 mg/kg-day 4.0E-02 mg/kg-day 2.3E-04

Fluorene 2.3E+02 mg/kg NA 1.2E-05 mg/kg-day 4.0E-02 mg/kg-day 3.0E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 1.6E-06 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 3.4E-05 mg/kg-day 2.0E-02 mg/kg-day 1.7E-03

Pyrene 3.9E+02 mg/kg NA 2.0E-05 mg/kg-day 3.0E-02 mg/kg-day 6.7E-04

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 2.5E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 2.0E+00 1/(mg/kg-day) 3.6E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 3.7E-07 mg/kg-day 2.0E-05 mg/kg-day 1.9E-02

Aluminum 1.5E+04 mg/kg NA 5.9E-05 mg/kg-day 1.0E+00 mg/kg-day 5.9E-05

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 1.8E-07 mg/kg-day 3.0E-04 mg/kg-day 5.9E-04

Cadmium 1.0E+01 mg/kg NA 4.0E-09 mg/kg-day 2.5E-05 mg/kg-day 1.6E-04

Chromium 8.5E+01 mg/kg 2.0E+01 1/(mg/kg-day) 3.4E-07 mg/kg-day 7.5E-05 mg/kg-day 4.5E-03

Cobalt 1.1E+01 mg/kg NA 4.4E-08 mg/kg-day 3.0E-04 mg/kg-day 1.5E-04

Copper 2.7E+02 mg/kg NA 1.1E-06 mg/kg-day 4.0E-02 mg/kg-day 2.8E-05

Iron 3.4E+04 mg/kg NA 1.3E-04 mg/kg-day 7.0E-01 mg/kg-day 1.9E-04

Lead 1.2E+03 mg/kg NA 4.8E-06 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 1.2E-06 mg/kg-day 7.0E-01 mg/kg-day 1.8E-06

Vanadium 4.6E+01 mg/kg NA 1.8E-07 mg/kg-day 5.0E-03 mg/kg-day 3.7E-05

Exp. Route Total 0.0E+00 3.2E-02

Exposure Point Total 0.0E+00 5.6E-02

0.0E+00 5.6E-02

Overflow Surface Sediment Total 0.0E+00 5.6E-02

Exposure Medium Total

Page 250: Appendix L HHRA Combined

TABLE 7.5.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

WaterCanal Overflow - Surface Water

Ingestion

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 2.7E-08 mg/kg-day 7.0E-02 mg/kg-day 3.9E-07

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 3.8E-08 mg/kg-day 4.0E-03 mg/kg-day 9.6E-06

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 2.6E-08 mg/kg-day 1.0E-02 mg/kg-day 2.6E-06

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 4.0E-08 mg/kg-day 1.0E-01 mg/kg-day 4.0E-07

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 1.1E-06 mg/kg-day 1.0E-02 mg/kg-day 1.1E-04

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 4.8E-09 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 9.4E-09 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 8.7E-09 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 4.6E-09 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.3E-08 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 1.7E-08 mg/kg-day 2.0E-02 mg/kg-day 8.3E-07

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 7.6E-07 mg/kg-day 3.0E-04 mg/kg-day 2.5E-03

Chromium 8.5E+00 ug/L 5.0E-01 1/(mg/kg-day) 3.9E-07 mg/kg-day 3.0E-03 mg/kg-day 1.3E-04

Cobalt 3.9E+00 ug/L NA 1.8E-07 mg/kg-day 3.0E-04 mg/kg-day 6.0E-04

Lead 1.5E+01 ug/L NA 6.8E-07 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 1.5E-06 mg/kg-day 5.0E-03 mg/kg-day 3.1E-04

Exp. Route Total 0.0E+00 3.7E-03

Page 251: Appendix L HHRA Combined

TABLE 7.5.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

WaterCanal Overflow - Surface Water

Dermal

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 1.9E-07 mg/kg-day 7.0E-02 mg/kg-day 2.7E-06

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 7.8E-08 mg/kg-day 4.0E-03 mg/kg-day 1.9E-05

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 2.7E-08 mg/kg-day 1.0E-02 mg/kg-day 2.7E-06

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 2.7E-07 mg/kg-day 1.0E-01 mg/kg-day 2.7E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 7.0E-06 mg/kg-day 1.0E-02 mg/kg-day 7.0E-04

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 6.2E-07 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 2.1E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.0E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 1.6E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 5.2E-06 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 1.2E-07 mg/kg-day 2.0E-02 mg/kg-day 6.0E-06

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 8.7E-08 mg/kg-day 3.0E-04 mg/kg-day 2.9E-04

Chromium 8.5E+00 ug/L 2.0E+01 1/(mg/kg-day) 8.9E-08 mg/kg-day 7.5E-05 mg/kg-day 1.2E-03

Cobalt 3.9E+00 ug/L NA 8.1E-09 mg/kg-day 3.0E-04 mg/kg-day 2.7E-05

Lead 1.5E+01 ug/L NA 7.8E-09 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 1.8E-07 mg/kg-day 5.0E-03 mg/kg-day 3.5E-05

Exp. Route Total 0.0E+00 2.3E-03

Exposure Point Total 0.0E+00 6.0E-03

0.0E+00 6.0E-03

Overflow Surface Water Total 0.0E+00 6.0E-03

Total Total of Receptor Risks Across All Media 0.0E+00 Total of Receptor Hazards Across All Media 1.1E+00

Notes-

NA = Not available / Not applicable.

DAevent for surface water calculated on Table 7.5.RME Supplement A.

Total includes maximum between air prior to and after aeration system operations, and surface water, and sediment.

Exposure Medium Total

Page 252: Appendix L HHRA Combined

TABLE 7.5.RME Supplement A

Calculation of Daevent Wet Event

Residential Scenario

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Water Permeability Lag Fraction Duration

of Potential Concentration Coefficient Time Absorbed Water of Event

Concern (CW) (Kp) B (τevent) t* (FA) (tevent) DAevent

(µg/L) (cm/hr) (dimensionless) (hr) (hr) (dimensionless) (hr) (mg/cm2-event) Eq

1,4-dichlorobenzene 5.9E-01 4.2E-02 2.0E-01 7.1E-01 1.7E+00 1.0E+00 2.6 9.6E-08 3

Benzene 8.4E-01 1.5E-02 5.1E-02 2.9E-01 7.0E-01 1.0E+00 2.6 3.9E-08 3

Chloroform 5.6E-01 6.8E-03 2.9E-02 5.0E-01 1.2E+00 1.0E+00 2.6 1.4E-08 3

Ethylbenzene 8.7E-01 4.9E-02 2.0E-01 4.2E-01 1.0E+00 1.0E+00 2.6 1.4E-07 3

Tetrachloroethylene(PCE) 2.4E+01 3.3E-02 1.7E-01 9.1E-01 2.2E+00 1.0E+00 2.6 3.5E-06 3

Benzo(a)anthracene 1.0E-01 4.7E-01 2.8E+00 2.0E+00 8.5E+00 1.0E+00 2.6 3.1E-07 2

Benzo(a)pyrene 2.1E-01 7.0E-01 4.3E+00 2.7E+00 1.2E+01 1.0E+00 2.6 1.0E-06 2

Benzo(b)fluoranthene 1.9E-01 7.0E-01 4.3E+00 2.8E+00 1.2E+01 1.0E+00 2.6 9.8E-07 2

Dibenz(a,h)anthracene 1.0E-01 1.5E+00 9.7E+00 3.9E+00 1.8E+01 6.0E-01 2.6 8.0E-07 2

Indeno(1,2,3-c,d)pyrene 5.0E-01 1.0E+00 6.7E+00 3.8E+00 1.7E+01 6.0E-01 2.6 2.6E-06 2

Naphthalene 3.6E-01 4.7E-02 2.0E-01 5.6E-01 1.3E+00 1.0E+00 2.6 6.0E-08 3

Arsenic 1.7E+01 1.0E-03 NA NA NA NA 2.6 4.3E-08 1

Chromium 8.5E+00 2.0E-03 NA NA NA NA 2.6 4.4E-08 1

Cobalt 3.9E+00 4.0E-04 NA NA NA NA 2.6 4.1E-09 1

Lead 1.5E+01 1.0E-04 NA NA NA NA 2.6 3.9E-09 1

Selenium 3.4E+01 1.0E-03 NA NA NA NA 2.6 8.7E-08 1

Inorganics: DAevent (mg/cm2-event) =

Kp x CW x tevent x 0.001 mg/µg x 0.001 l/cm3 (eq 1)

Organics: DAevent (mg/cm2-event) =

If tevent<t*, then DAevent =

2 x FA x Kp x CW x (sqrt((6 x τevent x tevent)/π)) x 0.001 mg/µg x 0.001 l/cm3 (eq 2)

If tevent>t*, then DAevent =

FA x Kp x CW x ( tevent/(1+B) + 2 x τevent x ((1 + 3xB + 3xB2)/(1+B)2) x 0.001 mg/µg x 0.001 l/cm3 (eq 3)

Notes:

NA - Not applicable

Permeability constants and other input parameter values from EPA 2004, Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E,

Supplemental Guidance for Dermal Risk Assessment - Final). EPA/540/R/99/005. The default value of 0.001 was assigned to inorganics not listed in this document.

B - Dimensionless ratio of the permeability coefficient of a compound through the stratum corneum relative to its permeability

coefficient across the viable epidermis (dimensionless).

t* - Time to reach steady-state

Page 253: Appendix L HHRA Combined

TABLE 7.6.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at street

levelInhalation

(pre-aeration system Benzene 1.3E-03 mg/m3 7.8E-06 1/(ug/m3) 1.2E-03 mg/m3 3.0E-02 mg/m34.0E-02

operation) Chloroform 2.5E-04 mg/m3 2.3E-05 1/(ug/m3) 2.3E-04 mg/m3 9.8E-02 mg/m32.4E-03

Ethylbenzene 1.1E-03 mg/m3 2.5E-06 1/(ug/m3) 1.0E-03 mg/m3 1.0E+00 mg/m31.0E-03

Naphthalene 1.3E-03 mg/m3 3.4E-05 1/(ug/m3) 1.2E-03 mg/m3 3.0E-03 mg/m34.2E-01

Exp. Route Total 4.6E-01

Exposure Point Total 4.6E-01

4.6E-01

Ambient air at street level Total - Pre-aeration system operation 4.6E-01

Air AirAmbient air at street

levelInhalation

(after aeration system Benzene 1.1E-03 mg/m3 7.8E-06 1/(ug/m3) 1.1E-03 mg/m3 3.0E-02 mg/m33.5E-02

started) Chloroform 3.3E-04 mg/m3 2.3E-05 1/(ug/m3) 3.2E-04 mg/m3 9.8E-02 mg/m33.2E-03

Ethylbenzene 1.2E-03 mg/m3 2.5E-06 1/(ug/m3) 1.2E-03 mg/m3 1.0E+00 mg/m31.2E-03

Naphthalene 3.0E-03 mg/m3 3.4E-05 1/(ug/m3) 2.9E-03 mg/m3 3.0E-03 mg/m39.7E-01

Exp. Route Total 1.0E+00

Exposure Point Total 1.0E+00

1.0E+00

Ambient air at street level Total - After aeration system turned on 1.0E+00

Exposure Medium Total

Exposure Medium Total

Page 254: Appendix L HHRA Combined

TABLE 7.6.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Ingestion

2-methylnaphthalene 3.6E+02 mg/kg NA 1/(mg/kg-day) 1.2E-04 mg/kg-day 4.0E-03 mg/kg-day 2.9E-02

Acenaphthene 3.1E+02 mg/kg NA 1.0E-04 mg/kg-day 6.0E-02 mg/kg-day 1.7E-03

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 4.2E-05 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 2.4E-05 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 2.6E-05 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 1.3E-05 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 4.8E-06 mg/kg-day 2.0E-02 mg/kg-day 2.4E-04

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 4.2E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 1.8E-06 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 5.9E-05 mg/kg-day 4.0E-02 mg/kg-day 1.5E-03

Fluorene 2.3E+02 mg/kg NA 7.6E-05 mg/kg-day 4.0E-02 mg/kg-day 1.9E-03

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 1.0E-05 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 2.2E-04 mg/kg-day 2.0E-02 mg/kg-day 1.1E-02

Pyrene 3.9E+02 mg/kg NA 1.3E-04 mg/kg-day 3.0E-02 mg/kg-day 4.2E-03

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 1.5E-11 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 2.0E+00 1/(mg/kg-day) 2.1E-06 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 2.2E-06 mg/kg-day 2.0E-05 mg/kg-day 1.1E-01

Aluminum 1.5E+04 mg/kg NA 4.8E-03 mg/kg-day 1.0E+00 mg/kg-day 4.8E-03

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 4.8E-06 mg/kg-day 3.0E-04 mg/kg-day 1.6E-02

Cadmium 1.0E+01 mg/kg NA 3.3E-06 mg/kg-day 1.0E-03 mg/kg-day 3.3E-03

Chromium 8.5E+01 mg/kg 5.0E-01 2.8E-05 mg/kg-day 3.0E-03 mg/kg-day 9.3E-03

Cobalt 1.1E+01 mg/kg NA 3.6E-06 mg/kg-day 3.0E-04 mg/kg-day 1.2E-02

Copper 2.7E+02 mg/kg NA 9.0E-05 mg/kg-day 4.0E-02 mg/kg-day 2.3E-03

Iron 3.4E+04 mg/kg NA 1.1E-02 mg/kg-day 7.0E-01 mg/kg-day 1.6E-02

Lead 1.2E+03 mg/kg NA 3.9E-04 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 1.0E-04 mg/kg-day 1.4E-01 mg/kg-day 7.2E-04

Vanadium 4.6E+01 mg/kg NA 1.5E-05 mg/kg-day 5.0E-03 mg/kg-day 3.0E-03

Exp. Route Total 2.3E-01

Page 255: Appendix L HHRA Combined

TABLE 7.6.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Dermal

2-methylnaphthalene 3.6E+02 mg/kg NA 4.3E-05 mg/kg-day 4.0E-03 mg/kg-day 1.1E-02

Acenaphthene 3.1E+02 mg/kg NA 3.7E-05 mg/kg-day 6.0E-02 mg/kg-day 6.2E-04

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 1.5E-05 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 8.8E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 9.5E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 4.9E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 1.3E-06 mg/kg-day 2.0E-02 mg/kg-day 6.7E-05

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 1.5E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 6.5E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 2.2E-05 mg/kg-day 4.0E-02 mg/kg-day 5.4E-04

Fluorene 2.3E+02 mg/kg NA 2.8E-05 mg/kg-day 4.0E-02 mg/kg-day 6.9E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 3.8E-06 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 7.8E-05 mg/kg-day 2.0E-02 mg/kg-day 3.9E-03

Pyrene 3.9E+02 mg/kg NA 4.6E-05 mg/kg-day 3.0E-02 mg/kg-day 1.5E-03

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 5.8E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 2.0E+00 1/(mg/kg-day) 8.3E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 8.5E-07 mg/kg-day 2.0E-05 mg/kg-day 4.3E-02

Aluminum 1.5E+04 mg/kg NA 1.3E-04 mg/kg-day 1.0E+00 mg/kg-day 1.3E-04

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 4.1E-07 mg/kg-day 3.0E-04 mg/kg-day 1.4E-03

Cadmium 1.0E+01 mg/kg NA 9.2E-09 mg/kg-day 2.5E-05 mg/kg-day 3.7E-04

Chromium 8.5E+01 mg/kg 2.0E+01 1/(mg/kg-day) 7.8E-07 mg/kg-day 7.5E-05 mg/kg-day 1.0E-02

Cobalt 1.1E+01 mg/kg NA 1.0E-07 mg/kg-day 3.0E-04 mg/kg-day 3.4E-04

Copper 2.7E+02 mg/kg NA 2.5E-06 mg/kg-day 4.0E-02 mg/kg-day 6.3E-05

Iron 3.4E+04 mg/kg NA 3.1E-04 mg/kg-day 7.0E-01 mg/kg-day 4.4E-04

Lead 1.2E+03 mg/kg NA 1.1E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 2.8E-06 mg/kg-day 7.0E-01 mg/kg-day 4.0E-06

Vanadium 4.6E+01 mg/kg NA 4.2E-07 mg/kg-day 5.0E-03 mg/kg-day 8.5E-05

Exp. Route Total 7.4E-02

Exposure Point Total 3.0E-01

3.0E-01

Overflow Surface Sediment Total 3.0E-01

Exposure Medium Total

Page 256: Appendix L HHRA Combined

TABLE 7.6.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

WaterCanal Overflow - Surface Water

Ingestion

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 1.3E-07 mg/kg-day 7.0E-02 mg/kg-day 1.8E-06

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 1.8E-07 mg/kg-day 4.0E-03 mg/kg-day 4.5E-05

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 1.2E-07 mg/kg-day 1.0E-02 mg/kg-day 1.2E-05

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 1.9E-07 mg/kg-day 1.0E-01 mg/kg-day 1.9E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 5.2E-06 mg/kg-day 1.0E-02 mg/kg-day 5.2E-04

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.2E-08 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 4.4E-08 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 4.0E-08 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 2.2E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.1E-07 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 7.8E-08 mg/kg-day 2.0E-02 mg/kg-day 3.9E-06

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 3.5E-06 mg/kg-day 3.0E-04 mg/kg-day 1.2E-02

Chromium 8.5E+00 ug/L 5.0E-01 1/(mg/kg-day) 1.8E-06 mg/kg-day 3.0E-03 mg/kg-day 6.1E-04

Cobalt 3.9E+00 ug/L NA 8.3E-07 mg/kg-day 3.0E-04 mg/kg-day 2.8E-03

Lead 1.5E+01 ug/L NA 3.2E-06 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 7.2E-06 mg/kg-day 5.0E-03 mg/kg-day 1.4E-03

Exp. Route Total 1.7E-02

Page 257: Appendix L HHRA Combined

TABLE 7.6.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

WaterCanal Overflow - Surface Water

Dermal

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 4.4E-07 mg/kg-day 7.0E-02 mg/kg-day 6.3E-06

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 1.8E-07 mg/kg-day 4.0E-03 mg/kg-day 4.4E-05

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 6.2E-08 mg/kg-day 1.0E-02 mg/kg-day 6.2E-06

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 6.2E-07 mg/kg-day 1.0E-01 mg/kg-day 6.2E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 1.6E-05 mg/kg-day 1.0E-02 mg/kg-day 1.6E-03

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.4E-06 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 4.8E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 4.5E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 3.7E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.2E-05 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 2.8E-07 mg/kg-day 2.0E-02 mg/kg-day 1.4E-05

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 2.0E-07 mg/kg-day 3.0E-04 mg/kg-day 6.6E-04

Chromium 8.5E+00 ug/L 2.0E+01 1/(mg/kg-day) 2.0E-07 mg/kg-day 7.5E-05 mg/kg-day 2.7E-03

Cobalt 3.9E+00 ug/L NA 1.9E-08 mg/kg-day 3.0E-04 mg/kg-day 6.2E-05

Lead 1.5E+01 ug/L NA 1.8E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 4.0E-07 mg/kg-day 5.0E-03 mg/kg-day 8.0E-05

Exp. Route Total 5.2E-03

Exposure Point Total 2.2E-02

2.2E-02

Overflow Surface Water Total 2.2E-02

Total Total of Receptor Risks Across All Media Total of Receptor Hazards Across All Media 1.3E+00

Notes-

NA = Not available / Not applicable.

DAevent for surface water calculated on Table 7.5.RME Supplement A.

Total includes maximum between air prior to and after aeration system operations, and surface water, and sediment.

Exposure Medium Total

Page 258: Appendix L HHRA Combined

TABLE 7.7.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at street

levelInhalation

(pre-aeration system Benzene 1.3E-03 mg/m3 3.7E-01 ug/m3 7.8E-06 1/(ug/m3) 2.9E-06 3.0E-02 mg/m3

operation) Chloroform 2.5E-04 mg/m3 7.2E-02 ug/m3 2.3E-05 1/(ug/m3) 1.7E-06 9.8E-02 mg/m3

Ethylbenzene 1.1E-03 mg/m3 3.2E-01 ug/m3 2.5E-06 1/(ug/m3) 8.0E-07 1.0E+00 mg/m3

Naphthalene 1.3E-03 mg/m3 3.8E-01 ug/m3 3.4E-05 1/(ug/m3) 1.3E-05 3.0E-03 mg/m3

Exp. Route Total 1.8E-05

Exposure Point Total 1.8E-05

1.8E-05

Ambient air at street level Total - Pre-aeration system operation 1.8E-05

Air AirAmbient air at street

levelInhalation

(after aeration system Benzene 1.1E-03 mg/m3 3.3E-01 ug/m3 7.8E-06 1/(ug/m3) 2.5E-06 3.0E-02 mg/m3

started) Chloroform 3.3E-04 mg/m3 9.7E-02 ug/m3 2.3E-05 1/(ug/m3) 2.2E-06 9.8E-02 mg/m3

Ethylbenzene 1.2E-03 mg/m3 3.6E-01 ug/m3 2.5E-06 1/(ug/m3) 9.1E-07 1.0E+00 mg/m3

Naphthalene 3.0E-03 mg/m3 8.9E-01 ug/m3 3.4E-05 1/(ug/m3) 3.0E-05 3.0E-03 mg/m3

Exp. Route Total 3.6E-05

Exposure Point Total 3.6E-05

3.6E-05

Ambient air at street level Total - After aeration system turned on 3.6E-05

Exposure Medium Total

Exposure Medium Total

Page 259: Appendix L HHRA Combined

TABLE 7.7.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Ingestion

2-methylnaphthalene 3.6E+02 mg/kg 1.4E-05 mg/kg-day NA 1/(mg/kg-day) NA 4.0E-03 mg/kg-day

Acenaphthene 3.1E+02 mg/kg 1.2E-05 mg/kg-day NA NA 6.0E-02 mg/kg-day

Benzo(a)anthracene11.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 1.6E-05 NA

Benzo(a)pyrene17.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 9.2E-05 NA

Benzo(b)fluoranthene17.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 1.0E-05 NA

Benzo(k)fluoranthene14.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 5.2E-07 NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 5.8E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 8.2E-09 2.0E-02 mg/kg-day

Chrysene11.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 1.6E-07 NA

Dibenz(a,h)anthracene15.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 6.9E-06 NA

Fluoranthene 1.8E+02 mg/kg 7.2E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Fluorene 2.3E+02 mg/kg 9.3E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Indeno(1,2,3-c,d)pyrene13.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 4.0E-06 NA

Naphthalene 6.6E+02 mg/kg 2.6E-05 mg/kg-day NA NA 2.0E-02 mg/kg-day

Pyrene 3.9E+02 mg/kg 1.6E-05 mg/kg-day NA NA 3.0E-02 mg/kg-day

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.8E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.8E-07 NA

Nondioxin-Like PCB 6.4E+00 mg/kg 2.6E-07 mg/kg-day 2.0E+00 1/(mg/kg-day) 5.2E-07 NA

Total PCB 6.6E+00 mg/kg 2.7E-07 mg/kg-day NA NA 2.0E-05 mg/kg-day

Aluminum 1.5E+04 mg/kg 5.9E-04 mg/kg-day NA NA 1.0E+00 mg/kg-day

Arsenic 1.5E+01 mg/kg 5.9E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 8.9E-07 3.0E-04 mg/kg-day

Cadmium 1.0E+01 mg/kg 4.0E-07 mg/kg-day NA NA 1.0E-03 mg/kg-day

Chromium18.5E+01 mg/kg 5.0E-01 1/(mg/kg-day) 7.3E-08 3.0E-03 mg/kg-day

Cobalt 1.1E+01 mg/kg 4.4E-07 mg/kg-day NA NA 3.0E-04 mg/kg-day

Copper 2.7E+02 mg/kg 1.1E-05 mg/kg-day NA NA 4.0E-02 mg/kg-day

Iron 3.4E+04 mg/kg 1.4E-03 mg/kg-day NA NA 7.0E-01 mg/kg-day

Lead 1.2E+03 mg/kg 4.8E-05 mg/kg-day NA NA NA

Manganese 3.1E+02 mg/kg 1.2E-05 mg/kg-day NA NA 1.4E-01 mg/kg-day

Vanadium 4.6E+01 mg/kg 1.8E-06 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 1.3E-04

Page 260: Appendix L HHRA Combined

TABLE 7.7.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in areas adjacent to Gowanus Canal

associated with canal overflow

Dermal

2-methylnaphthalene 3.6E+02 mg/kg 1.0E-05 mg/kg-day NA NA 4.0E-03 mg/kg-day

Acenaphthene 3.1E+02 mg/kg 8.7E-06 mg/kg-day NA NA 6.0E-02 mg/kg-day

Benzo(a)anthracene11.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 8.2E-06 NA

Benzo(a)pyrene17.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 4.7E-05 NA

Benzo(b)fluoranthene17.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 5.1E-06 NA

Benzo(k)fluoranthene14.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 2.6E-07 NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 3.1E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 4.4E-09 2.0E-02 mg/kg-day

Chrysene11.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 8.1E-08 NA

Dibenz(a,h)anthracene15.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 3.5E-06 NA

Fluoranthene 1.8E+02 mg/kg 5.1E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Fluorene 2.3E+02 mg/kg 6.5E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Indeno(1,2,3-c,d)pyrene13.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 2.0E-06 NA

Naphthalene 6.6E+02 mg/kg 1.8E-05 mg/kg-day NA NA 2.0E-02 mg/kg-day

Pyrene 3.9E+02 mg/kg 1.1E-05 mg/kg-day NA NA 3.0E-02 mg/kg-day

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.4E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.1E-07 NA

Nondioxin-Like PCB 6.4E+00 mg/kg 2.0E-07 mg/kg-day 2.0E+00 1/(mg/kg-day) 3.9E-07 NA

Total PCB 6.6E+00 mg/kg 2.0E-07 mg/kg-day NA NA 2.0E-05 mg/kg-day

Aluminum 1.5E+04 mg/kg 3.2E-05 mg/kg-day NA NA 1.0E+00 mg/kg-day

Arsenic 1.5E+01 mg/kg 9.6E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.4E-07 3.0E-04 mg/kg-day

Cadmium 1.0E+01 mg/kg 2.2E-09 mg/kg-day NA NA 2.5E-05 mg/kg-day

Chromium18.5E+01 mg/kg 2.0E+01 1/(mg/kg-day) 1.1E-06 7.5E-05 mg/kg-day

Cobalt 1.1E+01 mg/kg 2.4E-08 mg/kg-day NA NA 3.0E-04 mg/kg-day

Copper 2.7E+02 mg/kg 5.9E-07 mg/kg-day NA NA 4.0E-02 mg/kg-day

Iron 3.4E+04 mg/kg 7.3E-05 mg/kg-day NA NA 7.0E-01 mg/kg-day

Lead 1.2E+03 mg/kg 2.6E-06 mg/kg-day NA NA NA

Manganese 3.1E+02 mg/kg 6.6E-07 mg/kg-day NA NA 7.0E-01 mg/kg-day

Vanadium 4.6E+01 mg/kg 9.9E-08 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 6.8E-05

Exposure Point Total 2.0E-04

2.0E-04

Overflow Surface Sediment Total 2.0E-04

Exposure Medium Total

Page 261: Appendix L HHRA Combined

TABLE 7.7.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow

Surface WaterCanal Overflow - Surface Water

Ingestion

1,4-dichlorobenzene 5.9E-01 ug/L 2.0E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.1E-10 7.0E-02 mg/kg-day

Benzene 8.4E-01 ug/L 2.8E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.6E-09 4.0E-03 mg/kg-day

Chloroform 5.6E-01 ug/L 1.9E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 5.9E-10 1.0E-02 mg/kg-day

Ethylbenzene 8.7E-01 ug/L 2.9E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 3.2E-10 1.0E-01 mg/kg-day

Tetrachloroethylene(PCE) 2.4E+01 ug/L 8.3E-07 mg/kg-day 5.4E-01 1/(mg/kg-day) 4.5E-07 1.0E-02 mg/kg-day

Benzo(a)anthracene11.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 9.6E-09 NA

Benzo(a)pyrene12.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 1.9E-07 NA

Benzo(b)fluoranthene11.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.7E-08 NA

Dibenz(a,h)anthracene11.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 9.3E-08 NA

Indeno(1,2,3-c,d)pyrene15.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 4.6E-08 NA

Naphthalene 3.6E-01 ug/L 1.2E-08 mg/kg-day NA NA 2.0E-02 mg/kg-day

Arsenic 1.7E+01 ug/L 5.6E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 8.4E-07 3.0E-04 mg/kg-day

Chromium18.5E+00 ug/L 5.0E-01 1/(mg/kg-day) 5.4E-07 3.0E-03 mg/kg-day

Cobalt 3.9E+00 ug/L 1.3E-07 mg/kg-day NA NA 3.0E-04 mg/kg-day

Lead 1.5E+01 ug/L 5.0E-07 mg/kg-day NA NA NA

Selenium 3.4E+01 ug/L 1.1E-06 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 2.2E-06

Page 262: Appendix L HHRA Combined

TABLE 7.7.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow

Surface WaterCanal Overflow - Surface Water

Dermal

1,4-dichlorobenzene 5.9E-01 ug/L 1.0E-07 mg/kg-day 5.4E-03 1/(mg/kg-day) 5.6E-10 7.0E-02 mg/kg-day

Benzene 8.4E-01 ug/L 4.2E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 2.3E-09 4.0E-03 mg/kg-day

Chloroform 5.6E-01 ug/L 1.5E-08 mg/kg-day 3.1E-02 1/(mg/kg-day) 4.5E-10 1.0E-02 mg/kg-day

Ethylbenzene 8.7E-01 ug/L 1.5E-07 mg/kg-day 1.1E-02 1/(mg/kg-day) 1.6E-09 1.0E-01 mg/kg-day

Tetrachloroethylene(PCE) 2.4E+01 ug/L 3.8E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 2.0E-06 1.0E-02 mg/kg-day

Benzo(a)anthracene11.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 7.6E-07 NA

Benzo(a)pyrene12.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 2.6E-05 NA

Benzo(b)fluoranthene11.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.4E-06 NA

Dibenz(a,h)anthracene11.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 2.0E-05 NA

Indeno(1,2,3-c,d)pyrene15.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 6.4E-06 NA

Naphthalene 3.6E-01 ug/L 6.5E-08 mg/kg-day NA NA 2.0E-02 mg/kg-day

Arsenic 1.7E+01 ug/L 4.7E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 7.0E-08 3.0E-04 mg/kg-day

Chromium18.5E+00 ug/L 2.0E+01 1/(mg/kg-day) 3.6E-06 7.5E-05 mg/kg-day

Cobalt 3.9E+00 ug/L 4.4E-09 mg/kg-day NA NA 3.0E-04 mg/kg-day

Lead 1.5E+01 ug/L 4.2E-09 mg/kg-day NA NA NA

Selenium 3.4E+01 ug/L 9.5E-08 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 6.1E-05

Exposure Point Total 6.3E-05

6.3E-05

Overflow Surface Water Total 6.3E-05

Total Total of Receptor Risks Across All Media 3.0E-04 Total of Receptor Hazards Across All Media

Notes-

NA = Not available / Not applicable.

DAevent for surface water calculated on Table 7.5.RME Supplement A.

Total includes maximum between air prior to and after aeration system operations, and surface water, and sediment.

1. See Table 7.7.RME Supplement A for calculation of intake and cancer risk following MMOA method.

Exposure Medium Total

Page 263: Appendix L HHRA Combined

TABLE 7.7.RME Supplement A

CALCULATION OF CHEMICAL CANCER RISKS FOR COPC WITH MUTAGENIC MODE OF ACTION

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Future

Receptor Population: Resident

Receptor Age: Adult/Child

Chemical of EPC Cancer Risk Calculations

Medium Exposure Medium Exposure Point Exposure Route Potential Concern Intake CSF/Unit Risk

Value Units Value Value Cancer Risk

0-2 yrs 2-6 yrs 6-16 years 16-30 yrs0-2 yrs

(ADAF=10)

2-6 yrs

(ADAF=3)

6-16 yrs

(ADAF=3)

16-30 yrs

(ADAF=1)

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow Ingestion Benzo(a)anthracene 1.3E+02 mg/kg 1.2E-06 2.4E-06 6.4E-07 9.0E-07 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 mg/kg/day 1.6E-05

Benzo(a)pyrene 7.3E+01 mg/kg 6.9E-07 1.4E-06 3.7E-07 5.2E-07 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 mg/kg/day 9.2E-05

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.4E-07 1.5E-06 4.0E-07 5.6E-07 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 mg/kg/day 1.0E-05

Benzo(k)fluoranthene 4.1E+01 mg/kg 3.9E-07 7.7E-07 2.1E-07 2.9E-07 mg/kg/day 7.3E-01 2.2E-01 2.2E-01 7.3E-02 mg/kg/day 5.2E-07

Chrysene 1.3E+02 mg/kg 1.2E-06 2.4E-06 6.4E-07 8.9E-07 mg/kg/day 7.3E-02 2.2E-02 2.2E-02 7.3E-03 mg/kg/day 1.6E-07

Dibenz(a,h)anthracene 5.5E+00 mg/kg 5.1E-08 1.0E-07 2.7E-08 3.8E-08 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 mg/kg/day 6.9E-06

Indeno(1,2,3-cd)pyrene 3.1E+01 mg/kg 2.9E-07 5.9E-07 1.6E-07 2.2E-07 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 mg/kg/day 4.0E-06

Chromium 8.5E-01 mg/kg 8.0E-09 1.6E-08 4.3E-09 6.0E-09 mg/kg/day 5.0E+00 1.5E+00 1.5E+00 5.0E-01 mg/kg/day 7.3E-08

Dermal Benzo(a)anthracene 1.3E+02 mg/kg 4.4E-07 8.8E-07 9.5E-07 1.3E-06 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 mg/kg/day 8.2E-06

Benzo(a)pyrene 7.3E+01 mg/kg 2.5E-07 5.0E-07 5.5E-07 7.6E-07 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 mg/kg/day 4.7E-05

Benzo(b)fluoranthene 7.9E+01 mg/kg 2.7E-07 5.4E-07 5.9E-07 8.3E-07 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 mg/kg/day 5.1E-06

Benzo(k)fluoranthene 4.1E+01 mg/kg 1.4E-07 2.8E-07 3.1E-07 4.3E-07 mg/kg/day 7.3E-01 2.2E-01 2.2E-01 7.3E-02 mg/kg/day 2.6E-07

Chrysene 1.3E+02 mg/kg 4.3E-07 8.7E-07 9.5E-07 1.3E-06 mg/kg/day 7.3E-02 2.2E-02 2.2E-02 7.3E-03 mg/kg/day 8.1E-08

Dibenz(a,h)anthracene 5.5E+00 mg/kg 1.9E-08 3.7E-08 4.1E-08 5.7E-08 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 mg/kg/day 3.5E-06

Indeno(1,2,3-cd)pyrene 3.1E+01 mg/kg 1.1E-07 2.1E-07 2.3E-07 3.3E-07 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 mg/kg/day 2.0E-06

Chromium 8.5E+01 mg/kg 2.2E-09 4.4E-09 4.8E-09 6.8E-09 mg/kg/day 2.0E+02 6.0E+01 6.0E+01 2.0E+01 mg/kg/day 1.1E-06

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Ingestion Benzo(a)anthracene 1.0E-01 ug/L 6.3E-10 1.3E-09 6.8E-10 9.5E-10 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 9.6E-09

Benzo(a)pyrene 2.1E-01 ug/L 1.3E-09 2.5E-09 1.3E-09 1.9E-09 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 1.9E-07

Benzo(b)fluoranthene 1.9E-01 ug/L 1.2E-09 2.3E-09 1.2E-09 1.7E-09 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 1.7E-08

Dibenz(a,h)anthracene 1.0E-01 ug/L 6.2E-10 1.2E-09 6.6E-10 9.3E-10 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 9.3E-08

Indeno(1,2,3-cd)pyrene 5.0E-01 ug/L 3.1E-09 6.1E-09 3.3E-09 4.6E-09 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 4.6E-08

Chromium 8.5E+00 ug/L 5.2E-08 1.0E-07 5.6E-08 7.8E-08 mg/kg/day 5.0E+00 1.5E+00 1.5E+00 5.0E-01 1/(mg/kg-day) 5.4E-07

Dermal Benzo(a)anthracene 1.0E-01 ug/L 4.1E-08 8.2E-08 8.9E-08 1.2E-07 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 7.6E-07

Benzo(a)pyrene 2.1E-01 ug/L 1.4E-07 2.8E-07 3.0E-07 4.2E-07 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 2.6E-05

Benzo(b)fluoranthene 1.9E-01 ug/L 1.3E-07 2.6E-07 2.8E-07 3.9E-07 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 2.4E-06

Dibenz(a,h)anthracene 1.0E-01 ug/L 1.0E-07 2.1E-07 2.3E-07 3.2E-07 mg/kg/day 7.3E+01 2.2E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 2.0E-05

Indeno(1,2,3-cd)pyrene 5.0E-01 ug/L 3.4E-07 6.8E-07 7.5E-07 1.0E-06 mg/kg/day 7.3E+00 2.2E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 6.4E-06

Chromium 8.5E+00 ug/L 7.9E-09 1.6E-08 1.3E-08 1.8E-08 mg/kg/day 2.0E+02 6.0E+01 6.0E+01 2.0E+01 1/(mg/kg-day) 3.6E-06

Cancer risk = (Intake0-2 x CSF0-2) + (Intake2-6 x CSF2-6) + (Intake6-16 x CSF6-16) + (Intake16-30 x CSF16-30)

Units Units

Page 43 of 96

Page 264: Appendix L HHRA Combined

TABLE 7.8.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Striped Bass in Gowanus Canal

Ingestion

p,p'-DDE 1.2E-02 mg/kg 7.2E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 2.4E-07 2.1E-06 mg/kg-day NA NA

p,p'-DDT 9.6E-03 mg/kg 5.7E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 2.0E-07 1.7E-06 mg/kg-day 5.0E-04 mg/kg-day 3.4E-03

Dioxin-Like PCB TEQ 4.3E-06 mg/kg 2.6E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 4.0E-05 7.5E-10 mg/kg-day NA NA

Nondioxin-Like 4.1E-01 mg/kg 2.4E-05 mg/kg-day 2.0E+00 1/(mg/kg-day) 4.9E-05 7.1E-05 mg/kg-day NA NA

Total PCB 4.4E-01 mg/kg 2.6E-05 mg/kg-day NA NA 7.6E-05 mg/kg-day 2.0E-05 mg/kg-day 3.8E+00

Arsenic 6.8E-02 mg/kg 4.1E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 6.1E-06 1.2E-05 mg/kg-day 3.0E-04 mg/kg-day 4.0E-02

Mercury 2.0E-01 mg/kg 1.2E-05 mg/kg-day NA NA 3.5E-05 mg/kg-day 1.0E-04 mg/kg-day 3.5E-01

Selenium 1.2E+00 mg/kg 7.2E-05 mg/kg-day NA NA 2.1E-04 mg/kg-day 5.0E-03 mg/kg-day 4.2E-02

Exp. Route Total 9.6E-05 4.2E+00

Exposure Point Total 9.6E-05 4.2E+00

Exposure Medium Total - Striped Bass in Gowanus Canal 9.6E-05 4.2E+00

Fish and Crab Tissue

White Perch in Gowanus Canal

Ingestion

Dioxin-Like PCB TEQ 5.8E-06 mg/kg 6.4E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 9.9E-06 1.9E-10 mg/kg-day NA NA

Nondioxin-Like 4.4E-01 mg/kg 4.8E-06 mg/kg-day 2.0E+00 1/(mg/kg-day) 9.6E-06 1.5E-05 mg/kg-day NA NA

Total PCB 4.6E-01 mg/kg 5.1E-06 mg/kg-day NA NA 1.5E-05 mg/kg-day 2.0E-05 mg/kg-day 7.7E-01

Mercury 1.9E-01 mg/kg 1.1E-05 mg/kg-day NA NA 6.4E-06 mg/kg-day 1.0E-04 mg/kg-day 6.4E-02

Selenium 1.4E+00 mg/kg 8.0E-05 mg/kg-day NA NA 4.7E-05 mg/kg-day 5.0E-03 mg/kg-day 9.4E-03

Exp. Route Total 2.0E-05 8.5E-01

Exposure Point Total 2.0E-05 8.5E-01

Exposure Medium Total - White Perch in Gowanus Canal 2.0E-05 8.5E-01

Page 265: Appendix L HHRA Combined

TABLE 7.8.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Eel in Gowanus Canal Ingestion

alpha-Chlordane 2.2E-02 mg/kg 1.2E-06 mg/kg-day 3.5E-01 1/(mg/kg-day) 4.3E-07 3.6E-06 mg/kg-day 5.0E-04 mg/kg-day 7.2E-03

Dieldrin 1.7E-02 mg/kg 9.5E-07 mg/kg-day 1.6E+01 1/(mg/kg-day) 1.5E-05 2.8E-06 mg/kg-day 5.0E-05 mg/kg-day 5.6E-02

gamma-Chlordane 1.3E-02 mg/kg 7.3E-07 mg/kg-day 3.5E-01 1/(mg/kg-day) 2.5E-07 2.1E-06 mg/kg-day 5.0E-04 mg/kg-day 4.2E-03

p,p'-DDD 3.8E-02 mg/kg 2.1E-06 mg/kg-day 2.4E-01 1/(mg/kg-day) 5.1E-07 6.2E-06 mg/kg-day NA NA

p,p'-DDE 2.5E-02 mg/kg 1.4E-06 mg/kg-day 3.4E-01 1/(mg/kg-day) 4.8E-07 4.1E-06 mg/kg-day NA NA

p,p'-DDT 4.7E-02 mg/kg 2.6E-06 mg/kg-day 3.4E-01 1/(mg/kg-day) 9.0E-07 7.7E-06 mg/kg-day 5.0E-04 mg/kg-day 1.5E-02

Dioxin-Like PCB TEQ 1.4E-05 mg/kg 7.9E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.2E-04 2.3E-09 mg/kg-day NA NA

Nondioxin-Like 1.2E+00 mg/kg 6.8E-05 mg/kg-day 2.0E+00 1/(mg/kg-day) 1.4E-04 2.0E-04 mg/kg-day NA NA

Total PCB 1.4E+00 mg/kg 7.6E-05 mg/kg-day NA NA 2.2E-04 mg/kg-day 2.0E-05 mg/kg-day 1.1E+01

Arsenic 5.0E-02 mg/kg 2.8E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.2E-06 8.2E-06 mg/kg-day 3.0E-04 mg/kg-day 2.7E-02

Chromium 6.7E-01 mg/kg 3.8E-05 mg/kg-day 5.0E-01 1/(mg/kg-day) 1.9E-05 1.1E-04 mg/kg-day 3.0E-03 mg/kg-day 3.6E-02

Copper 7.4E+00 mg/kg 4.1E-04 mg/kg-day NA NA 1.2E-03 mg/kg-day 4.0E-02 mg/kg-day 3.0E-02

Cyanide, total 3.1E+00 mg/kg 1.7E-04 mg/kg-day NA NA 5.1E-04 mg/kg-day 2.0E-02 2.5E-02

Mercury 2.6E-01 mg/kg 1.5E-05 mg/kg-day NA NA 4.2E-05 mg/kg-day 1.0E-04 4.2E-01

Selenium 1.4E+00 mg/kg 7.8E-05 mg/kg-day NA NA 2.3E-04 mg/kg-day 5.0E-03 mg/kg-day 4.6E-02

Exp. Route Total 3.0E-04 1.2E+01

Exposure Point Total 3.0E-04 1.2E+01

Exposure Medium Total - Eel in Gowanus Canal 3.0E-04 1.2E+01

Page 266: Appendix L HHRA Combined

TABLE 7.8.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Blue Crab in Gowanus Canal

Ingestion

Benzo(a)anthracene 7.7E-03 mg/kg 8.7E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.3E-07 2.5E-06 mg/kg-day NA NA

Benzo(a)pyrene 1.2E-02 mg/kg 1.3E-06 mg/kg-day 7.3E+00 1/(mg/kg-day) 9.7E-06 3.9E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 6.4E-03 mg/kg 7.2E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 5.3E-07 2.1E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 3.9E-03 mg/kg 4.4E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.2E-06 1.3E-06 mg/kg-day NA NA

Indeno(1,2,3-cd)pyrene 9.9E-03 mg/kg 1.1E-06 mg/kg-day 7.3E-01 1/(mg/kg-day) 8.1E-07 3.3E-06 mg/kg-day NA NA

Dioxin-Like PCB TEQ 5.0E-06 mg/kg 5.7E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 8.9E-05 1.7E-09 mg/kg-day NA NA

Nondioxin-Like 1.4E-01 mg/kg 1.6E-05 mg/kg-day 2.0E+00 1/(mg/kg-day) 3.2E-05 4.7E-05 mg/kg-day NA NA

Total PCB 1.7E-01 mg/kg 1.9E-05 mg/kg-day NA NA 5.5E-05 mg/kg-day 2.0E-05 mg/kg-day 2.7E+00

Arsenic 1.3E-01 mg/kg 1.5E-05 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.2E-05 4.3E-05 mg/kg-day 3.0E-04 mg/kg-day 1.4E-01

Copper 1.0E+01 mg/kg 1.1E-03 mg/kg-day NA NA 3.4E-03 mg/kg-day 4.0E-02 mg/kg-day 8.4E-02

Mercury 1.2E-01 mg/kg 1.4E-05 mg/kg-day NA NA 4.1E-05 mg/kg-day 1.0E-04 mg/kg-day 4.1E-01

Exp. Route Total 1.6E-04 3.4E+00

Exposure Point Total 1.6E-04 3.4E+00

Exposure Medium Total - Crab in Gowanus Canal 1.6E-04 3.4E+00

Total Fish Total of Receptor Risks - Fish 4.2E-04 Total of Receptor Hazards - Fish 1.7E+01

Total Blue Crab Total of Receptor Risks - Blur Crab 1.6E-04 Total of Receptor Hazards - Blue Crab 3.4E+00

Notes-

NA = Not available / Not applicable.

Page 267: Appendix L HHRA Combined

TABLE 7.9.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Striped Bass in Gowanus Canal

Ingestion

p,p'-DDE 1.2E-02 mg/kg 1.4E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 4.9E-08 1.7E-06 mg/kg-day NA NA

p,p'-DDT 9.6E-03 mg/kg 1.2E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 3.9E-08 1.3E-06 mg/kg-day 5.0E-04 mg/kg-day 2.7E-03

Dioxin-Like PCB TEQ 4.3E-06 mg/kg 5.2E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 8.1E-06 6.0E-10 mg/kg-day NA NA

Nondioxin-Like 4.1E-01 mg/kg 4.9E-06 mg/kg-day 2.0E+00 1/(mg/kg-day) 9.8E-06 5.7E-05 mg/kg-day NA NA

Total PCB 4.4E-01 mg/kg 5.2E-06 mg/kg-day NA NA 6.1E-05 mg/kg-day 2.0E-05 mg/kg-day 3.0E+00

Arsenic 6.8E-02 mg/kg 8.2E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.2E-06 9.5E-06 mg/kg-day 3.0E-04 mg/kg-day 3.2E-02

Mercury 2.0E-01 mg/kg 2.4E-06 mg/kg-day NA NA 2.8E-05 mg/kg-day 1.0E-04 mg/kg-day 2.8E-01

Selenium 1.2E+00 mg/kg 1.4E-05 mg/kg-day NA NA 1.7E-04 mg/kg-day 5.0E-03 mg/kg-day 3.4E-02

Exp. Route Total 1.9E-05 3.4E+00

Exposure Point Total 1.9E-05 3.4E+00

Exposure Medium Total - Striped Bass in Gowanus Canal 1.9E-05 3.4E+00

Fish and Crab Tissue

White Perch in Gowanus Canal

Ingestion

Dioxin-Like PCB TEQ 5.8E-06 mg/kg 1.3E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.1E-06 1.6E-10 mg/kg-day NA NA

Nondioxin-Like 4.4E-01 mg/kg 1.0E-06 mg/kg-day 2.0E+00 1/(mg/kg-day) 2.0E-06 1.2E-05 mg/kg-day NA NA

Total PCB 4.6E-01 mg/kg 1.1E-06 mg/kg-day NA NA 1.2E-05 mg/kg-day 2.0E-05 mg/kg-day 6.2E-01

Mercury 1.9E-01 mg/kg 4.4E-07 mg/kg-day NA NA 5.1E-06 mg/kg-day 1.0E-04 mg/kg-day 5.1E-02

Selenium 1.4E+00 mg/kg 3.2E-06 mg/kg-day NA NA 3.8E-05 mg/kg-day 5.0E-03 mg/kg-day 7.5E-03

Exp. Route Total 4.1E-06 6.8E-01

Exposure Point Total 4.1E-06 6.8E-01

Exposure Medium Total - White Perch in Gowanus Canal 4.1E-06 6.8E-01

Page 268: Appendix L HHRA Combined

TABLE 7.9.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Eel in Gowanus Canal Ingestion

alpha-Chlordane 2.2E-02 mg/kg 2.5E-07 mg/kg-day 3.5E-01 1/(mg/kg-day) 8.7E-08 2.9E-06 mg/kg-day 5.0E-04 mg/kg-day 5.8E-03

Dieldrin 1.7E-02 mg/kg 1.9E-07 mg/kg-day 1.6E+01 1/(mg/kg-day) 3.1E-06 2.2E-06 mg/kg-day 5.0E-05 mg/kg-day 4.5E-02

gamma-Chlordane 1.3E-02 mg/kg 1.5E-07 mg/kg-day 3.5E-01 1/(mg/kg-day) 5.1E-08 1.7E-06 mg/kg-day 5.0E-04 mg/kg-day 3.4E-03

p,p'-DDD 3.8E-02 mg/kg 4.3E-07 mg/kg-day 2.4E-01 1/(mg/kg-day) 1.0E-07 5.0E-06 mg/kg-day NA NA

p,p'-DDE 2.5E-02 mg/kg 2.8E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 9.6E-08 3.3E-06 mg/kg-day NA NA

p,p'-DDT 4.7E-02 mg/kg 5.3E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 1.8E-07 6.2E-06 mg/kg-day 5.0E-04 mg/kg-day 1.2E-02

Dioxin-Like PCB TEQ 1.4E-05 mg/kg 1.6E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.5E-05 1.9E-09 mg/kg-day NA NA

Nondioxin-Like 1.2E+00 mg/kg 1.4E-05 mg/kg-day 2.0E+00 1/(mg/kg-day) 2.7E-05 1.6E-04 mg/kg-day NA NA

Total PCB 1.4E+00 mg/kg 1.5E-05 mg/kg-day NA NA 1.8E-04 mg/kg-day 2.0E-05 mg/kg-day 8.9E+00

Arsenic 5.0E-02 mg/kg 5.6E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 8.4E-07 6.6E-06 mg/kg-day 3.0E-04 mg/kg-day 2.2E-02

Chromium (12-16)* 6.7E-01 mg/kg 5.0E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 7.5E-06 8.8E-05 mg/kg-day 3.0E-03 mg/kg-day 2.9E-02

Chromium (16-18)* 6.7E-01 mg/kg 2.5E-06 mg/kg-day 5.0E-01 1/(mg/kg-day) 1.3E-06

Copper 7.4E+00 mg/kg 8.3E-05 mg/kg-day NA NA 9.7E-04 mg/kg-day 4.0E-02 mg/kg-day 2.4E-02

Cyanide, total 3.1E+00 mg/kg 3.5E-05 mg/kg-day NA NA 4.1E-04 mg/kg-day 2.0E-02 mg/kg-day 2.0E-02

Mercury 2.6E-01 mg/kg 2.9E-06 mg/kg-day NA NA 3.4E-05 mg/kg-day 1.0E-04 mg/kg-day 3.4E-01

Selenium 1.4E+00 mg/kg 1.6E-05 mg/kg-day NA NA 1.8E-04 mg/kg-day 5.0E-03 mg/kg-day 3.7E-02

Exp. Route Total 6.5E-05 9.4E+00

Exposure Point Total 6.5E-05 9.4E+00

Exposure Medium Total - Eel in Gowanus Canal 6.5E-05 9.4E+00

Page 269: Appendix L HHRA Combined

TABLE 7.9.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Blue Crab in Gowanus Canal

Ingestion

Benzo(a)anthracene (12-16)* 7.7E-03 mg/kg 1.2E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.5E-07 2.0E-06 mg/kg-day NA NA

Benzo(a)anthracene (16-18)* 7.7E-03 mg/kg 5.8E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.2E-08

Benzo(a)pyrene (12-16)* 1.2E-02 mg/kg 1.8E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 3.9E-06 3.1E-06 mg/kg-day NA NA

Benzo(a)pyrene (16-18)* 1.2E-02 mg/kg 8.9E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.5E-07

Benzo(b)fluoranthene (12-16)* 6.4E-03 mg/kg 9.6E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.1E-07 1.7E-06 mg/kg-day NA NA

Benzo(b)fluoranthene (16-18)* 6.4E-03 mg/kg 4.8E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.5E-08

Dibenz(a,h)anthracene (12-16)* 3.9E-03 mg/kg 5.9E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.3E-06 1.0E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (16-18)* 3.9E-03 mg/kg 3.0E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.2E-07

Indeno(1,2,3-cd)pyrene (12-16)* 9.9E-03 mg/kg 1.5E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.3E-07 2.6E-06 mg/kg-day NA NA

Indeno(1,2,3-cd)pyrene (16-18)* 9.9E-03 mg/kg 7.5E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 5.4E-08

Dioxin-Like PCB TEQ 5.0E-06 mg/kg 1.1E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.8E-05 1.3E-09 mg/kg-day NA NA

Nondioxin-Like 1.4E-01 mg/kg 3.2E-06 mg/kg-day 2.0E+00 1/(mg/kg-day) 6.5E-06 3.8E-05 mg/kg-day NA NA

Total PCB 1.7E-01 mg/kg 3.7E-06 mg/kg-day NA NA 4.4E-05 mg/kg-day 2.0E-05 mg/kg-day 2.2E+00

Arsenic 1.3E-01 mg/kg 3.0E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.4E-06 3.4E-05 mg/kg-day 3.0E-04 mg/kg-day 1.1E-01

Copper 1.0E+01 mg/kg 2.3E-04 mg/kg-day NA NA 2.7E-03 mg/kg-day 4.0E-02 mg/kg-day 6.7E-02

Mercury 1.2E-01 mg/kg 2.8E-06 mg/kg-day NA NA 3.3E-05 mg/kg-day 1.0E-04 mg/kg-day 3.3E-01

Exp. Route Total 3.6E-05 2.7E+00

Exposure Point Total 3.6E-05 2.7E+00

Exposure Medium Total - Crab in Gowanus Canal 3.6E-05 2.7E+00

Total Fish Total of Receptor Risks - Fish 8.9E-05 Total of Receptor Hazards - Fish 1.3E+01

Total Blue Crab Total of Receptor Risks - Blur Crab 3.6E-05 Total of Receptor Hazards - Blue Crab 2.7E+00

Notes-

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used to adjust CSF for 12-16 year old for exposure duration of 4 years, ADAF of 1 used to adjust CSF for 16-18 year old for exposure duration of 2 years.

Non-cancer calculations shown under 12-16 year old only, as non-cancer calculations are not adjusted for MMOA.

NA = Not available / Not applicable.

Page 270: Appendix L HHRA Combined

TABLE 7.10.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Striped Bass in Gowanus Canal

Ingestion

p,p'-DDE 1.2E-02 mg/kg 2.9E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 9.9E-08 3.4E-06 mg/kg-day NA NA

p,p'-DDT 9.6E-03 mg/kg 2.3E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 7.9E-08 2.7E-06 mg/kg-day 5.0E-04 mg/kg-day 5.4E-03

Dioxin-Like PCB TEQ 4.3E-06 mg/kg 1.0E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.6E-05 1.2E-09 mg/kg-day NA NA

Nondioxin-Like 4.1E-01 mg/kg 9.9E-06 mg/kg-day 2.0E+00 1/(mg/kg-day) 2.0E-05 1.2E-04 mg/kg-day NA NA

Total PCB 4.4E-01 mg/kg 1.1E-05 mg/kg-day NA NA 1.2E-04 mg/kg-day 2.0E-05 mg/kg-day 6.1E+00

Arsenic 6.8E-02 mg/kg 1.6E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.5E-06 1.9E-05 mg/kg-day 3.0E-04 mg/kg-day 6.4E-02

Mercury 2.0E-01 mg/kg 4.8E-06 mg/kg-day NA 1/(mg/kg-day) NA 5.6E-05 mg/kg-day 1.0E-04 mg/kg-day 5.6E-01

Selenium 1.2E+00 mg/kg 2.9E-05 mg/kg-day NA NA 3.4E-04 mg/kg-day 5.0E-03 mg/kg-day 6.8E-02

Exp. Route Total 3.9E-05 6.8E+00

Exposure Point Total 3.9E-05 6.8E+00

Exposure Medium Total - Striped Bass in Gowanus Canal 3.9E-05 6.8E+00

Fish and Crab Tissue

White Perch in Gowanus Canal

Ingestion

Dioxin-Like PCB TEQ 5.8E-06 mg/kg 2.7E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 4.2E-06 3.1E-10 mg/kg-day NA NA

Nondioxin-Like 4.4E-01 mg/kg 2.0E-06 mg/kg-day 2.0E+00 1/(mg/kg-day) 4.0E-06 2.4E-05 mg/kg-day NA NA

Total PCB 4.6E-01 mg/kg 2.1E-06 mg/kg-day NA NA 2.5E-05 mg/kg-day 2.0E-05 mg/kg-day 1.2E+00

Mercury 1.9E-01 mg/kg 8.8E-07 mg/kg-day NA NA 1.0E-05 mg/kg-day 1.0E-04 mg/kg-day 1.0E-01

Selenium 1.4E+00 mg/kg 6.5E-06 mg/kg-day NA NA 7.6E-05 mg/kg-day 5.0E-03 mg/kg-day 1.5E-02

Exp. Route Total 8.2E-06 1.4E+00

Exposure Point Total 8.2E-06 1.4E+00

Exposure Medium Total - White Perch in Gowanus Canal 8.2E-06 1.4E+00

Page 271: Appendix L HHRA Combined

TABLE 7.10.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Eel in Gowanus Canal Ingestion

alpha-Chlordane 2.2E-02 mg/kg 5.0E-07 mg/kg-day 3.5E-01 1/(mg/kg-day) 1.7E-07 5.8E-06 mg/kg-day 5.0E-04 mg/kg-day 1.2E-02

Dieldrin 1.7E-02 mg/kg 3.8E-07 mg/kg-day 1.6E+01 1/(mg/kg-day) 6.2E-06 4.5E-06 mg/kg-day 5.0E-05 mg/kg-day 9.0E-02

gamma-Chlordane 1.3E-02 mg/kg 2.9E-07 mg/kg-day 3.5E-01 1/(mg/kg-day) 1.0E-07 3.4E-06 mg/kg-day 5.0E-04 mg/kg-day 6.9E-03

p,p'-DDD 3.8E-02 mg/kg 8.6E-07 mg/kg-day 2.4E-01 1/(mg/kg-day) 2.1E-07 1.0E-05 mg/kg-day NA NA

p,p'-DDE 2.5E-02 mg/kg 5.7E-07 mg/kg-day 3.4E-01 1/(mg/kg-day) 1.9E-07 6.6E-06 mg/kg-day NA NA

p,p'-DDT 4.7E-02 mg/kg 1.1E-06 mg/kg-day 3.4E-01 1/(mg/kg-day) 3.6E-07 1.2E-05 mg/kg-day 5.0E-04 mg/kg-day 2.5E-02

Dioxin-Like PCB TEQ 1.4E-05 mg/kg 3.2E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 5.0E-05 3.7E-09 mg/kg-day NA NA

Nondioxin-Like 1.2E+00 mg/kg 2.8E-05 mg/kg-day 2.0E+00 1/(mg/kg-day) 5.5E-05 3.2E-04 mg/kg-day NA NA

Total PCB 1.4E+00 mg/kg 3.1E-05 mg/kg-day NA NA 3.6E-04 mg/kg-day 2.0E-05 mg/kg-day 1.8E+01

Arsenic 5.0E-02 mg/kg 1.1E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.7E-06 1.3E-05 mg/kg-day 3.0E-04 mg/kg-day 4.4E-02

Chromium (0-2)* 6.7E-01 mg/kg 5.1E-06 mg/kg-day 5.0E+00 1/(mg/kg-day) 2.5E-05 1.8E-04 mg/kg-day 3.0E-03 mg/kg-day 5.9E-02

Chromium (2-6)* 6.7E-01 mg/kg 1.0E-05 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.5E-05

Copper 7.4E+00 mg/kg 1.7E-04 mg/kg-day NA NA 2.0E-03 mg/kg-day 4.0E-02 mg/kg-day 4.9E-02

Cyanide, total 3.1E+00 mg/kg 7.0E-05 mg/kg-day NA NA 8.2E-04 mg/kg-day 2.0E-02 mg/kg-day 4.1E-02

Mercury 2.6E-01 mg/kg 5.9E-06 mg/kg-day NA NA 6.9E-05 mg/kg-day 1.0E-04 mg/kg-day 6.9E-01

Selenium 1.4E+00 mg/kg 3.2E-05 mg/kg-day NA NA 3.7E-04 mg/kg-day 5.0E-03 mg/kg-day 7.4E-02

Exp. Route Total 1.5E-04 1.9E+01

Exposure Point Total 1.5E-04 1.9E+01

Exposure Medium Total - Eel in Gowanus Canal 1.5E-04 1.9E+01

Page 272: Appendix L HHRA Combined

TABLE 7.10.RME

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Fish and Crab Tissue

Blue Crab in Gowanus Canal

Ingestion

Benzo(a)anthracene (0-2)* 7.7E-03 mg/kg 1.2E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 8.6E-07 4.1E-06 mg/kg-day NA NA

Benzo(a)anthracene (2-6)* 7.7E-03 mg/kg 2.3E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.1E-07

Benzo(a)pyrene (0-2)* 1.2E-02 mg/kg 1.8E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 1.3E-05 6.3E-06 mg/kg-day NA NA

Benzo(a)pyrene (2-6)* 1.2E-02 mg/kg 3.6E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 7.9E-06

Benzo(b)fluoranthene (0-2)* 6.4E-03 mg/kg 9.7E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 7.1E-07 3.4E-06 mg/kg-day NA NA

Benzo(b)fluoranthene (2-6)* 6.4E-03 mg/kg 1.9E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 4.3E-07

Dibenz(a,h)anthracene (0-2)* 3.9E-03 mg/kg 6.0E-08 mg/kg-day 7.3E+01 1/(mg/kg-day) 4.4E-06 2.1E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (2-6)* 3.9E-03 mg/kg 1.2E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.6E-06

Indeno(1,2,3-cd)pyrene (0-2)* 9.9E-03 mg/kg 1.5E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.1E-06 5.3E-06 mg/kg-day NA NA

Indeno(1,2,3-cd)pyrene (2-6)* 9.9E-03 mg/kg 3.0E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.6E-07

Dioxin-Like PCB TEQ 5.0E-06 mg/kg 2.3E-10 mg/kg-day 1.6E+05 1/(mg/kg-day) 3.6E-05 2.7E-09 mg/kg-day NA NA

Nondioxin-Like 1.4E-01 mg/kg 6.5E-06 mg/kg-day 2.0E+00 1/(mg/kg-day) 1.3E-05 7.6E-05 mg/kg-day NA NA

Total PCB 1.7E-01 mg/kg 7.6E-06 mg/kg-day NA NA 8.9E-05 mg/kg-day 2.0E-05 mg/kg-day 4.4E+00

Arsenic 1.3E-01 mg/kg 6.0E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 9.0E-06 7.0E-05 mg/kg-day 3.0E-04 mg/kg-day 2.3E-01

Copper 1.0E+01 mg/kg 4.7E-04 mg/kg-day NA NA 5.4E-03 mg/kg-day 4.0E-02 mg/kg-day 1.4E-01

Mercury 1.2E-01 mg/kg 5.7E-06 mg/kg-day NA NA 6.6E-05 mg/kg-day 1.0E-04 mg/kg-day 6.6E-01

Exp. Route Total 9.0E-05 5.5E+00

Exposure Point Total 9.0E-05 5.5E+00

Exposure Medium Total - Crab in Gowanus Canal 9.0E-05 5.5E+00

Total Fish Total of Receptor Risks - Fish 2.0E-04 Total of Receptor Hazards - Fish 2.7E+01

Total Blue Crab Total of Receptor Risks - Blur Crab 9.0E-05 Total of Receptor Hazards - Blue Crab 5.5E+00

Notes-

NA = Not available / Not applicable.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 used to adjust CSF for 2-6 year old for exposure duration of 4 years.

Non-cancer calculations shown under 0-2 year old only, as non-cancer calculations are not adjusted for MMOA.

Page 273: Appendix L HHRA Combined

TABLE 7.1.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Ingestion

Acenaphthene 3.7E+02 mg/kg 2.0E-07 mg/kg-day NA NA 4.7E-06 mg/kg-day 6.0E-02 mg/kg-day 7.8E-05

Benzo(a)anthracene 1.3E+02 mg/kg 6.9E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 5.1E-08 1.6E-06 mg/kg-day NA NA

Benzo(a)pyrene 1.1E+02 mg/kg 5.8E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.3E-07 1.4E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 1.1E+02 mg/kg 6.2E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.5E-08 1.4E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 6.5E+01 mg/kg 3.5E-08 mg/kg-day 7.3E-02 1/(mg/kg-day) 2.6E-09 8.2E-07 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 1.8E-08 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.5E-10 4.2E-07 mg/kg-day 2.0E-02 mg/kg-day 2.1E-05

Chrysene 2.5E+02 mg/kg 1.4E-07 mg/kg-day 7.3E-03 1/(mg/kg-day) 1.0E-09 3.2E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 6.2E+00 mg/kg 3.4E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.5E-08 7.9E-08 mg/kg-day NA NA

Fluoranthene 5.0E+02 mg/kg 2.7E-07 mg/kg-day NA NA 6.3E-06 mg/kg-day 4.0E-02 mg/kg-day 1.6E-04

Indeno(1,2,3-c,d)pyrene 4.9E+01 mg/kg 2.7E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.9E-08 6.2E-07 mg/kg-day NA NA

Naphthalene 3.4E+00 mg/kg 1.9E-09 mg/kg-day NA NA 4.3E-08 mg/kg-day 2.0E-02 mg/kg-day 2.2E-06

Pyrene 5.3E+02 mg/kg 2.9E-07 mg/kg-day NA NA 6.7E-06 mg/kg-day 3.0E-02 mg/kg-day 2.2E-04

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 2.2E-14 mg/kg-day 1.6E+05 1/(mg/kg-day) 3.4E-09 5.1E-13 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 2.9E-09 mg/kg-day 1.0E+00 1/(mg/kg-day) 2.9E-09 6.7E-08 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 2.9E-09 mg/kg-day NA NA 6.9E-08 mg/kg-day 2.0E-05 mg/kg-day 3.4E-03

Aluminum 1.6E+04 mg/kg 8.7E-06 mg/kg-day NA NA 2.0E-04 mg/kg-day 1.0E+00 mg/kg-day 2.0E-04

Arsenic 1.8E+01 mg/kg 9.8E-09 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.5E-08 2.3E-07 mg/kg-day 3.0E-04 mg/kg-day 7.6E-04

Cadmium 9.6E+00 mg/kg 5.2E-09 mg/kg-day NA NA 1.2E-07 mg/kg-day 1.0E-03 mg/kg-day 1.2E-04

Chromium 9.4E+01 mg/kg 5.1E-08 mg/kg-day 5.0E-01 1/(mg/kg-day) 2.5E-08 1.2E-06 mg/kg-day 3.0E-03 mg/kg-day 4.0E-04

Cobalt 1.3E+01 mg/kg 7.0E-09 mg/kg-day NA NA 1.6E-07 mg/kg-day 3.0E-04 mg/kg-day 5.5E-04

Copper 3.5E+02 mg/kg 1.9E-07 mg/kg-day NA NA 4.5E-06 mg/kg-day 4.0E-02 mg/kg-day 1.1E-04

Iron 4.0E+04 mg/kg 2.2E-05 mg/kg-day NA NA 5.1E-04 mg/kg-day 7.0E-01 mg/kg-day 7.3E-04

Lead 1.9E+03 mg/kg 1.0E-06 mg/kg-day NA NA 2.4E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 1.7E-07 mg/kg-day NA NA 4.0E-06 mg/kg-day 1.4E-01 mg/kg-day 2.9E-05

Vanadium 5.0E+01 mg/kg 2.7E-08 mg/kg-day NA NA 6.4E-07 mg/kg-day 5.0E-03 mg/kg-day 1.3E-04

Exp. Route Total 6.2E-07 6.9E-03

Page 274: Appendix L HHRA Combined

TABLE 7.1.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Dermal

Acenaphthene 3.7E+02 mg/kg 2.2E-06 mg/kg-day NA NA 5.0E-05 mg/kg-day 6.0E-02 mg/kg-day 8.4E-04

Benzo(a)anthracene 1.3E+02 mg/kg 7.5E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 5.5E-07 1.7E-05 mg/kg-day NA NA

Benzo(a)pyrene 1.1E+02 mg/kg 6.3E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.6E-06 1.5E-05 mg/kg-day NA NA

Benzo(b)fluoranthene 1.1E+02 mg/kg 6.7E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.9E-07 1.6E-05 mg/kg-day NA NA

Benzo(k)fluoranthene 6.5E+01 mg/kg 3.8E-07 mg/kg-day 7.3E-02 1/(mg/kg-day) 2.8E-08 8.9E-06 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 1.5E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.1E-09 3.5E-06 mg/kg-day 2.0E-02 mg/kg-day 1.8E-04

Chrysene 2.5E+02 mg/kg 1.5E-06 mg/kg-day 7.3E-03 1/(mg/kg-day) 1.1E-08 3.5E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene 6.2E+00 mg/kg 3.6E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.7E-07 8.5E-07 mg/kg-day NA NA

Fluoranthene 5.0E+02 mg/kg 2.9E-06 mg/kg-day NA NA 6.8E-05 mg/kg-day 4.0E-02 mg/kg-day 1.7E-03

Indeno(1,2,3-c,d)pyrene 4.9E+01 mg/kg 2.9E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.1E-07 6.7E-06 mg/kg-day NA NA

Naphthalene 3.4E+00 mg/kg 2.0E-08 mg/kg-day NA NA 4.7E-07 mg/kg-day 2.0E-02 mg/kg-day 2.3E-05

Pyrene 5.3E+02 mg/kg 3.1E-06 mg/kg-day NA NA 7.3E-05 mg/kg-day 3.0E-02 mg/kg-day 2.4E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 2.5E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 4.0E-08 5.9E-12 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 3.3E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 3.3E-08 7.7E-07 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 3.4E-08 mg/kg-day NA NA 8.0E-07 mg/kg-day 2.0E-05 mg/kg-day 4.0E-02

Aluminum 1.6E+04 mg/kg 7.2E-06 mg/kg-day NA NA 1.7E-04 mg/kg-day 1.0E+00 mg/kg-day 1.7E-04

Arsenic 1.8E+01 mg/kg 2.4E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 3.7E-08 5.7E-07 mg/kg-day 3.0E-04 mg/kg-day 1.9E-03

Cadmium 9.6E+00 mg/kg 4.4E-10 mg/kg-day NA NA 1.0E-08 mg/kg-day 2.5E-05 mg/kg-day 4.1E-04

Chromium 9.4E+01 mg/kg 4.2E-08 mg/kg-day 2.0E+01 1/(mg/kg-day) 8.5E-07 9.9E-07 mg/kg-day 7.5E-05 mg/kg-day 1.3E-02

Cobalt 1.3E+01 mg/kg 5.8E-09 mg/kg-day NA NA 1.4E-07 mg/kg-day 3.0E-04 mg/kg-day 4.5E-04

Copper 3.5E+02 mg/kg 1.6E-07 mg/kg-day NA NA 3.7E-06 mg/kg-day 4.0E-02 mg/kg-day 9.3E-05

Iron 4.0E+04 mg/kg 1.8E-05 mg/kg-day NA NA 4.2E-04 mg/kg-day 7.0E-01 mg/kg-day 6.0E-04

Lead 1.9E+03 mg/kg 8.5E-07 mg/kg-day NA NA 2.0E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 1.4E-07 mg/kg-day NA NA 3.3E-06 mg/kg-day 9.6E-04 mg/kg-day 3.5E-03

Vanadium 5.0E+01 mg/kg 2.3E-08 mg/kg-day NA NA 5.3E-07 mg/kg-day 5.0E-03 mg/kg-day 1.1E-04

Exp. Route Total 7.1E-06 6.5E-02

Exposure Point Total 7.7E-06 7.2E-02

7.7E-06 7.2E-02

Exposed Surface Sediment Total 7.7E-06 7.2E-02

Exposure Medium Total

Page 275: Appendix L HHRA Combined

TABLE 7.1.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Dry event) Benzene 2.2E+00 ug/L 1.6E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 8.7E-11 3.7E-08 mg/kg-day 4.0E-03 mg/kg-day 9.3E-06

Benzo(a)anthracene 2.7E-01 ug/L 1.9E-10 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.4E-10 4.4E-09 mg/kg-day NA NA

Benzo(a)pyrene 6.6E-01 ug/L 4.7E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.4E-09 1.1E-08 mg/kg-day NA NA

Benzo(b)fluoranthene 3.0E-01 ug/L 2.1E-10 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.5E-10 4.9E-09 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 1.7E-09 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.4E-11 4.1E-08 mg/kg-day 2.0E-02 mg/kg-day 2.0E-06

Indeno(1,2,3-c,d)pyrene 1.3E-01 ug/L 9.4E-11 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.8E-11 2.2E-09 mg/kg-day NA NA

Arsenic 2.0E+01 ug/L 1.4E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.1E-08 3.3E-07 mg/kg-day 3.0E-04 mg/kg-day 1.1E-03

Chromium 1.9E+01 ug/L 1.3E-08 mg/kg-day 5.0E-01 1/(mg/kg-day) 6.7E-09 3.1E-07 mg/kg-day 3.0E-03 mg/kg-day 1.0E-04

Copper 1.7E+02 ug/L 1.2E-07 mg/kg-day NA NA 2.8E-06 mg/kg-day 4.0E-02 mg/kg-day 7.1E-05

Selenium 4.1E+01 ug/L 2.9E-08 mg/kg-day NA NA 6.8E-07 mg/kg-day 5.0E-03 mg/kg-day 1.4E-04

Exp. Route Total 3.2E-08 1.4E-03

Dermal

Benzene 2.2E+00 ug/L 2.4E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.3E-09 5.7E-07 mg/kg-day 4.0E-03 mg/kg-day 1.4E-04

Benzo(a)anthracene 2.7E-01 ug/L 2.2E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.6E-07 5.1E-06 mg/kg-day NA NA

Benzo(a)pyrene 6.6E-01 ug/L 9.4E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.8E-06 2.2E-05 mg/kg-day NA NA

Benzo(b)fluoranthene 3.0E-01 ug/L 4.3E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 3.1E-07 1.0E-05 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 2.5E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 3.5E-09 5.8E-06 mg/kg-day 2.0E-02 mg/kg-day 2.9E-04

Indeno(1,2,3-c,d)pyrene 1.3E-01 ug/L 1.9E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.4E-07 4.4E-06 mg/kg-day NA NA

Arsenic 2.0E+01 ug/L 1.0E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.5E-08 2.4E-07 mg/kg-day 3.0E-04 mg/kg-day 7.9E-04

Chromium 1.9E+01 ug/L 1.9E-08 mg/kg-day 2.0E+01 1/(mg/kg-day) 3.9E-07 4.5E-07 mg/kg-day 7.5E-05 mg/kg-day 6.0E-03

Copper 1.7E+02 ug/L 8.8E-08 mg/kg-day NA NA 2.0E-06 mg/kg-day 4.0E-02 mg/kg-day 5.1E-05

Selenium 4.1E+01 ug/L 2.1E-08 mg/kg-day NA NA 4.9E-07 mg/kg-day 5.0E-03 mg/kg-day 9.8E-05

Exp. Route Total 7.9E-06 7.4E-03

Exposure Point Total 7.9E-06 8.8E-03

7.9E-06 8.8E-03

Surface Water Total - Dry Event 7.9E-06 8.8E-03

Exposure Medium Total

Page 276: Appendix L HHRA Combined

TABLE 7.1.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 4.2E-10 mg/kg-day 5.4E-03 1/(mg/kg-day) 2.3E-12 9.8E-09 mg/kg-day 7.0E-02 mg/kg-day 1.4E-07

Benzene 8.4E-01 ug/L 5.9E-10 mg/kg-day 5.5E-02 1/(mg/kg-day) 3.3E-11 1.4E-08 mg/kg-day 4.0E-03 mg/kg-day 3.5E-06

Chloroform 5.6E-01 ug/L 4.0E-10 mg/kg-day 3.1E-02 1/(mg/kg-day) 1.2E-11 9.2E-09 mg/kg-day 1.0E-02 mg/kg-day 9.2E-07

Ethylbenzene 8.7E-01 ug/L 6.2E-10 mg/kg-day 1.1E-02 1/(mg/kg-day) 6.8E-12 1.4E-08 mg/kg-day 1.0E-01 mg/kg-day 1.4E-07

Tetrachloroethylene(PCE) 2.4E+01 ug/L 1.7E-08 mg/kg-day 5.4E-01 1/(mg/kg-day) 9.3E-09 4.0E-07 mg/kg-day 1.0E-02 mg/kg-day 4.0E-05

Benzo(a)anthracene 1.0E-01 ug/L 7.4E-11 mg/kg-day 7.3E-01 1/(mg/kg-day) 5.4E-11 1.7E-09 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 1.5E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.1E-09 3.4E-09 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 1.3E-10 mg/kg-day 7.3E-01 1/(mg/kg-day) 9.8E-11 3.1E-09 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.2E-11 mg/kg-day 7.3E+00 1/(mg/kg-day) 5.2E-10 1.7E-09 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 3.5E-10 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.6E-10 8.3E-09 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 2.6E-10 mg/kg-day NA NA 6.0E-09 mg/kg-day 2.0E-02 mg/kg-day 3.0E-07

Arsenic 1.7E+01 ug/L 1.2E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.8E-08 2.7E-07 mg/kg-day 3.0E-04 mg/kg-day 9.2E-04

Chromium 8.5E+00 ug/L 6.0E-09 mg/kg-day 5.0E-01 1/(mg/kg-day) 3.0E-09 1.4E-07 mg/kg-day 3.0E-03 mg/kg-day 4.7E-05

Cobalt 3.9E+00 ug/L 2.8E-09 mg/kg-day NA NA 6.4E-08 mg/kg-day 3.0E-04 mg/kg-day 2.1E-04

Lead 1.5E+01 ug/L 1.1E-08 mg/kg-day NA NA 2.5E-07 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 2.4E-08 mg/kg-day NA NA 5.6E-07 mg/kg-day 5.0E-03 mg/kg-day 1.1E-04

Exp. Route Total 3.2E-08 1.3E-03

Page 277: Appendix L HHRA Combined

TABLE 7.1.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Dermal

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 2.6E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.4E-10 6.0E-07 mg/kg-day 7.0E-02 mg/kg-day 8.6E-06

Benzene 8.4E-01 ug/L 9.1E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 5.0E-10 2.1E-07 mg/kg-day 4.0E-03 mg/kg-day 5.3E-05

Chloroform 5.6E-01 ug/L 3.4E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 1.1E-10 8.0E-08 mg/kg-day 1.0E-02 mg/kg-day 8.0E-06

Ethylbenzene 8.7E-01 ug/L 3.5E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 3.8E-10 8.1E-07 mg/kg-day 1.0E-01 mg/kg-day 8.1E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 9.5E-07 mg/kg-day 5.4E-01 1/(mg/kg-day) 5.1E-07 2.2E-05 mg/kg-day 1.0E-02 mg/kg-day 2.2E-03

Benzo(a)anthracene 1.0E-01 ug/L 8.6E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 6.3E-08 2.0E-06 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 2.9E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.1E-06 6.8E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 2.7E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.0E-07 6.4E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 2.2E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.6E-06 5.2E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.2E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 5.3E-07 1.7E-05 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 1.6E-08 mg/kg-day NA NA 3.7E-07 mg/kg-day 2.0E-02 mg/kg-day 1.8E-05

Arsenic 1.7E+01 ug/L 8.5E-09 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.3E-08 2.0E-07 mg/kg-day 3.0E-04 mg/kg-day 6.6E-04

Chromium 8.5E+00 ug/L 8.7E-09 mg/kg-day 2.0E+01 1/(mg/kg-day) 1.7E-07 2.0E-07 mg/kg-day 7.5E-05 mg/kg-day 2.7E-03

Cobalt 3.9E+00 ug/L 8.0E-10 mg/kg-day NA NA 1.9E-08 mg/kg-day 3.0E-04 mg/kg-day 6.2E-05

Lead 1.5E+01 ug/L 7.6E-10 mg/kg-day NA NA 1.8E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 1.7E-08 mg/kg-day NA NA 4.0E-07 mg/kg-day 5.0E-03 mg/kg-day 8.0E-05

Exp. Route Total 5.2E-06 5.8E-03

Exposure Point Total 5.3E-06 7.2E-03

5.3E-06 7.2E-03

Surface Water Total - Wet Event 5.3E-06 7.2E-03

Total Total of Receptor Risks Across All Media 1.6E-05 Total of Receptor Hazards Across All Media 8.1E-02

Notes-

NA = Not available / Not applicable.

DAevent for surface water from dry event calculated on Table 7.1.CTE Supplement A.

DAevent for surface water from wet event calculated on Table 7.1.CTE Supplement B.

Total includes sum of exposed and near shore sediment, and maximum of dry event and wet event surface water

Exposure Medium Total

Page 278: Appendix L HHRA Combined

TABLE 7.1.CTE Supplement A

Calculation of Daevent Dry Event

Recreational Scenario

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Water Permeability Lag Fraction Duration

of Potential Concentration Coefficient Time Absorbed Water of Event

Concern (CW) (Kp) B (τevent) t* (FA) (tevent) DAevent

(µg/L) (cm/hr) (dimensionless) (hr) (hr) (dimensionless) (hr) (mg/cm2-event) Eq

Benzene 2.2E+00 1.5E-02 5.1E-02 2.9E-01 7.0E-01 1.0E+00 1.3 6.2E-08 3

Benzo(a)anthracene 2.7E-01 4.7E-01 2.8E+00 2.0E+00 8.5E+00 1.0E+00 1.3 5.6E-07 2

Benzo(a)pyrene 6.6E-01 7.0E-01 4.3E+00 2.7E+00 1.2E+01 1.0E+00 1.3 2.4E-06 2

Benzo(b)fluoranthene 3.0E-01 7.0E-01 4.3E+00 2.8E+00 1.2E+01 1.0E+00 1.3 1.1E-06 2

Bis(2-ethylhexyl) phthalate 2.5E+00 2.5E-02 1.9E-01 1.7E+01 4.0E+01 8.0E-01 1.3 6.3E-07 2

Indeno(1,2,3-c,d)pyrene 1.3E-01 1.0E+00 6.7E+00 3.8E+00 1.7E+01 6.0E-01 1.3 4.9E-07 2

Arsenic 2.0E+01 1.0E-03 NA NA NA NA 1.3 2.6E-08 1

Chromium 1.9E+01 2.0E-03 NA NA NA NA 1.3 4.9E-08 1

Copper 1.7E+02 1.0E-03 NA NA NA NA 1.3 2.2E-07 1

Selenium 4.1E+01 1.0E-03 NA NA NA NA 1.3 5.3E-08 1

Inorganics: DAevent (mg/cm2-event) =

Kp x CW x tevent x 0.001 mg/µg x 0.001 l/cm3 (eq 1)

Organics: DAevent (mg/cm2-event) =

If tevent<t*, then DAevent =

2 x FA x Kp x CW x (sqrt((6 x τevent x tevent)/π)) x 0.001 mg/µg x 0.001 l/cm3 (eq 2)

If tevent>t*, then DAevent =

FA x Kp x CW x ( tevent/(1+B) + 2 x τevent x ((1 + 3xB + 3xB2)/(1+B)2) x 0.001 mg/µg x 0.001 l/cm3 (eq 3)

Notes:

NA - Not applicable

Permeability constants and other input parameter values from EPA 2004, Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E,

Supplemental Guidance for Dermal Risk Assessment - Final). EPA/540/R/99/005. The default value of 0.001 was assigned to inorganics not listed in this document.

B - Dimensionless ratio of the permeability coefficient of a compound through the stratum corneum relative to its permeability

coefficient across the viable epidermis (dimensionless).

t* - Time to reach steady-state

Page 279: Appendix L HHRA Combined

TABLE 7.1.CTE Supplement B

Calculation of Daevent Wet Event

Recreational Scenario

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Water Permeability Lag Fraction Duration

of Potential Concentration Coefficient Time Absorbed Water of Event

Concern (CW) (Kp) B (τevent) t* (FA) (tevent) DAevent

(µg/L) (cm/hr) (dimensionless) (hr) (hr) (dimensionless) (hr) (mg/cm2-event) Eq

1,4-dichlorobenzene 5.9E-01 4.2E-02 2.0E-01 7.1E-01 1.7E+00 1.0E+00 1.3 6.6E-08 2

Benzene 8.4E-01 1.5E-02 5.1E-02 2.9E-01 7.0E-01 1.0E+00 1.3 2.3E-08 3

Chloroform 5.6E-01 6.8E-03 2.9E-02 5.0E-01 1.2E+00 1.0E+00 1.3 8.7E-09 3

Ethylbenzene 8.7E-01 4.9E-02 2.0E-01 4.2E-01 1.0E+00 1.0E+00 1.3 8.9E-08 3

Tetrachloroethylene(PCE) 2.4E+01 3.3E-02 1.7E-01 9.1E-01 2.2E+00 1.0E+00 1.3 2.4E-06 2

Benzo(a)anthracene 1.0E-01 4.7E-01 2.8E+00 2.0E+00 8.5E+00 1.0E+00 1.3 2.2E-07 2

Benzo(a)pyrene 2.1E-01 7.0E-01 4.3E+00 2.7E+00 1.2E+01 1.0E+00 1.3 7.4E-07 2

Benzo(b)fluoranthene 1.9E-01 7.0E-01 4.3E+00 2.8E+00 1.2E+01 1.0E+00 1.3 6.9E-07 2

Dibenz(a,h)anthracene 1.0E-01 1.5E+00 9.7E+00 3.9E+00 1.8E+01 6.0E-01 1.3 5.6E-07 2

Indeno(1,2,3-c,d)pyrene 5.0E-01 1.0E+00 6.7E+00 3.8E+00 1.7E+01 6.0E-01 1.3 1.8E-06 2

Naphthalene 3.6E-01 4.7E-02 2.0E-01 5.6E-01 1.3E+00 1.0E+00 1.3 4.0E-08 2

Arsenic 1.7E+01 1.0E-03 NA NA NA NA 1.3 2.2E-08 1

Chromium 8.5E+00 2.0E-03 NA NA NA NA 1.3 2.2E-08 1

Cobalt 3.9E+00 4.0E-04 NA NA NA NA 1.3 2.0E-09 1

Lead 1.5E+01 1.0E-04 NA NA NA NA 1.3 1.9E-09 1

Selenium 3.4E+01 1.0E-03 NA NA NA NA 1.3 4.4E-08 1

Inorganics: DAevent (mg/cm2-event) =

Kp x CW x tevent x 0.001 mg/µg x 0.001 l/cm3 (eq 1)

Organics: DAevent (mg/cm2-event) =

If tevent<t*, then DAevent =

2 x FA x Kp x CW x (sqrt((6 x τevent x tevent)/π)) x 0.001 mg/µg x 0.001 l/cm3 (eq 2)

If tevent>t*, then DAevent =

FA x Kp x CW x ( tevent/(1+B) + 2 x τevent x ((1 + 3xB + 3xB2)/(1+B)2) x 0.001 mg/µg x 0.001 l/cm3 (eq 3)

Notes:

NA - Not applicable

Permeability constants and other input parameter values from EPA 2004, Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E,

Supplemental Guidance for Dermal Risk Assessment - Final). EPA/540/R/99/005. The default value of 0.001 was assigned to inorganics not listed in this document.

B - Dimensionless ratio of the permeability coefficient of a compound through the stratum corneum relative to its permeability

coefficient across the viable epidermis (dimensionless).

t* - Time to reach steady-state

Page 280: Appendix L HHRA Combined

TABLE 7.2.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Ingestion

Acenaphthene 3.7E+02 mg/kg 2.5E-07 mg/kg-day NA NA 5.7E-06 mg/kg-day 6.0E-02 mg/kg-day 9.5E-05

Benzo(a)anthracene (12-15)* 1.3E+02 mg/kg 8.5E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.9E-07 2.0E-06 mg/kg-day NA NA

Benzo(a)pyrene (12-15)* 1.1E+02 mg/kg 7.2E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.6E-06 1.7E-06 mg/kg-day NA NA

Benzo(b)fluoranthene (12-15)* 1.1E+02 mg/kg 7.6E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.7E-07 1.8E-06 mg/kg-day NA NA

Benzo(k)fluoranthene (12-15)* 6.5E+01 mg/kg 4.3E-08 mg/kg-day 2.2E-01 1/(mg/kg-day) 9.5E-09 1.0E-06 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 2.2E-08 mg/kg-day 1.4E-02 1/(mg/kg-day) 3.1E-10 5.2E-07 mg/kg-day 2.0E-02 mg/kg-day 2.6E-05

Chrysene (12-15)* 2.5E+02 mg/kg 1.7E-07 mg/kg-day 2.2E-02 1/(mg/kg-day) 3.7E-09 4.0E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (12-15)* 6.2E+00 mg/kg 4.1E-09 mg/kg-day 2.2E+01 1/(mg/kg-day) 9.1E-08 9.7E-08 mg/kg-day NA NA

Fluoranthene 5.0E+02 mg/kg 3.3E-07 mg/kg-day NA NA 7.7E-06 mg/kg-day 4.0E-02 mg/kg-day 1.9E-04

Indeno(1,2,3-c,d)pyrene (12-15)* 4.9E+01 mg/kg 3.3E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 7.2E-08 7.6E-07 mg/kg-day NA NA

Naphthalene 3.4E+00 mg/kg 2.3E-09 mg/kg-day NA NA 5.3E-08 mg/kg-day 2.0E-02 mg/kg-day 2.7E-06

Pyrene 5.3E+02 mg/kg 3.5E-07 mg/kg-day NA NA 8.3E-06 mg/kg-day 3.0E-02 mg/kg-day 2.8E-04

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 2.7E-14 mg/kg-day 1.6E+05 1/(mg/kg-day) 4.2E-09 6.3E-13 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 3.5E-09 mg/kg-day 1.0E+00 1/(mg/kg-day) 3.5E-09 8.2E-08 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 3.6E-09 mg/kg-day NA NA 8.4E-08 mg/kg-day 2.0E-05 mg/kg-day 4.2E-03

Aluminum 1.6E+04 mg/kg 1.1E-05 mg/kg-day NA NA 2.5E-04 mg/kg-day 1.0E+00 mg/kg-day 2.5E-04

Arsenic 1.8E+01 mg/kg 1.2E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.8E-08 2.8E-07 mg/kg-day 3.0E-04 mg/kg-day 9.4E-04

Cadmium 9.6E+00 mg/kg 6.4E-09 mg/kg-day NA NA 1.5E-07 mg/kg-day 1.0E-03 mg/kg-day 1.5E-04

Chromium (12-15)* 9.4E+01 mg/kg 6.3E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 9.4E-08 1.5E-06 mg/kg-day 3.0E-03 mg/kg-day 4.9E-04

Cobalt 1.3E+01 mg/kg 8.6E-09 mg/kg-day NA NA 2.0E-07 mg/kg-day 3.0E-04 mg/kg-day 6.7E-04

Copper 3.5E+02 mg/kg 2.4E-07 mg/kg-day NA NA 5.5E-06 mg/kg-day 4.0E-02 mg/kg-day 1.4E-04

Iron 4.0E+04 mg/kg 2.7E-05 mg/kg-day NA NA 6.2E-04 mg/kg-day 7.0E-01 mg/kg-day 8.9E-04

Lead 1.9E+03 mg/kg 1.3E-06 mg/kg-day NA NA 2.9E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 2.1E-07 mg/kg-day NA NA 4.9E-06 mg/kg-day 1.4E-01 mg/kg-day 3.5E-05

Vanadium 5.0E+01 mg/kg 3.4E-08 mg/kg-day NA NA 7.8E-07 mg/kg-day 5.0E-03 mg/kg-day 1.6E-04

Exp. Route Total 2.2E-06 8.5E-03

Page 281: Appendix L HHRA Combined

TABLE 7.2.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Dermal

Acenaphthene 3.7E+02 mg/kg 2.7E-06 mg/kg-day NA NA 6.2E-05 mg/kg-day 6.0E-02 mg/kg-day 1.0E-03

Benzo(a)anthracene (12-15)* 1.3E+02 mg/kg 9.3E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.0E-06 2.2E-05 mg/kg-day NA NA

Benzo(a)pyrene (12-15)* 1.1E+02 mg/kg 7.8E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.7E-05 1.8E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (12-15)* 1.1E+02 mg/kg 8.2E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.8E-06 1.9E-05 mg/kg-day NA NA

Benzo(k)fluoranthene (12-15)* 6.5E+01 mg/kg 4.7E-07 mg/kg-day 2.2E-01 1/(mg/kg-day) 1.0E-07 1.1E-05 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 1.9E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.6E-09 4.4E-06 mg/kg-day 2.0E-02 mg/kg-day 2.2E-04

Chrysene (12-15)* 2.5E+02 mg/kg 1.8E-06 mg/kg-day 2.2E-02 1/(mg/kg-day) 4.0E-08 4.3E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene (12-15)* 6.2E+00 mg/kg 4.5E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 9.9E-07 1.1E-06 mg/kg-day NA NA

Fluoranthene 5.0E+02 mg/kg 3.6E-06 mg/kg-day NA NA 8.4E-05 mg/kg-day 4.0E-02 mg/kg-day 2.1E-03

Indeno(1,2,3-c,d)pyrene (12-15)* 4.9E+01 mg/kg 3.6E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 7.8E-07 8.3E-06 mg/kg-day NA NA

Naphthalene 3.4E+00 mg/kg 2.5E-08 mg/kg-day NA NA 5.8E-07 mg/kg-day 2.0E-02 mg/kg-day 2.9E-05

Pyrene 5.3E+02 mg/kg 3.9E-06 mg/kg-day NA NA 9.0E-05 mg/kg-day 3.0E-02 mg/kg-day 3.0E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 3.2E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 4.9E-08 7.4E-12 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 4.1E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 4.1E-08 9.6E-07 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 4.2E-08 mg/kg-day NA NA 9.9E-07 mg/kg-day 2.0E-05 mg/kg-day 4.9E-02

Aluminum 1.6E+04 mg/kg 8.9E-06 mg/kg-day NA NA 2.1E-04 mg/kg-day 1.0E+00 mg/kg-day 2.1E-04

Arsenic 1.8E+01 mg/kg 3.0E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.5E-08 7.1E-07 mg/kg-day 3.0E-04 mg/kg-day 2.4E-03

Cadmium 9.6E+00 mg/kg 5.4E-10 mg/kg-day NA NA 1.3E-08 mg/kg-day 2.5E-05 mg/kg-day 5.0E-04

Chromium (12-15)* 9.4E+01 mg/kg 5.2E-08 mg/kg-day 6.0E+01 1/(mg/kg-day) 3.1E-06 1.2E-06 mg/kg-day 7.5E-05 mg/kg-day 1.6E-02

Cobalt 1.3E+01 mg/kg 7.2E-09 mg/kg-day NA NA 1.7E-07 mg/kg-day 3.0E-04 mg/kg-day 5.6E-04

Copper 3.5E+02 mg/kg 2.0E-07 mg/kg-day NA NA 4.6E-06 mg/kg-day 4.0E-02 mg/kg-day 1.2E-04

Iron 4.0E+04 mg/kg 2.2E-05 mg/kg-day NA NA 5.2E-04 mg/kg-day 7.0E-01 mg/kg-day 7.5E-04

Lead 1.9E+03 mg/kg 1.0E-06 mg/kg-day NA NA 2.4E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 1.8E-07 mg/kg-day NA NA 4.1E-06 mg/kg-day 9.6E-04 mg/kg-day 4.3E-03

Vanadium 5.0E+01 mg/kg 2.8E-08 mg/kg-day NA NA 6.6E-07 mg/kg-day 5.0E-03 mg/kg-day 1.3E-04

Exp. Route Total 2.6E-05 8.1E-02

Exposure Point Total 2.8E-05 8.9E-02

2.8E-05 8.9E-02

Exposed Surface Sediment Total 2.8E-05 8.9E-02

Exposure Medium Total

Page 282: Appendix L HHRA Combined

TABLE 7.2.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Dry event) Benzene 2.2E+00 ug/L 1.9E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.1E-10 4.5E-08 mg/kg-day 4.0E-03 mg/kg-day 1.1E-05

Benzo(a)anthracene (12-15)* 2.7E-01 ug/L 2.3E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.1E-10 5.4E-09 mg/kg-day NA NA

Benzo(a)pyrene (12-15)* 6.6E-01 ug/L 5.7E-10 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.3E-08 1.3E-08 mg/kg-day NA NA

Benzo(b)fluoranthene (12-15)* 3.0E-01 ug/L 2.6E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.7E-10 6.1E-09 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 2.1E-09 mg/kg-day 1.4E-02 1/(mg/kg-day) 3.0E-11 5.0E-08 mg/kg-day 2.0E-02 mg/kg-day 2.5E-06

Indeno(1,2,3-c,d)pyrene (12-15)* 1.3E-01 ug/L 1.1E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.5E-10 2.7E-09 mg/kg-day NA NA

Arsenic 2.0E+01 ug/L 1.7E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.6E-08 4.0E-07 mg/kg-day 3.0E-04 mg/kg-day 1.3E-03

Chromium (12-15)* 1.9E+01 ug/L 1.6E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.5E-08 3.8E-07 mg/kg-day 3.0E-03 mg/kg-day 1.3E-04

Copper 1.7E+02 ug/L 1.5E-07 mg/kg-day NA 3.5E-06 mg/kg-day 4.0E-02 mg/kg-day 8.7E-05

Selenium 4.1E+01 ug/L 3.6E-08 mg/kg-day NA 8.3E-07 mg/kg-day 5.0E-03 mg/kg-day 1.7E-04

Exp. Route Total 6.5E-08 1.7E-03

Dermal

Benzene 2.2E+00 ug/L 2.6E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.4E-09 6.1E-07 mg/kg-day 4.0E-03 mg/kg-day 1.5E-04

Benzo(a)anthracene (12-15)* 2.7E-01 ug/L 2.4E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.2E-07 5.5E-06 mg/kg-day NA NA

Benzo(a)pyrene (12-15)* 6.6E-01 ug/L 1.0E-06 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.2E-05 2.4E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (12-15)* 3.0E-01 ug/L 4.6E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.0E-06 1.1E-05 mg/kg-day NA NA

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 2.7E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 3.7E-09 6.2E-06 mg/kg-day 2.0E-02 mg/kg-day 3.1E-04

Indeno(1,2,3-c,d)pyrene (12-15)* 1.3E-01 ug/L 2.0E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 4.5E-07 4.8E-06 mg/kg-day NA NA

Arsenic 2.0E+01 ug/L 1.1E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.6E-08 2.5E-07 mg/kg-day 3.0E-04 mg/kg-day 8.5E-04

Chromium (12-15)* 1.9E+01 ug/L 2.1E-08 mg/kg-day 6.0E+01 1/(mg/kg-day) 1.2E-06 4.8E-07 mg/kg-day 7.5E-05 mg/kg-day 6.5E-03

Copper 1.7E+02 ug/L 9.4E-08 mg/kg-day NA NA 2.2E-06 mg/kg-day 4.0E-02 mg/kg-day 5.5E-05

Selenium 4.1E+01 ug/L 2.2E-08 mg/kg-day NA NA 5.2E-07 mg/kg-day 5.0E-03 mg/kg-day 1.0E-04

Exp. Route Total 2.5E-05 7.9E-03

Exposure Point Total 2.5E-05 9.7E-03

2.5E-05 9.7E-03

Surface Water Total - Dry Event 2.5E-05 9.7E-03

Exposure Medium Total

Page 283: Appendix L HHRA Combined

TABLE 7.2.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 5.1E-10 mg/kg-day 5.4E-03 1/(mg/kg-day) 2.8E-12 1.2E-08 mg/kg-day 7.0E-02 mg/kg-day 1.7E-07

Benzene 8.4E-01 ug/L 7.3E-10 mg/kg-day 5.5E-02 1/(mg/kg-day) 4.0E-11 1.7E-08 mg/kg-day 4.0E-03 mg/kg-day 4.2E-06

Chloroform 5.6E-01 ug/L 4.9E-10 mg/kg-day 3.1E-02 1/(mg/kg-day) 1.5E-11 1.1E-08 mg/kg-day 1.0E-02 mg/kg-day 1.1E-06

Ethylbenzene 8.7E-01 ug/L 7.6E-10 mg/kg-day 1.1E-02 1/(mg/kg-day) 8.3E-12 1.8E-08 mg/kg-day 1.0E-01 mg/kg-day 1.8E-07

Tetrachloroethylene(PCE) 2.4E+01 ug/L 2.1E-08 mg/kg-day 5.4E-01 1/(mg/kg-day) 1.1E-08 5.0E-07 mg/kg-day 1.0E-02 mg/kg-day 5.0E-05

Benzo(a)anthracene (12-15)* 1.0E-01 ug/L 9.1E-11 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.0E-10 2.1E-09 mg/kg-day NA NA

Benzo(a)pyrene (12-15)* 2.1E-01 ug/L 1.8E-10 mg/kg-day 2.2E+01 1/(mg/kg-day) 3.9E-09 4.2E-09 mg/kg-day NA NA

Benzo(b)fluoranthene (12-15)* 1.9E-01 ug/L 1.6E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.6E-10 3.8E-09 mg/kg-day NA NA

Dibenz(a,h)anthracene (12-15)* 1.0E-01 ug/L 8.8E-11 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.9E-09 2.1E-09 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (12-15)* 5.0E-01 ug/L 4.4E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 9.5E-10 1.0E-08 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 3.2E-10 mg/kg-day NA NA 7.4E-09 mg/kg-day 2.0E-02 mg/kg-day 3.7E-07

Arsenic 1.7E+01 ug/L 1.4E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.2E-08 3.4E-07 mg/kg-day 3.0E-04 mg/kg-day 1.1E-03

Chromium (12-15)* 8.5E+00 ug/L 7.4E-09 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.1E-08 1.7E-07 mg/kg-day 3.0E-03 mg/kg-day 5.8E-05

Cobalt 3.9E+00 ug/L 3.4E-09 mg/kg-day NA NA 7.9E-08 mg/kg-day 3.0E-04 mg/kg-day 2.6E-04

Lead 1.5E+01 ug/L 1.3E-08 mg/kg-day NA NA 3.0E-07 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 2.9E-08 mg/kg-day NA NA 6.8E-07 mg/kg-day 5.0E-03 mg/kg-day 1.4E-04

Exp. Route Total 5.2E-08 1.6E-03

Page 284: Appendix L HHRA Combined

TABLE 7.2.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Dermal

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 2.8E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.5E-10 6.5E-07 mg/kg-day 7.0E-02 mg/kg-day 9.3E-06

Benzene 8.4E-01 ug/L 9.8E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 5.4E-10 2.3E-07 mg/kg-day 4.0E-03 mg/kg-day 5.7E-05

Chloroform 5.6E-01 ug/L 3.7E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 1.1E-10 8.6E-08 mg/kg-day 1.0E-02 mg/kg-day 8.6E-06

Ethylbenzene 8.7E-01 ug/L 3.7E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 4.1E-10 8.7E-07 mg/kg-day 1.0E-01 mg/kg-day 8.7E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 1.0E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 5.5E-07 2.4E-05 mg/kg-day 1.0E-02 mg/kg-day 2.4E-03

Benzo(a)anthracene (12-15)* 1.0E-01 ug/L 9.3E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.0E-07 2.2E-06 mg/kg-day NA NA

Benzo(a)pyrene (12-15)* 2.1E-01 ug/L 3.1E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 6.9E-06 7.3E-06 mg/kg-day NA NA

Benzo(b)fluoranthene (12-15)* 1.9E-01 ug/L 2.9E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.4E-07 6.8E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (12-15)* 1.0E-01 ug/L 2.4E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 5.2E-06 5.6E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (12-15)* 5.0E-01 ug/L 7.8E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.7E-06 1.8E-05 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L 1.7E-08 mg/kg-day NA NA 4.0E-07 mg/kg-day 2.0E-02 mg/kg-day 2.0E-05

Arsenic 1.7E+01 ug/L 9.1E-09 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.4E-08 2.1E-07 mg/kg-day 3.0E-04 mg/kg-day 7.1E-04

Chromium (12-15)* 8.5E+00 ug/L 9.4E-09 mg/kg-day 6.0E+01 1/(mg/kg-day) 5.6E-07 2.2E-07 mg/kg-day 7.5E-05 mg/kg-day 2.9E-03

Cobalt 3.9E+00 ug/L 8.6E-10 mg/kg-day NA NA 2.0E-08 mg/kg-day 3.0E-04 mg/kg-day 6.7E-05

Lead 1.5E+01 ug/L 8.2E-10 mg/kg-day NA NA 1.9E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 1.8E-08 mg/kg-day NA NA 4.3E-07 mg/kg-day 5.0E-03 mg/kg-day 8.6E-05

Exp. Route Total 1.6E-05 6.3E-03

Exposure Point Total 1.6E-05 7.9E-03

1.6E-05 7.9E-03

Surface Water Total - Wet Event 1.6E-05 7.9E-03

Total Total of Receptor Risks Across All Media 5.4E-05 Total of Receptor Hazards Across All Media 9.9E-02

Notes-

NA = Not available / Not applicable.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used to adjust CSF for 12-15 year old for exposure duration of 3 years, the CTE exposure duration for an adolescent.

DAevent for surface water from dry event calculated on Table 7.1.CTE Supplement A.

DAevent for surface water from wet event calculated on Table 7.1.CTE Supplement B.

Total includes sum of exposed and near shore sediment, and maximum of dry event and wet event surface water

Exposure Medium Total

Page 285: Appendix L HHRA Combined

TABLE 7.3.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Ingestion

Acenaphthene 3.7E+02 mg/kg 1.9E-06 mg/kg-day NA NA 4.3E-05 mg/kg-day 6.0E-02 mg/kg-day 7.2E-04

Benzo(a)anthracene (0-2)* 1.3E+02 mg/kg 4.3E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.1E-06 1.5E-05 mg/kg-day NA NA

Benzo(a)anthracene (2-3)* 1.3E+02 mg/kg 2.2E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 4.7E-07

Benzo(a)pyrene (0-2)* 1.1E+02 mg/kg 3.6E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 2.6E-05 1.3E-05 mg/kg-day NA NA

Benzo(a)pyrene (2-3)* 1.1E+02 mg/kg 1.8E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.0E-06

Benzo(b)fluoranthene (0-2)* 1.1E+02 mg/kg 3.8E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.8E-06 1.3E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-3)* 1.1E+02 mg/kg 1.9E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 4.2E-07

Benzo(k)fluoranthene (0-2)* 6.5E+01 mg/kg 2.2E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 1.6E-07 7.7E-06 mg/kg-day NA NA

Benzo(k)fluoranthene (2-3)* 6.5E+01 mg/kg 1.1E-07 mg/kg-day 2.2E-01 1/(mg/kg-day) 2.4E-08

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 1.7E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.4E-09 4.0E-06 mg/kg-day 2.0E-02 mg/kg-day 2.0E-04

Chrysene (0-2)* 2.5E+02 mg/kg 8.6E-07 mg/kg-day 7.3E-02 1/(mg/kg-day) 6.3E-08 3.0E-05 mg/kg-day NA NA

Chrysene (2-3)* 2.5E+02 mg/kg 4.3E-07 mg/kg-day 2.2E-02 1/(mg/kg-day) 9.4E-09

Dibenz(a,h)anthracene (0-2)* 6.2E+00 mg/kg 2.1E-08 mg/kg-day 7.3E+01 1/(mg/kg-day) 1.5E-06 7.3E-07 mg/kg-day NA NA

Dibenz(a,h)anthracene (0-2)* 6.2E+00 mg/kg 1.0E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.3E-07

Fluoranthene 5.0E+02 mg/kg 2.5E-06 mg/kg-day NA NA 5.9E-05 mg/kg-day 4.0E-02 mg/kg-day 1.5E-03

Indeno(1,2,3-c,d)pyrene (0-2)* 4.9E+01 mg/kg 1.7E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.2E-06 5.8E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-3)* 4.9E+01 mg/kg 8.3E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.8E-07

Naphthalene 3.4E+00 mg/kg 1.7E-08 mg/kg-day NA NA 4.0E-07 mg/kg-day 2.0E-02 mg/kg-day 2.0E-05

Pyrene 5.3E+02 mg/kg 2.7E-06 mg/kg-day NA NA 6.3E-05 mg/kg-day 3.0E-02 mg/kg-day 2.1E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 2.0E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 3.2E-08 4.8E-12 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 2.7E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 2.7E-08 6.2E-07 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 2.7E-08 mg/kg-day NA NA 6.4E-07 mg/kg-day 2.0E-05 mg/kg-day 3.2E-02

Aluminum 1.6E+04 mg/kg 8.1E-05 mg/kg-day NA NA 1.9E-03 mg/kg-day 1.0E+00 mg/kg-day 1.9E-03

Arsenic 1.8E+01 mg/kg 9.2E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.4E-07 2.1E-06 mg/kg-day 3.0E-04 mg/kg-day 7.1E-03

Cadmium 9.6E+00 mg/kg 4.9E-08 mg/kg-day NA NA 1.1E-06 mg/kg-day 1.0E-03 mg/kg-day 1.1E-03

Chromium (0-2)* 9.4E+01 mg/kg 3.2E-07 mg/kg-day 5.0E+00 1/(mg/kg-day) 1.6E-06 1.1E-05 mg/kg-day 3.0E-03 mg/kg-day 3.7E-03

Chromium (2-3)* 9.4E+01 mg/kg 1.6E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.4E-07

Cobalt 1.3E+01 mg/kg 6.6E-08 mg/kg-day NA NA 1.5E-06 mg/kg-day 3.0E-04 mg/kg-day 5.1E-03

Copper 3.5E+02 mg/kg 1.8E-06 mg/kg-day NA NA 4.2E-05 mg/kg-day 4.0E-02 mg/kg-day 1.0E-03

Iron 4.0E+04 mg/kg 2.0E-04 mg/kg-day NA NA 4.7E-03 mg/kg-day 7.0E-01 mg/kg-day 6.8E-03

Lead 1.9E+03 mg/kg 9.5E-06 mg/kg-day NA NA 2.2E-04 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 1.6E-06 mg/kg-day NA NA 3.7E-05 mg/kg-day 1.4E-01 mg/kg-day 2.7E-04

Vanadium 5.0E+01 mg/kg 2.5E-07 mg/kg-day NA NA 5.9E-06 mg/kg-day 5.0E-03 mg/kg-day 1.2E-03

Exp. Route Total 4.3E-05 6.5E-02

Page 286: Appendix L HHRA Combined

TABLE 7.3.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Sediment Surface SedimentExposed and near shore sediment in Gowanus Canal

Dermal

Acenaphthene 3.7E+02 mg/kg 2.7E-06 mg/kg-day NA NA 6.3E-05 mg/kg-day 6.0E-02 mg/kg-day 1.1E-03

Benzo(a)anthracene (0-2)* 1.3E+02 mg/kg 6.3E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.6E-06 2.2E-05 mg/kg-day NA NA

Benzo(a)anthracene (2-3)* 1.3E+02 mg/kg 3.1E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.9E-07

Benzo(a)pyrene (0-2)* 1.1E+02 mg/kg 5.3E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 3.9E-05 1.8E-05 mg/kg-day NA NA

Benzo(a)pyrene (2-3)* 1.1E+02 mg/kg 2.6E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 5.8E-06

Benzo(b)fluoranthene (0-2)* 1.1E+02 mg/kg 5.6E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.1E-06 2.0E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-3)* 1.1E+02 mg/kg 2.8E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.1E-07

Benzo(k)fluoranthene (0-2)* 6.5E+01 mg/kg 3.2E-07 mg/kg-day 7.3E-01 1/(mg/kg-day) 2.3E-07 1.1E-05 mg/kg-day NA NA

Benzo(k)fluoranthene (2-3)* 6.5E+01 mg/kg 1.6E-07 mg/kg-day 2.2E-01 1/(mg/kg-day) 3.5E-08

Bis(2-ethylhexyl) phthalate 3.3E+01 mg/kg 1.9E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 2.7E-09 4.4E-06 mg/kg-day 2.0E-02 mg/kg-day 2.2E-04

Chrysene (0-2)* 2.5E+02 mg/kg 1.2E-06 mg/kg-day 7.3E-02 1/(mg/kg-day) 9.1E-08 4.4E-05 mg/kg-day NA NA

Chrysene (2-3)* 2.5E+02 mg/kg 6.2E-07 mg/kg-day 2.2E-02 1/(mg/kg-day) 1.4E-08

Dibenz(a,h)anthracene (0-2)* 6.2E+00 mg/kg 3.1E-08 mg/kg-day 7.3E+01 1/(mg/kg-day) 2.2E-06 1.1E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (0-2)* 6.2E+00 mg/kg 1.5E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 3.3E-07

Fluoranthene 5.0E+02 mg/kg 3.7E-06 mg/kg-day NA NA 8.6E-05 mg/kg-day 4.0E-02 mg/kg-day 2.1E-03

Indeno(1,2,3-c,d)pyrene (0-2)* 4.9E+01 mg/kg 2.4E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.8E-06 8.5E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-3)* 4.9E+01 mg/kg 1.2E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.6E-07

Naphthalene 3.4E+00 mg/kg 2.5E-08 mg/kg-day NA NA 5.9E-07 mg/kg-day 2.0E-02 mg/kg-day 2.9E-05

Pyrene 5.3E+02 mg/kg 3.9E-06 mg/kg-day NA NA 9.1E-05 mg/kg-day 3.0E-02 mg/kg-day 3.0E-03

Dioxin-Like PCB TEQ 4.0E-05 mg/kg 3.2E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 5.0E-08 7.5E-12 mg/kg-day NA NA

Nondioxin-Like PCB 5.2E+00 mg/kg 4.2E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 4.2E-08 9.7E-07 mg/kg-day NA NA

Total PCB 5.4E+00 mg/kg 4.3E-08 mg/kg-day NA NA 1.0E-06 mg/kg-day 2.0E-05 mg/kg-day 5.0E-02

Aluminum 1.6E+04 mg/kg 9.1E-06 mg/kg-day NA NA 2.1E-04 mg/kg-day 1.0E+00 mg/kg-day 2.1E-04

Arsenic 1.8E+01 mg/kg 3.1E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.6E-08 7.2E-07 mg/kg-day 3.0E-04 mg/kg-day 2.4E-03

Cadmium 9.6E+00 mg/kg 5.5E-10 mg/kg-day NA NA 1.3E-08 mg/kg-day 2.5E-05 mg/kg-day 5.1E-04

Chromium (0-2)* 9.4E+01 mg/kg 3.6E-08 mg/kg-day 2.0E+02 1/(mg/kg-day) 7.1E-06 1.2E-06 mg/kg-day 7.5E-05 mg/kg-day 1.7E-02

Chromium (2-3)* 9.4E+01 mg/kg 1.8E-08 mg/kg-day 6.0E+01 1/(mg/kg-day) 1.1E-06

Cobalt 1.3E+01 mg/kg 7.4E-09 mg/kg-day NA NA 1.7E-07 mg/kg-day 3.0E-04 mg/kg-day 5.7E-04

Copper 3.5E+02 mg/kg 2.0E-07 mg/kg-day NA NA 4.7E-06 mg/kg-day 4.0E-02 mg/kg-day 1.2E-04

Iron 4.0E+04 mg/kg 2.3E-05 mg/kg-day NA NA 5.3E-04 mg/kg-day 7.0E-01 mg/kg-day 7.6E-04

Lead 1.9E+03 mg/kg 1.1E-06 mg/kg-day NA NA 2.5E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg 1.8E-07 mg/kg-day NA NA 4.2E-06 mg/kg-day 9.6E-04 mg/kg-day 4.3E-03

Vanadium 5.0E+01 mg/kg 2.9E-08 mg/kg-day NA NA 6.7E-07 mg/kg-day 5.0E-03 mg/kg-day 1.3E-04

Exp. Route Total 6.8E-05 8.2E-02

Exposure Point Total 1.1E-04 1.5E-01

1.1E-04 1.5E-01Exposure Medium Total

Page 287: Appendix L HHRA Combined

TABLE 7.3.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Exposed Surface Sediment Total 1.1E-04 1.5E-01

Page 288: Appendix L HHRA Combined

TABLE 7.3.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Dry event) Benzene 2.2E+00 ug/L 7.4E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 4.1E-10 1.7E-07 mg/kg-day 4.0E-03 mg/kg-day 4.3E-05

Benzo(a)anthracene (0-2)* 2.7E-01 ug/L 5.9E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.3E-09 2.1E-08 mg/kg-day NA NA

Benzo(a)anthracene (2-3)* 2.7E-01 ug/L 2.9E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 6.4E-10

Benzo(a)pyrene (0-2)* 6.6E-01 ug/L 1.5E-09 mg/kg-day 7.3E+01 1/(mg/kg-day) 1.1E-07 5.1E-08 mg/kg-day NA NA

Benzo(a)pyrene (2-3)* 6.6E-01 ug/L 7.3E-10 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.6E-08

Benzo(b)fluoranthene (0-2)* 3.0E-01 ug/L 6.6E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.8E-09 2.3E-08 mg/kg-day NA NA

Benzo(b)fluoranthene (2-3)* 3.0E-01 ug/L 3.3E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 7.2E-10

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 8.1E-09 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.1E-10 1.9E-07 mg/kg-day 2.0E-02 mg/kg-day 9.5E-06

Indeno(1,2,3-c,d)pyrene (0-2)* 1.3E-01 ug/L 2.9E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.1E-09 1.0E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-3)* 1.3E-01 ug/L 1.5E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.2E-10

Arsenic 2.0E+01 ug/L 6.6E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 9.9E-08 1.5E-06 mg/kg-day 3.0E-04 mg/kg-day 5.1E-03

Chromium (0-2)* 1.9E+01 ug/L 4.2E-08 mg/kg-day 5.0E+00 1/(mg/kg-day) 2.1E-07 1.5E-06 mg/kg-day 3.0E-03 mg/kg-day 4.9E-04

Chromium (2-3)* 1.9E+01 ug/L 2.1E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 3.1E-08

Copper 1.7E+02 ug/L 5.7E-07 mg/kg-day NA 1.3E-05 mg/kg-day 4.0E-02 mg/kg-day 3.3E-04

Selenium 4.1E+01 ug/L 1.4E-07 mg/kg-day NA 3.2E-06 mg/kg-day 5.0E-03 mg/kg-day 6.3E-04

Exp. Route Total 4.7E-07 6.6E-03

Dermal

Benzene 2.2E+00 ug/L 4.2E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 2.3E-09 9.7E-07 mg/kg-day 4.0E-03 mg/kg-day 2.4E-04

Benzo(a)anthracene (0-2)* 2.7E-01 ug/L 2.5E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.8E-06 8.8E-06 mg/kg-day NA NA

Benzo(a)anthracene (2-3)* 2.7E-01 ug/L 1.3E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.8E-07

Benzo(a)pyrene (0-2)* 6.6E-01 ug/L 1.1E-06 mg/kg-day 7.3E+01 1/(mg/kg-day) 7.8E-05 3.7E-05 mg/kg-day NA NA

Benzo(a)pyrene (2-3)* 6.6E-01 ug/L 5.3E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.2E-05

Benzo(b)fluoranthene (0-2)* 3.0E-01 ug/L 4.9E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.6E-06 1.7E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-3)* 3.0E-01 ug/L 2.5E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 5.4E-07

Bis(2-ethylhexyl) phthalate 2.5E+00 ug/L 4.2E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 5.9E-09 9.9E-06 mg/kg-day 2.0E-02 mg/kg-day 4.9E-04

Indeno(1,2,3-c,d)pyrene (0-2)* 1.3E-01 ug/L 2.2E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.6E-06 7.6E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-3)* 1.3E-01 ug/L 1.1E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.4E-07

Arsenic 2.0E+01 ug/L 1.7E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.6E-08 4.1E-07 mg/kg-day 3.0E-04 mg/kg-day 1.4E-03

Chromium (0-2)* 1.9E+01 ug/L 2.2E-08 mg/kg-day 2.0E+02 1/(mg/kg-day) 4.4E-06 7.7E-07 mg/kg-day 7.5E-05 mg/kg-day 1.0E-02

Chromium (2-3)* 1.9E+01 ug/L 1.1E-08 mg/kg-day 6.0E+01 1/(mg/kg-day) 6.6E-07

Copper 1.7E+02 ug/L 1.5E-07 mg/kg-day NA NA 3.5E-06 mg/kg-day 4.0E-02 mg/kg-day 8.8E-05

Selenium 4.1E+01 ug/L 3.6E-08 mg/kg-day NA NA 8.4E-07 mg/kg-day 5.0E-03 mg/kg-day 1.7E-04

Exp. Route Total 1.0E-04 1.3E-02

Exposure Point Total 1.0E-04 1.9E-02

1.0E-04 1.9E-02

Surface Water Total - Dry Event 1.0E-04 1.9E-02

Exposure Medium Total

Page 289: Appendix L HHRA Combined

TABLE 7.3.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Ingestion

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 2.0E-09 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.1E-11 4.6E-08 mg/kg-day 7.0E-02 mg/kg-day 6.5E-07

Benzene 8.4E-01 ug/L 2.8E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.5E-10 6.4E-08 mg/kg-day 4.0E-03 mg/kg-day 1.6E-05

Chloroform 5.6E-01 ug/L 1.8E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 5.7E-11 4.3E-08 mg/kg-day 1.0E-02 mg/kg-day 4.3E-06

Ethylbenzene 8.7E-01 ug/L 2.9E-09 mg/kg-day 1.1E-02 1/(mg/kg-day) 3.2E-11 6.7E-08 mg/kg-day 1.0E-01 mg/kg-day 6.7E-07

Tetrachloroethylene(PCE) 2.4E+01 ug/L 8.1E-08 mg/kg-day 5.4E-01 1/(mg/kg-day) 4.4E-08 1.9E-06 mg/kg-day 1.0E-02 mg/kg-day 1.9E-04

Benzo(a)anthracene (0-2)* 1.0E-01 ug/L 2.3E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 1.7E-09 8.0E-09 mg/kg-day NA NA

Benzo(a)anthracene (2-3)* 1.0E-01 ug/L 1.1E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.5E-10

Benzo(a)pyrene (0-2)* 2.1E-01 ug/L 4.5E-10 mg/kg-day 7.3E+01 1/(mg/kg-day) 3.3E-08 1.6E-08 mg/kg-day NA NA

Benzo(a)pyrene (2-3)* 2.1E-01 ug/L 2.3E-10 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.9E-09

Benzo(b)fluoranthene (0-2)* 1.9E-01 ug/L 4.2E-10 mg/kg-day 7.3E+00 1/(mg/kg-day) 3.0E-09 1.5E-08 mg/kg-day NA NA

Benzo(b)fluoranthene (2-3)* 1.9E-01 ug/L 2.1E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 4.6E-10

Dibenz(a,h)anthracene (0-2)* 1.0E-01 ug/L 2.2E-10 mg/kg-day 7.3E+01 1/(mg/kg-day) 1.6E-08 7.8E-09 mg/kg-day NA NA

Dibenz(a,h)anthracene (0-2)* 1.0E-01 ug/L 1.1E-10 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.4E-09

Indeno(1,2,3-c,d)pyrene (0-2)* 5.0E-01 ug/L 1.1E-09 mg/kg-day 7.3E+00 1/(mg/kg-day) 8.0E-09 3.9E-08 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-3)* 5.0E-01 ug/L 5.5E-10 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.2E-09

Naphthalene 3.6E-01 ug/L 1.2E-09 mg/kg-day NA NA 2.8E-08 mg/kg-day 2.0E-02 mg/kg-day 1.4E-06

Arsenic 1.7E+01 ug/L 5.5E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 8.2E-08 1.3E-06 mg/kg-day 3.0E-04 mg/kg-day 4.3E-03

Chromium (0-2)* 8.5E+00 ug/L 1.9E-08 mg/kg-day 5.0E+00 1/(mg/kg-day) 9.4E-08 6.6E-07 mg/kg-day 3.0E-03 mg/kg-day 2.2E-04

Chromium (2-3)* 8.5E+00 ug/L 9.4E-09 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.4E-08

Cobalt 3.9E+00 ug/L 1.3E-08 mg/kg-day NA NA 3.0E-07 mg/kg-day 3.0E-04 mg/kg-day 1.0E-03

Lead 1.5E+01 ug/L 4.9E-08 mg/kg-day NA NA 1.1E-06 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 1.1E-07 mg/kg-day NA NA 2.6E-06 mg/kg-day 5.0E-03 mg/kg-day 5.2E-04

Exp. Route Total 3.1E-07 6.2E-03

Page 290: Appendix L HHRA Combined

TABLE 7.3.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water Surface Water Gowanus Canal Dermal

(Wet event) 1,4-dichlorobenzene 5.9E-01 ug/L 4.4E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 2.4E-10 1.0E-06 mg/kg-day 7.0E-02 mg/kg-day 1.5E-05

Benzene 8.4E-01 ug/L 1.6E-08 mg/kg-day 5.5E-02 1/(mg/kg-day) 8.5E-10 3.6E-07 mg/kg-day 4.0E-03 mg/kg-day 9.1E-05

Chloroform 5.6E-01 ug/L 5.9E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 1.8E-10 1.4E-07 mg/kg-day 1.0E-02 mg/kg-day 1.4E-05

Ethylbenzene 8.7E-01 ug/L 6.0E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 6.6E-10 1.4E-06 mg/kg-day 1.0E-01 mg/kg-day 1.4E-05

Tetrachloroethylene(PCE) 2.4E+01 ug/L 1.6E-06 mg/kg-day 5.4E-01 1/(mg/kg-day) 8.8E-07 3.8E-05 mg/kg-day 1.0E-02 mg/kg-day 3.8E-03

Benzo(a)anthracene (0-2)* 1.0E-01 ug/L 9.8E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 7.2E-07 3.4E-06 mg/kg-day NA NA

Benzo(a)anthracene (2-3)* 1.0E-01 ug/L 1.7E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 3.6E-07

Benzo(a)pyrene (0-2)* 2.1E-01 ug/L 3.3E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 2.4E-05 1.2E-05 mg/kg-day NA NA

Benzo(a)pyrene (2-3)* 2.1E-01 ug/L 1.6E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 3.4E-06

Benzo(b)fluoranthene (0-2)* 1.9E-01 ug/L 3.1E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.3E-06 1.1E-05 mg/kg-day NA NA

Benzo(b)fluoranthene (2-3)* 1.9E-01 ug/L 1.3E-07 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.8E-07

Dibenz(a,h)anthracene (0-2)* 1.0E-01 ug/L 2.5E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 1.8E-05 8.8E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (0-2)* 1.0E-01 ug/L 4.1E-07 mg/kg-day 2.2E+01 1/(mg/kg-day) 9.0E-06

Indeno(1,2,3-c,d)pyrene (0-2)* 5.0E-01 ug/L 8.2E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 6.0E-06 2.9E-05 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene (2-3)* 5.0E-01 ug/L 9.0E-09 mg/kg-day 2.2E+00 1/(mg/kg-day) 2.0E-08

Naphthalene 3.6E-01 ug/L 2.7E-08 mg/kg-day NA NA 6.3E-07 mg/kg-day 2.0E-02 mg/kg-day 3.2E-05

Arsenic 1.7E+01 ug/L 1.4E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 2.2E-08 3.4E-07 mg/kg-day 3.0E-04 mg/kg-day 1.1E-03

Chromium (0-2)* 8.5E+00 ug/L 9.9E-09 mg/kg-day 2.0E+02 1/(mg/kg-day) 2.0E-06 3.5E-07 mg/kg-day 7.5E-05 mg/kg-day 4.6E-03

Chromium (2-3)* 8.5E+00 ug/L 4.5E-10 mg/kg-day 6.0E+01 1/(mg/kg-day) 2.7E-08

Cobalt 3.9E+00 ug/L 1.4E-09 mg/kg-day NA NA 3.2E-08 mg/kg-day 3.0E-04 mg/kg-day 1.1E-04

Lead 1.5E+01 ug/L 1.3E-09 mg/kg-day NA NA 3.0E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L 2.9E-08 mg/kg-day NA NA 6.8E-07 mg/kg-day 5.0E-03 mg/kg-day 1.4E-04

Exp. Route Total 6.8E-05 1.0E-02

Exposure Point Total 6.8E-05 1.6E-02

6.8E-05 1.6E-02

Surface Water Total - Wet Event 6.8E-05 1.6E-02

Total Total of Receptor Risks Across All Media 2.1E-04 Total of Receptor Hazards Across All Media 1.7E-01

Notes-

NA = Not available / Not applicable.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 used to adjust CSF for 2-3 year old for exposure duration of 1 year, for a total CTE exposure duration of 3 years.

Non-cancer calculations shown under 0-2 year old only, as non-cancer calculations are not adjusted for MMOA.

DAevent for surface water from dry event calculated on Table 7.1.CTE Supplement A.

DAevent for surface water from wet event calculated on Table 7.1.CTE Supplement B.

Total includes sum of exposed and near shore sediment, and maximum of dry event and wet event surface water

Exposure Medium Total

Page 291: Appendix L HHRA Combined

TABLE 7.4.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at street

levelInhalation

(pre-aeration system Benzene 1.3E-03 mg/m37.8E-06 1/(ug/m3) 8.1E-04 mg/m3

3.0E-02 mg/m32.7E-02

operation) Chloroform 2.5E-04 mg/m32.3E-05 1/(ug/m3) 1.6E-04 mg/m3

9.8E-02 mg/m31.6E-03

Ethylbenzene 1.1E-03 mg/m32.5E-06 1/(ug/m3) 7.0E-04 mg/m3

1.0E+00 mg/m37.0E-04

Naphthalene 1.3E-03 mg/m33.4E-05 1/(ug/m3) 8.3E-04 mg/m3

3.0E-03 mg/m32.8E-01

Exp. Route Total 0.0E+00 3.1E-01

Exposure Point Total 0.0E+00 3.1E-01

0.0E+00 3.1E-01

Ambient air at street level Total - Pre-aeration system operation 0.0E+00 3.1E-01

Air AirAmbient air at street

levelInhalation

(after aeration system Benzene 1.1E-03 mg/m37.8E-06 1/(ug/m3) 7.1E-04 mg/m3 3.0E-02 mg/m3

2.4E-02

started) Chloroform 3.3E-04 mg/m32.3E-05 1/(ug/m3) 2.1E-04 mg/m3 9.8E-02 mg/m3

2.2E-03

Ethylbenzene 1.2E-03 mg/m32.5E-06 1/(ug/m3) 7.9E-04 mg/m3 1.0E+00 mg/m3

7.9E-04

Naphthalene 3.0E-03 mg/m33.4E-05 1/(ug/m3) 1.9E-03 mg/m3 3.0E-03 mg/m3

6.5E-01

Exp. Route Total 0.0E+00 6.7E-01

Exposure Point Total 0.0E+00 6.7E-01

0.0E+00 6.7E-01

Ambient air at street level Total - After aeration system turned on 0.0E+00 6.7E-01

Exposure Medium Total

Exposure Medium Total

Page 292: Appendix L HHRA Combined

TABLE 7.4.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow

Ingestion

2-methylnaphthalene 3.6E+02 mg/kg NA 1/(mg/kg-day) 3.2E-06 mg/kg-day 4.0E-03 mg/kg-day 7.9E-04

Acenaphthene 3.1E+02 mg/kg NA 2.7E-06 mg/kg-day 6.0E-02 mg/kg-day 4.5E-05

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 1.1E-06 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 6.4E-07 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 7.0E-07 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 3.6E-07 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 1.3E-07 mg/kg-day 2.0E-02 mg/kg-day 6.4E-06

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 1.1E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 4.8E-08 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 1.6E-06 mg/kg-day 4.0E-02 mg/kg-day 4.0E-05

Fluorene 2.3E+02 mg/kg NA 2.0E-06 mg/kg-day 4.0E-02 mg/kg-day 5.1E-05

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 2.8E-07 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 5.8E-06 mg/kg-day 2.0E-02 mg/kg-day 2.9E-04

Pyrene 3.9E+02 mg/kg NA 3.4E-06 mg/kg-day 3.0E-02 mg/kg-day 1.1E-04

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 4.0E-13 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 1.0E+00 1/(mg/kg-day) 5.7E-08 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 5.8E-08 mg/kg-day 2.0E-05 mg/kg-day 2.9E-03

Aluminum 1.5E+04 mg/kg NA 1.3E-04 mg/kg-day 1.0E+00 mg/kg-day 1.3E-04

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 1.3E-07 mg/kg-day 3.0E-04 mg/kg-day 4.3E-04

Cadmium 1.0E+01 mg/kg NA 8.8E-08 mg/kg-day 1.0E-03 mg/kg-day 8.8E-05

Chromium 8.5E+01 mg/kg 5.0E-01 7.4E-07 mg/kg-day 3.0E-03 mg/kg-day 2.5E-04

Cobalt 1.1E+01 mg/kg NA 9.7E-08 mg/kg-day 3.0E-04 mg/kg-day 3.2E-04

Copper 2.7E+02 mg/kg NA 2.4E-06 mg/kg-day 4.0E-02 mg/kg-day 6.0E-05

Iron 3.4E+04 mg/kg NA 3.0E-04 mg/kg-day 7.0E-01 mg/kg-day 4.2E-04

Lead 1.2E+03 mg/kg NA 1.1E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 2.7E-06 mg/kg-day 1.4E-01 mg/kg-day 1.9E-05

Vanadium 4.6E+01 mg/kg NA 4.0E-07 mg/kg-day 5.0E-03 mg/kg-day 8.1E-05

Exp. Route Total 0.0E+00 6.1E-03

Page 293: Appendix L HHRA Combined

TABLE 7.4.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow

Dermal

2-methylnaphthalene 3.6E+02 mg/kg NA 9.3E-06 mg/kg-day 4.0E-03 mg/kg-day 2.3E-03

Acenaphthene 3.1E+02 mg/kg NA 8.1E-06 mg/kg-day 6.0E-02 mg/kg-day 1.3E-04

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 3.3E-06 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 1.9E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 2.1E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 1.1E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 2.9E-07 mg/kg-day 2.0E-02 mg/kg-day 1.5E-05

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 3.3E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 1.4E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 4.7E-06 mg/kg-day 4.0E-02 mg/kg-day 1.2E-04

Fluorene 2.3E+02 mg/kg NA 6.0E-06 mg/kg-day 4.0E-02 mg/kg-day 1.5E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 8.2E-07 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 1.7E-05 mg/kg-day 2.0E-02 mg/kg-day 8.5E-04

Pyrene 3.9E+02 mg/kg NA 1.0E-05 mg/kg-day 3.0E-02 mg/kg-day 3.4E-04

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 1.3E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 1.0E+00 1/(mg/kg-day) 1.8E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 1.9E-07 mg/kg-day 2.0E-05 mg/kg-day 9.3E-03

Aluminum 1.5E+04 mg/kg NA 2.9E-05 mg/kg-day 1.0E+00 mg/kg-day 2.9E-05

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 8.9E-08 mg/kg-day 3.0E-04 mg/kg-day 3.0E-04

Cadmium 1.0E+01 mg/kg NA 2.0E-09 mg/kg-day 2.5E-05 mg/kg-day 8.0E-05

Chromium 8.5E+01 mg/kg 2.0E+01 0.0E+00 1.7E-07 mg/kg-day 7.5E-05 mg/kg-day 2.3E-03

Cobalt 1.1E+01 mg/kg NA 2.2E-08 mg/kg-day 3.0E-04 mg/kg-day 7.4E-05

Copper 2.7E+02 mg/kg NA 5.5E-07 mg/kg-day 4.0E-02 mg/kg-day 1.4E-05

Iron 3.4E+04 mg/kg NA 6.7E-05 mg/kg-day 7.0E-01 mg/kg-day 9.6E-05

Lead 1.2E+03 mg/kg NA 2.4E-06 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 6.1E-07 mg/kg-day 7.0E-01 mg/kg-day 8.8E-07

Vanadium 4.6E+01 mg/kg NA 9.2E-08 mg/kg-day 5.0E-03 mg/kg-day 1.8E-05

Exp. Route Total 0.0E+00 1.6E-02

Exposure Point Total 0.0E+00 2.2E-02

0.0E+00 2.2E-02

Overflow Surface Sediment Total 0.0E+00 2.2E-02

Exposure Medium Total

Page 294: Appendix L HHRA Combined

TABLE 7.4.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Ingestion

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 3.4E-09 mg/kg-day 7.0E-02 mg/kg-day 4.8E-08

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 4.8E-09 mg/kg-day 4.0E-03 mg/kg-day 1.2E-06

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 3.2E-09 mg/kg-day 1.0E-02 mg/kg-day 3.2E-07

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 5.0E-09 mg/kg-day 1.0E-01 mg/kg-day 5.0E-08

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 1.4E-07 mg/kg-day 1.0E-02 mg/kg-day 1.4E-05

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 6.0E-10 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 1.2E-09 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.1E-09 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 5.8E-10 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.9E-09 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 2.1E-09 mg/kg-day 2.0E-02 mg/kg-day 1.0E-07

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 9.5E-08 mg/kg-day 3.0E-04 mg/kg-day 3.2E-04

Chromium 8.5E+00 ug/L 5.0E-01 1/(mg/kg-day) 4.9E-08 mg/kg-day 3.0E-03 mg/kg-day 1.6E-05

Cobalt 3.9E+00 ug/L NA 2.2E-08 mg/kg-day 3.0E-04 mg/kg-day 7.4E-05

Lead 1.5E+01 ug/L NA 8.5E-08 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 1.9E-07 mg/kg-day 5.0E-03 mg/kg-day 3.8E-05

Exp. Route Total 0.0E+00 4.6E-04

Page 295: Appendix L HHRA Combined

TABLE 7.4.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Dermal

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 6.6E-08 mg/kg-day 7.0E-02 mg/kg-day 9.4E-07

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 2.3E-08 mg/kg-day 4.0E-03 mg/kg-day 5.8E-06

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 8.7E-09 mg/kg-day 1.0E-02 mg/kg-day 8.7E-07

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 8.9E-08 mg/kg-day 1.0E-01 mg/kg-day 8.9E-07

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 2.4E-06 mg/kg-day 1.0E-02 mg/kg-day 2.4E-04

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.2E-07 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 7.4E-07 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 7.0E-07 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 5.7E-07 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.8E-06 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 4.1E-08 mg/kg-day 2.0E-02 mg/kg-day 2.0E-06

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 2.2E-08 mg/kg-day 3.0E-04 mg/kg-day 7.2E-05

Chromium 8.5E+00 ug/L 2.0E+01 1/(mg/kg-day) 2.2E-08 mg/kg-day 7.5E-05 mg/kg-day 3.0E-04

Cobalt 3.9E+00 ug/L NA 2.0E-09 mg/kg-day 3.0E-04 mg/kg-day 6.8E-06

Lead 1.5E+01 ug/L NA 1.9E-09 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 4.4E-08 mg/kg-day 5.0E-03 mg/kg-day 8.8E-06

Exp. Route Total 0.0E+00 6.4E-04

Exposure Point Total 0.0E+00 1.1E-03

0.0E+00 1.1E-03

Overflow Surface Water Total 0.0E+00 1.1E-03

Total Total of Receptor Risks Across All Media 0.0E+00 Total of Receptor Hazards Across All Media 7.0E-01

Notes-

NA = Not available / Not applicable.

DAevent for surface water calculated on Table 7.4.CTE Supplement A.

Total includes maximum between air prior to and after aeration system operations, and surface water, and sediment.

Exposure Medium Total

Page 296: Appendix L HHRA Combined

TABLE 7.4.CTE Supplement A

Calculation of Daevent Wet Event

Residential Scenario

Gowanus Canal Remedial Investigation, Brooklyn, New York

Chemical Water Permeability Lag Fraction Duration

of Potential Concentration Coefficient Time Absorbed Water of Event

Concern (CW) (Kp) B (τevent) t* (FA) (tevent) DAevent

(µg/L) (cm/hr) (dimensionless) (hr) (hr) (dimensionless) (hr) (mg/cm2-event) Eq

1,4-dichlorobenzene 5.9E-01 4.2E-02 2.0E-01 7.1E-01 1.7E+00 1.0E+00 1.3 6.6E-08 2

Benzene 8.4E-01 1.5E-02 5.1E-02 2.9E-01 7.0E-01 1.0E+00 1.3 2.3E-08 3

Chloroform 5.6E-01 6.8E-03 2.9E-02 5.0E-01 1.2E+00 1.0E+00 1.3 8.7E-09 3

Ethylbenzene 8.7E-01 4.9E-02 2.0E-01 4.2E-01 1.0E+00 1.0E+00 1.3 8.9E-08 3

Tetrachloroethylene(PCE) 2.4E+01 3.3E-02 1.7E-01 9.1E-01 2.2E+00 1.0E+00 1.3 2.4E-06 2

Benzo(a)anthracene 1.0E-01 4.7E-01 2.8E+00 2.0E+00 8.5E+00 1.0E+00 1.3 2.2E-07 2

Benzo(a)pyrene 2.1E-01 7.0E-01 4.3E+00 2.7E+00 1.2E+01 1.0E+00 1.3 7.4E-07 2

Benzo(b)fluoranthene 1.9E-01 7.0E-01 4.3E+00 2.8E+00 1.2E+01 1.0E+00 1.3 6.9E-07 2

Dibenz(a,h)anthracene 1.0E-01 1.5E+00 9.7E+00 3.9E+00 1.8E+01 6.0E-01 1.3 5.6E-07 2

Indeno(1,2,3-c,d)pyrene 5.0E-01 1.0E+00 6.7E+00 3.8E+00 1.7E+01 6.0E-01 1.3 1.8E-06 2

Naphthalene 3.6E-01 4.7E-02 2.0E-01 5.6E-01 1.3E+00 1.0E+00 1.3 4.0E-08 2

Arsenic 1.7E+01 1.0E-03 NA NA NA NA 1.3 2.2E-08 1

Chromium 8.5E+00 2.0E-03 NA NA NA NA 1.3 2.2E-08 1

Cobalt 3.9E+00 4.0E-04 NA NA NA NA 1.3 2.0E-09 1

Lead 1.5E+01 1.0E-04 NA NA NA NA 1.3 1.9E-09 1

Selenium 3.4E+01 1.0E-03 NA NA NA NA 1.3 4.4E-08 1

Organics: DAevent (mg/cm2-event) =

If tevent<t*, then DAevent =

2 x FA x Kp x CW x (sqrt((6 x τevent x tevent)/π)) x 0.001 mg/µg x 0.001 l/cm3 (eq 2)

If tevent>t*, then DAevent =

FA x Kp x CW x ( tevent/(1+B) + 2 x τevent x ((1 + 3xB + 3xB2)/(1+B)2) x 0.001 mg/µg x 0.001 l/cm3 (eq 3)

Notes:

NA - Not applicable

Permeability constants and other input parameter values from EPA 2004, Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part E,

Supplemental Guidance for Dermal Risk Assessment - Final). EPA/540/R/99/005. The default value of 0.001 was assigned to inorganics not listed in this document.

B - Dimensionless ratio of the permeability coefficient of a compound through the stratum corneum relative to its permeability

coefficient across the viable epidermis (dimensionless).

t* - Time to reach steady-state

Page 297: Appendix L HHRA Combined

TABLE 7.5.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at street

levelInhalation

(pre-aeration system Benzene 1.3E-03 mg/m37.8E-06 1/(ug/m3) 8.1E-04 mg/m3

3.0E-02 mg/m32.7E-02

operation) Chloroform 2.5E-04 mg/m32.3E-05 1/(ug/m3) 1.6E-04 mg/m3

9.8E-02 mg/m31.6E-03

Ethylbenzene 1.1E-03 mg/m32.5E-06 1/(ug/m3) 7.0E-04 mg/m3

1.0E+00 mg/m37.0E-04

Naphthalene 1.3E-03 mg/m33.4E-05 1/(ug/m3) 8.3E-04 mg/m3

3.0E-03 mg/m32.8E-01

Exp. Route Total 3.1E-01

Exposure Point Total 3.1E-01

3.1E-01

Ambient air at street level Total - Pre-aeration system operation 3.1E-01

Air AirAmbient air at street

levelInhalation

(after aeration system Benzene 1.1E-03 mg/m3 7.8E-06 1/(ug/m3) 7.1E-04 mg/m3 3.0E-02 mg/m32.4E-02

started) Chloroform 3.3E-04 mg/m3 2.3E-05 1/(ug/m3) 2.1E-04 mg/m3 9.8E-02 mg/m32.2E-03

Ethylbenzene 1.2E-03 mg/m3 2.5E-06 1/(ug/m3) 7.9E-04 mg/m3 1.0E+00 mg/m37.9E-04

Naphthalene 3.0E-03 mg/m3 3.4E-05 1/(ug/m3) 1.9E-03 mg/m3 3.0E-03 mg/m36.5E-01

Exp. Route Total 6.7E-01

Exposure Point Total 6.7E-01

6.7E-01

Ambient air at street level Total - After aeration system turned on 6.7E-01

Exposure Medium Total

Exposure Medium Total

Page 298: Appendix L HHRA Combined

TABLE 7.5.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow

Ingestion

2-methylnaphthalene 3.6E+02 mg/kg NA 1/(mg/kg-day) 2.9E-05 mg/kg-day 4.0E-03 mg/kg-day 7.4E-03

Acenaphthene 3.1E+02 mg/kg NA 2.5E-05 mg/kg-day 6.0E-02 mg/kg-day 4.2E-04

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 1.1E-05 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 6.0E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 6.5E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 3.4E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 1.2E-06 mg/kg-day 2.0E-02 mg/kg-day 6.0E-05

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 1.0E-05 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 4.5E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 1.5E-05 mg/kg-day 4.0E-02 mg/kg-day 3.7E-04

Fluorene 2.3E+02 mg/kg NA 1.9E-05 mg/kg-day 4.0E-02 mg/kg-day 4.7E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 2.6E-06 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 5.4E-05 mg/kg-day 2.0E-02 mg/kg-day 2.7E-03

Pyrene 3.9E+02 mg/kg NA 3.2E-05 mg/kg-day 3.0E-02 mg/kg-day 1.1E-03

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 3.7E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 1.0E+00 1/(mg/kg-day) 5.3E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 5.4E-07 mg/kg-day 2.0E-05 mg/kg-day 2.7E-02

Aluminum 1.5E+04 mg/kg NA 1.2E-03 mg/kg-day 1.0E+00 mg/kg-day 1.2E-03

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 1.2E-06 mg/kg-day 3.0E-04 mg/kg-day 4.0E-03

Cadmium 1.0E+01 mg/kg NA 8.2E-07 mg/kg-day 1.0E-03 mg/kg-day 8.2E-04

Chromium 8.5E+01 mg/kg 5.0E-01 6.9E-06 mg/kg-day 3.0E-03 mg/kg-day 2.3E-03

Cobalt 1.1E+01 mg/kg NA 9.0E-07 mg/kg-day 3.0E-04 mg/kg-day 3.0E-03

Copper 2.7E+02 mg/kg NA 2.3E-05 mg/kg-day 4.0E-02 mg/kg-day 5.6E-04

Iron 3.4E+04 mg/kg NA 2.8E-03 mg/kg-day 7.0E-01 mg/kg-day 3.9E-03

Lead 1.2E+03 mg/kg NA 9.9E-05 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 2.5E-05 mg/kg-day 1.4E-01 mg/kg-day 1.8E-04

Vanadium 4.6E+01 mg/kg NA 3.8E-06 mg/kg-day 5.0E-03 mg/kg-day 7.5E-04

Exp. Route Total 5.7E-02

Page 299: Appendix L HHRA Combined

TABLE 7.5.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow

Dermal

2-methylnaphthalene 3.6E+02 mg/kg NA 2.1E-05 mg/kg-day 4.0E-03 mg/kg-day 5.4E-03

Acenaphthene 3.1E+02 mg/kg NA 1.8E-05 mg/kg-day 6.0E-02 mg/kg-day 3.1E-04

Benzo(a)anthracene 1.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 7.7E-06 mg/kg-day NA NA

Benzo(a)pyrene 7.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 4.4E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 7.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 4.7E-06 mg/kg-day NA NA

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 2.5E-06 mg/kg-day NA NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.4E-02 1/(mg/kg-day) 6.7E-07 mg/kg-day 2.0E-02 mg/kg-day 3.3E-05

Chrysene 1.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 7.6E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 5.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 3.3E-07 mg/kg-day NA NA

Fluoranthene 1.8E+02 mg/kg NA 1.1E-05 mg/kg-day 4.0E-02 mg/kg-day 2.7E-04

Fluorene 2.3E+02 mg/kg NA 1.4E-05 mg/kg-day 4.0E-02 mg/kg-day 3.5E-04

Indeno(1,2,3-c,d)pyrene 3.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 1.9E-06 mg/kg-day NA NA

Naphthalene 6.6E+02 mg/kg NA 3.9E-05 mg/kg-day 2.0E-02 mg/kg-day 2.0E-03

Pyrene 3.9E+02 mg/kg NA 2.3E-05 mg/kg-day 3.0E-02 mg/kg-day 7.7E-04

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 1.6E+05 1/(mg/kg-day) 2.9E-12 mg/kg-day NA NA

Nondioxin-Like PCB 6.4E+00 mg/kg 1.0E+00 1/(mg/kg-day) 4.1E-07 mg/kg-day NA NA

Total PCB 6.6E+00 mg/kg NA 4.3E-07 mg/kg-day 2.0E-05 mg/kg-day 2.1E-02

Aluminum 1.5E+04 mg/kg NA 6.7E-05 mg/kg-day 1.0E+00 mg/kg-day 6.7E-05

Arsenic 1.5E+01 mg/kg 1.5E+00 1/(mg/kg-day) 2.0E-07 mg/kg-day 3.0E-04 mg/kg-day 6.8E-04

Cadmium 1.0E+01 mg/kg NA 4.6E-09 mg/kg-day 2.5E-05 mg/kg-day 1.8E-04

Chromium 8.5E+01 mg/kg 2.0E+01 0.0E+00 3.9E-07 mg/kg-day 7.5E-05 mg/kg-day 5.2E-03

Cobalt 1.1E+01 mg/kg NA 5.1E-08 mg/kg-day 3.0E-04 mg/kg-day 1.7E-04

Copper 2.7E+02 mg/kg NA 1.3E-06 mg/kg-day 4.0E-02 mg/kg-day 3.2E-05

Iron 3.4E+04 mg/kg NA 1.5E-04 mg/kg-day 7.0E-01 mg/kg-day 2.2E-04

Lead 1.2E+03 mg/kg NA 5.5E-06 mg/kg-day NA NA

Manganese 3.1E+02 mg/kg NA 1.4E-06 mg/kg-day 7.0E-01 mg/kg-day 2.0E-06

Vanadium 4.6E+01 mg/kg NA 2.1E-07 mg/kg-day 5.0E-03 mg/kg-day 4.2E-05

Exp. Route Total 3.7E-02

Exposure Point Total 9.3E-02

9.3E-02

Overflow Surface Sediment Total 9.3E-02

Exposure Medium Total

Page 300: Appendix L HHRA Combined

TABLE 7.5.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Ingestion

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 1.6E-08 mg/kg-day 7.0E-02 mg/kg-day 2.3E-07

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 2.2E-08 mg/kg-day 4.0E-03 mg/kg-day 5.6E-06

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 1.5E-08 mg/kg-day 1.0E-02 mg/kg-day 1.5E-06

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 2.3E-08 mg/kg-day 1.0E-01 mg/kg-day 2.3E-07

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 6.5E-07 mg/kg-day 1.0E-02 mg/kg-day 6.5E-05

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.8E-09 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 5.5E-09 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 5.0E-09 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 2.7E-09 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.3E-08 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 9.7E-09 mg/kg-day 2.0E-02 mg/kg-day 4.9E-07

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 4.4E-07 mg/kg-day 3.0E-04 mg/kg-day 1.5E-03

Chromium 8.5E+00 ug/L 5.0E-01 1/(mg/kg-day) 2.3E-07 mg/kg-day 3.0E-03 mg/kg-day 7.6E-05

Cobalt 3.9E+00 ug/L NA 1.0E-07 mg/kg-day 3.0E-04 mg/kg-day 3.5E-04

Lead 1.5E+01 ug/L NA 4.0E-07 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 9.0E-07 mg/kg-day 5.0E-03 mg/kg-day 1.8E-04

Exp. Route Total 2.2E-03

Page 301: Appendix L HHRA Combined

TABLE 7.5.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Dermal

1,4-dichlorobenzene 5.9E-01 ug/L 5.4E-03 1/(mg/kg-day) 1.5E-07 mg/kg-day 7.0E-02 mg/kg-day 2.2E-06

Benzene 8.4E-01 ug/L 5.5E-02 1/(mg/kg-day) 5.3E-08 mg/kg-day 4.0E-03 mg/kg-day 1.3E-05

Chloroform 5.6E-01 ug/L 3.1E-02 1/(mg/kg-day) 2.0E-08 mg/kg-day 1.0E-02 mg/kg-day 2.0E-06

Ethylbenzene 8.7E-01 ug/L 1.1E-02 1/(mg/kg-day) 2.0E-07 mg/kg-day 1.0E-01 mg/kg-day 2.0E-06

Tetrachloroethylene(PCE) 2.4E+01 ug/L 5.4E-01 1/(mg/kg-day) 5.6E-06 mg/kg-day 1.0E-02 mg/kg-day 5.6E-04

Benzo(a)anthracene 1.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 5.1E-07 mg/kg-day NA NA

Benzo(a)pyrene 2.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 1.7E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 1.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.6E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 1.3E-06 mg/kg-day NA NA

Indeno(1,2,3-c,d)pyrene 5.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 4.2E-06 mg/kg-day NA NA

Naphthalene 3.6E-01 ug/L NA 9.3E-08 mg/kg-day 2.0E-02 mg/kg-day 4.6E-06

Arsenic 1.7E+01 ug/L 1.5E+00 1/(mg/kg-day) 5.0E-08 mg/kg-day 3.0E-04 mg/kg-day 1.7E-04

Chromium 8.5E+00 ug/L 2.0E+01 1/(mg/kg-day) 5.1E-08 mg/kg-day 7.5E-05 mg/kg-day 6.8E-04

Cobalt 3.9E+00 ug/L NA 4.7E-09 mg/kg-day 3.0E-04 mg/kg-day 1.6E-05

Lead 1.5E+01 ug/L NA 4.5E-09 mg/kg-day NA NA

Selenium 3.4E+01 ug/L NA 1.0E-07 mg/kg-day 5.0E-03 mg/kg-day 2.0E-05

Exp. Route Total 1.5E-03

Exposure Point Total 3.6E-03

3.6E-03

Overflow Surface Water Total 3.6E-03

Total Total of Receptor Risks Across All Media Total of Receptor Hazards Across All Media 7.7E-01

Notes-

NA = Not available / Not applicable.

DAevent for surface water calculated on Table 7.4.CTE Supplement A.

Total includes maximum between air prior to and after aeration system operations, and surface water, and sediment.

Exposure Medium Total

Page 302: Appendix L HHRA Combined

TABLE 7.6.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Air AirAmbient air at street

levelInhalation

(pre-aeration system Benzene 1.3E-03 mg/m3 1.0E-01 ug/m3 7.8E-06 1/(ug/m3) 8.1E-07 3.0E-02 mg/m3

operation) Chloroform 2.5E-04 mg/m3 2.0E-02 ug/m3 2.3E-05 1/(ug/m3) 4.6E-07 9.8E-02 mg/m3

Ethylbenzene 1.1E-03 mg/m3 9.0E-02 ug/m3 2.5E-06 1/(ug/m3) 2.2E-07 1.0E+00 mg/m3

Naphthalene 1.3E-03 mg/m3 1.1E-01 ug/m3 3.4E-05 1/(ug/m3) 3.6E-06 3.0E-03 mg/m3

Exp. Route Total 5.1E-06

Exposure Point Total 5.1E-06

5.1E-06

Ambient air at street level Total - Pre-aeration system operation 5.1E-06

Air AirAmbient air at street

levelInhalation

(after aeration system Benzene 1.1E-03 mg/m3 9.1E-02 ug/m3 7.8E-06 1/(ug/m3) 7.1E-07 3.0E-02 mg/m3

started) Chloroform 3.3E-04 mg/m3 2.7E-02 ug/m3 2.3E-05 1/(ug/m3) 6.3E-07 9.8E-02 mg/m3

Ethylbenzene 1.2E-03 mg/m3 1.0E-01 ug/m3 2.5E-06 1/(ug/m3) 2.6E-07 1.0E+00 mg/m3

Naphthalene 3.0E-03 mg/m3 2.5E-01 ug/m3 3.4E-05 1/(ug/m3) 8.5E-06 3.0E-03 mg/m3

Exp. Route Total 1.0E-05

Exposure Point Total 1.0E-05

1.0E-05

Ambient air at street level Total - After aeration system turned on 1.0E-05

Exposure Medium Total

Exposure Medium Total

Page 303: Appendix L HHRA Combined

TABLE 7.6.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow

Ingestion

2-methylnaphthalene 3.6E+02 mg/kg 2.7E-06 mg/kg-day NA 1/(mg/kg-day) NA 4.0E-03 mg/kg-day

Acenaphthene 3.1E+02 mg/kg 2.3E-06 mg/kg-day NA NA 6.0E-02 mg/kg-day

Benzo(a)anthracene11.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 3.5E-06 NA

Benzo(a)pyrene17.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 2.0E-05 NA

Benzo(b)fluoranthene17.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 2.2E-06 NA

Benzo(k)fluoranthene14.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 1.1E-07 NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 1.1E-07 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.5E-09 2.0E-02 mg/kg-day

Chrysene11.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 3.5E-08 NA

Dibenz(a,h)anthracene15.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 1.5E-06 NA

Fluoranthene 1.8E+02 mg/kg 1.3E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Fluorene 2.3E+02 mg/kg 1.7E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Indeno(1,2,3-c,d)pyrene13.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 8.7E-07 NA

Naphthalene 6.6E+02 mg/kg 4.9E-06 mg/kg-day NA NA 2.0E-02 mg/kg-day

Pyrene 3.9E+02 mg/kg 2.9E-06 mg/kg-day NA NA 3.0E-02 mg/kg-day

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 3.4E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 5.2E-08 NA

Nondioxin-Like PCB 6.4E+00 mg/kg 4.8E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 4.8E-08 NA

Total PCB 6.6E+00 mg/kg 4.9E-08 mg/kg-day NA NA 2.0E-05 mg/kg-day

Aluminum 1.5E+04 mg/kg 1.1E-04 mg/kg-day NA NA 1.0E+00 mg/kg-day

Arsenic 1.5E+01 mg/kg 1.1E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.6E-07 3.0E-04 mg/kg-day

Cadmium 1.0E+01 mg/kg 7.4E-08 mg/kg-day NA NA 1.0E-03 mg/kg-day

Chromium18.5E+01 mg/kg 5.0E-01 1/(mg/kg-day) 1.6E-08 3.0E-03 mg/kg-day

Cobalt 1.1E+01 mg/kg 8.2E-08 mg/kg-day NA NA 3.0E-04 mg/kg-day

Copper 2.7E+02 mg/kg 2.0E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Iron 3.4E+04 mg/kg 2.5E-04 mg/kg-day NA NA 7.0E-01 mg/kg-day

Lead 1.2E+03 mg/kg 8.9E-06 mg/kg-day NA NA NA

Manganese 3.1E+02 mg/kg 2.3E-06 mg/kg-day NA NA 1.4E-01 mg/kg-day

Vanadium 4.6E+01 mg/kg 3.4E-07 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 2.9E-05

Page 304: Appendix L HHRA Combined

TABLE 7.6.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow

Dermal

2-methylnaphthalene 3.6E+02 mg/kg 3.0E-06 mg/kg-day NA NA 4.0E-03 mg/kg-day

Acenaphthene 3.1E+02 mg/kg 2.6E-06 mg/kg-day NA NA 6.0E-02 mg/kg-day

Benzo(a)anthracene11.3E+02 mg/kg 7.3E-01 1/(mg/kg-day) 2.7E-06 NA

Benzo(a)pyrene17.3E+01 mg/kg 7.3E+00 1/(mg/kg-day) 1.5E-05 NA

Benzo(b)fluoranthene17.9E+01 mg/kg 7.3E-01 1/(mg/kg-day) 1.6E-06 NA

Benzo(k)fluoranthene14.1E+01 mg/kg 7.3E-02 1/(mg/kg-day) 8.5E-08 NA

Bis(2-ethylhexyl)phthalate 1.5E+01 mg/kg 9.5E-08 mg/kg-day 1.4E-02 1/(mg/kg-day) 1.3E-09 2.0E-02 mg/kg-day

Chrysene11.3E+02 mg/kg 7.3E-03 1/(mg/kg-day) 2.6E-08 NA

Dibenz(a,h)anthracene15.5E+00 mg/kg 7.3E+00 1/(mg/kg-day) 1.1E-06 NA

Fluoranthene 1.8E+02 mg/kg 1.5E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Fluorene 2.3E+02 mg/kg 2.0E-06 mg/kg-day NA NA 4.0E-02 mg/kg-day

Indeno(1,2,3-c,d)pyrene13.1E+01 mg/kg 7.3E-01 1/(mg/kg-day) 6.5E-07 NA

Naphthalene 6.6E+02 mg/kg 5.6E-06 mg/kg-day NA NA 2.0E-02 mg/kg-day

Pyrene 3.9E+02 mg/kg 3.3E-06 mg/kg-day NA NA 3.0E-02 mg/kg-day

Dioxin-Like PCB TEQ 4.5E-05 mg/kg 4.1E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 6.5E-08 NA

Nondioxin-Like PCB 6.4E+00 mg/kg 5.9E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 5.9E-08 NA

Total PCB 6.6E+00 mg/kg 6.1E-08 mg/kg-day NA NA 2.0E-05 mg/kg-day

Aluminum 1.5E+04 mg/kg 9.5E-06 mg/kg-day NA NA 1.0E+00 mg/kg-day

Arsenic 1.5E+01 mg/kg 2.9E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.3E-08 3.0E-04 mg/kg-day

Cadmium 1.0E+01 mg/kg 6.5E-10 mg/kg-day NA NA 2.5E-05 mg/kg-day

Chromium18.5E+01 mg/kg 2.0E+01 1/(mg/kg-day) 3.7E-07 7.5E-05 mg/kg-day

Cobalt 1.1E+01 mg/kg 7.2E-09 mg/kg-day NA NA 3.0E-04 mg/kg-day

Copper 2.7E+02 mg/kg 1.8E-07 mg/kg-day NA NA 4.0E-02 mg/kg-day

Iron 3.4E+04 mg/kg 2.2E-05 mg/kg-day NA NA 7.0E-01 mg/kg-day

Lead 1.2E+03 mg/kg 7.8E-07 mg/kg-day NA NA NA

Manganese 3.1E+02 mg/kg 2.0E-07 mg/kg-day NA NA 7.0E-01 mg/kg-day

Vanadium 4.6E+01 mg/kg 3.0E-08 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 2.2E-05

Exposure Point Total 5.1E-05

5.1E-05

Overflow Surface Sediment Total 5.1E-05

Exposure Medium Total

Page 305: Appendix L HHRA Combined

TABLE 7.6.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Ingestion

1,4-dichlorobenzene 5.9E-01 ug/L 1.8E-09 mg/kg-day 5.4E-03 1/(mg/kg-day) 9.5E-12 7.0E-02 mg/kg-day

Benzene 8.4E-01 ug/L 2.5E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 1.4E-10 4.0E-03 mg/kg-day

Chloroform 5.6E-01 ug/L 1.7E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 5.2E-11 1.0E-02 mg/kg-day

Ethylbenzene 8.7E-01 ug/L 2.6E-09 mg/kg-day 1.1E-02 1/(mg/kg-day) 2.8E-11 1.0E-01 mg/kg-day

Tetrachloroethylene(PCE) 2.4E+01 ug/L 7.3E-08 mg/kg-day 5.4E-01 1/(mg/kg-day) 3.9E-08 1.0E-02 mg/kg-day

Benzo(a)anthracene11.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 9.5E-10 NA

Benzo(a)pyrene12.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 2.2E-08 NA

Benzo(b)fluoranthene11.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 2.1E-09 NA

Dibenz(a,h)anthracene11.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 1.1E-08 NA

Indeno(1,2,3-c,d)pyrene15.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 5.4E-09 NA

Naphthalene 3.6E-01 ug/L 1.1E-09 mg/kg-day NA NA 2.0E-02 mg/kg-day

Arsenic 1.7E+01 ug/L 4.9E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 7.4E-08 3.0E-04 mg/kg-day

Chromium18.5E+00 ug/L 5.0E-01 1/(mg/kg-day) 6.4E-08 3.0E-03 mg/kg-day

Cobalt 3.9E+00 ug/L 1.2E-08 mg/kg-day NA NA 3.0E-04 mg/kg-day

Lead 1.5E+01 ug/L 4.4E-08 mg/kg-day NA NA NA

Selenium 3.4E+01 ug/L 1.0E-07 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 2.2E-07

Page 306: Appendix L HHRA Combined

TABLE 7.6.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium

Exposure

Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk Cancer Risk Intake/Exposure Concentration RfD/RfC

Hazard

Quotient

Value Units Value Units Value Units Value Units

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Dermal

1,4-dichlorobenzene 5.9E-01 ug/L 2.1E-08 mg/kg-day 5.4E-03 1/(mg/kg-day) 1.2E-10 7.0E-02 mg/kg-day

Benzene 8.4E-01 ug/L 7.5E-09 mg/kg-day 5.5E-02 1/(mg/kg-day) 4.2E-10 4.0E-03 mg/kg-day

Chloroform 5.6E-01 ug/L 2.8E-09 mg/kg-day 3.1E-02 1/(mg/kg-day) 8.8E-11 1.0E-02 mg/kg-day

Ethylbenzene 8.7E-01 ug/L 2.9E-08 mg/kg-day 1.1E-02 1/(mg/kg-day) 3.2E-10 1.0E-01 mg/kg-day

Tetrachloroethylene(PCE) 2.4E+01 ug/L 7.9E-07 mg/kg-day 5.4E-01 1/(mg/kg-day) 4.3E-07 1.0E-02 mg/kg-day

Benzo(a)anthracene11.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.8E-07 NA

Benzo(a)pyrene12.1E-01 ug/L 7.3E+00 1/(mg/kg-day) 5.9E-06 NA

Benzo(b)fluoranthene11.9E-01 ug/L 7.3E-01 1/(mg/kg-day) 5.5E-07 NA

Dibenz(a,h)anthracene11.0E-01 ug/L 7.3E+00 1/(mg/kg-day) 4.5E-06 NA

Indeno(1,2,3-c,d)pyrene15.0E-01 ug/L 7.3E-01 1/(mg/kg-day) 1.5E-06 NA

Naphthalene 3.6E-01 ug/L 1.3E-08 mg/kg-day NA NA 2.0E-02 mg/kg-day

Arsenic 1.7E+01 ug/L 7.0E-09 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.1E-08 3.0E-04 mg/kg-day

Chromium18.5E+00 ug/L 2.0E+01 1/(mg/kg-day) 8.8E-07 7.5E-05 mg/kg-day

Cobalt 3.9E+00 ug/L 6.6E-10 mg/kg-day NA NA 3.0E-04 mg/kg-day

Lead 1.5E+01 ug/L 6.3E-10 mg/kg-day NA NA NA

Selenium 3.4E+01 ug/L 1.4E-08 mg/kg-day NA NA 5.0E-03 mg/kg-day

Exp. Route Total 1.4E-05

Exposure Point Total 1.4E-05

1.4E-05

Overflow Surface Water Total 1.4E-05

Total Total of Receptor Risks Across All Media 7.5E-05 Total of Receptor Hazards Across All Media

Notes-

NA = Not available / Not applicable.

DAevent for surface water calculated on Table 7.4.CTE Supplement A.

Total includes maximum between air prior to and after aeration system operations, and surface water, and sediment.

1. See Table 7.6.CTE Supplement A for calculation of intake and cancer risk following MMOA method.

Exposure Medium Total

Page 307: Appendix L HHRA Combined

TABLE 7.6.CTE Supplement A

CALCULATION OF CHEMICAL CANCER RISKS FOR COPC WITH MUTAGENIC MODE OF ACTION

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Future

Receptor Population: Resident

Receptor Age: Adult/Child

Chemical of EPC Cancer Risk Calculations

Medium Exposure Medium Exposure Point Exposure Route Potential Concern Intake CSF/Unit Risk

Value Units Value Value Cancer Risk

0-2 yrs 2-6 yrs 16-19 yrs0-2 yrs

(ADAF=10)

2-6 yrs

(ADAF=3)

16-19 yrs

(ADAF=1)

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal

overflow Ingestion Benzo(a)anthracene 1.3E+02 mg/kg 3.0E-07 6.0E-07 4.8E-08 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 mg/kg/day 3.5E-06

Benzo(a)pyrene 7.3E+01 mg/kg 1.7E-07 3.4E-07 2.8E-08 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 mg/kg/day 2.0E-05

Benzo(b)fluoranthene 7.9E+01 mg/kg 1.9E-07 3.7E-07 3.0E-08 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 mg/kg/day 2.2E-06

Benzo(k)fluoranthene 4.1E+01 mg/kg 9.6E-08 1.9E-07 1.5E-08 mg/kg/day 7.3E-01 2.2E-01 7.3E-02 mg/kg/day 1.1E-07

Chrysene 1.3E+02 mg/kg 3.0E-07 6.0E-07 4.8E-08 mg/kg/day 7.3E-02 2.2E-02 7.3E-03 mg/kg/day 3.5E-08

Dibenz(a,h)anthracene 5.5E+00 mg/kg 1.3E-08 2.6E-08 2.1E-09 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 mg/kg/day 1.5E-06

Indeno(1,2,3-cd)pyrene 3.1E+01 mg/kg 7.4E-08 1.5E-07 1.2E-08 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 mg/kg/day 8.7E-07

Chromium 8.5E-01 mg/kg 2.0E-09 4.0E-09 3.2E-10 mg/kg/day 5.0E+00 1.5E+00 5.0E-01 mg/kg/day 1.6E-08

Dermal Benzo(a)anthracene 1.3E+02 mg/kg 2.2E-07 4.4E-07 1.4E-07 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 mg/kg/day 2.7E-06

Benzo(a)pyrene 7.3E+01 mg/kg 1.3E-07 2.5E-07 8.2E-08 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 mg/kg/day 1.5E-05

Benzo(b)fluoranthene 7.9E+01 mg/kg 1.4E-07 2.7E-07 8.9E-08 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 mg/kg/day 1.6E-06

Benzo(k)fluoranthene 4.1E+01 mg/kg 7.0E-08 1.4E-07 4.6E-08 mg/kg/day 7.3E-01 2.2E-01 7.3E-02 mg/kg/day 8.5E-08

Chrysene 1.3E+02 mg/kg 2.2E-07 4.3E-07 1.4E-07 mg/kg/day 7.3E-02 2.2E-02 7.3E-03 mg/kg/day 2.6E-08

Dibenz(a,h)anthracene 5.5E+00 mg/kg 9.3E-09 1.9E-08 6.1E-09 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 mg/kg/day 1.1E-06

Indeno(1,2,3-cd)pyrene 3.1E+01 mg/kg 5.4E-08 1.1E-07 3.5E-08 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 mg/kg/day 6.5E-07

Chromium 8.5E+01 mg/kg 1.1E-09 2.2E-09 7.3E-10 mg/kg/day 2.0E+02 6.0E+01 2.0E+01 mg/kg/day 3.7E-07

Surface WaterOverflow Surface

Water

Canal Overflow -

Surface Water Ingestion Benzo(a)anthracene 1.0E-01 ug/L 7.9E-11 1.6E-10 2.6E-11 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 9.5E-10

Benzo(a)pyrene 2.1E-01 ug/L 1.6E-10 3.1E-10 5.0E-11 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 2.2E-08

Benzo(b)fluoranthene 1.9E-01 ug/L 1.4E-10 2.9E-10 4.6E-11 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 2.1E-09

Dibenz(a,h)anthracene 1.0E-01 ug/L 7.7E-11 1.5E-10 2.5E-11 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 1.1E-08

Indeno(1,2,3-cd)pyrene 5.0E-01 ug/L 3.8E-10 7.6E-10 1.2E-10 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 5.4E-09

Chromium 8.5E+00 ug/L 6.5E-09 1.3E-08 2.1E-09 mg/kg/day 5.0E+00 1.5E+00 5.0E-01 1/(mg/kg-day) 6.4E-08

Dermal Benzo(a)anthracene 1.0E-01 ug/L 1.4E-08 2.9E-08 9.4E-09 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 1.8E-07

Benzo(a)pyrene 2.1E-01 ug/L 4.9E-08 9.8E-08 3.2E-08 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 5.9E-06

Benzo(b)fluoranthene 1.9E-01 ug/L 4.6E-08 9.1E-08 3.0E-08 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 5.5E-07

Dibenz(a,h)anthracene 1.0E-01 ug/L 3.7E-08 7.4E-08 2.4E-08 mg/kg/day 7.3E+01 2.2E+01 7.3E+00 1/(mg/kg-day) 4.5E-06

Indeno(1,2,3-cd)pyrene 5.0E-01 ug/L 1.2E-07 2.4E-07 7.9E-08 mg/kg/day 7.3E+00 2.2E+00 7.3E-01 1/(mg/kg-day) 1.5E-06

Chromium 8.5E+00 ug/L 2.7E-09 5.3E-09 1.7E-09 mg/kg/day 2.0E+02 6.0E+01 2.0E+01 1/(mg/kg-day) 8.8E-07

Units Units

Page 87 of 96

Page 308: Appendix L HHRA Combined

TABLE 7.7.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Striped Bass in Gowanus Canal

Ingestion

p,p'-DDE 1.2E-02 mg/kg 9.7E-09 mg/kg-day 3.4E-01 1/(mg/kg-day) 3.3E-09 2.3E-07 mg/kg-day NA NA

p,p'-DDT 9.6E-03 mg/kg 7.7E-09 mg/kg-day 3.4E-01 1/(mg/kg-day) 2.6E-09 1.8E-07 mg/kg-day 5.0E-04 mg/kg-day 3.6E-04

Dioxin-Like PCB TEQ 4.3E-06 mg/kg 3.5E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 5.4E-07 8.1E-11 mg/kg-day NA NA

Nondioxin-Like 4.1E-01 mg/kg 3.3E-07 mg/kg-day 1.0E+00 1/(mg/kg-day) 3.3E-07 7.7E-06 mg/kg-day NA NA

Total PCB 4.4E-01 mg/kg 3.5E-07 mg/kg-day NA NA 8.2E-06 mg/kg-day 2.0E-05 mg/kg-day 4.1E-01

Arsenic 6.8E-02 mg/kg 5.5E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 8.2E-08 1.3E-06 mg/kg-day 3.0E-04 mg/kg-day 4.3E-03

Mercury 2.0E-01 mg/kg 1.6E-07 mg/kg-day NA NA 3.8E-06 mg/kg-day 1.0E-04 mg/kg-day 3.8E-02

Selenium 1.2E+00 mg/kg 9.7E-07 mg/kg-day NA NA 2.3E-05 mg/kg-day 5.0E-03 mg/kg-day 4.5E-03

Exp. Route Total 9.6E-07 4.6E-01

Exposure Point Total 9.6E-07 4.6E-01

Exposure Medium Total - Striped Bass in Gowanus Canal 9.6E-07 4.6E-01

Fish and Crab Tissue

White Perch in Gowanus Canal

Ingestion

Dioxin-Like PCB TEQ 5.8E-06 mg/kg 5.1E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 8.0E-08 1.2E-11 mg/kg-day NA NA

Nondioxin-Like 4.4E-01 mg/kg 3.9E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 3.9E-08 9.0E-07 mg/kg-day NA NA

Total PCB 4.6E-01 mg/kg 4.1E-08 mg/kg-day NA NA 9.5E-07 mg/kg-day 2.0E-05 mg/kg-day 4.8E-02

Mercury 1.9E-01 mg/kg 1.7E-08 mg/kg-day NA NA 3.9E-07 mg/kg-day 1.0E-04 mg/kg-day 3.9E-03

Selenium 1.4E+00 mg/kg 1.2E-07 mg/kg-day NA NA 2.9E-06 mg/kg-day 5.0E-03 mg/kg-day 5.8E-04

Exp. Route Total 1.2E-07 5.2E-02

Exposure Point Total 1.2E-07 5.2E-02

Exposure Medium Total - White Perch in Gowanus Canal 1.2E-07 5.2E-02

Page 309: Appendix L HHRA Combined

TABLE 7.7.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Eel in Gowanus Canal Ingestion

alpha-Chlordane 2.2E-02 mg/kg 1.6E-08 mg/kg-day 3.5E-01 1/(mg/kg-day) 5.5E-09 3.7E-07 mg/kg-day 5.0E-04 mg/kg-day 7.3E-04

Dieldrin 1.7E-02 mg/kg 1.2E-08 mg/kg-day 1.6E+01 1/(mg/kg-day) 1.9E-07 2.8E-07 mg/kg-day 5.0E-05 mg/kg-day 5.6E-03

gamma-Chlordane 1.3E-02 mg/kg 9.2E-09 mg/kg-day 3.5E-01 1/(mg/kg-day) 3.2E-09 2.2E-07 mg/kg-day 5.0E-04 mg/kg-day 4.3E-04

p,p'-DDD 3.8E-02 mg/kg 2.7E-08 mg/kg-day 2.4E-01 1/(mg/kg-day) 6.5E-09 6.3E-07 mg/kg-day NA NA

p,p'-DDE 2.5E-02 mg/kg 1.8E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 6.0E-09 4.1E-07 mg/kg-day NA NA

p,p'-DDT 4.7E-02 mg/kg 3.3E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 1.1E-08 7.8E-07 mg/kg-day 5.0E-04 mg/kg-day 1.6E-03

Dioxin-Like PCB TEQ 1.4E-05 mg/kg 1.0E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.6E-06 2.3E-10 mg/kg-day NA NA

Nondioxin-Like 1.2E+00 mg/kg 8.7E-07 mg/kg-day 1.0E+00 1/(mg/kg-day) 8.7E-07 2.0E-05 mg/kg-day NA NA

Total PCB 1.4E+00 mg/kg 9.6E-07 mg/kg-day NA NA 2.2E-05 mg/kg-day 2.0E-05 mg/kg-day 1.1E+00

Arsenic 5.0E-02 mg/kg 3.6E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 5.3E-08 8.3E-07 mg/kg-day 3.0E-04 mg/kg-day 2.8E-03

Chromium 6.7E-01 mg/kg 4.8E-07 mg/kg-day 5.0E-01 1/(mg/kg-day) 2.4E-07 1.1E-05 mg/kg-day 3.0E-03 mg/kg-day 3.7E-03

Copper 7.4E+00 mg/kg 5.3E-06 mg/kg-day NA NA 1.2E-04 mg/kg-day 4.0E-02 mg/kg-day 3.1E-03

Cyanide, total 3.1E+00 mg/kg 2.2E-06 mg/kg-day NA NA 5.1E-05 mg/kg-day 2.0E-02 2.6E-03

Mercury 2.6E-01 mg/kg 1.8E-07 mg/kg-day NA NA 4.3E-06 mg/kg-day 1.0E-04 4.3E-02

Selenium 1.4E+00 mg/kg 1.0E-06 mg/kg-day NA NA 2.3E-05 mg/kg-day 5.0E-03 mg/kg-day 4.6E-03

Exp. Route Total 2.9E-06 1.2E+00

Exposure Point Total 2.9E-06 1.2E+00

Exposure Medium Total - Eel in Gowanus Canal 2.9E-06 1.2E+00

Page 310: Appendix L HHRA Combined

TABLE 7.7.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Blue Crab in Gowanus Canal

Ingestion

Benzo(a)anthracene 7.7E-03 mg/kg 7.5E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 5.5E-08 1.8E-06 mg/kg-day NA NA

Benzo(a)pyrene 1.2E-02 mg/kg 1.2E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 8.4E-07 2.7E-06 mg/kg-day NA NA

Benzo(b)fluoranthene 6.4E-03 mg/kg 6.3E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 4.6E-08 1.5E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene 3.9E-03 mg/kg 3.9E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 2.8E-07 9.0E-07 mg/kg-day NA NA

Indeno(1,2,3-cd)pyrene 9.9E-03 mg/kg 9.7E-08 mg/kg-day 7.3E-01 1/(mg/kg-day) 7.1E-08 2.3E-06 mg/kg-day NA NA

Dioxin-Like PCB TEQ 5.0E-06 mg/kg 4.9E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 7.7E-06 1.2E-09 mg/kg-day NA NA

Nondioxin-Like 1.4E-01 mg/kg 1.4E-06 mg/kg-day 1.0E+00 1/(mg/kg-day) 1.4E-06 3.3E-05 mg/kg-day NA NA

Total PCB 1.7E-01 mg/kg 1.6E-06 mg/kg-day NA NA 3.8E-05 mg/kg-day 2.0E-05 mg/kg-day 1.9E+00

Arsenic 1.3E-01 mg/kg 1.3E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.9E-06 3.0E-05 mg/kg-day 3.0E-04 mg/kg-day 1.0E-01

Copper 1.0E+01 mg/kg 1.0E-04 mg/kg-day NA NA 2.3E-03 mg/kg-day 4.0E-02 mg/kg-day 5.8E-02

Mercury 1.2E-01 mg/kg 1.2E-06 mg/kg-day NA NA 2.8E-05 mg/kg-day 1.0E-04 mg/kg-day 2.8E-01

Exp. Route Total 1.2E-05 2.3E+00

Exposure Point Total 1.2E-05 2.3E+00

Exposure Medium Total - Crab in Gowanus Canal 1.2E-05 2.3E+00

Total Fish Total of Receptor Risks - Fish 4.0E-06 Total of Receptor Hazards - Fish 1.7E+00

Total Blue Crab Total of Receptor Risks - Blur Crab 1.2E-05 Total of Receptor Hazards - Blue Crab 2.3E+00

Notes-

NA = Not available / Not applicable.

Page 311: Appendix L HHRA Combined

TABLE 7.8.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Striped Bass in Gowanus Canal

Ingestion

p,p'-DDE 1.2E-02 mg/kg 7.9E-09 mg/kg-day 3.4E-01 1/(mg/kg-day) 2.7E-09 1.8E-07 mg/kg-day NA NA

p,p'-DDT 9.6E-03 mg/kg 6.3E-09 mg/kg-day 3.4E-01 1/(mg/kg-day) 2.1E-09 1.5E-07 mg/kg-day 5.0E-04 mg/kg-day 2.9E-04

Dioxin-Like PCB TEQ 4.3E-06 mg/kg 2.8E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 4.4E-07 6.6E-11 mg/kg-day NA NA

Nondioxin-Like 4.1E-01 mg/kg 2.7E-07 mg/kg-day 1.0E+00 1/(mg/kg-day) 2.7E-07 6.3E-06 mg/kg-day NA NA

Total PCB 4.4E-01 mg/kg 2.9E-07 mg/kg-day NA NA 6.7E-06 mg/kg-day 2.0E-05 mg/kg-day 3.3E-01

Arsenic 6.8E-02 mg/kg 4.5E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 6.7E-08 1.0E-06 mg/kg-day 3.0E-04 mg/kg-day 3.5E-03

Mercury 2.0E-01 mg/kg 1.3E-07 mg/kg-day NA NA 3.1E-06 mg/kg-day 1.0E-04 mg/kg-day 3.1E-02

Selenium 1.2E+00 mg/kg 7.9E-07 mg/kg-day NA NA 1.8E-05 mg/kg-day 5.0E-03 mg/kg-day 3.7E-03

Exp. Route Total 7.8E-07 3.7E-01

Exposure Point Total 7.8E-07 3.7E-01

Exposure Medium Total - Striped Bass in Gowanus Canal 7.8E-07 3.7E-01

Fish and Crab Tissue

White Perch in Gowanus Canal

Ingestion

Dioxin-Like PCB TEQ 5.8E-06 mg/kg 4.0E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 6.2E-08 9.3E-12 mg/kg-day NA NA

Nondioxin-Like 4.4E-01 mg/kg 3.0E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 3.0E-08 7.0E-07 mg/kg-day NA NA

Total PCB 4.6E-01 mg/kg 3.2E-08 mg/kg-day NA NA 7.4E-07 mg/kg-day 2.0E-05 mg/kg-day 3.7E-02

Mercury 1.9E-01 mg/kg 1.3E-08 mg/kg-day NA NA 3.0E-07 mg/kg-day 1.0E-04 mg/kg-day 3.0E-03

Selenium 1.4E+00 mg/kg 9.6E-08 mg/kg-day NA NA 2.2E-06 mg/kg-day 5.0E-03 mg/kg-day 4.5E-04

Exp. Route Total 9.2E-08 4.1E-02

Exposure Point Total 9.2E-08 4.1E-02

Exposure Medium Total - White Perch in Gowanus Canal 9.2E-08 4.1E-02

Page 312: Appendix L HHRA Combined

TABLE 7.8.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Eel in Gowanus Canal Ingestion

alpha-Chlordane 2.2E-02 mg/kg 1.2E-08 mg/kg-day 3.5E-01 1/(mg/kg-day) 4.3E-09 2.8E-07 mg/kg-day 5.0E-04 mg/kg-day 5.7E-04

Dieldrin 1.7E-02 mg/kg 9.4E-09 mg/kg-day 1.6E+01 1/(mg/kg-day) 1.5E-07 2.2E-07 mg/kg-day 5.0E-05 mg/kg-day 4.4E-03

gamma-Chlordane 1.3E-02 mg/kg 7.2E-09 mg/kg-day 3.5E-01 1/(mg/kg-day) 2.5E-09 1.7E-07 mg/kg-day 5.0E-04 mg/kg-day 3.4E-04

p,p'-DDD 3.8E-02 mg/kg 2.1E-08 mg/kg-day 2.4E-01 1/(mg/kg-day) 5.1E-09 4.9E-07 mg/kg-day NA NA

p,p'-DDE 2.5E-02 mg/kg 1.4E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 4.7E-09 3.2E-07 mg/kg-day NA NA

p,p'-DDT 4.7E-02 mg/kg 2.6E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 8.9E-09 6.1E-07 mg/kg-day 5.0E-04 mg/kg-day 1.2E-03

Dioxin-Like PCB TEQ 1.4E-05 mg/kg 7.8E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.2E-06 1.8E-10 mg/kg-day NA NA

Nondioxin-Like 1.2E+00 mg/kg 6.8E-07 mg/kg-day 1.0E+00 1/(mg/kg-day) 6.8E-07 1.6E-05 mg/kg-day NA NA

Total PCB 1.4E+00 mg/kg 7.5E-07 mg/kg-day NA NA 1.7E-05 mg/kg-day 2.0E-05 mg/kg-day 8.7E-01

Arsenic 5.0E-02 mg/kg 2.8E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 4.2E-08 6.5E-07 mg/kg-day 3.0E-04 mg/kg-day 2.2E-03

Chromium (12-15)* 6.7E-01 mg/kg 3.7E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 5.6E-07 8.7E-06 mg/kg-day 3.0E-03 mg/kg-day 2.9E-03

Copper 7.4E+00 mg/kg 4.1E-06 mg/kg-day NA NA 9.6E-05 mg/kg-day 4.0E-02 mg/kg-day 2.4E-03

Cyanide, total 3.1E+00 mg/kg 1.7E-06 mg/kg-day NA NA 4.0E-05 mg/kg-day 2.0E-02 mg/kg-day 2.0E-03

Mercury 2.6E-01 mg/kg 1.4E-07 mg/kg-day NA NA 3.4E-06 mg/kg-day 1.0E-04 mg/kg-day 3.4E-02

Selenium 1.4E+00 mg/kg 7.8E-07 mg/kg-day NA NA 1.8E-05 mg/kg-day 5.0E-03 mg/kg-day 3.6E-03

Exp. Route Total 2.7E-06 9.3E-01

Exposure Point Total 2.7E-06 9.3E-01

Exposure Medium Total - Eel in Gowanus Canal 2.7E-06 9.3E-01

Page 313: Appendix L HHRA Combined

TABLE 7.8.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Blue Crab in Gowanus Canal

Ingestion

Benzo(a)anthracene (12-15)* 7.7E-03 mg/kg 5.9E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.3E-07 1.4E-06 mg/kg-day NA NA

Benzo(a)pyrene (12-15)* 1.2E-02 mg/kg 9.1E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 2.0E-06 2.1E-06 mg/kg-day NA NA

Benzo(b)fluoranthene (12-15)* 6.4E-03 mg/kg 4.9E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.1E-07 1.2E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (12-15)* 3.9E-03 mg/kg 3.0E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 6.7E-07 7.1E-07 mg/kg-day NA NA

Indeno(1,2,3-cd)pyrene (12-15)* 9.9E-03 mg/kg 7.6E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.7E-07 1.8E-06 mg/kg-day NA NA

Dioxin-Like PCB TEQ 5.0E-06 mg/kg 3.9E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 6.1E-06 1.8E-10 mg/kg-day NA NA

Nondioxin-Like 1.4E-01 mg/kg 1.1E-06 mg/kg-day 1.0E+00 1/(mg/kg-day) 1.1E-06 5.1E-06 mg/kg-day NA NA

Total PCB 1.7E-01 mg/kg 1.3E-06 mg/kg-day NA NA 6.0E-06 mg/kg-day 2.0E-05 mg/kg-day 3.0E-01

Arsenic 1.3E-01 mg/kg 1.0E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.5E-06 2.4E-05 mg/kg-day 3.0E-04 mg/kg-day 7.9E-02

Copper 1.0E+01 mg/kg 7.9E-05 mg/kg-day NA NA 1.8E-03 mg/kg-day 4.0E-02 mg/kg-day 4.6E-02

Mercury 1.2E-01 mg/kg 9.6E-07 mg/kg-day NA NA 2.2E-05 mg/kg-day 1.0E-04 mg/kg-day 2.2E-01

Exp. Route Total 1.2E-05 6.5E-01

Exposure Point Total 1.2E-05 6.5E-01

Exposure Medium Total - Crab in Gowanus Canal 1.2E-05 6.5E-01

Total Fish Total of Receptor Risks - Fish 3.5E-06 Total of Receptor Hazards - Fish 1.3E+00

Total Blue Crab Total of Receptor Risks - Blur Crab 1.2E-05 Total of Receptor Hazards - Blue Crab 6.5E-01

Notes-

NA = Not available / Not applicable.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used to adjust CSF for 12-15 year old for exposure duration of 3 years, the CTE exposure duration for an adolescent.

Page 314: Appendix L HHRA Combined

TABLE 7.9.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Striped Bass in Gowanus Canal

Ingestion

p,p'-DDE 1.2E-02 mg/kg 1.5E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 5.2E-09 3.6E-07 mg/kg-day NA NA

p,p'-DDT 9.6E-03 mg/kg 1.2E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 4.1E-09 2.8E-07 mg/kg-day 5.0E-04 mg/kg-day 5.7E-04

Dioxin-Like PCB TEQ 4.3E-06 mg/kg 5.5E-12 mg/kg-day 1.6E+05 1/(mg/kg-day) 8.5E-07 1.3E-10 mg/kg-day NA NA

Nondioxin-Like 4.1E-01 mg/kg 5.2E-07 mg/kg-day 1.0E+00 1/(mg/kg-day) 5.2E-07 1.2E-05 mg/kg-day NA NA

Total PCB 4.4E-01 mg/kg 5.5E-07 mg/kg-day NA NA 1.3E-05 mg/kg-day 2.0E-05 mg/kg-day 6.4E-01

Arsenic 6.8E-02 mg/kg 8.6E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 1.3E-07 2.0E-06 mg/kg-day 3.0E-04 mg/kg-day 6.7E-03

Mercury 2.0E-01 mg/kg 2.5E-07 mg/kg-day NA 1/(mg/kg-day) NA 5.9E-06 mg/kg-day 1.0E-04 mg/kg-day 5.9E-02

Selenium 1.2E+00 mg/kg 1.5E-06 mg/kg-day NA NA 3.6E-05 mg/kg-day 5.0E-03 mg/kg-day 7.1E-03

Exp. Route Total 1.5E-06 7.2E-01

Exposure Point Total 1.5E-06 7.2E-01

Exposure Medium Total - Striped Bass in Gowanus Canal 1.5E-06 7.2E-01

Fish and Crab Tissue

White Perch in Gowanus Canal

Ingestion

Dioxin-Like PCB TEQ 5.8E-06 mg/kg 8.1E-13 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.3E-07 1.9E-11 mg/kg-day NA NA

Nondioxin-Like 4.4E-01 mg/kg 6.1E-08 mg/kg-day 1.0E+00 1/(mg/kg-day) 6.1E-08 1.4E-06 mg/kg-day NA NA

Total PCB 4.6E-01 mg/kg 6.4E-08 mg/kg-day NA NA 1.5E-06 mg/kg-day 2.0E-05 mg/kg-day 7.5E-02

Mercury 1.9E-01 mg/kg 2.6E-08 mg/kg-day NA NA 6.2E-07 mg/kg-day 1.0E-04 mg/kg-day 6.2E-03

Selenium 1.4E+00 mg/kg 1.9E-07 mg/kg-day NA NA 4.5E-06 mg/kg-day 5.0E-03 mg/kg-day 9.1E-04

Exp. Route Total 1.9E-07 8.2E-02

Exposure Point Total 1.9E-07 8.2E-02

Exposure Medium Total - White Perch in Gowanus Canal 1.9E-07 8.2E-02

Page 315: Appendix L HHRA Combined

TABLE 7.9.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Surface Water/Sediment

Fish and Crab Tissue

Eel in Gowanus Canal Ingestion

alpha-Chlordane 2.2E-02 mg/kg 2.5E-08 mg/kg-day 3.5E-01 1/(mg/kg-day) 8.6E-09 5.7E-07 mg/kg-day 5.0E-04 mg/kg-day 1.1E-03

Dieldrin 1.7E-02 mg/kg 1.9E-08 mg/kg-day 1.6E+01 1/(mg/kg-day) 3.0E-07 4.4E-07 mg/kg-day 5.0E-05 mg/kg-day 8.9E-03

gamma-Chlordane 1.3E-02 mg/kg 1.5E-08 mg/kg-day 3.5E-01 1/(mg/kg-day) 5.1E-09 3.4E-07 mg/kg-day 5.0E-04 mg/kg-day 6.8E-04

p,p'-DDD 3.8E-02 mg/kg 4.3E-08 mg/kg-day 2.4E-01 1/(mg/kg-day) 1.0E-08 9.9E-07 mg/kg-day NA NA

p,p'-DDE 2.5E-02 mg/kg 2.8E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 9.5E-09 6.5E-07 mg/kg-day NA NA

p,p'-DDT 4.7E-02 mg/kg 5.3E-08 mg/kg-day 3.4E-01 1/(mg/kg-day) 1.8E-08 1.2E-06 mg/kg-day 5.0E-04 mg/kg-day 2.5E-03

Dioxin-Like PCB TEQ 1.4E-05 mg/kg 1.6E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 2.5E-06 3.7E-10 mg/kg-day NA NA

Nondioxin-Like 1.2E+00 mg/kg 1.4E-06 mg/kg-day 1.0E+00 1/(mg/kg-day) 1.4E-06 3.2E-05 mg/kg-day NA NA

Total PCB 1.4E+00 mg/kg 1.5E-06 mg/kg-day NA NA 3.5E-05 mg/kg-day 2.0E-05 mg/kg-day 1.8E+00

Arsenic 5.0E-02 mg/kg 5.6E-08 mg/kg-day 1.5E+00 1/(mg/kg-day) 8.4E-08 1.3E-06 mg/kg-day 3.0E-04 mg/kg-day 4.4E-03

Chromium (0-2)* 6.7E-01 mg/kg 5.0E-07 mg/kg-day 5.0E+00 1/(mg/kg-day) 2.5E-06 1.8E-05 mg/kg-day 3.0E-03 mg/kg-day 5.8E-03

Chromium (2-3)* 6.7E-01 mg/kg 2.5E-07 mg/kg-day 1.5E+00 1/(mg/kg-day) 3.8E-07

Copper 7.4E+00 mg/kg 8.3E-06 mg/kg-day NA NA 1.9E-04 mg/kg-day 4.0E-02 mg/kg-day 4.8E-03

Cyanide, total 3.1E+00 mg/kg 3.5E-06 mg/kg-day NA NA 8.1E-05 mg/kg-day 2.0E-02 mg/kg-day 4.1E-03

Mercury 2.6E-01 mg/kg 2.9E-07 mg/kg-day NA NA 6.8E-06 mg/kg-day 1.0E-04 mg/kg-day 6.8E-02

Selenium 1.4E+00 mg/kg 1.6E-06 mg/kg-day NA NA 3.7E-05 mg/kg-day 5.0E-03 mg/kg-day 7.3E-03

Exp. Route Total 7.1E-06 1.9E+00

Exposure Point Total 7.1E-06 1.9E+00

Exposure Medium Total - Eel in Gowanus Canal 7.1E-06 1.9E+00

Page 316: Appendix L HHRA Combined

TABLE 7.9.CTE

CALCULATION OF CHEMICAL CANCER RISKS AND NON-CANCER HAZARDS

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium

Exposure Medium Exposure Point Exposure Route Chemical of EPC Cancer Risk Calculations Non-Cancer Hazard Calculations

Potential ConcernValue Units Intake/Exposure Concentration CSF/Unit Risk

Cancer RiskIntake/Exposure Concentration RfD/RfC

Hazard Quotient

Value Units Value Units Value Units Value Units

Fish and Crab Tissue

Blue Crab in Gowanus Canal

Ingestion

Benzo(a)anthracene (0-2)* 7.7E-03 mg/kg 7.8E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 5.7E-07 2.7E-06 mg/kg-day NA NA

Benzo(a)anthracene (2-3)* 7.7E-03 mg/kg 3.9E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 8.5E-08

Benzo(a)pyrene (0-2)* 1.2E-02 mg/kg 1.2E-07 mg/kg-day 7.3E+01 1/(mg/kg-day) 8.7E-06 4.2E-06 mg/kg-day NA NA

Benzo(a)pyrene (2-3)* 1.2E-02 mg/kg 6.0E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 1.3E-06

Benzo(b)fluoranthene (0-2)* 6.4E-03 mg/kg 6.5E-08 mg/kg-day 7.3E+00 1/(mg/kg-day) 4.7E-07 2.3E-06 mg/kg-day NA NA

Benzo(b)fluoranthene (2-3)* 6.4E-03 mg/kg 3.2E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 7.1E-08

Dibenz(a,h)anthracene (0-2)* 3.9E-03 mg/kg 4.0E-08 mg/kg-day 7.3E+01 1/(mg/kg-day) 2.9E-06 1.4E-06 mg/kg-day NA NA

Dibenz(a,h)anthracene (2-3)* 3.9E-03 mg/kg 2.0E-08 mg/kg-day 2.2E+01 1/(mg/kg-day) 4.4E-07

Indeno(1,2,3-cd)pyrene (0-2)* 9.9E-03 mg/kg 1.0E-07 mg/kg-day 7.3E+00 1/(mg/kg-day) 7.3E-07 3.5E-06 mg/kg-day NA NA

Indeno(1,2,3-cd)pyrene (2-3)* 9.9E-03 mg/kg 5.0E-08 mg/kg-day 2.2E+00 1/(mg/kg-day) 1.1E-07

Dioxin-Like PCB TEQ 5.0E-06 mg/kg 7.6E-11 mg/kg-day 1.6E+05 1/(mg/kg-day) 1.2E-05 1.8E-09 mg/kg-day NA NA

Nondioxin-Like 1.4E-01 mg/kg 2.2E-06 mg/kg-day 1.0E+00 1/(mg/kg-day) 2.2E-06 5.1E-05 mg/kg-day NA NA

Total PCB 1.7E-01 mg/kg 2.5E-06 mg/kg-day NA NA 5.9E-05 mg/kg-day 2.0E-05 mg/kg-day 2.9E+00

Arsenic 1.3E-01 mg/kg 2.0E-06 mg/kg-day 1.5E+00 1/(mg/kg-day) 3.0E-06 4.6E-05 mg/kg-day 3.0E-04 mg/kg-day 1.5E-01

Copper 1.0E+01 mg/kg 1.5E-04 mg/kg-day NA NA 3.6E-03 mg/kg-day 4.0E-02 mg/kg-day 9.0E-02

Mercury 1.2E-01 mg/kg 1.9E-06 mg/kg-day NA NA 4.4E-05 mg/kg-day 1.0E-04 mg/kg-day 4.4E-01

Exp. Route Total 3.2E-05 3.6E+00

Exposure Point Total 3.2E-05 3.6E+00

Exposure Medium Total - Crab in Gowanus Canal 3.2E-05 3.6E+00

Total Fish Total of Receptor Risks - Fish 8.8E-06 Total of Receptor Hazards - Fish 2.7E+00

Total Blue Crab Total of Receptor Risks - Blur Crab 3.2E-05 Total of Receptor Hazards - Blue Crab 3.6E+00

Notes-

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 used to adjust CSF for 2-3 year old for exposure duration of 1 year, for a total CTE exposure duration of 3 years.

Non-cancer calculations shown under 0-2 year old only, as non-cancer calculations are not adjusted for MMOA.

NA = Not available / Not applicable.

Page 317: Appendix L HHRA Combined

TABLE 9.1.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Acenaphthene NA NA NA 0.0E+00 Liver 3.1E-04 NA 1.7E-03 2.0E-03

Benzo(a)anthracene 1.6E-06 NA 8.7E-06 1.0E-05 NA NA NA 0.0E+00

Benzo(a)pyrene 1.4E-05 NA 7.4E-05 8.7E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene 1.4E-06 NA 7.8E-06 9.2E-06 NA NA NA 0.0E+00

Benzo(k)fluoranthene 8.2E-08 NA 4.4E-07 5.3E-07 NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate 8.2E-09 NA 3.4E-08 4.2E-08 Increased Liver Weight 8.5E-05 NA 3.5E-04 4.4E-04

Chrysene 3.2E-08 NA 1.7E-07 2.1E-07 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 7.9E-07 NA 4.3E-06 5.0E-06 NA NA NA 0.0E+00

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 6.3E-04 NA 3.4E-03 4.0E-03

Indeno(1,2,3-c,d)pyrene 6.2E-07 NA 3.4E-06 4.0E-06 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 8.7E-06 NA 4.7E-05 5.6E-05

Pyrene NA NA NA 0.0E+00 Kidney 9.0E-04 NA 4.8E-03 5.7E-03

Dioxin-Like PCB TEQ 1.1E-07 NA 6.4E-07 7.5E-07 NA NA NA 0.0E+00

Nondioxin-Like PCB 1.8E-07 NA 1.1E-06 1.2E-06 NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.4E-02 NA 8.0E-02 9.3E-02

Aluminum NA NA NA 0.0E+00 Neurological 8.1E-04 NA 3.4E-04 1.1E-03

Arsenic 4.7E-07 NA 5.9E-07 1.1E-06 Skin, Vascular 3.1E-03 NA 3.8E-03 6.9E-03

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) 4.9E-04 NA 8.1E-04 1.3E-03

Chromium 8.2E-07 NA 1.4E-05 1.4E-05 Not identified 1.6E-03 NA 2.6E-02 2.8E-02

Cobalt NA NA NA 0.0E+00 Thyroid 2.2E-03 NA 9.1E-04 3.1E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 4.5E-04 NA 1.9E-04 6.3E-04

Iron NA NA NA 0.0E+00 Gastrointestinal 2.9E-03 NA 1.2E-03 4.1E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Manganese NA NA NA 0.0E+00 CNS 1.1E-04 NA 6.9E-03 7.0E-03

Vanadium NA NA NA 0.0E+00 Hair 5.1E-04 NA 2.1E-04 7.2E-04

Chemical Total 2.0E-05 NA 1.1E-04 1.3E-04 2.8E-02 NA 1.3E-01 1.6E-01

Exposed Surface Sediment Total 1.3E-04 1.6E-01

Page 318: Appendix L HHRA Combined

TABLE 9.1.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Dry event) Benzene 5.6E-09 NA 3.6E-08 4.1E-08 Blood, Immune 7.4E-05 NA 4.7E-04 5.5E-04

Benzo(a)anthracene 8.8E-09 NA 3.6E-06 3.6E-06 NA NA NA 0.0E+00

Benzo(a)pyrene 2.2E-07 NA 1.5E-04 1.6E-04 NA NA NA 0.0E+00

Benzo(b)fluoranthene 9.9E-09 NA 7.1E-06 7.1E-06 NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate 1.6E-09 NA 7.8E-08 8.0E-08 Increased Liver Weight 1.6E-05 NA 8.2E-04 8.3E-04

Indeno(1,2,3-c,d)pyrene 4.4E-09 NA 3.1E-06 3.2E-06 NA NA NA 0.0E+00

Arsenic 1.4E-06 NA 4.9E-07 1.8E-06 Skin, Vascular 8.8E-03 NA 3.2E-03 1.2E-02

Chromium 4.3E-07 NA 1.2E-05 1.3E-05 Not identified 8.3E-04 NA 2.4E-02 2.5E-02

Copper 0.0E+00 NA NA 0.0E+00 Gastrointestinal 5.7E-04 NA 2.0E-04 7.7E-04

Selenium 0.0E+00 NA NA 0.0E+00 Whole Body 1.1E-03 NA 3.9E-04 1.5E-03

Chemical Total 2.0E-06 NA 1.8E-04 1.8E-04 1.1E-02 NA 2.9E-02 4.0E-02

Surface Water Total - Dry Event 1.8E-04 4.0E-02

Page 319: Appendix L HHRA Combined

TABLE 9.1.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) 1,4-dichlorobenzene 1.4E-10 NA 3.2E-09 3.4E-09 Liver 1.1E-06 NA 2.5E-05 2.6E-05

Benzene 2.1E-09 NA 1.3E-08 1.5E-08 Blood, Immune 2.8E-05 NA 1.8E-04 2.0E-04

Chloroform 7.9E-10 NA 2.6E-09 3.4E-09 Liver, Body Weight 7.4E-06 NA 2.5E-05 3.2E-05

Ethylbenzene 4.3E-10 NA 9.3E-09 9.8E-09 Liver, Kidney 1.1E-06 NA 2.5E-05 2.6E-05

Tetrachloroethylene(PCE) 6.0E-07 NA 1.2E-05 1.2E-05 Liver 3.2E-04 NA 6.4E-03 6.7E-03

Benzo(a)anthracene 3.4E-09 NA 1.4E-06 1.4E-06 NA NA NA 0.0E+00

Benzo(a)pyrene 6.8E-08 NA 4.8E-05 4.8E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene 6.3E-09 NA 4.5E-06 4.5E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 3.3E-08 NA 3.7E-05 3.7E-05 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene 1.7E-08 NA 1.2E-05 1.2E-05 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 2.4E-06 NA 5.5E-05 5.7E-05

Arsenic 1.1E-06 NA 4.1E-07 1.5E-06 Skin, Vascular 7.3E-03 NA 2.6E-03 1.0E-02

Chromium 1.9E-07 NA 5.6E-06 5.8E-06 Not identified 3.8E-04 NA 1.1E-02 1.1E-02

Cobalt NA NA NA 0.0E+00 Thyroid 1.7E-03 NA 2.5E-04 2.0E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Selenium NA NA NA 0.0E+00 Whole Body 8.9E-04 NA 3.2E-04 1.2E-03

Chemical Total 2.1E-06 NA 1.2E-04 1.2E-04 1.1E-02 NA 2.1E-02 3.1E-02

Surface Water Total - Wet Event 1.2E-04 3.1E-02

Page 320: Appendix L HHRA Combined

TABLE 9.1.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at canal

level

(pre-aeration system Benzene NA 1.9E-08 NA 1.9E-08 Blood NA 2.4E-04 NA 2.4E-04

operation) Chloroform NA 1.4E-08 NA 1.4E-08 Liver NA 1.7E-05 NA 1.7E-05

Ethylbenzene NA 1.5E-08 NA 1.5E-08 Developmental NA 1.7E-05 NA 1.7E-05

Xylene, total NA NA NA 0.0E+00 Impaired motor coordination NA 7.8E-04 NA 7.8E-04

Naphthalene NA 1.9E-07 NA 1.9E-07 Nasal, Respiratory NA 5.4E-03 NA 5.4E-03

Chemical Total NA 2.4E-07 NA 2.4E-07 NA 6.4E-03 NA 6.4E-03

Ambient air at canal level Total - Pre-aeration system operation 2.4E-07 6.4E-03

Air Air

Ambient air at canal

level

(after aeration system Benzene NA 4.0E-08 NA 4.0E-08 Blood NA 5.0E-04 NA 5.0E-04

started) Chloroform NA 1.2E-08 NA 1.2E-08 Liver NA 1.6E-05 NA 1.6E-05

Ethylbenzene NA 1.4E-08 NA 1.4E-08 Developmental NA 1.6E-05 NA 1.6E-05

Xylene, total NA NA NA 0.0E+00 Impaired motor coordination NA 1.3E-03 NA 1.3E-03

Naphthalene NA 2.0E-07 NA 2.0E-07 Nasal, Respiratory NA 5.6E-03 NA 5.6E-03

Chemical Total NA 2.6E-07 NA 2.6E-07 NA 7.5E-03 NA 7.5E-03

Ambient air at canal level Total - After aeration system turned on 2.6E-07 7.5E-03

Receptor Total 3.2E-04 Receptor HI Total 2.1E-01

Page 321: Appendix L HHRA Combined

TABLE 9.1.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 5.1E-03

CNS - Central Nervous System Total Body Weight HI Across All Media = 1.4E-04

Receptor Total and target organ total includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air Total Developmental HI Across All Media = 1.7E-05

prior to areation system operation and after aeration system started Total Finger and Toe Nails HI Across All Media = 9.3E-02

Total Gastrointestinal HI Across All Media = 5.5E-03

Total Hair HI Across All Media = 7.2E-04

Total Kidney HI Across All Media = 1.1E-02

Total Immune HI Across All Media = 5.5E-04

Total Liver HI Across All Media = 1.4E-02

Total Nasal HI Across All Media = 5.6E-03

Total Nervous System HI Across All Media = 9.5E-03

Total Ocular HI Across All Media = 9.3E-02

Total Respiratory HI Across All Media = 5.6E-03

Total Skin HI Across All Media = 1.9E-02

Total Thyroid HI Across All Media = 5.1E-03

Total Vascular HI Across All Media = 1.9E-02

Total Whole Body HI Across All Media = 1.5E-03

Page 322: Appendix L HHRA Combined

TABLE 9.2.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Acenaphthene NA NA NA 0.0E+00 Liver 3.8E-04 NA 2.1E-03 2.5E-03

Benzo(a)anthracene (12-16)* 9.9E-07 NA 5.4E-06 6.4E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (16-18)* 1.7E-07 NA 9.0E-07 1.1E-06

Benzo(a)pyrene (12-16)* 8.4E-06 NA 4.6E-05 5.4E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 1.4E-06 NA 7.6E-06 9.0E-06

Benzo(b)fluoranthene (12-16)* 8.8E-07 NA 4.8E-06 5.7E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (16-18)* 1.5E-07 NA 8.0E-07 9.5E-07

Benzo(k)fluoranthene (12-16)* 5.1E-08 NA 2.8E-07 3.3E-07 NA NA NA 0.0E+00

Benzo(k)fluoranthene (16-18)* 8.4E-09 NA 4.6E-08 5.4E-08

Bis(2-ethylhexyl) phthalate 2.5E-09 NA 1.0E-08 1.3E-08 Increased Liver Weight 1.0E-04 NA 4.4E-04 5.4E-04

Chrysene (12-16)* 2.0E-08 NA 1.1E-07 1.3E-07 NA NA NA 0.0E+00

Chrysene (16-18)* 3.3E-09 NA 1.8E-08 2.1E-08

Dibenz(a,h)anthracene (12-16)* 4.8E-07 NA 2.6E-06 3.1E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (16-18)* 8.1E-08 NA 4.4E-07 5.2E-07

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 7.7E-04 NA 4.2E-03 5.0E-03

Indeno(1,2,3-c,d)pyrene (12-16)* 3.8E-07 NA 2.1E-06 2.5E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (16-18)* 6.4E-08 NA 3.5E-07 4.1E-07

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 1.1E-05 NA 5.8E-05 6.9E-05

Pyrene NA NA NA 0.0E+00 Kidney 1.1E-03 NA 6.0E-03 7.1E-03

Dioxin-Like PCB TEQ 3.4E-08 NA 2.0E-07 2.3E-07 NA NA NA 0.0E+00

Nondioxin-Like PCB 5.6E-08 NA 3.3E-07 3.8E-07 NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.7E-02 NA 9.9E-02 1.2E-01

Aluminum NA NA NA 0.0E+00 Neurological 9.9E-04 NA 4.2E-04 1.4E-03

Arsenic 1.4E-07 NA 1.8E-07 3.3E-07 Skin, Vascular 3.7E-03 NA 4.7E-03 8.5E-03

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) 6.0E-04 NA 1.0E-03 1.6E-03

Chromium (12-16)* 5.0E-07 NA 8.4E-06 8.9E-06 Not identified 1.9E-03 NA 3.3E-02 3.5E-02

Chromium (16-18)* 8.3E-08 NA 1.4E-06 1.5E-06

Cobalt NA NA NA 0.0E+00 Thyroid 2.7E-03 NA 1.1E-03 3.8E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 5.5E-04 NA 2.3E-04 7.8E-04

Iron NA NA NA 0.0E+00 Gastrointestinal 3.6E-03 NA 1.5E-03 5.1E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Manganese NA NA NA 0.0E+00 CNS 1.4E-04 NA 8.6E-03 8.7E-03

Vanadium NA NA NA 0.0E+00 Hair 6.3E-04 NA 2.6E-04 8.9E-04

Chemical Total 1.4E-05 NA 8.2E-05 9.5E-05 3.4E-02 NA 1.6E-01 2.0E-01

Exposed Surface Sediment Total 9.5E-05 2.0E-01

Page 323: Appendix L HHRA Combined

TABLE 9.2.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Dry event) Benzene 1.7E-09 NA 9.6E-09 1.1E-08 Blood, Immune 9.1E-05 NA 5.1E-04 6.0E-04

Benzo(a)anthracene (12-16)* 5.4E-09 NA 2.0E-06 2.0E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (16-18)* 9.0E-10 NA 3.3E-07 3.3E-07

Benzo(a)pyrene (12-16)* 1.3E-07 NA 8.3E-05 8.3E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 2.2E-08 NA 1.4E-05 1.4E-05

Benzo(b)fluoranthene (12-16)* 6.1E-09 NA 3.8E-06 3.8E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (16-18)* 1.0E-09 NA 6.4E-07 6.4E-07

Bis(2-ethylhexyl) phthalate 4.8E-10 NA 2.1E-08 2.2E-08 Increased Liver Weight 2.0E-05 NA 8.8E-04 9.0E-04

Indeno(1,2,3-c,d)pyrene (12-16)* 2.7E-09 NA 1.7E-06 1.7E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (16-18)* 4.5E-10 NA 2.8E-07 2.8E-07

Arsenic 4.2E-07 NA 1.3E-07 5.5E-07 Skin, Vascular 1.1E-02 NA 3.4E-03 1.4E-02

Chromium (12-16)* 2.6E-07 NA 6.6E-06 6.9E-06 Not identified 1.0E-03 NA 2.6E-02 2.7E-02

Chromium (16-18)* 4.4E-08 NA 1.1E-06 1.1E-06

Copper 0.0E+00 NA NA 0.0E+00 Gastrointestinal 7.0E-04 NA 2.2E-04 9.2E-04

Selenium 0.0E+00 NA NA 0.0E+00 Whole Body 1.3E-03 NA 4.2E-04 1.8E-03

Chemical Total 9.0E-07 NA 1.1E-04 1.1E-04 1.4E-02 NA 3.1E-02 4.5E-02

Surface Water Total - Dry Event 1.1E-04 4.5E-02

Page 324: Appendix L HHRA Combined

TABLE 9.2.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) 1,4-dichlorobenzene 4.4E-11 NA 8.7E-10 9.2E-10 Liver 1.4E-06 NA 2.7E-05 2.8E-05

Benzene 6.4E-10 NA 3.6E-09 4.2E-09 Blood, Immune 3.4E-05 NA 1.9E-04 2.2E-04

Chloroform 2.4E-10 NA 7.1E-10 9.5E-10 Liver, Body Weight 9.1E-06 NA 2.7E-05 3.6E-05

Ethylbenzene 1.3E-10 NA 2.5E-09 2.6E-09 Liver, Kidney 1.4E-06 NA 2.7E-05 2.8E-05

Tetrachloroethylene(PCE) 1.8E-07 NA 3.2E-06 3.4E-06 Liver 4.0E-04 NA 6.9E-03 7.3E-03

Benzo(a)anthracene (12-16)* 2.1E-09 NA 7.6E-07 7.7E-07 NA NA NA 0.0E+00

Benzo(a)anthracene (16-18)* 3.5E-10 NA 4.3E-07 4.3E-07

Benzo(a)pyrene (12-16)* 4.2E-08 NA 2.6E-05 2.6E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 6.9E-09 NA 4.0E-06 4.0E-06

Benzo(b)fluoranthene (12-16)* 3.8E-09 NA 2.4E-06 2.4E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (16-18)* 6.4E-10 NA 3.3E-07 3.3E-07

Dibenz(a,h)anthracene (12-16)* 2.1E-08 NA 2.0E-05 2.0E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (16-18)* 3.4E-09 NA 1.1E-05 1.1E-05

Indeno(1,2,3-c,d)pyrene (12-16)* 1.0E-08 NA 6.4E-06 6.4E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (16-18)* 1.7E-09 NA 2.5E-08 2.6E-08

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 3.0E-06 NA 5.9E-05 6.2E-05

Arsenic 3.5E-07 NA 1.1E-07 4.6E-07 Skin, Vascular 9.0E-03 NA 2.8E-03 1.2E-02

Chromium (12-16)* 1.2E-07 NA 3.0E-06 3.1E-06 Not identified 4.6E-04 NA 1.2E-02 1.2E-02

Chromium (16-18)* 2.0E-08 NA 5.0E-07 5.2E-07

Cobalt NA NA NA 0.0E+00 Thyroid 2.1E-03 NA 2.7E-04 2.4E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Selenium NA NA NA 0.0E+00 Whole Body 1.1E-03 NA 3.4E-04 1.4E-03

Chemical Total 7.6E-07 NA 7.7E-05 7.8E-05 1.3E-02 NA 2.2E-02 3.5E-02

Surface Water Total - Wet Event 7.8E-05 3.5E-02

Page 325: Appendix L HHRA Combined

TABLE 9.2.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at canal

level

(pre-aeration system Benzene NA 4.7E-09 NA 4.7E-09 Blood NA 2.4E-04 NA 2.4E-04

operation) Chloroform NA 3.4E-09 NA 3.4E-09 Liver NA 1.7E-05 NA 1.7E-05

Ethylbenzene NA 3.7E-09 NA 3.7E-09 Developmental NA 1.7E-05 NA 1.7E-05

Xylene, total NA NA NA 0.0E+00 Impaired motor coordination NA 7.8E-04 NA 7.8E-04

Naphthalene NA 4.7E-08 NA 4.7E-08 Nasal, Respiratory NA 5.4E-03 NA 5.4E-03

Chemical Total NA 5.9E-08 NA 5.9E-08 NA 6.4E-03 NA 6.4E-03

Ambient air at canal level Total - Pre-aeration system operation 5.9E-08 6.4E-03

Air Air

Ambient air at canal

level

(after aeration system Benzene NA 1.0E-08 NA 1.0E-08 Blood NA 5.0E-04 NA 5.0E-04

started) Chloroform NA 3.1E-09 NA 3.1E-09 Liver NA 1.6E-05 NA 1.6E-05

Ethylbenzene NA 3.5E-09 NA 3.5E-09 Developmental NA 1.6E-05 NA 1.6E-05

Xylene, total NA NA NA 0.0E+00 Impaired motor coordination NA 1.3E-03 NA 1.3E-03

Naphthalene NA 4.9E-08 NA 4.9E-08 Nasal, Respiratory NA 5.6E-03 NA 5.6E-03

Chemical Total NA 6.6E-08 NA 6.6E-08 NA 7.5E-03 NA 7.5E-03

Ambient air at canal level Total - After aeration system turned on 6.6E-08 7.5E-03

Receptor Total 2.1E-04 Receptor HI Total 2.5E-01

Page 326: Appendix L HHRA Combined

TABLE 9.2.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 6.1E-03

CNS - Central Nervous System Total Body Weight HI Across All Media = 1.7E-04

Receptor Total and target organ total includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air Total Developmental HI Across All Media = 1.7E-05

prior to areation system operation and after aeration system started Total Finger and Toe Nails HI Across All Media = 1.2E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used to adjust CSF for 12-16 year old for exposure duration of 4 years, Total Gastrointestinal HI Across All Media = 6.8E-03

ADAF of 1 used to adjust CSF for 16-18 year old for exposure duration of 2 years. Non-cancer calculations shown under 12-16 year old only, Total Hair HI Across All Media = 8.9E-04

as non-cancer calculations are not adjusted for MMOA. Total Kidney HI Across All Media = 1.4E-02

Total Immune HI Across All Media = 6.0E-04

Total Liver HI Across All Media = 1.6E-02

Total Nasal HI Across All Media = 5.6E-03

Total Nervous System HI Across All Media = 1.1E-02

Total Ocular HI Across All Media = 1.2E-01

Total Respiratory HI Across All Media = 5.6E-03

Total Skin HI Across All Media = 2.3E-02

Total Thyroid HI Across All Media = 6.2E-03

Total Vascular HI Across All Media = 2.3E-02

Total Whole Body HI Across All Media = 1.8E-03

Page 327: Appendix L HHRA Combined

TABLE 9.3.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Acenaphthene NA NA NA 0.0E+00 Liver 2.9E-03 NA 2.1E-03 5.0E-03

Benzo(a)anthracene (0-2)* 1.3E-05 NA 9.2E-06 2.2E-05 NA NA NA 0.0E+00

Benzo(a)anthracene (2-6)* 7.5E-06 NA 5.5E-06 1.3E-05

Benzo(a)pyrene (0-2)* 1.1E-04 NA 7.7E-05 1.8E-04 NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 6.4E-05 NA 4.6E-05 1.1E-04

Benzo(b)fluoranthene (0-2)* 1.1E-05 NA 8.1E-06 1.9E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-6)* 6.7E-06 NA 4.9E-06 1.2E-05

Benzo(k)fluoranthene (0-2)* 6.4E-07 NA 4.7E-07 1.1E-06 NA NA NA 0.0E+00

Benzo(k)fluoranthene (2-6)* 3.8E-07 NA 2.8E-07 6.6E-07

Bis(2-ethylhexyl) phthalate 1.9E-08 NA 1.1E-08 3.0E-08 Increased Liver Weight 7.9E-04 NA 4.4E-04 1.2E-03

Chrysene (0-2)* 2.5E-07 NA 1.8E-07 4.3E-07 NA NA NA 0.0E+00

Chrysene (2-6)* 1.5E-07 NA 1.1E-07 2.6E-07

Dibenz(a,h)anthracene (0-2)* 6.1E-06 NA 4.5E-06 1.1E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-6)* 3.7E-06 NA 2.7E-06 6.3E-06

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 5.9E-03 NA 4.3E-03 1.0E-02

Indeno(1,2,3-c,d)pyrene (0-2)* 4.8E-06 NA 3.5E-06 8.4E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-6)* 2.9E-06 NA 2.1E-06 5.0E-06

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 8.1E-05 NA 5.9E-05 1.4E-04

Pyrene NA NA NA 0.0E+00 Kidney 8.4E-03 NA 6.1E-03 1.4E-02

Dioxin-Like PCB TEQ 2.6E-07 NA 2.0E-07 4.6E-07 NA NA NA 0.0E+00

Nondioxin-Like PCB 4.3E-07 NA 3.3E-07 7.6E-07 NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.3E-01 NA 1.0E-01 2.3E-01

Aluminum NA NA NA 0.0E+00 Neurological 7.6E-03 NA 4.2E-04 8.0E-03

Arsenic 1.1E-06 NA 1.8E-07 1.3E-06 Skin, Vascular 2.8E-02 NA 4.8E-03 3.3E-02

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) 4.6E-03 NA 1.0E-03 5.6E-03

Chromium 6.3E-06 NA 1.4E-05 2.1E-05 Not identified 1.5E-02 NA 3.3E-02 4.8E-02

3.8E-06 NA 8.5E-06 1.2E-05

Cobalt NA NA NA 0.0E+00 Thyroid 2.0E-02 NA 1.1E-03 2.2E-02

Copper NA NA NA 0.0E+00 Gastrointestinal 4.2E-03 NA 2.3E-04 4.4E-03

Iron NA NA NA 0.0E+00 Gastrointestinal 2.7E-02 NA 1.5E-03 2.9E-02

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Manganese NA NA NA 0.0E+00 CNS 1.1E-03 NA 8.7E-03 9.8E-03

Vanadium NA NA NA 0.0E+00 Hair 4.8E-03 NA 2.7E-04 5.0E-03

Chemical Total 2.4E-04 NA 1.9E-04 4.3E-04 2.6E-01 NA 1.6E-01 4.2E-01

Exposed Surface Sediment Total 4.3E-04 4.2E-01

Page 328: Appendix L HHRA Combined

TABLE 9.3.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Dry event) Benzene 6.5E-09 NA 1.5E-08 2.2E-08 Blood, Immune 3.5E-04 NA 8.1E-04 1.2E-03

Benzo(a)anthracene (0-2)* 3.4E-08 NA 5.2E-06 5.2E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-6)* 2.1E-08 NA 3.1E-06 3.1E-06

Benzo(a)pyrene (0-2)* 8.5E-07 NA 2.2E-04 2.2E-04 NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 5.1E-07 NA 1.3E-04 1.3E-04

Benzo(b)fluoranthene (0-2)* 3.8E-08 NA 1.0E-05 1.0E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-6)* 2.3E-08 NA 6.1E-06 6.1E-06

Bis(2-ethylhexyl) phthalate 1.8E-09 NA 3.4E-08 3.5E-08 Increased Liver Weight 7.6E-05 NA 1.4E-03 1.5E-03

Indeno(1,2,3-c,d)pyrene (0-2)* 1.7E-08 NA 4.5E-06 4.5E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-6)* 1.0E-08 NA 2.7E-06 2.7E-06

Arsenic 1.6E-06 NA 2.1E-07 1.8E-06 Skin, Vascular 4.1E-02 NA 5.4E-03 4.6E-02

Chromium (0-2)* 1.7E-06 NA 1.8E-05 1.9E-05 Not identified 3.9E-03 NA 4.1E-02 4.5E-02

Chromium (2-6)* 1.0E-06 NA 1.1E-05 1.2E-05

Copper 0.0E+00 NA NA 0.0E+00 Gastrointestinal 2.7E-03 NA 3.5E-04 3.0E-03

Selenium 0.0E+00 NA NA 0.0E+00 Whole Body 5.1E-03 NA 6.7E-04 5.7E-03

Chemical Total 5.8E-06 NA 4.1E-04 4.2E-04 5.3E-02 NA 5.0E-02 1.0E-01

Surface Water Total - Dry Event 4.2E-04 1.0E-01

Page 329: Appendix L HHRA Combined

TABLE 9.3.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) 1,4-dichlorobenzene 1.7E-10 NA 1.4E-09 1.6E-09 Liver 5.2E-06 NA 4.3E-05 4.8E-05

Benzene 2.4E-09 NA 5.7E-09 8.1E-09 Blood, Immune 1.3E-04 NA 3.0E-04 4.3E-04

Chloroform 9.2E-10 NA 1.1E-09 2.0E-09 Liver, Body Weight 3.5E-05 NA 4.2E-05 7.7E-05

Ethylbenzene 5.1E-10 NA 4.0E-09 4.5E-09 Liver, Kidney 5.4E-06 NA 4.2E-05 4.8E-05

Tetrachloroethylene(PCE) 7.0E-07 NA 5.1E-06 5.8E-06 Liver 1.5E-03 NA 1.1E-02 1.2E-02

Benzo(a)anthracene (0-2)* 1.3E-08 NA 2.0E-06 2.0E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-6)* 8.0E-09 NA 1.2E-06 1.2E-06

Benzo(a)pyrene (0-2)* 2.6E-07 NA 6.9E-05 6.9E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 1.6E-07 NA 4.1E-05 4.1E-05

Benzo(b)fluoranthene (0-2)* 2.4E-08 NA 6.4E-06 6.4E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-6)* 1.5E-08 NA 3.8E-06 3.9E-06

Dibenz(a,h)anthracene (0-2)* 1.3E-07 NA 5.2E-05 5.2E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-6)* 7.8E-08 NA 3.1E-05 3.1E-05

Indeno(1,2,3-c,d)pyrene (0-2)* 6.4E-08 NA 1.7E-05 1.7E-05 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-6)* 3.9E-08 NA 1.0E-05 1.0E-05

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 1.1E-05 NA 9.4E-05 1.1E-04

Arsenic 1.3E-06 NA 1.7E-07 1.5E-06 Skin, Vascular 3.4E-02 NA 4.5E-03 3.9E-02

Chromium (0-2)* 7.5E-07 NA 7.9E-06 8.7E-06 Not identified 1.8E-03 NA 1.9E-02 2.0E-02

Chromium (2-6)* 4.5E-07 NA 4.8E-06 5.2E-06

Cobalt NA NA NA 0.0E+00 Thyroid 8.0E-03 NA 4.2E-04 8.4E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Selenium NA NA NA 0.0E+00 Whole Body 4.1E-03 NA 5.5E-04 4.7E-03

Chemical Total 4.0E-06 NA 2.5E-04 2.6E-04 5.0E-02 NA 3.6E-02 8.5E-02

Surface Water Total - Wet Event 2.6E-04 8.5E-02

Page 330: Appendix L HHRA Combined

TABLE 9.3.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at canal

level

(pre-aeration system Benzene NA 4.7E-09 NA 4.7E-09 Blood NA 2.4E-04 NA 2.4E-04

operation) Chloroform NA 3.4E-09 NA 3.4E-09 Liver NA 1.7E-05 NA 1.7E-05

Ethylbenzene NA 3.7E-09 NA 3.7E-09 Developmental NA 1.7E-05 NA 1.7E-05

Xylene, total NA NA NA 0.0E+00 Impaired motor coordination NA 7.8E-04 NA 7.8E-04

Naphthalene NA 4.7E-08 NA 4.7E-08 Nasal, Respiratory NA 5.4E-03 NA 5.4E-03

Chemical Total NA 5.9E-08 NA 5.9E-08 NA 6.4E-03 NA 6.4E-03

Ambient air at canal level Total - Pre-aeration system operation 5.9E-08 6.4E-03

Air Air

Ambient air at canal

level

(after aeration system Benzene NA 1.0E-08 NA 1.0E-08 Blood NA 5.0E-04 NA 5.0E-04

started) Chloroform NA 3.1E-09 NA 3.1E-09 Liver NA 1.6E-05 NA 1.6E-05

Ethylbenzene NA 3.5E-09 NA 3.5E-09 Developmental NA 1.6E-05 NA 1.6E-05

Xylene, total NA NA NA 0.0E+00 Impaired motor coordination NA 1.3E-03 NA 1.3E-03

Naphthalene NA 4.9E-08 NA 4.9E-08 Nasal, Respiratory NA 5.6E-03 NA 5.6E-03

Chemical Total NA 6.6E-08 NA 6.6E-08 NA 7.5E-03 NA 7.5E-03

Ambient air at canal level Total - After aeration system turned on 6.6E-08 7.5E-03

Receptor Total 8.5E-04 Receptor HI Total 5.3E-01

Page 331: Appendix L HHRA Combined

TABLE 9.3.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 1.2E-02

CNS - Central Nervous System Total Body Weight HI Across All Media = 3.2E-04

Receptor Total and target organ total includes sum of exposed and near shore sediment, maximum of dry event and wet event surface water, and maximum of air Total Developmental HI Across All Media = 1.7E-05

prior to areation system operation and after aeration system started Total Finger and Toe Nails HI Across All Media = 2.3E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, Total Gastrointestinal HI Across All Media = 3.6E-02

ADAF of 3 used to adjust CSF for 2-6 year old for exposure duration of 4 years. Non-cancer calculations shown under 0-2 year old only, Total Hair HI Across All Media = 5.0E-03

as non-cancer calculations are not adjusted for MMOA. as non-cancer calculations are not adjusted for MMOA. Total Kidney HI Across All Media = 3.0E-02

Total Immune HI Across All Media = 1.2E-03

Total Liver HI Across All Media = 3.1E-02

Total Nasal HI Across All Media = 5.6E-03

Total Nervous System HI Across All Media = 1.9E-02

Total Ocular HI Across All Media = 2.3E-01

Total Respiratory HI Across All Media = 5.6E-03

Total Skin HI Across All Media = 8.0E-02

Total Thyroid HI Across All Media = 3.0E-02

Total Vascular HI Across All Media = 8.0E-02

Total Whole Body HI Across All Media = 5.7E-03

Page 332: Appendix L HHRA Combined

TABLE 9.4.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA 2.4E-06 NA 2.4E-06 Blood NA 2.9E-02 NA 2.9E-02

operation) Chloroform NA 1.4E-06 NA 1.4E-06 Liver NA 1.7E-03 NA 1.7E-03

Ethylbenzene NA 6.7E-07 NA 6.7E-07 Developmental NA 7.5E-04 NA 7.5E-04

Naphthalene NA 1.1E-05 NA 1.1E-05 Nasal, Respiratory NA 3.0E-01 NA 3.0E-01

Chemical Total NA 1.5E-05 NA 1.5E-05 NA 3.3E-01 NA 3.3E-01

Ambient air at street level Total - Pre-aeration system operation 1.5E-05 3.3E-01

Air Air

Ambient air at canal

level

(after aeration system Benzene NA 2.1E-06 NA 2.1E-06 Blood NA 2.5E-02 NA 2.5E-02

started) Chloroform NA 1.9E-06 NA 1.9E-06 Liver NA 2.3E-03 NA 2.3E-03

Ethylbenzene NA 7.6E-07 NA 7.6E-07 Developmental NA 8.5E-04 NA 8.5E-04

Naphthalene NA 2.5E-05 NA 2.5E-05 Nasal, Respiratory NA 6.9E-01 NA 6.9E-01

Chemical Total NA 3.0E-05 NA 3.0E-05 NA 7.2E-01 NA 7.2E-01

Ambient air at street level Total - After aeration system turned on 3.0E-05 7.2E-01

Page 333: Appendix L HHRA Combined

TABLE 9.4.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

2-methylnaphthalene NA NA NA 0.0E+00 Lung 3.2E-03 NA 2.7E-03 5.9E-03

Acenaphthene NA NA NA 0.0E+00 Liver 1.8E-04 NA 1.6E-04 3.4E-04

Benzo(a)anthracene 1.2E-06 NA 1.0E-06 2.2E-06 NA NA NA 0.0E+00

Benzo(a)pyrene 6.7E-06 NA 5.8E-06 1.2E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene 7.3E-07 NA 6.2E-07 1.4E-06 NA NA NA 0.0E+00

Benzo(k)fluoranthene 3.8E-08 NA 3.2E-08 7.0E-08 NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate 2.6E-09 NA 1.7E-09 4.3E-09 Increased Liver Weight 2.6E-05 NA 1.7E-05 4.3E-05

Chrysene 1.2E-08 NA 1.0E-08 2.2E-08 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 5.0E-07 NA 4.3E-07 9.3E-07 NA NA NA 0.0E+00

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 1.6E-04 NA 1.4E-04 2.9E-04

Fluorene NA NA NA 0.0E+00 Blood 2.0E-04 NA 1.7E-04 3.8E-04

Indeno(1,2,3-c,d)pyrene 2.9E-07 NA 2.5E-07 5.4E-07 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 1.2E-03 NA 9.9E-04 2.1E-03

Pyrene NA NA NA 0.0E+00 Kidney 4.5E-04 NA 3.9E-04 8.4E-04

Dioxin-Like PCB TEQ 8.9E-08 NA 8.2E-08 1.7E-07 NA NA NA 0.0E+00

Nondioxin-Like PCB 1.6E-07 NA 1.5E-07 3.1E-07 NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.2E-02 NA 1.1E-02 2.2E-02

Aluminum NA NA NA 0.0E+00 Neurological 5.1E-04 NA 3.4E-05 5.5E-04

Arsenic 2.8E-07 NA 5.5E-08 3.3E-07 Skin, Vascular 1.7E-03 NA 3.4E-04 2.1E-03

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) 3.5E-04 NA 9.3E-05 4.4E-04

Chromium 5.3E-07 NA 1.4E-06 1.9E-06 Not identified 9.9E-04 NA 2.6E-03 3.6E-03

Cobalt NA NA NA 0.0E+00 Thyroid 1.3E-03 NA 8.5E-05 1.4E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 2.4E-04 NA 1.6E-05 2.6E-04

Iron NA NA NA 0.0E+00 Gastrointestinal 1.7E-03 NA 1.1E-04 1.8E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Manganese NA NA NA 0.0E+00 CNS 7.7E-05 NA 1.0E-06 7.8E-05

Vanadium NA NA NA 0.0E+00 Hair 3.2E-04 NA 2.1E-05 3.4E-04

Chemical Total 1.1E-05 NA 9.8E-06 2.0E-05 2.4E-02 NA 1.9E-02 4.3E-02

Overflow Surface Sediment Total 2.0E-05 4.3E-02

Page 334: Appendix L HHRA Combined

TABLE 9.4.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

1,4-dichlorobenzene 1.6E-10 NA 8.0E-10 9.6E-10 Liver 1.2E-06 NA 6.0E-06 7.1E-06

Benzene 5.1E-10 NA 4.1E-09 4.6E-09 Blood, Immune 2.9E-05 NA 5.2E-05 8.1E-05

Chloroform 1.9E-10 NA 7.4E-10 9.4E-10 Liver, Body Weight 7.9E-06 NA 6.7E-06 1.5E-05

Ethylbenzene 1.1E-10 NA 2.6E-09 2.7E-09 Liver, Kidney 1.2E-06 NA 6.6E-06 7.8E-06

Tetrachloroethylene(PCE) 1.5E-07 NA 2.8E-06 2.9E-06 Liver 3.4E-04 NA 1.5E-03 1.8E-03

Benzo(a)anthracene 8.4E-10 NA 2.9E-07 2.9E-07 NA NA NA 0.0E+00

Benzo(a)pyrene 1.7E-08 NA 9.6E-06 9.6E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene 1.5E-09 NA 9.0E-07 9.0E-07 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 8.2E-09 NA 7.3E-06 7.3E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene 4.0E-09 NA 2.4E-06 2.4E-06 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 2.6E-06 NA 1.4E-05 1.6E-05

Arsenic 2.8E-07 NA 1.4E-07 4.2E-07 Skin, Vascular 7.8E-03 NA 8.9E-04 8.7E-03

Chromium 4.7E-08 NA 2.0E-06 2.0E-06 Not identified 4.0E-04 NA 3.7E-03 4.1E-03

Cobalt NA NA NA 0.0E+00 Thyroid 1.8E-03 NA 8.4E-05 1.9E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Selenium NA NA NA 0.0E+00 Whole Body 9.5E-04 NA 1.1E-04 1.1E-03

Chemical Total 5.0E-07 NA 2.5E-05 2.6E-05 1.1E-02 NA 6.3E-03 1.8E-02

Overflow Surface Water Total 2.6E-05 1.8E-02

Receptor Total 7.6E-05 Receptor HI Total 7.8E-01

Page 335: Appendix L HHRA Combined

TABLE 9.4.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Industrial Worker

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 3.0E-02

CNS - Central Nervous System Total Body Weight HI Across All Media = 2.2E-03

Receptor Total and target organ totals includes maximum between air prior to and after aeration system operation, and surface water, and sediment. Total Developmental HI Across All Media = 1.6E-03

Total Finger and Toe Nails HI Across All Media = 2.2E-02

Total Gastrointestinal HI Across All Media = 2.1E-03

Total Hair HI Across All Media = 3.4E-04

Total Kidney HI Across All Media = 1.6E-03

Total Immune HI Across All Media = 8.1E-05

Total Liver HI Across All Media = 4.8E-03

Total Lung HI Across All Media = 5.9E-03

Total Nasal HI Across All Media = 6.9E-01

Total Nervous System HI Across All Media = 6.3E-04

Total Ocular HI Across All Media = 2.2E-02

Total Respiratory HI Across All Media = 6.9E-01

Total Skin HI Across All Media = 1.1E-02

Total Thyroid HI Across All Media = 3.3E-03

Total Vascular HI Across All Media = 1.1E-02

Total Whole Body HI Across All Media = 1.1E-03

Page 336: Appendix L HHRA Combined

TABLE 9.5.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA NA NA Blood NA 4.0E-02 NA 4.0E-02

operation) Chloroform NA NA NA Liver NA 2.4E-03 NA 2.4E-03

Ethylbenzene NA NA NA Developmental NA 1.0E-03 NA 1.0E-03

Naphthalene NA NA NA Nasal, Respiratory NA 4.2E-01 NA 4.2E-01

Chemical Total NA NA NA NA 4.6E-01 NA 4.6E-01

Ambient air at street level Total - Pre-aeration system operation 4.6E-01

Air Air

Ambient air at canal

level

(after aeration system Benzene NA NA NA Blood NA 3.5E-02 NA 3.5E-02

started) Chloroform NA NA NA Liver NA 3.2E-03 NA 3.2E-03

Ethylbenzene NA NA NA Developmental NA 1.2E-03 NA 1.2E-03

Naphthalene NA NA NA Nasal, Respiratory NA 9.7E-01 NA 9.7E-01

Chemical Total NA NA NA NA 1.0E+00 NA 1.0E+00

Ambient air at street level Total - After aeration system turned on 1.0E+00

Page 337: Appendix L HHRA Combined

TABLE 9.5.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal 2-methylnaphthalene NA NA NA Lung 3.2E-03 NA 4.7E-03 7.8E-03

Acenaphthene NA NA NA Liver 1.8E-04 NA 2.7E-04 4.5E-04

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Benzo(k)fluoranthene NA NA NA NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate NA NA NA Increased Liver Weight 2.6E-05 NA 2.9E-05 5.5E-05

Chrysene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Fluoranthene NA NA NA Kidney, Liver, Blood 1.6E-04 NA 2.3E-04 3.9E-04

Fluorene NA NA NA Blood 2.0E-04 NA 3.0E-04 5.0E-04

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 1.2E-03 NA 1.7E-03 2.9E-03

Pyrene NA NA NA Kidney 4.5E-04 NA 6.7E-04 1.1E-03

Dioxin-Like PCB TEQ NA NA NA NA NA NA 0.0E+00

Nondioxin-Like PCB NA NA NA NA NA NA 0.0E+00

Total PCB NA NA NA Ocular, Finger and Toe Nails 1.2E-02 NA 1.9E-02 3.0E-02

Aluminum NA NA NA Neurological 5.1E-04 NA 5.9E-05 5.7E-04

Arsenic NA NA NA Skin, Vascular 1.7E-03 NA 5.9E-04 2.3E-03

Cadmium NA NA NA Proteinuria (Kidney) 3.5E-04 NA 1.6E-04 5.1E-04

Chromium NA NA NA Not identified 9.9E-04 NA 4.5E-03 5.5E-03

Cobalt NA NA NA Thyroid 1.3E-03 NA 1.5E-04 1.4E-03

Copper NA NA NA Gastrointestinal 2.4E-04 NA 2.8E-05 2.7E-04

Iron NA NA NA Gastrointestinal 1.7E-03 NA 1.9E-04 1.9E-03

Lead NA NA NA NA NA NA 0.0E+00

Manganese NA NA NA CNS 7.7E-05 NA 1.8E-06 7.9E-05

Vanadium NA NA NA Hair 3.2E-04 NA 3.7E-05 3.6E-04

Chemical Total NA NA NA 2.4E-02 NA 3.2E-02 5.6E-02

Overflow Surface Sediment Total 5.6E-02

Page 338: Appendix L HHRA Combined

TABLE 9.5.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

1,4-dichlorobenzene NA NA NA Liver 3.9E-07 NA 2.7E-06 3.1E-06

Benzene NA NA NA Blood, Immune 9.6E-06 NA 1.9E-05 2.9E-05

Chloroform NA NA NA Liver, Body Weight 2.6E-06 NA 2.7E-06 5.3E-06

Ethylbenzene NA NA NA Liver, Kidney 4.0E-07 NA 2.7E-06 3.1E-06

Tetrachloroethylene(PCE) NA NA NA Liver 1.1E-04 NA 7.0E-04 8.1E-04

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 8.3E-07 NA 6.0E-06 6.8E-06

Arsenic NA NA NA Skin, Vascular 2.5E-03 NA 2.9E-04 2.8E-03

Chromium NA NA NA Not identified 1.3E-04 NA 1.2E-03 1.3E-03

Cobalt NA NA NA Thyroid 6.0E-04 NA 2.7E-05 6.2E-04

Lead NA NA NA NA NA NA 0.0E+00

Selenium NA NA NA Whole Body 3.1E-04 NA 3.5E-05 3.4E-04

Chemical Total NA NA NA 3.7E-03 NA 2.3E-03 6.0E-03

Overflow Surface Water Total 6.0E-03

Receptor Total Receptor HI Total 1.1E+00

Page 339: Appendix L HHRA Combined

TABLE 9.5.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 4.1E-02

CNS - Central Nervous System Total Body Weight HI Across All Media = 2.9E-03

Receptor Total and target organ totals includes maximum between air prior to and after aeration system operation, and surface water, and sediment. Total Developmental HI Across All Media = 2.2E-03

Total Finger and Toe Nails HI Across All Media = 3.0E-02

Total Gastrointestinal HI Across All Media = 2.2E-03

Total Hair HI Across All Media = 3.6E-04

Total Kidney HI Across All Media = 2.0E-03

Total Immune HI Across All Media = 2.9E-05

Total Liver HI Across All Media = 5.0E-03

Total Lung HI Across All Media = 7.8E-03

Total Nasal HI Across All Media = 9.7E-01

Total Nervous System HI Across All Media = 6.5E-04

Total Ocular HI Across All Media = 3.0E-02

Total Respiratory HI Across All Media = 9.7E-01

Total Skin HI Across All Media = 5.1E-03

Total Thyroid HI Across All Media = 2.1E-03

Total Vascular HI Across All Media = 5.1E-03

Total Whole Body HI Across All Media = 3.4E-04

Page 340: Appendix L HHRA Combined

TABLE 9.6.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA NA NA Blood NA 4.0E-02 NA 4.0E-02

operation) Chloroform NA NA NA Liver NA 2.4E-03 NA 2.4E-03

Ethylbenzene NA NA NA Developmental NA 1.0E-03 NA 1.0E-03

Naphthalene NA NA NA Nasal, Respiratory NA 4.2E-01 NA 4.2E-01

Chemical Total NA NA NA NA 4.6E-01 NA 4.6E-01

Ambient air at street level Total - Pre-aeration system operation 4.6E-01

Air Air

Ambient air at canal

level

(after aeration system Benzene NA NA NA Blood NA 3.5E-02 NA 3.5E-02

started) Chloroform NA NA NA Liver NA 3.2E-03 NA 3.2E-03

Ethylbenzene NA NA NA Developmental NA 1.2E-03 NA 1.2E-03

Naphthalene NA NA NA Nasal, Respiratory NA 9.7E-01 NA 9.7E-01

Chemical Total NA NA NA NA 1.0E+00 NA 1.0E+00

Ambient air at street level Total - After aeration system turned on 1.0E+00

Page 341: Appendix L HHRA Combined

TABLE 9.6.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal 2-methylnaphthalene NA NA NA Lung 2.9E-02 NA 1.1E-02 4.0E-02

Acenaphthene NA NA NA Liver 1.7E-03 NA 6.2E-04 2.3E-03

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Benzo(k)fluoranthene NA NA NA NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate NA NA NA Increased Liver Weight 2.4E-04 NA 6.7E-05 3.1E-04

Chrysene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Fluoranthene NA NA NA Kidney, Liver, Blood 1.5E-03 NA 5.4E-04 2.0E-03

Fluorene NA NA NA Blood 1.9E-03 NA 6.9E-04 2.6E-03

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 1.1E-02 NA 3.9E-03 1.5E-02

Pyrene NA NA NA Kidney 4.2E-03 NA 1.5E-03 5.8E-03

Dioxin-Like PCB TEQ NA NA NA NA NA NA 0.0E+00

Nondioxin-Like PCB NA NA NA NA NA NA 0.0E+00

Total PCB NA NA NA Ocular, Finger and Toe Nails 1.1E-01 NA 4.3E-02 1.5E-01

Aluminum NA NA NA Neurological 4.8E-03 NA 1.3E-04 4.9E-03

Arsenic NA NA NA Skin, Vascular 1.6E-02 NA 1.4E-03 1.7E-02

Cadmium NA NA NA Proteinuria (Kidney) 3.3E-03 NA 3.7E-04 3.7E-03

Chromium NA NA NA Not identified 9.3E-03 NA 1.0E-02 2.0E-02

Cobalt NA NA NA Thyroid 1.2E-02 NA 3.4E-04 1.2E-02

Copper NA NA NA Gastrointestinal 2.3E-03 NA 6.3E-05 2.3E-03

Iron NA NA NA Gastrointestinal 1.6E-02 NA 4.4E-04 1.6E-02

Lead NA NA NA NA NA NA 0.0E+00

Manganese NA NA NA CNS 7.2E-04 NA 4.0E-06 7.2E-04

Vanadium NA NA NA Hair 3.0E-03 NA 8.5E-05 3.1E-03

Chemical Total NA NA NA 2.3E-01 NA 7.4E-02 3.0E-01

Overflow Surface Sediment Total 3.0E-01

Page 342: Appendix L HHRA Combined

TABLE 9.6.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

1,4-dichlorobenzene NA NA NA Liver 1.8E-06 NA 6.3E-06 8.1E-06

Benzene NA NA NA Blood, Immune 4.5E-05 NA 4.4E-05 8.9E-05

Chloroform NA NA NA Liver, Body Weight 1.2E-05 NA 6.2E-06 1.8E-05

Ethylbenzene NA NA NA Liver, Kidney 1.9E-06 NA 6.2E-06 8.1E-06

Tetrachloroethylene(PCE) NA NA NA Liver 5.2E-04 NA 1.6E-03 2.1E-03

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 3.9E-06 NA 1.4E-05 1.8E-05

Arsenic NA NA NA Skin, Vascular 1.2E-02 NA 6.6E-04 1.2E-02

Chromium NA NA NA Not identified 6.1E-04 NA 2.7E-03 3.3E-03

Cobalt NA NA NA Thyroid 2.8E-03 NA 6.2E-05 2.8E-03

Lead NA NA NA NA NA NA 0.0E+00

Selenium NA NA NA Whole Body 1.4E-03 NA 8.0E-05 1.5E-03

Chemical Total NA NA NA 1.7E-02 NA 5.2E-03 2.2E-02

Overflow Surface Water Total 2.2E-02

Receptor Total Receptor HI Total 1.3E+00

Page 343: Appendix L HHRA Combined

TABLE 9.6.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 4.5E-02

CNS - Central Nervous System Total Body Weight HI Across All Media = 1.5E-02

Receptor Total and target organ totals includes maximum between air prior to and after aeration system operation, and surface water, and sediment. Total Developmental HI Across All Media = 2.2E-03

Total Finger and Toe Nails HI Across All Media = 1.5E-01

Total Gastrointestinal HI Across All Media = 1.9E-02

Total Hair HI Across All Media = 3.1E-03

Total Kidney HI Across All Media = 1.1E-02

Total Immune HI Across All Media = 8.9E-05

Total Liver HI Across All Media = 1.0E-02

Total Lung HI Across All Media = 4.0E-02

Total Nasal HI Across All Media = 9.7E-01

Total Nervous System HI Across All Media = 5.7E-03

Total Ocular HI Across All Media = 1.5E-01

Total Respiratory HI Across All Media = 9.7E-01

Total Skin HI Across All Media = 3.0E-02

Total Thyroid HI Across All Media = 1.5E-02

Total Vascular HI Across All Media = 3.0E-02

Total Whole Body HI Across All Media = 1.5E-03

Page 344: Appendix L HHRA Combined

TABLE 9.7.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA 2.9E-06 NA 2.9E-06 Blood NA NA NA

operation) Chloroform NA 1.7E-06 NA 1.7E-06 Liver NA NA NA

Ethylbenzene NA 8.0E-07 NA 8.0E-07 Developmental NA NA NA

Naphthalene NA 1.3E-05 NA 1.3E-05 Nasal, Respiratory NA NA NA

Chemical Total NA 1.8E-05 NA 1.8E-05 NA NA NA

Ambient air at street level Total - Pre-aeration system operation 1.8E-05

Air Air

Ambient air at canal

level

(after aeration system Benzene NA 2.5E-06 NA 2.5E-06 Blood NA NA NA

started) Chloroform NA 2.2E-06 NA 2.2E-06 Liver NA NA NA

Ethylbenzene NA 9.1E-07 NA 9.1E-07 Developmental NA NA NA

Naphthalene NA 3.0E-05 NA 3.0E-05 Nasal, Respiratory NA NA NA

Chemical Total NA 3.6E-05 NA 3.6E-05 NA NA NA

Ambient air at street level Total - After aeration system turned on 3.6E-05

Page 345: Appendix L HHRA Combined

TABLE 9.7.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal 2-methylnaphthalene NA NA NA 0.0E+00 Lung NA NA NA

Acenaphthene NA NA NA 0.0E+00 Liver NA NA NA

Benzo(a)anthracene11.6E-05 NA 8.2E-06 2.4E-05 NA NA NA

Benzo(a)pyrene19.2E-05 NA 4.7E-05 1.4E-04 NA NA NA

Benzo(b)fluoranthene11.0E-05 NA 5.1E-06 1.5E-05 NA NA NA

Benzo(k)fluoranthene15.2E-07 NA 2.6E-07 7.8E-07 NA NA NA

Bis(2-ethylhexyl) phthalate 8.2E-09 NA 4.4E-09 1.3E-08 Increased Liver Weight NA NA NA

Chrysene11.6E-07 NA 8.1E-08 2.4E-07 NA NA NA

Dibenz(a,h)anthracene16.9E-06 NA 3.5E-06 1.0E-05 NA NA NA

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood NA NA NA

Fluorene NA NA NA 0.0E+00 Blood NA NA NA

Indeno(1,2,3-c,d)pyrene14.0E-06 NA 2.0E-06 6.0E-06 NA NA NA

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight NA NA NA

Pyrene NA NA NA 0.0E+00 Kidney NA NA NA

Dioxin-Like PCB TEQ 2.8E-07 NA 2.1E-07 5.0E-07 NA NA NA

Nondioxin-Like PCB 5.2E-07 NA 3.9E-07 9.1E-07 NA NA NA

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails NA NA NA

Aluminum NA NA NA 0.0E+00 Neurological NA NA NA

Arsenic 8.9E-07 NA 1.4E-07 1.0E-06 Skin, Vascular NA NA NA

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) NA NA NA

Chromium17.3E-08 NA 1.1E-06 1.2E-06 Not identified NA NA NA

Cobalt NA NA NA 0.0E+00 Thyroid NA NA NA

Copper NA NA NA 0.0E+00 Gastrointestinal NA NA NA

Iron NA NA NA 0.0E+00 Gastrointestinal NA NA NA

Lead NA NA NA 0.0E+00 NA NA NA

Manganese NA NA NA 0.0E+00 CNS NA NA NA

Vanadium NA NA NA 0.0E+00 Hair NA NA NA

Chemical Total 1.3E-04 NA 6.8E-05 2.0E-04 NA NA NA

Overflow Surface Sediment Total 2.0E-04

Page 346: Appendix L HHRA Combined

TABLE 9.7.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

1,4-dichlorobenzene 1.1E-10 NA 5.6E-10 6.7E-10 Liver NA NA NA

Benzene 1.6E-09 NA 2.3E-09 3.9E-09 Blood, Immune NA NA NA

Chloroform 5.9E-10 NA 4.5E-10 1.0E-09 Liver, Body Weight NA NA NA

Ethylbenzene 3.2E-10 NA 1.6E-09 1.9E-09 Liver, Kidney NA NA NA

Tetrachloroethylene(PCE) 4.5E-07 NA 2.0E-06 2.5E-06 Liver NA NA NA

Benzo(a)anthracene19.6E-09 NA 7.6E-07 7.7E-07 NA NA NA

Benzo(a)pyrene11.9E-07 NA 2.6E-05 2.6E-05 NA NA NA

Benzo(b)fluoranthene11.7E-08 NA 2.4E-06 2.4E-06 NA NA NA

Dibenz(a,h)anthracene19.3E-08 NA 2.0E-05 2.0E-05 NA NA NA

Indeno(1,2,3-c,d)pyrene14.6E-08 NA 6.4E-06 6.4E-06 NA NA NA

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight NA NA NA

Arsenic 8.4E-07 NA 7.0E-08 9.1E-07 Skin, Vascular NA NA NA

Chromium15.4E-07 NA 3.6E-06 4.2E-06 Not identified NA NA NA

Cobalt NA NA NA 0.0E+00 Thyroid NA NA NA

Lead NA NA NA 0.0E+00 NA NA NA

Selenium NA NA NA 0.0E+00 Whole Body NA NA NA

Chemical Total 2.2E-06 NA 6.1E-05 6.3E-05 NA NA NA

Overflow Surface Water Total 6.3E-05

Receptor Total 3.0E-04 Receptor HI Total

Receptor Total includes maximum between air prior to and after aeration system operation, and surface water, and sediment.

1. Constituent acts via a mutagenic mode of action (MMOA). See Table 7.7.RME Supplement A for calculation of intake and cancer risk following MMOA method.

Page 347: Appendix L HHRA Combined

TABLE 9.8.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

p,p'-DDE 2.4E-07 NA NA 2.4E-07 NA NA NA NA 0.0E+00

p,p'-DDT 2.0E-07 NA NA 2.0E-07 Liver 3.4E-03 NA NA 3.4E-03

Dioxin-Like PCB TEQ 4.0E-05 NA NA 4.0E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 4.9E-05 NA NA 4.9E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.8E+00 NA NA 3.8E+00

Arsenic 6.1E-06 NA NA 6.1E-06 Skin, Vascular 4.0E-02 NA NA 4.0E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.5E-01 NA NA 3.5E-01

Selenium NA NA NA 0.0E+00 Whole Body 4.2E-02 NA NA 4.2E-02

Chemical Total 9.6E-05 NA NA 9.6E-05 4.2E+00 NA NA 4.2E+00

Striped Bass in Gowanus Canal Total 9.6E-05 4.2E+00

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 9.9E-06 NA NA 9.9E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 9.6E-06 NA NA 9.6E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 7.7E-01 NA NA 7.7E-01

Mercury NA NA NA 0.0E+00 Developmental Neurological 6.4E-02 NA NA 6.4E-02

Selenium NA NA NA 0.0E+00 Whole Body 9.4E-03 NA NA 9.4E-03

Chemical Total 2.0E-05 NA NA 2.0E-05 8.5E-01 NA NA 8.5E-01

White Perch in Gowanus Canal Total 2.0E-05 8.5E-01

Page 348: Appendix L HHRA Combined

TABLE 9.8.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

alpha-Chlordane 4.3E-07 NA NA 4.3E-07 Liver 7.2E-03 NA NA 7.2E-03

Dieldrin 1.5E-05 NA NA 1.5E-05 Liver 5.6E-02 NA NA 5.6E-02

gamma-Chlordane 2.5E-07 NA NA 2.5E-07 Liver 4.2E-03 NA NA 4.2E-03

p,p'-DDD 5.1E-07 NA NA 5.1E-07 NA NA NA NA 0.0E+00

p,p'-DDE 4.8E-07 NA NA 4.8E-07 NA NA NA NA 0.0E+00

p,p'-DDT 9.0E-07 NA NA 9.0E-07 Liver 1.5E-02 NA NA 1.5E-02

Dioxin-Like PCB TEQ 1.2E-04 NA NA 1.2E-04 NA NA NA NA 0.0E+00

Nondioxin-Like 1.4E-04 NA NA 1.4E-04 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.1E+01 NA NA 1.1E+01

Arsenic 4.2E-06 NA NA 4.2E-06 Skin, Vascular 2.7E-02 NA NA 2.7E-02

Chromium 1.9E-05 NA NA 1.9E-05 Not identified 3.6E-02 NA NA 3.6E-02

Copper NA NA NA 0.0E+00 Gastrointestinal 3.0E-02 NA NA 3.0E-02

Cyanide, total NA NA NA 0.0E+00 Weight Loss, Thyroid 2.5E-02 NA NA 2.5E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 4.2E-01 NA NA 4.2E-01

Selenium NA NA NA 0.0E+00 Whole Body 4.6E-02 NA NA 4.6E-02

Chemical Total 3.0E-04 NA NA 3.0E-04 1.2E+01 NA NA 1.2E+01

Eel in Gowanus Canal Total 3.0E-04 1.2E+01

Page 349: Appendix L HHRA Combined

TABLE 9.8.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)anthracene 6.3E-07 NA NA 6.3E-07 NA NA NA NA 0.0E+00

Benzo(a)pyrene 9.7E-06 NA NA 9.7E-06 NA NA NA NA 0.0E+00

Benzo(b)fluoranthene 5.3E-07 NA NA 5.3E-07 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene 3.2E-06 NA NA 3.2E-06 NA NA NA NA 0.0E+00

Indeno(1,2,3-cd)pyrene 8.1E-07 NA NA 8.1E-07 NA NA NA NA 0.0E+00

Dioxin-Like PCB TEQ 8.9E-05 NA NA 8.9E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 3.2E-05 NA NA 3.2E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 2.7E+00 NA NA 2.7E+00

Arsenic 2.2E-05 NA NA 2.2E-05 Skin, Vascular 1.4E-01 NA NA 1.4E-01

Copper NA NA NA 0.0E+00 Gastrointestinal 8.4E-02 NA NA 8.4E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 4.1E-01 NA NA 4.1E-01

Chemical Total 1.6E-04 NA NA 1.6E-04 3.4E+00 NA NA 3.4E+00

Crab in Gowanus Canal Total 1.6E-04 3.4E+00

Receptor Total - Fish 4.2E-04 Receptor HI Total - Fiish 1.7E+01

Receptor Total - Blue Crab 1.6E-04 Receptor HI Total - Blue Crab 3.4E+00

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Body Weight HI Across All Media = 2.5E-02 Total Developmental HI Across All Media = 4.1E-01

Total Developmental HI Across All Media = 8.4E-01 Total Finger and Toe Nails HI Across All Media = 2.7E+00

Total Finger and Toe Nails HI Across All Media = 1.6E+01 Total Gastrointestinal HI Across All Media = 8.4E-02

Total Gastrointestinal HI Across All Media = 3.0E-02 Total Neurological HI Across All Media = 4.1E-01

Total Liver HI Across All Media = 8.6E-02 Total Ocular HI Across All Media = 2.7E+00

Total Neurological HI Across All Media = 8.4E-01 Total Skin HI Across All Media = 1.4E-01

Total Ocular HI Across All Media = 1.6E+01 Total Vascular HI Across All Media = 1.4E-01

Total Skin HI Across All Media = 6.7E-02

Total Thyroid HI Across All Media = 2.5E-02

Total Vascular HI Across All Media = 6.7E-02

Total Whole Body HI Across All Media = 9.7E-02

Page 350: Appendix L HHRA Combined

TABLE 9.9.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

p,p'-DDE 4.9E-08 NA NA 4.9E-08 NA NA NA NA 0.0E+00

p,p'-DDT 3.9E-08 NA NA 3.9E-08 Liver 2.7E-03 NA NA 2.7E-03

Dioxin-Like PCB TEQ 8.1E-06 NA NA 8.1E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 9.8E-06 NA NA 9.8E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.0E+00 NA NA 3.0E+00

Arsenic 1.2E-06 NA NA 1.2E-06 Skin, Vascular 3.2E-02 NA NA 3.2E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 2.8E-01 NA NA 2.8E-01

Selenium NA NA NA 0.0E+00 Whole Body 3.4E-02 NA NA 3.4E-02

Chemical Total 1.9E-05 NA NA 1.9E-05 3.4E+00 NA NA 3.4E+00

Striped Bass in Gowanus Canal Total 1.9E-05 3.4E+00

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 2.1E-06 NA NA 2.1E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 2.0E-06 NA NA 2.0E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 6.2E-01 NA NA 6.2E-01

Mercury NA NA NA 0.0E+00 Developmental Neurological 5.1E-02 NA NA 5.1E-02

Selenium NA NA NA 0.0E+00 Whole Body 7.5E-03 NA NA 7.5E-03

Chemical Total 4.1E-06 NA NA 4.1E-06 6.8E-01 NA NA 6.8E-01

White Perch in Gowanus Canal Total 4.1E-06 6.8E-01

Page 351: Appendix L HHRA Combined

TABLE 9.9.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

alpha-Chlordane 8.7E-08 NA NA 8.7E-08 Liver 5.8E-03 NA NA 5.8E-03

Dieldrin 3.1E-06 NA NA 3.1E-06 Liver 4.5E-02 NA NA 4.5E-02

gamma-Chlordane 5.1E-08 NA NA 5.1E-08 Liver 3.4E-03 NA NA 3.4E-03

p,p'-DDD 1.0E-07 NA NA 1.0E-07 NA NA NA NA 0.0E+00

p,p'-DDE 9.6E-08 NA NA 9.6E-08 NA NA NA NA 0.0E+00

p,p'-DDT 1.8E-07 NA NA 1.8E-07 Liver 1.2E-02 NA NA 1.2E-02

Dioxin-Like PCB TEQ 2.5E-05 NA NA 2.5E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 2.7E-05 NA NA 2.7E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 8.9E+00 NA NA 8.9E+00

Arsenic 8.4E-07 NA NA 8.4E-07 Skin, Vascular 2.2E-02 NA NA 2.2E-02

Chromium (12-16)* 7.5E-06 NA NA 7.5E-06 Not identified 2.9E-02 NA NA 2.9E-02

Chromium (16-18)* 1.3E-06 NA NA 1.3E-06

Copper NA NA NA 0.0E+00 Gastrointestinal 2.4E-02 NA NA 2.4E-02

Cyanide, total NA NA NA 0.0E+00 Weight Loss, Thyroid 2.0E-02 NA NA 2.0E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.4E-01 NA NA 3.4E-01

Selenium NA NA NA 0.0E+00 Whole Body 3.7E-02 NA NA 3.7E-02

Chemical Total 6.5E-05 NA NA 6.5E-05 9.4E+00 NA NA 9.4E+00

Eel in Gowanus Canal Total 6.5E-05 9.4E+00

Page 352: Appendix L HHRA Combined

TABLE 9.9.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)anthracene (12-16)* 2.5E-07 NA NA 2.5E-07 NA NA NA NA 0.0E+00

Benzo(a)anthracene (16-18)* 4.2E-08 NA NA 4.2E-08

Benzo(a)pyrene (12-16)* 3.9E-06 NA NA 3.9E-06 NA NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 6.5E-07 NA NA 6.5E-07

Benzo(b)fluoranthene (12-16)* 2.1E-07 NA NA 2.1E-07 NA NA NA NA 0.0E+00

Benzo(b)fluoranthene (16-18)* 3.5E-08 NA NA 3.5E-08

Dibenz(a,h)anthracene (12-16)* 1.3E-06 NA NA 1.3E-06 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene (16-18)* 2.2E-07 NA NA 2.2E-07

Indeno(1,2,3-cd)pyrene (12-16)* 3.3E-07 NA NA 3.3E-07 NA NA NA NA 0.0E+00

Indeno(1,2,3-cd)pyrene (16-18)* 5.4E-08 NA NA 5.4E-08

Dioxin-Like PCB TEQ 1.8E-05 NA NA 1.8E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 6.5E-06 NA NA 6.5E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 2.2E+00 NA NA 2.2E+00

Arsenic 4.4E-06 NA NA 4.4E-06 Skin, Vascular 1.1E-01 NA NA 1.1E-01

Copper NA NA NA 0.0E+00 Gastrointestinal 6.7E-02 NA NA 6.7E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.3E-01 NA NA 3.3E-01

Chemical Total 3.6E-05 NA NA 3.6E-05 2.7E+00 NA NA 2.7E+00

Crab in Gowanus Canal Total 3.6E-05 2.7E+00

Receptor Total - Fish 8.9E-05 Receptor HI Total - Fiish 1.3E+01

Receptor Total - Blue Crab 3.6E-05 Receptor HI Total - Blue Crab 2.7E+00

Page 353: Appendix L HHRA Combined

TABLE 9.9.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Body Weight HI Across All Media = 2.0E-02 Total Developmental HI Across All Media = 3.3E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 Total Developmental HI Across All Media = 6.7E-01 Total Finger and Toe Nails HI Across All Media = 2.2E+00

used to adjust CSF for 12-16 year old for exposure duration of 4 years, Total Finger and Toe Nails HI Across All Media = 1.3E+01 Total Gastrointestinal HI Across All Media = 6.7E-02

ADAF of 1 used to adjust CSF for 16-18 year old for exposure duration Total Gastrointestinal HI Across All Media = 2.4E-02 Total Neurological HI Across All Media = 3.3E-01

of 2 years. Non-cancer calculations shown under 12-16 year old only, Total Liver HI Across All Media = 6.9E-02 Total Ocular HI Across All Media = 2.2E+00

as non-cancer calculations are not adjusted for MMOA. Total Neurological HI Across All Media = 6.7E-01 Total Skin HI Across All Media = 1.1E-01

Total Ocular HI Across All Media = 1.3E+01 Total Vascular HI Across All Media = 1.1E-01

Total Skin HI Across All Media = 5.4E-02

Total Thyroid HI Across All Media = 2.0E-02

Total Vascular HI Across All Media = 5.4E-02

Total Whole Body HI Across All Media = 7.8E-02

Page 354: Appendix L HHRA Combined

TABLE 9.10.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

p,p'-DDE 9.9E-08 NA NA 9.9E-08 NA NA NA NA 0.0E+00

p,p'-DDT 7.9E-08 NA NA 7.9E-08 Liver 5.4E-03 NA NA 5.4E-03

Dioxin-Like PCB TEQ 1.6E-05 NA NA 1.6E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 2.0E-05 NA NA 2.0E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 6.1E+00 NA NA 6.1E+00

Arsenic 2.5E-06 NA NA 2.5E-06 Skin, Vascular 6.4E-02 NA NA 6.4E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 5.6E-01 NA NA 5.6E-01

Selenium NA NA NA 0.0E+00 Whole Body 6.8E-02 NA NA 6.8E-02

Chemical Total 3.9E-05 NA NA 3.9E-05 6.8E+00 NA NA 6.8E+00

Striped Bass in Gowanus Canal Total 3.9E-05 6.8E+00

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 4.2E-06 NA NA 4.2E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 4.0E-06 NA NA 4.0E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.2E+00 NA NA 1.2E+00

Mercury NA NA NA 0.0E+00 Developmental Neurological 1.0E-01 NA NA 1.0E-01

Selenium NA NA NA 0.0E+00 Whole Body 1.5E-02 NA NA 1.5E-02

Chemical Total 8.2E-06 NA NA 8.2E-06 1.4E+00 NA NA 1.4E+00

White Perch in Gowanus Canal Total 8.2E-06 1.4E+00

Page 355: Appendix L HHRA Combined

TABLE 9.10.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

alpha-Chlordane 1.7E-07 NA NA 1.7E-07 Liver 1.2E-02 NA NA 1.2E-02

Dieldrin 6.2E-06 NA NA 6.2E-06 Liver 9.0E-02 NA NA 9.0E-02

gamma-Chlordane 1.0E-07 NA NA 1.0E-07 Liver 6.9E-03 NA NA 6.9E-03

p,p'-DDD 2.1E-07 NA NA 2.1E-07 NA NA NA NA 0.0E+00

p,p'-DDE 1.9E-07 NA NA 1.9E-07 NA NA NA NA 0.0E+00

p,p'-DDT 3.6E-07 NA NA 3.6E-07 Liver 2.5E-02 NA NA 2.5E-02

Dioxin-Like PCB TEQ 5.0E-05 NA NA 5.0E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 5.5E-05 NA NA 5.5E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.8E+01 NA NA 1.8E+01

Arsenic 1.7E-06 NA NA 1.7E-06 Skin, Vascular 4.4E-02 NA NA 4.4E-02

Chromium (0-2)* 2.5E-05 NA NA 2.5E-05 Not identified 5.9E-02 NA NA 5.9E-02

Chromium (2-6)* 1.5E-05 NA NA 1.5E-05

Copper NA NA NA 0.0E+00 Gastrointestinal 4.9E-02 NA NA 4.9E-02

Cyanide, total NA NA NA 0.0E+00 Weight Loss, Thyroid 4.1E-02 NA NA 4.1E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 6.9E-01 NA NA 6.9E-01

Selenium NA NA NA 0.0E+00 Whole Body 7.4E-02 NA NA 7.4E-02

Chemical Total 1.5E-04 NA NA 1.5E-04 1.9E+01 NA NA 1.9E+01

Eel in Gowanus Canal Total 1.5E-04 1.9E+01

Page 356: Appendix L HHRA Combined

TABLE 9.10.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)anthracene (0-2)* 8.6E-07 NA NA 8.6E-07 NA NA NA NA 0.0E+00

Benzo(a)anthracene (2-6)* 5.1E-07 NA NA 5.1E-07

Benzo(a)pyrene (0-2)* 1.3E-05 NA NA 1.3E-05 NA NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 7.9E-06 NA NA 7.9E-06

Benzo(b)fluoranthene (0-2)* 7.1E-07 NA NA 7.1E-07 NA NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-6)* 4.3E-07 NA NA 4.3E-07

Dibenz(a,h)anthracene (0-2)* 4.4E-06 NA NA 4.4E-06 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-6)* 2.6E-06 NA NA 2.6E-06

Indeno(1,2,3-cd)pyrene (0-2)* 1.1E-06 NA NA 1.1E-06 NA NA NA NA 0.0E+00

Indeno(1,2,3-cd)pyrene (2-6)* 6.6E-07 NA NA 6.6E-07

Dioxin-Like PCB TEQ 3.6E-05 NA NA 3.6E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 1.3E-05 NA NA 1.3E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 4.4E+00 NA NA 4.4E+00

Arsenic 9.0E-06 NA NA 9.0E-06 Skin, Vascular 2.3E-01 NA NA 2.3E-01

Copper NA NA NA 0.0E+00 Gastrointestinal 1.4E-01 NA NA 1.4E-01

Mercury NA NA NA 0.0E+00 Developmental Neurological 6.6E-01 NA NA 6.6E-01

Chemical Total 9.0E-05 NA NA 9.0E-05 5.5E+00 NA NA 5.5E+00

Crab in Gowanus Canal Total 9.0E-05 5.5E+00

Receptor Total - Fish 2.0E-04 Receptor HI Total - Fiish 2.7E+01

Receptor Total - Blue Crab 9.0E-05 Receptor HI Total - Blue Crab 5.5E+00

Page 357: Appendix L HHRA Combined

TABLE 9.10.RME

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Body Weight HI Across All Media = 4.1E-02 Total Developmental HI Across All Media = 6.6E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used Total Developmental HI Across All Media = 1.4E+00 Total Finger and Toe Nails HI Across All Media = 4.4E+00

to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 Total Finger and Toe Nails HI Across All Media = 2.5E+01 Total Gastrointestinal HI Across All Media = 1.4E-01

used to adjust CSF for 2-6 year old for exposure duration of 4 years. Total Gastrointestinal HI Across All Media = 4.9E-02 Total Neurological HI Across All Media = 6.6E-01

Non-cancer calculations shown under 0-2 year old only, Total Liver HI Across All Media = 1.4E-01 Total Ocular HI Across All Media = 4.4E+00

as non-cancer calculations are not adjusted for MMOA. Total Neurological HI Across All Media = 1.4E+00 Total Skin HI Across All Media = 2.3E-01

Total Ocular HI Across All Media = 2.5E+01 Total Vascular HI Across All Media = 2.3E-01

Total Skin HI Across All Media = 1.1E-01

Total Thyroid HI Across All Media = 4.1E-02

Total Vascular HI Across All Media = 1.1E-01

Total Whole Body HI Across All Media = 1.6E-01

Page 358: Appendix L HHRA Combined

TABLE 9.1.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Acenaphthene NA NA NA 0.0E+00 Liver 7.8E-05 NA 8.4E-04 9.2E-04

Benzo(a)anthracene 5.1E-08 NA 5.5E-07 6.0E-07 NA NA NA 0.0E+00

Benzo(a)pyrene 4.3E-07 NA 4.6E-06 5.0E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene 4.5E-08 NA 4.9E-07 5.3E-07 NA NA NA 0.0E+00

Benzo(k)fluoranthene 2.6E-09 NA 2.8E-08 3.0E-08 NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate 2.5E-10 NA 2.1E-09 2.4E-09 Increased Liver Weight 2.1E-05 NA 1.8E-04 2.0E-04

Chrysene 1.0E-09 NA 1.1E-08 1.2E-08 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 2.5E-08 NA 2.7E-07 2.9E-07 NA NA NA 0.0E+00

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 1.6E-04 NA 1.7E-03 1.9E-03

Indeno(1,2,3-c,d)pyrene 1.9E-08 NA 2.1E-07 2.3E-07 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 2.2E-06 NA 2.3E-05 2.6E-05

Pyrene NA NA NA 0.0E+00 Kidney 2.2E-04 NA 2.4E-03 2.6E-03

Dioxin-Like PCB TEQ 3.4E-09 NA 4.0E-08 4.3E-08 NA NA NA 0.0E+00

Nondioxin-Like PCB 2.9E-09 NA 3.3E-08 3.6E-08 NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.4E-03 NA 4.0E-02 4.3E-02

Aluminum NA NA NA 0.0E+00 Neurological 2.0E-04 NA 1.7E-04 3.7E-04

Arsenic 1.5E-08 NA 3.7E-08 5.1E-08 Skin, Vascular 7.6E-04 NA 1.9E-03 2.7E-03

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) 1.2E-04 NA 4.1E-04 5.3E-04

Chromium 2.5E-08 NA 8.5E-07 8.7E-07 Not identified 4.0E-04 NA 1.3E-02 1.4E-02

Cobalt NA NA NA 0.0E+00 Thyroid 5.5E-04 NA 4.5E-04 1.0E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 1.1E-04 NA 9.3E-05 2.0E-04

Iron NA NA NA 0.0E+00 Gastrointestinal 7.3E-04 NA 6.0E-04 1.3E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Manganese NA NA NA 0.0E+00 CNS 2.9E-05 NA 3.5E-03 3.5E-03

Vanadium NA NA NA 0.0E+00 Hair 1.3E-04 NA 1.1E-04 2.3E-04

Chemical Total 6.2E-07 NA 7.1E-06 7.7E-06 6.9E-03 NA 6.5E-02 7.2E-02

Exposed Surface Sediment Total 7.7E-06 7.2E-02

Page 359: Appendix L HHRA Combined

TABLE 9.1.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Dry event) Benzene 8.7E-11 NA 1.3E-09 1.4E-09 Blood, Immune 9.3E-06 NA 1.4E-04 1.5E-04

Benzo(a)anthracene 1.4E-10 NA 1.6E-07 1.6E-07 NA NA NA 0.0E+00

Benzo(a)pyrene 3.4E-09 NA 6.8E-06 6.8E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene 1.5E-10 NA 3.1E-07 3.1E-07 NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate 2.4E-11 NA 3.5E-09 3.5E-09 Increased Liver Weight 2.0E-06 NA 2.9E-04 2.9E-04

Indeno(1,2,3-c,d)pyrene 6.8E-11 NA 1.4E-07 1.4E-07 NA NA NA 0.0E+00

Arsenic 2.1E-08 NA 1.5E-08 3.6E-08 Skin, Vascular 1.1E-03 NA 7.9E-04 1.9E-03

Chromium 6.7E-09 NA 3.9E-07 3.9E-07 Not identified 1.0E-04 NA 6.0E-03 6.1E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 7.1E-05 NA 5.1E-05 1.2E-04

Selenium NA NA NA 0.0E+00 Whole Body 1.4E-04 NA 9.8E-05 2.3E-04

Chemical Total 3.2E-08 NA 7.9E-06 7.9E-06 1.4E-03 NA 7.4E-03 8.8E-03

Surface Water Total - Dry Event 7.9E-06 8.8E-03

Page 360: Appendix L HHRA Combined

TABLE 9.1.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) 1,4-dichlorobenzene 2.3E-12 NA 1.4E-10 1.4E-10 Liver 1.4E-07 NA 8.6E-06 8.7E-06

Benzene 3.3E-11 NA 5.0E-10 5.3E-10 Blood, Immune 3.5E-06 NA 5.3E-05 5.6E-05

Chloroform 1.2E-11 NA 1.1E-10 1.2E-10 Liver, Body Weight 9.2E-07 NA 8.0E-06 8.9E-06

Ethylbenzene 6.8E-12 NA 3.8E-10 3.9E-10 Liver, Kidney 1.4E-07 NA 8.1E-06 8.3E-06

Tetrachloroethylene(PCE) 9.3E-09 NA 5.1E-07 5.2E-07 Liver 4.0E-05 NA 2.2E-03 2.3E-03

Benzo(a)anthracene 5.4E-11 NA 6.3E-08 6.3E-08 NA NA NA 0.0E+00

Benzo(a)pyrene 1.1E-09 NA 2.1E-06 2.1E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene 9.8E-11 NA 2.0E-07 2.0E-07 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 5.2E-10 NA 1.6E-06 1.6E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene 2.6E-10 NA 5.3E-07 5.3E-07 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 3.0E-07 NA 1.8E-05 1.9E-05

Arsenic 1.8E-08 NA 1.3E-08 3.0E-08 Skin, Vascular 9.2E-04 NA 6.6E-04 1.6E-03

Chromium 3.0E-09 NA 1.7E-07 1.8E-07 Not identified 4.7E-05 NA 2.7E-03 2.8E-03

Cobalt NA NA NA 0.0E+00 Thyroid 2.1E-04 NA 6.2E-05 2.8E-04

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Selenium NA NA NA 0.0E+00 Whole Body 1.1E-04 NA 8.0E-05 1.9E-04

Chemical Total 3.2E-08 NA 5.2E-06 5.3E-06 1.3E-03 NA 5.8E-03 7.2E-03

Surface Water Total - Wet Event 5.3E-06 7.2E-03

Receptor Total 1.6E-05 Receptor HI Total 8.1E-02

Page 361: Appendix L HHRA Combined

TABLE 9.1.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 2.0E-03

CNS - Central Nervous System Total Body Weight HI Across All Media = 5.3E-05

Receptor Total and target organ totals includes sum of exposed and near shore sediment, and maximum of dry event and wet event surface water. Total Finger and Toe Nails HI Across All Media = 4.3E-02

Total Gastrointestinal HI Across All Media = 1.7E-03

Total Hair HI Across All Media = 2.3E-04

Total Kidney HI Across All Media = 5.0E-03

Total Immune HI Across All Media = 1.5E-04

Total Liver HI Across All Media = 5.5E-03

Total Nervous System HI Across All Media = 3.9E-03

Total Ocular HI Across All Media = 4.3E-02

Total Skin HI Across All Media = 4.6E-03

Total Thyroid HI Across All Media = 1.3E-03

Total Vascular HI Across All Media = 4.6E-03

Total Whole Body HI Across All Media = 4.2E-04

Page 362: Appendix L HHRA Combined

TABLE 9.2.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Acenaphthene NA NA NA 0.0E+00 Liver 9.5E-05 NA 1.0E-03 1.1E-03

Benzo(a)anthracene (12-15)* 1.9E-07 NA 2.0E-06 2.2E-06 NA NA NA 0.0E+00

Benzo(a)pyrene (12-15)* 1.6E-06 NA 1.7E-05 1.9E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene (12-15)* 1.7E-07 NA 1.8E-06 2.0E-06 NA NA NA 0.0E+00

Benzo(k)fluoranthene (12-15)* 9.5E-09 NA 1.0E-07 1.1E-07 NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate 3.1E-10 NA 2.6E-09 2.9E-09 Increased Liver Weight 2.6E-05 NA 2.2E-04 2.4E-04

Chrysene (12-15)* 3.7E-09 NA 4.0E-08 4.4E-08 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (12-15)* 9.1E-08 NA 9.9E-07 1.1E-06 NA NA NA 0.0E+00

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 1.9E-04 NA 2.1E-03 2.3E-03

Indeno(1,2,3-c,d)pyrene (12-15)* 7.2E-08 NA 7.8E-07 8.5E-07 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 2.7E-06 NA 2.9E-05 3.2E-05

Pyrene NA NA NA 0.0E+00 Kidney 2.8E-04 NA 3.0E-03 3.3E-03

Dioxin-Like PCB TEQ 4.2E-09 NA 4.9E-08 5.3E-08 NA NA NA 0.0E+00

Nondioxin-Like PCB 3.5E-09 NA 4.1E-08 4.5E-08 NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 4.2E-03 NA 4.9E-02 5.4E-02

Aluminum NA NA NA 0.0E+00 Neurological 2.5E-04 NA 2.1E-04 4.6E-04

Arsenic 1.8E-08 NA 4.5E-08 6.3E-08 Skin, Vascular 9.4E-04 NA 2.4E-03 3.3E-03

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) 1.5E-04 NA 5.0E-04 6.5E-04

Chromium (12-15)* 9.4E-08 NA 3.1E-06 3.2E-06 Not identified 4.9E-04 NA 1.6E-02 1.7E-02

Cobalt NA NA NA 0.0E+00 Thyroid 6.7E-04 NA 5.6E-04 1.2E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 1.4E-04 NA 1.2E-04 2.5E-04

Iron NA NA NA 0.0E+00 Gastrointestinal 8.9E-04 NA 7.5E-04 1.6E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Manganese NA NA NA 0.0E+00 CNS 3.5E-05 NA 4.3E-03 4.3E-03

Vanadium NA NA NA 0.0E+00 Hair 1.6E-04 NA 1.3E-04 2.9E-04

Chemical Total 2.2E-06 NA 2.6E-05 2.8E-05 8.5E-03 NA 8.1E-02 8.9E-02

Exposed Surface Sediment Total 2.8E-05 8.9E-02

Page 363: Appendix L HHRA Combined

TABLE 9.2.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Dry event) Benzene 1.1E-10 NA 1.4E-09 1.5E-09 Blood, Immune 1.1E-05 NA 1.5E-04 1.6E-04

Benzo(a)anthracene (12-15)* 5.1E-10 NA 5.2E-07 5.2E-07 NA NA NA 0.0E+00

Benzo(a)pyrene (12-15)* 1.3E-08 NA 2.2E-05 2.2E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene (12-15)* 5.7E-10 NA 1.0E-06 1.0E-06 NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate 3.0E-11 NA 3.7E-09 3.8E-09 Increased Liver Weight 2.5E-06 NA 3.1E-04 3.1E-04

Indeno(1,2,3-c,d)pyrene (12-15)* 2.5E-10 NA 4.5E-07 4.5E-07 NA NA NA 0.0E+00

Arsenic 2.6E-08 NA 1.6E-08 4.2E-08 Skin, Vascular 1.3E-03 NA 8.5E-04 2.2E-03

Chromium (12-15)* 2.5E-08 NA 1.2E-06 1.3E-06 Not identified 1.3E-04 NA 6.5E-03 6.6E-03

Copper 0.0E+00 NA NA 0.0E+00 Gastrointestinal 8.7E-05 NA 5.5E-05 1.4E-04

Selenium 0.0E+00 NA NA 0.0E+00 Whole Body 1.7E-04 NA 1.0E-04 2.7E-04

Chemical Total 6.5E-08 NA 2.5E-05 2.5E-05 1.7E-03 NA 7.9E-03 9.7E-03

Surface Water Total - Dry Event 2.5E-05 9.7E-03

Page 364: Appendix L HHRA Combined

TABLE 9.2.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) 1,4-dichlorobenzene 2.8E-12 NA 1.5E-10 1.5E-10 Liver 1.7E-07 NA 9.3E-06 9.4E-06

Benzene 4.0E-11 NA 5.4E-10 5.8E-10 Blood, Immune 4.2E-06 NA 5.7E-05 6.1E-05

Chloroform 1.5E-11 NA 1.1E-10 1.3E-10 Liver, Body Weight 1.1E-06 NA 8.6E-06 9.7E-06

Ethylbenzene 8.3E-12 NA 4.1E-10 4.2E-10 Liver, Kidney 1.8E-07 NA 8.7E-06 8.9E-06

Tetrachloroethylene(PCE) 1.1E-08 NA 5.5E-07 5.6E-07 Liver 5.0E-05 NA 2.4E-03 2.4E-03

Benzo(a)anthracene (12-15)* 2.0E-10 NA 2.0E-07 2.0E-07 NA NA NA 0.0E+00

Benzo(a)pyrene (12-15)* 3.9E-09 NA 6.9E-06 6.9E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (12-15)* 3.6E-10 NA 6.4E-07 6.4E-07 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (12-15)* 1.9E-09 NA 5.2E-06 5.2E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (12-15)* 9.5E-10 NA 1.7E-06 1.7E-06 NA NA NA 0.0E+00

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 3.7E-07 NA 2.0E-05 2.0E-05

Arsenic 2.2E-08 NA 1.4E-08 3.5E-08 Skin, Vascular 1.1E-03 NA 7.1E-04 1.8E-03

Chromium (12-15)* 1.1E-08 NA 5.6E-07 5.7E-07 Not identified 5.8E-05 NA 2.9E-03 3.0E-03

Cobalt NA NA NA 0.0E+00 Thyroid 2.6E-04 NA 6.7E-05 3.3E-04

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Selenium NA NA NA 0.0E+00 Whole Body 1.4E-04 NA 8.6E-05 2.2E-04

Chemical Total 5.2E-08 NA 1.6E-05 1.6E-05 1.6E-03 NA 6.3E-03 7.9E-03

Surface Water Total - Wet Event 1.6E-05 7.9E-03

Receptor Total 5.4E-05 Receptor HI Total 9.9E-02

Page 365: Appendix L HHRA Combined

TABLE 9.2.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 2.5E-03

CNS - Central Nervous System Total Body Weight HI Across All Media = 6.2E-05

Receptor Total and target organ totals includes sum of exposed and near shore sediment, and maximum of dry event and wet event surface water. Total Finger and Toe Nails HI Across All Media = 5.4E-02

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used to adjust CSF for 12-15 year old for exposure duration of 3 years, Total Gastrointestinal HI Across All Media = 2.0E-03

the CTE exposure duration for an adolescent. Total Hair HI Across All Media = 2.9E-04

Total Kidney HI Across All Media = 6.2E-03

Total Immune HI Across All Media = 1.6E-04

Total Liver HI Across All Media = 6.5E-03

Total Nervous System HI Across All Media = 4.8E-03

Total Ocular HI Across All Media = 5.4E-02

Total Skin HI Across All Media = 5.5E-03

Total Thyroid HI Across All Media = 1.6E-03

Total Vascular HI Across All Media = 5.5E-03

Total Whole Body HI Across All Media = 4.9E-04

Page 366: Appendix L HHRA Combined

TABLE 9.3.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Acenaphthene NA NA NA 0.0E+00 Liver 7.2E-04 NA 1.1E-03 1.8E-03

Benzo(a)anthracene (0-2)* 3.1E-06 NA 4.6E-06 7.7E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-3)* 4.7E-07 NA 6.9E-07 1.2E-06

Benzo(a)pyrene (0-2)* 2.6E-05 NA 3.9E-05 6.5E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 4.0E-06 NA 5.8E-06 9.8E-06

Benzo(b)fluoranthene (0-2)* 2.8E-06 NA 4.1E-06 6.9E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-3)* 4.2E-07 NA 6.1E-07 1.0E-06

Benzo(k)fluoranthene (0-2)* 1.6E-07 NA 2.3E-07 3.9E-07 NA NA NA 0.0E+00

Benzo(k)fluoranthene (2-3)* 2.4E-08 NA 3.5E-08 5.9E-08

Bis(2-ethylhexyl) phthalate 2.4E-09 NA 2.7E-09 5.0E-09 Increased Liver Weight 2.0E-04 NA 2.2E-04 4.2E-04

Chrysene (0-2)* 6.3E-08 NA 9.1E-08 1.5E-07 NA NA NA 0.0E+00

Chrysene (2-3)* 9.4E-09 NA 1.4E-08 2.3E-08

Dibenz(a,h)anthracene (0-2)* 1.5E-06 NA 2.2E-06 3.8E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (0-2)* 2.3E-07 NA 3.3E-07 5.6E-07

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 1.5E-03 NA 2.1E-03 3.6E-03

Indeno(1,2,3-c,d)pyrene (0-2)* 1.2E-06 NA 1.8E-06 3.0E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-3)* 1.8E-07 NA 2.6E-07 4.5E-07

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 2.0E-05 NA 2.9E-05 5.0E-05

Pyrene NA NA NA 0.0E+00 Kidney 2.1E-03 NA 3.0E-03 5.1E-03

Dioxin-Like PCB TEQ 3.2E-08 NA 5.0E-08 8.2E-08 NA NA NA 0.0E+00

Nondioxin-Like PCB 2.7E-08 NA 4.2E-08 6.8E-08 NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.2E-02 NA 5.0E-02 8.2E-02

Aluminum NA NA NA 0.0E+00 Neurological 1.9E-03 NA 2.1E-04 2.1E-03

Arsenic 1.4E-07 NA 4.6E-08 1.8E-07 Skin, Vascular 7.1E-03 NA 2.4E-03 9.5E-03

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) 1.1E-03 NA 5.1E-04 1.7E-03

Chromium (0-2)* 1.6E-06 NA 7.1E-06 8.7E-06 Not identified 3.7E-03 NA 1.7E-02 2.0E-02

Chromium (2-3)* 2.4E-07 NA 1.1E-06 1.3E-06

Cobalt NA NA NA 0.0E+00 Thyroid 5.1E-03 NA 5.7E-04 5.7E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 1.0E-03 NA 1.2E-04 1.2E-03

Iron NA NA NA 0.0E+00 Gastrointestinal 6.8E-03 NA 7.6E-04 7.5E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Manganese NA NA NA 0.0E+00 CNS 2.7E-04 NA 4.3E-03 4.6E-03

Vanadium NA NA NA 0.0E+00 Hair 1.2E-03 NA 1.3E-04 1.3E-03

Chemical Total 4.3E-05 NA 6.8E-05 1.1E-04 6.5E-02 NA 8.2E-02 1.5E-01

Exposed Surface Sediment Total 1.1E-04 1.5E-01

Page 367: Appendix L HHRA Combined

TABLE 9.3.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Dry event) Benzene 4.1E-10 NA 2.3E-09 2.7E-09 Blood, Immune 4.3E-05 NA 2.4E-04 2.9E-04

Benzo(a)anthracene (0-2)* 4.3E-09 NA 1.8E-06 1.8E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-3)* 6.4E-10 NA 2.8E-07 2.8E-07

Benzo(a)pyrene (0-2)* 1.1E-07 NA 7.8E-05 7.8E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 1.6E-08 NA 1.2E-05 1.2E-05

Benzo(b)fluoranthene (0-2)* 4.8E-09 NA 3.6E-06 3.6E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-3)* 7.2E-10 NA 5.4E-07 5.4E-07

Bis(2-ethylhexyl) phthalate 1.1E-10 NA 5.9E-09 6.0E-09 Increased Liver Weight 9.5E-06 NA 4.9E-04 5.0E-04

Indeno(1,2,3-c,d)pyrene (0-2)* 2.1E-09 NA 1.6E-06 1.6E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-3)* 3.2E-10 NA 2.4E-07 2.4E-07

Arsenic 9.9E-08 NA 2.6E-08 1.2E-07 Skin, Vascular 5.1E-03 NA 1.4E-03 6.5E-03

Chromium (0-2)* 2.1E-07 NA 4.4E-06 4.6E-06 Not identified 4.9E-04 NA 1.0E-02 1.1E-02

Chromium (2-3)* 3.1E-08 NA 6.6E-07 6.9E-07

Copper 0.0E+00 NA NA 0.0E+00 Gastrointestinal 3.3E-04 NA 8.8E-05 4.2E-04

Selenium 0.0E+00 NA NA 0.0E+00 Whole Body 6.3E-04 NA 1.7E-04 8.0E-04

Chemical Total 4.7E-07 NA 1.0E-04 1.0E-04 6.6E-03 NA 1.3E-02 1.9E-02

Surface Water Total - Dry Event 1.0E-04 1.9E-02

Page 368: Appendix L HHRA Combined

TABLE 9.3.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) 1,4-dichlorobenzene 1.1E-11 NA 2.4E-10 2.5E-10 Liver 6.5E-07 NA 1.5E-05 1.5E-05

Benzene 1.5E-10 NA 8.5E-10 1.0E-09 Blood, Immune 1.6E-05 NA 9.1E-05 1.1E-04

Chloroform 5.7E-11 NA 1.8E-10 2.4E-10 Liver, Body Weight 4.3E-06 NA 1.4E-05 1.8E-05

Ethylbenzene 3.2E-11 NA 6.6E-10 6.9E-10 Liver, Kidney 6.7E-07 NA 1.4E-05 1.5E-05

Tetrachloroethylene(PCE) 4.4E-08 NA 8.8E-07 9.2E-07 Liver 1.9E-04 NA 3.8E-03 4.0E-03

Benzo(a)anthracene (0-2)* 1.7E-09 NA 7.2E-07 7.2E-07 NA NA NA 0.0E+00

Benzo(a)anthracene (2-3)* 2.5E-10 NA 3.6E-07 3.6E-07

Benzo(a)pyrene (0-2)* 3.3E-08 NA 2.4E-05 2.4E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 4.9E-09 NA 3.4E-06 3.4E-06

Benzo(b)fluoranthene (0-2)* 3.0E-09 NA 2.3E-06 2.3E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-3)* 4.6E-10 NA 2.8E-07 2.8E-07

Dibenz(a,h)anthracene (0-2)* 1.6E-08 NA 1.8E-05 1.8E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (0-2)* 2.4E-09 NA 9.0E-06 9.0E-06

Indeno(1,2,3-c,d)pyrene (0-2)* 8.0E-09 NA 6.0E-06 6.0E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-3)* 1.2E-09 NA 2.0E-08 2.1E-08

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight 1.4E-06 NA 3.2E-05 3.3E-05

Arsenic 8.2E-08 NA 2.2E-08 1.0E-07 Skin, Vascular 4.3E-03 NA 1.1E-03 5.4E-03

Chromium (0-2)* 9.4E-08 NA 2.0E-06 2.1E-06 Not identified 2.2E-04 NA 4.6E-03 4.9E-03

Chromium (2-3)* 1.4E-08 NA 2.7E-08 4.1E-08

Cobalt NA NA NA 0.0E+00 Thyroid 1.0E-03 NA 1.1E-04 1.1E-03

Lead NA NA NA 0.0E+00 NA NA NA 0.0E+00

Selenium NA NA NA 0.0E+00 Whole Body 5.2E-04 NA 1.4E-04 6.6E-04

Chemical Total 3.1E-07 NA 6.8E-05 6.8E-05 6.2E-03 NA 1.0E-02 1.6E-02

Surface Water Total - Wet Event 6.8E-05 1.6E-02

Receptor Total 2.1E-04 Receptor HI Total 1.7E-01

Page 369: Appendix L HHRA Combined

TABLE 9.3.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 3.9E-03

CNS - Central Nervous System Total Body Weight HI Across All Media = 1.0E-04

Receptor Total and target organ totals includes sum of exposed and near shore sediment, and maximum of dry event and wet event surface water. Total Finger and Toe Nails HI Across All Media = 8.2E-02

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 Total Gastrointestinal HI Across All Media = 9.1E-03

used to adjust CSF for 2-3 year old for exposure duration of 1 year, for a total CTE exposure duration of 3 years. Non-cancer calculations shown under 0-2 year old only, Total Hair HI Across All Media = 1.3E-03

as non-cancer calculations are not adjusted for MMOA. Total Kidney HI Across All Media = 1.0E-02

Total Immune HI Across All Media = 2.9E-04

Total Liver HI Across All Media = 1.0E-02

Total Nervous System HI Across All Media = 6.7E-03

Total Ocular HI Across All Media = 8.2E-02

Total Skin HI Across All Media = 1.6E-02

Total Thyroid HI Across All Media = 6.8E-03

Total Vascular HI Across All Media = 1.6E-02

Total Whole Body HI Across All Media = 1.5E-03

Page 370: Appendix L HHRA Combined

TABLE 9.4.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA NA NA Blood NA 2.7E-02 NA 2.7E-02

operation) Chloroform NA NA NA Liver NA 1.6E-03 NA 1.6E-03

Ethylbenzene NA NA NA Developmental NA 7.0E-04 NA 7.0E-04

Naphthalene NA NA NA Nasal, Respiratory NA 2.8E-01 NA 2.8E-01

Chemical Total NA NA NA NA 3.1E-01 NA 3.1E-01

Ambient air at street level Total - Pre-aeration system operation 3.1E-01

Air Air

Ambient air at canal

level

(after aeration system Benzene NA NA NA Blood NA 2.4E-02 NA 2.4E-02

started) Chloroform NA NA NA Liver NA 2.2E-03 NA 2.2E-03

Ethylbenzene NA NA NA Developmental NA 7.9E-04 NA 7.9E-04

Naphthalene NA NA NA Nasal, Respiratory NA 6.5E-01 NA 6.5E-01

Chemical Total NA NA NA NA 6.7E-01 NA 6.7E-01

Ambient air at street level Total - After aeration system turned on 6.7E-01

Page 371: Appendix L HHRA Combined

TABLE 9.4.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal 2-methylnaphthalene NA NA NA Lung 7.9E-04 NA 2.3E-03 3.1E-03

Acenaphthene NA NA NA Liver 4.5E-05 NA 1.3E-04 1.8E-04

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Benzo(k)fluoranthene NA NA NA NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate NA NA NA Increased Liver Weight 6.4E-06 NA 1.5E-05 2.1E-05

Chrysene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Fluoranthene NA NA NA Kidney, Liver, Blood 4.0E-05 NA 1.2E-04 1.6E-04

Fluorene NA NA NA Blood 5.1E-05 NA 1.5E-04 2.0E-04

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 2.9E-04 NA 8.5E-04 1.1E-03

Pyrene NA NA NA Kidney 1.1E-04 NA 3.4E-04 4.5E-04

Dioxin-Like PCB TEQ NA NA NA NA NA NA 0.0E+00

Nondioxin-Like PCB NA NA NA NA NA NA 0.0E+00

Total PCB NA NA NA Ocular, Finger and Toe Nails 2.9E-03 NA 9.3E-03 1.2E-02

Aluminum NA NA NA Neurological 1.3E-04 NA 2.9E-05 1.6E-04

Arsenic NA NA NA Skin, Vascular 4.3E-04 NA 3.0E-04 7.3E-04

Cadmium NA NA NA Proteinuria (Kidney) 8.8E-05 NA 8.0E-05 1.7E-04

Chromium NA NA NA Not identified 2.5E-04 NA 2.3E-03 2.5E-03

Cobalt NA NA NA Thyroid 3.2E-04 NA 7.4E-05 4.0E-04

Copper NA NA NA Gastrointestinal 6.0E-05 NA 1.4E-05 7.4E-05

Iron NA NA NA Gastrointestinal 4.2E-04 NA 9.6E-05 5.2E-04

Lead NA NA NA NA NA NA 0.0E+00

Manganese NA NA NA CNS 1.9E-05 NA 8.8E-07 2.0E-05

Vanadium NA NA NA Hair 8.1E-05 NA 1.8E-05 9.9E-05

Chemical Total NA NA NA 6.1E-03 NA 1.6E-02 2.2E-02

Overflow Surface Sediment Total 2.2E-02

Page 372: Appendix L HHRA Combined

TABLE 9.4.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

1,4-dichlorobenzene NA NA NA Liver 4.8E-08 NA 9.4E-07 9.9E-07

Benzene NA NA NA Blood, Immune 1.2E-06 NA 5.8E-06 7.0E-06

Chloroform NA NA NA Liver, Body Weight 3.2E-07 NA 8.7E-07 1.2E-06

Ethylbenzene NA NA NA Liver, Kidney 5.0E-08 NA 8.9E-07 9.4E-07

Tetrachloroethylene(PCE) NA NA NA Liver 1.4E-05 NA 2.4E-04 2.6E-04

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 1.0E-07 NA 2.0E-06 2.1E-06

Arsenic NA NA NA Skin, Vascular 3.2E-04 NA 7.2E-05 3.9E-04

Chromium NA NA NA Not identified 1.6E-05 NA 3.0E-04 3.1E-04

Cobalt NA NA NA Thyroid 7.4E-05 NA 6.8E-06 8.1E-05

Lead NA NA NA NA NA NA 0.0E+00

Selenium NA NA NA Whole Body 3.8E-05 NA 8.8E-06 4.7E-05

Chemical Total NA NA NA 4.6E-04 NA 6.4E-04 1.1E-03

Overflow Surface Water Total 1.1E-03

Receptor Total Receptor HI Total 7.0E-01

Page 373: Appendix L HHRA Combined

TABLE 9.4.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 2.7E-02

CNS - Central Nervous System Total Body Weight HI Across All Media = 1.1E-03

Receptor Total and target organ totals includes maximum between air prior to and after aeration system operation, and surface water, and sediment. Total Developmental HI Across All Media = 1.5E-03

Total Finger and Toe Nails HI Across All Media = 1.2E-02

Total Gastrointestinal HI Across All Media = 5.9E-04

Total Hair HI Across All Media = 9.9E-05

Total Kidney HI Across All Media = 7.8E-04

Total Immune HI Across All Media = 7.0E-06

Total Liver HI Across All Media = 2.8E-03

Total Lung HI Across All Media = 3.1E-03

Total Nasal HI Across All Media = 6.5E-01

Total Nervous System HI Across All Media = 1.8E-04

Total Ocular HI Across All Media = 1.2E-02

Total Respiratory HI Across All Media = 6.5E-01

Total Skin HI Across All Media = 1.1E-03

Total Thyroid HI Across All Media = 4.8E-04

Total Vascular HI Across All Media = 1.1E-03

Total Whole Body HI Across All Media = 4.7E-05

Page 374: Appendix L HHRA Combined

TABLE 9.5.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA NA NA Blood NA 2.7E-02 NA 2.7E-02

operation) Chloroform NA NA NA Liver NA 1.6E-03 NA 1.6E-03

Ethylbenzene NA NA NA Developmental NA 7.0E-04 NA 7.0E-04

Naphthalene NA NA NA Nasal, Respiratory NA 2.8E-01 NA 2.8E-01

Chemical Total NA NA NA NA 3.1E-01 NA 3.1E-01

Ambient air at street level Total - Pre-aeration system operation 3.1E-01

Air Air

Ambient air at canal

level

(after aeration system Benzene NA NA NA Blood NA 2.4E-02 NA 2.4E-02

started) Chloroform NA NA NA Liver NA 2.2E-03 NA 2.2E-03

Ethylbenzene NA NA NA Developmental NA 7.9E-04 NA 7.9E-04

Naphthalene NA NA NA Nasal, Respiratory NA 6.5E-01 NA 6.5E-01

Chemical Total NA NA NA NA 6.7E-01 NA 6.7E-01

Ambient air at street level Total - After aeration system turned on 6.7E-01

Page 375: Appendix L HHRA Combined

TABLE 9.5.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal 2-methylnaphthalene NA NA NA Lung 7.4E-03 NA 5.4E-03 1.3E-02

Acenaphthene NA NA NA Liver 4.2E-04 NA 3.1E-04 7.3E-04

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Benzo(k)fluoranthene NA NA NA NA NA NA 0.0E+00

Bis(2-ethylhexyl) phthalate NA NA NA Increased Liver Weight 6.0E-05 NA 3.3E-05 9.3E-05

Chrysene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Fluoranthene NA NA NA Kidney, Liver, Blood 3.7E-04 NA 2.7E-04 6.4E-04

Fluorene NA NA NA Blood 4.7E-04 NA 3.5E-04 8.2E-04

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 2.7E-03 NA 2.0E-03 4.7E-03

Pyrene NA NA NA Kidney 1.1E-03 NA 7.7E-04 1.8E-03

Dioxin-Like PCB TEQ NA NA NA NA NA NA 0.0E+00

Nondioxin-Like PCB NA NA NA NA NA NA 0.0E+00

Total PCB NA NA NA Ocular, Finger and Toe Nails 2.7E-02 NA 2.1E-02 4.9E-02

Aluminum NA NA NA Neurological 1.2E-03 NA 6.7E-05 1.3E-03

Arsenic NA NA NA Skin, Vascular 4.0E-03 NA 6.8E-04 4.7E-03

Cadmium NA NA NA Proteinuria (Kidney) 8.2E-04 NA 1.8E-04 1.0E-03

Chromium NA NA NA Not identified 2.3E-03 NA 5.2E-03 7.5E-03

Cobalt NA NA NA Thyroid 3.0E-03 NA 1.7E-04 3.2E-03

Copper NA NA NA Gastrointestinal 5.6E-04 NA 3.2E-05 5.9E-04

Iron NA NA NA Gastrointestinal 3.9E-03 NA 2.2E-04 4.2E-03

Lead NA NA NA NA NA NA 0.0E+00

Manganese NA NA NA CNS 1.8E-04 NA 2.0E-06 1.8E-04

Vanadium NA NA NA Hair 7.5E-04 NA 4.2E-05 8.0E-04

Chemical Total NA NA NA 5.7E-02 NA 3.7E-02 9.3E-02

Overflow Surface Sediment Total 9.3E-02

Page 376: Appendix L HHRA Combined

TABLE 9.5.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

1,4-dichlorobenzene NA NA NA Liver 2.3E-07 NA 2.2E-06 2.4E-06

Benzene NA NA NA Blood, Immune 5.6E-06 NA 1.3E-05 1.9E-05

Chloroform NA NA NA Liver, Body Weight 1.5E-06 NA 2.0E-06 3.5E-06

Ethylbenzene NA NA NA Liver, Kidney 2.3E-07 NA 2.0E-06 2.3E-06

Tetrachloroethylene(PCE) NA NA NA Liver 6.5E-05 NA 5.6E-04 6.2E-04

Benzo(a)anthracene NA NA NA NA NA NA 0.0E+00

Benzo(a)pyrene NA NA NA NA NA NA 0.0E+00

Benzo(b)fluoranthene NA NA NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene NA NA NA NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene NA NA NA NA NA NA 0.0E+00

Naphthalene NA NA NA Decreased Body Weight 4.9E-07 NA 4.6E-06 5.1E-06

Arsenic NA NA NA Skin, Vascular 1.5E-03 NA 1.7E-04 1.6E-03

Chromium NA NA NA Not identified 7.6E-05 NA 6.8E-04 7.6E-04

Cobalt NA NA NA Thyroid 3.5E-04 NA 1.6E-05 3.6E-04

Lead NA NA NA NA NA NA 0.0E+00

Selenium NA NA NA Whole Body 1.8E-04 NA 2.0E-05 2.0E-04

Chemical Total NA NA NA 2.2E-03 NA 1.5E-03 3.6E-03

Overflow Surface Water Total 3.6E-03

Receptor Total Receptor HI Total 7.7E-01

Page 377: Appendix L HHRA Combined

TABLE 9.5.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

HI - Hazard Index Total Blood HI Across All Media = 2.8E-02

CNS - Central Nervous System Total Body Weight HI Across All Media = 4.7E-03

Receptor Total and target organ totals includes maximum between air prior to and after aeration system operation, and surface water, and sediment. Total Developmental HI Across All Media = 1.5E-03

Total Finger and Toe Nails HI Across All Media = 4.9E-02

Total Gastrointestinal HI Across All Media = 4.8E-03

Total Hair HI Across All Media = 8.0E-04

Total Kidney HI Across All Media = 3.5E-03

Total Immune HI Across All Media = 1.9E-05

Total Liver HI Across All Media = 4.3E-03

Total Lung HI Across All Media = 1.3E-02

Total Nasal HI Across All Media = 6.5E-01

Total Nervous System HI Across All Media = 1.4E-03

Total Ocular HI Across All Media = 4.9E-02

Total Respiratory HI Across All Media = 6.5E-01

Total Skin HI Across All Media = 6.3E-03

Total Thyroid HI Across All Media = 3.5E-03

Total Vascular HI Across All Media = 6.3E-03

Total Whole Body HI Across All Media = 2.0E-04

Page 378: Appendix L HHRA Combined

TABLE 9.6.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA 8.1E-07 NA 8.1E-07 Blood NA NA NA

operation) Chloroform NA 4.6E-07 NA 4.6E-07 Liver NA NA NA

Ethylbenzene NA 2.2E-07 NA 2.2E-07 Developmental NA NA NA

Naphthalene NA 3.6E-06 NA 3.6E-06 Nasal, Respiratory NA NA NA

Chemical Total NA 5.1E-06 NA 5.1E-06 NA NA NA

Ambient air at street level Total - Pre-aeration system operation 5.1E-06

Air Air

Ambient air at canal

level

(after aeration system Benzene NA 7.1E-07 NA 7.1E-07 Blood NA NA NA

started) Chloroform NA 6.3E-07 NA 6.3E-07 Liver NA NA NA

Ethylbenzene NA 2.6E-07 NA 2.6E-07 Developmental NA NA NA

Naphthalene NA 8.5E-06 NA 8.5E-06 Nasal, Respiratory NA NA NA

Chemical Total NA 1.0E-05 NA 1.0E-05 NA NA NA

Ambient air at street level Total - After aeration system turned on 1.0E-05

Page 379: Appendix L HHRA Combined

TABLE 9.6.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal 2-methylnaphthalene NA NA NA 0.0E+00 Lung NA NA NA

Acenaphthene NA NA NA 0.0E+00 Liver NA NA NA

Benzo(a)anthracene 3.5E-06 NA 2.7E-06 6.2E-06 NA NA NA

Benzo(a)pyrene 2.0E-05 NA 1.5E-05 3.5E-05 NA NA NA

Benzo(b)fluoranthene 2.2E-06 NA 1.6E-06 3.8E-06 NA NA NA

Benzo(k)fluoranthene 1.1E-07 NA 8.5E-08 2.0E-07 NA NA NA

Bis(2-ethylhexyl) phthalate 1.5E-09 NA 1.3E-09 2.8E-09 Increased Liver Weight NA NA NA

Chrysene 3.5E-08 NA 2.6E-08 6.2E-08 NA NA NA

Dibenz(a,h)anthracene 1.5E-06 NA 1.1E-06 2.6E-06 NA NA NA

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood NA NA NA

Fluorene NA NA NA 0.0E+00 Blood NA NA NA

Indeno(1,2,3-c,d)pyrene 8.7E-07 NA 6.5E-07 1.5E-06 NA NA NA

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight NA NA NA

Pyrene NA NA NA 0.0E+00 Kidney NA NA NA

Dioxin-Like PCB TEQ 5.2E-08 NA 6.5E-08 1.2E-07 NA NA NA

Nondioxin-Like PCB 4.8E-08 NA 5.9E-08 1.1E-07 NA NA NA

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails NA NA NA

Aluminum NA NA NA 0.0E+00 Neurological NA NA NA

Arsenic 1.6E-07 NA 4.3E-08 2.1E-07 Skin, Vascular NA NA NA

Cadmium NA NA NA 0.0E+00 Proteinuria (Kidney) NA NA NA

Chromium 1.6E-08 NA 3.7E-07 3.9E-07 Not identified NA NA NA

Cobalt NA NA NA 0.0E+00 Thyroid NA NA NA

Copper NA NA NA 0.0E+00 Gastrointestinal NA NA NA

Iron NA NA NA 0.0E+00 Gastrointestinal NA NA NA

Lead NA NA NA 0.0E+00 NA NA NA

Manganese NA NA NA 0.0E+00 CNS NA NA NA

Vanadium NA NA NA 0.0E+00 Hair NA NA NA

Chemical Total 2.9E-05 NA 2.2E-05 5.1E-05 NA NA NA

Overflow Surface Sediment Total 5.1E-05

Page 380: Appendix L HHRA Combined

TABLE 9.6.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

1,4-dichlorobenzene 9.5E-12 NA 1.2E-10 1.3E-10 Liver NA NA NA

Benzene 1.4E-10 NA 4.2E-10 5.5E-10 Blood, Immune NA NA NA

Chloroform 5.2E-11 NA 8.8E-11 1.4E-10 Liver, Body Weight NA NA NA

Ethylbenzene 2.8E-11 NA 3.2E-10 3.5E-10 Liver, Kidney NA NA NA

Tetrachloroethylene(PCE) 3.9E-08 NA 4.3E-07 4.7E-07 Liver NA NA NA

Benzo(a)anthracene 9.5E-10 NA 1.8E-07 1.8E-07 NA NA NA

Benzo(a)pyrene 2.2E-08 NA 5.9E-06 6.0E-06 NA NA NA

Benzo(b)fluoranthene 2.1E-09 NA 5.5E-07 5.6E-07 NA NA NA

Dibenz(a,h)anthracene 1.1E-08 NA 4.5E-06 4.5E-06 NA NA NA

Indeno(1,2,3-c,d)pyrene 5.4E-09 NA 1.5E-06 1.5E-06 NA NA NA

Naphthalene NA NA NA 0.0E+00 Decreased Body Weight NA NA NA

Arsenic 7.4E-08 NA 1.1E-08 8.5E-08 Skin, Vascular NA NA NA

Chromium 6.4E-08 NA 8.8E-07 9.5E-07 Not identified NA NA NA

Cobalt NA NA NA 0.0E+00 Thyroid NA NA NA

Lead NA NA NA 0.0E+00 NA NA NA

Selenium NA NA NA 0.0E+00 Whole Body NA NA NA

Chemical Total 2.2E-07 NA 1.4E-05 1.4E-05 NA NA NA

Overflow Surface Water Total 1.4E-05

Receptor Total 7.5E-05 Receptor HI Total

Receptor Total includes maximum between air prior to and after aeration system operation, and surface water, and sediment.

Page 381: Appendix L HHRA Combined

TABLE 9.7.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

p,p'-DDE 3.3E-09 NA NA 3.3E-09 NA NA NA NA 0.0E+00

p,p'-DDT 2.6E-09 NA NA 2.6E-09 Liver 3.6E-04 NA NA 3.6E-04

Dioxin-Like PCB TEQ 5.4E-07 NA NA 5.4E-07 NA NA NA NA 0.0E+00

Nondioxin-Like 3.3E-07 NA NA 3.3E-07 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 4.1E-01 NA NA 4.1E-01

Arsenic 8.2E-08 NA NA 8.2E-08 Skin, Vascular 4.3E-03 NA NA 4.3E-03

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.8E-02 NA NA 3.8E-02

Selenium NA NA NA 0.0E+00 Whole Body 4.5E-03 NA NA 4.5E-03

Chemical Total 9.6E-07 NA NA 9.6E-07 4.6E-01 NA NA 4.6E-01

Striped Bass in Gowanus Canal Total 9.6E-07 4.6E-01

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 8.0E-08 NA NA 8.0E-08 NA NA NA NA 0.0E+00

Nondioxin-Like 3.9E-08 NA NA 3.9E-08 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 4.8E-02 NA NA 4.8E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.9E-03 NA NA 3.9E-03

Selenium NA NA NA 0.0E+00 Whole Body 5.8E-04 NA NA 5.8E-04

Chemical Total 1.2E-07 NA NA 1.2E-07 5.2E-02 NA NA 5.2E-02

White Perch in Gowanus Canal Total 1.2E-07 5.2E-02

Page 382: Appendix L HHRA Combined

TABLE 9.7.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

alpha-Chlordane 5.5E-09 NA NA 5.5E-09 Liver 7.3E-04 NA NA 7.3E-04

Dieldrin 1.9E-07 NA NA 1.9E-07 Liver 5.6E-03 NA NA 5.6E-03

gamma-Chlordane 3.2E-09 NA NA 3.2E-09 Liver 4.3E-04 NA NA 4.3E-04

p,p'-DDD 6.5E-09 NA NA 6.5E-09 NA NA NA NA 0.0E+00

p,p'-DDE 6.0E-09 NA NA 6.0E-09 NA NA NA NA 0.0E+00

p,p'-DDT 1.1E-08 NA NA 1.1E-08 Liver 1.6E-03 NA NA 1.6E-03

Dioxin-Like PCB TEQ 1.6E-06 NA NA 1.6E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 8.7E-07 NA NA 8.7E-07 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.1E+00 NA NA 1.1E+00

Arsenic 5.3E-08 NA NA 5.3E-08 Skin, Vascular 2.8E-03 NA NA 2.8E-03

Chromium 2.4E-07 NA NA 2.4E-07 Not identified 3.7E-03 NA NA 3.7E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 3.1E-03 NA NA 3.1E-03

Cyanide, total NA NA NA 0.0E+00 Weight Loss, Thyroid 2.6E-03 NA NA 2.6E-03

Mercury NA NA NA 0.0E+00 Developmental Neurological 4.3E-02 NA NA 4.3E-02

Selenium NA NA NA 0.0E+00 Whole Body 4.6E-03 NA NA 4.6E-03

Chemical Total 2.9E-06 NA NA 2.9E-06 1.2E+00 NA NA 1.2E+00

Eel in Gowanus Canal Total 2.9E-06 1.2E+00

Page 383: Appendix L HHRA Combined

TABLE 9.7.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)anthracene 5.5E-08 NA NA 5.5E-08 NA NA NA NA 0.0E+00

Benzo(a)pyrene 8.4E-07 NA NA 8.4E-07 NA NA NA NA 0.0E+00

Benzo(b)fluoranthene 4.6E-08 NA NA 4.6E-08 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene 2.8E-07 NA NA 2.8E-07 NA NA NA NA 0.0E+00

Indeno(1,2,3-cd)pyrene 7.1E-08 NA NA 7.1E-08 NA NA NA NA 0.0E+00

Dioxin-Like PCB TEQ 7.7E-06 NA NA 7.7E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 1.4E-06 NA NA 1.4E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.9E+00 NA NA 1.9E+00

Arsenic 1.9E-06 NA NA 1.9E-06 Skin, Vascular 1.0E-01 NA NA 1.0E-01

Copper NA NA NA 0.0E+00 Gastrointestinal 5.8E-02 NA NA 5.8E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 2.8E-01 NA NA 2.8E-01

Chemical Total 1.2E-05 NA NA 1.2E-05 2.3E+00 NA NA 2.3E+00

Crab in Gowanus Canal Total 1.2E-05 2.3E+00

Receptor Total - Fish 4.0E-06 Receptor HI Total - Fiish 1.7E+00

Receptor Total - Blue Crab 1.2E-05 Receptor HI Total - Blue Crab 2.3E+00

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Body Weight HI Across All Media = 2.6E-03 Total Developmental HI Across All Media = 2.8E-01

Total Developmental HI Across All Media = 8.5E-02 Total Finger and Toe Nails HI Across All Media = 1.9E+00

Total Finger and Toe Nails HI Across All Media = 1.6E+00 Total Gastrointestinal HI Across All Media = 5.8E-02

Total Gastrointestinal HI Across All Media = 3.1E-03 Total Neurological HI Across All Media = 2.8E-01

Total Liver HI Across All Media = 8.7E-03 Total Ocular HI Across All Media = 1.9E+00

Total Neurological HI Across All Media = 8.5E-02 Total Skin HI Across All Media = 1.0E-01

Total Ocular HI Across All Media = 1.6E+00 Total Vascular HI Across All Media = 1.0E-01

Total Skin HI Across All Media = 7.0E-03

Total Thyroid HI Across All Media = 2.6E-03

Total Vascular HI Across All Media = 7.0E-03

Total Whole Body HI Across All Media = 9.7E-03

Page 384: Appendix L HHRA Combined

TABLE 9.8.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

p,p'-DDE 2.7E-09 NA NA 2.7E-09 NA NA NA NA 0.0E+00

p,p'-DDT 2.1E-09 NA NA 2.1E-09 Liver 2.9E-04 NA NA 2.9E-04

Dioxin-Like PCB TEQ 4.4E-07 NA NA 4.4E-07 NA NA NA NA 0.0E+00

Nondioxin-Like 2.7E-07 NA NA 2.7E-07 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.3E-01 NA NA 3.3E-01

Arsenic 6.7E-08 NA NA 6.7E-08 Skin, Vascular 3.5E-03 NA NA 3.5E-03

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.1E-02 NA NA 3.1E-02

Selenium NA NA NA 0.0E+00 Whole Body 3.7E-03 NA NA 3.7E-03

Chemical Total 7.8E-07 NA NA 7.8E-07 3.7E-01 NA NA 3.7E-01

Striped Bass in Gowanus Canal Total 7.8E-07 3.7E-01

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 6.2E-08 NA NA 6.2E-08 NA NA NA NA 0.0E+00

Nondioxin-Like 3.0E-08 NA NA 3.0E-08 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.7E-02 NA NA 3.7E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.0E-03 NA NA 3.0E-03

Selenium NA NA NA 0.0E+00 Whole Body 4.5E-04 NA NA 4.5E-04

Chemical Total 9.2E-08 NA NA 9.2E-08 4.1E-02 NA NA 4.1E-02

White Perch in Gowanus Canal Total 9.2E-08 4.1E-02

Page 385: Appendix L HHRA Combined

TABLE 9.8.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

alpha-Chlordane 4.3E-09 NA NA 4.3E-09 Liver 5.7E-04 NA NA 5.7E-04

Dieldrin 1.5E-07 NA NA 1.5E-07 Liver 4.4E-03 NA NA 4.4E-03

gamma-Chlordane 2.5E-09 NA NA 2.5E-09 Liver 3.4E-04 NA NA 3.4E-04

p,p'-DDD 5.1E-09 NA NA 5.1E-09 NA NA NA NA 0.0E+00

p,p'-DDE 4.7E-09 NA NA 4.7E-09 NA NA NA NA 0.0E+00

p,p'-DDT 8.9E-09 NA NA 8.9E-09 Liver 1.2E-03 NA NA 1.2E-03

Dioxin-Like PCB TEQ 1.2E-06 NA NA 1.2E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 6.8E-07 NA NA 6.8E-07 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 8.7E-01 NA NA 8.7E-01

Arsenic 4.2E-08 NA NA 4.2E-08 Skin, Vascular 2.2E-03 NA NA 2.2E-03

Chromium (12-15)* 5.6E-07 NA NA 5.6E-07 Not identified 2.9E-03 NA NA 2.9E-03

Copper NA NA NA 0.0E+00 Gastrointestinal 2.4E-03 NA NA 2.4E-03

Cyanide, total NA NA NA 0.0E+00 Weight Loss, Thyroid 2.0E-03 NA NA 2.0E-03

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.4E-02 NA NA 3.4E-02

Selenium NA NA NA 0.0E+00 Whole Body 3.6E-03 NA NA 3.6E-03

Chemical Total 2.7E-06 NA NA 2.7E-06 9.3E-01 NA NA 9.3E-01

Eel in Gowanus Canal Total 2.7E-06 9.3E-01

Page 386: Appendix L HHRA Combined

TABLE 9.8.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)anthracene (12-15)* 1.3E-07 NA NA 1.3E-07 NA NA NA NA 0.0E+00

Benzo(a)pyrene (12-15)* 2.0E-06 NA NA 2.0E-06 NA NA NA NA 0.0E+00

Benzo(b)fluoranthene (12-15)* 1.1E-07 NA NA 1.1E-07 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene (12-15)* 6.7E-07 NA NA 6.7E-07 NA NA NA NA 0.0E+00

Indeno(1,2,3-cd)pyrene (12-15)* 1.7E-07 NA NA 1.7E-07 NA NA NA NA 0.0E+00

Dioxin-Like PCB TEQ 6.1E-06 NA NA 6.1E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 1.1E-06 NA NA 1.1E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.0E-01 NA NA 3.0E-01

Arsenic 1.5E-06 NA NA 1.5E-06 Skin, Vascular 7.9E-02 NA NA 7.9E-02

Copper NA NA NA 0.0E+00 Gastrointestinal 4.6E-02 NA NA 4.6E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 2.2E-01 NA NA 2.2E-01

Chemical Total 1.2E-05 NA NA 1.2E-05 6.5E-01 NA NA 6.5E-01

Crab in Gowanus Canal Total 1.2E-05 6.5E-01

Receptor Total - Fish 3.5E-06 Receptor HI Total - Fiish 1.3E+00

Receptor Total - Blue Crab 1.2E-05 Receptor HI Total - Blue Crab 6.5E-01

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Body Weight HI Across All Media = 2.0E-03 Total Developmental HI Across All Media = 2.2E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used Total Developmental HI Across All Media = 6.7E-02 Total Finger and Toe Nails HI Across All Media = 3.0E-01

to adjust CSF for 12-15 year old for exposure duration of 3 years, Total Finger and Toe Nails HI Across All Media = 1.2E+00 Total Gastrointestinal HI Across All Media = 4.6E-02

the CTE exposure duration for an adolescent. Total Gastrointestinal HI Across All Media = 2.4E-03 Total Neurological HI Across All Media = 2.2E-01

Total Liver HI Across All Media = 6.8E-03 Total Ocular HI Across All Media = 3.0E-01

Total Neurological HI Across All Media = 6.7E-02 Total Skin HI Across All Media = 7.9E-02

Total Ocular HI Across All Media = 1.2E+00 Total Vascular HI Across All Media = 7.9E-02

Total Skin HI Across All Media = 5.6E-03

Total Thyroid HI Across All Media = 2.0E-03

Total Vascular HI Across All Media = 5.6E-03

Total Whole Body HI Across All Media = 7.7E-03

Page 387: Appendix L HHRA Combined

TABLE 9.9.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

p,p'-DDE 5.2E-09 NA NA 5.2E-09 NA NA NA NA 0.0E+00

p,p'-DDT 4.1E-09 NA NA 4.1E-09 Liver 5.7E-04 NA NA 5.7E-04

Dioxin-Like PCB TEQ 8.5E-07 NA NA 8.5E-07 NA NA NA NA 0.0E+00

Nondioxin-Like 5.2E-07 NA NA 5.2E-07 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 6.4E-01 NA NA 6.4E-01

Arsenic 1.3E-07 NA NA 1.3E-07 Skin, Vascular 6.7E-03 NA NA 6.7E-03

Mercury NA NA NA 0.0E+00 Developmental Neurological 5.9E-02 NA NA 5.9E-02

Selenium NA NA NA 0.0E+00 Whole Body 7.1E-03 NA NA 7.1E-03

Chemical Total 1.5E-06 NA NA 1.5E-06 7.2E-01 NA NA 7.2E-01

Striped Bass in Gowanus Canal Total 1.5E-06 7.2E-01

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 1.3E-07 NA NA 1.3E-07 NA NA NA NA 0.0E+00

Nondioxin-Like 6.1E-08 NA NA 6.1E-08 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 7.5E-02 NA NA 7.5E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 6.2E-03 NA NA 6.2E-03

Selenium NA NA NA 0.0E+00 Whole Body 9.1E-04 NA NA 9.1E-04

Chemical Total 1.9E-07 NA NA 1.9E-07 8.2E-02 NA NA 8.2E-02

White Perch in Gowanus Canal Total 1.9E-07 8.2E-02

Page 388: Appendix L HHRA Combined

TABLE 9.9.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

alpha-Chlordane 8.6E-09 NA NA 8.6E-09 Liver 1.1E-03 NA NA 1.1E-03

Dieldrin 3.0E-07 NA NA 3.0E-07 Liver 8.9E-03 NA NA 8.9E-03

gamma-Chlordane 5.1E-09 NA NA 5.1E-09 Liver 6.8E-04 NA NA 6.8E-04

p,p'-DDD 1.0E-08 NA NA 1.0E-08 NA NA NA NA 0.0E+00

p,p'-DDE 9.5E-09 NA NA 9.5E-09 NA NA NA NA 0.0E+00

p,p'-DDT 1.8E-08 NA NA 1.8E-08 Liver 2.5E-03 NA NA 2.5E-03

Dioxin-Like PCB TEQ 2.5E-06 NA NA 2.5E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 1.4E-06 NA NA 1.4E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.8E+00 NA NA 1.8E+00

Arsenic 8.4E-08 NA NA 8.4E-08 Skin, Vascular 4.4E-03 NA NA 4.4E-03

Chromium (0-2)* 2.5E-06 NA NA 2.5E-06 Not identified 5.8E-03 NA NA 5.8E-03

Chromium (2-3)* 3.8E-07 NA NA 3.8E-07

Copper NA NA NA 0.0E+00 Gastrointestinal 4.8E-03 NA NA 4.8E-03

Cyanide, total NA NA NA 0.0E+00 Weight Loss, Thyroid 4.1E-03 NA NA 4.1E-03

Mercury NA NA NA 0.0E+00 Developmental Neurological 6.8E-02 NA NA 6.8E-02

Selenium NA NA NA 0.0E+00 Whole Body 7.3E-03 NA NA 7.3E-03

Chemical Total 7.1E-06 NA NA 7.1E-06 1.9E+00 NA NA 1.9E+00

Eel in Gowanus Canal Total 7.1E-06 1.9E+00

Page 389: Appendix L HHRA Combined

TABLE 9.9.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)anthracene (0-2)* 5.7E-07 NA NA 5.7E-07 NA NA NA NA 0.0E+00

Benzo(a)anthracene (2-3)* 8.5E-08 NA NA 8.5E-08

Benzo(a)pyrene (0-2)* 8.7E-06 NA NA 8.7E-06 NA NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 1.3E-06 NA NA 1.3E-06

Benzo(b)fluoranthene (0-2)* 4.7E-07 NA NA 4.7E-07 NA NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-3)* 7.1E-08 NA NA 7.1E-08

Dibenz(a,h)anthracene (0-2)* 2.9E-06 NA NA 2.9E-06 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-3)* 4.4E-07 NA NA 4.4E-07

Indeno(1,2,3-cd)pyrene (0-2)* 7.3E-07 NA NA 7.3E-07 NA NA NA NA 0.0E+00

Indeno(1,2,3-cd)pyrene (2-3)* 1.1E-07 NA NA 1.1E-07

Dioxin-Like PCB TEQ 1.2E-05 NA NA 1.2E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 2.2E-06 NA NA 2.2E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 2.9E+00 NA NA 2.9E+00

Arsenic 3.0E-06 NA NA 3.0E-06 Skin, Vascular 1.5E-01 NA NA 1.5E-01

Copper NA NA NA 0.0E+00 Gastrointestinal 9.0E-02 NA NA 9.0E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 4.4E-01 NA NA 4.4E-01

Chemical Total 3.2E-05 NA NA 3.2E-05 3.6E+00 NA NA 3.6E+00

Crab in Gowanus Canal Total 3.2E-05 3.6E+00

Receptor Total - Fish 8.8E-06 Receptor HI Total - Fiish 2.7E+00

Receptor Total - Blue Crab 3.2E-05 Receptor HI Total - Blue Crab 3.6E+00

Page 390: Appendix L HHRA Combined

TABLE 9.9.CTE

SUMMARY OF RECEPTOR RISKS AND HAZARDS FOR COPCs

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Body Weight HI Across All Media = 4.1E-03 Total Developmental HI Across All Media = 4.4E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used Total Developmental HI Across All Media = 1.3E-01 Total Finger and Toe Nails HI Across All Media = 2.9E+00

to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 Total Finger and Toe Nails HI Across All Media = 2.5E+00 Total Gastrointestinal HI Across All Media = 9.0E-02

used to adjust CSF for 2-3 year old for exposure duration of 1 year, for a total Total Gastrointestinal HI Across All Media = 4.8E-03 Total Neurological HI Across All Media = 4.4E-01

CTE exposure duration of 3 years. Non-cancer calculations shown under Total Liver HI Across All Media = 1.4E-02 Total Ocular HI Across All Media = 2.9E+00

0-2 year old only, as non-cancer calculations are not adjusted for MMOA. Total Neurological HI Across All Media = 1.3E-01 Total Skin HI Across All Media = 1.5E-01

Total Ocular HI Across All Media = 2.5E+00 Total Vascular HI Across All Media = 1.5E-01

Total Skin HI Across All Media = 1.1E-02

Total Thyroid HI Across All Media = 4.1E-03

Total Vascular HI Across All Media = 1.1E-02

Total Whole Body HI Across All Media = 1.5E-02

Page 391: Appendix L HHRA Combined

TABLE 10.1.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Benzo(a)anthracene 1.6E-06 NA 8.7E-06 1.0E-05 NA NA NA 0.0E+00

Benzo(a)pyrene 1.4E-05 NA 7.4E-05 8.7E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene 1.4E-06 NA 7.8E-06 9.2E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 7.9E-07 NA 4.3E-06 5.0E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene 6.2E-07 NA 3.4E-06 4.0E-06 NA NA NA 0.0E+00

Nondioxin-Like PCB 1.8E-07 NA 1.1E-06 1.2E-06 NA NA NA 0.0E+00

Arsenic 4.7E-07 NA 5.9E-07 1.1E-06 Skin, Vascular 3.1E-03 NA 3.8E-03 6.9E-03

Chromium 8.2E-07 NA 1.4E-05 1.4E-05 Not identified 1.6E-03 NA 2.6E-02 2.8E-02

Chemical Total 2.0E-05 NA 1.1E-04 1.3E-04 4.6E-03 NA 3.0E-02 3.5E-02

Exposed Surface Sediment Total 1.3E-04 3.5E-02

Surface Water Surface Water Gowanus Canal

(Dry event) Benzo(a)anthracene 8.8E-09 NA 3.6E-06 3.6E-06 NA NA NA 0.0E+00

Benzo(a)pyrene 2.2E-07 NA 1.5E-04 1.6E-04 NA NA NA 0.0E+00

Benzo(b)fluoranthene 9.9E-09 NA 7.1E-06 7.1E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene 4.4E-09 NA 3.1E-06 3.2E-06 NA NA NA 0.0E+00

Arsenic 1.4E-06 NA 4.9E-07 1.8E-06 Skin, Vascular 8.8E-03 NA 3.2E-03 1.2E-02

Chromium 4.3E-07 NA 1.2E-05 1.3E-05 Not identified 8.3E-04 NA 2.4E-02 2.5E-02

Chemical Total 2.0E-06 NA 1.8E-04 1.8E-04 9.6E-03 NA 2.7E-02 3.7E-02

Surface Water Total - Dry Event 1.8E-04 3.7E-02

Page 392: Appendix L HHRA Combined

TABLE 10.1.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) Tetrachloroethylene(PCE) 6.0E-07 NA 1.2E-05 1.2E-05 Liver 3.2E-04 NA 6.4E-03 6.7E-03

Benzo(a)anthracene 3.4E-09 NA 1.4E-06 1.4E-06 NA NA NA 0.0E+00

Benzo(a)pyrene 6.8E-08 NA 4.8E-05 4.8E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene 6.3E-09 NA 4.5E-06 4.5E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene 3.3E-08 NA 3.7E-05 3.7E-05 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene 1.7E-08 NA 1.2E-05 1.2E-05 NA NA NA 0.0E+00

Arsenic 1.1E-06 NA 4.1E-07 1.5E-06 Skin, Vascular 7.3E-03 NA 2.6E-03 1.0E-02

Chromium 1.9E-07 NA 5.6E-06 5.8E-06 Not identified 3.8E-04 NA 1.1E-02 1.1E-02

Chemical Total 2.0E-06 NA 1.2E-04 1.2E-04 8.0E-03 NA 2.0E-02 2.8E-02

Surface Water Total - Wet Event 1.2E-04 2.8E-02

Receptor Total 3.2E-04 Receptor HI Total 7.2E-02

HI - Hazard Index Total Skin HI Across All Media = 1.9E-02

CNS - Central Nervous System Total Vascular HI Across All Media = 1.9E-02

Receptor Total and target organ total includes sum of exposed and near shore sediment and maximum of dry event and wet event surface water.

Page 393: Appendix L HHRA Combined

TABLE 10.2.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Benzo(a)anthracene (12-16)* 9.9E-07 NA 5.4E-06 6.4E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (16-18)* 1.7E-07 NA 9.0E-07 1.1E-06

Benzo(a)pyrene (12-16)* 8.4E-06 NA 4.6E-05 5.4E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 1.4E-06 NA 7.6E-06 9.0E-06

Benzo(b)fluoranthene (12-16)* 8.8E-07 NA 4.8E-06 5.7E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (12-16)* 4.8E-07 NA 2.6E-06 3.1E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (16-18)* 8.1E-08 NA 4.4E-07 5.2E-07

Indeno(1,2,3-c,d)pyrene (12-16)* 3.8E-07 NA 2.1E-06 2.5E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (16-18)* 6.4E-08 NA 3.5E-07 4.1E-07

Chromium (12-16)* 5.0E-07 NA 8.4E-06 8.9E-06 Not identified 1.9E-03 NA 3.3E-02 3.5E-02

Chromium (16-18)* 8.3E-08 NA 1.4E-06 1.5E-06

Chemical Total 1.3E-05 NA 8.0E-05 9.3E-05 1.9E-03 NA 3.3E-02 3.5E-02

Exposed Surface Sediment Total 9.3E-05 3.5E-02

Surface Water Surface Water Gowanus Canal

(Dry event) Benzo(a)anthracene (12-16)* 5.4E-09 NA 2.0E-06 2.0E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (16-18)* 9.0E-10 NA 3.3E-07 3.3E-07

Benzo(a)pyrene (12-16)* 1.3E-07 NA 8.3E-05 8.3E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 2.2E-08 NA 1.4E-05 1.4E-05

Benzo(b)fluoranthene (12-16)* 6.1E-09 NA 3.8E-06 3.8E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (16-18)* 1.0E-09 NA 6.4E-07 6.4E-07

Indeno(1,2,3-c,d)pyrene (12-16)* 2.7E-09 NA 1.7E-06 1.7E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (16-18)* 4.5E-10 NA 2.8E-07 2.8E-07

Chromium (12-16)* 2.6E-07 NA 6.6E-06 6.9E-06 Not identified 1.0E-03 NA 2.6E-02 2.7E-02

Chromium (16-18)* 4.4E-08 NA 1.1E-06 1.1E-06

Chemical Total 4.8E-07 NA 1.1E-04 1.1E-04 1.0E-03 NA 2.6E-02 2.7E-02

Surface Water Total - Dry Event 1.1E-04 2.7E-02

Page 394: Appendix L HHRA Combined

TABLE 10.2.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) Tetrachloroethylene(PCE) 1.8E-07 NA 3.2E-06 3.4E-06 Liver 4.0E-04 NA 6.9E-03 7.3E-03

Benzo(a)anthracene (12-16)* 2.1E-09 NA 7.6E-07 7.7E-07 NA NA NA 0.0E+00

Benzo(a)anthracene (16-18)* 3.5E-10 NA 4.3E-07 4.3E-07

Benzo(a)pyrene (12-16)* 4.2E-08 NA 2.6E-05 2.6E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 6.9E-09 NA 4.0E-06 4.0E-06

Benzo(b)fluoranthene (12-16)* 3.8E-09 NA 2.4E-06 2.4E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (16-18)* 6.4E-10 NA 3.3E-07 3.3E-07

Dibenz(a,h)anthracene (12-16)* 2.1E-08 NA 2.0E-05 2.0E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (16-18)* 3.4E-09 NA 1.1E-05 1.1E-05

Indeno(1,2,3-c,d)pyrene (12-16)* 1.0E-08 NA 6.4E-06 6.4E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (16-18)* 1.7E-09 NA 2.5E-08 2.6E-08

Chromium (12-16)* 1.2E-07 NA 3.0E-06 3.1E-06 Not identified 4.6E-04 NA 1.2E-02 1.2E-02

Chromium (16-18)* 2.0E-08 NA 5.0E-07 5.2E-07

Chemical Total 4.1E-07 NA 7.7E-05 7.8E-05 8.6E-04 NA 1.9E-02 1.9E-02

Surface Water Total - Wet Event 7.8E-05 1.9E-02

Receptor Total 2.1E-04 Receptor HI Total 6.1E-02

HI - Hazard Index Total Liver HI Across All Media = 7.3E-03

CNS - Central Nervous System

Receptor Total and target organ total includes sum of exposed and near shore sediment and maximum of dry event and wet event surface water.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 used to adjust CSF for 12-16 year old for exposure duration of 4 years,

ADAF of 1 used to adjust CSF for 16-18 year old for exposure duration of 2 years. Non-cancer calculations shown under 12-16 year old only,

as non-cancer calculations are not adjusted for MMOA.

Page 395: Appendix L HHRA Combined

TABLE 10.3.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Benzo(a)anthracene (0-2)* 1.3E-05 NA 9.2E-06 2.2E-05 NA NA NA 0.0E+00

Benzo(a)anthracene (2-6)* 7.5E-06 NA 5.5E-06 1.3E-05

Benzo(a)pyrene (0-2)* 1.1E-04 NA 7.7E-05 1.8E-04 NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 6.4E-05 NA 4.6E-05 1.1E-04

Benzo(b)fluoranthene (0-2)* 1.1E-05 NA 8.1E-06 1.9E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-6)* 6.7E-06 NA 4.9E-06 1.2E-05

Benzo(k)fluoranthene (0-2)* 6.4E-07 NA 4.7E-07 1.1E-06 NA NA NA 0.0E+00

Benzo(k)fluoranthene (2-6)* 3.8E-07 NA 2.8E-07 6.6E-07

Dibenz(a,h)anthracene (0-2)* 6.1E-06 NA 4.5E-06 1.1E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-6)* 3.7E-06 NA 2.7E-06 6.3E-06

Fluoranthene NA NA NA 0.0E+00 Kidney, Liver, Blood 5.9E-03 NA 4.3E-03 1.0E-02

Indeno(1,2,3-c,d)pyrene (0-2)* 4.8E-06 NA 3.5E-06 8.4E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-6)* 2.9E-06 NA 2.1E-06 5.0E-06

Arsenic 1.1E-06 NA 1.8E-07 1.3E-06 Skin, Vascular 2.8E-02 NA 4.8E-03 3.3E-02

Chromium 6.3E-06 NA 1.4E-05 2.1E-05 Not identified 1.5E-02 NA 3.3E-02 4.8E-02

3.8E-06 NA 8.5E-06 1.2E-05

Chemical Total 2.4E-04 NA 1.9E-04 4.2E-04 4.9E-02 NA 4.2E-02 9.1E-02

Exposed Surface Sediment Total 4.2E-04 9.1E-02

Surface Water Surface Water Gowanus Canal

(Dry event) Benzo(a)anthracene (0-2)* 3.4E-08 NA 5.2E-06 5.2E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-6)* 2.1E-08 NA 3.1E-06 3.1E-06

Benzo(a)pyrene (0-2)* 8.5E-07 NA 2.2E-04 2.2E-04 NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 5.1E-07 NA 1.3E-04 1.3E-04

Benzo(b)fluoranthene (0-2)* 3.8E-08 NA 1.0E-05 1.0E-05 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-6)* 2.3E-08 NA 6.1E-06 6.1E-06

Indeno(1,2,3-c,d)pyrene (0-2)* 1.7E-08 NA 4.5E-06 4.5E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-6)* 1.0E-08 NA 2.7E-06 2.7E-06

Arsenic 1.6E-06 NA 2.1E-07 1.8E-06 Skin, Vascular 4.1E-02 NA 5.4E-03 4.6E-02

Chromium (0-2)* 1.7E-06 NA 1.8E-05 1.9E-05 Not identified 3.9E-03 NA 4.1E-02 4.5E-02

Chromium (2-6)* 1.0E-06 NA 1.1E-05 1.2E-05

Chemical Total 5.7E-06 NA 4.1E-04 4.2E-04 4.5E-02 NA 4.6E-02 9.1E-02

Surface Water Total - Dry Event 4.2E-04 9.1E-02

Page 396: Appendix L HHRA Combined

TABLE 10.3.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) Tetrachloroethylene(PCE) 7.0E-07 NA 5.1E-06 5.8E-06 Liver 1.5E-03 NA 1.1E-02 1.2E-02

Benzo(a)anthracene (0-2)* 1.3E-08 NA 2.0E-06 2.0E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-6)* 8.0E-09 NA 1.2E-06 1.2E-06

Benzo(a)pyrene (0-2)* 2.6E-07 NA 6.9E-05 6.9E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 1.6E-07 NA 4.1E-05 4.1E-05

Benzo(b)fluoranthene (0-2)* 2.4E-08 NA 6.4E-06 6.4E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-6)* 1.5E-08 NA 3.8E-06 3.9E-06

Dibenz(a,h)anthracene (0-2)* 1.3E-07 NA 5.2E-05 5.2E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-6)* 7.8E-08 NA 3.1E-05 3.1E-05

Indeno(1,2,3-c,d)pyrene (0-2)* 6.4E-08 NA 1.7E-05 1.7E-05 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-6)* 3.9E-08 NA 1.0E-05 1.0E-05

Arsenic 1.3E-06 NA 1.7E-07 1.5E-06 Skin, Vascular 3.4E-02 NA 4.5E-03 3.9E-02

Chromium (0-2)* 7.5E-07 NA 7.9E-06 8.7E-06 Not identified 1.8E-03 NA 1.9E-02 2.0E-02

Chromium (2-6)* 4.5E-07 NA 4.8E-06 5.2E-06

Chemical Total 4.0E-06 NA 2.5E-04 2.6E-04 3.7E-02 NA 3.4E-02 7.1E-02

Surface Water Total - Wet Event 2.6E-04 7.1E-02

Receptor Total 8.4E-04 Receptor HI Total 1.8E-01

HI - Hazard Index Total Blood HI Across All Media = 1.0E-02

CNS - Central Nervous System Total Kidney HI Across All Media = 1.0E-02

Receptor Total and target organ total includes sum of exposed and near shore sediment and maximum of dry event and wet event surface water. Total Liver HI Across All Media = 2.3E-02

Total Skin HI Across All Media = 8.0E-02

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, Total Vascular HI Across All Media = 8.0E-02

ADAF of 3 used to adjust CSF for 2-6 year old for exposure duration of 4 years. Non-cancer calculations shown under 0-2 year old only,

as non-cancer calculations are not adjusted for MMOA. as non-cancer calculations are not adjusted for MMOA.

Page 397: Appendix L HHRA Combined

TABLE 10.4.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system

operation) Naphthalene NA NA NA Nasal, Respiratory NA 4.2E-01 NA 4.2E-01

Chemical Total NA NA NA NA 4.2E-01 NA 4.2E-01

Ambient air at street level Total - Pre-aeration system operation 4.2E-01

Air Air

Ambient air at canal

level

(after aeration system

started) Naphthalene NA NA NA Nasal, Respiratory NA 9.7E-01 NA 9.7E-01

Chemical Total NA NA NA NA 9.7E-01 NA 9.7E-01

Ambient air at street level Total - After aeration system turned on 9.7E-01

Receptor Total Receptor HI Total 9.7E-01

HI - Hazard Index Total Nasal HI Across All Media = 9.7E-01

CNS - Central Nervous System Total Respiratory HI Across All Media = 9.7E-01

Receptor Total and target organ totals includes maximum between air prior to and after aeration system operation.

Page 398: Appendix L HHRA Combined

TABLE 10.5.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system

operation) Naphthalene NA NA NA Nasal, Respiratory NA 4.2E-01 NA 4.2E-01

Chemical Total NA NA NA NA 4.2E-01 NA 4.2E-01

Ambient air at street level Total - Pre-aeration system operation 4.2E-01

Air Air

Ambient air at canal

level

(after aeration system

started) Naphthalene NA NA NA Nasal, Respiratory NA 9.7E-01 NA 9.7E-01

Chemical Total NA NA NA NA 9.7E-01 NA 9.7E-01

Ambient air at street level Total - After aeration system turned on 9.7E-01

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal Total PCB NA NA NA Ocular, Finger and Toe Nails 1.1E-01 NA 4.3E-02 1.5E-01

Chemical Total NA NA NA 1.1E-01 NA 4.3E-02 1.5E-01

Overflow Surface Sediment Total 1.5E-01

Receptor Total Receptor HI Total 1.1E+00

HI - Hazard Index Total Finger and Toe Nails HI Across All Media = 1.5E-01

CNS - Central Nervous System Total Nasal HI Across All Media = 9.7E-01

Receptor Total and target organ totals includes maximum between air prior to and after aeration system operation, and sediment. Total Ocular HI Across All Media = 1.5E-01

Total Respiratory HI Across All Media = 9.7E-01

Page 399: Appendix L HHRA Combined

TABLE 10.6.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Air Air

Ambient air at street

level

(pre-aeration system Benzene NA 2.9E-06 NA 2.9E-06 Blood NA NA NA

operation) Chloroform NA 1.7E-06 NA 1.7E-06 Liver NA NA NA

Naphthalene NA 1.3E-05 NA 1.3E-05 Nasal, Respiratory NA NA NA

Chemical Total NA 1.8E-05 NA 1.8E-05 NA NA NA

Ambient air at street level Total - Pre-aeration system operation 1.8E-05

Air Air

Ambient air at canal

level

(after aeration system Benzene NA 2.5E-06 NA 2.5E-06 Blood NA NA NA

started) Chloroform NA 2.2E-06 NA 2.2E-06 Liver NA NA NA

Naphthalene NA 3.0E-05 NA 3.0E-05 Nasal, Respiratory NA NA NA

Chemical Total NA 3.5E-05 NA 3.5E-05 NA NA NA

Ambient air at street level Total - After aeration system turned on 3.5E-05

SedimentOverflow Surface

Sediment

Sediment deposited in

areas adjacent to

Gowanus Canal

associated with canal Benzo(a)anthracene1

1.6E-05 NA 8.2E-06 2.4E-05 NA NA NA

Benzo(a)pyrene19.2E-05 NA 4.7E-05 1.4E-04 NA NA NA

Benzo(b)fluoranthene11.0E-05 NA 5.1E-06 1.5E-05 NA NA NA

Dibenz(a,h)anthracene16.9E-06 NA 3.5E-06 1.0E-05 NA NA NA

Indeno(1,2,3-c,d)pyrene14.0E-06 NA 2.0E-06 6.0E-06 NA NA NA

Arsenic 8.9E-07 NA 1.4E-07 1.0E-06 Skin, Vascular NA NA NA

Chromium17.3E-08 NA 1.1E-06 1.2E-06 Not identified NA NA NA

Chemical Total 1.3E-04 NA 6.7E-05 2.0E-04 NA NA NA

Overflow Surface Sediment Total 2.0E-04

Page 400: Appendix L HHRA Combined

TABLE 10.6.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Resident

Receptor Age: Child/Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water

Overflow Surface

Water

Canal Overflow -

Surface Water

Tetrachloroethylene(PCE) 4.5E-07 NA 2.0E-06 2.5E-06 Liver NA NA NA

Benzo(a)pyrene11.9E-07 NA 2.6E-05 2.6E-05 NA NA NA

Benzo(b)fluoranthene11.7E-08 NA 2.4E-06 2.4E-06 NA NA NA

Dibenz(a,h)anthracene19.3E-08 NA 2.0E-05 2.0E-05 NA NA NA

Indeno(1,2,3-c,d)pyrene14.6E-08 NA 6.4E-06 6.4E-06 NA NA NA

Chromium15.4E-07 NA 3.6E-06 4.2E-06 Not identified NA NA NA

Chemical Total 1.3E-06 NA 6.0E-05 6.1E-05 NA NA NA

Overflow Surface Water Total 6.1E-05

Receptor Total 2.9E-04 Receptor HI Total

Receptor Total includes maximum between air prior to and after aeration system operation, and surface water, and sediment.

1. Constituent acts via a mutagenic mode of action (MMOA). See Table 7.7.RME Supplement A for calculation of intake and cancer risk following MMOA method.

Page 401: Appendix L HHRA Combined

TABLE 10.7.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

Dioxin-Like PCB TEQ 4.0E-05 NA NA 4.0E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 4.9E-05 NA NA 4.9E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.8E+00 NA NA 3.8E+00

Arsenic 6.1E-06 NA NA 6.1E-06 Skin, Vascular 4.0E-02 NA NA 4.0E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.5E-01 NA NA 3.5E-01

Chemical Total 9.5E-05 NA NA 9.5E-05 4.2E+00 NA NA 4.2E+00

Striped Bass in Gowanus Canal Total 9.5E-05 4.2E+00

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 9.9E-06 NA NA 9.9E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 9.6E-06 NA NA 9.6E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 7.7E-01 NA NA 7.7E-01

Chemical Total 2.0E-05 NA NA 2.0E-05 7.7E-01 NA NA 7.7E-01

White Perch in Gowanus Canal Total 2.0E-05 7.7E-01

Page 402: Appendix L HHRA Combined

TABLE 10.7.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

Dieldrin 1.5E-05 NA NA 1.5E-05 Liver 5.6E-02 NA NA 5.6E-02

Dioxin-Like PCB TEQ 1.2E-04 NA NA 1.2E-04 NA NA NA NA 0.0E+00

Nondioxin-Like 1.4E-04 NA NA 1.4E-04 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.1E+01 NA NA 1.1E+01

Arsenic 4.2E-06 NA NA 4.2E-06 Skin, Vascular 2.7E-02 NA NA 2.7E-02

Chromium 1.9E-05 NA NA 1.9E-05 Not identified 3.6E-02 NA NA 3.6E-02

Mercury NA NA NA 0.0E+00 #REF! 4.2E-01 NA NA 4.2E-01

Chemical Total 3.0E-04 NA NA 3.0E-04 1.2E+01 NA NA 1.2E+01

Eel in Gowanus Canal Total 3.0E-04 1.2E+01

Page 403: Appendix L HHRA Combined

TABLE 10.7.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)pyrene 9.7E-06 NA NA 9.7E-06 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene 3.2E-06 NA NA 3.2E-06 NA NA NA NA 0.0E+00

Dioxin-Like PCB TEQ 8.9E-05 NA NA 8.9E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 3.2E-05 NA NA 3.2E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 2.7E+00 NA NA 2.7E+00

Arsenic 2.2E-05 NA NA 2.2E-05 Skin, Vascular 1.4E-01 NA NA 1.4E-01

Mercury NA NA NA 0.0E+00 #REF! 4.1E-01 NA NA 4.1E-01

Chemical Total 1.6E-04 NA NA 1.6E-04 3.3E+00 NA NA 3.3E+00

Crab in Gowanus Canal Total 1.6E-04 3.3E+00

Receptor Total - Fish 4.1E-04 Receptor HI Total - Fiish 1.7E+01

Receptor Total - Blue Crab 1.6E-04 Receptor HI Total - Blue Crab 3.3E+00

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Developmental HI Across All Media = 3.5E-01 Total Developmental HI Across All Media = 4.1E-01

Total Finger and Toe Nails HI Across All Media = 1.6E+01 Total Finger and Toe Nails HI Across All Media = 2.7E+00

Total Liver HI Across All Media = 5.6E-02 Total Neurological HI Across All Media = 4.1E-01

Total Neurological HI Across All Media = 7.7E-01 Total Ocular HI Across All Media = 2.7E+00

Total Ocular HI Across All Media = 1.6E+01 Total Skin HI Across All Media = 1.4E-01

Total Skin HI Across All Media = 6.7E-02 Total Vascular HI Across All Media = 1.4E-01

Total Vascular HI Across All Media = 6.7E-02

Page 404: Appendix L HHRA Combined

TABLE 10.8.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

Dioxin-Like PCB TEQ 8.1E-06 NA NA 8.1E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 9.8E-06 NA NA 9.8E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 3.0E+00 NA NA 3.0E+00

Arsenic 1.2E-06 NA NA 1.2E-06 Skin, Vascular 3.2E-02 NA NA 3.2E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 2.8E-01 NA NA 2.8E-01

Chemical Total 1.9E-05 NA NA 1.9E-05 3.4E+00 NA NA 3.4E+00

Striped Bass in Gowanus Canal Total 1.9E-05 3.4E+00

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 2.1E-06 NA NA 2.1E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 2.0E-06 NA NA 2.0E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 6.2E-01 NA NA 6.2E-01

Chemical Total 4.1E-06 NA NA 4.1E-06 6.2E-01 NA NA 6.2E-01

White Perch in Gowanus Canal Total 4.1E-06 6.2E-01

Page 405: Appendix L HHRA Combined

TABLE 10.8.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

Dieldrin 3.1E-06 NA NA 3.1E-06 Liver 4.5E-02 NA NA 4.5E-02

Dioxin-Like PCB TEQ 2.5E-05 NA NA 2.5E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 2.7E-05 NA NA 2.7E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 8.9E+00 NA NA 8.9E+00

Chromium (12-16)* 7.5E-06 NA NA 7.5E-06 Not identified 2.9E-02 NA NA 2.9E-02

Chromium (16-18)* 1.3E-06 NA NA 1.3E-06

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.4E-01 NA NA 3.4E-01

Chemical Total 6.4E-05 NA NA 6.4E-05 9.3E+00 NA NA 9.3E+00

Eel in Gowanus Canal Total 6.4E-05 9.3E+00

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)pyrene (12-16)* 3.9E-06 NA NA 3.9E-06 NA NA NA NA 0.0E+00

Benzo(a)pyrene (16-18)* 6.5E-07 NA NA 6.5E-07

Dibenz(a,h)anthracene (12-16)* 1.3E-06 NA NA 1.3E-06 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene (16-18)* 2.2E-07 NA NA 2.2E-07

Dioxin-Like PCB TEQ 1.8E-05 NA NA 1.8E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 6.5E-06 NA NA 6.5E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 2.2E+00 NA NA 2.2E+00

Arsenic 4.4E-06 NA NA 4.4E-06 Skin, Vascular 1.1E-01 NA NA 1.1E-01

Mercury NA NA NA 0.0E+00 Developmental Neurological 3.3E-01 NA NA 3.3E-01

Chemical Total 3.5E-05 NA NA 3.5E-05 2.6E+00 NA NA 2.6E+00

Crab in Gowanus Canal Total 3.5E-05 2.6E+00

Receptor Total - Fish 8.7E-05 Receptor HI Total - Fiish 1.3E+01

Receptor Total - Blue Crab 3.5E-05 Receptor HI Total - Blue Crab 2.6E+00

Page 406: Appendix L HHRA Combined

TABLE 10.8.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adolescent

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Developmental HI Across All Media = 6.2E-01 Total Developmental HI Across All Media = 3.3E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 3 Total Finger and Toe Nails HI Across All Media = 1.3E+01 Total Finger and Toe Nails HI Across All Media = 2.2E+00

used to adjust CSF for 12-16 year old for exposure duration of 4 years, Total Liver HI Across All Media = 4.5E-02 Total Neurological HI Across All Media = 3.3E-01

ADAF of 1 used to adjust CSF for 16-18 year old for exposure duration Total Neurological HI Across All Media = 6.2E-01 Total Ocular HI Across All Media = 2.2E+00

of 2 years. Non-cancer calculations shown under 12-16 year old only, Total Ocular HI Across All Media = 1.3E+01 Total Skin HI Across All Media = 1.1E-01

as non-cancer calculations are not adjusted for MMOA. Total Skin HI Across All Media = 3.2E-02 Total Vascular HI Across All Media = 1.1E-01

Total Vascular HI Across All Media = 3.2E-02

Page 407: Appendix L HHRA Combined

TABLE 10.9.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

Dioxin-Like PCB TEQ 1.6E-05 NA NA 1.6E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 2.0E-05 NA NA 2.0E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 6.1E+00 NA NA 6.1E+00

Arsenic 2.5E-06 NA NA 2.5E-06 Skin, Vascular 6.4E-02 NA NA 6.4E-02

Mercury NA NA NA 0.0E+00 Developmental Neurological 5.6E-01 NA NA 5.6E-01

Chemical Total 3.8E-05 NA NA 3.8E-05 6.8E+00 NA NA 6.8E+00

Striped Bass in Gowanus Canal Total 3.8E-05 6.8E+00

Surface

Water/Sediment

Fish and Crab

Tissue

White Perch in

Gowanus Canal

Dioxin-Like PCB TEQ 4.2E-06 NA NA 4.2E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 4.0E-06 NA NA 4.0E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.2E+00 NA NA 1.2E+00

Mercury NA NA NA 0.0E+00 Developmental Neurological 1.0E-01 NA NA 1.0E-01

Chemical Total 8.2E-06 NA NA 8.2E-06 1.4E+00 NA NA 1.4E+00

White Perch in Gowanus Canal Total 8.2E-06 1.4E+00

Page 408: Appendix L HHRA Combined

TABLE 10.9.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

Dieldrin 6.2E-06 NA NA 6.2E-06 Liver 9.0E-02 NA NA 9.0E-02

Dioxin-Like PCB TEQ 5.0E-05 NA NA 5.0E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 5.5E-05 NA NA 5.5E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.8E+01 NA NA 1.8E+01

Arsenic 1.7E-06 NA NA 1.7E-06 Skin, Vascular 4.4E-02 NA NA 4.4E-02

Chromium (0-2)* 2.5E-05 NA NA 2.5E-05 Not identified 5.9E-02 NA NA 5.9E-02

Chromium (2-6)* 1.5E-05 NA NA 1.5E-05

Mercury NA NA NA 0.0E+00 Developmental Neurological 6.9E-01 NA NA 6.9E-01

Chemical Total 1.5E-04 NA NA 1.5E-04 1.9E+01 NA NA 1.9E+01

Eel in Gowanus Canal Total 1.5E-04 1.9E+01

Page 409: Appendix L HHRA Combined

TABLE 10.9.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)pyrene (0-2)* 1.3E-05 NA NA 1.3E-05 NA NA NA NA 0.0E+00

Benzo(a)pyrene (2-6)* 7.9E-06 NA NA 7.9E-06

Dibenz(a,h)anthracene (0-2)* 4.4E-06 NA NA 4.4E-06 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-6)* 2.6E-06 NA NA 2.6E-06

Indeno(1,2,3-cd)pyrene (0-2)* 1.1E-06 NA NA 1.1E-06 NA NA NA NA 0.0E+00

Indeno(1,2,3-cd)pyrene (2-6)* 6.6E-07 NA NA 6.6E-07

Dioxin-Like PCB TEQ 3.6E-05 NA NA 3.6E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 1.3E-05 NA NA 1.3E-05 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 4.4E+00 NA NA 4.4E+00

Arsenic 9.0E-06 NA NA 9.0E-06 Skin, Vascular 2.3E-01 NA NA 2.3E-01

Copper NA NA NA 0.0E+00 Gastrointestinal 1.4E-01 NA NA 1.4E-01

Mercury NA NA NA 0.0E+00 Developmental Neurological 6.6E-01 NA NA 6.6E-01

Chemical Total 8.8E-05 NA NA 8.8E-05 5.5E+00 NA NA 5.5E+00

Crab in Gowanus Canal Total 8.8E-05 5.5E+00

Receptor Total - Fish 2.0E-04 Receptor HI Total - Fiish 2.7E+01

Receptor Total - Blue Crab 8.8E-05 Receptor HI Total - Blue Crab 5.5E+00

Page 410: Appendix L HHRA Combined

TABLE 10.9.RME

RISK SUMMARY

REASONABLE MAXIMUM EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Developmental HI Across All Media = 1.4E+00 Total Developmental HI Across All Media = 6.6E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used Total Finger and Toe Nails HI Across All Media = 2.5E+01 Total Finger and Toe Nails HI Across All Media = 4.4E+00

to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 Total Liver HI Across All Media = 9.0E-02 Total Gastrointestinal HI Across All Media = 1.4E-01

used to adjust CSF for 2-6 year old for exposure duration of 4 years. Total Neurological HI Across All Media = 1.4E+00 Total Neurological HI Across All Media = 6.6E-01

Non-cancer calculations shown under 0-2 year old only, Total Ocular HI Across All Media = 2.5E+01 Total Ocular HI Across All Media = 4.4E+00

as non-cancer calculations are not adjusted for MMOA. Total Skin HI Across All Media = 1.1E-01 Total Skin HI Across All Media = 2.3E-01

Total Vascular HI Across All Media = 1.1E-01 Total Vascular HI Across All Media = 2.3E-01

Page 411: Appendix L HHRA Combined

TABLE 10.1.CTE

RISK SUMMARY

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Sediment Surface Sediment

Exposed and near

shore sediment in

Gowanus Canal

Benzo(a)anthracene (0-2)* 3.1E-06 NA 4.6E-06 7.7E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-3)* 4.7E-07 NA 6.9E-07 1.2E-06

Benzo(a)pyrene (0-2)* 2.6E-05 NA 3.9E-05 6.5E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 4.0E-06 NA 5.8E-06 9.8E-06

Benzo(b)fluoranthene (0-2)* 2.8E-06 NA 4.1E-06 6.9E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-3)* 4.2E-07 NA 6.1E-07 1.0E-06

Dibenz(a,h)anthracene (0-2)* 1.5E-06 NA 2.2E-06 3.8E-06 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (0-2)* 2.3E-07 NA 3.3E-07 5.6E-07

Indeno(1,2,3-c,d)pyrene (0-2)* 1.2E-06 NA 1.8E-06 3.0E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-3)* 1.8E-07 NA 2.6E-07 4.5E-07

Chromium (0-2)* 1.6E-06 NA 7.1E-06 8.7E-06 Not identified 3.7E-03 NA 1.7E-02 2.0E-02

Chromium (2-3)* 2.4E-07 NA 1.1E-06 1.3E-06

Chemical Total 4.2E-05 NA 6.7E-05 1.1E-04 3.7E-03 NA 1.7E-02 2.0E-02

Exposed Surface Sediment Total 1.1E-04 2.0E-02

Page 412: Appendix L HHRA Combined

TABLE 10.1.CTE

RISK SUMMARY

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Dry event) Benzo(a)anthracene (0-2)* 4.3E-09 NA 1.8E-06 1.8E-06 NA NA NA 0.0E+00

Benzo(a)anthracene (2-3)* 6.4E-10 NA 2.8E-07 2.8E-07

Benzo(a)pyrene (0-2)* 1.1E-07 NA 7.8E-05 7.8E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 1.6E-08 NA 1.2E-05 1.2E-05

Benzo(b)fluoranthene (0-2)* 4.8E-09 NA 3.6E-06 3.6E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-3)* 7.2E-10 NA 5.4E-07 5.4E-07

Indeno(1,2,3-c,d)pyrene (0-2)* 2.1E-09 NA 1.6E-06 1.6E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-3)* 3.2E-10 NA 2.4E-07 2.4E-07

Chromium (0-2)* 2.1E-07 NA 4.4E-06 4.6E-06 Not identified 4.9E-04 NA 1.0E-02 1.1E-02

Chromium (2-3)* 3.1E-08 NA 6.6E-07 6.9E-07

Chemical Total 3.7E-07 NA 1.0E-04 1.0E-04 4.9E-04 NA 1.0E-02 1.1E-02

Surface Water Total - Dry Event 1.0E-04 1.1E-02

Page 413: Appendix L HHRA Combined

TABLE 10.1.CTE

RISK SUMMARY

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Recreational

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface Water Surface Water Gowanus Canal

(Wet event) Benzo(a)anthracene (0-2)* 1.7E-09 NA 7.2E-07 7.2E-07 NA NA NA 0.0E+00

Benzo(a)anthracene (2-3)* 2.5E-10 NA 3.6E-07 3.6E-07

Benzo(a)pyrene (0-2)* 3.3E-08 NA 2.4E-05 2.4E-05 NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 4.9E-09 NA 3.4E-06 3.4E-06

Benzo(b)fluoranthene (0-2)* 3.0E-09 NA 2.3E-06 2.3E-06 NA NA NA 0.0E+00

Benzo(b)fluoranthene (2-3)* 4.6E-10 NA 2.8E-07 2.8E-07

Dibenz(a,h)anthracene (0-2)* 1.6E-08 NA 1.8E-05 1.8E-05 NA NA NA 0.0E+00

Dibenz(a,h)anthracene (0-2)* 2.4E-09 NA 9.0E-06 9.0E-06

Indeno(1,2,3-c,d)pyrene (0-2)* 8.0E-09 NA 6.0E-06 6.0E-06 NA NA NA 0.0E+00

Indeno(1,2,3-c,d)pyrene (2-3)* 1.2E-09 NA 2.0E-08 2.1E-08

Chromium (0-2)* 9.4E-08 NA 2.0E-06 2.1E-06 Not identified 2.2E-04 NA 4.6E-03 4.9E-03

Chromium (2-3)* 1.4E-08 NA 2.7E-08 4.1E-08

Chemical Total 1.8E-07 NA 6.7E-05 6.7E-05 2.2E-04 NA 4.6E-03 4.9E-03

Surface Water Total - Wet Event 6.7E-05 4.9E-03

Receptor Total 2.1E-04 Receptor HI Total 3.1E-02

HI - Hazard Index

Receptor Total and target organ totals includes sum of exposed and near shore sediment, and maximum of dry event and wet event surface water.

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3

used to adjust CSF for 2-3 year old for exposure duration of 1 year, for a total CTE exposure duration of 3 years. Non-cancer calculations shown under 0-2 year old only,

as non-cancer calculations are not adjusted for MMOA.

Page 414: Appendix L HHRA Combined

TABLE 10.2.CTE

RISK SUMMARY

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 4.1E-01 NA NA 4.1E-01

Chemical Total 0.0E+00 NA NA 0.0E+00 4.1E-01 NA NA 4.1E-01

Striped Bass in Gowanus Canal Total 0.0E+00 4.1E-01

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

Dioxin-Like PCB TEQ 1.6E-06 NA NA 1.6E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.1E+00 NA NA 1.1E+00

Chemical Total 1.6E-06 NA NA 1.6E-06 1.1E+00 NA NA 1.1E+00

Eel in Gowanus Canal Total 1.6E-06 1.1E+00

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Dioxin-Like PCB TEQ 7.7E-06 NA NA 7.7E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 1.4E-06 NA NA 1.4E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.9E+00 NA NA 1.9E+00

Arsenic 1.9E-06 NA NA 1.9E-06 Skin, Vascular 1.0E-01 NA NA 1.0E-01

Mercury NA NA NA 0.0E+00 Developmental Neurological 2.8E-01 NA NA 2.8E-01

Chemical Total 1.1E-05 NA NA 1.1E-05 2.3E+00 NA NA 2.3E+00

Crab in Gowanus Canal Total 1.1E-05 2.3E+00

Receptor Total - Fish 1.6E-06 Receptor HI Total - Fiish 1.5E+00

Receptor Total - Blue Crab 1.1E-05 Receptor HI Total - Blue Crab 2.3E+00

Page 415: Appendix L HHRA Combined

TABLE 10.2.CTE

RISK SUMMARY

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Adult

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Finger and Toe Nails HI Across All Media = 1.5E+00 Total Developmental HI Across All Media = 2.8E-01

Total Ocular HI Across All Media = 1.5E+00 Total Finger and Toe Nails HI Across All Media = 1.9E+00

Total Neurological HI Across All Media = 2.8E-01

Total Ocular HI Across All Media = 1.9E+00

Total Skin HI Across All Media = 1.0E-01

Total Vascular HI Across All Media = 1.0E-01

Page 416: Appendix L HHRA Combined

TABLE 10.3.CTE

RISK SUMMARY

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Striped Bass in

Gowanus Canal

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 6.4E-01 NA NA 6.4E-01

Chemical Total 0.0E+00 NA NA 0.0E+00 6.4E-01 NA NA 6.4E-01

Striped Bass in Gowanus Canal Total 0.0E+00 6.4E-01

Surface

Water/Sediment

Fish and Crab

TissueEel in Gowanus Canal

Dioxin-Like PCB TEQ 2.5E-06 NA NA 2.5E-06 NA NA NA NA 0.0E+00

Nondioxin-Like 1.4E-06 NA NA 1.4E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 1.8E+00 NA NA 1.8E+00

Chromium (0-2)* 2.5E-06 NA NA 2.5E-06 Not identified 5.8E-03 NA NA 5.8E-03

Chromium (2-3)* 3.8E-07 NA NA 3.8E-07

Chemical Total 6.7E-06 NA NA 6.7E-06 1.8E+00 NA NA 1.8E+00

Eel in Gowanus Canal Total 6.7E-06 1.8E+00

Page 417: Appendix L HHRA Combined

TABLE 10.3.CTE

RISK SUMMARY

CENTRAL TENDENCY EXPOSURE

Gowanus Canal Remedial Investigation, Brooklyn, New York

Scenario Timeframe: Current/Future

Receptor Population: Angler

Receptor Age: Child

Medium Exposure Exposure Chemical Carcinogenic Risk Non-Carcinogenic Hazard Quotient

Medium Point of Potential

Concern Ingestion Inhalation Dermal Exposure Primary Ingestion Inhalation Dermal Exposure

Routes Total Target Organ(s) Routes Total

Surface

Water/Sediment

Fish and Crab

Tissue

Blue Crab in Gowanus

Canal

Benzo(a)pyrene (0-2)* 8.7E-06 NA NA 8.7E-06 NA NA NA NA 0.0E+00

Benzo(a)pyrene (2-3)* 1.3E-06 NA NA 1.3E-06

Dibenz(a,h)anthracene (0-2)* 2.9E-06 NA NA 2.9E-06 NA NA NA NA 0.0E+00

Dibenz(a,h)anthracene (2-3)* 4.4E-07 NA NA 4.4E-07

Dioxin-Like PCB TEQ 1.2E-05 NA NA 1.2E-05 NA NA NA NA 0.0E+00

Nondioxin-Like 2.2E-06 NA NA 2.2E-06 NA NA NA NA 0.0E+00

Total PCB NA NA NA 0.0E+00 Ocular, Finger and Toe Nails 2.9E+00 NA NA 2.9E+00

Arsenic 3.0E-06 NA NA 3.0E-06 Skin, Vascular 1.5E-01 NA NA 1.5E-01

Mercury NA NA NA 0.0E+00 Developmental Neurological 4.4E-01 NA NA 4.4E-01

Chemical Total 3.0E-05 NA NA 3.0E-05 3.5E+00 NA NA 3.5E+00

Crab in Gowanus Canal Total 3.0E-05 3.5E+00

Receptor Total - Fish 6.7E-06 Receptor HI Total - Fiish 2.4E+00

Receptor Total - Blue Crab 3.0E-05 Receptor HI Total - Blue Crab 3.5E+00

Target organ totals for Fish Target organ totals for Blue Crab

HI - Hazard Index Total Finger and Toe Nails HI Across All Media = 2.4E+00 Total Developmental HI Across All Media = 4.4E-01

* Constituent acts via a mutagenic mode of action (MMOA). ADAF of 10 used Total Ocular HI Across All Media = 2.4E+00 Total Finger and Toe Nails HI Across All Media = 2.9E+00

to adjust CSF for 0-2 year old for exposure duration of 2 years, ADAF of 3 Total Neurological HI Across All Media = 4.4E-01

used to adjust CSF for 2-3 year old for exposure duration of 1 year, for a total Total Ocular HI Across All Media = 2.9E+00

CTE exposure duration of 3 years. Non-cancer calculations shown under Total Skin HI Across All Media = 1.5E-01

0-2 year old only, as non-cancer calculations are not adjusted for MMOA. Total Vascular HI Across All Media = 1.5E-01

Page 418: Appendix L HHRA Combined

Calculations of Preliminary Remediation Goals (PRGs)

Table 11.1

Calculations of Blood Lead Concentrations (PbBs), Recreational Adult, Exposed Sediment

U.S. EPA Technical Review Workgroup for Lead, Adult Lead Committee

Version date 6/21/09 EDIT RED CELLS

Variable Units

GSDi and PbBo from

Analysis of NHANES

1999-2004

GSDi and PbBo from

Analysis of NHANES

III (Phases 1&2)

PbS ug/g or ppm 660 660

Rfetal/maternal -- 0.9 0.9

BKSF ug/dL per

ug/day

0.4 0.4

GSDi -- 1.8 2.1

PbB0 ug/dL 1.0 1.5

IRS g/day 0.050 0.050

IRS+D g/day -- --

WS -- -- --

KSD -- -- --

AFS, D -- 0.12 0.12

EFS, D days/yr 26 26

ATS, D days/yr 365 365

PbBadult PbB of adult worker, geometric meanug/dL 1.1 1.6

PbBfetal, 0.95 95th percentile PbB among fetuses of adult workers ug/dL 2.6 4.9

PbBt Target PbB level of concern (e.g., 10 ug/dL) ug/dL 10.0 10.0

P(PbBfetal > PbBt) Probability that fetal PbB > PbBt, assuming lognormal distribution% 0.005% 0.5%

Baseline PbB

Description of Variable

Soil lead concentration

Fetal/maternal PbB ratio

Biokinetic Slope Factor

Geometric standard deviation PbB

Averaging time (same for soil and dust)

Soil ingestion rate (including soil-derived indoor dust)

Total ingestion rate of outdoor soil and indoor dust

Weighting factor; fraction of IRS+D ingested as outdoor soil

Mass fraction of soil in dust

Absorption fraction (same for soil and dust)

Exposure frequency (same for soil and dust)

Source: U.S. EPA (1996). Recommendations of the Technical Review Workgroup for Lead

for an Interim Approach to Assessing Risks Associated with Adult Exposures to Lead in Soil Printed 1/14/2011 12:50 AM

Page 419: Appendix L HHRA Combined

Table 11.2

Recreational Child, Exposed Sediment and Surface Water

LEAD MODEL FOR WINDOWS Version 1.1

==================================================================================

Model Version: 1.1 Build11

User Name: R. Warren

Date: 1/13/2011

Site Name: Gowanus Canal

Operable Unit:

Run Mode: Research

==================================================================================

****** Air ******

Indoor Air Pb Concentration: 30.000 percent of outdoor.

Other Air Parameters:

Age Time Ventilation Lung Outdoor Air

Outdoors Rate Absorption Pb Conc

(hours) (m³/day) (%) (µg Pb/m³)

----------------------------------------------------------------------

.5-1 1.000 2.000 32.000 0.100

1-2 2.000 3.000 32.000 0.100

2-3 3.000 5.000 32.000 0.100

3-4 4.000 5.000 32.000 0.100

4-5 4.000 5.000 32.000 0.100

5-6 4.000 7.000 32.000 0.100

6-7 4.000 7.000 32.000 0.100

****** Diet ******

Age Diet Intake(µg/day)

-----------------------------------

.5-1 2.260

1-2 1.960

2-3 2.130

3-4 2.040

4-5 1.950

5-6 2.050

6-7 2.220

****** Drinking Water ******

Water Consumption:

Page 420: Appendix L HHRA Combined

Table 11.2

Recreational Child, Exposed Sediment and Surface Water

LEAD MODEL FOR WINDOWS Version 1.1

Age Water (L/day)

-----------------------------------

.5-1 0.200

1-2 0.500

2-3 0.520

3-4 0.530

4-5 0.550

5-6 0.580

6-7 0.590

Drinking Water Concentration: 13.000 µg Pb/L

****** Soil & Dust ******

Multiple Source Analysis Used

Average multiple source concentration: 472.000 µg/g

Mass fraction of outdoor soil to indoor dust conversion factor: 0.700

Outdoor airborne lead to indoor household dust lead concentration: 100.000

Use alternate indoor dust Pb sources? No

Age Soil (µg Pb/g) House Dust (µg Pb/g)

--------------------------------------------------------

.5-1 660.000 472.000

1-2 660.000 472.000

2-3 660.000 472.000

3-4 660.000 472.000

4-5 660.000 472.000

5-6 660.000 472.000

6-7 660.000 472.000

****** Alternate Intake ******

Age Alternate (µg Pb/day)

-----------------------------------

.5-1 0.000

1-2 0.000

2-3 0.000

3-4 0.000

4-5 0.000

5-6 0.000

Page 421: Appendix L HHRA Combined

Table 11.2

Recreational Child, Exposed Sediment and Surface Water

LEAD MODEL FOR WINDOWS Version 1.1

6-7 0.000

****** Maternal Contribution: Infant Model ******

Maternal Blood Concentration: 1.000 µg Pb/dL

*****************************************

CALCULATED BLOOD LEAD AND LEAD UPTAKES:

*****************************************

Year Air Diet Alternate Water

(µg/day) (µg/day) (µg/day) (µg/day)

-------------------------------------------------------------------------------

.5-1 0.021 0.959 0.000 1.104

1-2 0.034 0.804 0.000 2.667

2-3 0.062 0.896 0.000 2.843

3-4 0.067 0.877 0.000 2.963

4-5 0.067 0.877 0.000 3.215

5-6 0.093 0.938 0.000 3.449

6-7 0.093 1.025 0.000 3.542

Year Soil+Dust Total Blood

(µg/day) (µg/day) (µg/dL)

---------------------------------------------------------------

.5-1 12.048 14.132 7.5

1-2 18.501 22.007 8.9

2-3 18.964 22.765 8.4

3-4 19.391 23.299 8.1

4-5 15.018 19.177 6.8

5-6 13.748 18.228 5.8

6-7 13.109 17.770 5.1

Page 422: Appendix L HHRA Combined

Calculations of Preliminary Remediation Goals (PRGs)

Table 11.2

Calculations of Blood Lead Concentrations (PbBs), Industrial Worker and Adult Resident, Overflow Sediment

U.S. EPA Technical Review Workgroup for Lead, Adult Lead Committee

Version date 6/21/09 EDIT RED CELLS

Variable Units

GSDi and PbBo from

Analysis of NHANES

1999-2004

GSDi and PbBo from

Analysis of NHANES

III (Phases 1&2)

PbS ug/g or ppm 533 533

Rfetal/maternal -- 0.9 0.9

BKSF ug/dL per

ug/day

0.4 0.4

GSDi -- 1.8 2.1

PbB0 ug/dL 1.0 1.5

IRS g/day 0.100 0.100

IRS+D g/day -- --

WS -- -- --

KSD -- -- --

AFS, D -- 0.12 0.12

EFS, D days/yr 9 9

ATS, D days/yr 365 365

PbBadult PbB of adult worker, geometric meanug/dL 1.1 1.6

PbBfetal, 0.95 95th percentile PbB among fetuses of adult workers ug/dL 2.5 4.8

PbBt Target PbB level of concern (e.g., 10 ug/dL) ug/dL 10.0 10.0

P(PbBfetal > PbBt) Probability that fetal PbB > PbBt, assuming lognormal distribution% 0.003% 0.4%

Baseline PbB

Biokinetic Slope Factor

Description of Variable

Geometric standard deviation PbB

Soil lead concentration

Fetal/maternal PbB ratio

Soil ingestion rate (including soil-derived indoor dust)

Total ingestion rate of outdoor soil and indoor dust

Averaging time (same for soil and dust)

Exposure frequency (same for soil and dust)

Absorption fraction (same for soil and dust)

Mass fraction of soil in dust

Weighting factor; fraction of IRS+D ingested as outdoor soil

Source: U.S. EPA (1996). Recommendations of the Technical Review Workgroup for Lead

for an Interim Approach to Assessing Risks Associated with Adult Exposures to Lead in Soil Printed 1/14/2011 12:50 AM

Page 423: Appendix L HHRA Combined

Table 11.4

Residential Child, Overflow Sediment and Surface Water

LEAD MODEL FOR WINDOWS Version 1.1

==================================================================================

Model Version: 1.1 Build11

User Name:

Date:

Site Name:

Operable Unit:

Run Mode: Research

==================================================================================

****** Air ******

Indoor Air Pb Concentration: 30.000 percent of outdoor.

Other Air Parameters:

Age Time Ventilation Lung Outdoor Air

Outdoors Rate Absorption Pb Conc

(hours) (m³/day) (%) (µg Pb/m³)

----------------------------------------------------------------------

.5-1 1.000 2.000 32.000 0.100

1-2 2.000 3.000 32.000 0.100

2-3 3.000 5.000 32.000 0.100

3-4 4.000 5.000 32.000 0.100

4-5 4.000 5.000 32.000 0.100

5-6 4.000 7.000 32.000 0.100

6-7 4.000 7.000 32.000 0.100

****** Diet ******

Age Diet Intake(µg/day)

-----------------------------------

.5-1 2.260

1-2 1.960

2-3 2.130

3-4 2.040

4-5 1.950

5-6 2.050

6-7 2.220

****** Drinking Water ******

Water Consumption:

Page 424: Appendix L HHRA Combined

Age Water (L/day)

-----------------------------------

.5-1 0.200

1-2 0.500

2-3 0.520

3-4 0.530

4-5 0.550

5-6 0.580

6-7 0.590

Drinking Water Concentration: 13.000 µg Pb/L

****** Soil & Dust ******

Multiple Source Analysis Used

Average multiple source concentration: 383.100 µg/g

Mass fraction of outdoor soil to indoor dust conversion factor: 0.700

Outdoor airborne lead to indoor household dust lead concentration: 100.000

Use alternate indoor dust Pb sources? No

Age Soil (µg Pb/g) House Dust (µg Pb/g)

--------------------------------------------------------

.5-1 533.000 383.100

1-2 533.000 383.100

2-3 533.000 383.100

3-4 533.000 383.100

4-5 533.000 383.100

5-6 533.000 383.100

6-7 533.000 383.100

****** Alternate Intake ******

Age Alternate (µg Pb/day)

-----------------------------------

.5-1 0.000

1-2 0.000

2-3 0.000

3-4 0.000

4-5 0.000

5-6 0.000

6-7 0.000

****** Maternal Contribution: Infant Model ******

Page 425: Appendix L HHRA Combined

Maternal Blood Concentration: 1.000 µg Pb/dL

*****************************************

CALCULATED BLOOD LEAD AND LEAD UPTAKES:

*****************************************

Year Air Diet Alternate Water

(µg/day) (µg/day) (µg/day) (µg/day)

-------------------------------------------------------------------------------

.5-1 0.021 0.982 0.000 1.130

1-2 0.034 0.827 0.000 2.743

2-3 0.062 0.918 0.000 2.914

3-4 0.067 0.897 0.000 3.028

4-5 0.067 0.890 0.000 3.263

5-6 0.093 0.949 0.000 3.491

6-7 0.093 1.036 0.000 3.580

Year Soil+Dust Total Blood

(µg/day) (µg/day) (µg/dL)

---------------------------------------------------------------

.5-1 9.989 12.123 6.5

1-2 15.398 19.002 7.7

2-3 15.732 19.626 7.3

3-4 16.041 20.033 6.9

4-5 12.338 16.558 5.8

5-6 11.265 15.798 5.0

6-7 10.725 15.435 4.4

Page 426: Appendix L HHRA Combined

==================================================================================

==================================================================================

Page 427: Appendix L HHRA Combined

0

25

50

75

100

Prob. Distribution (%)

0 4 8 12 16 20 24 28 32 36 40 44 48

Blood Pb Conc (µg/dL)

Age Range = 0 to 84 months

Run Mode = Research

Cutoff = 10.000 µg/dl

Geo Mean = 7.091

GSD = 1.600

% Above = 23.227

Page 428: Appendix L HHRA Combined

0

25

50

75

100

Prob. Distribution (%)

0 4 8 12 16 20 24 28 32 36 40 44 48

Blood Pb Conc (µg/dL)

Age Range = 0 to 84 months

Run Mode = Research

Cutoff = 10.000 µg/dl

Geo Mean = 6.137

GSD = 1.600

% Above = 14.947